Referencia Nombre DescripciónS1009G BEZ235 (NVP-BEZ235) 50mg BEZ235 (NVP-BEZ235)is a dual ATP-competS1009H BEZ235 (NVP-BEZ235) 100mg BEZ235 (NVP-BEZ235)is a dual ATP-competS1011C Afatinib (BIBW2992) 5mg BIBW2992 (Afatinib, Tomtovok, Tovok) irS1011D Afatinib (BIBW2992) 10mg BIBW2992 (Afatinib, Tomtovok, Tovok) irS1011G Afatinib (BIBW2992) 50mg BIBW2992 (Afatinib, Tomtovok, Tovok) irS1011I Afatinib (BIBW2992) 200mg BIBW2992 (Afatinib, Tomtovok, Tovok) irS1019D CI-1033 (Canertinib) 10mg CI-1033 is a potent inhibitor of EGFR and S1019F CI-1033 (Canertinib) 25mg CI-1033 is a potent inhibitor of EGFR and S1019G CI-1033 (Canertinib) 50mg CI-1033 is a potent inhibitor of EGFR and S1019I CI-1033 (Canertinib) 200mg CI-1033 is a potent inhibitor of EGFR and S1022C Deforolimus (Ridaforolimus) 5mg Deforolimus (Ridaforolimus, AP23573, MK-8S1022D Deforolimus (Ridaforolimus) 10mg Deforolimus (Ridaforolimus, AP23573, MK-8S1022G Deforolimus (Ridaforolimus) 50mg Deforolimus (Ridaforolimus, AP23573, MK-8S1022I Deforolimus (Ridaforolimus) 200mg Deforolimus (Ridaforolimus, AP23573, MK-8S1023H Erlotinib Hcl 100mg Erlotinib HCl(CP-358774, OSI-774, NSC 71S1023K Erlotinib Hcl 500mg Erlotinib HCl(CP-358774, OSI-774, NSC 71S1025H Gefitinib (Iressa) 100mg Gefitinib (Iressa, ZD-1839) is an EGFR iS1025J Gefitinib (Iressa) 250mg Gefitinib (Iressa, ZD-1839) is an EGFR iS1028F Lapatinib Ditosylate (Tykerb) 25mg Lapatinib Ditosylate (GW572016, GW2016, TS1028H Lapatinib Ditosylate (Tykerb) 100mg Lapatinib Ditosylate (GW572016, GW2016, TS1037C Perifosine 5mg Perifosine (KRX-0401) is a novel Akt inhibiS1037D Perifosine 10mg Perifosine (KRX-0401) is a novel Akt inhibiS1037G Perifosine 50mg Perifosine (KRX-0401) is a novel Akt inhibiS1037I Perifosine 200mg Perifosine (KRX-0401) is a novel Akt inhibiS1038C PI-103 5mg PI-103 is a potent, ATP-competitive PI3S1038D PI-103 10mg PI-103 is a potent, ATP-competitive PI3S1038F PI-103 25mg PI-103 is a potent, ATP-competitive PI3S1038G PI-103 50mg PI-103 is a potent, ATP-competitive PI3S1038H PI-103 100mg PI-103 is a potent, ATP-competitive PI3S1039C Rapamycin (Sirolimus) 5mg Rapamycin (Sirolimus, AY-22989, WY-09021S1039F Rapamycin (Sirolimus) 25mg Rapamycin (Sirolimus, AY-22989, WY-09021S1039H Rapamycin (Sirolimus) 100mg Rapamycin (Sirolimus, AY-22989, WY-09021S1044D Temsirolimus (Torisel) 10mg Temsirolimus (CCI-779, Torisel) is a speciS1044F Temsirolimus (Torisel) 25mg Temsirolimus (CCI-779, Torisel) is a speciS1044G Temsirolimus (Torisel) 50mg Temsirolimus (CCI-779, Torisel) is a speciS1044I Temsirolimus (Torisel) 200mg Temsirolimus (CCI-779, Torisel) is a speciS1056C BMS-599626 (AC480) 5mg BMS-599626 (AC480) is a selective and effS1056F BMS-599626 (AC480) 25mg BMS-599626 (AC480) is a selective and effS1056H BMS-599626 (AC480) 100mg BMS-599626 (AC480) is a selective and effS1065C GDC-0941 5mg GDC-0941 is a potent inhibitor of PI3KalS1065D GDC-0941 10mg GDC-0941 is a potent inhibitor of PI3KalS1065G GDC-0941 50mg GDC-0941 is a potent inhibitor of PI3KalS1065I GDC-0941 200mg GDC-0941 is a potent inhibitor of PI3KalS1072D ZSTK474 10mg ZSTK474 is a potent pan-class I PI3K inhibS1072G ZSTK474 50mg ZSTK474 is a potent pan-class I PI3K inhibS1075C SB 216763 5mg SB 216763 is a potent and selective GSK-3S1075D SB 216763 10mg SB 216763 is a potent and selective GSK-3S1075G SB 216763 50mg SB 216763 is a potent and selective GSK-3S1075H SB 216763 100mg SB 216763 is a potent and selective GSK-3S1078C MK-2206 2HCl 5mg MK-2206 2HCl is a highly selective inhibitS1078D MK-2206 2HCl 10mg MK-2206 2HCl is a highly selective inhibitS1078F MK-2206 2HCl 25mg MK-2206 2HCl is a highly selective inhibitS1078G MK-2206 2HCl 50mg MK-2206 2HCl is a highly selective inhibitS1079D PD153035 HCL 10mg PD153035 is a potent and specific inhibitoS1079G PD153035 HCL 50mg PD153035 is a potent and specific inhibitoS1079I PD153035 HCL 200mg PD153035 is a potent and specific inhibito

S1092C KU-55933 5mg KU-55933 is a potent and specific ATM inhiS1092D KU-55933 10mg KU-55933 is a potent and specific ATM inhiS1092G KU-55933 50mg KU-55933 is a potent and specific ATM inhiS1105D LY294002 10mg LY294002 is a PI3K inhibitor for p110alphS1105F LY294002 25mg LY294002 is a PI3K inhibitor for p110alphS1105I LY294002 200mg LY294002 is a PI3K inhibitor for p110alphS1106C OSU-03012 5mg OSU-03012 is a potent inhibitor of recombS1106F OSU-03012 25mg OSU-03012 is a potent inhibitor of recombS1106H OSU-03012 100mg OSU-03012 is a potent inhibitor of recombS1113D GSK690693 10mg GSK690693 is a pan-Akt inhibitor targetingS1113G GSK690693 50mg GSK690693 is a pan-Akt inhibitor targetingS1113I GSK690693 200mg GSK690693 is a pan-Akt inhibitor targetingS1117C Triciribine 5mg Triciribine (TCN, API-2) is a DNA synthesisS1117D Triciribine 10mg Triciribine (TCN, API-2) is a DNA synthesisS1117G Triciribine 50mg Triciribine (TCN, API-2) is a DNA synthesisS1117I Triciribine 200mg Triciribine (TCN, API-2) is a DNA synthesisS1118D XL147 10mg XL147 (SAR245408) is a selective and reverS1118G XL147 50mg XL147 (SAR245408) is a selective and reverS1118H XL147 100mg XL147 (SAR245408) is a selective and reverS1118I XL147 200mg XL147 (SAR245408) is a selective and reverS1120D Everolimus (RAD001) 10mg Everolimus (RAD001) is an mTOR inhibitorS1120F Everolimus (RAD001) 25mg Everolimus (RAD001) is an mTOR inhibitorS1120H Everolimus (RAD001) 100mg Everolimus (RAD001) is an mTOR inhibitorS1134B AT9283 2mg AT9283 is a potent pan-Aurora inhibitor fS1134C AT9283 5mg AT9283 is a potent pan-Aurora inhibitor fS1134D AT9283 10mg AT9283 is a potent pan-Aurora inhibitor fS1134G AT9283 50mg AT9283 is a potent pan-Aurora inhibitor fS1134H AT9283 100mg AT9283 is a potent pan-Aurora inhibitor fS1143D AG-490 10mg AG-490 (Tyrphostin B42) is an inhibitor oS1143F AG-490 25mg AG-490 (Tyrphostin B42) is an inhibitor oS1155C NSC 74859 (S3I-201) 5mg S3I-201 (NSC 74859) is a Stat3 inhibitor wS1155D NSC 74859 (S3I-201) 10mg S3I-201 (NSC 74859) is a Stat3 inhibitor wS1155G NSC 74859 (S3I-201) 50mg S3I-201 (NSC 74859) is a Stat3 inhibitor wS1167C CP-724714 5mg CP-724,714 is a potent, selective inhibitorS1167D CP-724714 10mg CP-724,714 is a potent, selective inhibitorS1167F CP-724714 25mg CP-724,714 is a potent, selective inhibitorS1167G CP-724714 50mg CP-724,714 is a potent, selective inhibitorS1169C TGX-221 5mg TGX-221 is a potent, selective PI3K inhibiS1169F TGX-221 25mg TGX-221 is a potent, selective PI3K inhibiS1169H TGX-221 100mg TGX-221 is a potent, selective PI3K inhibiS1170C WZ3146 5mg WZ3146 is a mutant-selective irreversiblS1170D WZ3146 10mg WZ3146 is a mutant-selective irreversiblS1170G WZ3146 50mg WZ3146 is a mutant-selective irreversiblS1170I WZ3146 200mg WZ3146 is a mutant-selective irreversiblS1173D WZ4002 10mg WZ4002 is a novel, mutant-selective EGFS1173G WZ4002 50mg WZ4002 is a novel, mutant-selective EGFS1173H WZ4002 100mg WZ4002 is a novel, mutant-selective EGFS1173I WZ4002 200mg WZ4002 is a novel, mutant-selective EGFS1179C WZ8040 5mg WZ8040 is a novel mutant-selective irreveS1179D WZ8040 10mg WZ8040 is a novel mutant-selective irreveS1179G WZ8040 50mg WZ8040 is a novel mutant-selective irreveS1179I WZ8040 200mg WZ8040 is a novel mutant-selective irreveS1187C PIK-90 5mg PIK-90 is a potent and cell permeable inS1187D PIK-90 10mg PIK-90 is a potent and cell permeable inS1187G PIK-90 50mg PIK-90 is a potent and cell permeable inS1194D CUDC-101 10mg CUDC-101 is a potent multi-target inhibitS1194G CUDC-101 50mg CUDC-101 is a potent multi-target inhibit

S1194J CUDC-101 200mg CUDC-101 is a potent multi-target inhibitS1205D PIK-75 10mg PIK-75 is a selective and competitive inhiS1205F PIK-75 25mg PIK-75 is a selective and competitive inhiS1205H PIK-75 100mg PIK-75 is a selective and competitive inhiS1219C YM201636 5mg YM201636 is a selective PIKfyve inhibitor S1219D YM201636 10mg YM201636 is a selective PIKfyve inhibitor S1219F YM201636 25mg YM201636 is a selective PIKfyve inhibitor S1219G YM201636 50mg YM201636 is a selective PIKfyve inhibitor S1226C Ku-0063794 5mg KU-0063794 is a potent and highly speciS1226D Ku-0063794 10mg KU-0063794 is a potent and highly speciS1226G Ku-0063794 50mg KU-0063794 is a potent and highly speciS1226H Ku-0063794 100mg KU-0063794 is a potent and highly speciS1266C WYE-354 5mg WYE-354 is a potent, specific and ATP-comS1266D WYE-354 10mg WYE-354 is a potent, specific and ATP-comS1266G WYE-354 50mg WYE-354 is a potent, specific and ATP-comS1268C IC-87114 5mg IC-87114 is a selective inhibitor of PI3KdeS1268D IC-87114 10mg IC-87114 is a selective inhibitor of PI3KdeS1268G IC-87114 50mg IC-87114 is a selective inhibitor of PI3KdeS1274D BX-795 10mg BX795 is a potent and specific TBK1 and IKS1274F BX-795 25mg BX795 is a potent and specific TBK1 and IKS1274G BX-795 50mg BX795 is a potent and specific TBK1 and IKS1274H BX-795 100mg BX795 is a potent and specific TBK1 and IKS1275B BX-912 2mg BX912 is a selective potent PDK1 inhibitorS1275C BX-912 5mg BX912 is a selective potent PDK1 inhibitorS1275G BX-912 50mg BX912 is a selective potent PDK1 inhibitorS1275H BX-912 100mg BX912 is a selective potent PDK1 inhibitorS1352C TG100-115 5mg TG100-115 is a potent and dual selective S1352D TG100-115 10mg TG100-115 is a potent and dual selective S1352G TG100-115 50mg TG100-115 is a potent and dual selective S1352H TG100-115 100mg TG100-115 is a potent and dual selective S1378C Ruxolitinib (INCB018424) 5mg INCB018424 (Ruxolitinib) is a JAK family S1378D Ruxolitinib (INCB018424) 10mg INCB018424 (Ruxolitinib) is a JAK family S1378F Ruxolitinib (INCB018424) 25mg INCB018424 (Ruxolitinib) is a JAK family S1378H Ruxolitinib (INCB018424) 100mg INCB018424 (Ruxolitinib) is a JAK family S1392C Pelitinib (EKB-569) 5mg Pelitinib (EKB-569) is a potent EGFR inhibS1392F Pelitinib (EKB-569) 25mg Pelitinib (EKB-569) is a potent EGFR inhibS1392H Pelitinib (EKB-569) 100mg Pelitinib (EKB-569) is a potent EGFR inhibS1410C AS-605240 5mg AS-605240 is a novel, potent and selectivS1410D AS-605240 10mg AS-605240 is a novel, potent and selectivS1410G AS-605240 50mg AS-605240 is a novel, potent and selectivS1410H AS-605240 100mg AS-605240 is a novel, potent and selectivS1462C AZD6482 5mg AZD6482 is an inhibitor of PI3Kbeta with S1462D AZD6482 10mg AZD6482 is an inhibitor of PI3Kbeta with S1462G AZD6482 50mg AZD6482 is an inhibitor of PI3Kbeta with S1486C AEE788 (NVP-AEE788) 5mg AEE788 is a potent dual inhibitor of EGFRS1486D AEE788 (NVP-AEE788) 10mg AEE788 is a potent dual inhibitor of EGFRS1486F AEE788 (NVP-AEE788) 25mg AEE788 is a potent dual inhibitor of EGFRS1486G AEE788 (NVP-AEE788) 50mg AEE788 is a potent dual inhibitor of EGFRS1489C PIK-93 5mg PIK-93 is a novel and potent inhibitor ofS1489F PIK-93 25mg PIK-93 is a novel and potent inhibitor ofS1489H PIK-93 100mg PIK-93 is a novel and potent inhibitor ofS1491D Fludarabine (Fludara) 10mg Fludarabine (Fludara, F-ara-A, NSC 118218)S1491G Fludarabine (Fludara) 50mg Fludarabine (Fludara, F-ara-A, NSC 118218)S1491H Fludarabine (Fludara) 100mg Fludarabine (Fludara, F-ara-A, NSC 118218)S1523C XL765 5mg XL765 is a dual inhibitor of mTOR/PI3k fS1523D XL765 10mg XL765 is a dual inhibitor of mTOR/PI3k fS1523G XL765 50mg XL765 is a dual inhibitor of mTOR/PI3k f

S1523I XL765 200mg XL765 is a dual inhibitor of mTOR/PI3k fS1555D AZD8055 10mg AZD8055 is a novel ATP-competitive inhibiS1555G AZD8055 50mg AZD8055 is a novel ATP-competitive inhibiS1556D PHT-427 10mg PHT-427 is a dual Akt and PDPK1 inhibitorS1556G PHT-427 50mg PHT-427 is a dual Akt and PDPK1 inhibitorS1556I PHT-427 200mg PHT-427 is a dual Akt and PDPK1 inhibitorS1558D AT7867 10mg AT7867 is a potent ATP-competitive inhibitS1558G AT7867 50mg AT7867 is a potent ATP-competitive inhibitS1558I AT7867 200mg AT7867 is a potent ATP-competitive inhibitS1570D KU-60019 10mg KU-60019 is a potent and specific ATM inhiS1570G KU-60019 50mg KU-60019 is a potent and specific ATM inhiS1570I KU-60019 200mg KU-60019 is a potent and specific ATM inhiS1590D TWS119 10mg TWS119 is a GSK-3beta inhibitor with IC5S1590F TWS119 25mg TWS119 is a GSK-3beta inhibitor with IC5S1590G TWS119 50mg TWS119 is a GSK-3beta inhibitor with IC5S1802G Acadesine 50mg Acadesine is an AMP-activated protein kinaS1802I Acadesine 200mg Acadesine is an AMP-activated protein kinaS2111F Lapatinib 25mg Lapatinib, used in the form of Lapatinib DiS2111H Lapatinib 100mg Lapatinib, used in the form of Lapatinib DiS2150C Neratinib (HKI-272) 5mg Neratinib (HKI-272) is a highly selective S2150F Neratinib (HKI-272) 25mg Neratinib (HKI-272) is a highly selective S2150H Neratinib (HKI-272) 100mg Neratinib (HKI-272) is a highly selective S2162C AZD1480 5mg AZD1480 is a novel ATP-competitive inhibiS2162D AZD1480 10mg AZD1480 is a novel ATP-competitive inhibiS2162G AZD1480 50mg AZD1480 is a novel ATP-competitive inhibiS2162I AZD1480 200mg AZD1480 is a novel ATP-competitive inhibiS2179C LY2784544 5mg LY2784544 is selective to V617F mutant JAS2179D LY2784544 10mg LY2784544 is selective to V617F mutant JAS2179G LY2784544 50mg LY2784544 is selective to V617F mutant JAS2179I LY2784544 200mg LY2784544 is selective to V617F mutant JAS2185C AST-1306 5mg AST-1306 is a novel irreversible inhibitorS2185D AST-1306 10mg AST-1306 is a novel irreversible inhibitorS2185G AST-1306 50mg AST-1306 is a novel irreversible inhibitorS2185I AST-1306 200mg AST-1306 is a novel irreversible inhibitorS2192C AZD8931 5mg AZD8931 is a reversible, ATP competitive S2192D AZD8931 10mg AZD8931 is a reversible, ATP competitive S2192G AZD8931 50mg AZD8931 is a reversible, ATP competitive S2192I AZD8931 200mg AZD8931 is a reversible, ATP competitive S2198C SGI-1776 free base 5mg SGI-1776 is a novel ATP competitive inhibS2198D SGI-1776 free base 10mg SGI-1776 is a novel ATP competitive inhibS2198G SGI-1776 free base 50mg SGI-1776 is a novel ATP competitive inhibS2205C OSI-420 5mg OSI-420 (Desmethyl Erlotinib, CP-473420) iS2205D OSI-420 10mg OSI-420 (Desmethyl Erlotinib, CP-473420) iS2205G OSI-420 50mg OSI-420 (Desmethyl Erlotinib, CP-473420) iS2205I OSI-420 200mg OSI-420 (Desmethyl Erlotinib, CP-473420) iS2207C PIK-293 5mg PIK-293 is a PI3-K inhibitor for p110alpS2207D PIK-293 10mg PIK-293 is a PI3-K inhibitor for p110alpS2207G PIK-293 50mg PIK-293 is a PI3-K inhibitor for p110alpS2207I PIK-293 200mg PIK-293 is a PI3-K inhibitor for p110alpS2214B AZ 960 2mg AZ 960 is a novel ATP competitive JAK2 inS2214C AZ 960 5mg AZ 960 is a novel ATP competitive JAK2 inS2214D AZ 960 10mg AZ 960 is a novel ATP competitive JAK2 inS2214G AZ 960 50mg AZ 960 is a novel ATP competitive JAK2 inS2218C PP242 5mg PP242 is a selective mTOR inhibitor with S2218D PP242 10mg PP242 is a selective mTOR inhibitor with S2218G PP242 50mg PP242 is a selective mTOR inhibitor with S2219D Cyt387 10mg CYT387 is an ATP-competitive inhibitor o

S2219G Cyt387 50mg CYT387 is an ATP-competitive inhibitor oS2219I Cyt387 200mg CYT387 is an ATP-competitive inhibitor oS2226D CAL-101 (GS-1101) 10mg CAL-101 is a selective PI3K class I inhibitS2226G CAL-101 (GS-1101) 50mg CAL-101 is a selective PI3K class I inhibitS2226I CAL-101 (GS-1101) 200mg CAL-101 is a selective PI3K class I inhibitS2227C PIK-294 5mg PIK-294 is a highly potent and selective p1S2227D PIK-294 10mg PIK-294 is a highly potent and selective p1S2227G PIK-294 50mg PIK-294 is a highly potent and selective p1S2227I PIK-294 200mg PIK-294 is a highly potent and selective p1S2238D Palomid 529 10mg Palomid 529 (P529) is a PI3K/Akt/mTOR inS2238G Palomid 529 50mg Palomid 529 (P529) is a PI3K/Akt/mTOR inS2238I Palomid 529 200mg Palomid 529 (P529) is a PI3K/Akt/mTOR inS2245B CP-466722 2mg CP-466722 is an potent and reversible ATMS2245C CP-466722 5mg CP-466722 is an potent and reversible ATMS2245F CP-466722 25mg CP-466722 is an potent and reversible ATMS2310D Honokiol 10mg Honokiol is a biphenolic compound present S2310F Honokiol 25mg Honokiol is a biphenolic compound present S2310G Honokiol 50mg Honokiol is a biphenolic compound present S2310H Honokiol 100mg Honokiol is a biphenolic compound present S2542K Phenformin Hcl 500mg Phenformin hydrochloride is a hydrochloriS2622D PP-121 10mg PP-121 is a multi-target inhibitor of PDS2622G PP-121 50mg PP-121 is a multi-target inhibitor of PDS2622I PP-121 200mg PP-121 is a multi-target inhibitor of PDS2624C OSI-027 5mg OSI-027 is a selective and potent dual iS2624D OSI-027 10mg OSI-027 is a selective and potent dual iS2624G OSI-027 50mg OSI-027 is a selective and potent dual iS2628C PF-05212384 (PKI-587) 5mg PKI-587 is a highly potent dual inhibitorS2628D PF-05212384 (PKI-587) 10mg PKI-587 is a highly potent dual inhibitorS2628G PF-05212384 (PKI-587) 50mg PKI-587 is a highly potent dual inhibitorS2628I PF-05212384 (PKI-587) 200mg PKI-587 is a highly potent dual inhibitorS2635C CCT128930 5mg CCT128930 is a potent, ATP-competitive andS2635D CCT128930 10mg CCT128930 is a potent, ATP-competitive andS2635G CCT128930 50mg CCT128930 is a potent, ATP-competitive andS2635I CCT128930 200mg CCT128930 is a potent, ATP-competitive andS2636C A66 5mg A66 is a potent and specific p110alpha inhS2636D A66 10mg A66 is a potent and specific p110alpha inhS2636G A66 50mg A66 is a potent and specific p110alpha inhS2636I A66 200mg A66 is a potent and specific p110alpha inhS2638C NU7441 (KU-57788) 5mg NU7441 is a highly potent and selective DS2638D NU7441 (KU-57788) 10mg NU7441 is a highly potent and selective DS2638G NU7441 (KU-57788) 50mg NU7441 is a highly potent and selective DS2638I NU7441 (KU-57788) 200mg NU7441 is a highly potent and selective DS2661C WYE-125132 5mg WYE-125132 is a highly potent, ATP-competS2661D WYE-125132 10mg WYE-125132 is a highly potent, ATP-competS2661G WYE-125132 50mg WYE-125132 is a highly potent, ATP-competS2661I WYE-125132 200mg WYE-125132 is a highly potent, ATP-competS2668C WYE-687 5mg WYE-687 is an ATP-competitive and selectiS2668D WYE-687 10mg WYE-687 is an ATP-competitive and selectiS2668G WYE-687 50mg WYE-687 is an ATP-competitive and selectiS2668I WYE-687 200mg WYE-687 is an ATP-competitive and selectiS2670B A-674563 2mg A-674563 shows Akt1 inhibitory effect withS2670C A-674563 5mg A-674563 shows Akt1 inhibitory effect withS2670D A-674563 10mg A-674563 shows Akt1 inhibitory effect withS2670G A-674563 50mg A-674563 shows Akt1 inhibitory effect withS2670H A-674563 100mg A-674563 shows Akt1 inhibitory effect withS2671B AS-252424 2mg AS-252424 is a novel, potent and selectivS2671C AS-252424 5mg AS-252424 is a novel, potent and selectiv

S2671F AS-252424 25mg AS-252424 is a novel, potent and selectivS2671H AS-252424 100mg AS-252424 is a novel, potent and selectivS2681B AS-604850 2mg Description AS-604850 is a selective, ATPS2681C AS-604850 5mg Description AS-604850 is a selective, ATPS2681F AS-604850 25mg Description AS-604850 is a selective, ATPS2681H AS-604850 100mg Description AS-604850 is a selective, ATPS2682D CAY10505 10mg CAY10505 is a PI3Kgamma inhibitor with S2682F CAY10505 25mg CAY10505 is a PI3Kgamma inhibitor with S2682G CAY10505 50mg CAY10505 is a PI3Kgamma inhibitor with S2682I CAY10505 200mg CAY10505 is a PI3Kgamma inhibitor with S2686C NVP-BSK805 5mg NVP-BSK805 is a potent and selective ATP-S2686D NVP-BSK805 10mg NVP-BSK805 is a potent and selective ATP-S2686G NVP-BSK805 50mg NVP-BSK805 is a potent and selective ATP-S2686I NVP-BSK805 200mg NVP-BSK805 is a potent and selective ATP-S2689C WAY-600 5mg WAY-600 is a potent, ATP-competitive and S2689D WAY-600 10mg WAY-600 is a potent, ATP-competitive and S2689G WAY-600 50mg WAY-600 is a potent, ATP-competitive and S2689I WAY-600 200mg WAY-600 is a potent, ATP-competitive and S2692C TG101209 5mg TG101209 is a potent inhibitor of JAK2, FS2692D TG101209 10mg TG101209 is a potent inhibitor of JAK2, FS2692G TG101209 50mg TG101209 is a potent inhibitor of JAK2, FS2692I TG101209 200mg TG101209 is a potent inhibitor of JAK2, FS2696C GDC-0980 (RG7422) 5mg GDC-0980 (RG7422) is a potent, selective S2696D GDC-0980 (RG7422) 10mg GDC-0980 (RG7422) is a potent, selective S2696G GDC-0980 (RG7422) 50mg GDC-0980 (RG7422) is a potent, selective S2696I GDC-0980 (RG7422) 200mg GDC-0980 (RG7422) is a potent, selective S2697C A-769662 5mg A-769662 is a potent, reversible AMPK actiS2697D A-769662 10mg A-769662 is a potent, reversible AMPK actiS2697G A-769662 50mg A-769662 is a potent, reversible AMPK actiS2697I A-769662 200mg A-769662 is a potent, reversible AMPK actiS2699 CH5132799 CH5132799 exhibits a strong inhibitory actS2727C Dacomitinib (PF299804,PF-00299804) 5mPF299804 is a potent, irreversible pan-ErS2727D Dacomitinib (PF299804,PF-00299804) 10 PF299804 is a potent, irreversible pan-ErS2727G Dacomitinib (PF299804,PF-00299804) 50 PF299804 is a potent, irreversible pan-ErS2727I Dacomitinib (PF299804,PF-00299804) 20 PF299804 is a potent, irreversible pan-ErS2728C AG-1478 (Tyrphostin AG-1478) 5mg AG-1478 (Tyrphostin AG-1478) is a selectiS2728D AG-1478 (Tyrphostin AG-1478) 10mg AG-1478 (Tyrphostin AG-1478) is a selectiS2728F AG-1478 (Tyrphostin AG-1478) 25mg AG-1478 (Tyrphostin AG-1478) is a selectiS2728G AG-1478 (Tyrphostin AG-1478) 50mg AG-1478 (Tyrphostin AG-1478) is a selectiS2729D SB 415286 10mg SB 415286 is a potent GSK3alpha and GSK3S2729G SB 415286 50mg SB 415286 is a potent GSK3alpha and GSK3S2736C TG101348 (SAR302503) 5mg TG-101348 (SAR302503) is a selective inhiS2736D TG101348 (SAR302503) 10mg TG-101348 (SAR302503) is a selective inhiS2736F TG101348 (SAR302503) 25mg TG-101348 (SAR302503) is a selective inhiS2736G TG101348 (SAR302503) 50mg TG-101348 (SAR302503) is a selective inhiS2739C PKI-402 5mg PKI-402 is a potent dual PI3K/mTOR inhibS2739D PKI-402 10mg PKI-402 is a potent dual PI3K/mTOR inhibS2739G PKI-402 50mg PKI-402 is a potent dual PI3K/mTOR inhibS2739I PKI-402 200mg PKI-402 is a potent dual PI3K/mTOR inhibS2743C PF-04691502 5mg PF-04691502 is an ATP-competitive PI3K/mS2743D PF-04691502 10mg PF-04691502 is an ATP-competitive PI3K/mS2743G PF-04691502 50mg PF-04691502 is an ATP-competitive PI3K/mS2743I PF-04691502 200mg PF-04691502 is an ATP-competitive PI3K/mS2745C CHIR-98014 5mg CHIR-98014 is a potent and selective GSK-S2745F CHIR-98014 25mg CHIR-98014 is a potent and selective GSK-S2749C NVP-BGT226 5mg NVP-BGT226 is a novel dual PI3K/mTOR inhS2749D NVP-BGT226 10mg NVP-BGT226 is a novel dual PI3K/mTOR inh

S2749G NVP-BGT226 50mg NVP-BGT226 is a novel dual PI3K/mTOR inhS2749I NVP-BGT226 200mg NVP-BGT226 is a novel dual PI3K/mTOR inhS2752C Arry-380 5mg ARRY-380 is a potent and selective HER2 iS2752D Arry-380 10mg ARRY-380 is a potent and selective HER2 iS2752G Arry-380 50mg ARRY-380 is a potent and selective HER2 iS2752I Arry-380 200mg ARRY-380 is a potent and selective HER2 iS2755C ARRY334543 5mg ARRY334543 is a selective and potent ErbBS2755D ARRY334543 10mg ARRY334543 is a selective and potent ErbBS2755G ARRY334543 50mg ARRY334543 is a selective and potent ErbBS2755I ARRY334543 200mg ARRY334543 is a selective and potent ErbBS2758C Wortmannin 5mg Wortmannin is a multi-target inhibitor of S2758D Wortmannin 10mg Wortmannin is a multi-target inhibitor of S2758E Wortmannin 20mg Wortmannin is a multi-target inhibitor of S2759C PI3K_HDAC InhibitorI 5mg PI3K/HDAC Inhibitor I is a dual PI3K andS2759D PI3K_HDAC InhibitorI 10mg PI3K/HDAC Inhibitor I is a dual PI3K andS2759G PI3K_HDAC InhibitorI 50mg PI3K/HDAC Inhibitor I is a dual PI3K andS2759I PI3K_HDAC InhibitorI 200mg PI3K/HDAC Inhibitor I is a dual PI3K andS2767G 3-Methyladenine 50mg 3-Methyladenine (3-MA) is a selective PI3S2767K 3-Methyladenine 500mg 3-Methyladenine (3-MA) is a selective PI3S2783C AZD2014 5mg AZD2014 is a novel dual mTORC1 and mTORC2S2783D AZD2014 10mg AZD2014 is a novel dual mTORC1 and mTORC2S2783H AZD2014 100mg AZD2014 is a novel dual mTORC1 and mTORC2S2783I AZD2014 200mg AZD2014 is a novel dual mTORC1 and mTORC2S2784C TAK-285 5mg TAK-285 is a novel dual HER2 and EGFR inS2784D TAK-285 10mg TAK-285 is a novel dual HER2 and EGFR inS2784G TAK-285 50mg TAK-285 is a novel dual HER2 and EGFR inS2784H TAK-285 100mg TAK-285 is a novel dual HER2 and EGFR inS2789C Tofacitinib (CP-690550, Tasocitinib) 5mg CP-690550 is a novel inhibitor of JAK3 witS2789D Tofacitinib (CP-690550, Tasocitinib) 10mgCP-690550 is a novel inhibitor of JAK3 witS2789G Tofacitinib (CP-690550, Tasocitinib) 50mgCP-690550 is a novel inhibitor of JAK3 witS2789H Tofacitinib (CP-690550, Tasocitinib) 100mCP-690550 is a novel inhibitor of JAK3 witS2796D WP1066 10mg WP1066 is a novel inhibitor of JAK2 and SS2796F WP1066 25mg WP1066 is a novel inhibitor of JAK2 and SS2806C CEP33779 5mg CEP33779 is a selective JAK2 inhibitor witS2806D CEP33779 10mg CEP33779 is a selective JAK2 inhibitor witS2806G CEP33779 50mg CEP33779 is a selective JAK2 inhibitor witS2806H CEP33779 100mg CEP33779 is a selective JAK2 inhibitor witS2808C GDC-0068 5mg GDC-0068 is a highly selective pan-Akt inhS2808D GDC-0068 10mg GDC-0068 is a highly selective pan-Akt inhS2808G GDC-0068 50mg GDC-0068 is a highly selective pan-Akt inhS2808H GDC-0068 100mg GDC-0068 is a highly selective pan-Akt inhS2811C INK 128 5mg INK 128 is a potent and selective mTOR inhS2811D INK 128 10mg INK 128 is a potent and selective mTOR inhS2811G INK 128 50mg INK 128 is a potent and selective mTOR inhS2811H INK 128 100mg INK 128 is a potent and selective mTOR inhS2814C BYL719 5mg BYL719 strongly and selectively inhibits tS2814D BYL719 10mg BYL719 strongly and selectively inhibits tS2814E BYL719 20mg BYL719 strongly and selectively inhibits tS2814G BYL719 50mg BYL719 strongly and selectively inhibits tS2814H BYL719 100mg BYL719 strongly and selectively inhibits tS2814I BYL719 200mg BYL719 strongly and selectively inhibits tS2823G Tideglusib 50mg Tideglusib (NP031112, NP-12) is a potent S2823I Tideglusib 200mg Tideglusib (NP031112, NP-12) is a potent S2826F Desmethyl Erlotinib (CP-473420) 25mg Desmethyl Erlotinib (CP-473420) is a free S2826J Desmethyl Erlotinib (CP-473420) 250mg Desmethyl Erlotinib (CP-473420) is a free S2827D Torin 1 10mg Torin1 is a potent inhibitor of mTOR with S2827F Torin 1 25mg Torin1 is a potent inhibitor of mTOR with

S2827G Torin 1 50mg Torin1 is a potent inhibitor of mTOR with S3030I Niclosamide (Niclocide) 200mg Niclosamide can inhibit DNA replication anS5001D Tofacitinib citrate (CP-690550 citrate) 10 Tofacitinib citrate (CP-690550) is a potentS5001G Tofacitinib citrate (CP-690550 citrate) 50 Tofacitinib citrate (CP-690550) is a potentS2220D SB590885 10mg SB590885 is a potent B-Raf inhibitor with S2220G SB590885 50mg SB590885 is a potent B-Raf inhibitor with S2220I SB590885 200mg SB590885 is a potent B-Raf inhibitor with S1369 Bafetinib (INNO-406) Bafetinib (INNO-406) is a potent and selectS1090C PCI-24781 5mg PCI-24781 (CRA-024781) is a novel broaS1090D PCI-24781 10mg PCI-24781 (CRA-024781) is a novel broaS1090E PCI-24781 20mg PCI-24781 (CRA-024781) is a novel broaS1090I PCI-24781 200mg PCI-24781 (CRA-024781) is a novel broaS1095D LAQ824 (NVP-LAQ824, Dacinostat) 10mgLAQ824 (NVP-LAQ824) is a novel HDAC inhS1095G LAQ824 (NVP-LAQ824, Dacinostat) 50mgLAQ824 (NVP-LAQ824) is a novel HDAC inhS1095I LAQ824 (NVP-LAQ824, Dacinostat) 200mLAQ824 (NVP-LAQ824) is a novel HDAC inhS1096C JNJ-26481585 5mg JNJ-26481585 (Quisinostat) is an HDAC iS1096D JNJ-26481585 10mg JNJ-26481585 (Quisinostat) is an HDAC iS1096G JNJ-26481585 50mg JNJ-26481585 (Quisinostat) is an HDAC iS1096I JNJ-26481585 200mg JNJ-26481585 (Quisinostat) is an HDAC iS1168I Valproic acid sodium salt (Sodium valpro Valproic acid sodium salt (Sodium valproatS1422C Droxinostat 5mg Droxinostat (CMH, 5809354) is a selectivS1422D Droxinostat 10mg Droxinostat (CMH, 5809354) is a selectivS1422F Droxinostat 25mg Droxinostat (CMH, 5809354) is a selectivS1515C SB939 (Pracinostat) 5mg SB939 is a potent HDAC inhibitor with IC5S1515D SB939 (Pracinostat) 10mg SB939 is a potent HDAC inhibitor with IC5S1515G SB939 (Pracinostat) 50mg SB939 is a potent HDAC inhibitor with IC5S2170C ITF2357 (Givinostat) 5mg ITF2357 (Givinostat) is a potent inhibitorS2170D ITF2357 (Givinostat) 10mg ITF2357 (Givinostat) is a potent inhibitorS2170G ITF2357 (Givinostat) 50mg ITF2357 (Givinostat) is a potent inhibitorS2170I ITF2357 (Givinostat) 200mg ITF2357 (Givinostat) is a potent inhibitorS2244B AR-42 (HDAC-42) 2mg AR-42 (HDAC-42, OSU-HDAC42) is a pan-HS2244C AR-42 (HDAC-42) 5mg AR-42 (HDAC-42, OSU-HDAC42) is a pan-HS2244D AR-42 (HDAC-42) 10mg AR-42 (HDAC-42, OSU-HDAC42) is a pan-HS2244G AR-42 (HDAC-42) 50mg AR-42 (HDAC-42, OSU-HDAC42) is a pan-HS2627D Tubastatin A Hcl 10mg Tubastatin A is a potent HDAC6 inhibitor wS2627G Tubastatin A Hcl 50mg Tubastatin A is a potent HDAC6 inhibitor wS2627H Tubastatin A Hcl 100mg Tubastatin A is a potent HDAC6 inhibitor wS2627I Tubastatin A Hcl 200mg Tubastatin A is a potent HDAC6 inhibitor wS2818D CI994 (Tacedinaline) 10mg CI994 (Tacedinaline) is an anti-cancer drS2818G CI994 (Tacedinaline) 50mg CI994 (Tacedinaline) is an anti-cancer drS2012D PCI-34051 10mg PCI-34051 is a potent and specific HDAC8 S2012H PCI-34051 100mg PCI-34051 is a potent and specific HDAC8 S2779C M344 5mg M344 is a potent HDAC inhibitor with IC50S2779G M344 50mg M344 is a potent HDAC inhibitor with IC50S3020A Romidepsin 1mg Romidepsin (FK228, FR901228, depsipeptiS3020C Romidepsin 5mg Romidepsin (FK228, FR901228, depsipeptiS1484D MC1568 10mg MC1568 is a selective HDAC inhibitor withS1484F MC1568 25mg MC1568 is a selective HDAC inhibitor withS1122C Mocetinostat (MGCD0103) 5mg MGCD0103 (Mocetinostat) is a potent HDAS1122D Mocetinostat (MGCD0103) 10mg MGCD0103 (Mocetinostat) is a potent HDAS1122F Mocetinostat (MGCD0103) 25mg MGCD0103 (Mocetinostat) is a potent HDAS1122G Mocetinostat (MGCD0103) 50mg MGCD0103 (Mocetinostat) is a potent HDAS1085D Belinostat (PXD101) 10mg Belinostat (PXD101) is a novel HDAC inhibiS1085G Belinostat (PXD101) 50mg Belinostat (PXD101) is a novel HDAC inhibiS1085H Belinostat (PXD101) 100mg Belinostat (PXD101) is a novel HDAC inhibiS1085I Belinostat (PXD101) 200mg Belinostat (PXD101) is a novel HDAC inhibiS1045C Trichostatin A (TSA) 5mg Trichostatin A (TSA) is an HDAC inhibitor

S1045D Trichostatin A (TSA) 10mg Trichostatin A (TSA) is an HDAC inhibitor S1045G Trichostatin A (TSA) 50mg Trichostatin A (TSA) is an HDAC inhibitor S1030D Panobinostat (LBH589) 10mg LBH589 (Panobinostat) is a novel broad-sS1030G Panobinostat (LBH589) 50mg LBH589 (Panobinostat) is a novel broad-sS1030I Panobinostat (LBH589) 200mg LBH589 (Panobinostat) is a novel broad-sS1053D Entinostat (MS-275, SNDX-275) 10mg MS-275 is an HDAC inhibitor of HDAC1 andS1053F Entinostat (MS-275, SNDX-275) 25mg MS-275 is an HDAC inhibitor of HDAC1 andS1053G Entinostat (MS-275, SNDX-275) 50mg MS-275 is an HDAC inhibitor of HDAC1 andS1053I Entinostat (MS-275, SNDX-275) 200mg MS-275 is an HDAC inhibitor of HDAC1 andS1047I Vorinostat (SAHA) 200mg Vorinostat (suberoylanilide hydroxamic aciS1047K Vorinostat (SAHA) 500mg Vorinostat (suberoylanilide hydroxamic aciS2824D TPCA-1 10mg TPCA-1 is an inhibitor of IKK-2 with IC50 S1459C Thiazovivin 5mg Thiazovivin (Tzv) is a novel ROCK inhibitoS1459D Thiazovivin 10mg Thiazovivin (Tzv) is a novel ROCK inhibitoS1459G Thiazovivin 50mg Thiazovivin (Tzv) is a novel ROCK inhibitoS1573I Fasudil HCl (HA-1077) 200mg Fasudil HCl is cyclic nucleotide-dependent S1573K Fasudil HCl (HA-1077) 500mg Fasudil HCl is cyclic nucleotide-dependent S1049B Y-27632 2HCl 2mg Y-27632 2HCl is a selective ROCK1 (p160RS1049C Y-27632 2HCl 5mg Y-27632 2HCl is a selective ROCK1 (p160RS1049D Y-27632 2HCl 10mg Y-27632 2HCl is a selective ROCK1 (p160RS1049G Y-27632 2HCl 50mg Y-27632 2HCl is a selective ROCK1 (p160RS1314F Zoledronic Acid (Zoledronate) 25mg Zoledronic acid, one of the most potent niS1314H Zoledronic Acid (Zoledronate) 100mg Zoledronic acid, one of the most potent niS2791C Sotrastaurin (AEB071) 5mg Sotrastaurin (AEB071) is a potent selectivS2791F Sotrastaurin (AEB071) 25mg Sotrastaurin (AEB071) is a potent selectivS1292C Chelerythrine Chloride 5mg Chelerythrine is a benzophenanthridine alkaS1292D Chelerythrine Chloride10mg Chelerythrine is a benzophenanthridine alkaS1292G Chelerythrine Chloride 50mg Chelerythrine is a benzophenanthridine alkaS2248B CX-4945 2mg CX-4945 is a potent and selective inhibitS2248C CX-4945 5mg CX-4945 is a potent and selective inhibitS2248G CX-4945 50mg CX-4945 is a potent and selective inhibitS2248H CX-4945 100mg CX-4945 is a potent and selective inhibitS1421B Staurosporine 2mg Staurosporine (AM-2282) is a potent PKC inS1421C Staurosporine 5mg Staurosporine (AM-2282) is a potent PKC inS1421D Staurosporine 10mg Staurosporine (AM-2282) is a potent PKC inS1421H Staurosporine 100mg Staurosporine (AM-2282) is a potent PKC inS1055D Enzastaurin (LY317615) 10mg Enzastaurin (LY317615) is a potent PKC iS1055G Enzastaurin (LY317615) 50mg Enzastaurin (LY317615) is a potent PKC iS1055I Enzastaurin (LY317615) 200mg Enzastaurin (LY317615) is a potent PKC iS2158D KW 2449 10mg KW-2449 potently inhibits Flt3 and Abl witS2158G KW 2449 50mg KW-2449 potently inhibits Flt3 and Abl witS2158I KW 2449 200mg KW-2449 potently inhibits Flt3 and Abl witS2243C WP1130 5mg WP1130 (degrasyn) is a selective deubiquitS2243D WP1130 10mg WP1130 (degrasyn) is a selective deubiquitS2243G WP1130 50mg WP1130 (degrasyn) is a selective deubiquitS2243I WP1130 200mg WP1130 (degrasyn) is a selective deubiquitS2634D DCC-2036 (Rebastinib) 10mg DCC-2036 is a conformational control inhibS2634G DCC-2036 (Rebastinib) 50mg DCC-2036 is a conformational control inhibS2634H DCC-2036 (Rebastinib) 100mg DCC-2036 is a conformational control inhibS2634I DCC-2036 (Rebastinib) 200mg DCC-2036 is a conformational control inhibS1107C Danusertib (PHA-739358) 5mg Danusertib (PHA-739358) is an Aurora inhiS1107D Danusertib (PHA-739358) 10mg Danusertib (PHA-739358) is an Aurora inhiS1107G Danusertib (PHA-739358) 50mg Danusertib (PHA-739358) is an Aurora inhiS1490D Ponatinib (AP24534) 10mg AP24534 is a novel, potent multi-target iS1490G Ponatinib (AP24534) 50mg AP24534 is a novel, potent multi-target iS1490I Ponatinib (AP24534) 200mg AP24534 is a novel, potent multi-target iS1033F Nilotinib (AMN-107) 25mg Nilotinib (AMN-107, Tasigna) is a Bcr-Abl i

S1033H Nilotinib (AMN-107) 100mg Nilotinib (AMN-107, Tasigna) is a Bcr-Abl iS1033L Nilotinib (AMN-107) 300mg Nilotinib (AMN-107, Tasigna) is a Bcr-Abl iS1006D Saracatinib (AZD0530) 10mg Saracatinib (AZD0530) is a Src inhibitor foS1006F Saracatinib (AZD0530) 25mg Saracatinib (AZD0530) is a Src inhibitor foS1006I Saracatinib (AZD0530) 200mg Saracatinib (AZD0530) is a Src inhibitor foS5002H Fingolimod (FTY720) 100mg FTY720 (Fingolimod, Gilenya) is a S1P antS5002I Fingolimod (FTY720) 200mg FTY720 (Fingolimod, Gilenya) is a S1P antS1026H Imatinib Mesylate 100mg Imatinib Mesylate is orally bioavailability S1026J Imatinib Mesylate 250mg Imatinib Mesylate is orally bioavailability S1021F Dasatinib (BMS-354825) 25mg Dasatinib (BMS-354825, Sprycel) is a Src/AbS1021H Dasatinib (BMS-354825) 100mg Dasatinib (BMS-354825, Sprycel) is a Src/AbS2805D LY364947 10mg LY364947 is a potent ATP-competitive inhiS2805F LY364947 25mg LY364947 is a potent ATP-competitive inhiS2805G LY364947 50mg LY364947 is a potent ATP-competitive inhiS2750C GW788388 5mg GW788388 is a potent and selective inhibiS2750D GW788388 10mg GW788388 is a potent and selective inhibiS2750F GW788388 25mg GW788388 is a potent and selective inhibiS2750G GW788388 50mg GW788388 is a potent and selective inhibiS2186D SB-505124 10mg SB505124 is a selective inhibitor of ALK4S2186G SB-505124 50mg SB505124 is a selective inhibitor of ALK4S2704C LY2109761 5mg LY2109761 is a novel selective TGF-beta recS2704D LY2109761 10mg LY2109761 is a novel selective TGF-beta recS2704G LY2109761 50mg LY2109761 is a novel selective TGF-beta recS2704I LY2109761 200mg LY2109761 is a novel selective TGF-beta recS1476C SB 525334 5mg SB 525334 is a potent and selective inhibiS1476D SB 525334 10mg SB 525334 is a potent and selective inhibiS1476G SB 525334 50mg SB 525334 is a potent and selective inhibiS1476H SB 525334 100mg SB 525334 is a potent and selective inhibiS2618B LDN193189 2mg LDN193189 is a selective inhibitor of ALKS2618C LDN193189 5mg LDN193189 is a selective inhibitor of ALKS2618F LDN193189 25mg LDN193189 is a selective inhibitor of ALKS2230C LY2157299 5mg LY2157299 is a potent TGFbeta receptor I (S2230D LY2157299 10mg LY2157299 is a potent TGFbeta receptor I (S2230G LY2157299 50mg LY2157299 is a potent TGFbeta receptor I (S2230I LY2157299 200mg LY2157299 is a potent TGFbeta receptor I (S1067D SB 431542 10mg SB 431542 is a potent and selective inhibiS1067G SB 431542 50mg SB 431542 is a potent and selective inhibiS1067I SB 431542 200mg SB 431542 is a potent and selective inhibiS1460D SP600125 10mg SP600125 is a broad-spectrum JNK inhibitS1460G SP600125 50mg SP600125 is a broad-spectrum JNK inhibitS1460I SP600125 200mg SP600125 is a broad-spectrum JNK inhibitS2726C PH-797804 5mg PH-797804 is a novel pyridinone inhibitor S2726D PH-797804 10mg PH-797804 is a novel pyridinone inhibitor S2726G PH-797804 50mg PH-797804 is a novel pyridinone inhibitor S2726I PH-797804 200mg PH-797804 is a novel pyridinone inhibitor S1458D VX-745 10mg VX-745 is a potent and selective inhibitS1458G VX-745 50mg VX-745 is a potent and selective inhibitS6005D VX-702 10mg VX-702 is a highly selective inhibitor of S6005F VX-702 250mg VX-702 is a highly selective inhibitor of S6005H VX-702 100mg VX-702 is a highly selective inhibitor of S6005I VX-702 200mg VX-702 is a highly selective inhibitor of S1494C LY2228820 5mg LY2228820 is a novel and potent inhibitorS1494D LY2228820 10mg LY2228820 is a novel and potent inhibitorS1494G LY2228820 50mg LY2228820 is a novel and potent inhibitorS1494I LY2228820 200mg LY2228820 is a novel and potent inhibitorS1077F SB 202190 25mg SB 202190 (FHPI) is a potent p38 MAPK inhS1077H SB 202190 100mg SB 202190 (FHPI) is a potent p38 MAPK inh

S1574C BIRB 796 (Doramapimod) 5mg BIRB 796 (Doramapimod) is a highly selectS1574D BIRB 796 (Doramapimod) 10mg BIRB 796 (Doramapimod) is a highly selectS1574G BIRB 796 (Doramapimod) 50mg BIRB 796 (Doramapimod) is a highly selectS1574I BIRB 796 (Doramapimod) 200mg BIRB 796 (Doramapimod) is a highly selectS1076F SB 203580 25mg SB203580 is a p38 MAPK inhibitor with ICS1076G SB 203580 50mg SB203580 is a p38 MAPK inhibitor with ICS1076H SB 203580 100mg SB203580 is a p38 MAPK inhibitor with ICS1076I SB 203580 200mg SB203580 is a p38 MAPK inhibitor with ICS2200D Raf265 derivative 10mg A derivative of Raf265. But the effects of tS2200F Raf265 derivative 25mg A derivative of Raf265. But the effects of tS2200G Raf265 derivative 50mg A derivative of Raf265. But the effects of tS2200H Raf265 derivative 100mg A derivative of Raf265. But the effects of tS2720C ZM 336372 5mg ZM 336372 is a potent and selective c-Raf S2720D ZM 336372 10mg ZM 336372 is a potent and selective c-Raf S2720G ZM 336372 50mg ZM 336372 is a potent and selective c-Raf S2720I ZM 336372 200mg ZM 336372 is a potent and selective c-Raf S2746C AZ628 5mg AZ628 is a potent inhibitor for wild-typeS2746F AZ628 25mg AZ628 is a potent inhibitor for wild-typeS2807C Dabrafenib (GSK2118436A) 5mg Dabrafenib (GSK2118436) is a potent ATP-cS2807D Dabrafenib (GSK2118436A) 10mg Dabrafenib (GSK2118436) is a potent ATP-cS2807E Dabrafenib (GSK2118436A) 20mg Dabrafenib (GSK2118436) is a potent ATP-cS2807G Dabrafenib (GSK2118436A) 50mg Dabrafenib (GSK2118436) is a potent ATP-cS2807H Dabrafenib (GSK2118436A) 100mg Dabrafenib (GSK2118436) is a potent ATP-cS2202C NVP-BHG712 5mg NVP-BHG712 is a specific inhibitor of c-RS2202D NVP-BHG712 10mg NVP-BHG712 is a specific inhibitor of c-RS2202G NVP-BHG712 50mg NVP-BHG712 is a specific inhibitor of c-RS2202I NVP-BHG712 200mg NVP-BHG712 is a specific inhibitor of c-RS2161C RAF265 (CHIR-265) 5mg RAF265 (CHIR-265) is a selective and poteS2161D RAF265 (CHIR-265) 10mg RAF265 (CHIR-265) is a selective and poteS2161G RAF265 (CHIR-265) 50mg RAF265 (CHIR-265) is a selective and poteS2161H RAF265 (CHIR-265) 100mg RAF265 (CHIR-265) is a selective and poteS1178C Regorafenib (BAY 73-4506) 5mg Regorafenib (BAY 73-4506, Fluoro-SorafenS1178D Regorafenib (BAY 73-4506) 10mg Regorafenib (BAY 73-4506, Fluoro-SorafenS1178F Regorafenib (BAY 73-4506) 25mg Regorafenib (BAY 73-4506, Fluoro-SorafenS1178H Regorafenib (BAY 73-4506) 100mg Regorafenib (BAY 73-4506, Fluoro-SorafenS1104B GDC-0879 2mg GDC-0879 is a novel potent, selective B-RaS1104C GDC-0879 5mg GDC-0879 is a novel potent, selective B-RaS1104D GDC-0879 10mg GDC-0879 is a novel potent, selective B-RaS1104F GDC-0879 25mg GDC-0879 is a novel potent, selective B-RaS1152D PLX-4720 10mg PLX-4720 is a potent and selective inhibS1152F PLX-4720 25mg PLX-4720 is a potent and selective inhibS1152H PLX-4720 100mg PLX-4720 is a potent and selective inhibS1040C Sorafenib (Nexavar) 5mg Sorafenib Tosylate (Bay 43-9006, Nexavar)S1040D Sorafenib (Nexavar) 10mg Sorafenib Tosylate (Bay 43-9006, Nexavar)S1040G Sorafenib (Nexavar) 50mg Sorafenib Tosylate (Bay 43-9006, Nexavar)S1040H Sorafenib (Nexavar) 100mg Sorafenib Tosylate (Bay 43-9006, Nexavar)S1267D Vemurafenib (PLX4032) 10mg PLX4032 (Vemurafenib, RG7204, Zelboraf, S1267G Vemurafenib (PLX4032) 50mg PLX4032 (Vemurafenib, RG7204, Zelboraf, S1267I Vemurafenib (PLX4032) 200mg PLX4032 (Vemurafenib, RG7204, Zelboraf, S1475C AS703026 5mg AS703026 is a highly selective and potent S1475D AS703026 10mg AS703026 is a highly selective and potent S1475F AS703026 25mg AS703026 is a highly selective and potent S1475G AS703026 50mg AS703026 is a highly selective and potent S1530C BIX 02188 5mg BIX02188 is a selective inhibitor of MEK5 S1530D BIX 02188 10mg BIX02188 is a selective inhibitor of MEK5 S1530G BIX 02188 50mg BIX02188 is a selective inhibitor of MEK5 S1530I BIX 02188 200mg BIX02188 is a selective inhibitor of MEK5

S1568C PD318088 5mg PD318088 is a non-ATP competitive allosteS1568D PD318088 10mg PD318088 is a non-ATP competitive allosteS1568G PD318088 50mg PD318088 is a non-ATP competitive allosteS1568I PD318088 200mg PD318088 is a non-ATP competitive allosteS2134C AZD8330 5mg AZD8330 (ARRY-424704) is a MEK 1/2 inhibS2134D AZD8330 10mg AZD8330 (ARRY-424704) is a MEK 1/2 inhibS2134G AZD8330 50mg AZD8330 (ARRY-424704) is a MEK 1/2 inhibS2134I AZD8330 200mg AZD8330 (ARRY-424704) is a MEK 1/2 inhibS2617C TAK-733 5mg TAK-733 is a potent, selective, non ATP-coS2617D TAK-733 10mg TAK-733 is a potent, selective, non ATP-coS2617G TAK-733 50mg TAK-733 is a potent, selective, non ATP-coS2617I TAK-733 200mg TAK-733 is a potent, selective, non ATP-coS1531C BIX 02189 5mg BIX02189 is a selective inhibitor of MEK5 S1531D BIX 02189 10mg BIX02189 is a selective inhibitor of MEK5 S1531G BIX 02189 50mg BIX02189 is a selective inhibitor of MEK5 S1531I BIX 02189 200mg BIX02189 is a selective inhibitor of MEK5 S2673C GSK1120212 (JTP-74057) 5mg GSK1120212 (JTP-74057, trametinib) is a hS2673D GSK1120212 (JTP-74057) 10mg GSK1120212 (JTP-74057, trametinib) is a hS2673G GSK1120212 (JTP-74057) 50mg GSK1120212 (JTP-74057, trametinib) is a hS2673H GSK1120212 (JTP-74057) 100mg GSK1120212 (JTP-74057, trametinib) is a hS1177D PD98059 10mg PD98059 is a non-competitive MEK inhibitoS1177G PD98059 50mg PD98059 is a non-competitive MEK inhibitoS1177I PD98059 200mg PD98059 is a non-competitive MEK inhibitoS1102F U0126-EtOH (UO126 EtOH) 25mg U0126-EtOH is a highly selective inhibitoS1102H U0126-EtOH (UO126 EtOH) 100mg U0126-EtOH is a highly selective inhibitoS1102L U0126-EtOH (UO126 EtOH) 300mg U0126-EtOH is a highly selective inhibitoS1020C CI-1040 (PD184352) 5mg CI-1040 (PD 184352) is an ATP non-competS1020D CI-1040 (PD184352) 10mg CI-1040 (PD 184352) is an ATP non-competS1020F CI-1040 (PD184352) 25mg CI-1040 (PD 184352) is an ATP non-competS1020H CI-1040 (PD184352) 100mg CI-1040 (PD 184352) is an ATP non-competS1020I CI-1040 (PD184352) 200mg CI-1040 (PD 184352) is an ATP non-competS1036C PD0325901 5mg PD0325901 (PD325901) is selective and noS1036D PD0325901 10mg PD0325901 (PD325901) is selective and noS1036F PD0325901 25mg PD0325901 (PD325901) is selective and noS1036H PD0325901 100mg PD0325901 (PD325901) is selective and noS1008G AZD6244 (Selumetinib) 50mg AZD6244 (Selumetinib, ARRY-142886) is hiS1008H AZD6244 (Selumetinib) 100mg AZD6244 (Selumetinib, ARRY-142886) is hiS1008I AZD6244 (Selumetinib) 200mg AZD6244 (Selumetinib, ARRY-142886) is hiS1008K AZD6244 (Selumetinib) 500mg AZD6244 (Selumetinib, ARRY-142886) is hiS1001C ABT-263 (Navitoclax) 5mg ABT-263 (Navitoclax) is a potent inhibitorS1001D ABT-263 (Navitoclax) 10mg ABT-263 (Navitoclax) is a potent inhibitorS1001F ABT-263 (Navitoclax) 25mg ABT-263 (Navitoclax) is a potent inhibitorS1001H ABT-263 (Navitoclax) 100mg ABT-263 (Navitoclax) is a potent inhibitorS1002C ABT-737 5mg ABT-737 is a BH3 mimetic inhibitor of BclS1002D ABT-737 10mg ABT-737 is a BH3 mimetic inhibitor of BclS1002G ABT-737 50mg ABT-737 is a BH3 mimetic inhibitor of BclS1002H ABT-737 100mg ABT-737 is a BH3 mimetic inhibitor of BclS1029G Lenalidomide (Revlimid) 50mg Lenalidomide (Revlimid, CC-5013) is a TNF-S1029K Lenalidomide (Revlimid) 500mg Lenalidomide (Revlimid, CC-5013) is a TNF-S1052C Elesclomol 5mg Elesclomol (STA-4783) is a novel potent oxiS1052D Elesclomol 10mg Elesclomol (STA-4783) is a novel potent oxiS1052G Elesclomol 50mg Elesclomol (STA-4783) is a novel potent oxiS1052I Elesclomol 200mg Elesclomol (STA-4783) is a novel potent oxiS1057C Obatoclax mesylate (GX15-070) 5mg Obatoclax (GX15-070) is an inhibitor of BclS1057D Obatoclax mesylate (GX15-070) 10mg Obatoclax (GX15-070) is an inhibitor of BclS1057G Obatoclax mesylate (GX15-070) 50mg Obatoclax (GX15-070) is an inhibitor of BclS1061C Nutlin-3 5mg Nutlin-3 is a potent and selective Mdm2 an

S1061D Nutlin-3 10mg Nutlin-3 is a potent and selective Mdm2 anS1061F Nutlin-3 25mg Nutlin-3 is a potent and selective Mdm2 anS1061H Nutlin-3 100mg Nutlin-3 is a potent and selective Mdm2 anS1064D Masitinib (AB1010) 10mg Masitinib is an inhibitor of recombinant huS1064F Masitinib (AB1010) 25mg Masitinib is an inhibitor of recombinant huS1064I Masitinib (AB1010) 200mg Masitinib is an inhibitor of recombinant huS1069C AUY922 (NVP-AUY922) 5mg NVP-AUY922 (VER-52296) is a highly poteS1069D AUY922 (NVP-AUY922) 10mg NVP-AUY922 (VER-52296) is a highly poteS1069F AUY922 (NVP-AUY922) 25mg NVP-AUY922 (VER-52296) is a highly poteS1069I AUY922 (NVP-AUY922) 200mg NVP-AUY922 (VER-52296) is a highly poteS1121D TW-37 10mg TW-37 is a novel nonpeptide inhibitor to rS1121G TW-37 50mg TW-37 is a novel nonpeptide inhibitor to rS1130C YM155 5mg YM155 is a potent IAP (inhibitor of apoptosiS1130D YM155 10mg YM155 is a potent IAP (inhibitor of apoptosiS1130F YM155 25mg YM155 is a potent IAP (inhibitor of apoptosiS1130H YM155 100mg YM155 is a potent IAP (inhibitor of apoptosiS1141F 17-AAG (Tanespimycin) 25mg 17-AAG (Tanespimycin) is a potent HSP90 iS1141H 17-AAG (Tanespimycin) 100mg 17-AAG (Tanespimycin) is a potent HSP90 iS1141I 17-AAG (Tanespimycin) 200mg 17-AAG (Tanespimycin) is a potent HSP90 iS1142F 17-DMAG HCl (Alvespimycin) 25mg 17-DMAG (Alvespimycin, KOS-1022, NSC 70S1142H 17-DMAG HCl (Alvespimycin) 100mg 17-DMAG (Alvespimycin, KOS-1022, NSC 70S1142I 17-DMAG HCl (Alvespimycin) 200mg 17-DMAG (Alvespimycin, KOS-1022, NSC 70S1148D Docetaxel (Taxotere) 10mg Docetaxel (Taxotere) is a semi-synthetic, S1148G Docetaxel (Taxotere) 50mg Docetaxel (Taxotere) is a semi-synthetic, S1150D Paclitaxel (Taxol) 10mg Paclitaxel (Taxol, Onxol, Nov-Onxol) is a mS1150G Paclitaxel (Taxol) 50mg Paclitaxel (Taxol, Onxol, Nov-Onxol) is a mS1159D Ganetespib (STA-9090) 10mg Ganetespib is an HSP90 inhibitor with IC50S1159I Ganetespib (STA-9090) 200mg Ganetespib is an HSP90 inhibitor with IC50S1163C AT13387 5mg AT13387 is a selective potent Hsp90 inhibiS1163D AT13387 10mg AT13387 is a selective potent Hsp90 inhibiS1163G AT13387 50mg AT13387 is a selective potent Hsp90 inhibiS1163I AT13387 200mg AT13387 is a selective potent Hsp90 inhibiS1172C JNJ 26854165 (Serdemetan) 5mg JNJ 26854165 (Serdemetan) is an orally bS1172F JNJ 26854165 (Serdemetan) 25mg JNJ 26854165 (Serdemetan) is an orally bS1172H JNJ 26854165 (Serdemetan) 100mg JNJ 26854165 (Serdemetan) is an orally bS1175C BIIB021 5mg BIIB021 is a novel inhibitor of HSP90 withS1175D BIIB021 10mg BIIB021 is a novel inhibitor of HSP90 withS1175F BIIB021 25mg BIIB021 is a novel inhibitor of HSP90 withS1175G BIIB021 50mg BIIB021 is a novel inhibitor of HSP90 withS1180D XAV-939 10mg XAV-939 is a selective Wnt beta-catenin-mS1180F XAV-939 25mg XAV-939 is a selective Wnt beta-catenin-mS1180G XAV-939 50mg XAV-939 is a selective Wnt beta-catenin-mS1180I XAV-939 200mg XAV-939 is a selective Wnt beta-catenin-mS1183B Danoprevir 2mg Danoprevir is a peptidomimetic inhibitor oS1183C Danoprevir 5mg Danoprevir is a peptidomimetic inhibitor oS1183G Danoprevir 50mg Danoprevir is a peptidomimetic inhibitor oS1185D Ritonavir 10mg Ritonavir is an inhibitor of HIV protease uS1185G Ritonavir 50mg Ritonavir is an inhibitor of HIV protease uS1185H Ritonavir 100mg Ritonavir is an inhibitor of HIV protease uS1244B Amuvatinib (MP-470) 2mg MP-470 (Amuvatinib) is a potent and multS1244C Amuvatinib (MP-470) 5mg MP-470 (Amuvatinib) is a potent and multS1244D Amuvatinib (MP-470) 10mg MP-470 (Amuvatinib) is a potent and multS1244G Amuvatinib (MP-470) 50mg MP-470 (Amuvatinib) is a potent and multS1297B Epothilone A 2mg Epothilone A is a Taxol-like microtubule-stS1297C Epothilone A 5mg Epothilone A is a Taxol-like microtubule-stS1364B Epothilone B (EPO906) 2mg Epothilone B is a Taxol-like microtubule-stS1364C Epothilone B (EPO906) 5mg Epothilone B is a Taxol-like microtubule-st

S1364D Epothilone B (EPO906) 10mg Epothilone B is a Taxol-like microtubule-stS1364F Epothilone B (EPO906) 25mg Epothilone B is a Taxol-like microtubule-stS1366C BMS-707035 5mg BMS-707035 is a specific HIV-I integrase (IS1366D BMS-707035 10mg BMS-707035 is a specific HIV-I integrase (IS1366G BMS-707035 50mg BMS-707035 is a specific HIV-I integrase (IS1366I BMS-707035 200mg BMS-707035 is a specific HIV-I integrase (IS1380D Lopinavir (ABT-378) 10mg Lopinavir (ABT-378) is an antiretroviral ofS1380H Lopinavir (ABT-378) 100mg Lopinavir (ABT-378) is an antiretroviral ofS1380I Lopinavir (ABT-378) 200mg Lopinavir (ABT-378) is an antiretroviral ofS1398F Stavudine 25mg Stavudine is a nucleoside analog reverse trS1398G Stavudine 50mg Stavudine is a nucleoside analog reverse trS1398H Stavudine 100mg Stavudine is a nucleoside analog reverse trS1400D Tenofovir Disoproxil Fumarate 10mg Tenofovir disoproxil fumarate belongs to a S1400G Tenofovir Disoproxil Fumarate 50mg Tenofovir disoproxil fumarate belongs to a S1400H Tenofovir Disoproxil Fumarate 100mg Tenofovir disoproxil fumarate belongs to a S1401C Tenofovir (Viread) 5mg Tenofovir (Viread) is a drug used to treat S1401E Tenofovir (Viread) 20mg Tenofovir (Viread) is a drug used to treat S1401G Tenofovir (Viread) 50mg Tenofovir (Viread) is a drug used to treat S1452D Ispinesib (SB-715992) 10mg Ispinesib (SB-715992, CK0238273) is a poteS1452G Ispinesib (SB-715992) 50mg Ispinesib (SB-715992, CK0238273) is a poteS1452I Ispinesib (SB-715992) 200mg Ispinesib (SB-715992, CK0238273) is a poteS1457C Atazanavir sulfate 5mg Atazanavir sulfate(BMS-232632-05) is a sulS1457D Atazanavir sulfate 10mg Atazanavir sulfate(BMS-232632-05) is a sulS1457G Atazanavir sulfate 50mg Atazanavir sulfate(BMS-232632-05) is a sulS1480C VX-222 5mg VX-222 (VCH-222) is a novel, potent and sS1480D VX-222 10mg VX-222 (VCH-222) is a novel, potent and sS1480G VX-222 50mg VX-222 (VCH-222) is a novel, potent and sS1480I VX-222 200mg VX-222 (VCH-222) is a novel, potent and sS1482C BMS-790052 5mg BMS-790052 is a highly selective inhibitS1482D BMS-790052 10mg BMS-790052 is a highly selective inhibitS1482G BMS-790052 50mg BMS-790052 is a highly selective inhibitS1482I BMS-790052 200mg BMS-790052 is a highly selective inhibitS1498C NVP-BEP800 5mg NVP-BEP800 is a novel, fully synthetic HSS1498D NVP-BEP800 10mg NVP-BEP800 is a novel, fully synthetic HSS1498G NVP-BEP800 50mg NVP-BEP800 is a novel, fully synthetic HSS1498I NVP-BEP800 200mg NVP-BEP800 is a novel, fully synthetic HSS1538C Telaprevir (VX-950) 5mg Telaprevir (VX-950) is an HCV NS3-4A seriS1538D Telaprevir (VX-950) 10mg Telaprevir (VX-950) is an HCV NS3-4A seriS1538G Telaprevir (VX-950) 50mg Telaprevir (VX-950) is an HCV NS3-4A seriS1567C Pomalidomide 5mg Pomalidomide inhibits LPS-induced TNF-alS1567D Pomalidomide 10mg Pomalidomide inhibits LPS-induced TNF-alS1567G Pomalidomide 50mg Pomalidomide inhibits LPS-induced TNF-alS1567I Pomalidomide 200mg Pomalidomide inhibits LPS-induced TNF-alS1704D Emtricitabine (Emtriva) 10mg Emtricitabine (Emtriva) is a nucleoside revS1704G Emtricitabine (Emtriva) 50mg Emtricitabine (Emtriva) is a nucleoside revS2001D Elvitegravir (GS-9137) 10mg Elvitegravir (EVG, JTK-303/GS-9137) is a S2001G Elvitegravir (GS-9137) 50mg Elvitegravir (EVG, JTK-303/GS-9137) is a S2001I Elvitegravir (GS-9137) 200mg Elvitegravir (EVG, JTK-303/GS-9137) is a S2003C Maraviroc 5mg Maraviroc (Selzentry, UK-427857, CelsentrS2003F Maraviroc 25mg Maraviroc (Selzentry, UK-427857, CelsentrS2003H Maraviroc 100mg Maraviroc (Selzentry, UK-427857, CelsentrS2004C Vicriviroc Malate 5mg Vicriviroc (SCH-417690, SCH-D) is a potenS2004D Vicriviroc Malate 10mg Vicriviroc (SCH-417690, SCH-D) is a potenS2004G Vicriviroc Malate 50mg Vicriviroc (SCH-417690, SCH-D) is a potenS2005C Raltegravir (MK-0518) 5mg Raltegravir (MK-0518, Isentress) is a poteS2005D Raltegravir (MK-0518) 10mg Raltegravir (MK-0518, Isentress) is a poteS2005G Raltegravir (MK-0518) 50mg Raltegravir (MK-0518, Isentress) is a pote

S2182C SB 743921 5mg SB 743921 is a KSP inhibitor with IC50 oS2182D SB 743921 10mg SB 743921 is a KSP inhibitor with IC50 oS2182G SB 743921 50mg SB 743921 is a KSP inhibitor with IC50 oS2182I SB 743921 200mg SB 743921 is a KSP inhibitor with IC50 oS2195C CYT997 5mg CYT997 is a potent tubulin polymerization S2195D CYT997 10mg CYT997 is a potent tubulin polymerization S2195G CYT997 50mg CYT997 is a potent tubulin polymerization S2195I CYT997 200mg CYT997 is a potent tubulin polymerization S2209C Vinflunine Tartrate 5mg Vinflunine is a new vinca alkaloid uniquely fS2209D Vinflunine Tartrate 10mg Vinflunine is a new vinca alkaloid uniquely fS2209G Vinflunine Tartrate 50mg Vinflunine is a new vinca alkaloid uniquely fS2209I Vinflunine Tartrate 200mg Vinflunine is a new vinca alkaloid uniquely fS2228 VX-765 VX-765 is a potent and selective inhibitor S2639C SNX-2112 5mg SNX-2112 selectively binds to the ATP poS2639D SNX-2112 10mg SNX-2112 selectively binds to the ATP poS2639G SNX-2112 50mg SNX-2112 selectively binds to the ATP poS2639I SNX-2112 200mg SNX-2112 selectively binds to the ATP poS2656C PF-04929113 (SNX-5422) 5mg PF-04929113 (SNX-5422) is a potent and seS2656D PF-04929113 (SNX-5422) 10mg PF-04929113 (SNX-5422) is a potent and seS2656G PF-04929113 (SNX-5422) 50mg PF-04929113 (SNX-5422) is a potent and seS2656I PF-04929113 (SNX-5422) 200mg PF-04929113 (SNX-5422) is a potent and seS2662C ICG-001 5mg ICG-001 specifically binds to CBP with ICS2662F ICG-001 25mg ICG-001 specifically binds to CBP with ICS2662H ICG-001 100mg ICG-001 specifically binds to CBP with ICS2667C S_GSK1349572 (GSK1349572) 5mg S/GSK1349572 (GSK1349572) is a two-metalS2667D S_GSK1349572 (GSK1349572) 10mg S/GSK1349572 (GSK1349572) is a two-metalS2667G S_GSK1349572 (GSK1349572) 50mg S/GSK1349572 (GSK1349572) is a two-metalS2667I S_GSK1349572 (GSK1349572) 200mg S/GSK1349572 (GSK1349572) is a two-metalS2672C PF-00562271(PF-562271) 5mg PF-562271 is a potent, ATP-competitive, reS2672D PF-00562271(PF-562271) 10mg PF-562271 is a potent, ATP-competitive, reS2672G PF-00562271(PF-562271) 50mg PF-562271 is a potent, ATP-competitive, reS2672I PF-00562271(PF-562271) 200mg PF-562271 is a potent, ATP-competitive, reS2678C NSC-207895 5mg NSC-207895 is novel inhibitor of MDMX andS2678D NSC-207895 10mg NSC-207895 is novel inhibitor of MDMX andS2678G NSC-207895 50mg NSC-207895 is novel inhibitor of MDMX andS2678I NSC-207895 200mg NSC-207895 is novel inhibitor of MDMX andS2685C KW-2478 5mg KW-2478 is a nonansamycin HSP90 inhibitoS2685D KW-2478 10mg KW-2478 is a nonansamycin HSP90 inhibitoS2685G KW-2478 50mg KW-2478 is a nonansamycin HSP90 inhibitoS2685I KW-2478 200mg KW-2478 is a nonansamycin HSP90 inhibitoS2713C Geldanamycin 5mg Geldanamycin is a natural existing HSP90 iS2713D Geldanamycin 10mg Geldanamycin is a natural existing HSP90 iS2713G Geldanamycin 50mg Geldanamycin is a natural existing HSP90 iS2725C PF-03814735 5mg PF-03814735 is a novel, potent and reversiS2725D PF-03814735 10mg PF-03814735 is a novel, potent and reversiS2725G PF-03814735 50mg PF-03814735 is a novel, potent and reversiS2725I PF-03814735 200mg PF-03814735 is a novel, potent and reversiS2731D AZ 3146 10mg AZ3146 is a selective Mps1 inhibitor with S2731G AZ 3146 50mg AZ3146 is a selective Mps1 inhibitor with S2738D PAC-1 10mg PAC-1 is a potent procaspase-3 activator S2738F PAC-1 25mg PAC-1 is a potent procaspase-3 activator S2738G PAC-1 50mg PAC-1 is a potent procaspase-3 activator S2738J PAC-1 250mg PAC-1 is a potent procaspase-3 activator S2754C AT-406 5mg AT-406 is a potent IAP (inhibitor of apoptoS2754D AT-406 10mg AT-406 is a potent IAP (inhibitor of apoptoS2754G AT-406 50mg AT-406 is a potent IAP (inhibitor of apoptoS2754I AT-406 200mg AT-406 is a potent IAP (inhibitor of apopto

S2765C MK-2048 5mg MK-2048 is an potent inhibitor of integrasS2765D MK-2048 10mg MK-2048 is an potent inhibitor of integrasS2765G MK-2048 50mg MK-2048 is an potent inhibitor of integrasS2765I MK-2048 200mg MK-2048 is an potent inhibitor of integrasS2775D Nocodazole 10mg Nocodazole inhibits Abl, Abl(E255K) and AS2775G Nocodazole 50mg Nocodazole inhibits Abl, Abl(E255K) and AS2781C RITA (NSC 652287) 5mg RITA (NSC 652287) is a DNA damaging ageS2781D RITA (NSC 652287) 10mg RITA (NSC 652287) is a DNA damaging ageS2781G RITA (NSC 652287) 50mg RITA (NSC 652287) is a DNA damaging ageS2820C NVP-TAE226 5mg NVP-TAE226, a potent dual FAK/IGF-IR, inhS2820D NVP-TAE226 10mg NVP-TAE226, a potent dual FAK/IGF-IR, inhS2820H NVP-TAE226 100mg NVP-TAE226, a potent dual FAK/IGF-IR, inhS2820I NVP-TAE226 200mg NVP-TAE226, a potent dual FAK/IGF-IR, inhS3165D Abacavir sulfate 10mg Abacavir is a commonly used nucleoside anaS3165G Abacavir sulfate 50mg Abacavir is a commonly used nucleoside anaS1115C Odanacatib (MK 0822) 5mg Odanacatib (MK 0822) is a potent, selectivS1115D Odanacatib (MK 0822) 10mg Odanacatib (MK 0822) is a potent, selectivS1115G Odanacatib (MK 0822) 50mg Odanacatib (MK 0822) is a potent, selectivS1542C MK3207 Hcl 5mg MK 3207 is a potent CGRP receptor antagoS1542D MK3207 Hcl 10mg MK 3207 is a potent CGRP receptor antagoS1542G MK3207 Hcl 50mg MK 3207 is a potent CGRP receptor antagoS1542I MK3207 Hcl 200mg MK 3207 is a potent CGRP receptor antagoS2694C WAY-362450 5mg WAY-362450 is a potent, selective FXR agS2694D WAY-362450 10mg WAY-362450 is a potent, selective FXR agS2694G WAY-362450 50mg WAY-362450 is a potent, selective FXR agS2694I WAY-362450 200mg WAY-362450 is a potent, selective FXR agS2632C BMS-806 (BMS 378806) 5mg BMS-806 (BMS 378806) selectively inhibitiS2632D BMS-806 (BMS 378806) 10mg BMS-806 (BMS 378806) selectively inhibitiS2632G BMS-806 (BMS 378806) 50mg BMS-806 (BMS 378806) selectively inhibitiS1322J Dexamethasone 250mg Dexamethasone is a potent synthetic memberS1322K Dexamethasone 500mg Dexamethasone is a potent synthetic memberS2630C GW3965 Hcl 5mg GW3965 is a potent, selective LXR agonisS2630D GW3965 Hcl 10mg GW3965 is a potent, selective LXR agonisS2630G GW3965 Hcl 50mg GW3965 is a potent, selective LXR agonisS2630I GW3965 Hcl 200mg GW3965 is a potent, selective LXR agonisS1343F Ginkgolide B 25mg Ginkgolide B (BN 52021) is a PAFR antagonS1343G Ginkgolide B 50mg Ginkgolide B (BN 52021) is a PAFR antagonS1343K Ginkgolide B 500mg Ginkgolide B (BN 52021) is a PAFR antagonS2717C CP-91149 5mg CP-91149 is a selective glycogen phosphorS2717D CP-91149 10mg CP-91149 is a selective glycogen phosphorS2717H CP-91149 100mg CP-91149 is a selective glycogen phosphorS1189B Aprepitant (MK-0869) 2mg Aprepitant is an antiemetic chemical compoS1189C Aprepitant (MK-0869) 5mg Aprepitant is an antiemetic chemical compoS1189D Aprepitant (MK-0869) 10mg Aprepitant is an antiemetic chemical compoS1189F Aprepitant (MK-0869) 25mg Aprepitant is an antiemetic chemical compoS2196C BIBR 953 (Dabigatran etexilate, Pradaxa) BIBR 953 (Dabigatran, Pradaxa) is potent nS2196D BIBR 953 (Dabigatran etexilate, Pradaxa) BIBR 953 (Dabigatran, Pradaxa) is potent nS2196G BIBR 953 (Dabigatran etexilate, Pradaxa) BIBR 953 (Dabigatran, Pradaxa) is potent nS2196I BIBR 953 (Dabigatran etexilate, Pradaxa) BIBR 953 (Dabigatran, Pradaxa) is potent nS2773C SB705498 5mg SB705498 is a TRPV1 antagonist for hTRPVS2773D SB705498 10mg SB705498 is a TRPV1 antagonist for hTRPVS2773G SB705498 50mg SB705498 is a TRPV1 antagonist for hTRPVS2773I SB705498 200mg SB705498 is a TRPV1 antagonist for hTRPVS1013C Bortezomib (Velcade) 5mg Bortezomib (PS-341, Velcade) is a potent pS1013F Bortezomib (Velcade) 25mg Bortezomib (PS-341, Velcade) is a potent pS1013H Bortezomib (Velcade) 100mg Bortezomib (PS-341, Velcade) is a potent pS2619C MG-132 5mg MG-132 (carbobenzoxyl-leucyl-leucyl-leucin

S2619F MG-132 25mg MG-132 (carbobenzoxyl-leucyl-leucyl-leucinS2619H MG-132 100mg MG-132 (carbobenzoxyl-leucyl-leucyl-leucinS2180C MLN2238 5mg MLN2238 inhibits the chymotrypsin-like proS2180D MLN2238 10mg MLN2238 inhibits the chymotrypsin-like proS2180I MLN2238 200mg MLN2238 inhibits the chymotrypsin-like proS2181C MLN9708 5mg MLN9708 is a selective inhibitor of chymotS2181D MLN9708 10mg MLN9708 is a selective inhibitor of chymotS2181G MLN9708 50mg MLN9708 is a selective inhibitor of chymotS2181I MLN9708 200mg MLN9708 is a selective inhibitor of chymotS1386D Nafamostat mesylate 10mg Nafamostat is an anticoagulant. Broad specS1386G Nafamostat mesylate 50mg Nafamostat is an anticoagulant. Broad specS1386H Nafamostat mesylate 100mg Nafamostat is an anticoagulant. Broad specS2204C Atazanavir 5mg Atazanavir is an antiretroviral drug of the S2204D Atazanavir 10mg Atazanavir is an antiretroviral drug of the S2204F Atazanavir 25mg Atazanavir is an antiretroviral drug of the S2204G Atazanavir 50mg Atazanavir is an antiretroviral drug of the S1157 Delanzomib (CEP-18770) CEP-18770 is a potent chymotrypsin-like pS2101C Gabexate mesylate 5mg Gabexate is a serine protease inhibitor witS2101G Gabexate mesylate 50mg Gabexate is a serine protease inhibitor witS2853C Carfilzomib (PR-171) 5mg Carfilzomib (PR-171) is a proteasome inhibS2853D Carfilzomib (PR-171) 10mg Carfilzomib (PR-171) is a proteasome inhibS2853G Carfilzomib (PR-171) 50mg Carfilzomib (PR-171) is a proteasome inhibS2853H Carfilzomib (PR-171) 100mg Carfilzomib (PR-171) is a proteasome inhibS2853I Carfilzomib (PR-171) 200mg Carfilzomib (PR-171) is a proteasome inhibS1184 Indinavir Indinavir is a potent and competitive HIV pS1575C RO4929097 5mg RO4929097 is a gamma secretase (GS) inhiS1575D RO4929097 10mg RO4929097 is a gamma secretase (GS) inhiS1575G RO4929097 50mg RO4929097 is a gamma secretase (GS) inhiS1575I RO4929097 200mg RO4929097 is a gamma secretase (GS) inhiS2215C DAPT (GSI-IX) 5mg DAPT (GSI-IX) is a novel gamma-secretase S2215D DAPT (GSI-IX) 10mg DAPT (GSI-IX) is a novel gamma-secretase S2215F DAPT (GSI-IX) 25mg DAPT (GSI-IX) is a novel gamma-secretase S2215G DAPT (GSI-IX) 50mg DAPT (GSI-IX) is a novel gamma-secretase S1262C BMS-708163 (Avagacestat) 5mg BMS-708163 is a potent, selective gamma-sS1262D BMS-708163 (Avagacestat) 10mg BMS-708163 is a potent, selective gamma-sS1262G BMS-708163 (Avagacestat) 50mg BMS-708163 is a potent, selective gamma-sS1262I BMS-708163 (Avagacestat) 200mg BMS-708163 is a potent, selective gamma-sS1594C Semagacestat (LY450139) 5mg Semagacestat (LY450139) is a gamma-secreS1594D Semagacestat (LY450139) 10mg Semagacestat (LY450139) is a gamma-secreS1594G Semagacestat (LY450139) 50mg Semagacestat (LY450139) is a gamma-secreS1594I Semagacestat (LY450139) 200mg Semagacestat (LY450139) is a gamma-secreS2660C MK-0752 5mg MK-0752 is a moderately potent gamma-secS2660D MK-0752 10mg MK-0752 is a moderately potent gamma-secS2660G MK-0752 50mg MK-0752 is a moderately potent gamma-secS2660I MK-0752 200mg MK-0752 is a moderately potent gamma-secS2711B YO-01027 2mg YO-01027 (Dibenzazepine, DBZ) is a dipeptS2711C YO-01027 5mg YO-01027 (Dibenzazepine, DBZ) is a dipeptS2711F YO-01027 25mg YO-01027 (Dibenzazepine, DBZ) is a dipeptS2711H YO-01027 100mg YO-01027 (Dibenzazepine, DBZ) is a dipeptS2714 LY411575 LY-411575 is a potent gamma-secretase inS2122C Deuterated Atazanivir-D3-1 5mg Atazanivir-D3-1 is a azapeptide derivative S2122E Deuterated Atazanivir-D3-1 20mg Atazanivir-D3-1 is a azapeptide derivative S2122G Deuterated Atazanivir-D3-1 50mg Atazanivir-D3-1 is a azapeptide derivative S2122I Deuterated Atazanivir-D3-1 200mg Atazanivir-D3-1 is a azapeptide derivative S3010C Deuterated Atazanivir-D3-2 5mg Atazanivir-D3-2 is a azapeptide derivative S3010E Deuterated Atazanivir-D3-2 20mg Atazanivir-D3-2 is a azapeptide derivative S3010G Deuterated Atazanivir-D3-2 50mg Atazanivir-D3-2 is a azapeptide derivative

S3010I Deuterated Atazanivir-D3-2 200mg Atazanivir-D3-2 is a azapeptide derivative S3011C Deuterated Atazanivir-D3-3 5mg Atazanivir-D3-3 is a azapeptide derivative S3011E Deuterated Atazanivir-D3-3 20mg Atazanivir-D3-3 is a azapeptide derivative S3011G Deuterated Atazanivir-D3-3 50mg Atazanivir-D3-3 is a azapeptide derivative S3011I Deuterated Atazanivir-D3-3 200mg Atazanivir-D3-3 is a azapeptide derivative S4002I Sitagliptin phosphate monohydrate 200mgSitagliptin phosphate (MK-0431) is a potentS1344E Glimepiride 20mg Glimepiride (Amaryl, Glista OD) is a mediumS1344G Glimepiride 50mg Glimepiride (Amaryl, Glista OD) is a mediumS1344I Glimepiride 200mg Glimepiride (Amaryl, Glista OD) is a mediumS1540D Saxagliptin (BMS-477118,Onglyza) 10mg Saxagliptin (BMS-477118, Onglyza) is a selS1540F Saxagliptin (BMS-477118,Onglyza) 25mg Saxagliptin (BMS-477118, Onglyza) is a selS1540H Saxagliptin (BMS-477118,Onglyza) 100m Saxagliptin (BMS-477118, Onglyza) is a selS3031C Linagliptin (BI-1356) 5mg Linagliptin is a highly potent, selective DPS3031D Linagliptin (BI-1356) 10mg Linagliptin is a highly potent, selective DPS3031H Linagliptin (BI-1356) 100mg Linagliptin is a highly potent, selective DPS3031I Linagliptin (BI-1356) 200mg Linagliptin is a highly potent, selective DPS3033D Vildagliptin (LAF-237) 10mg Vildagliptin (LAF-237) inhibits DPP-4 with S3033F Vildagliptin (LAF-237) 25mg Vildagliptin (LAF-237) inhibits DPP-4 with S1293E Cilnidipine 20mg Cilnidipine is a calcium channel blocker. S1293G Cilnidipine 50mg Cilnidipine is a calcium channel blocker. S1293K Cilnidipine 500mg Cilnidipine is a calcium channel blocker. S2481D Manidipine (Manyper) 10mg Manidipine (Manyper) is a lipophilic, thirdS2481H Manidipine (Manyper) 100mg Manidipine (Manyper) is a lipophilic, thirdS1813G Amlodipine besylate (Norvasc) 50mg Amlodipine(Norvasc) is a long-acting calciS1813J Amlodipine besylate (Norvasc) 250mg Amlodipine(Norvasc) is a long-acting calciS1885D Felodipine (Plendil) 10mg Felodipine (Plendil) is a selective L-type S1885F Felodipine (Plendil) 25mg Felodipine (Plendil) is a selective L-type S1885G Felodipine (Plendil) 50mg Felodipine (Plendil) is a selective L-type S1885H Felodipine (Plendil) 100mg Felodipine (Plendil) is a selective L-type S1425G Ranolazine 2HCl 50mg Ranolazine(Ranexa), is an antianginal medicS1425H Ranolazine 2HCl 100mg Ranolazine(Ranexa), is an antianginal medicS1425K Ranolazine 2HCl 500mg Ranolazine(Ranexa), is an antianginal medicS1905H Amlodipine (Norvasc) 100mg Amlodipine(Norvasc) is a long-acting calciS3053D Azelnidipine 10mg Azelnidipine is a dihydropyridine calcium S3053G Azelnidipine 50mg Azelnidipine is a dihydropyridine calcium S2080D Cleviprex (Clevidipine) 10mg Cleviprex (Clevidipine) is a dihydropyridinS2080H Cleviprex (Clevidipine) 100mg Cleviprex (Clevidipine) is a dihydropyridinS2050D Strontium ranelate (Protelos) 10mg Strontium ranelate (Protelos) is a strontiuS2030B Flunarizine 2HCl 2mg Flunarizine dihydrochloride is a dihydrochlS2721D Nilvadipine (ARC029) 10mg Nilvadipine (ARC029) is a potent calcium cS2721G Nilvadipine (ARC029) 50mg Nilvadipine (ARC029) is a potent calcium cS2017H Benidipine Hcl 100mg Benidipine hydrochloride is a hydrochlorideS1994D Lacidipine (Lacipil, Motens) 10mg Lacidipine (Lacipil, Motens) also inhibitsS1994G Lacidipine (Lacipil, Motens) 50mg Lacidipine (Lacipil, Motens) also inhibitsS2482F Manidipine 2HCl (CV-4093) 25mg Manidipine HCl is a HCl salt form of ManidS2482G Manidipine 2HCl (CV-4093) 50mg Manidipine HCl is a HCl salt form of ManidS2482I Manidipine 2HCl (CV-4093) 200mg Manidipine HCl is a HCl salt form of ManidS2491G Nitrendipine 50mg Nitrendipine is a dihydropyridine calcium S2491H Nitrendipine 100mg Nitrendipine is a dihydropyridine calcium S1747I Nimodipine (Nimotop) 200mg Nimodipine(Nimotop) is a dihydropyridine dS1253D Lacosamide 10mg Lacosamide is a medication developed for tS1253F Lacosamide 25mg Lacosamide is a medication developed for tS1253H Lacosamide 100mg Lacosamide is a medication developed for tS1614G Riluzole (Rilutek) 50mg Riluzole(Rilutek) is a drug used to treat aS1614I Riluzole (Rilutek) 200mg Riluzole(Rilutek) is a drug used to treat aS1614K Riluzole (Rilutek) 500mg Riluzole(Rilutek) is a drug used to treat aS1256D Rufinamide (Banzel) 10mg Rufinamide, a triazole derivative, is an a

S1256F Rufinamide (Banzel) 25mg Rufinamide, a triazole derivative, is an aS1256H Rufinamide (Banzel) 100mg Rufinamide, a triazole derivative, is an aS2524I Phenytoin sodium (Dilantin) 200mg Phenytoin sodium (Dilantin) is an inactiveS1693H Carbamazepine (Carbatrol) 100mg Carbamazepine (Carbatrol) is a sodium chaS2525M Phenytoin (Lepitoin) 1gr Phenytoin (Lepitoin; NSC 8722; Phenytek; PS2500D Propafenone (Rytmonorm) 10mg Propafenone(Rytmonorm) is a classic anti-arrS2500F Propafenone (Rytmonorm) 25mg Propafenone(Rytmonorm) is a classic anti-arrS2500G Propafenone (Rytmonorm) 50mg Propafenone(Rytmonorm) is a classic anti-arrS3024D Lamotrigine 10mg Lamotrigine is a novel anticonvulsant drugS3024G Lamotrigine 50mg Lamotrigine is a novel anticonvulsant drugS2785D A-803467 10mg A-803467 is a selective NaV1.8 channel blS2785G A-803467 50mg A-803467 is a selective NaV1.8 channel blS2110E Vinpocetine (Cavinton) 20mg Vinpocetine is a selectively inhibitor of vS2110H Vinpocetine (Cavinton) 100mg Vinpocetine is a selectively inhibitor of vS2118D Ibutilide fumarate 10mg Ibutilide is a Class III antiarrhythmic agentS2118H Ibutilide fumarate 100mg Ibutilide is a Class III antiarrhythmic agentS1828M Proparacaine Hcl 1gr Proparacaine HCl is a voltage-gated sodiS2560I Amiloride HCl dihydrate 200mg Amiloride hydrochloride dihydrate is a poteS1478C Oligomycin A 5mg Oligomycins are macrolides created by StreS1478D Oligomycin A 10mg Oligomycins are macrolides created by StreS1478F Oligomycin A 25mg Oligomycins are macrolides created by StreS2623C Omecamtiv mecarbil (CK-1827452) 5mg Omecamtiv mecarbil (CK-1827452) is a specifiS2623D Omecamtiv mecarbil (CK-1827452) 10mg Omecamtiv mecarbil (CK-1827452) is a specifiS2623G Omecamtiv mecarbil (CK-1827452) 50mg Omecamtiv mecarbil (CK-1827452) is a specifiS2623I Omecamtiv mecarbil (CK-1827452) 200m Omecamtiv mecarbil (CK-1827452) is a specifiS2484H Milrinone (Primacor) 100mg Milrinone(Primacor) is a a potent and selecS2000H Sodium orthovanadate 100mg Sodium orthovanadate is an alkaline phosS1389H Omeprazole (Prilosec) 100mg Omeprazole(Prilosec) is a proton pump inhS1389K Omeprazole (Prilosec) 500mg Omeprazole(Prilosec) is a proton pump inhS2222 PF 3716556 PF 3716556 is a potent, and selective acidS2233C Esomeprazole sodium (Nexium) 5mg Esomeprazole sodium (Nexium) is a sodium sS2233D Esomeprazole sodium (Nexium) 10mg Esomeprazole sodium (Nexium) is a sodium sS2233G Esomeprazole sodium (Nexium) 50mg Esomeprazole sodium (Nexium) is a sodium sS2233I Esomeprazole sodium (Nexium) 200mg Esomeprazole sodium (Nexium) is a sodium sS3019I Ciclopirox ethanolamine 200mg Ciclopirox ethanolamine (Ciclopirox olaminS1426G Repaglinide 50mg Repaglinide is for the treatment of type IS1426H Repaglinide 100mg Repaglinide is for the treatment of type IS1426I Repaglinide 200mg Repaglinide is for the treatment of type IS1426L Repaglinide 300mg Repaglinide is for the treatment of type IS1971H Nicorandil (Ikorel) 100mg Nicorandil(Ikorel)is potassium channel actS1971I Nicorandil (Ikorel) 200mg Nicorandil(Ikorel)is potassium channel actS2489D Nateglinide (Starlix) 10mg Nateglinide(Starlix) is an insulin secretaS2489F Nateglinide (Starlix) 25mg Nateglinide(Starlix) is an insulin secretaS2489G Nateglinide (Starlix) 50mg Nateglinide(Starlix) is an insulin secretaS2489H Nateglinide (Starlix) 100mg Nateglinide(Starlix) is an insulin secretaS2456M Chlorpromazine (Sonazine) 1gr Chlorpromazine (Sonazine) is a dopamine anS1160C TRAM-34 5mg TRAM-34 is a selective and potent inhibitS1160F TRAM-34 25mg TRAM-34 is a selective and potent inhibitS2073H Mitiglinide calcium 100mg Mitiglinide is a blood glucose-lowering druS2073J Mitiglinide calcium 250mg Mitiglinide is a blood glucose-lowering druS2443I Tolbutamide 200mg Tolbutamide is an inhibitor of cAMP with S3014D Retigabine (Ezogabine) 10mg Retigabine (Ezogabine, D-23129, Potiga, TS3014G Retigabine (Ezogabine) 50mg Retigabine (Ezogabine, D-23129, Potiga, TS1979M Amiodarone HCL 1gr Amiodarone HCl is an antiarrhythmic drug fS3151M Gliquidone 1gr Gliquidone is an ATP-sensitive K+ channelS2825C ML133 HCL 5mg ML133 is a potent potassium channel inhibiS2825D ML133 HCL 10mg ML133 is a potent potassium channel inhibi

S2825F ML133 HCL 25mg ML133 is a potent potassium channel inhibiS2825G ML133 HCL 50mg ML133 is a potent potassium channel inhibiS1338D Gabapentin HCL 10mg Gabapentin Hydrochloride is a GABA analoguS1338G Gabapentin HCL 50mg Gabapentin Hydrochloride is a GABA analoguS1332F Flumazenil 25mg Flumazenil, an imidazobenzodiazepine derivS1332G Flumazenil 50mg Flumazenil, an imidazobenzodiazepine derivS1332H Flumazenil 100mg Flumazenil, an imidazobenzodiazepine derivS1332I Flumazenil 500mg Flumazenil, an imidazobenzodiazepine derivS1329D Etomidate 10mg Etomidate is a GABAA receptors agonist at S1329F Etomidate 25mg Etomidate is a GABAA receptors agonist at S1329G Etomidate 50mg Etomidate is a GABAA receptors agonist at S2133F Gabapentin (Neurontin) 25mg Gabapentin (Neurontin) is a pharmaceuticaS2133H Gabapentin (Neurontin) 100mg Gabapentin (Neurontin) is a pharmaceuticaS1589 SKF 89976A HCl SKF 89976A is a GABA transporter type 1 S1969G Nefiracetam (Translon) 50mg Nefiracetam (Translon) is a GABAergic, cS1969J Nefiracetam (Translon) 250mg Nefiracetam (Translon) is a GABAergic, cS2026D Ginkgolide A 10mg Ginkgolide A is an extract from in Ginkgo S2026F Ginkgolide A 25mg Ginkgolide A is an extract from in Ginkgo S3018H Niflumic acid 100mg Niflumic acid is an inhibitor of cyclooxygeS1082C Vismodegib (GDC-0449) 5mg GDC-0449 (Vismodegib, HhAntag691) is a poS1082D Vismodegib (GDC-0449) 10mg GDC-0449 (Vismodegib, HhAntag691) is a poS1082G Vismodegib (GDC-0449) 50mg GDC-0449 (Vismodegib, HhAntag691) is a poS1082I Vismodegib (GDC-0449) 200mg GDC-0449 (Vismodegib, HhAntag691) is a poS1481C LY335979 (Zosuquidar 3HCl) 5mg LY335979 (Zosuquidar) is a potent modulatS1481D LY335979 (Zosuquidar 3HCl) 10mg LY335979 (Zosuquidar) is a potent modulatS1481G LY335979 (Zosuquidar 3HCl) 50mg LY335979 (Zosuquidar) is a potent modulatS1481I LY335979 (Zosuquidar 3HCl) 200mg LY335979 (Zosuquidar) is a potent modulatS1354K Lansoprazole 500mg Lansoprazole is a proton-pump inhibitor (PS1413 Bafilomycin A1 Bafilomycin A1 is a vacuolar H+-ATPase inhS2105H Pantoprazole (Protonix) 100mg S2105HS2105K Pantoprazole (Protonix) 500mg S2105KS1565C VX-809 5mg VX-809 is a CFTR modulator with EC50 ofS1565D VX-809 10mg VX-809 is a CFTR modulator with EC50 ofS1565G VX-809 50mg VX-809 is a CFTR modulator with EC50 ofS1565I VX-809 200mg VX-809 is a CFTR modulator with EC50 ofS1144C Ivacaftor (VX-770) 5mg Ivacaftor (VX-770, Kalydeco) is a potentS1144D Ivacaftor (VX-770) 10mg Ivacaftor (VX-770, Kalydeco) is a potentS1144G Ivacaftor (VX-770) 50mg Ivacaftor (VX-770, Kalydeco) is a potentS1144I Ivacaftor (VX-770) 200mg Ivacaftor (VX-770, Kalydeco) is a potentS1003C Linifanib (ABT-869) 5mg Linifanib (ABT-869) is a novel, potent ATPS1003D Linifanib (ABT-869) 10mg Linifanib (ABT-869) is a novel, potent ATPS1003G Linifanib (ABT-869) 50mg Linifanib (ABT-869) is a novel, potent ATPS1003I Linifanib (ABT-869) 200mg Linifanib (ABT-869) is a novel, potent ATPS1005G Axitinib 50mg Axitinib (AG-013736) is a multi-target inS1005H Axitinib 100mg Axitinib (AG-013736) is a multi-target inS1007D FG-4592 10mg FG-4592 is an HIFalpha prolyl hydroxylase S1007G FG-4592 50mg FG-4592 is an HIFalpha prolyl hydroxylase S1010C BIBF1120 (Vargatef) 5mg BIBF1120 (Vargatef) is a potent inhibitoS1010D BIBF1120 (Vargatef) 10mg BIBF1120 (Vargatef) is a potent inhibitoS1010G BIBF1120 (Vargatef) 50mg BIBF1120 (Vargatef) is a potent inhibitoS1010I BIBF1120 (Vargatef) 200mg BIBF1120 (Vargatef) is a potent inhibitoS1014D Bosutinib (SKI-606) 10mg Bosutinib (SKI-606) is a novel, dual Src/AbS1014G Bosutinib (SKI-606) 50mg Bosutinib (SKI-606) is a novel, dual Src/AbS1017C Cediranib (AZD2171) 5mg Cediranib (AZD2171) is a highly potent VES1017D Cediranib (AZD2171) 10mg Cediranib (AZD2171) is a highly potent VES1017F Cediranib (AZD2171) 25mg Cediranib (AZD2171) is a highly potent VES1017G Cediranib (AZD2171) 50mg Cediranib (AZD2171) is a highly potent VE

S1018D Dovitinib (TKI-258) 10mg Dovitinib (TKI258, CHIR258) is a novel mulS1018F Dovitinib (TKI-258) 25mg Dovitinib (TKI258, CHIR258) is a novel mulS1018G Dovitinib (TKI-258) 50mg Dovitinib (TKI258, CHIR258) is a novel mulS1032C Motesanib Diphosphate (AMG-706) 5mg Motesanib Diphosphate (AMG-706) is a potS1032D Motesanib Diphosphate (AMG-706) 10mg Motesanib Diphosphate (AMG-706) is a potS1032G Motesanib Diphosphate (AMG-706) 50mg Motesanib Diphosphate (AMG-706) is a potS1032I Motesanib Diphosphate (AMG-706) 200m Motesanib Diphosphate (AMG-706) is a potS1035D Pazopanib Hcl 10mg Pazopanib Hydrochloride (GW786034, VotriS1035F Pazopanib Hcl 25mg Pazopanib Hydrochloride (GW786034, VotriS1035H Pazopanib Hcl 100mg Pazopanib Hydrochloride (GW786034, VotriS1042G Sunitinib Malate (Sutent) 50mg Sunitinib Malate (Sutent, SU11248) is a mS1042H Sunitinib Malate (Sutent) 100mg Sunitinib Malate (Sutent, SU11248) is a mS1042K Sunitinib Malate (Sutent) 500mg Sunitinib Malate (Sutent, SU11248) is a mS1043F Tandutinib (MLN518) 25mg Tandutinib (MLN518, CT53518) is an ATP-coS1043H Tandutinib (MLN518) 100mg Tandutinib (MLN518, CT53518) is an ATP-coS1043I Tandutinib (MLN518) 200mg Tandutinib (MLN518, CT53518) is an ATP-coS1046F Vandetanib (Zactima) 25mg Vandetanib (Zactima, ZD6474) is a potent S1046H Vandetanib (Zactima) 100mg Vandetanib (Zactima, ZD6474) is a potent S1046K Vandetanib (Zactima) 500mg Vandetanib (Zactima, ZD6474) is a potent S1068C Crizotinib (PF-02341066) 5mg PF-2341066 (Crizotinib) is a potent inhibiS1068D Crizotinib (PF-02341066) 10mg PF-2341066 (Crizotinib) is a potent inhibiS1068G Crizotinib (PF-02341066) 50mg PF-2341066 (Crizotinib) is a potent inhibiS1083 XL647 Inhibitor of the EGFR and ErbB2 with IC50S1084C Brivanib (BMS-540215) 5mg Brivanib is an ATP-competitive inhibitorS1084D Brivanib (BMS-540215) 10mg Brivanib is an ATP-competitive inhibitorS1084G Brivanib (BMS-540215) 50mg Brivanib is an ATP-competitive inhibitorS1084I Brivanib (BMS-540215) 200mg Brivanib is an ATP-competitive inhibitorS1101D Vatalanib 2HCl (PTK787) 10mg Vatalanib (PTK787) is a VEGFR inhibitor oS1101G Vatalanib 2HCl (PTK787) 50mg Vatalanib (PTK787) is a VEGFR inhibitor oS1101H Vatalanib 2HCl (PTK787) 100mg Vatalanib (PTK787) is a VEGFR inhibitor oS1108C TAE684 (NVP-TAE684) 5mg TAE684 is a potent and selective ALK inhibS1108D TAE684 (NVP-TAE684) 10mg TAE684 is a potent and selective ALK inhibS1108G TAE684 (NVP-TAE684) 50mg TAE684 is a potent and selective ALK inhibS1108I TAE684 (NVP-TAE684) 200mg TAE684 is a potent and selective ALK inhibS1111C Foretinib (GSK1363089, XL880) 5mg XL880 (GSK1363089, EXEL-2880) is an ATP-S1111G Foretinib (GSK1363089, XL880) 50mg XL880 (GSK1363089, EXEL-2880) is an ATP-S1111I Foretinib (GSK1363089, XL880) 200mg XL880 (GSK1363089, EXEL-2880) is an ATP-S1119C XL-184 free base (Cabozantinib) 5mg XL184 (Cabozantinib) is a potent VEGFR2 iS1119D XL-184 free base (Cabozantinib) 10mg XL184 (Cabozantinib) is a potent VEGFR2 iS1119G XL-184 free base (Cabozantinib) 50mg XL184 (Cabozantinib) is a potent VEGFR2 iS1119I XL-184 free base (Cabozantinib) 200mg XL184 (Cabozantinib) is a potent VEGFR2 iS1138D Brivanib alaninate (BMS-582664) 10mg BMS-582664, also named "brivanib alaninatS1138G Brivanib alaninate (BMS-582664) 50mg BMS-582664, also named "brivanib alaninatS1164B E7080 (Lenvatinib) 2mg E7080 (Lenvatinib) is a multi-target inhiS1164C E7080 (Lenvatinib) 5mg E7080 (Lenvatinib) is a multi-target inhiS1164D E7080 (Lenvatinib) 10mg E7080 (Lenvatinib) is a multi-target inhiS1164G E7080 (Lenvatinib) 50mg E7080 (Lenvatinib) is a multi-target inhiS1164H E7080 (Lenvatinib) 100mg E7080 (Lenvatinib) is a multi-target inhiS1171D CYC116 10mg CYC116 is a potent inhibitor of Aurora A aS1171G CYC116 50mg CYC116 is a potent inhibitor of Aurora A aS1171I CYC116 200mg CYC116 is a potent inhibitor of Aurora A aS1176C NPI-2358 (Plinabulin) 5mg NPI-2358 is a tubulin-depolymerizing agentS1176D NPI-2358 (Plinabulin) 10mg NPI-2358 is a tubulin-depolymerizing agentS1176G NPI-2358 (Plinabulin) 50mg NPI-2358 is a tubulin-depolymerizing agentS1176I NPI-2358 (Plinabulin) 200mg NPI-2358 is a tubulin-depolymerizing agentS1181C ENMD-2076 5mg ENMD-2076 is a selective inhibitor of AurS1181D ENMD-2076 10mg ENMD-2076 is a selective inhibitor of Aur

S1181G ENMD-2076 50mg ENMD-2076 is a selective inhibitor of AurS1181I ENMD-2076 200mg ENMD-2076 is a selective inhibitor of AurS1207C Tivozanib (AV-951) 5mg AV-951 (Tivozanib, KRN-951) is a potentS1207D Tivozanib (AV-951) 10mg AV-951 (Tivozanib, KRN-951) is a potentS1207G Tivozanib (AV-951) 50mg AV-951 (Tivozanib, KRN-951) is a potentS1220C OSI-930 5mg OSI-930 is a potent inhibitor of Kit, KDR,S1220F OSI-930 25mg OSI-930 is a potent inhibitor of Kit, KDR,S1220G OSI-930 50mg OSI-930 is a potent inhibitor of Kit, KDR,S1233D 2-Methoxyestradiol 10mg 2-Methoxyestradiol is an endogenous estroS1233G 2-Methoxyestradiol 50mg 2-Methoxyestradiol is an endogenous estroS1233H 2-Methoxyestradiol 100mg 2-Methoxyestradiol is an endogenous estroS1233L 2-Methoxyestradiol 300mg 2-Methoxyestradiol is an endogenous estroS1264C PD173074 5mg PD173074 is a potent FGFR1 inhibitor witS1264D PD173074 10mg PD173074 is a potent FGFR1 inhibitor witS1264G PD173074 50mg PD173074 is a potent FGFR1 inhibitor witS1361C MGCD-265 5mg MGCD-265 is a potent, multi-target and AS1361D MGCD-265 10mg MGCD-265 is a potent, multi-target and AS1361G MGCD-265 50mg MGCD-265 is a potent, multi-target and AS1361I MGCD-265 200mg MGCD-265 is a potent, multi-target and AS1363C Ki8751 5mg Ki8751 is a potent and selective inhibitorS1363D Ki8751 10mg Ki8751 is a potent and selective inhibitorS1363F Ki8751 25mg Ki8751 is a potent and selective inhibitorS1363G Ki8751 50mg Ki8751 is a potent and selective inhibitorS1419 Quinomycin A (Echinomycin) Quinomycin A (Echinomycin) binds to DNA S1470C TSU-68 (SU6668) 5mg TSU-68 (SU6668, Orantinib) is a potent inS1470D TSU-68 (SU6668) 10mg TSU-68 (SU6668, Orantinib) is a potent inS1470G TSU-68 (SU6668) 50mg TSU-68 (SU6668, Orantinib) is a potent inS1470I TSU-68 (SU6668) 200mg TSU-68 (SU6668, Orantinib) is a potent inS1526C Quizartinib (AC220) 5mg AC220 (Quizartinib) is a potent and selectiS1526D Quizartinib (AC220) 10mg AC220 (Quizartinib) is a potent and selectiS1526G Quizartinib (AC220) 50mg AC220 (Quizartinib) is a potent and selectiS1526I Quizartinib (AC220) 200mg AC220 (Quizartinib) is a potent and selectiS1533D R406 (free base) 10mg R406 (free base) is a Syk inhibitor with ICS1533G R406 (free base) 50mg R406 (free base) is a Syk inhibitor with ICS1533I R406 (free base) 200mg R406 (free base) is a Syk inhibitor with ICS1537C DMXAA (ASA404) 5mg DMXAA (ASA404) is a competitive inhibitoS1537F DMXAA (ASA404) 25mg DMXAA (ASA404) is a competitive inhibitoS1537H DMXAA (ASA404) 100mg DMXAA (ASA404) is a competitive inhibitoS1557C KRN 633 5mg KRN 633 is an ATP-competitive inhibitorS1557D KRN 633 10mg KRN 633 is an ATP-competitive inhibitorS1557G KRN 633 50mg KRN 633 is an ATP-competitive inhibitorS1557I KRN 633 200mg KRN 633 is an ATP-competitive inhibitorS2183C BGJ398 (NVP-BGJ398) 5mg BGJ398 (NVP-BGJ398) is a potent and seleS2183D BGJ398 (NVP-BGJ398) 10mg BGJ398 (NVP-BGJ398) is a potent and seleS2183F BGJ398 (NVP-BGJ398) 25mg BGJ398 (NVP-BGJ398) is a potent and seleS2183H BGJ398 (NVP-BGJ398) 100mg BGJ398 (NVP-BGJ398) is a potent and seleS2183I BGJ398 (NVP-BGJ398) 200mg BGJ398 (NVP-BGJ398) is a potent and seleS2194B R406 2mg R406 is a potent spleen tyrosine kinase (SS2194C R406 5mg R406 is a potent spleen tyrosine kinase (SS2194D R406 10mg R406 is a potent spleen tyrosine kinase (SS2194G R406 50mg R406 is a potent spleen tyrosine kinase (SS2194I R406 200mg R406 is a potent spleen tyrosine kinase (SS2201C BMS 794833 5mg BMS794833 is a potent ATP competitive inS2201D BMS 794833 10mg BMS794833 is a potent ATP competitive inS2201G BMS 794833 50mg BMS794833 is a potent ATP competitive inS2201I BMS 794833 200mg BMS794833 is a potent ATP competitive inS2206C R935788 (Fostamatinib disodium, R788) R935788 (Fostamatinib disodium, R788) is

S2206D R935788 (Fostamatinib disodium, R788) R935788 (Fostamatinib disodium, R788) is S2206G R935788 (Fostamatinib disodium, R788) R935788 (Fostamatinib disodium, R788) is S2206I R935788 (Fostamatinib disodium, R788) R935788 (Fostamatinib disodium, R788) is S2216D Mubritinib (TAK 165) 10mg Mubritinib (TAK 165) is a potent inhibitor S2216F Mubritinib (TAK 165) 25mg Mubritinib (TAK 165) is a potent inhibitor S2216I Mubritinib (TAK 165) 200mg Mubritinib (TAK 165) is a potent inhibitor S2221D Apatinib (YN968D1) 10mg Apatinib (YN968D1) is a small-molecule seleS2221G Apatinib (YN968D1) 50mg Apatinib (YN968D1) is a small-molecule seleS2221I Apatinib (YN968D1) 200mg Apatinib (YN968D1) is a small-molecule seleS2231C Telatinib (BAY 57-9352) 5mg Telatinib (BAY 57-9352) is a potent inhiS2231D Telatinib (BAY 57-9352) 10mg Telatinib (BAY 57-9352) is a potent inhiS2231G Telatinib (BAY 57-9352) 50mg Telatinib (BAY 57-9352) is a potent inhiS2231I Telatinib (BAY 57-9352) 200mg Telatinib (BAY 57-9352) is a potent inhiS2475J Imatinib (Gleevec) 250mg Imatinib is a multi-target inhibitor of v-AS2475K Imatinib (Gleevec) 500mg Imatinib is a multi-target inhibitor of v-AS2625B R788 (Fostamatinib) 2mg R788 (Fostamatinib) is a Syk inhibitor witS2625C R788 (Fostamatinib) 5mg R788 (Fostamatinib) is a Syk inhibitor witS2625D R788 (Fostamatinib) 10mg R788 (Fostamatinib) is a Syk inhibitor witS2625G R788 (Fostamatinib) 50mg R788 (Fostamatinib) is a Syk inhibitor witS2625H R788 (Fostamatinib) 100mg R788 (Fostamatinib) is a Syk inhibitor witS2680C PCI-32765 (Ibrutinib) 5mg PCI-32765 (Ibrutinib) is a potent and highlyS2680D PCI-32765 (Ibrutinib) 10mg PCI-32765 (Ibrutinib) is a potent and highlyS2680G PCI-32765 (Ibrutinib) 50mg PCI-32765 (Ibrutinib) is a potent and highlyS2680I PCI-32765 (Ibrutinib) 200mg PCI-32765 (Ibrutinib) is a potent and highlyS2700C KX2-391 5mg KX2-391 (KX01) is a highly selective non ATS2700D KX2-391 10mg KX2-391 (KX01) is a highly selective non ATS2700G KX2-391 50mg KX2-391 (KX01) is a highly selective non ATS2700H KX2-391 100mg KX2-391 (KX01) is a highly selective non ATS2700I KX2-391 200mg KX2-391 (KX01) is a highly selective non ATS2703C GSK1838705A 5mg GSK1838705A is a potent inhibitor of IGF-S2703D GSK1838705A 10mg GSK1838705A is a potent inhibitor of IGF-S2703G GSK1838705A 50mg GSK1838705A is a potent inhibitor of IGF-S2703I GSK1838705A 200mg GSK1838705A is a potent inhibitor of IGF-S2730C Crenolanib (CP-868596) 5mg Crenolanib (CP-868569) is a potent and sS2730D Crenolanib (CP-868596) 10mg Crenolanib (CP-868569) is a potent and sS2730G Crenolanib (CP-868596) 50mg Crenolanib (CP-868569) is a potent and sS2730I Crenolanib (CP-868596) 200mg Crenolanib (CP-868569) is a potent and sS2762C CH5424802 5mg CH5424802 is a potent and selective ALK iS2762D CH5424802 10mg CH5424802 is a potent and selective ALK iS2762G CH5424802 50mg CH5424802 is a potent and selective ALK iS2762H CH5424802 100mg CH5424802 is a potent and selective ALK iS2774C MK-2461 5mg MK-2461 is a potent inhibitor of c-Met, RS2774D MK-2461 10mg MK-2461 is a potent inhibitor of c-Met, RS2774G MK-2461 50mg MK-2461 is a potent inhibitor of c-Met, RS2774H MK-2461 100mg MK-2461 is a potent inhibitor of c-Met, RS2801C AZD4547 5mg AZD4547 is a novel selective FGFR inhibiS2801D AZD4547 10mg AZD4547 is a novel selective FGFR inhibiS2801G AZD4547 50mg AZD4547 is a novel selective FGFR inhibiS2801H AZD4547 100mg AZD4547 is a novel selective FGFR inhibiS2801I AZD4547 200mg AZD4547 is a novel selective FGFR inhibiS2816C Tyrphostin AG 879 (AG 879) 5mg AG879 inhibits both ErbB2 and Flk-1 with S2816D Tyrphostin AG 879 (AG 879) 10mg AG879 inhibits both ErbB2 and Flk-1 with S2816F Tyrphostin AG 879 (AG 879) 25mg AG879 inhibits both ErbB2 and Flk-1 with S2842D SAR131675 10mg SAR131675 is a potent and selective VEGFS2842G SAR131675 50mg SAR131675 is a potent and selective VEGFS2845C Semaxanib (SU5416) 5mg Adrenalone is an adrenergic agonist with S2845D Semaxanib (SU5416) 10mg Adrenalone is an adrenergic agonist with

S2845G Semaxanib (SU5416) 50mg Adrenalone is an adrenergic agonist with S2845H Semaxanib (SU5416) 100mg Adrenalone is an adrenergic agonist with S2851C Baricitinib (LY3009104) 5mg Baricitinib is a selective JAK1 and JAK2 inS2851D Baricitinib (LY3009104) 10mg Baricitinib is a selective JAK1 and JAK2 inS2851G Baricitinib (LY3009104) 50mg Baricitinib is a selective JAK1 and JAK2 inS2851I Baricitinib (LY3009104) 200mg Baricitinib is a selective JAK1 and JAK2 inS2859C Golvatinib 5mg E7050 is a dual c-Met and VEGFR-2 inhibitS2859D Golvatinib 10mg E7050 is a dual c-Met and VEGFR-2 inhibitS2859G Golvatinib 50mg E7050 is a dual c-Met and VEGFR-2 inhibitS2859I Golvatinib 200mg E7050 is a dual c-Met and VEGFR-2 inhibitS2867D WHI-P154 10mg WHI-P154 is a potent JAK3 inhibitor with S2867G WHI-P154 50mg WHI-P154 is a potent JAK3 inhibitor with S3012F Pazopanib 25mg Pazopanib is a potent and selective multS3012H Pazopanib 100mg Pazopanib is a potent and selective multS3026D Piceatannol 10mg Piceatannol is a selective Syk inhibitor wiS3026F Piceatannol 25mg Piceatannol is a selective Syk inhibitor wiS3026G Piceatannol 50mg Piceatannol is a selective Syk inhibitor wiS1012 BMS-536924 BMS-536924 is an ATP-competitive IGF-IR aS1034 NVP-AEW541 NVP-AEW541 is a potent inhibitor of IGF-IS1048F VX-680 (MK-0457, Tozasertib) 25mg VX-680 (MK-0457, Tozasertib) is a pan-AurS1048H VX-680 (MK-0457, Tozasertib) 100mg VX-680 (MK-0457, Tozasertib) is a pan-AurS1048J VX-680 (MK-0457, Tozasertib) 250mg VX-680 (MK-0457, Tozasertib) is a pan-AurS1070C PHA-665752 5mg PHA-665752 is a potent, selective and ATP-S1070D PHA-665752 10mg PHA-665752 is a potent, selective and ATP-S1070G PHA-665752 50mg PHA-665752 is a potent, selective and ATP-S1070I PHA-665752 200mg PHA-665752 is a potent, selective and ATP-S1080B SU11274 2mg SU11274 is a selective Met inhibitor with S1080C SU11274 5mg SU11274 is a selective Met inhibitor with S1080F SU11274 25mg SU11274 is a selective Met inhibitor with S1080I SU11274 200mg SU11274 is a selective Met inhibitor with S1088C NVP-ADW742 5mg NVP-ADW742 is an IGF-1R inhibitor with IS1088D NVP-ADW742 10mg NVP-ADW742 is an IGF-1R inhibitor with IS1088G NVP-ADW742 50mg NVP-ADW742 is an IGF-1R inhibitor with IS1088I NVP-ADW742 200mg NVP-ADW742 is an IGF-1R inhibitor with IS1091C Linsitinib (OSI-906) 5mg OSI-906 (Linsitinib) is a selective inhibitS1091D Linsitinib (OSI-906) 10mg OSI-906 (Linsitinib) is a selective inhibitS1091G Linsitinib (OSI-906) 50mg OSI-906 (Linsitinib) is a selective inhibitS1091I Linsitinib (OSI-906) 200mg OSI-906 (Linsitinib) is a selective inhibitS1093D GSK1904529A 10mg GSK1904529A is a selective inhibitor of IS1093G GSK1904529A 50mg GSK1904529A is a selective inhibitor of IS1094C PF-04217903 5mg PF-04217903 is a selective ATP-competitiveS1094D PF-04217903 10mg PF-04217903 is a selective ATP-competitiveS1094G PF-04217903 50mg PF-04217903 is a selective ATP-competitiveS1094H PF-04217903 100mg PF-04217903 is a selective ATP-competitiveS1100C MLN8054 5mg MLN8054 is a potent and selective inhibitoS1100D MLN8054 10mg MLN8054 is a potent and selective inhibitoS1100G MLN8054 50mg MLN8054 is a potent and selective inhibitoS1100I MLN8054 200mg MLN8054 is a potent and selective inhibitoS1103C ZM-447439 5mg ZM-447439 is a selective and ATP-competitS1103D ZM-447439 10mg ZM-447439 is a selective and ATP-competitS1103F ZM-447439 25mg ZM-447439 is a selective and ATP-competitS1103G ZM-447439 50mg ZM-447439 is a selective and ATP-competitS1109C BI 2536 5mg BI 2536 is a potent Plk1 inhibitor with IC5S1109D BI 2536 10mg BI 2536 is a potent Plk1 inhibitor with IC5S1109G BI 2536 50mg BI 2536 is a potent Plk1 inhibitor with IC5S1109H BI 2536 100mg BI 2536 is a potent Plk1 inhibitor with IC5S1112C SGX-523 5mg SGX-523 is a selective Met inhibitor with

S1112D SGX-523 10mg SGX-523 is a selective Met inhibitor with S1112F SGX-523 25mg SGX-523 is a selective Met inhibitor with S1112G SGX-523 50mg SGX-523 is a selective Met inhibitor with S1114B JNJ-38877605 2mg JNJ-38877605 is an ATP-competitive inhibiS1114C JNJ-38877605 5mg JNJ-38877605 is an ATP-competitive inhibiS1114D JNJ-38877605 10mg JNJ-38877605 is an ATP-competitive inhibiS1114G JNJ-38877605 50mg JNJ-38877605 is an ATP-competitive inhibiS1114H JNJ-38877605 100mg JNJ-38877605 is an ATP-competitive inhibiS1116C PD 0332991 Hcl 5mg PD 0332991 is a highly selective inhibitoS1116D PD 0332991 Hcl 10mg PD 0332991 is a highly selective inhibitoS1116G PD 0332991 Hcl 50mg PD 0332991 is a highly selective inhibitoS1124 BMS-754807 BMS-754807 is an IGF-1R inhibitor with aS1133C MLN8237 (Alisertib) 5mg MLN8237 (Alisertib) is a selective Aurora AS1133D MLN8237 (Alisertib) 10mg MLN8237 (Alisertib) is a selective Aurora AS1133G MLN8237 (Alisertib) 50mg MLN8237 (Alisertib) is a selective Aurora AS1133I MLN8237 (Alisertib) 200mg MLN8237 (Alisertib) is a selective Aurora AS1145C SNS-032 (BMS-387032) 5mg SNS-032 is a novel, potent and selectiveS1145D SNS-032 (BMS-387032) 10mg SNS-032 is a novel, potent and selectiveS1145G SNS-032 (BMS-387032) 50mg SNS-032 is a novel, potent and selectiveS1145I SNS-032 (BMS-387032) 200mg SNS-032 is a novel, potent and selectiveS1147C Barasertib (AZD1152-HQPA) 5mg AZD1152-HQPA (Barasertib) is a highly seleS1147D Barasertib (AZD1152-HQPA) 10mg AZD1152-HQPA (Barasertib) is a highly seleS1147G Barasertib (AZD1152-HQPA) 50mg AZD1152-HQPA (Barasertib) is a highly seleS1153D Roscovitine (Seliciclib, CYC202) 10mg Roscovitine (Seliciclib, CYC202, R-roscoviS1153G Roscovitine (Seliciclib, CYC202) 50mg Roscovitine (Seliciclib, CYC202, R-roscoviS1153I Roscovitine (Seliciclib, CYC202) 200mg Roscovitine (Seliciclib, CYC202, R-roscoviS1154C SNS-314 5mg SNS-314 Mesylate is a potent and selectiveS1154D SNS-314 10mg SNS-314 Mesylate is a potent and selectiveS1154G SNS-314 50mg SNS-314 Mesylate is a potent and selectiveS1154I SNS-314 200mg SNS-314 Mesylate is a potent and selectiveS1230C Flavopiridol (Alvocidib) 5mg Flavopiridol (Alvocidib, HMR-1275, L86-S1230F Flavopiridol (Alvocidib) 25mg Flavopiridol (Alvocidib, HMR-1275, L86-S1230H Flavopiridol (Alvocidib) 100mg Flavopiridol (Alvocidib, HMR-1275, L86-S1234C AG-1024 5mg AG-1024 (Tyrphostin) is a specific IGF-1R S1234D AG-1024 10mg AG-1024 (Tyrphostin) is a specific IGF-1R S1239 TAK-960 TAK-960 is a novel, potent and selective PlS1249B JNJ-7706621 2mg JNJ-7706621 is a potent and multi-target S1249C JNJ-7706621 5mg JNJ-7706621 is a potent and multi-target S1249D JNJ-7706621 10mg JNJ-7706621 is a potent and multi-target S1249G JNJ-7706621 50mg JNJ-7706621 is a potent and multi-target S1249H JNJ-7706621 100mg JNJ-7706621 is a potent and multi-target S1316D AMG-208 10mg AMG-208 is a highly selective c-Met inhibitS1316G AMG-208 50mg AMG-208 is a highly selective c-Met inhibitS1316I AMG-208 200mg AMG-208 is a highly selective c-Met inhibitS1362C ON-01910 5mg ON-01910 (Estybon, Novonex, Rigosertib) iS1362D ON-01910 10mg ON-01910 (Estybon, Novonex, Rigosertib) iS1362G ON-01910 50mg ON-01910 (Estybon, Novonex, Rigosertib) iS1362I ON-01910 200mg ON-01910 (Estybon, Novonex, Rigosertib) iS1451C Aurora A Inhibitor I 5mg Aurora A Inhibitor I is a novel, potent, andS1451D Aurora A Inhibitor I 10mg Aurora A Inhibitor I is a novel, potent, andS1451G Aurora A Inhibitor I 50mg Aurora A Inhibitor I is a novel, potent, andS1454C PHA-680632 5mg PHA-680632 is potent inhibitor of Aurora S1454D PHA-680632 10mg PHA-680632 is potent inhibitor of Aurora S1454G PHA-680632 50mg PHA-680632 is potent inhibitor of Aurora S1454I PHA-680632 200mg PHA-680632 is potent inhibitor of Aurora S1474B GSK429286A 2mg GSK429286A is a selective inhibitor of RS1474G GSK429286A 50mg GSK429286A is a selective inhibitor of R

S1485C HMN-214 5mg HMN-214 (IVX-214) is a potent inhibitor ofS1485D HMN-214 10mg HMN-214 (IVX-214) is a potent inhibitor ofS1485G HMN-214 50mg HMN-214 (IVX-214) is a potent inhibitor ofS1485I HMN-214 200mg HMN-214 (IVX-214) is a potent inhibitor ofS1487C PHA-793887 5mg PHA-793887 is a novel and potent inhibitS1487D PHA-793887 10mg PHA-793887 is a novel and potent inhibitS1487G PHA-793887 50mg PHA-793887 is a novel and potent inhibitS1487I PHA-793887 200mg PHA-793887 is a novel and potent inhibitS1519C CCT129202 5mg CCT129202 is an ATP-competitive pan-AurorS1519D CCT129202 10mg CCT129202 is an ATP-competitive pan-AurorS1519G CCT129202 50mg CCT129202 is an ATP-competitive pan-AurorS1519I CCT129202 200mg CCT129202 is an ATP-competitive pan-AurorS1524C AT7519 5mg AT7519 is a novel multi-CDK inhibitor foS1524D AT7519 10mg AT7519 is a novel multi-CDK inhibitor foS1524F AT7519 25mg AT7519 is a novel multi-CDK inhibitor foS1524H AT7519 100mg AT7519 is a novel multi-CDK inhibitor foS1525C MK-1775 5mg MK-1775 is a potent and selective Wee1 inhS1525D MK-1775 10mg MK-1775 is a potent and selective Wee1 inhS1525F MK-1775 25mg MK-1775 is a potent and selective Wee1 inhS1525G MK-1775 50mg MK-1775 is a potent and selective Wee1 inhS1529C Hesperadin 5mg Hesperadin inhibits Aurora B and T. bruceS1529D Hesperadin 10mg Hesperadin inhibits Aurora B and T. bruceS1529G Hesperadin 50mg Hesperadin inhibits Aurora B and T. bruceS1529I Hesperadin 200mg Hesperadin inhibits Aurora B and T. bruceS1532B AZD7762 2mg AZD7762 is a novel CHK1 and CHK2 inhibitS1532C AZD7762 5mg AZD7762 is a novel CHK1 and CHK2 inhibitS1532F AZD7762 25mg AZD7762 is a novel CHK1 and CHK2 inhibitS1532H AZD7762 100mg AZD7762 is a novel CHK1 and CHK2 inhibitS1561C BMS 777607 5mg BMS-777607 is a Met-related inhibitor for S1561D BMS 777607 10mg BMS-777607 is a Met-related inhibitor for S1561G BMS 777607 50mg BMS-777607 is a Met-related inhibitor for S1572D BS-181 Hcl 10mg BS-181 is a highly selective CDK inhibitorS1572G BS-181 Hcl 50mg BS-181 is a highly selective CDK inhibitorS2014C BMS-265246 5mg BMS265246 is a potent and selective CDK iS2014D BMS-265246 10mg BMS265246 is a potent and selective CDK iS2014G BMS-265246 50mg BMS265246 is a potent and selective CDK iS2014I BMS-265246 200mg BMS265246 is a potent and selective CDK iS2193D GSK461364 10mg GSK461364 inhibits purified Plk1 with Ki oS2193G GSK461364 50mg GSK461364 inhibits purified Plk1 with Ki oS2225C TAME 5mg Tosyl-L-Arginine Methyl Ester (TAME) is anS2225D TAME 10mg Tosyl-L-Arginine Methyl Ester (TAME) is anS2225G TAME 50mg Tosyl-L-Arginine Methyl Ester (TAME) is anS2225I TAME 200mg Tosyl-L-Arginine Methyl Ester (TAME) is anS2235C BI6727 (Volasertib) 5mg BI6727 (Volasertib) is a highly potent Plk1 S2235D BI6727 (Volasertib) 10mg BI6727 (Volasertib) is a highly potent Plk1 S2235G BI6727 (Volasertib) 50mg BI6727 (Volasertib) is a highly potent Plk1 S2280M Chlorogenic acid 1g S2280S2621D AZD5438 10mg AZD5438 is a potent inhibitor of CDK1, CS2621G AZD5438 50mg AZD5438 is a potent inhibitor of CDK1, CS2621I AZD5438 200mg AZD5438 is a potent inhibitor of CDK1, CS2626C LY2603618 (IC-83) 5mg LY2603618 (IC-83) is a selective Chk1 inhibiS2626D LY2603618 (IC-83) 10mg LY2603618 (IC-83) is a selective Chk1 inhibiS2626G LY2603618 (IC-83) 50mg LY2603618 (IC-83) is a selective Chk1 inhibiS2626I LY2603618 (IC-83) 200mg LY2603618 (IC-83) is a selective Chk1 inhibiS2679D Flavopiridol Hcl 10mg Flavopiridol competes with ATP to inhibS2679F Flavopiridol Hcl 25mg Flavopiridol competes with ATP to inhibS2679G Flavopiridol Hcl 50mg Flavopiridol competes with ATP to inhib

S2679H Flavopiridol Hcl 100mg Flavopiridol competes with ATP to inhibS2679I Flavopiridol Hcl 200mg Flavopiridol competes with ATP to inhibS2683B CHIR-124 2mg CHIR-124 is a novel and potent Chk1 inhibiS2683C CHIR-124 5mg CHIR-124 is a novel and potent Chk1 inhibiS2683F CHIR-124 25mg CHIR-124 is a novel and potent Chk1 inhibiS2683H CHIR-124 100mg CHIR-124 is a novel and potent Chk1 inhibiS2688 R547 R547 is a potent and selective CDK inhibitS2718C TAK-901 5mg TAK-901 is a novel inhibitor of Aurora A aS2718D TAK-901 10mg TAK-901 is a novel inhibitor of Aurora A aS2718G TAK-901 50mg TAK-901 is a novel inhibitor of Aurora A aS2718I TAK-901 200mg TAK-901 is a novel inhibitor of Aurora A aS2719C AMG 900 5mg AMG 900 is a potent and highly selective pS2719D AMG 900 10mg AMG 900 is a potent and highly selective pS2719G AMG 900 50mg AMG 900 is a potent and highly selective pS2719I AMG 900 200mg AMG 900 is a potent and highly selective pS2735C SCH 900776 5mg SCH 900776 is a selective Chk1 inhibitor wS2735D SCH 900776 10mg SCH 900776 is a selective Chk1 inhibitor wS2735G SCH 900776 50mg SCH 900776 is a selective Chk1 inhibitor wS2735I SCH 900776 200mg SCH 900776 is a selective Chk1 inhibitor wS2740C GSK1070916 5mg GSK1070916 is a reversible and ATP-competS2740D GSK1070916 10mg GSK1070916 is a reversible and ATP-competS2740G GSK1070916 5mg GSK1070916 is a reversible and ATP-competS2740I GSK1070916 200mg GSK1070916 is a reversible and ATP-competS2742D PHA-767491 10mg PHA-767491 is a potent ATP-competitive dS2742G PHA-767491 50mg PHA-767491 is a potent ATP-competitive dS2744D CCT137690 10mg CCT137690 is a highly selective inhibitorS2744G CCT137690 50mg CCT137690 is a highly selective inhibitorS2747C AMG458 5mg AMG 458 is a potent c-Met inhibitor of huS2747D AMG458 10mg AMG 458 is a potent c-Met inhibitor of huS2747G AMG458 50mg AMG 458 is a potent c-Met inhibitor of huS2747I AMG458 200mg AMG 458 is a potent c-Met inhibitor of huS2751C PHA-848125 5mg PHA-848125 is a potent, ATP-competitive cS2751D PHA-848125 10mg PHA-848125 is a potent, ATP-competitive cS2751G PHA-848125 50mg PHA-848125 is a potent, ATP-competitive cS2751I PHA-848125 200mg PHA-848125 is a potent, ATP-competitive cS2753G ARQ 197 (Tivantinib) 50mg ARQ-197 is a novel and selective human c-S2753I ARQ 197 (Tivantinib) 200mg ARQ-197 is a novel and selective human c-S2761C NVP-BVU972 5mg NVP-BVU972 is a selective and potent Met S2761D NVP-BVU972 10mg NVP-BVU972 is a selective and potent Met S2761G NVP-BVU972 50mg NVP-BVU972 is a selective and potent Met S2761I NVP-BVU972 200mg NVP-BVU972 is a selective and potent Met S2768C Dinaciclib (SCH727965) 5mg Dinaciclib (SCH727965) is a novel and poS2768F Dinaciclib (SCH727965) 25mg Dinaciclib (SCH727965) is a novel and poS2768G Dinaciclib (SCH727965) 50mg Dinaciclib (SCH727965) is a novel and poS2768I Dinaciclib (SCH727965) 200mg Dinaciclib (SCH727965) is a novel and poS2770C MK-5108 (VX-689) 5mg MK-5108 (VX-689) is a highly selective AurS2770D MK-5108 (VX-689) 10mg MK-5108 (VX-689) is a highly selective AurS2770G MK-5108 (VX-689) 50mg MK-5108 (VX-689) is a highly selective AurS2770I MK-5108 (VX-689) 200mg MK-5108 (VX-689) is a highly selective AurS2788D INCB28060 10mg INCB28060 is a novel, ATP-competitive inhS2788G INCB28060 50mg INCB28060 is a novel, ATP-competitive inhS1149F Gemcitabine HCl (Gemzar) 25mg Gemcitabine Hydrochloride (Gemzar) is a S1149H Gemcitabine HCl (Gemzar) 100mg Gemcitabine Hydrochloride (Gemzar) is a S1166I Cisplatin 200mg Cisplatin is a platinum-based chemotherapyS1135D Pemetrexed (Alimta) 10mg Pemetrexed disodium (Alimta) is a novel aS1135G Pemetrexed (Alimta) 50mg Pemetrexed disodium (Alimta) is a novel aS1135I Pemetrexed (Alimta) 200mg Pemetrexed disodium (Alimta) is a novel a

S1200D Decitabine 10mg Decitabine is a potent inhibitor of DNA meS1200F Decitabine 25mg Decitabine is a potent inhibitor of DNA meS1200G Decitabine 50mg Decitabine is a potent inhibitor of DNA meS1200H Decitabine 100mg Decitabine is a potent inhibitor of DNA meS1214D Bleomycin sulfate 10mg Bleomycin sulfate (Blenoxane) is a glycopS1214G Bleomycin sulfate 50mg Bleomycin sulfate (Blenoxane) is a glycopS1215G Carboplatin 50mg Carboplatin is a DNA synthesis inhibitor byS1215H Carboplatin 100mg Carboplatin is a DNA synthesis inhibitor byS1215I Carboplatin 200mg Carboplatin is a DNA synthesis inhibitor byS1156M Capecitabine (Xeloda) 1g Capecitabine is a tumor-selective fluoropyS2029N Uridine 2g Uridine is a nucleoside, contains a uracil aS1981I Adenine 200mg Adenine is a purine derivative and a nucleS1983I Adenine Hcl 200mg Adenine hydrochloride is a hydrochloride sS1982K Adenine sulfate 50mg Adenine sulfate is a sulfate salt form of S2684C CX-5461 5mg CX-5461 selectively inhibits Pol I-driven tS2684D CX-5461 10mg CX-5461 selectively inhibits Pol I-driven tS2684G CX-5461 50mg CX-5461 selectively inhibits Pol I-driven tS2684I CX-5461 200mg CX-5461 selectively inhibits Pol I-driven tS2554D Daphnetin 10mg Daphnetin is an inhibitor of EGFR, PKA anS2554F Daphnetin 25mg Daphnetin is an inhibitor of EGFR, PKA anS2554G Daphnetin 50mg Daphnetin is an inhibitor of EGFR, PKA anS1648M Cytarabine 1g Cytarabine (Cytosine arabinoside, AraC) iS1782I Azacitidine( Vidaza) 200mg Azacitidine(Vidaza)and its deoxy derivativS1221H Dacarbazine (DTIC-Dome) 100mg Dacarbazine(DTIC-Dome) is an antineoplastiS1714H Gemcitabine(Gemzar) 100mg Gemcitabine(Gemzar) belongs to the group oS1714L Gemcitabine(Gemzar) 300mg Gemcitabine(Gemzar) belongs to the group oS1384D Mizoribine (Bredinin) 10mg Mizoribine (Bredinin) is an imidazole nuclS1384F Mizoribine (Bredinin) 25mg Mizoribine (Bredinin) is an imidazole nuclS1384H Mizoribine (Bredinin) 100mg Mizoribine (Bredinin) is an imidazole nuclS1384I Mizoribine (Bredinin) 200mg Mizoribine (Bredinin) is an imidazole nuclS1334D Flupirtine maleate 10mg Flupirtine maleate is the salt form of FlupiS1334F Flupirtine maleate 25mg Flupirtine maleate is the salt form of FlupiS1334H Flupirtine maleate 100mg Flupirtine maleate is the salt form of FlupiS1299G Floxuridine (Fludara) 50mg Floxuridine (Fludara) is a prodrugs of floxS1299I Floxuridine (Fludara) 200mg Floxuridine (Fludara) is a prodrugs of floxS1300D Ftorafur 10mg Ftorafur is a substance being used in the tS1300G Ftorafur 50mg Ftorafur is a substance being used in the tS1302M Ifosfamide 1g Ifosfamide is a nitrogen mustard alkylating S1289G Carmofur 50mg Carmofur (INN) is a pyrimidine analogue useS1224G Oxaliplatin (Eloxatin) 50mg Oxaliplatin (Eloxatin) is a 1,2-diaminocycS1224H Oxaliplatin (Eloxatin) 100mg Oxaliplatin (Eloxatin) is a 1,2-diaminocycS1224I Oxaliplatin (Eloxatin) 200mg Oxaliplatin (Eloxatin) is a 1,2-diaminocycS1213C Nelarabine (Arranon) 5mg Nelarabine (Arranon, 506U78) is a purine nS1213D Nelarabine (Arranon) 10mg Nelarabine (Arranon, 506U78) is a purine nS1213G Nelarabine (Arranon) 50mg Nelarabine (Arranon, 506U78) is a purine nS1213I Nelarabine (Arranon) 200mg Nelarabine (Arranon, 506U78) is a purine nS1217H Clafen (Cyclophosphamide) 100mg Cyclophosphamide is a synthetic alkylatingS1217I Clafen (Cyclophosphamide) 200mg Cyclophosphamide is a synthetic alkylatingS1218D Clofarabine 10mg Clofarabine is a second generation purine nS1218G Clofarabine 50mg Clofarabine is a second generation purine nS1199F Cladribine 25mg Cladribine (Leustatin, Litak, 2CDA) is anS1199G Cladribine 50mg Cladribine (Leustatin, Litak, 2CDA) is anS1192D Raltitrexed (Tomudex) 10mg Raltitrexed (Tomudex) is a thymidylate syntS1192G Raltitrexed (Tomudex) 50mg Raltitrexed (Tomudex) is a thymidylate syntS1192H Raltitrexed (Tomudex) 100mg Raltitrexed (Tomudex) is a thymidylate syntS1208D Doxorubicin (Adriamycin) 10mg Doxorubicin (Adriamycin) is an antibioticS1208F Doxorubicin (Adriamycin) 25mg Doxorubicin (Adriamycin) is an antibiotic

S1208H Doxorubicin (Adriamycin) 100mg Doxorubicin (Adriamycin) is an antibioticS1225H Etoposide (VP-16) 100mg Two subclones of the OCI/AML-2 cell line,S1225K Etoposide (VP-16) 500mg Two subclones of the OCI/AML-2 cell line,S1231G Topotecan Hcl 50mg Topotecan (Hycamtin, NSC 609699) is a topS1231H Topotecan Hcl 100mg Topotecan (Hycamtin, NSC 609699) is a topS1198H Irinotecan 100mg Irinotecan (Camptosar, Campto, CPT-11) is S1198I Irinotecan 200mg Irinotecan (Camptosar, Campto, CPT-11) is S1288H Camptothecin 100mg Camptothecin (Camptohecine, 20-(S)-CamptS1288J Camptothecin 250mg Camptothecin (Camptohecine, 20-(S)-CamptS1288K Camptothecin 500mg Camptothecin (Camptohecine, 20-(S)-CamptS1223C Epirubicin Hcl 5mg Epirubicin Hydrochloride (Ellence) is an anS1223D Epirubicin Hcl 10mg Epirubicin Hydrochloride (Ellence) is an anS1223F Epirubicin Hcl 25mg Epirubicin Hydrochloride (Ellence) is an anS1223H Epirubicin Hcl 100mg Epirubicin Hydrochloride (Ellence) is an anS1465G Moxifloxacin Hcl 50mg Moxifloxacin(Avelox, Avalox) is a fourth geS1465I Moxifloxacin Hcl 200mg Moxifloxacin(Avelox, Avalox) is a fourth geS1463I Ofloxacin (Floxin) 200mg Ofloxacin is a synthetic chemotherapeutic aS1393D Pirarubicin 10mg Pirarubicin is an anthracycline drug. An anS1393G Pirarubicin 50mg Pirarubicin is an anthracycline drug. An anS1393I Pirarubicin 200mg Pirarubicin is an anthracycline drug. An anS1367D Amonafide 10mg Amonafide (NSC-308847) is a selective topoS1367G Amonafide 50mg Amonafide (NSC-308847) is a selective topoS1367H Amonafide 100mg Amonafide (NSC-308847) is a selective topoS1327K Ellagic acid 500mg Ellagic acid is a polyphenol antioxidant foS1342F Genistein 25mg Genistein is a soy-derived isoflavone and pS1342G Genistein 50mg Genistein is a soy-derived isoflavone and pS1342H Genistein 100mg Genistein is a soy-derived isoflavone and pS1228C Idarubicin Hcl 5mg Idarubicin HCl (Idamycin, Zavedos, 4-demetS1228D Idarubicin Hcl 10mg Idarubicin HCl (Idamycin, Zavedos, 4-demetS1228G Idarubicin Hcl 50mg Idarubicin HCl (Idamycin, Zavedos, 4-demetS1060D Olaparib (AZD2281) 10mg Olaparib (AZD2281, KU0059436) is a selecS1060F Olaparib (AZD2281) 25mg Olaparib (AZD2281, KU0059436) is a selecS1060H Olaparib (AZD2281) 100mg Olaparib (AZD2281, KU0059436) is a selecS1060K Olaparib (AZD2281) 500mg Olaparib (AZD2281, KU0059436) is a selecS1004D ABT-888 (Veliparib) 10mg ABT-888 (Veliparib, NSC 737664) is a poteS1004G ABT-888 (Veliparib) 50mg ABT-888 (Veliparib, NSC 737664) is a poteS1004I ABT-888 (Veliparib) 200mg ABT-888 (Veliparib, NSC 737664) is a poteS1087D Iniparib (BSI-201) 10mg BSI-201 (Iniparib, SAR240550) is a PARP1 S1087G Iniparib (BSI-201) 50mg BSI-201 (Iniparib, SAR240550) is a PARP1 S1087I Iniparib (BSI-201) 200mg BSI-201 (Iniparib, SAR240550) is a PARP1 S1098C Rucaparib (AG-014699 , PF-01367338) 5 Rucaparib (AG-014699, PF-01367338) is an S1098D Rucaparib (AG-014699 , PF-01367338) 1 Rucaparib (AG-014699, PF-01367338) is an S1098G Rucaparib (AG-014699 , PF-01367338) 5 Rucaparib (AG-014699, PF-01367338) is an S1098I Rucaparib (AG-014699 , PF-01367338) 2 Rucaparib (AG-014699, PF-01367338) is an S2178C AG14361 5mg AG14361 is a potent inhibitor of PARP-1 wiS2178D AG14361 10mg AG14361 is a potent inhibitor of PARP-1 wiS2178G AG14361 50mg AG14361 is a potent inhibitor of PARP-1 wiS2178H AG14361 100mg AG14361 is a potent inhibitor of PARP-1 wiS1132C INO-1001 5mg INO-1001 is a potent inhibitor of PARP wiS1132D INO-1001 10mg INO-1001 is a potent inhibitor of PARP wiS1132G INO-1001 50mg INO-1001 is a potent inhibitor of PARP wiS1132I INO-1001 200mg INO-1001 is a potent inhibitor of PARP wiS2197C A-966492 5mg A-966492 is a novel and potent inhibitor S2197D A-966492 10mg A-966492 is a novel and potent inhibitor S2197G A-966492 50mg A-966492 is a novel and potent inhibitor S2197I A-966492 200mg A-966492 is a novel and potent inhibitor S2886 PJ34 PJ-34 is a potent PARP inhibitor with EC5

S2741 MK-4827 MK-4827 is an selective inhibitor of PARPS2505F Rosiglitazone maleate 25mg Rosiglitazone maleate (Avandia) is an anti-S2505I Rosiglitazone maleate 200mg Rosiglitazone maleate (Avandia) is an anti-S2556F Rosiglitazone (Avandia) 25mg Rosiglitazone (Avandia) is a potent antihypS2556G Rosiglitazone (Avandia) 50mg Rosiglitazone (Avandia) is a potent antihypS2556I Rosiglitazone (Avandia) 200mg Rosiglitazone (Avandia) is a potent antihypS2665F Ciprofibrate 25mg Ciprofibrate is a peroxisome proliferator-aS2665H Ciprofibrate 100mg Ciprofibrate is a peroxisome proliferator-aS2665I Ciprofibrate 200mg Ciprofibrate is a peroxisome proliferator-aS2075C Rosiglitazone Hcl 5mg Rosiglitazone is a blood glucose-lowering dS2798 GW6471 GW6471 is an inhibitor of PPARalpha withS2871C T0070907 5mg T0070907 is a potent and selective PPARgS2871D T0070907 10mg T0070907 is a potent and selective PPARgS2871F T0070907 25mg T0070907 is a potent and selective PPARgS2871G T0070907 50mg T0070907 is a potent and selective PPARgS1541C EX 527 5mg EX 527 is a potent and selective SIRT1 inhS1541D EX 527 10mg EX 527 is a potent and selective SIRT1 inhS1541F EX 527 25mg EX 527 is a potent and selective SIRT1 inhS1396H Resveratrol 100mg Resveratrol is a phytoalexin produced naturS1396I Resveratrol 200mg Resveratrol is a phytoalexin produced naturS1396K Resveratrol 500mg Resveratrol is a phytoalexin produced naturS2804C Sirtinol 5mg Sirtinol is a specific SIRT1 and SIRT2 inhS2804F Sirtinol 25mg Sirtinol is a specific SIRT1 and SIRT2 inhS1129C SRT1720 5mg SRT1720 is a selective SIRT1 activator wiS1129D SRT1720 10mg SRT1720 is a selective SIRT1 activator wiS1129G SRT1720 50mg SRT1720 is a selective SIRT1 activator wiS1129I SRT1720 200mg SRT1720 is a selective SIRT1 activator wiS1186D BIBR 1532 10mg BIBR 1532 is a potent and selective telomeS1186G BIBR 1532 50mg BIBR 1532 is a potent and selective telomeS1186I BIBR 1532 200mg BIBR 1532 is a potent and selective telomeS1319C Costunolide 5mg Costunolide inhibits FPTase with IC50 ofS1319D Costunolide 10mg Costunolide inhibits FPTase with IC50 ofS3035D Daunorubicin HCl (Daunomycin Hcl) 10mgDaunorubicin HCl inhibits both DNA and RNS3035G Daunorubicin HCl (Daunomycin Hcl) 50mgDaunorubicin HCl inhibits both DNA and RNS2507J Salbutamol sulfate (Albuterol) 250mg Salbutamol(Albuterol) is a short-acting betS2507K Salbutamol sulfate (Albuterol) 500mg Salbutamol(Albuterol) is a short-acting betS1613C Silodosin (Rapaflo) 5mg Silodosin(Rapaflo) is an alpha1-adrenoceptoS1613D Silodosin (Rapaflo) 10mg Silodosin(Rapaflo) is an alpha1-adrenoceptoS1613G Silodosin (Rapaflo) 50mg Silodosin(Rapaflo) is an alpha1-adrenoceptoS1613I Silodosin (Rapaflo) 200mg Silodosin(Rapaflo) is an alpha1-adrenoceptoS2516M Xylazine HCl 1g Xylazine HCl is alpha2 class of adrenergic S1283D Asenapine 10mg Asenapine is a new atypical antipsychotic S1283G Asenapine 50mg Asenapine is a new atypical antipsychotic S1283H Asenapine 100mg Asenapine is a new atypical antipsychotic S1324G Doxazosin mesylate 50mg Doxazosin mesylate , a quinazoline compounS1324J Doxazosin mesylate 250mg Doxazosin mesylate , a quinazoline compounS2495H Oxymetazoline HCl 100mg Oxymetazoline hydrochloride is an alpha1 anS2495I Oxymetazoline HCl 200mg Oxymetazoline hydrochloride is an alpha1 anS2522G L-Adrenaline (Epinephrine) 50mg L-Adrenaline (Epinephrine) belongs to a grS2438C Synephrine HCl 5mg Synephrine HCl (Oxedrine, p-Synephrine) S2438D Synephrine HCl 10mg Synephrine HCl (Oxedrine, p-Synephrine) S2438H Synephrine HCl 100mg Synephrine HCl (Oxedrine, p-Synephrine) S2438I Synephrine HCl 200mg Synephrine HCl (Oxedrine, p-Synephrine) S2113F Cisatracurium besylate (Nimbex) 25mg Cisatracurium besylate is a nondepolarizinS2113H Cisatracurium besylate (Nimbex) 100mg Cisatracurium besylate is a nondepolarizinS2083D Procaterol Hcl 10mg Procaterol is a short-acting beta2-adrenerS2083G Procaterol Hcl 50mg Procaterol is a short-acting beta2-adrener

S2086D Ivabradine HCl (Procoralan) 10mg Ivabradine, a new If inhibitor with IC 50 ofS2086H Ivabradine HCl (Procoralan) 100mg Ivabradine, a new If inhibitor with IC 50 ofS2090D Dexmedetomidine HCl (Precedex) 10mg Dexmedetomidine is a highly selective and S2090G Dexmedetomidine HCl (Precedex) 50mg Dexmedetomidine is a highly selective and S2091D Betaxolol (Betoptic) 10mg Betaxolol is a selective beta1 adrenergic S2091G Betaxolol (Betoptic) 50mg Betaxolol is a selective beta1 adrenergic S2092D Detomidine HCl 10mg Detomidine produce dose-dependent sedativS2092H Detomidine HCl 100mg Detomidine produce dose-dependent sedativS2059G Terazosin HCl (Hytrin) 50mg Hytrin (terazosin) is an alpha-adrenergic bS2059J Terazosin HCl (Hytrin) 250mg Hytrin (terazosin) is an alpha-adrenergic bS1856G Metoprolol tartrate 50mg Metoprolol tartrate is a cardioselective beS2545H Scopine 100mg Scopine is the metabolite of anisodine, whS2038H Phentolamine mesilate 100mg Phentolamine mesilate is a nonselective aS2038K Phentolamine mesilate 500mg Phentolamine mesilate is a nonselective aS1827D Betaxolol HCl (Betoptic) 10mg Betaxolol hydrochloride (Betoptic) is a betS1827G Betaxolol HCl (Betoptic) 50mg Betaxolol hydrochloride (Betoptic) is a betS2020D Formoterol hemifumarate 10mg Formoterol hemifumarate is a potent, selecS2020G Formoterol hemifumarate 50mg Formoterol hemifumarate is a potent, selecS3083C Indacaterol Maleate 5mg Indacaterol is an ultra-long-acting beta-aS3083D Indacaterol Maleate 10mg Indacaterol is an ultra-long-acting beta-aS3083G Indacaterol Maleate 50mg Indacaterol is an ultra-long-acting beta-aS3083I Indacaterol Maleate 200mg Indacaterol is an ultra-long-acting beta-aS3061I Epinephrine HCl (Adrenaline) 200mg Epinephrine HCl is a hormone and a neuroS3060D Medetomidine Hcl 10mg S3060S3060G Medetomidine Hcl 50mg S3060S3075H Dexmedetomidine 100mg Dexmedetomidine is a sedative medication S2840C ARN-509 5mg ARN-509 is a selective androgen receptor iS2840D ARN-509 10mg ARN-509 is a selective androgen receptor iS2840G ARN-509 50mg ARN-509 is a selective androgen receptor iS2840H ARN-509 100mg ARN-509 is a selective androgen receptor iS3185H Adrenalone Hcl 100mg Adrenalone is an adrenergic agonist used aS3153D Levalbuterol HCl 10mg Levalbuterol HCl is a relatively selective S3153G Levalbuterol HCl 50mg Levalbuterol HCl is a relatively selective S2569H Phenylephrine HCl 100mg Phenylephrine hydrochloride used primarilyS2566K Isoprenaline HCl 500mg Isoprenaline hydrochloride is a beta-adreneS2533K Ritodrine HCl (Yutopar) 500mg Ritodrine hydrochloride (DU 21220; MioleneS2519G Naphazoline HCl (Naphcon) 50mg Naphazoline hydrochloride (Naphcon) is an S2521H Epinephrine bitartrate (Adrenalinium) 10 Epinephrine bitartrate (D02149, AdrenaliniS2521I Epinephrine bitartrate (Adrenalinium) 20 Epinephrine bitartrate (D02149, AdrenaliniS2509G Sotalol (Betapace) 50mg Sotalol (Betapace) is a non-selective beta S2509H Sotalol (Betapace) 100mg Sotalol (Betapace) is a non-selective beta S2509I Sotalol (Betapace) 200mg Sotalol (Betapace) is a non-selective beta S2499H Phenoxybenzamine HCl 100mg Phenoxybenzamine HCl is a non-specific, irS2604D Dehydroepiandrosterone(DHEA) 10mg Dehydroepiandrosterone(DHEA) is a 19-carboS2126F Naftopidil (Flivas) 25mg Naftopidil (Flivas) is a selective alpha1-adS2126G Naftopidil (Flivas) 50mg Naftopidil (Flivas) is a selective alpha1-adS2126H Naftopidil (Flivas) 100mg Naftopidil (Flivas) is a selective alpha1-adS1579D Detomidine HCl (Dormosedan) 10mg Detomidine hydrochloride is a nonnarcotic,S1579G Detomidine HCl (Dormosedan) 50mg Detomidine hydrochloride is a nonnarcotic,S1579I Detomidine HCl (Dormosedan) 200mg Detomidine hydrochloride is a nonnarcotic,S1549D Nebivolol (Bystolic) 10mg Nebivolol selectively inhibits beta1-adrenoS1549F Nebivolol (Bystolic) 25mg Nebivolol selectively inhibits beta1-adrenoS1409D Alfuzosin HCl(Uroxatral) 10mg Alfuzosin(Uroxatral) is an alpha1 receptor S1409G Alfuzosin HCl(Uroxatral) 50mg Alfuzosin(Uroxatral) is an alpha1 receptor S1409I Alfuzosin HCl(Uroxatral) 200mg Alfuzosin(Uroxatral) is an alpha1 receptor S1387F Naftopidil DiHCl 25mg Naftopidil DiHCl is a selective 5-HT1A andS1387G Naftopidil DiHCl 50mg Naftopidil DiHCl is a selective 5-HT1A and

S1387K Naftopidil DiHCl 500mg Naftopidil DiHCl is a selective 5-HT1A andS1406D Zilpaterol HCl 10mg Zilpaterol is a beta-adrenergic agonist.S1406G Zilpaterol HCl 50mg Zilpaterol is a beta-adrenergic agonist.S1206F Bisoprolol 25mg Bisoprolol is a beta-adrenoceptor blocking S1206H Bisoprolol 100mg Bisoprolol is a beta-adrenoceptor blocking S1243D Agomelatine 10mg Agomelatine is an antidepressant drug. It S1243G Agomelatine 50mg Agomelatine is an antidepressant drug. It S1243H Agomelatine 100mg Agomelatine is an antidepressant drug. It S1432F Sumatriptan succinate 25mg Sumatriptan succinate(mitrex, Imigran) is S1432G Sumatriptan succinate 50mg Sumatriptan succinate(mitrex, Imigran) is S1432I Sumatriptan succinate 200mg Sumatriptan succinate(mitrex, Imigran) is S1432K Sumatriptan succinate 500mg Sumatriptan succinate(mitrex, Imigran) is S2493H Olanzapine (Zyprexa) 100mg Olanzapine(Zyprexa) is a high affinity forS2493L Olanzapine (Zyprexa) 300mg Olanzapine(Zyprexa) is a high affinity forS2459H Clozapine (Clozaril) 100mg Clozapine (Clozaril) is a potent 5-HT1C recS2459K Clozapine (Clozaril) 500mg Clozapine (Clozaril) is a potent 5-HT1C recS1436D Tianeptine sodium 10mg Tianeptine (INN) (Stablon, Coaxil, TatinolS1436G Tianeptine sodium 50mg Tianeptine (INN) (Stablon, Coaxil, TatinolS1436H Tianeptine sodium 100mg Tianeptine (INN) (Stablon, Coaxil, TatinolS2663D WAY-100635 10mg WAY 100635 is a potent and selective 5-HTS2663G WAY-100635 50mg WAY 100635 is a potent and selective 5-HTS2663I WAY-100635 200mg WAY 100635 is a potent and selective 5-HTS2875D Prucalopride 10mg Prucalopride is a potent 5-HT4 receptor inhS2875G Prucalopride 50mg Prucalopride is a potent 5-HT4 receptor inhS2865D VUF 10166 10mg VUF10166 is a novel, potent and competitiS2865G VUF 10166 50mg VUF10166 is a novel, potent and competitiS3005D Paroxetine HCl 10mg Paroxetine is an antidepressant drug of thS3005G Paroxetine HCl 50mg Paroxetine is an antidepressant drug of thS2106D Azasetron HCl 10mg Azasetron HCl is a selective 5-HT3 recepS2106G Azasetron HCl 50mg Azasetron HCl is a selective 5-HT3 recepS2096D Almotriptan malate (Axert) 10mg Almotriptan malate (Axert) is a selective S2096H Almotriptan malate (Axert) 100mg Almotriptan malate (Axert) is a selective S2112E Blonanserin (Lonasen) 20mg Blonanserin is a novel atypical antipsychoS2112H Blonanserin (Lonasen) 100mg Blonanserin is a novel atypical antipsychoS2084D Duloxetine HCl (Cymbalta) 10mg Duloxetine is a serotonin-norepinephrine rS2084H Duloxetine HCl (Cymbalta) 100mg Duloxetine is a serotonin-norepinephrine rS1975H Aripiprazole (Abilify) 100mg Aripiprazole is a human 5-HT1A receptor paS1975K Aripiprazole (Abilify) 500mg Aripiprazole is a human 5-HT1A receptor paS2025H Urapidil HCl 100mg Urapidil hydrochloride is a hydrochloride S2025K Urapidil HCl 500mg Urapidil hydrochloride is a hydrochloride S2018C Y-25130 HCl 5mg Y-25130 hydrochloride is a selective and pS2018G Y-25130 HCl 50mg Y-25130 hydrochloride is a selective and pS2582H Trazodone HCl (Desyrel) 100mg Trazodone hydrochloride (Desyrel) is a hydS2698C RS-127445 5mg RS-127445 is a selective 5-HT2B antagonisS2698D RS-127445 10mg RS-127445 is a selective 5-HT2B antagonisS2698G RS-127445 50mg RS-127445 is a selective 5-HT2B antagonisS1996D Ondansetron (Zofran) 10mg Ondansetron (Zofran) is a serotonin 5-HT3 S1996G Ondansetron (Zofran) 50mg Ondansetron (Zofran) is a serotonin 5-HT3 S3050D Palonosetron HCl 10mg Palonosetron is a 5-HT3 antagonist used S2849D SB-269970 Hcl 10mg SB-269970 HCl is a hydrochloride salt formS2849G SB-269970 Hcl 50mg SB-269970 HCl is a hydrochloride salt formS2852D BRL 54443 10mg BRL 54443 is a 5-HT1E and 5-HT1F receptorS2852G BRL 54443 50mg BRL 54443 is a 5-HT1E and 5-HT1F receptorS2677C BRL-15572 5mg BRL-15572 is a 5-HT1D antagonist with pKiS2677D BRL-15572 10mg BRL-15572 is a 5-HT1D antagonist with pKiS2677G BRL-15572 50mg BRL-15572 is a 5-HT1D antagonist with pKiS2677I BRL-15572 200mg BRL-15572 is a 5-HT1D antagonist with pKi

S2669D LY310762 10mg LY310762 is a 5-HT1D antagonist with Ki S2669G LY310762 50mg LY310762 is a 5-HT1D antagonist with Ki S2669I LY310762 200mg LY310762 is a 5-HT1D antagonist with Ki S2860D IEM 1754 Dihydrobromide 10mg IEM 1754 dihydrobroMide is a selective AMS2860G IEM 1754 Dihydrobromide 50mg IEM 1754 dihydrobroMide is a selective AMS3175D Atomoxetine Hcl 10mg S3175S3175G Atomoxetine Hcl 50mg S3175S3180D Eletriptan Hbr 10mg S3180S3180G Eletriptan Hbr 50mg S3180S3183G Amitriptyline Hcl 50mg Amitriptyline inhibits serotonin receptor,S2691D BMY 7378 10mg BMY 7378 is a multiple inhibitors of alphS2691G BMY 7378 50mg BMY 7378 is a multiple inhibitors of alphS2691I BMY 7378 200mg BMY 7378 is a multiple inhibitors of alphS2541M Clomipramine HCl (Anafranil) 1g Clomipramine hydrochloride (Anafranil) is S1869F Dapoxetine HCl (Priligy) 25mg Dapoxetine hydrochloride is a short-acting S1869G Dapoxetine HCl (Priligy) 50mg Dapoxetine hydrochloride is a short-acting S1869H Dapoxetine HCl (Priligy) 100mg Dapoxetine hydrochloride is a short-acting S1649D Zolmitriptan (Zomig) 10mg Zolmitriptan(Zomig) is a selective serotonS1649F Zolmitriptan (Zomig) 25mg Zolmitriptan(Zomig) is a selective serotonS1649G Zolmitriptan (Zomig) 50mg Zolmitriptan(Zomig) is a selective serotonS1649H Zolmitriptan (Zomig) 100mg Zolmitriptan(Zomig) is a selective serotonS1607D Rizatriptan Benzoate (Maxalt) 10mg Rizatriptan Benzoate(Maxalt) is a 5-HT1 agS1607G Rizatriptan Benzoate (Maxalt) 50mg Rizatriptan Benzoate(Maxalt) is a 5-HT1 agS1607H Rizatriptan Benzoate (Maxalt) 100mg Rizatriptan Benzoate(Maxalt) is a 5-HT1 agS1615D Risperidone (Risperdal) 10mg Risperidone(Risperdal) is an atypical antipS1615G Risperidone (Risperdal) 50mg Risperidone(Risperdal) is an atypical antipS1615I Risperidone (Risperdal) 200mg Risperidone(Risperdal) is an atypical antipS1488D Naratriptan (Amerge)10mg Naratriptan(Amerge and Naramig) is a triptS1488G Naratriptan (Amerge) 50mg Naratriptan(Amerge and Naramig) is a triptS1441F Venlafaxine 25mg Venlafaxine is an arylalkanolamine serotoniS1441G Venlafaxine 50mg Venlafaxine is an arylalkanolamine serotoniS1441I Venlafaxine 200mg Venlafaxine is an arylalkanolamine serotoniS1385D Mosapride citrate 10mg Mosapride is a gastroprokinetic agent thatS1385F Mosapride citrate 25mg Mosapride is a gastroprokinetic agent thatS1385G Mosapride citrate 50mg Mosapride is a gastroprokinetic agent thatS1385H Mosapride citrate 100mg Mosapride is a gastroprokinetic agent thatS1390D Ondansetron HCl (Zofran) 10mg Ondansetron is a serotonin 5-HT3 receptor S1390F Ondansetron HCl (Zofran) 25mg Ondansetron is a serotonin 5-HT3 receptor S1390G Ondansetron HCl (Zofran) 50mg Ondansetron is a serotonin 5-HT3 receptor S1333D Fluoxetine HCl 10mg Fluoxetine HCl is an antidepressant of the S1333F Fluoxetine HCl 25mg Fluoxetine HCl is an antidepressant of the S1333G Fluoxetine HCl 50mg Fluoxetine HCl is an antidepressant of the S1345F Granisetron HCl 25mg Granisetron HCl is a serotonin 5-HT3 recepS1345G Granisetron HCl 50mg Granisetron HCl is a serotonin 5-HT3 recepS1345H Granisetron HCl 100mg Granisetron HCl is a serotonin 5-HT3 recepS2462D Donepezil HCl (Aricept) 10mg Donepezil is a specific and potent AChE iS2462F Donepezil HCl (Aricept) 25mg Donepezil is a specific and potent AChE iS2462G Donepezil HCl (Aricept) 50mg Donepezil is a specific and potent AChE iS2462H Donepezil HCl (Aricept) 100mg Donepezil is a specific and potent AChE iS1623D Acetylcysteine 10mg Acetylcysteine is a pharmaceutical drug anS1623G Acetylcysteine 50mg Acetylcysteine is a pharmaceutical drug anS1440C Varenicline tartrate 5mg Varenicline is a prescription medication usS1440D Varenicline tartrate 10mg Varenicline is a prescription medication usS1440G Varenicline tartrate 50mg Varenicline is a prescription medication usS1440H Varenicline tartrate 100mg Varenicline is a prescription medication usS1397D Rocuronium bromide 10mg Rocuronium is an aminosteroid non-depolariS1397F Rocuronium bromide 25mg Rocuronium is an aminosteroid non-depolari

S1754K Oxybutynin(Ditropan) 500mg Oxybutynin(Ditropan) is an anticholinergic S2240B Fesoterodine fumarate (Toviaz) 2mg Fesoterodine fumarate (Toviaz) is an antimuS2240C Fesoterodine fumarate (Toviaz) 5mg Fesoterodine fumarate (Toviaz) is an antimuS2240D Fesoterodine fumarate (Toviaz) 10mg Fesoterodine fumarate (Toviaz) is an antimuS2240G Fesoterodine fumarate (Toviaz) 50mg Fesoterodine fumarate (Toviaz) is an antimuS2087G Rivastigmine tartrate (Exelon) 50mg Rivastigmine, a cholinesterase inhibitor wS2054H Orphenadrine citrate (Norflex) 100mg Orphenadrine citrate is a skeletal muscle rS1913H Tropicamide 100mg Tropicamide is an anticholinergic and a muS2659C 5-hydroxymethyl tolterodine (PNU 2005775-hydroxymethyl tolterodine (PNU 200577) S2659D 5-hydroxymethyl tolterodine (PNU 2005775-hydroxymethyl tolterodine (PNU 200577) S2659G 5-hydroxymethyl tolterodine (PNU 2005775-hydroxymethyl tolterodine (PNU 200577) S2659I 5-hydroxymethyl tolterodine (PNU 2005775-hydroxymethyl tolterodine (PNU 200577) S3048D Solifenacin succinate 10mg Solifenacin is a urinary antispasmodic of tS3048I Solifenacin succinate 200mg Solifenacin is a urinary antispasmodic of tS3047 Otilonium Bromide Otilonium bromide is an antimuscarinic.S3144D Darifenacin HBr 10mg Darifenacin is a selective M3 muscarinic reS3144H Darifenacin HBr 100mg Darifenacin is a selective M3 muscarinic reS3117 Oxybutynin chloride Oxybutynin is an anticholinergic medication S2614J Arecoline 250mg Arecoline is a muscarinic acetylcholine reS2629D PNU-120596 10mg PNU-120596 is a positive allosteric moduS2629G PNU-120596 50mg PNU-120596 is a positive allosteric moduS2629I PNU-120596 200mg PNU-120596 is a positive allosteric moduS2547C Tiotropium Bromide hydrate 5mg Tiotropium Bromide hydrate is a hydrate ofS2547D Tiotropium Bromide hydrate 25mg Tiotropium Bromide hydrate is a hydrate ofS2547G Tiotropium Bromide hydrate 50mg Tiotropium Bromide hydrate is a hydrate ofS2547H Tiotropium Bromide hydrate 100mg Tiotropium Bromide hydrate is a hydrate ofS2549F Trospium chloride (Sanctura) 25mg Trospium chloride (Sanctura) is a competitS2549G Trospium chloride (Sanctura) 50mg Trospium chloride (Sanctura) is a competitS2549I Trospium chloride (Sanctura) 200mg Trospium chloride (Sanctura) is a competitS2550D Tolterodine tartrate (Detrol LA) 10mg Tolterodine tartrate (Detrol LA) is a tartraS2550F Tolterodine tartrate (Detrol LA) 25mg Tolterodine tartrate (Detrol LA) is a tartraS2550G Tolterodine tartrate (Detrol LA) 50mg Tolterodine tartrate (Detrol LA) is a tartraS2550H Tolterodine tartrate (Detrol LA) 100mg Tolterodine tartrate (Detrol LA) is a tartraS2455J Bethanechol chloride 250mg Bethanechol chloride is a selective muscariS2490H Neostigmine bromide (Prostigmin) 100mg Neostigmine bromide(Prostigmin) is a reverS2130D Atropine10mg Atropine is a competitive muscarinic acetylS2130G Atropine 50mg Atropine is a competitive muscarinic acetylS1978G Methscopolamine (Pamine) 50mg Methscopolamine (Pamine)is a muscarinic aceS1978I Methscopolamine (Pamine) 200mg Methscopolamine (Pamine)is a muscarinic aceS1929H Irsogladine 100mg Irsogladine is an anti-gastric ulcer agent S1929J Irsogladine 250mg Irsogladine is an anti-gastric ulcer agent S1805G Acetylcholine chloride 50mg The chemical compound acetylcholine (ACh)S1805H Acetylcholine chloride 100mg The chemical compound acetylcholine (ACh)S1805I Acetylcholine chloride 200mg The chemical compound acetylcholine (ACh)S1805K Acetylcholine chloride 500mg The chemical compound acetylcholine (ACh)S1608D Pyridostigmine Bromide (Mestinon) 10mgPyridostigmine Bromide(Mestinon) is a paraS1608G Pyridostigmine Bromide (Mestinon) 50mgPyridostigmine Bromide(Mestinon) is a paraS1608H Pyridostigmine Bromide (Mestinon) 100mPyridostigmine Bromide(Mestinon) is a paraS1339G Galanthamine HBr 50mg Galanthamine (Razadyne, Reminyl) is an AS1339H Galanthamine HBr 100mg Galanthamine (Razadyne, Reminyl) is an AS1339K Galanthamine HBr 500mg Galanthamine (Razadyne, Reminyl) is an AS2907D Pirfenidone 10mg Pirfenidone is an orally active small moleculS2907G Pirfenidone 50mg Pirfenidone is an orally active small moleculS1146C Cyclopamine 5mg Cyclopamine is a specific Hedgehog (Hh) S1146D Cyclopamine 10mg Cyclopamine is a specific Hedgehog (Hh) S1146F Cyclopamine 25mg Cyclopamine is a specific Hedgehog (Hh) S1146G Cyclopamine 50mg Cyclopamine is a specific Hedgehog (Hh)

S2157C LY2940680 5mg LY2940680 binds to the Smo receptor and pS2157D LY2940680 10mg LY2940680 binds to the Smo receptor and pS2157G LY2940680 50mg LY2940680 binds to the Smo receptor and pS2157I LY2940680 200mg LY2940680 binds to the Smo receptor and pS2151C LDE225 (NVP-LDE225, Erismodegib) 5mgLDE225 (NVP-LDE225) is a smoothened antS2151D LDE225 (NVP-LDE225, Erismodegib) 10mLDE225 (NVP-LDE225) is a smoothened antS2151F LDE225 (NVP-LDE225, Erismodegib) 25mLDE225 (NVP-LDE225) is a smoothened antS2151G LDE225 (NVP-LDE225, Erismodegib) 50mLDE225 (NVP-LDE225) is a smoothened antS2777C PF-5274857 5mg PF-5274857 is a potent and selective SmooS2777D PF-5274857 10mg PF-5274857 is a potent and selective SmooS2777G PF-5274857 50mg PF-5274857 is a potent and selective SmooS2777H PF-5274857 100mg PF-5274857 is a potent and selective SmooS1358D Loratadine 10mg Loratadine is a selective inverse peripheraS1358G Loratadine 50mg Loratadine is a selective inverse peripheraS1358H Loratadine 100mg Loratadine is a selective inverse peripheraS1847H Clemastine Fumarate 100mg Clemastine Fumarate (Clemastine) is a selS1382H Mianserin Hcl 100mg Mianserin is a psychoactive drug of the teS1382I Mianserin Hcl 200mg Mianserin is a psychoactive drug of the teS1291H Cetirizine DiHCl 100mg Cetirizine Dihydrochloride, an antihistaminS1291I Cetirizine DiHCl 200mg Cetirizine Dihydrochloride, an antihistaminS1291K Cetirizine DiHCl 500mg Cetirizine Dihydrochloride, an antihistaminS1357P Lidocaine(Alphacaine) 5g Lidocaine (Alphacaine)is a selective inversS1845J Cimetidine(Tagamet) 250mg Cimetidine(Tagamet) , a histamine congener,S1816H Chlorpheniramine 100mg Chlorpheniramine (Chlorpheniramine maleaS3052D Rupatadine Fumarate 10mg Rupatadine is an inhibitor of PAFR and hisS3163M Benztropine mesylate 1g Benztropine is a dopamine transporter (DATS3176H Betahistine 2HCl 100mg Betahistine is a histamine H3 receptors inhS2813C Ciproxifan 5mg Ciproxifan is a highly potent and selectiveS2813F Ciproxifan 25mg Ciproxifan is a highly potent and selectiveS1880H Roxatidine acetate Hcl 100mg S1880S2107H Mizolastine (Mizollen) 100mg Mizolastine is a histamine H1-receptor antagS2065D Lafutidine 10mg Lafutidine, a newly developed histamine H(2S2065G Lafutidine 50mg Lafutidine, a newly developed histamine H(2S2044G Cyproheptadine HCl (Periactin) 50mg Cyproheptadine hydrochloride (Periactin) iS2024M Ketotifen fumarate (Zaditor) 1g Ketotifen fumarate (Zaditor) is a fumaric acS3037D Bepotastine Besilate 10mg Bepotastine is a non-sedating, selective anS3037G Bepotastine Besilate 50mg Bepotastine is a non-sedating, selective anS3208D Fexofenadine Hcl 10mg S3208S3208G Fexofenadine Hcl 50mg S3208S3186C Azatadine dimaleate 5mg Azatadine is an histamine and cholinergic S3186I Azatadine dimaleate 200mg Azatadine is an histamine and cholinergic S3146M Tripelennamine HCl 1g Tripelennamine is a widely used H1 antagonS3120M Doxepin HCl (Sinequan) 1g Doxepin is a psychotropic agent with tricycS2585H Brompheniramine 100mg Brompheniramine is a histamine H1 receptoS2552H Azelastine HCl (Astelin) 100mg Azelastine hydrochloride (Astelin) is a potS2552I Azelastine HCl (Astelin) 200mg Azelastine hydrochloride (Astelin) is a potS1890I Nizatidine 200mg Nizatidine is a histamine H2-receptor antaS1763F Quetiapine fumarate (Seroquel) 25mg Quetiapine fumarate(Seroquel) is an atypicS1763G Quetiapine fumarate (Seroquel) 50mg Quetiapine fumarate(Seroquel) is an atypicS1763H Quetiapine fumarate (Seroquel) 100mg Quetiapine fumarate(Seroquel) is an atypicS1280G Amisulpride 50mg Amisulpride is an atypical antipsychotic usS1280H Amisulpride 100mg Amisulpride is an atypical antipsychotic usS1280K Amisulpride 500mg Amisulpride is an atypical antipsychotic usS1771H Chlorprothixene 100mg Chlorprothixene has strong binding affiniS1724F Paliperidone(Invega) 25mg Paliperidone(Invega) is an atypical antipsyS1724G Paliperidone(Invega) 50mg Paliperidone(Invega) is an atypical antipsyS1724H Paliperidone(Invega) 100mg Paliperidone(Invega) is an atypical antipsy

S2104P Levosulpiride (Levogastrol) 5g Levosulpiride is a selective antagonist foS2089D Fenoldopam (Corlopam) 10mg Fenoldopam is a dopamine agonist that causS2089G Fenoldopam (Corlopam) 50mg Fenoldopam is a dopamine agonist that causS3044C Lurasidone HCL 5mg Lurasidone inhibits Dopamine D2 and 5-HTS3136I Ropinirole (Requip) 200mg Ropinirole is a dopamine agonist of the noS2529H Dopamine HCl (Inotropin) 100mg Dopamine hydrochloride (Inotropin) is a caS2529I Dopamine HCl (Inotropin) 200mg Dopamine hydrochloride (Inotropin) is a caS2191C U 95666E (Sumanirole maleate) 5mg Sumanirole maleate is a highly selective DS2191D U 95666E (Sumanirole maleate) 10mg Sumanirole maleate is a highly selective DS2191G U 95666E (Sumanirole maleate) 50mg Sumanirole maleate is a highly selective DS2191I U 95666E (Sumanirole maleate) 200mg Sumanirole maleate is a highly selective DS2452G Amfebutamone (Bupropion) 50mg Amfebutamone (Bupropion) is a selective norS2452H Amfebutamone (Bupropion) 100mg Amfebutamone (Bupropion) is a selective norS2452I Amfebutamone (Bupropion) 200mg Amfebutamone (Bupropion) is a selective norS2452K Amfebutamone (Bupropion) 500mg Amfebutamone (Bupropion) is a selective norS2453D Benserazide 10mg Benserazide is a peripherally-acting aromaS2453G Benserazide 50mg Benserazide is a peripherally-acting aromaS2453H Benserazide 100mg Benserazide is a peripherally-acting aromaS2451F Amantadine HCl (Symmetrel) 25mg Amantadine hydrochloride(Symmetrel) is useS2451H Amantadine HCl (Symmetrel) 100mg Amantadine hydrochloride(Symmetrel) is useS1941H Enalapril maleate (Vasotec) 100mg Enalapril maleate (Vasotec), the active metS1139C ADL5859 Hcl 5mg ADL5859 HCl is a delta-opioid receptor agoS1139D ADL5859 Hcl 10mg ADL5859 HCl is a delta-opioid receptor agoS1139G ADL5859 Hcl 50mg ADL5859 HCl is a delta-opioid receptor agoS1139I ADL5859 Hcl 200mg ADL5859 HCl is a delta-opioid receptor agoS2480M Loperamide Hcl 1g Loperamide is an opioid-receptor agonist wiS2722C JTC-801 5mg JTC-801 is a selective opioid receptor-likS2722D JTC-801 10mg JTC-801 is a selective opioid receptor-likS2722G JTC-801 50mg JTC-801 is a selective opioid receptor-likS2085H Trimebutine 100mg Trimebutine is an agonist of peripheral muS2103H Naltrexone Hcl 100mg Naltrexone is an opioid receptor antagoniS2103J Naltrexone Hcl 250mg Naltrexone is an opioid receptor antagoniS3066G Naloxone Hcl 50mg Naloxone HCl is an opioid inverse agonist S3066H Naloxone Hcl 100mg Naloxone HCl is an opioid inverse agonist S1544B AM-1241 2mg AM-1241 is a selective CB2 agonist with KiS1544C AM-1241 5mg AM-1241 is a selective CB2 agonist with KiS1544D AM-1241 10mg AM-1241 is a selective CB2 agonist with KiS1544F AM-1241 25mg AM-1241 is a selective CB2 agonist with KiS1534 Org 27569 Org 27569 is an allosteric modulator of CBS2778C GW-842166X 5mg GW842166X is a potent and highly selectivS2778D GW-842166X 10mg GW842166X is a potent and highly selectivS2778F GW-842166X 25mg GW842166X is a potent and highly selectivS3021D Rimonabant (SR141716) 10mg Rimonabant is a selective antagonist of S3021F Rimonabant (SR141716) 25mg Rimonabant is a selective antagonist of S3021G Rimonabant (SR141716) 50mg Rimonabant is a selective antagonist of S3021H Rimonabant (SR141716) 100mg Rimonabant is a selective antagonist of S2854D BML-190 10mg BML-190 is a selective CB2 inverse agonisS2854G BML-190 50mg BML-190 is a selective CB2 inverse agonisS2819C AM251 5mg AM251 is a cannabinoid 1 receptor antagonS2819D AM251 10mg AM251 is a cannabinoid 1 receptor antagonS2819G AM251 50mg AM251 is a cannabinoid 1 receptor antagonS2454H Bupivacaine HCl (Marcain) 100mg Bupivacaine hydrochloride(Marcain) is a mS2449D Forskolin 10mg Forskolin is a ubiquitous activator of eukaS2449F Forskolin 25mg Forskolin is a ubiquitous activator of eukaS2449G Forskolin 50mg Forskolin is a ubiquitous activator of eukaS2449I Forskolin 200mg Forskolin is a ubiquitous activator of eukaS1456C Zibotentan (ZD4054) 5mg Zibotentan (ZD4054) is a specific Endothel

S1456D Zibotentan (ZD4054) 10mg Zibotentan (ZD4054) is a specific EndothelS1456G Zibotentan (ZD4054) 50mg Zibotentan (ZD4054) is a specific EndothelS3034C Sitaxentan sodium (TBC-11251) 5mg Sitaxentan sodium (TBC-11251) is a selectS3034D Sitaxentan sodium (TBC-11251) 10mg Sitaxentan sodium (TBC-11251) is a selectS3034G Sitaxentan sodium (TBC-11251) 50mg Sitaxentan sodium (TBC-11251) is a selectS3034H Sitaxentan sodium (TBC-11251) 100mg Sitaxentan sodium (TBC-11251) is a selectS3051D Bosentan Hydrate 10mg Bosentan is an endothelin (ET) receptors S3051I Bosentan Hydrate 200mg Bosentan is an endothelin (ET) receptors S1260D AMG-073 HCl (Cinacalcet Hcl) 10mg AMG-073 HCl (Cinacalcet hydrochloride) reS1260H AMG-073 HCl (Cinacalcet Hcl) 100mg AMG-073 HCl (Cinacalcet hydrochloride) reS2633D NPS-2143 (SB262470) 10mg NPS 2143 is a novel potent and selective aS2633G NPS-2143 (SB262470) 50mg NPS 2143 is a novel potent and selective aS2633I NPS-2143 (SB262470) 200mg NPS 2143 is a novel potent and selective aS3013C Plerixafor 8HCl (DB06809) 5mg Plerixafor 8HCl (DB06809, Mozobil, AMD31S3013D Plerixafor 8HCl (DB06809) 10mg Plerixafor 8HCl (DB06809, Mozobil, AMD31S3013G Plerixafor 8HCl (DB06809) 50mg Plerixafor 8HCl (DB06809, Mozobil, AMD31S2879 AMD3465 AMD3465 is a monomacrocyclic CXCR4 antaS1545C SB-408124 5mg SB-408124 (Tocris-1963) is a non-peptide S1545D SB-408124 10mg SB-408124 (Tocris-1963) is a non-peptide S1545F SB-408124 25mg SB-408124 (Tocris-1963) is a non-peptide S1545H SB-408124 100mg SB-408124 (Tocris-1963) is a non-peptide S2878 CYM-5442 CYM-5442 is a potent and selective S1P1 S1548C Dapagliflozin 5mg Dapagliflozin is a potent and selective hSS1548D Dapagliflozin 10mg Dapagliflozin is a potent and selective hSS1548G Dapagliflozin 50mg Dapagliflozin is a potent and selective hSS1548I Dapagliflozin 200mg Dapagliflozin is a potent and selective hSS2760C Canagliflozin 5mg Canagliflozin is a highly potent and selS2760D Canagliflozin 10mg Canagliflozin is a highly potent and selS2760G Canagliflozin 50mg Canagliflozin is a highly potent and selS2760I Canagliflozin 200mg Canagliflozin is a highly potent and selS1315B Ki16425 2mg Ki16425 is a competitive, potent and reveS1315C Ki16425 5mg Ki16425 is a competitive, potent and reveS1315D Ki16425 10mg Ki16425 is a competitive, potent and reveS1578D Candesartan (Atacand) 10mg Candesartan (Atacand) is an angiotensin II S1578H Candesartan (Atacand) 100mg Candesartan (Atacand) is an angiotensin II S2199B Aliskiren hemifumarate 2mg Aliskiren hemifumarate is a direct renin inhS2199D Aliskiren hemifumarate 10mg Aliskiren hemifumarate is a direct renin inhS2199G Aliskiren hemifumarate 50mg Aliskiren hemifumarate is a direct renin inhS1507D Irbesartan (Avapro) 10mg Irbesartan (Avapro, SR-47436, BMS-186295) S1507G Irbesartan (Avapro) 50mg Irbesartan (Avapro, SR-47436, BMS-186295) S1359G Losartan potassium 50mg Losartan is an angiotensin II receptor antaS1359H Losartan potassium 100mg Losartan is an angiotensin II receptor antaS1359I Losartan potassium 200mg Losartan is an angiotensin II receptor antaS1506H Perindopril Erbumine (Aceon) 100mg Perindopril Erbumine (Aceon) is a potent AS1506I Perindopril Erbumine (Aceon) 200mg Perindopril Erbumine (Aceon) is a potent AS1506K Perindopril Erbumine (Aceon) 500mg Perindopril Erbumine (Aceon) is a potent AS1657G Enalaprilat dihydrate 50mg Enalaprilat is an angiotensin-converting eS1894D Valsartan (Diovan) 10mg Valsartan (Diovan) is an angiotensin II recS1894G Valsartan (Diovan) 50mg Valsartan (Diovan) is an angiotensin II recS1894H Valsartan (Diovan) 100mg Valsartan (Diovan) is an angiotensin II recS1894I Valsartan (Diovan) 200mg Valsartan (Diovan) is an angiotensin II recS1738G Telmisartan (Micardis) 50mg Telmisartan o(Micardis) is an angiotensin S1738H Telmisartan (Micardis) 100mg Telmisartan o(Micardis) is an angiotensin S1284G Benazepril Hcl 50mg Benazepril is a medication used to treat hiS1284J Benazepril Hcl 250mg Benazepril is a medication used to treat hiS1284K Benazepril Hcl 500mg Benazepril is a medication used to treat hiS1793K Ramipril (Altace) 500mg Ramipril (Altace) is an angiotensin-conver

S1604D Olmesartan medoxomil (Benicar) 10mg Olmesartan medoxomil (Benicar) is a compouS1604H Olmesartan medoxomil (Benicar) 100mg Olmesartan medoxomil (Benicar) is a compouS2664D Clinofibrate 10mg Clinofibrate inhibits hydroxymethylglutaS2664G Clinofibrate 50mg Clinofibrate inhibits hydroxymethylglutaS2664I Clinofibrate 200mg Clinofibrate inhibits hydroxymethylglutaS2581J Quinapril HCl (Accupril) 250mg Quinapril hydrochloride (Accupril) is the hS2051H Captopril (Capoten) 100mg Captopril (Capoten) is an angiotensin-convS2076H Lisinopril (Zestril) 100mg Lisinopril is angiotensin-converting enzymeS2081D Cilazapril monohydrate (Inhibace) 10mg Cilazapril is a angiotensin-converting enzyS2081H Cilazapril monohydrate (Inhibace) 100mg Cilazapril is a angiotensin-converting enzyS2094D Moexipril (Univasc) 10mg Moexipril is available as a prodrug of moexS2094H Moexipril (Univasc) 50mg Moexipril is available as a prodrug of moexS2095F Fosinopril sodium (Monopril) 25mg Fosinopril sodium (Monopril) is the ester pS2095H Fosinopril sodium (Monopril) 100mg Fosinopril sodium (Monopril) is the ester pS2100D Temocapril 10mg Temocapril is a long-acting angiotensin-coS2100F Temocapril 25mg Temocapril is a long-acting angiotensin-coS2109D Imidapril (Tanatril) 10mg Imidapril is a angiotensin-converting enzymS2109G Imidapril (Tanatril) 50mg Imidapril is a angiotensin-converting enzymS3046D Azilsartan (TAK-536) 10mg Azilsartan (TAK-536) is an angiotensin II tS3046G Azilsartan (TAK-536) 50mg Azilsartan (TAK-536) is an angiotensin II tS3057C Azilsartan Medoxomil (TAK-491) 5mg S3057S3057D Azilsartan Medoxomil (TAK-491) 10mg S3057S3057H Azilsartan Medoxomil (TAK-491) 100mg S3057S3057I Azilsartan Medoxomil (TAK-491) 200mg S3057S2099D Temocapril Hcl 10mg Temocapril HCl is the hydrochloride of TemS2099F Temocapril Hcl 25mg Temocapril HCl is the hydrochloride of TemS1191F Fulvestrant (Faslodex) 25mg Fulvestrant (Faslodex) is a synthetic estroS1191H Fulvestrant (Faslodex) 100mg Fulvestrant (Faslodex) is a synthetic estroS1972J Tamoxifen Citrate (Nolvadex) 250mg Tamoxifen Citrate (Nolvadex) is an estrogS1227G Evista(Raloxifene Hcl) 50mg Raloxifene has estrogen and tamoxifen-likeS1227H Evista(Raloxifene Hcl) 100mg Raloxifene has estrogen and tamoxifen-likeS1598C LY500307 (Erteberel) 5mg LY500307 (SERBA-1) is a potent, selectiveS1598D LY500307 (Erteberel) 10mg LY500307 (SERBA-1) is a potent, selectiveS1598G LY500307 (Erteberel) 50mg LY500307 (SERBA-1) is a potent, selectiveS1598I LY500307 (Erteberel) 200mg LY500307 (SERBA-1) is a potent, selectiveS1251D Dienogest 10mg Dienogest is an orally active synthetic progS1251F Dienogest 25mg Dienogest is an orally active synthetic progS1251H Dienogest 100mg Dienogest is an orally active synthetic progS1376D Gestodene 10mg Estrogens and progestins are female hormoS1376F Gestodene 25mg Estrogens and progestins are female hormoS1376H Gestodene 100mg Estrogens and progestins are female hormoS1377D Drospirenone 10mg Drospirenone is a synthetic progestin that iS1377F Drospirenone 25mg Drospirenone is a synthetic progestin that iS1377H Drospirenone 100mg Drospirenone is a synthetic progestin that iS1377K Drospirenone 500mg Drospirenone is a synthetic progestin that iS2832M Epiandrosterone (3beta-androsterone) 1g Epiandrosterone is a steroid hormone with S2593D Tolvaptan (OPC-41061) 10mg Tolvaptan (OPC-41061) is a selective, compS2593G Tolvaptan (OPC-41061) 50mg Tolvaptan (OPC-41061) is a selective, compS2611P Ethisterone 5g Ethisterone is a progestogen hormone beingS2450C Equol 5mg Equol is an isoflavandiol metabolized from dS2450F Equol 25mg Equol is an isoflavandiol metabolized from dS3160K Ethynodiol diacetate 500mg Ethynodiol diacetate is one of the first synS3149M Estradiol valerate 1g Estradiol is a synthetic ester used to trS3167H Altrenogest 100mg Altrenogest is a progestogen structurally reS2567M Medroxyprogesterone acetate 1g Medroxyprogesterone acetate is a progestiS2561M Clomifene citrate (Serophene) 1g Clomifene citrate (Serophene) is a selectivS2466M Estriol 1g Estriol is an antagonist of the G-protein c

S1776F Toremifene Citrate (Fareston, Acapodene Toremifene Citrate(Fareston, Acapodene) isS1776G Toremifene Citrate (Fareston, Acapodene Toremifene Citrate(Fareston, Acapodene) isS1776H Toremifene Citrate (Fareston, Acapodene Toremifene Citrate(Fareston, Acapodene) isS1776I Toremifene Citrate (Fareston, Acapodene Toremifene Citrate(Fareston, Acapodene) isS1665H Estrone 100mg Estrone is an estrogenic hormone secreted bS1665I Estrone 200mg Estrone is an estrogenic hormone secreted bS2606G Mifepristone (Mifeprex) 50mg Mifepristone (Mifeprex, RU-486, RU-38486, S1202D Dutasteride 10mg Dutasteride is a 5-alpha-reductase inhibitoS1202H Dutasteride 100mg Dutasteride is a 5-alpha-reductase inhibitoS1197H Finasteride 100mg Finasteride, a synthetic 4-azasteroid antiaS1197I Finasteride 200mg Finasteride, a synthetic 4-azasteroid antiaS1807G Acyclovir (Aciclovir) 50mg Acyclovir is a synthetic nucleoside analoguS1807H Acyclovir (Aciclovir) 100mg Acyclovir is a synthetic nucleoside analoguS1807I Acyclovir (Aciclovir) 200mg Acyclovir is a synthetic nucleoside analoguS1807K Acyclovir (Aciclovir) 500mg Acyclovir is a synthetic nucleoside analoguS1416 Leptomycin B Leptomycin B (LMB) inhibits nuclear exportS1303 Largazole Largazole is an HDAC1 inhibitor with IC50S1420 Resistomycin Resistomycin displays inhibition activityS1761D Suprofen (Profenal) 10mg Suprofen(Profenal) is an NSAID marketed inS1761G Suprofen (Profenal) 50mg Suprofen(Profenal) is an NSAID marketed inS2168C PD 128907 Hcl 5mg PD 128907 HCl is a drug used in scientific S2168D PD 128907 Hcl 10mg PD 128907 HCl is a drug used in scientific S2168G PD 128907 Hcl 50mg PD 128907 HCl is a drug used in scientific S2168H PD 128907 Hcl 100mg PD 128907 HCl is a drug used in scientific S2171 Vanoxerine (GBR-12909) Vanoxerine (GBR-12909) is a piperazine derS1582D H 89 2HC 10mg H 89 dihydrochloride is a protein kinase S1582G H 89 2HC 50mg H 89 dihydrochloride is a protein kinase S1582I H 89 2HC 200mg H 89 dihydrochloride is a protein kinase S1528C LY2811376 5mg LY2811376 is a non-peptidic BACE1 inhibiS1528D LY2811376 10mg LY2811376 is a non-peptidic BACE1 inhibiS1528G LY2811376 50mg LY2811376 is a non-peptidic BACE1 inhibiS1528I LY2811376 200mg LY2811376 is a non-peptidic BACE1 inhibiS1508C Alprostadil(Caverject) 5mg Alprostadil(Caverject) is used as a drug inS1508D Alprostadil(Caverject) 10mg Alprostadil(Caverject) is used as a drug inS1508G Alprostadil(Caverject) 50mg Alprostadil(Caverject) is used as a drug inS1508H Alprostadil(Caverject) 100mg Alprostadil(Caverject) is used as a drug inS1461 Denibulin (MN-029) Denibulin (MN-029) is vascular disrupting aS1250C MDV3100 (Enzalutamide) 5mg MDV3100 is an androgen-receptor (AR) antS1250D MDV3100 (Enzalutamide) 10mg MDV3100 is an androgen-receptor (AR) antS1250G MDV3100 (Enzalutamide) 50mg MDV3100 is an androgen-receptor (AR) antS1190G Bicalutamide (Casodex) 50mg Bicalutamide (Casodex, Cosudex, Calutide,S1190H Bicalutamide (Casodex) 100mg Bicalutamide (Casodex, Cosudex, Calutide,S1190I Bicalutamide (Casodex) 200mg Bicalutamide (Casodex, Cosudex, Calutide,S1174C Ostarine(MK-2866) 5mg Ostarine (GTx-024, MK-2866, Enobosarm, SS1174D Ostarine(MK-2866) 10mg Ostarine (GTx-024, MK-2866, Enobosarm, SS1174G Ostarine(MK-2866) 50mg Ostarine (GTx-024, MK-2866, Enobosarm, SS1174I Ostarine(MK-2866) 200mg Ostarine (GTx-024, MK-2866, Enobosarm, SS1140C Andarine (GTX-007) 5mg Andarine (GTX-007) is a selective nonsteroS1140D Andarine (GTX-007) 10mg Andarine (GTX-007) is a selective nonsteroS1140G Andarine (GTX-007) 50mg Andarine (GTX-007) is a selective nonsteroS1304M Megestrol Acetate 1g Megestrol Acetate is a synthetic progesterS1304P Megestrol Acetate 5g Megestrol Acetate is a synthetic progesterS1585 17 alpha-propionate 17 alpha-propionate is a new topical and pS2042H Cyproterone acetate 100mg Cyproterone acetate is an androgen receptS2042J Cyproterone acetate 250mg Cyproterone acetate is an androgen receptS2803C Galeterone (TOK-001) 5mg Galeterone (TOK-001, VN/124-1) is a selecS2803F Galeterone (TOK-001) 25mg Galeterone (TOK-001, VN/124-1) is a selec

S2803G Galeterone (TOK-001) 50mg Galeterone (TOK-001, VN/124-1) is a selecS2803I Galeterone (TOK-001) 200mg Galeterone (TOK-001, VN/124-1) is a selecS1188D Anastrozole 10mg Anastrozole inhibits the enzyme aromatase,S1188G Anastrozole 50mg Anastrozole inhibits the enzyme aromatase,S1188H Anastrozole 100mg Anastrozole inhibits the enzyme aromatase,S1196D Exemestane 10mg Exemestane is an irreversible, oral steroiS1196F Exemestane 25mg Exemestane is an irreversible, oral steroiS1196G Exemestane 50mg Exemestane is an irreversible, oral steroiS1196H Exemestane 100mg Exemestane is an irreversible, oral steroiS2208M Formestane 1g Formestane(Lentaron(R)) is a second generaS1672H Aminoglutethimide (Cytadren) 100mg Aminoglutethimide (AMG, Cytadren) is an aS1672I Aminoglutethimide (Cytadren) 200mg Aminoglutethimide (AMG, Cytadren) is an aS1672K Aminoglutethimide (Cytadren) 500mg Aminoglutethimide (AMG, Cytadren) is an aS2637C TAK-875 5mg TAK-875 is a selective GPR40 agonist witS2637D TAK-875 10mg TAK-875 is a selective GPR40 agonist witS2637G TAK-875 50mg TAK-875 is a selective GPR40 agonist witS2637I TAK-875 200mg TAK-875 is a selective GPR40 agonist witS2149D GSK1292263 10mg GSK-1292263 is a novel GPR119 agonist.S2149G GSK1292263 50mg GSK-1292263 is a novel GPR119 agonist.S1123C Abiraterone (CB-7598) 5mg Abiraterone (CB-7598) is a potent CYP17 inS1123F Abiraterone (CB-7598) 25mg Abiraterone (CB-7598) is a potent CYP17 inS1123H Abiraterone (CB-7598) 100mg Abiraterone (CB-7598) is a potent CYP17 inS1442D Voriconazole 10mg Voriconazole (VFEND) is a triazole antifunS1442F Voriconazole 25mg Voriconazole (VFEND) is a triazole antifunS1442H Voriconazole 100mg Voriconazole (VFEND) is a triazole antifunS1442I Voriconazole 200mg Voriconazole (VFEND) is a triazole antifunS2246C Abiraterone Acetate (CB7630) 5mg Abiraterone acetate (CB7630, CB 7630, CB-S2246F Abiraterone Acetate (CB7630) 25mg Abiraterone acetate (CB7630, CB 7630, CB-S2246H Abiraterone Acetate (CB7630) 100mg Abiraterone acetate (CB7630, CB 7630, CB-S2187D Avasimibe(CI-1011) 10mg Avasimibe inhibits ACAT and CYP2C9 with S2187G Avasimibe(CI-1011) 50mg Avasimibe inhibits ACAT and CYP2C9 with S2187I Avasimibe(CI-1011) 200mg Avasimibe inhibits ACAT and CYP2C9 with S1353H Ketoconazole 100mg Ketoconazole is a synthetic antifungal drugS1353K Ketoconazole 500mg Ketoconazole is a synthetic antifungal drugS2757 TH-302 TH-302 is selective hypoxia-activated prodS2046 Pioglitazone HCl (Actos) Pioglitazone hydrochloride (Actos) is a S2555H Clarithromycin (Biaxin, Klacid) 100mg Clarithromycin (Biaxin, Klacid) is a macrolS2555J Clarithromycin (Biaxin, Klacid) 250mg Clarithromycin (Biaxin, Klacid) is a macrolS2555K Clarithromycin (Biaxin, Klacid) 500mg Clarithromycin (Biaxin, Klacid) is a macrolS2526F Alizarin 25mg Alizarin strongly inhibits P450 isoform S2526H Alizarin 100mg Alizarin strongly inhibits P450 isoform S1908H Flutamide (Eulexin) 100mg Flutamide (Eulexin, Flutamin) is an oral nS1195C TAK-700 (Orteronel) 5mg TAK-700 (Orteronel) is a potent and highlyS1195D TAK-700 (Orteronel) 10mg TAK-700 (Orteronel) is a potent and highlyS1195G TAK-700 (Orteronel) 50mg TAK-700 (Orteronel) is a potent and highlyS1455C Cilomilast (SB-207499) 5mg Cilomilast (SB-207499) is a potent LPDE4 S1455D Cilomilast (SB-207499) 10mg Cilomilast (SB-207499) is a potent LPDE4 S1455G Cilomilast (SB-207499) 50mg Cilomilast (SB-207499) is a potent LPDE4 S1455I Cilomilast (SB-207499) 200mg Cilomilast (SB-207499) is a potent LPDE4 S2131C Roflumilast (Daxas) 5mg Roflumilast(Daxas) is a selective, long-actS2131D Roflumilast (Daxas) 10mg Roflumilast(Daxas) is a selective, long-actS2131F Roflumilast (Daxas) 25mg Roflumilast(Daxas) is a selective, long-actS2131G Roflumilast (Daxas) 50mg Roflumilast(Daxas) is a selective, long-actS1550C Pimobendan (Vetmedin) 5mg Pimobendan is a selective inhibitor of PDES1550D Pimobendan (Vetmedin) 10mg Pimobendan is a selective inhibitor of PDES1550G Pimobendan (Vetmedin) 50mg Pimobendan is a selective inhibitor of PDES1550I Pimobendan (Vetmedin) 200mg Pimobendan is a selective inhibitor of PDE

S1431F Sildenafil citrate 25mg Sildenafil citrate is an agent used to treaS1431G Sildenafil citrate 50mg Sildenafil citrate is an agent used to treaS1431K Sildenafil citrate 500mg Sildenafil citrate is an agent used to treaS1512G Tadalafil (Cialis) 50mg Tadalafil (Cialis) is a PDE inhibitor. TadaS1512H Tadalafil (Cialis) 100mg Tadalafil (Cialis) is a PDE inhibitor. TadaS1512K Tadalafil (Cialis) 500mg Tadalafil (Cialis) is a PDE inhibitor. TadaS1430D Rolipram 10mg Rolipram is a PDE4-inhibitor. Like most PDES1430F Rolipram 25mg Rolipram is a PDE4-inhibitor. Like most PDES1430G Rolipram 50mg Rolipram is a PDE4-inhibitor. Like most PDES3164D Ibudilast 10mg Ibudilast is a potent PDE4 inhibitor for PS3164G Ibudilast 50mg Ibudilast is a potent PDE4 inhibitor for PS3172D Anagrelide Hcl 10mg Anagrelide is a drug used for the treatmenS3172G Anagrelide Hcl 50mg Anagrelide is a drug used for the treatmenS2687C PF-2545920 5mg PF-2545920 is a potent and selective PDE1S2687D PF-2545920 10mg PF-2545920 is a potent and selective PDE1S2687G PF-2545920 50mg PF-2545920 is a potent and selective PDE1S2687I PF-2545920 200mg PF-2545920 is a potent and selective PDE1S2620D GSK256066 10mg GSK256066 is a selective PED4B inhibitor S2620G GSK256066 50mg GSK256066 is a selective PED4B inhibitor S2620I GSK256066 200mg GSK256066 is a selective PED4B inhibitor S2127C S-(+)-Rolipram 5mg S-(+)-Rolipram inhibits human monocyte cS2127D S-(+)-Rolipram 10mg S-(+)-Rolipram inhibits human monocyte cS2127F S-(+)-Rolipram 25mg S-(+)-Rolipram inhibits human monocyte cS2127G S-(+)-Rolipram 50mg S-(+)-Rolipram inhibits human monocyte cS1673F Aminophylline (Truphylline) 25mg Aminophylline(Phyllocontin, Truphylline) isS1673I Aminophylline (Truphylline) 200mg Aminophylline(Phyllocontin, Truphylline) isS1504H Dyphylline (Dilor) 100mg Dyphylline(Dilor, Lufyllin, diprophylline) iS1294F Cilostazol 25mg Cilostazol is a medication used in the allevS1294H Cilostazol 100mg Cilostazol is a medication used in the allevS1294K Cilostazol 500mg Cilostazol is a medication used in the allevS1375D Dorzolamide Hcl 10mg Dorzolamide HCl is a carbonic anhydrase inS1375F Dorzolamide Hcl 25mg Dorzolamide HCl is a carbonic anhydrase inS1375H Dorzolamide Hcl 100mg Dorzolamide HCl is a carbonic anhydrase inS2603K Tioxolone 500mg Tioxolone is a metalloenzyme carbonic anhydS3178D Brinzolamide 10mg Brinzolamide is a potent carbonic anhydraseS3178G Brinzolamide 50mg Brinzolamide is a potent carbonic anhydraseS2866C U-104 5mg U-104 is a potent carbonic anhydrase (CA) S2866D U-104 10mg U-104 is a potent carbonic anhydrase (CA) S2866F U-104 25mg U-104 is a potent carbonic anhydrase (CA) S2866G U-104 50mg U-104 is a potent carbonic anhydrase (CA) S1501G Mycophenolate mofetil (CellCept) 50mg Mycophenolate mofetil is a non-competitiveS1501H Mycophenolate mofetil (CellCept) 100mg Mycophenolate mofetil is a non-competitiveS1501I Mycophenolate mofetil (CellCept) 200mg Mycophenolate mofetil is a non-competitiveS1158C MK-8245 5mg MK-8245 is an inhibitor of stearoyl-CoA S1158D MK-8245 10mg MK-8245 is an inhibitor of stearoyl-CoA S1158G MK-8245 50mg MK-8245 is an inhibitor of stearoyl-CoA S1158I MK-8245 200mg MK-8245 is an inhibitor of stearoyl-CoA S2776C CPI-613 5mg CPI-613 inhibits mitochondrial enzymes S2776G CPI-613 50mg CPI-613 inhibits mitochondrial enzymes S2055F Gimeracil 25mg Gimeracil is an inhibitor of dihydropyrimiS3002C Rivaroxaban (Xarelto) 5mg Rivaroxaban (Xarelto, BAY 59-7939) is a diS3002D Rivaroxaban (Xarelto) 10mg Rivaroxaban (Xarelto, BAY 59-7939) is a diS3002G Rivaroxaban (Xarelto) 50mg Rivaroxaban (Xarelto, BAY 59-7939) is a diS1593D Apixaban 10mg Apixaban is a highly selective, reversible S1593G Apixaban 50mg Apixaban is a highly selective, reversible S1593I Apixaban 200mg Apixaban is a highly selective, reversible S2496D Ozagrel 10mg Ozagrel is a potent and selective thrombox

S2496F Ozagrel 25mg Ozagrel is a potent and selective thromboxS2496G Ozagrel 50mg Ozagrel is a potent and selective thromboxS2496I Ozagrel 200mg Ozagrel is a potent and selective thromboxS1571 BMS-740808 BMS-740808 is a highly potent, selective inS1909G Fluvastatin sodium (Lescol) 50mg Fluvastatin sodium (Lescol) is an orally aS1909H Fluvastatin sodium (Lescol) 100mg Fluvastatin sodium (Lescol) is an orally aS1909I Fluvastatin sodium (Lescol) 200mg Fluvastatin sodium (Lescol) is an orally aS2061G Lovastatin (Mevacor) 50mg Lovastatin is an inhibitor of HMG-CoA reduS2077G Atorvastatin calcium (Lipitor) 50mg Atorvastatin (Lipitor) is an inhibitor of HS2077K Atorvastatin calcium (Lipitor) 50mg Atorvastatin (Lipitor) is an inhibitor of HS3036G Pravastatin sodium 50mg Pravastatin sodium is an HMG-CoA reductasS3036I Pravastatin sodium 200mg Pravastatin sodium is an HMG-CoA reductasS1453D Tipifarnib (Zarnestra) 10mg Tipifarnib (Zarnestra, R115777) is a potentS1453G Tipifarnib (Zarnestra) 50mg Tipifarnib (Zarnestra, R115777) is a potentS1453I Tipifarnib (Zarnestra) 200mg Tipifarnib (Zarnestra, R115777) is a potentS2674C A 922500 5mg A 922500 is a DGAT-1 inhibitor for humanS2674D A 922500 10mg A 922500 is a DGAT-1 inhibitor for humanS2674G A 922500 50mg A 922500 is a DGAT-1 inhibitor for humanS2674I A 922500 200mg A 922500 is a DGAT-1 inhibitor for humanS2797C Lonafarnib (SCH66336) 5mg Lonafarnib (SCH 66336) is a selectively FPS2797D Lonafarnib (SCH66336) 10mg Lonafarnib (SCH 66336) is a selectively FPS2797H Lonafarnib (SCH66336) 100mg Lonafarnib (SCH 66336) is a selectively FPS2797I Lonafarnib (SCH66336) 200mg Lonafarnib (SCH 66336) is a selectively FPS2821D RG108 10mg RG108 is an inhibitor of DNA methyltransfS2821G RG108 50mg RG108 is an inhibitor of DNA methyltransfS2748C Anacetrapib (MK-0859) 5mg Anacetrapib (MK0859) is a potent and selS2748D Anacetrapib (MK-0859) 10mg Anacetrapib (MK0859) is a potent and selS2748G Anacetrapib (MK-0859) 50mg Anacetrapib (MK0859) is a potent and selS2748I Anacetrapib (MK-0859) 200mg Anacetrapib (MK0859) is a potent and selS2772C Dalcetrapib (JTT-705) 5mg Dalcetrapib (JTT-705) is a rhCETP inhibitoS2772D Dalcetrapib (JTT-705) 10mg Dalcetrapib (JTT-705) is a rhCETP inhibitoS2772G Dalcetrapib (JTT-705) 50mg Dalcetrapib (JTT-705) is a rhCETP inhibitoS2772H Dalcetrapib (JTT-705) 100mg Dalcetrapib (JTT-705) is a rhCETP inhibitoS2792D Torcetrapib (CP-529414) 10mg Torcetrapib (CP-529414) inhibits CETP witS2792G Torcetrapib (CP-529414) 50mg Torcetrapib (CP-529414) inhibits CETP witS1210H Abitrexate(Methotrexate) 100mg Abitrexate (Methotrexate) is an antimetaboS1210I Abitrexate(Methotrexate) 200mg Abitrexate (Methotrexate) is an antimetaboS1210K Abitrexate(Methotrexate) 500mg Abitrexate (Methotrexate) is an antimetaboS1497D Pralatrexate(Folotyn) 10mg Pralatrexate(Folotyn) is an antifolate, and sS1497G Pralatrexate(Folotyn) 50mg Pralatrexate(Folotyn) is an antifolate, and sS2631C URB597 5mg URB597 (KDS-4103) is a potent FAAH inhibS2631F URB597 25mg URB597 (KDS-4103) is a potent FAAH inhibS2631H URB597 100mg URB597 (KDS-4103) is a potent FAAH inhibS2631K URB597 500mg URB597 (KDS-4103) is a potent FAAH inhibS2666D PF-3845 10mg PF-3845 is a potent, selective and irreversS2666G PF-3845 50mg PF-3845 is a potent, selective and irreversS2666I PF-3845 200mg PF-3845 is a potent, selective and irreversS2828D JNJ 1661010 10mg JNJ-1661010 is a potent and selective FAAS2828F JNJ 1661010 25mg JNJ-1661010 is a potent and selective FAAS2828G JNJ 1661010 50mg JNJ-1661010 is a potent and selective FAAS1472C Safinamide Mesylate (FCE28073) 5mg Safinamide Mesylate is mesylate salt of SaS1472D Safinamide Mesylate (FCE28073) 10mg Safinamide Mesylate is mesylate salt of SaS1472G Safinamide Mesylate (FCE28073) 50mg Safinamide Mesylate is mesylate salt of SaS1472I Safinamide Mesylate (FCE28073) 200mg Safinamide Mesylate is mesylate salt of SaS2102G Rasagiline mesylate 50mg Rasagiline mesylate is a new MAO-B inhibitS2102H Rasagiline mesylate 100mg Rasagiline mesylate is a new MAO-B inhibitS3212D Moclobemide 10mg Moclobemide is MAO-A (5-HT) inhibitor wit

S3212G Moclobemide 50mg Moclobemide is MAO-A (5-HT) inhibitor witS2695C Nepicastat Hcl 5mg Nepicastat hydrochloride is a novel, potenS2695D Nepicastat Hcl 10mg Nepicastat hydrochloride is a novel, potenS2695G Nepicastat Hcl 50mg Nepicastat hydrochloride is a novel, potenS2695I Nepicastat Hcl 200mg Nepicastat hydrochloride is a novel, potenS1379I Isotretinoin 200mg Isotretinoin is a medication used for the trS1379K Isotretinoin 500mg Isotretinoin is a medication used for the trS1522C Tosedostat (CHR2797) 5mg CHR-2797 is an aminopeptidase inhibitor S1522D Tosedostat (CHR2797) 10mg CHR-2797 is an aminopeptidase inhibitor S1522G Tosedostat (CHR2797) 50mg CHR-2797 is an aminopeptidase inhibitor S1110C Varespladib (LY315920) 5mg LY315920 (Varespladib) is a potent and selS1110D Varespladib (LY315920) 10mg LY315920 (Varespladib) is a potent and selS1110G Varespladib (LY315920) 50mg LY315920 (Varespladib) is a potent and selS1110I Varespladib (LY315920) 200mg LY315920 (Varespladib) is a potent and selS2880 GW 843682X GW 843682X is a PLK inhibitor for PLK1 aS2924B CHIR-99021 (CT99021) HCL 2mg CHIR-99021 HCl (CT99021) is hydrochloridS2924C CHIR-99021 (CT99021) HCL 5mg CHIR-99021 HCl (CT99021) is hydrochloridS2924F CHIR-99021 (CT99021) HCL 25mg CHIR-99021 HCl (CT99021) is hydrochloridS2924H CHIR-99021 (CT99021) HCL 100mg CHIR-99021 HCl (CT99021) is hydrochloridS1630D Allopurinol (Zyloprim) 10mg Allopurinol (Zyloprim) is a xanthine oxidasS1630G Allopurinol (Zyloprim) 50mg Allopurinol (Zyloprim) is a xanthine oxidasS2658B GSK2126458 2mg GSK2126458 is a highly selective and potS2658C GSK2126458 5mg GSK2126458 is a highly selective and potS2658D GSK2126458 10mg GSK2126458 is a highly selective and potS2658G GSK2126458 50mg GSK2126458 is a highly selective and potS2473I Hexestrol(Bibenzyl) 200mg Hexestrol binds to ER alpha and ER beta S1235F Letrozole 25mg Letrozole 25mgS1235G Letrozole 50mg Letrozole 50mgS1235I Letrozole 200mg Letrozole 200mgIRKFAP0013-5 ug Recombinant Bovine IL-4IRKFAP0014-25 ug Recombinant Bovine IL-4IRKFAP0015-5 ug Recombinant Bovine IL-13IRKFAP0016-25 ug Recombinant Bovine IL-13IRKFAP0017-5 ug Recombinant Equine IL-4IRKFAP0018-25 ug Recombinant Equine IL-4IRKFAP0019-5 ug Recombinant Swine CXCL10IRKFAP0020-25 ug Recombinant Swine CXCL10IRKFAP0021-5 ug Recombinant Swine CXCL11IRKFAP0022-25 ug Recombinant Swine CXCL11IRKFAP0023-5 ug Recombinant Equine IL-2IRKFAP0024-25 ug Recombinant Equine IL-2IRKFAP0025-5 ug Recombinant Swine IL-13IRKFAP0026-25 ug Recombinant Swine IL-13IRKFAP0027-5 ug Recombinant Bovine IFN alpha AIRKFAP0028-25 ug Recombinant Bovine IFN alpha AIRKFAP0029-5 ug Recombinant Bovine IL-15IRKFAP0030-25 ug Recombinant Bovine IL-15IRKFAP0031-5 ug Recombinant Swine IFN alpha 1IRKFAP0032-25 ug Recombinant Swine IFN alpha 1IRKFAP0033-5 ug Recombinant Swine IFN-betaIRKFAP0034-25 ug Recombinant Swine IFN-betaIRKFAP0035-5 ug Recombinant Equine IFN gammaIRKFAP0036-25 ug Recombinant Equine IFN gammaIRKFAP0037-5 ug Recombinant Bovine IFN gammaIRKFAP0038-25 ug Recombinant Bovine IFN gammaIRKFAP0039-100 u Recombinant Bovine IFN gammaIRKFAP0040-5 ug Recombinant Bovine IL-6

IRKFAP0041-25 ug Recombinant Bovine IL-6IRKFAP0042-5 ug Recombinant Equine IL-6IRKFAP0043-25 ug Recombinant Equine IL-6IRKFAP0044-5 ug Recombinant Bovine CXCL11IRKFAP0045-25 ug Recombinant Bovine CXCL11IRKFAP0046-5 ug Recombinant Swine CCL2IRKFAP0047-25 ug Recombinant Swine CCL2IRKFAP0048-5 ug Recombinant Chicken IL-10IRKFAP0049-25 ug Recombinant Chicken IL-10IRKFAP0050-5 ug Recombinant Chicken IL-16IRKFAP0051-25 ug Recombinant Chicken IL-16IRKFAP0052-5 ug Recombinant Chicken IL-18IRKFAP0053-25 ug Recombinant Chicken IL-18IRKFAP0054-5 ug Recombinant Bovine IL-23 (p19)IRKFAP0055-25 ug Recombinant Bovine IL-23 (p19)IRKFAP0056-5 ug Recombinant Equine GM-CSFIRKFAP0057-25 ug Recombinant Equine GM-CSFIRKFAP0058-5 ug Recombinant Bovine IL-8IRKFAP0059-25 ug Recombinant Bovine IL-8IRKFAP0060-5 ug Recombinant Bovine CXCL9IRKFAP0061-25 ug Recombinant Bovine CXCL9IRKFAP0062-5 ug Recombinant Bovine IL-2IRKFAP0063-25 ug Recombinant Bovine IL-2IRKFAP0064-5 ug Recombinant Bovine CCL2IRKFAP0065-25 ug Recombinant Bovine CCL2IRKFAP0066-5 ug Recombinant Equine IL-15IRKFAP0067-25 ug Recombinant Equine IL-15IRKFAP0068-5 ug Recombinant Swine IL-15IRKFAP0069-25 ug Recombinant Swine IL-15IRKFAP0070-5 ug Recombinant Equine CCL2IRKFAP0071-25 ug Recombinant Equine CCL2IRKFAP0072-5 ug Recombinant Bovine TNF alphaIRKFAP0073-25 ug Recombinant Bovine TNF alphaIRKFAP0074-100 u Recombinant Bovine TNF alphaIRKFAP0075-5 ug Recombinant Bovine IL-17AIRKFAP0076-25 ug Recombinant Bovine IL-17AIRKFAP0077-100 u Recombinant Bovine IL-17AIRKFAP0078-5 ug Recombinant Equine CXCL9IRKFAP0079-25 ug Recombinant Equine CXCL9IRKFAP0080-5 ug Recombinant Equine CXCL10IRKFAP0081-25 ug Recombinant Equine CXCL10IRKFAP0082-5 ug Recombinant Swine CCL5IRKFAP0083-25 ug Recombinant Swine CCL5IRKFAP0084-5 ug Recombinant Equine IL-1 betaIRKFAP0085-25 ug Recombinant Equine IL-1 betaIRKFAP0086-5 ug Recombinant Chicken CCL20IRKFAP0087-25 ug Recombinant Chicken CCL20IRKFAP0088-5 ug Recombinant Bovine CCL5IRKFAP0089-25 ug Recombinant Bovine CCL5IRKFAP0090-5 ug Recombinant Chicken IL-2IRKFAP0091-25 ug Recombinant Chicken IL-2IRKFAP0092-5 ug Recombinant Chicken CCL4IRKFAP0093-25 ug Recombinant Chicken CCL4IRKFAP0094-5 ug Recombinant Equine CCL3IRKFAP0095-25 ug Recombinant Equine CCL3IRKFAP0096-5 ug Recombinant Equine CCL11IRKFAP0097-25 ug Recombinant Equine CCL11

IRKFAP0098-5 ug Recombinant Swine CCL4IRKFAP0099-25 ug Recombinant Swine CCL4IRKFAP0100-5 ug Recombinant Equine CCL5IRKFAP0101-25 ug Recombinant Equine CCL5IRKFAP0102-5 ug Recombinant Bovine CCL11IRKFAP0103-25 ug Recombinant Bovine CCL11IRKFAP0104-5 ug Recombinant Bovine VEGF-AIRKFAP0105-25 ug Recombinant Bovine VEGF-AIRKFAP0106-5 ug Recombinant Chicken MIFIRKFAP0107-25 ug Recombinant Chicken MIFIRKFAP0108-5 ug Recombinant Bovine IL-21IRKFAP0109-25 ug Recombinant Bovine IL-21IRKFAP0110-5 ug Recombinant Swine CCL3L1IRKFAP0111-25 ug Recombinant Swine CCL3L1IRKFAP0112-5 ug Recombinant Bovine IL-1F5IRKFAP0113-25 ug Recombinant Bovine IL-1F5IRKFAP0114-5 ug Recombinant Bovine IL-12 p40IRKFAP0115-25 ug Recombinant Bovine IL-12 p40IRKFAP0116-5 ug Recombinant Equine IL-17AIRKFAP0117-25 ug Recombinant Equine IL-17AIRKFAP0118-100 u Recombinant Equine IL-17AIRKFAP0119-5 ug Recombinant Bovine CXCL10IRKFAP0120-25 ug Recombinant Bovine CXCL10IRKFAP0121-5 ug Recombinant Swine TNF alphaIRKFAP0122-25 ug Recombinant Swine TNF alphaIRKFAP0123-5 ug Recombinant Canine IL-1 betaIRKFAP0124-25 ug Recombinant Canine IL-1 betaIRKFAP0125-5 ug Recombinant Bovine IL-1 alphaIRKFAP0126-25 ug Recombinant Bovine IL-1 alphaIRKFAP0127-5 ug Recombinant Feline IL-1 betaIRKFAP0128-25 ug Recombinant Feline IL-1 betaIRKFAP0129-5 ug Recombinant Feline IL-2IRKFAP0130-25 ug Recombinant Feline IL-2IRKFAP0131-5 ug Recombinant Canine IL-8IRKFAP0132-25 ug Recombinant Canine IL-8IRKFAP0133-5 ug Recombinant Equine IL-13IRKFAP0134-25 ug Recombinant Equine IL-13IRKFAP0135-5 ug Recombinant Canine IL-6IRKFAP0136-25 ug Recombinant Canine IL-6IRKFAP0137-5 ug Recombinant Equine IL-5IRKFAP0138-25 ug Recombinant Equine IL-5IRKFAP0139-5 ug Recombinant Bovine IL-1 betaIRKFAP0140-25 ug Recombinant Bovine IL-1 betaIRKFAP0141-5 ug Recombinant Feline IL-8IRKFAP0142-25 ug Recombinant Feline IL-8IRKFAP0143-5 ug Recombinant Swine IL-8IRKFAP0144-25 ug Recombinant Swine IL-8IRKFAP0145-5 ug Recombinant Chicken IL-4IRKFAP0146-25 ug Recombinant Chicken IL-4IRKFAP0147-5 ug Recombinant Chicken IFN gammaIRKFAP0148-25 ug Recombinant Chicken IFN gammaIRKFAP0149-5 ug Recombinant Chicken TNFSF15IRKFAP0150-25 ug Recombinant Chicken TNFSF15IRKFAP0151-5 ug Recombinant Canine IL-5IRKFAP0152-25 ug Recombinant Canine IL-5IRKFAP0153-5 ug Recombinant Swine CCL20IRKFAP0154-25 ug Recombinant Swine CCL20

IRKFAP0155-5 ug Recombinant Swine IFN gammaIRKFAP0156-25 ug Recombinant Swine IFN gammaIRKFAP0157-5 ug Recombinant Swine IL-17AIRKFAP0158-25 ug Recombinant Swine IL-17AIRKFAP0159-100 u Recombinant Swine IL-17AIRKFAP0160-5 ug Recombinant Canine IL-2IRKFAP0161-25 ug Recombinant Canine IL-2IRKFAP0162-100 u Recombinant Canine IL-2IRKFAP0163-5 ug Recombinant Turkey IL-1 betaIRKFAP0164-25 ug Recombinant Turkey IL-1 betaIRKFAP0165-5 ug Recombinant Feline IFN gammaIRKFAP0166-25 ug Recombinant Feline IFN gammaIRKFAP0167-5 ug Recombinant Rabbit IFN gammaIRKFAP0168-25 ug Recombinant Rabbit IFN gammaIRKFAP0169-5 ug Recombinant Equine TNF alphaIRKFAP0170-25 ug Recombinant Equine TNF alphaIRKFAP0171-5 ug Recombinant Swine IL-6IRKFAP0172-25 ug Recombinant Swine IL-6IRKFAP0173-5 ug Recombinant Bovine IL-5IRKFAP0174-25 ug Recombinant Bovine IL-5IRKFAP0175-5 ug Recombinant Rabbit IL-2IRKFAP0176-25 ug Recombinant Rabbit IL-2IRKFAP0177-5 ug Recombinant Rabbit IL-1 betaIRKFAP0178-25 ug Recombinant Rabbit IL-1 betaIRKFAP0179-5 ug Recombinant Equine IFN alpha 1IRKFAP0180-25 ug Recombinant Equine IFN alpha 1IRKFAP0181-5 ug Recombinant Rabbit IL-8IRKFAP0182-25 ug Recombinant Rabbit IL-8IRKFAP0183-5 ug Recombinant Feline SCFIRKFAP0184-25 ug Recombinant Feline SCFIRKFAP0185-5 ug Recombinant Turkey IGF-2IRKFAP0186-25 ug Recombinant Turkey IGF-2IRKFAP0187-5 ug Recombinant Canine SCFIRKFAP0188-25 ug Recombinant Canine SCFIRKFAP0189-5 ug Recombinant Canine VEGF-AIRKFAP0190-25 ug Recombinant Canine VEGF-AIRKFAP0191-5 ug Recombinant Turkey IGF-1IRKFAP0192-25 ug Recombinant Turkey IGF-1IRKFAP0193-5 ug Recombinant Canine IL-21IRKFAP0194-25 ug Recombinant Canine IL-21IRKFAP0195-5 ug Recombinant Canine TNF alphaIRKFAP0196-25 ug Recombinant Canine TNF alphaIRKFAP0197-5 ug Recombinant Swine IL-22IRKFAP0198-25 ug Recombinant Swine IL-22IRKFAP0199-5 ug Recombinant Chicken IL-22IRKFAP0200-25 ug Recombinant Chicken IL-22IRKFAP0201-5 ug Recombinant Rabbit IL-4IRKFAP0202-25 ug Recombinant Rabbit IL-4IRKFAP0203-5 ug Recombinant Canine IFN gammaIRKFAP0204-25 ug Recombinant Canine IFN gammaIRKFAP0205-100 u Recombinant Canine IFN gammaIRKFAP0206-5 ug Recombinant Chicken IL-12 p40IRKFAP0207-25 ug Recombinant Chicken IL-12 p40IRKFAP0208-5 ug Recombinant Chicken GM-CSFIRKFAP0209-25 ug Recombinant Chicken GM-CSFIRKFAP0210-5 ug Recombinant Swine IL-17FIRKFAP0211-25 ug Recombinant Swine IL-17F

IRKFAP0212-5 ug Recombinant Canine IL-24IRKFAP0213-25 ug Recombinant Canine IL-24IRKFAP0214-5 ug Recombinant Feline TNF alphaIRKFAP0215-25 ug Recombinant Feline TNF alphaIRKFAP0216-5 ug Recombinant Feline IL-1 alphaIRKFAP0217-25 ug Recombinant Feline IL-1 alphaIRKFAP0218-5 ug Recombinant Feline IL-4IRKFAP0219-25 ug Recombinant Feline IL-4IRKFAP0220-25 ug Recombinant Swine IL-1 betaIRKFAP0221-5 ug Recombinant Swine IL-1 betaIRKFAP0222-5 ug Recombinant Bovine IFN betaIRKFAP0223-25 ug Recombinant Bovine IFN betaIRKFAP0224-5 ug Recombinant Chicken IL-6IRKFAP0225-25 ug Recombinant Chicken IL-6IRKFAP0226-5 ug Recombinant Swine IL-4IRKFAP0227-25 ug Recombinant Swine IL-4IRKFAP0228-5 ug Recombinant Swine IL-10IRKFAP0229-25 ug Recombinant Swine IL-10IRKFAP0230-5 ug Recombinant Bovine IL-18IRKFAP0231-25 ug Recombinant Bovine IL-18IRKFAP0232-5 ug Recombinant Feline IL-6IRKFAP0233-25 ug Recombinant Feline IL-6IRKFAP0234-5 ug Recombinant Turkey IL-8IRKFAP0235-25 ug Recombinant Turkey IL-8IRKFAP0236-5 ug Recombinant Dolphin TNF alphaIRKFAP0237-25 ug Recombinant Dolphin TNF alphaIRKFAP0238-5 ug Recombinant Dolphin IL-8IRKFAP0239-25 ug Recombinant Dolphin IL-8IRKFAP0240-5 ug Recombinant Swine CXCL9IRKFAP0241-25 ug Recombinant Swine CXCL9IRKFAP0242-5 ug Recombinant Dolphin IL-1 alphaIRKFAP0243-25 ug Recombinant Dolphin IL-1 alphaIRKFAP0244-5 ug Recombinant Bovine IL-16IRKFAP0245-25 ug Recombinant Bovine IL-16IRKFAP0246-5 ug Recombinant Equine IL-8IRKFAP0247-25 ug Recombinant Equine IL-8IRKFAP0248-5 ug Recombinant Equine VEGF-AIRKFAP0249-25 ug Recombinant Equine VEGF-AIRKFAP0250-5 ug Recombinant Guinea Pig IL-1 betaIRKFAP0251-25 ug Recombinant Guinea Pig IL-1 betaIRKFAP0252-5 ug Recombinant Guinea Pig IL-8IRKFAP0253-25 ug Recombinant Guinea Pig IL-8IRKFAP0254-5 ug Recombinant Guinea Pig TNF alphaIRKFAP0255-25 ug Recombinant Guinea Pig TNF alphaIRKFAP0256-5 ug Recombinant Rabbit IL-1 alphaIRKFAP0257-25 ug Recombinant Rabbit IL-1 alphaIRKFAP0258-5 ug Recombinant Dolphin IL-1 betaIRKFAP0259-25 ug Recombinant Dolphin IL-1 betaIRKFAP0260-5 ug Recombinant Guinea Pig CCL5IRKFAP0261-25 ug Recombinant Guinea Pig CCL5IRKFAP0262-5 ug Recombinant Guinea Pig CCL11IRKFAP0263-25 ug Recombinant Guinea Pig CCL11IRKFAP0264-5 ug Recombinant Chicken IL-17FIRKFAP0265-25 ug Recombinant Chicken IL-17FIRKFAP0266-5 ug Recombinant Bovine IL-1 Receptor AntagonistIRKFAP0267-25 ug Recombinant Bovine IL-1 Receptor AntagonistIRKFAP0268-5 ug Recombinant Bovine IGF-1

IRKFAP0269-25 ug Recombinant Bovine IGF-1IRKFAP0270-5 ug Recombinant Mouse IL-17AIRKFAP0271-25 ug Recombinant Mouse IL-17AIRKFAP0272-100 u Recombinant Mouse IL-17AIRKFAP0273-5 ug Recombinant Equine IL-1 alphaIRKFAP0274-25 ug Recombinant Equine IL-1 alphaIRKFAP0275-100 u Recombinant Equine IL-1 alphaIRKFAP0276-5 ug Recombinant Mouse IL-1 betaIRKFAP0277-25 ug Recombinant Mouse IL-1 betaIRKFAP0278-100 u Recombinant Mouse IL-1 betaIRKFAP0279-5 ug Recombinant Mouse APRILIRKFAP0280-25 ug Recombinant Mouse APRILIRKFAP0281-5 ug Recombinant Bovine CCL4IRKFAP0282-25 ug Recombinant Bovine CCL4IRKFAP0283-100 u Recombinant Bovine CCL4IRKFAP0284-5 ug Recombinant Guinea Pig CCL2IRKFAP0285-25 ug Recombinant Guinea Pig CCL2IRKFAP0286-100 u Recombinant Guinea Pig CCL2IRKFAP0287-5 ug Recombinant Guinea Pig CXCL1IRKFAP0288-25 ug Recombinant Guinea Pig CXCL1IRKFAP0289-100 u Recombinant Guinea Pig CXCL1IRKFAP0290-5 ug Recombinant Mouse VEGF-AIRKFAP0291-25 ug Recombinant Mouse VEGF-AIRKFAP0292-100 u Recombinant Mouse VEGF-AIRKFAP0293-5 ug Recombinant Ovine IL-6IRKFAP0294-25 ug Recombinant Ovine IL-6IRKFAP0295-100 u Recombinant Ovine IL-6IRKFAP0296-5 ug Recombinant Mouse IL-2IRKFAP0297-25 ug Recombinant Mouse IL-2IRKFAP0298-100 u Recombinant Mouse IL-2IRKFAP0299-5 ug Recombinant Chicken IL-21IRKFAP0300-25 ug Recombinant Chicken IL-21IRKFAP0301-100 u Recombinant Chicken IL-21IRKFAP0302-5 ug Recombinant Mouse TNF alphaIRKFAP0303-25 ug Recombinant Mouse TNF alphaIRKFAP0304-5 ug Recombinant Dolphin IFN gammaIRKFAP0305-25 ug Recombinant Dolphin IFN gammaIRKFAP0306-5 ug Recombinant Bovine APRILIRKFAP0307-5 ug Recombinant Bovine IL-10IRKFAP0308-5 ug Recombinant Mouse IL-6IRKFAP0309-25 ug Recombinant Mouse IL-6IRKFAP0310-5 ug Recombinant Mouse IL-10IRKFAP0311-25 ug Recombinant Mouse IL-10IRKFAP0312-5 ug Recombinant Mouse IFN gammaIRKFAP0313-25 ug Recombinant Mouse IFN gammaIRKFAP0314-100 u Recombinant Mouse IFN gammaIRKFAP0315-5 ug Recombinant Rat APRILIRKFAP0316-25 ug Recombinant Rat APRILIRKFAP0317-100 u Recombinant Rat APRILIRKFAP0318-5 ug Recombinant Mouse FGF basic (FGF-2)IRKFAP0319-25 ug Recombinant Mouse FGF basic (FGF-2)IRKFAP0320-5 ug Recombinant Swine VEGF-AIRKFAP0321-25 ug Recombinant Swine VEGF-AIRKFAP0322-5 ug Recombinant Mouse CXCL12IRKFAP0323-25 ug Recombinant Mouse CXCL12IRKFAP0324-5 ug Recombinant Mouse BAFFIRKFAP0325-25 ug Recombinant Mouse BAFF

IRKFAP0326-5 ug Recombinant Rat VEGF-AIRKFAP0327-25 ug Recombinant Rat VEGF-AIRKFAP0328-5 ug Recombinant Mouse GM-CSFIRKFAP0329-25 ug Recombinant Mouse GM-CSFIRKFAP0330-100 u Recombinant Mouse GM-CSFIRKFAP0331-5 ug Recombinant Chicken IFN alphaIRKFAP0332-25 ug Recombinant Chicken IFN alphaIRKFAP0333-100 u Recombinant Chicken IFN alphaIRKFAP0334-5 ug Recombinant Dolphin IL-4IRKFAP0335-25 ug Recombinant Dolphin IL-4IRKFAP0336-5 ug Recombinant Swine APRILIRKFAP0337-5 ug Recombinant Swine IL-1 Receptor AntagonistIRKFAP0338-25 ug Recombinant Swine IL-1 Receptor AntagonistIRKFAP0339-100 u Recombinant Swine IL-1 Receptor AntagonistIRKFAP0340-5 ug Recombinant Ovine VEGF-AIRKFAP0341-25 ug Recombinant Ovine VEGF-AIRKFAP0342-100 u Recombinant Ovine VEGF-AIRKFAP0343-5 ug Recombinant Canine IL-1 Receptor AntagonistIRKFAP0344-25 ug Recombinant Canine IL-1 Receptor AntagonistIRKFAP0345-100 u Recombinant Canine IL-1 Receptor AntagonistIRKFAP0346-5 ug Recombinant Equine IL-1 Receptor AntagonistIRKFAP0347-25 ug Recombinant Equine IL-1 Receptor AntagonistIRKFAP0348-5 ug Recombinant Rabbit TNF alphaIRKFAP0349-25 ug Recombinant Rabbit TNF alphaIRKFAP0350-5 ug Recombinant Mouse IL-4IRKFAP0351-25 ug Recombinant Mouse IL-4IRKFAP0352-100 u Recombinant Mouse IL-4IRKFAP0353-5 ug Recombinant Rabbit CCL2IRKFAP0354-25 ug Recombinant Rabbit CCL2IRKFAP0355-5 ug Recombinant Rabbit CCL4IRKFAP0356-25 ug Recombinant Rabbit CCL4IRKFAP0357-5 ug Recombinant Mouse TNFSF11 (RANKL)IRKFAP0358-25 ug Recombinant Mouse TNFSF11 (RANKL)IRKFAP0359-100 u Recombinant Mouse TNFSF11 (RANKL)IRKFAP0360-5 ug Recombinant Human IFN gammaIRKFAP0361-25 ug Recombinant Human IFN gammaIRKFAP0362-100 u Recombinant Human IFN gammaIRKFAP0363-5 ug Recombinant Human IL-4IRKFAP0364-25 ug Recombinant Human IL-4IRKFAP0365-100 u Recombinant Human IL-4IRKFAP0366-5 ug Recombinant Human IL-8IRKFAP0367-25 ug Recombinant Human IL-8IRKFAP0368-100 u Recombinant Human IL-8IRPLA-EDTA-ANG-1Rat Renin Substrate Plasma Na EDTA 1mIn the renin-angiotensin system (RAS), renin activates angiotensinogen to yield angiotensin I, which is further converted into angiotensin II by angiotensin-converting enzyme. Removal of the kidney generates renin/prorenin deficient plasma with high levels of angiotensinogen. This nephrectomized rat plasma can be used as a source of angiotensinogen or as a substrate for renin generation of Ang I. Plasma is collected from male rats at least 48 hours post nephrectomy. The substrate activity is determined by incubation with renin followed by Ang I radio-immune assay (RIA).IRPLA-EDTA-ANG-1Rat Renin Substrate Plasma Na EDTA 1mIn the renin-angiotensin system (RAS), renin activates angiotensinogen to yield angiotensin I, which is further converted into angiotensin II by angiotensin-converting enzyme. Removal of the kidney generates renin/prorenin deficient plasma with high levels of angiotensinogen. This nephrectomized rat plasma can be used as a source of angiotensinogen or as a substrate for renin generation of Ang I. Plasma is collected from male rats at least 48 hours post nephrectomy. The substrate activity is determined by incubation with renin followed by Ang I radio-immune assay (RIA).IRPLA-EDTA-ANG-1Rat Renin Substrate Plasma Na EDTA 10 In the renin-angiotensin system (RAS), renin activates angiotensinogen to yield angiotensin I, which is further converted into angiotensin II by angiotensin-converting enzyme. Removal of the kidney generates renin/prorenin deficient plasma with high levels of angiotensinogen. This nephrectomized rat plasma can be used as a source of angiotensinogen or as a substrate for renin generation of Ang I. Plasma is collected from male rats at least 48 hours post nephrectomy. The substrate activity is determined by incubation with renin followed by Ang I radio-immune assay (RIA).IRPLA-EDTA-ANG-1Rat Renin Substrate Plasma Na EDTA 10 In the renin-angiotensin system (RAS), renin activates angiotensinogen to yield angiotensin I, which is further converted into angiotensin II by angiotensin-converting enzyme. Removal of the kidney generates renin/prorenin deficient plasma with high levels of angiotensinogen. This nephrectomized rat plasma can be used as a source of angiotensinogen or as a substrate for renin generation of Ang I. Plasma is collected from male rats at least 48 hours post nephrectomy. The substrate activity is determined by incubation with renin followed by Ang I radio-immune assay (RIA).IHPREN-HIS-0.1mgHuman Prorenin 8x His 0.1mg Recombinantly produced in HEK cell culture and purified by chelated metal affinity chromatography. Contains a 8X-Histidine tag at C terminus for purification. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminusIHPREN-HIS-1mg Human Prorenin 8x His 1mg Recombinantly produced in HEK cell culture and purified by chelated metal affinity chromatography. Contains a 8X-Histidine tag at C terminus for purification. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminusIHPREN-0.1mg Human Prorenin 0.1mg Recombinantly produced in HEK cell culture as untagged native form prorenin and purified by affinity chromatography. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus. This so called prosegment appears to block the full enzymatic potential of the active site (1). Renin activates the renin-angiotensin system by cleaving angiotensinogen, produced by the liver, to yield angiotensin I, which is further converted into angiotensin II by ACE, the angiotensin-converting enzyme primarily within the capillaries of the lungs. It has been reported that the levels of circulating prorenin (but not renin) are increased in diabetic subjects(2).IHPREN-1mg Human Prorenin 1mg Recombinantly produced in HEK cell culture as untagged native form prorenin and purified by affinity chromatography. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus. This so called prosegment appears to block the full enzymatic potential of the active site (1). Renin activates the renin-angiotensin system by cleaving angiotensinogen, produced by the liver, to yield angiotensin I, which is further converted into angiotensin II by ACE, the angiotensin-converting enzyme primarily within the capillaries of the lungs. It has been reported that the levels of circulating prorenin (but not renin) are increased in diabetic subjects(2).IHREN-0.1mg Human Renin 0.1mg Recombinantly produced in HEK cell culture as untagged native form prorenin and purified by affinity chromatography. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus.IHREN-1mg Human Renin 1mg Recombinantly produced in HEK cell culture as untagged native form prorenin and purified by affinity chromatography. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus.IRPREN-HIS-0.1mgRat Prorenin 8x His Tagged 0.1mg Recombinantly produced in HEK cell culture and purified by chelated metal affinity chromatography. Contains a 8X-Histidine tag at C terminus for purification. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus. This so called prosegment appears to block the full enzymatic potential of the active site (1). Renin activates the renin-angiotensin system by cleaving angiotensinogen, produced by the liver, to yield angiotensin I, which is further converted into angiotensin II by ACE, the angiotensin-converting enzyme primarily within the capillaries of the lungs.IRPREN-HIS-1mg Rat Prorenin 8x His Tagged 1mg Recombinantly produced in HEK cell culture and purified by chelated metal affinity chromatography. Contains a 8X-Histidine tag at C terminus for purification. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus. This so called prosegment appears to block the full enzymatic potential of the active site (1). Renin activates the renin-angiotensin system by cleaving angiotensinogen, produced by the liver, to yield angiotensin I, which is further converted into angiotensin II by ACE, the angiotensin-converting enzyme primarily within the capillaries of the lungs.IMPREN-HIS-0.1mgMouse Prorenin 8x His 0.1mg Recombinantly produced in HEK cell culture and purified by chelated metal affinity chromatography. Contains a 8X-Histidine tag at C terminus for purification. Resistant to activation to renin by trypsin digestion. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus.IMPREN-HIS-1mg Mouse Prorenin 8x His 1mg Recombinantly produced in HEK cell culture and purified by chelated metal affinity chromatography. Contains a 8X-Histidine tag at C terminus for purification. Resistant to activation to renin by trypsin digestion. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus.

IHPLA-SC-PREN-1.0Human Renin/Prorenin double Depleted PIRSA-100mg Sprague Dawley Rat Albumin 100mg Sprague Dawley Rat Albumin is a water-soluble protein with considerable structural stability which makes up 60percent of the total protein of plasma. It functions as a carrier of hormones, enzymes, fatty acids, metal ions, and medicinal products. Prepared from US origin rat plasma by proprietary fractionation methods and lyophilized. 95percent pure by SDS-PAGE.IRSA-200mg Sprague Dawley Rat Albumin 200mg Sprague Dawley Rat Albumin is a water-soluble protein with considerable structural stability which makes up 60percent of the total protein of plasma. It functions as a carrier of hormones, enzymes, fatty acids, metal ions, and medicinal products. Prepared from US origin rat plasma by proprietary fractionation methods and lyophilized. 95percent pure by SDS-PAGE.IRbSA-500mg Rabbit Plasma Albumin 500mg Rabbit albumin is a water-soluble protein with considerable structural stability which makes up 60percent of the total protein of plasma. It functions as a carrier of hormones, enzymes, fatty acids, metal ions, and medicinal products. Prepared from US origin rabbit plasma by proprietary fractionation methods and lyophilized. 95percent pure by SDS-PAGE.IRbSA-1000mg Rabbit Plasma Albumin 1000mg Rabbit albumin is a water-soluble protein with considerable structural stability which makes up 60percent of the total protein of plasma. It functions as a carrier of hormones, enzymes, fatty acids, metal ions, and medicinal products. Prepared from US origin rabbit plasma by proprietary fractionation methods and lyophilized. 95percent pure by SDS-PAGE.IEQSA-100mg Horse Albumin 100mg Albumin is a water-soluble protein with considerable structural stability which makes up 60percent of the total protein of plasma. It functions as a carrier of hormones, enzymes, fatty acids, metal ions, and medicinal products. Prepared from US origin horse plasma by proprietary fractionation methods and lyophilized. 95percent pure by SDS-PAGE.ICYSA-10mg Cyno Albumin 10mg Albumin is a water-soluble protein with considerable structural stability which makes up 60percent of the total protein of plasma. It functions as a carrier of hormones, enzymes, fatty acids, metal ions, and medicinal products. Prepared from cyno plasma by proprietary fractionation methods and lyophilized. 95percent pure by SDS-PAGE.IRDSA-100mg Canine Plasma Albumin 100mg Albumin is a water-soluble protein with considerable structural stability which makes up 60percent of the total protein of plasma. It functions as a carrier of hormones, enzymes, fatty acids, metal ions, and medicinal products. Prepared from US origin canine plasma by proprietary fractionation methods and lyophilized. 95percent pure by SDS-PAGE.IRDSA-200mg Canine Plasma Albumin 200mg Albumin is a water-soluble protein with considerable structural stability which makes up 60percent of the total protein of plasma. It functions as a carrier of hormones, enzymes, fatty acids, metal ions, and medicinal products. Prepared from US origin canine plasma by proprietary fractionation methods and lyophilized. 95percent pure by SDS-PAGE.IHSA-100mg Human Serum Albumiun 100mg Human Albumin (HSA) solubility: Albumin(s) are readily soluble in dionized water and can only preciptated by high concentrations of nuetral salts. Human Serum Albumin helps stabilize other solubilized proteins. Human Serum Albumin (HSA)is readily coagulated with heat. Human Serum Albumin(s) with other albumin(s) are acidic proteins which occur in abundance in body fluids and tissues. As a poducer, Manufacturer and supplier of finished human proteins for research and IVD manufacturing we can custom fill to your requirement.IHSA-200mg Human Serum Albumiun 200mg Human Albumin (HSA) solubility: Albumin(s) are readily soluble in dionized water and can only preciptated by high concentrations of nuetral salts. Human Serum Albumin helps stabilize other solubilized proteins. Human Serum Albumin (HSA)is readily coagulated with heat. Human Serum Albumin(s) with other albumin(s) are acidic proteins which occur in abundance in body fluids and tissues. As a poducer, Manufacturer and supplier of finished human proteins for research and IVD manufacturing we can custom fill to your requirement.IRMSA-100mg Mouse Plasma Albumin 100mgIRMSA-200mg Mouse Plasma Albumin 200mgIMPAI-I91L-0.5mg Mouse PAI-1 (stable active mutant) 0.5mgUsing information obtained from the studies which produced stabilized human PAI-1 (ICPAI) we have available a form of mouse PAI-1 that has a single conservative mutation (Isoleucine 91 to Leucine).IMPAI-L-0.5mg Mouse PAI-1 (wild type latent form) 0.5mgLatent mouse PAI-1 is a useful control for experiments when used in conjunction with the active form.IMPAI-L-1mg Mouse PAI-1 (wild type latent form) 1mg Latent mouse PAI-1 is a useful control for experiments when used in conjunction with the active form.IMPAI-0.5mg Mouse PAI-1 (wild type active form) 0.5mgRecombinant mouse PAI-1 is the ideal choice for studies involving this animal model of fibrinolysis and cancer studies. The active fraction typically contains 70percent active PAI-1.IMPAI-1mg Mouse PAI-1 (wild type active form) 1mg Recombinant mouse PAI-1 is the ideal choice for studies involving this animal model of fibrinolysis and cancer studies. The active fraction typically contains 70percent active PAI-1.IMPLA-SC-PAI-10mlMouse PAI-1 Depleted Plasma, Sodium CitPrepared from frozen mouse plasma using immobilized anti-mouse PAI-1 IgG.IMPLA-SC-PAI-100mMouse PAI-1 Depleted Plasma, Sodium CiPrepared from frozen mouse plasma using immobilized anti-mouse PAI-1 IgG.IPOPAI-0.5mg Porcine PAI-1 (wild type active form) 0.5mPorcine (pig) PAI-1 displays a close homology to bovine and human PAI-1 with 90 and 86percent amino acid homology, respectively.IPOPAI-1mg Porcine PAI-1 (wild type active form) 1mg Porcine (pig) PAI-1 displays a close homology to bovine and human PAI-1 with 90 and 86percent amino acid homology, respectively.IRbPAI-L-BIO-0.5m Rabbit PAI-1 (Biotin labeled latent fractio This latent fraction of recombinant rabbit PAI-1 is biotin labeled on lysine residues.IRbPAI-L-0.5mg Rabbit PAI-1 (wild type latent form) 0.5mgLatent Rabbit PAI-1 is a useful control for experiments when used in conjunction with the active formIRbPAI-L-1mg Rabbit PAI-1 (wild type latent form) 1mg Latent Rabbit PAI-1 is a useful control for experiments when used in conjunction with the active formIRbPAI-0.5mg Rabbit PAI-1 (wild type active form 0.5mg Rabbit PAI-1 is now available and is preferred for animal studies that utilize rabbit models. Wild type rabbit PAI-1 is less than 20percent active and may not be suitable for most experiments. As a replacement please consider rabbit PAI-1 stable mutant which is 70-80percent activeIRbPAI-1mg Rabbit PAI-1 (wild type active form 1mg Rabbit PAI-1 is now available and is preferred for animal studies that utilize rabbit models. Wild type rabbit PAI-1 is less than 20percent active and may not be suitable for most experiments. As a replacement please consider rabbit PAI-1 stable mutant which is 70-80percent activeIRbPLA-SC-PAI-10mRabbit PAI-1 Depleted Plasma, Sodium CitPrepared from frozen rabbit plasma using immobilized anti-rat PAI-1 IgG.IRbPLA-SC-PAI-100Rabbit PAI-1 Depleted Plasma, Sodium CiPrepared from frozen rabbit plasma using immobilized anti-rat PAI-1 IgG.IRPAI-I91L-0.5mg Rat PAI-1 (stable active mutant) 0.5mgIRPAI-I91L-1mg Rat PAI-1 (stable active mutant) 1mgIRPAI-L-0.5mg Rat PAI-1 (wild type latent form) 0.5mg Latent rat PAI-1 is a useful control for experiments when used in conjunction with the active form or stable mutant.IRPAI-L-1mg Rat PAI-1 (wild type latent form) 1mg Latent rat PAI-1 is a useful control for experiments when used in conjunction with the active form or stable mutant.IRPAI-0.5mg Rat PAI-1 (wild type active form) 0.5mg Recombinant rat PAI-1 is the ideal choice for studies involving this animal model of fibrinolysis and cancer studies. The active fraction typically contains 95percent active PAI-1.IRPAI-1mg Rat PAI-1 (wild type active form) 1mg Recombinant rat PAI-1 is the ideal choice for studies involving this animal model of fibrinolysis and cancer studies. The active fraction typically contains 95percent active PAI-1.IFPAI-0.5mg Human PAI -1 Cathepsin G Specific MutanA single mutation at the P1 position of PAI-1 alters the target specificity of PAI-1 from the plasminogen activators tPA and uPA to Cathepsin G.IFPAI-1mg Human PAI -1 Cathepsin G Specific Muta A single mutation at the P1 position of PAI-1 alters the target specificity of PAI-1 from the plasminogen activators tPA and uPA to Cathepsin G.IAPAI-0.5mg Human PAI -1 Elastase Specific Mutant 0 A single mutation at the P1 position of PAI-1 alters the target specificity of PAI-1 from the plasminogen activators tPA and uPA to elastase. PAI-1 is normally a substrate for pancreatic and neutrophil elastase becoming cleaved at the P3 position.IAPAI-1mg Human PAI -1 Elastase Specific Mutant 1 A single mutation at the P1 position of PAI-1 alters the target specificity of PAI-1 from the plasminogen activators tPA and uPA to elastase. PAI-1 is normally a substrate for pancreatic and neutrophil elastase becoming cleaved at the P3 position.IHPAI-AVI-0.5mg Human PAI -1 Elastase Specific Mutant FoThis human PAI-1 variant contains a mutation at the active site to make it specific for inhibition of neutrophil elastase. Additional mutations provide resistance to cleavage and stability.ICPAI-UPA-0.1mg Human PAI-1 uPA complex 0.1mg Human PAI-1 stable mutant is reacted with an excess of human urokinase at physiological pH. Excess uPA is removed from the resulting 1:1 molar complex by immobilized benzamidine resin.ICPAI-TPA-0.1mg Human PAI-1 tPA complex 0.1mg Human PAI-1 stable mutant is reacted with an excess of human sc-tPA at physiological pH. The resulting 1:1 molar complex is purified from the remaining tPA by cobalt metal affinity chromatography resin.IS119C-NBD-0.5mgHuman PAI-1 (NBD labeled mutant) 0.5m This mutant contains a Ser to Cys replacement around the vitronectin binding site. Incorporation of an NBD labels allows for the reporting of binding to vitronectin.IS119C-NBD-1mg Human PAI-1 (NBD labeled mutant) 1mg This mutant contains a Ser to Cys replacement around the vitronectin binding site. Incorporation of an NBD labels allows for the reporting of binding to vitronectin.IQ123K-0.5mg Human PAI-1 (vitronectin null binding mut A single mutation results in nearly complete loss of binding of the PAI-1 mutant to the important ligand vitronectin. All other aspects of PAI-1 biological activity such as anti-protease activity remain unaffected.IQ123K-1mg Human PAI-1 (vitronectin null binding mut A single mutation results in nearly complete loss of binding of the PAI-1 mutant to the important ligand vitronectin. All other aspects of PAI-1 biological activity such as anti-protease activity remain unaffected.INTFLCPAI-0.5mg Human PAI-1 (N-terminal fluorecein labeleStable mutant human PAI-1 fluorescein labeled by iodoacetamide substitution at the N-terminal cysteine (patent pending).INTFLCPAI-1mg Human PAI-1 (N-terminal fluorecein label Stable mutant human PAI-1 fluorescein labeled by iodoacetamide substitution at the N-terminal cysteine (patent pending).INTFLPAI-L-0.5mg Human PAI-1 (N-terminal fluorecein labeledLatent human PAI-1 fluorescein labeled by iodoacetamide substitution at the N-terminal cysteine (patent pending).INTFLPAI-L-1mg Human PAI-1 (N-terminal fluorecein labeledLatent human PAI-1 fluorescein labeled by iodoacetamide substitution at the N-terminal cysteine (patent pending).INTFLPAI-A-0.5mg Human PAI-1 (N-terminal fluorecein labeleLatent human PAI-1 fluorescein labeled by iodoacetamide substitution at the N-terminal cysteine (patent pending).INTFLPAI-A-1mg Human PAI-1 (N-terminal fluorecein labeleLatent human PAI-1 fluorescein labeled by iodoacetamide substitution at the N-terminal cysteine (patent pending).

Prepared from frozen human plasma using immobilized anti-human Renin IgG.0.1 ng/ml Renin, 0.1 ng/ml Prorenin AntigenFor In Vitro laboratory use only

Albumin is a water-soluble protein with considerable structural stability which makes up 60percent of the total protein of plasma. It functions as a carrier of hormones, enzymes, fatty acids, metal ions, and medicinal products. Prepared from US origin mouse (murine) plasma by proprietary fractionation methods and lyophilized. 95percent pure by SDS-PAGE. Add deionized water or buffer to original or desired volume, aliquot and freeze unused portion. Albumin is a water-soluble protein with considerable structural stability which makes up 60percent of the total protein of plasma. It functions as a carrier of hormones, enzymes, fatty acids, metal ions, and medicinal products. Prepared from US origin mouse (murine) plasma by proprietary fractionation methods and lyophilized. 95percent pure by SDS-PAGE. Add deionized water or buffer to original or desired volume, aliquot and freeze unused portion. 

This recombinant rat PAI-1 has a single conservative mutation (Isoleucine 91 to Leucine) that yields a rat PAI-1 with an enhanced half-life as compared to the wild type. This recombinant rat PAI-1 has a single conservative mutation (Isoleucine 91 to Leucine) that yields a rat PAI-1 with an enhanced half-life as compared to the wild type. 

INTBIOCPAI-0.5mgHuman PAI-1 (N-terminal biotin labeled st Stable mutant human PAI-1 biotin labeled by iodoacetamide substitution at the N-terminal cysteine (patent pending).INTBIOCPAI-1mg Human PAI-1 (N-terminal biotin labeled st Stable mutant human PAI-1 biotin labeled by iodoacetamide substitution at the N-terminal cysteine (patent pending).IGLYHPAI-L-0.5mg Human PAI-1 (glycosylated wild type latenGlycosylated wild type human PAI-1 produced in insect cells with molecular weight of 46,000 Da. Latent form.IGLYHPAI-L-1mg Human PAI-1 (glycosylated wild type latenGlycosylated wild type human PAI-1 produced in insect cells with molecular weight of 46,000 Da. Latent form.IGLYHPAI-A-0.5mg Human PAI-1 (glycosylated wild type) 0.5 Glycosylated wild type human PAI-1 produced in insect cells with molecular weight of 46,000 Da. Active form.IGLYHPAI-A-1mg Human PAI-1 (glycosylated wild type) 1mgGlycosylated wild type human PAI-1 produced in insect cells with molecular weight of 46,000 Da. Active form.I6X-HISPAI-0.5mg Human PAI-1 (stable mutant N-terminal polA patent pending mutant of human PAI-1 containing four mutations that stabilize the activity of PAI-1 has been made available. The N-terminus has been additionally modified with the introduction of a 6-X histidine tag. The tag allows for the immobilization of functionally active PAI-1 onto surfaces such as metal chelate microtiter plates or Ni+2 resins. Many new applications for PAI-1 can be envisioned with this unique reagent.I6X-HISPAI-1mg Human PAI-1 (stable mutant N-terminal polA patent pending mutant of human PAI-1 containing four mutations that stabilize the activity of PAI-1 has been made available. The N-terminus has been additionally modified with the introduction of a 6-X histidine tag. The tag allows for the immobilization of functionally active PAI-1 onto surfaces such as metal chelate microtiter plates or Ni+2 resins. Many new applications for PAI-1 can be envisioned with this unique reagent.ICPAI-0.5mg Human PAI-1 (stable mutant form) 0.5mg The human form of PAI-1 contains the following four mutations: K154T, Q319L, M354I and N150H. These mutations combine to confer great stability to the otherwise labile molecule essentially locking in into the active conformation. It is an ideal choice for in vivo studies.ICPAI-1mg Human PAI-1 (stable mutant form) 1mg The human form of PAI-1 contains the following four mutations: K154T, Q319L, M354I and N150H. These mutations combine to confer great stability to the otherwise labile molecule essentially locking in into the active conformation. It is an ideal choice for in vivo studies.ICPAI-Q123K-0.5 mHuman PAI-1 (stable vitronectin reduced bThe Q123K point mutation on the human PAI-1 stable mutant background (K154T, Q319L, M354I and N150H) results in PAI-1 with a greatly extended half life and reduced binding to the important ligand vitronectin.IGLYMPAI-I91L-0.5Glycosylated Mouse PAI-1 (stable mutant)IGLYCPAI-0.5 mg Human PAI-1 (Glycosylated - stable mutanIBPLM-1mg Bovine Plasmin 1mg Prepared from fresh bovine plasma by immobilized lysine chromatographyIBPLM-10mg Bovine Plasmin 10mg Prepared from fresh bovine plasma by immobilized lysine chromatographyIBPLG-1mg Bovine Plasminogen 1mg Prepared from fresh bovine plasma by immobilized lysine chromatography.IBPLG-10mg Bovine Plasminogen 10mg Prepared from fresh bovine plasma by immobilized lysine chromatography.IDPLG-1mg Canine Plasminogen 1mg Prepared from fresh US origin dog (canine) plasma by immobilized lysine chromatography.ICKPLM-1mg Chicken Plasmin 1mg Prepared from plasminogen by activation with immobilized human uPA. 100% functionally active plasmin is purified from the activation reaction by immobilized SBTI. Plasmin will undergo rapid auto proteolysis in the absence of benzamidine and should be used quickly once thawed. Aliquot to avoid freeze-thaw cyclesICKPLM-10mg Chicken Plasmin 10mg Prepared from plasminogen by activation with immobilized human uPA. 100% functionally active plasmin is purified from the activation reaction by immobilized SBTI. Plasmin will undergo rapid auto proteolysis in the absence of benzamidine and should be used quickly once thawed. Aliquot to avoid freeze-thaw cyclesICKPG-1mg Chicken Plasminogen 1mg Prepared from fresh chicken plasma by immobilized lysine chromatography.ICKPG-10mg Chicken Plasminogen 10mg Prepared from fresh chicken plasma by immobilized lysine chromatography.IMPLA-SER-PG-10mPlasminogen Depleted Mouse Serum 10mPrepared from frozen mouse serumIMPLA-SER-PG-50mPlasminogen Depleted Mouse Serum 50mPrepared from frozen mouse serumIMPLM-1mg Mouse Plasmin 1mg Prepared from plasminogen by activation with immobilized human uPA.IMPLM-10mg Mouse Plasmin 10mg Prepared from plasminogen by activation with immobilized human uPA.IMPLG-1mg Mouse Plasminogen 1mg Prepared from fresh mouse plasma by immobilized lysine chromatography.IRbPLM-1mg Rabbit Plasmin 1mg Prepared from plasminogen by activation with immobilized human uPA.IRbPLM-10mg Rabbit Plasmin 10mg Prepared from plasminogen by activation with immobilized human uPA.IRbPLG-1mg Rabbit Plasminogen 1mg Prepared from fresh rabbit plasma by immobilized lysine chromatography.IRbPLG-10mg Rabbit Plasminogen 10mg Prepared from fresh rabbit plasma by immobilized lysine chromatography.IRPLM-1mg Rat Plasmin 1mg Prepared from plasminogen by activation with immobilized human uPA.IRPLM-10mg Rat Plasmin 10mg Prepared from plasminogen by activation with immobilized human uPA.IRPLG-1mg Rat Plasminogen 1mg Prepared from fresh rat plasma by immobilized lysine chromatography.IRPLG-10mg Rat Plasminogen 10mg Prepared from fresh rat plasma by immobilized lysine chromatography.ID-VLK-pNA-25mg Chromogenic substrate for plasmin 25mg The plasmin substrate is chemically and functionally identical to Chromogenix S-2251. Each 25 mg of substrate is lyophilized with 60 mg mannitol as a bulking agentIHA2AP-1mg Human Alpha-2-Antiplasmin 1mg Efficiently inhibits the plasminogen-activator-induced lysis of fibrin clots. Found in plasma at about 70 ug per ml. Alpha-antiplasmin-deficiency is a rare coagulation disorder which allows unrestrained fibrinolytic activity.IHPLM-IN-1mg Inactivated Human Plasmin 1mg Prepared from Lys plasmin by active site-specific inactivation with Phe-Pro-Arg chloromethyl ketone.IHPLM-IN-10mg Inactivated Human Plasmin 10mg Prepared from Lys plasmin by active site-specific inactivation with Phe-Pro-Arg chloromethyl ketone.IHPLM-1mg Human Lys Plasmin 1mg Prepared from Glu plasminogen by activation with immobilized human uPA.IHPLM-10mg Human Lys Plasmin 10mg Prepared from Glu plasminogen by activation with immobilized human uPA.IHGPG-1mg Human Glu Plasminogen 1mg Prepared from fresh human plasma by immobilized lysine chromatography.IHGPG-10mg Human Glu Plasminogen 10mg Prepared from fresh human plasma by immobilized lysine chromatography.IMTPA-FITC-0.05m FITC labeled Mouse tPA 0.05mg Recombinantly produced in insect cells and fluorescein labeled.IMTPA-FITC-0.1mg FITC labeled Mouse tPA 0.1mg Recombinantly produced in insect cells and fluorescein labeled.IMTPA-BIO-0.05mgBiotin labeled Mouse tPA 0.05mg Recombinantly produced in insect cells and biotin labeled.IMTPA-BIO-0.1mg Biotin labeled Mouse tPA 0.1mg Recombinantly produced in insect cells and biotin labeled.IMTPA-ALANC-0.1 Non-enzymatic, non-cleavable Mouse tPAMouse tPA with a double mutation that is permanently single chain and lacks catalytic activity. The non-catalytic mutation site is S481A on the mature protein and S510A on the complete mRNA sequence (UniProtKB: locus TPA_MOUSE, accession P11214).IMTPA-ALANC-1mgNon-enzymatic, non-cleavable Mouse tPAMouse tPA with a double mutation that is permanently single chain and lacks catalytic activity. The non-catalytic mutation site is S481A on the mature protein and S510A on the complete mRNA sequence (UniProtKB: locus TPA_MOUSE, accession P11214).IMTPA-NC-0.1mg Mouse tPA, Non-cleavable 0.1mg The addition of an arginine to glutamic acid mutation generates mouse tPA that is 100percent single chain and resistant to cleavage by plasmin. The mutation site is R279E on the mature protein and R308E on the complete mRNA sequence (UniProtKB: locus TPA_MOUSE, accession P11214). Recombinantly produced in insect cells.IMTPA-NC-1mg Mouse tPA, Non-cleavable 1mg The addition of an arginine to glutamic acid mutation generates mouse tPA that is 100percent single chain and resistant to cleavage by plasmin. The mutation site is R279E on the mature protein and R308E on the complete mRNA sequence (UniProtKB: locus TPA_MOUSE, accession P11214). Recombinantly produced in insect cells.IMTPA-S481A-0.1mNon-enzymatic Mouse tPA 0.1mg This single chain mouse tPA has the active site serine mutated to alanine rendering the enzyme catalytically inactive. The mutation site is S481A on the mature protein and S510A on the complete mRNA sequence (UniProtKB: locus TPA_MOUSE, accession P11214). The tPA still retains exosite binding as well as other biological properties of tPA including but not limited to surface binding to fibrin.IMTPA-S481A-1mg Non-enzymatic Mouse tPA 1mg This single chain mouse tPA has the active site serine mutated to alanine rendering the enzyme catalytically inactive. The mutation site is S481A on the mature protein and S510A on the complete mRNA sequence (UniProtKB: locus TPA_MOUSE, accession P11214). The tPA still retains exosite binding as well as other biological properties of tPA including but not limited to surface binding to fibrin.IMTPA-0.1mg Active Mouse tPA (recombinant ) 0.1mg Recombinantly produced in insect cells. 95percent active.IMTPA-1mg Active Mouse tPA (recombinant ) 1mg Recombinantly produced in insect cells. 95percent active.IPTPA-0.1mg Active Porcine tPA (recombinant ) 0.1mg Recombinantly produced in insect cells. 95percent active. For ELISA and Western Blotting of pig tPA, please use our Rabbit Polyclonal Antibodies to Human tPA or our Mouse Monoclonal to Human tPA which cross reactIPTPA-1mg Active Porcine tPA (recombinant ) 1mg Recombinantly produced in insect cells. 95percent active. For ELISA and Western Blotting of pig tPA, please use our Rabbit Polyclonal Antibodies to Human tPA or our Mouse Monoclonal to Human tPA which cross react

Glycosylated mouse PAI-1 produced in insect cells with a single conservative mutation (Isoleucine 91 to Leucine) to increase stability. Glycolyslated human PAI-1 produced in insect cells with a molecular weight of 46,000 Da. The stable mutant contains mutations to confer additional stability to the otherwise labile molecule. 

IRbTPA-0.1mg Active Rabbit tPA (recombinant ) 0.1mg Rabbit tPA recombinantly produced in insect cells which is 95percent active.IRbTPA-1mg Active Rabbit tPA (recombinant ) 1mg Rabbit tPA recombinantly produced in insect cells which is 95percent active.IFPRCK-TPA-0.1mgHuman sc-tPA, ATA-FPR-CMK inactivatedPrepared from human tPA by incubation with an excess of ATA-Phe-Pro-Arg-CMK. After labeling at the active site, remaining free peptide is removed by dialysis.IHTPA-ALANC-0.1mNon-enzymatic, non-cleavable Human tPAThis human tPA has an active site serine to alanine mutation which renders it catalytically inactive. The mutation site is S478A on the mature protein and S513A on the complete mRNA sequence (UniProtKB: locus TPA_HUMAN, accession P00750)IHTPA-ALANC-1mgNon-enzymatic, non-cleavable Human tP This human tPA has an active site serine to alanine mutation which renders it catalytically inactive. The mutation site is S478A on the mature protein and S513A on the complete mRNA sequence (UniProtKB: locus TPA_HUMAN, accession P00750)IHTPA-NC-0.1mg Human tPA, Non-cleavable 0.1mg The addition of an arginine to glutamic acid mutation generates human tPA that is 100percent single chain and resistant to cleavage by plasmin. The mutation site is R275E on the mature protein and R310E on the complete mRNA sequence (UniProtKB: locus TPA_HUMAN, accession P00750). Recombinantly produced in insect cells.IHTPA-NC-1mg Human tPA, Non-cleavable 1mg The addition of an arginine to glutamic acid mutation generates human tPA that is 100percent single chain and resistant to cleavage by plasmin. The mutation site is R275E on the mature protein and R310E on the complete mRNA sequence (UniProtKB: locus TPA_HUMAN, accession P00750). Recombinantly produced in insect cells.IHTPA-ALA-0.1mg Non-enzymatic Human tPA 0.1mg This human tPA has an active site serine to alanine mutation which renders it catalytically inactive. The mutation site is S478A on the mature protein and S513A on the complete mRNA sequence (UniProtKB: locus TPA_HUMAN, accession P00750). It is 90percent single chain and retains exosite binding as well as other properties of wild type tPA. Recombinantly produced in insect cells.IHTPA-ALA-1mg Non-enzymatic Human tPA 1mg This human tPA has an active site serine to alanine mutation which renders it catalytically inactive. The mutation site is S478A on the mature protein and S513A on the complete mRNA sequence (UniProtKB: locus TPA_HUMAN, accession P00750). It is 90percent single chain and retains exosite binding as well as other properties of wild type tPA. Recombinantly produced in insect cells.IHTPA-0.1mg Human tissue plasminogen activator, 85% IHTPA-1mg Human tissue plasminogen activator, 85% IMPAI-TPA-0.1 mg Mouse PAI-1 tPA complex 0.1 mgIHPAI-YSY-0.5 mg tPA Specific Human PAI-1 0.5 mgIDUPA-0.05mg Active Dog Urokinase 0.05mg Active two-chain canine urokinase (uPA), recombinantly produced in insect cells.IDUPA-0.1mg Active Dog Urokinase 0.1mg Active two-chain canine urokinase (uPA), recombinantly produced in insect cells.ISMUPAR-HIS-0.1mSoluble Mouse Urokinase Receptor, His Mouse Urokinase Receptor, Soluble form. Recombinantly produced in insect cells. Contains a 6X-Histidine tag at N terminus for purification. Demonstrates preferential binding to mouse uPA over human uPA coated on an ELISA plate.ISMUPAR-HIS-1mgSoluble Mouse Urokinase Receptor, His Mouse Urokinase Receptor, Soluble form. Recombinantly produced in insect cells. Contains a 6X-Histidine tag at N terminus for purification. Demonstrates preferential binding to mouse uPA over human uPA coated on an ELISA plate.IMATF-0.1mg Amino Terminal Fragment of Mouse UrokiAmino terminal fragment of mouse urokinase.IMUPA-FITC-0.05mMouse HMW Urokinase, Fluorescein LabeFluorescein labeled Mouse Urokinase.IMUPA-FITC-0.1mgMouse HMW Urokinase, Fluorescein LabeFluorescein labeled Mouse Urokinase.IMUPA-BIO-0.05mgMouse HMW Urokinase, Biotin Labeled 0 Biotin labeled Mouse Urokinase.IMUPA-BIO-0.1mg Mouse HMW Urokinase, Biotin Labeled 0 Biotin labeled Mouse Urokinase.IMUPA-LMW-0.1mgActive Mouse Urokinase, Recombinant L Low molecular weight active mouse urokinase, recombinantly produced in insect cells.IMUPA-0.05mg Active Mouse Urokinase Recombinant H Active two-chain HMW mouse urokinase, recombinantly produced in insect cells.IMUPA-0.1mg Active Mouse Urokinase Recombinant H Active two-chain HMW mouse urokinase, recombinantly produced in insect cells.IrbUPA-0.05mg Active Rabbit Urokinase 0.05mg Active two-chain rabbit urokinase (uPA), recombinantly produced in insect cells.IrbUPA-0.1mg Active Rabbit Urokinase 0.1mg Active two-chain rabbit urokinase (uPA), recombinantly produced in insect cells.IUPA-LMW-FITC-0. Human LMW Urokinase, Flourescein LabeFITC labeled LMW urokinase purified from auto-catalytic digestion of HMW human urokinase. LMW uPA contains the proteinase domain and is separated from the amino terminal fragment by cleavage at the Lys135-Lys136 bond.IUPA-LMW-FITC-1mHuman LMW Urokinase, Flourescein LabeFITC labeled LMW urokinase purified from auto-catalytic digestion of HMW human urokinase. LMW uPA contains the proteinase domain and is separated from the amino terminal fragment by cleavage at the Lys135-Lys136 bond.IUPA-LMW-HRP-0. Human LMW Urokinase, HRP Conjugate Horseradish peroxidase conjugated LMW urokinase purified from auto-catalytic digestion of HMW human urokinase. LMW uPA contains the proteinase domain and is separated from the amino terminal fragment by cleavage at the Lys135-Lys136 bond.IUPA-LMW-HRP-1mHuman LMW Urokinase, HRP Conjugate Horseradish peroxidase conjugated LMW urokinase purified from auto-catalytic digestion of HMW human urokinase. LMW uPA contains the proteinase domain and is separated from the amino terminal fragment by cleavage at the Lys135-Lys136 bond.IUPA-LMW-0.1mg Human LMW Urokinase 0.1mg The low molecular weight form of uPA is purified from auto-catalytic digestion of recombinant human urokinase produced in insect cells. LMW uPA contains the proteinase domain and is separated from the amino terminal fragment by cleavage at the Lys135-Lys136 bond. For plasminogen activation and receptor binding studies.IUPA-LMW-1mg Human LMW Urokinase 1mg The low molecular weight form of uPA is purified from auto-catalytic digestion of recombinant human urokinase produced in insect cells. LMW uPA contains the proteinase domain and is separated from the amino terminal fragment by cleavage at the Lys135-Lys136 bond. For plasminogen activation and receptor binding studies.IUPA-HTC-FITC-0. Human HMW Urokinase,Fluorescein LabeIUPA-HTC-FITC-1mHuman HMW Urokinase,Fluorescein LabeIUPA-HTC-HRP-0.1Human HMW Urokinase, HRP Conjugate Horseradish peroxidase conjugated two-chain urokinaseIUPA-HTC-HRP-1mHuman HMW Urokinase, HRP Conjugate Horseradish peroxidase conjugated two-chain urokinaseIUPA-HTC-0.1mg Human HMW Urokinase, Recombinant 0. Prepared from human urine as the two-chain form. For plasminogen activation and receptor binding studies.IUPA-HTC-1mg Human HMW Urokinase, Recombinant 1mPrepared from human urine as the two-chain form. For plasminogen activation and receptor binding studies.IHMFBN-1mg Hamster Fibronectin 1mg Prepared from fresh hamster plasma. Ideal reagent for tissue culture studies and protein-protein interactions. Thaw the fibronectin by placing the vial in a 37 C water bath and leaving it undisturbed until completely thawed. Do not disturb the vial at any time during the thawing process. If the vial is disturbed or removed prior to complete thawing, the fibronectin will form a gel and be unusable. Mix very gently with pipette after thawing. Vortexing, excessive agitation, repeated freezing and thawing of fibronectin are not recommended.IMFBGN-1mg Mouse Fibrinogen 1mg Prepared from fresh mouse plasma using several chromatographic steps. Plasminogen depleted by lysine affinity chromatography. Thaw protein in a 37C water bathIMFBN-1mg Mouse Fibronectin 1mgIMVN-0.1mg Mouse Multimeric Vitronectin 0.1mg Prepared from fresh mouse plasma using urea as a denaturant.IMVN-1mg Mouse Multimeric Vitronectin 1mg Prepared from fresh mouse plasma using urea as a denaturant.IPFBGN-25mg Porcine Fibrinogen 25mg Prepared from fresh porcine plasma using several chromatographic steps. Plasminogen depleted by lysine affinity chromatography. Thaw protein in a 37C water bath.IRbFBGN-25mg Rabbit Fibrinogen 25mg Prepared from fresh rabbit plasma using several chromatographic steps. Plasminogen depleted by lysine affinity chromatography.IPVN-0.1mg Porcine Multimeric Vitronectin 0.1mg Prepared from fresh porcine (pig) plasma using urea as a denaturant.IPVN-1mg Porcine Multimeric Vitronectin 1mg Prepared from fresh porcine (pig) plasma using urea as a denaturant.IRbVN-0.1mg Rabbit Multimeric Vitronectin 0.1mg Prepared from fresh rabbit plasma using urea as a denaturant.IRbVN-1mg Rabbit Multimeric Vitronectin 1mg Prepared from fresh rabbit plasma using urea as a denaturant.IRFBGN-1mg Rat Fibrinogen 1mg Prepared from fresh rat plasma using several chromatographic steps. Plasminogen depleted by lysine affinity chromatography.IFIB-25mg Human Fibrinogen, Plasminogen Deplete Prepared from fresh human plasma using several chromatographic steps. Plasminogen depleted by lysine affinity chromatography. Thaw at 37C without agitation until completely liquid, then gently mix before useIFIB-1 Gram Human Fibrinogen, Plasminogen Deplete Prepared from fresh human plasma using several chromatographic steps. Plasminogen depleted by lysine affinity chromatography. Thaw at 37C without agitation until completely liquid, then gently mix before useIHFBN-1mg Human Fibornectin 1mg Prepared from fresh human plasma. Ideal reagent for tissue culture studies and protein-protein interactions. Thaw the fibronectin by placing the vial in a 37IBFBGN-25mg Bovine Fibrinogen 25mg Prepared from fresh bovine plasma using several chromatographic steps. Plasminogen depleted by lysine affinity chromatography. Thaw at 37C without agitation until completely liquid, then gently mix before use.IDGFBGN-1mg Dog Fibrinogen 1mg Prepared from fresh US origin dog (canine) plasma using several chromatographic steps. Plasminogen depleted by lysine affinity chromatography.IBVN-0.1mg Bovine Multimeric Vitronectin 0.1mg Prepared from fresh bovine plasma using urea as a denaturant.

Human tissue-type plasminogen activator (tPA) is a 527 amino acid glycoprotein. Synthesized from cDNA from a human melanoma cell line. It is recombinantly produced in Chinese Hamster Ovary (CHO) cells. Fully active, 85percent single chain. Human tissue-type plasminogen activator (tPA) is a 527 amino acid glycoprotein. Synthesized from cDNA from a human melanoma cell line. It is recombinantly produced in Chinese Hamster Ovary (CHO) cells. Fully active, 85percent single chain. Mouse sc-tPA is reacted with an excess of mouse PAI-1 stable mutant at physiological pH. The resulting 1:1 molar complex is purified from the remaining PAI-1 by affinity chromatography with immobilized antibodies to mouse tPA. A triple mutation on the wild-type background makes this Human PAI-1 selectively inhibit tPA. Urokinase inhibition is limited to 1/25,000 of tPA inhibition by the P3Tyr-P2Ser-P1Tyr mutation. 

Fluorescein labeled two-chain urokinase.0.05M Sodium Acetate; 0.1M NaCl; 1mM EDTA; pH 5.0 Fluorescein labeled two-chain urokinase.0.05M Sodium Acetate; 0.1M NaCl; 1mM EDTA; pH 5.0 

Prepared from fresh mouse plasma. Ideal reagent for tissue culture studies and protein-protein interactions. Thaw the fibronectin by placing the vial in a 37 C water bath and leaving it undisturbed until completely thawed. Do not disturb the vial at any time during the thawing process. If the vial is disturbed or removed prior to complete thawing, the fibronectin will form a gel and be unusable. Mix very gently with pipette after thawing. Vortexing, excessive agitation, repeated freezing and thawing of fibronectin are not recommended. 

IBVN-1mg Bovine Multimeric Vitronectin 1mg Prepared from fresh bovine plasma using urea as a denaturant.IDFBGN-FITC-1.0 mFITC Labeled Dog Fibrinogen 1.0 mgIMPT-0.1mg Mouse Prothrombin 0.1mg Prothrombin is activated on the surface of a phospholipid membrane that binds the amino end of prothrombin and factors Va and Xa in Ca-dependent interactions; factor Xa removes the activation peptide and cleaves the remaining part into light and heavy chains. The activation process starts slowly because factor V itself has to be activated by the initial, small amounts of thrombin.IMFXa-0.05mg Mouse Factor Xa 0.05mg Factor Xa is prepared by activating purified factor X with the factor X activator isolated from Russell's viper venom. Factor Xa is purified from the activation mixture by chromatography over benzamidine-Sepharose. Purity is determined by SDS-PAGE analysis and activity is measured in a factor Xa clotting assay and/or chromogenic substrate assay.IMFIXa-0.05mg Mouse Factor IXa 0.05mg Factor Xa is a vitamin K-dependent glycoprotein that converts prothrombin to thrombin in the presence of factor Va, calcium and phospholipid during blood clotting.IMT-0.05mg Mouse Thrombin 0.05mg Mouse thrombin is prepared from purified mouse prothrombin by activation with Saw Scaled Viper Venom. The venom was removed after activation. Complete activation is observed on SDS-PAGE.IMPC-0.05mg Mouse Protein C 0.05mg Protein C is a vitamin K-dependent serine protease that regulates blood coagulation by inactivating factors Va and VIIIa in the presence of calcium ions and phospholipids.IMPC-0.1mg Mouse Protein C 0.1mg Protein C is a vitamin K-dependent serine protease that regulates blood coagulation by inactivating factors Va and VIIIa in the presence of calcium ions and phospholipids.IMA2AP-HIS-0.1mgMouse alpha 2 antiplasmin, His tag 0.1mgRecombinantly produced in insect cells and purified by chelated metal affinity chromatography.IMA2AP-FLAG-0.1mMouse Alpha-2-Antiplasmin, Recombinan Recombinantly produced in insect cells and purified by FLAG affinity.IMATIII-1mg Mouse Antithrombin III 1mg Prepared from fresh mouse plasma using several chromatographic steps.IMATIII-10mg Mouse Antithrombin III 10mg Prepared from fresh mouse plasma using several chromatographic steps.IRbATIII-1mg Rabbit Antithrombin III 1mg Prepared from fresh rabbit plasma using several chromatographic steps.IRbATIII-10mg Rabbit Antithrombin III 10mg Prepared from fresh rabbit plasma using several chromatographic steps.IRTFIXa-0.1mg Rat Factor IXa 0.1mg Factor IXa is prepared from highly purified factor IX by activation with factor XIa. The factor IXa is further purified by gel filtration, followed by immunoaffinity purification. Purity is assessed by SDS-PAGE analysis. Activity is determined in a one-stage clotting assay.IRTT-0.1mg Rat Thrombin 0.1mg Rat thrombin is prepared from purified rat prothrombin by activation with Russells Viper Venom. This venom is removed after activation. Purity is 90percent as determined by SDS-PAGE analysis. Activity is measured in a thrombin specific clotting assay, and compared to standardized NIH thrombin.IRTFIX-0.05mg Rat Factor IX 0.05mg Rat factor IX is prepared from fresh frozen plasma by a combination of conventional procedures and immunoaffinity chromatography. Purity is determined by SDS-PAGE analysis and activity is measured using a factor IX clotting assay.

IHNE-0.5mg Human Neutrophil Elastase 0.5mgIHCII-0.5mg Human Heparin CoFactor II (HCII) 0.5mg Heparin cofactor II (HCII) (heparin cofactor A, antithrombin BM, dermatan sulfate cofactor, human leuserpin-2) is a single chain glycoprotein (Mr=65,600, 10% carbohydrate) member of the serine protease inhibitor (serpin) family (1-3). Amino acid sequence analysis of heparin cofactor II reveals 3 potential N-glycosylation sites and 2 sulfated tyrosines located in two internal repeats of 7 residues located near the NH2-terminal (4-6). The plasma concentration is estimated to be 90IHKa-1mg Human Kallikrein 1mg Activation of Prekallikrein with Factor a-XIIa produces the enzymatically active Kallikrein. Kallikrein is a serine protease which consists of a heavy chain (Mr 52kD) and light chains (Mr either 36 or 33 kD) linked by disulfide bridges. Kallikrein possesses enzymatic activity toward Factor XII, HK, Plasminogen, Factors XI, IX, and VII, prorenin and the complement system. After activation, the activating enzyme Factor XIIa is removed by affinity chromatography. Human Kallikrein purity is determined by SDS-PAGE and shows complete reduction upon incubation with 2-mercaptoethanol.IHPK-1mg Human Prekallikrein 1mg Purified from fresh frozen human plasma. Human Prekallikrein is a single chain gamma globulin glycoprotein that participates in the early phase of contact activation, kinin formation and fibrinolysis. Prekallikrein purity is determined by SDS-PAGE and shows no reduction upon incubation with 2-mercaptoethanol. Activity is determined via clotting assay.IHXFIIa-0.5mg Human Factor alpha-XIIa 0.5mg Human Factor XIIa is a serine protease responsible for the activation of Factor XI to XIa in the contact activation system. Human Factor XII and prekallikrein are thought to be involved in a reciprocal activation mechanism in which Factor XIIa activates prekallikrein to kallikrein, which in turn converts Factor XII to XIIa. Factor XIIa activates Factor XI to XIa thereby triggering the Contact Factor cascade. ERL offers Factor ?-XIIa which is activated by the autoactivation process with Dextran Sulfate and re-purified to remove the activator. The protein purity is determined by SDS-PAGE and activity is determined via clotting assay.IHXFIIa-1mg Human Factor alpha-XIIa 1mg Human Factor XIIa is a serine protease responsible for the activation of Factor XI to XIa in the contact activation system. Human Factor XII and prekallikrein are thought to be involved in a reciprocal activation mechanism in which Factor XIIa activates prekallikrein to kallikrein, which in turn converts Factor XII to XIIa. Factor XIIa activates Factor XI to XIa thereby triggering the Contact Factor cascade. ERL offers Factor ?-XIIa which is activated by the autoactivation process with Dextran Sulfate and re-purified to remove the activator. The protein purity is determined by SDS-PAGE and activity is determined via clotting assay.IHFXa-100 units Human Factor Xa 100 units Human Factor Xa is prepared from Human Factor X by activation with Russell's Viper Venom. This RVV-X is removed after activation. Complete activation is observed by SDS-PAGE. Factor Xa along with cofactor Va, phospholipids and calcium ions, (the prothrombinase complex) catalyzes the rapid conversion of prothrombin to thrombin.IHFXI-0.1mg Human Factor XI 0.1mgIHFXI-1mg Human Factor XI 1mgIHFX-100 units Human Factor X 100 unitsIHFIXab-0.5mg Human Factor IXab 0.5mg Prepared from fresh frozen human plasma. This protein purity is determined by SDS-PAGE and shows no reduction upon incubation with 2-mercaptoethanol.IHFIX-0.5mg Human Factor IX 0.5mgIAPC-0.1mg Human Activated Protein C 0.1mgIAPC-1mg Human Activated Protein C 1mgIHPC-0.1mg Human Protein C 0.1mg Purified from fresh frozen human plasma using a combination of salt precipitations and column chromatography. The protein purity is determined by SDS-PAGE and shows total reduction upon incubation with 2-mercaptoethanol. Protein C is activated to the serine protease, Activated Protein C (APC), by a-thrombin or the complex of a-thrombin/thrombomodulin and is a potent anticoagulant through the selective inactivation of Factors Va and VIIIa.IHPC-1mg Human Protein C 1mg Purified from fresh frozen human plasma using a combination of salt precipitations and column chromatography. The protein purity is determined by SDS-PAGE and shows total reduction upon incubation with 2-mercaptoethanol. Protein C is activated to the serine protease, Activated Protein C (APC), by a-thrombin or the complex of a-thrombin/thrombomodulin and is a potent anticoagulant through the selective inactivation of Factors Va and VIIIa.IHFVIIa -0.1mg Human Factor VIIa 0.1mgIHFVIIa -1mg Human Factor VIIa 1mgIHFV-0.05mg Human Factor V 0.05mgIHFV-0.5mg Human Factor V 0.5mgIHaT-1000 units Human alpha-Thrombin (Factor IIa) 1000 Prepared from homogeneous human prothrombin by activation with Factor Xa, Factor Va, and phospholipid. Human Thrombin purity is determined by SDS-PAGE. This activated enzyme has a minimum activity of 2,700 NIH units/mg when compared to NIH standard thrombin.IHPT-100 units Human Prothrombin (Factor II) 100 units Prepared from fresh frozen human plasma. Human Prothrombin is a glycoprotein of molecular weight 72,000, and consists of a single polypeptide chain. Activation of Prothrombin by Factor Va, Xa and phospholipids yields the serine protease Thrombin. Prothrombin purity is determined by SDS-PAGE and shows no reduction upon incubation with 2-mercaptoethanol.IHPT-1000 units Human Prothrombin (Factor II) 1000 unitsPrepared from fresh frozen human plasma. Human Prothrombin is a glycoprotein of molecular weight 72,000, and consists of a single polypeptide chain. Activation of Prothrombin by Factor Va, Xa and phospholipids yields the serine protease Thrombin. Prothrombin purity is determined by SDS-PAGE and shows no reduction upon incubation with 2-mercaptoethanol.IECT-1mg Ecotin (E. coli serine protease inhibitor) 1 Serine protease inhibitor purified from E. coli. At least 98percent pure as determined by SDS-PAGE.IECT-5mg Ecotin (E. coli serine protease inhibitor) 5 Serine protease inhibitor purified from E. coli. At least 98percent pure as determined by SDS-PAGE.IBAT-1mg Bovine Antithrombin 1mg The Bovine Antithrombin is 95% pure on SDS-PAGE gels and shows no reduction uponincubation with 2-mercaptoethanol. All bovine material is from U.S. cows /+ 36 months ofage

Canine fibrinogen amino terminal labeled with fluorescein isothiocyanate (FITC). Prepared from fresh dog plasma using several chromatographic steps. Plasminogen depleted by lysine affinity chromatography. Thaw at 37C without agitation until completely liquid, then gently mix before use. Keep fibrinogen at 25-37C, aliquot and flash freeze unused portion. 

Chromatographically purified from human leukocytes. The neutrophil form of elastase is 218 amino acids long, with two asparagine-linked carbohydrate chains. No detectable amounts of Cathepsin G or MPO.Human Neutrophil(s), also known as neutrophilic polymorphonuclear leukocytes, are the major class of white blood cell in human peripheral blood. Human Neutrophil(s), have a multilobed nucleus and neutrophilic granules. Neutrophil(s) are phagocytes and have an important role in engulfing and killing extracellular pathogens.

Prepared from fresh frozen human plasma. Human Factor XI is a two-chain glycoprotein with molecular weight of 160,000 daltons.  The two chains are identical disulfide bonded polypeptides with molecular weights of 80,000 daltons.  Factor XI is activated to Factor XIa by Factor Xlla. Purity of Factor XI is assessed by SDS-PAGE.  Activity is determined by clotting assay.Prepared from fresh frozen human plasma. Human Factor XI is a two-chain glycoprotein with molecular weight of 160,000 daltons.  The two chains are identical disulfide bonded polypeptides with molecular weights of 80,000 daltons.  Factor XI is activated to Factor XIa by Factor Xlla. Purity of Factor XI is assessed by SDS-PAGE.  Activity is determined by clotting assay.Prepared from fresh frozen human plasma. The purity of this Vitamin K dependent protein is determined by SDS-PAGE  and shows total reduction upon incubation with 2-mercaptoethanol. Activity is determined via clotting assay. Human Factor X, once activated via the Contact Factor Pathway or the Tissue Factor Pathway, is responsible for the conversion of Prothrombin to Thrombin.

Prepared from fresh frozen human plasma. This protein purity is determined by SDS-PAGE and shows no reduction upon incubation with 2-mercaptoethanol.  Activity is determined via clotting assay.  Human Factor IX, activated by either the Contact or Tissue Factor Pathway, is responsible for the activation of Factor X to Xa.Activated Protein C (APC) is a serine protease derived from the two chain vitamin K dependent zymogen, Protein C. APC inhibits blood coagulation through the selective inactivation of the cofactors Va and VIIIa. APC is prepared from protein C by activation with purified thrombin. This thrombin is removed after activation by ion exchange chromatography. Activated Protein C purity is determined by SDS-PAGE and shows complete reduction upon incubation with 2-mercaptoethanol.Activated Protein C (APC) is a serine protease derived from the two chain vitamin K dependent zymogen, Protein C. APC inhibits blood coagulation through the selective inactivation of the cofactors Va and VIIIa. APC is prepared from protein C by activation with purified thrombin. This thrombin is removed after activation by ion exchange chromatography. Activated Protein C purity is determined by SDS-PAGE and shows complete reduction upon incubation with 2-mercaptoethanol.

Prepared from purified Human Factor VII using Human Factor XIIa. The Factor Xlla is removed using affinity chromatography. Purity is determined by SDS-PAGE. Human Factor VIIa reduces to 29,500 and 23,500 with the addition of 2-mercaptoethanol. Activity is determined via clotting assay.  Factor Vlla, in the presence of calcium ions and Tissue factor, activates Factors IX and X to their enzymatically active forms, Factor IXa and Xa.Prepared from purified Human Factor VII using Human Factor XIIa. The Factor Xlla is removed using affinity chromatography. Purity is determined by SDS-PAGE. Human Factor VIIa reduces to 29,500 and 23,500 with the addition of 2-mercaptoethanol. Activity is determined via clotting assay.  Factor Vlla, in the presence of calcium ions and Tissue factor, activates Factors IX and X to their enzymatically active forms, Factor IXa and Xa.Human factor V is prepared from fresh frozen human plasma using immunoaffinity chromatography. Purity is determined by SDS-PAGE analysis and activity is measured in a factor V clotting assay.  Human factor V is prepared from fresh frozen human plasma using immunoaffinity chromatography. Purity is determined by SDS-PAGE analysis and activity is measured in a factor V clotting assay.  

IBFX-1mg Bovine Factor X 1mgIBPCa-0.1mg Bovine Activated Protein 0.1mgIBPC-1mg Bovine Protein C 1mg The Bovine Protein C is 95% on SDS-PAGE gels and shows total reduction upon incubationwith 2-mercaptoethanol. All bovine material is from U.S. cows /+ 36 months of agIHK-TC-1mg Two Chain High Molecular Wt. Kininogen Innovative offers the two chain Kinin-free form of Kininogen. This is prepared by Kallikrein digestion of Kininogen which is then repurified to remove traces of Kallikrein.IHK-LMW-0.1 mg Kininogen, LMW, Human Plasma 0.1 mg LMW Kininogn is involved in blood pressure regulation since it is an endogenous protein substrate for tissue kallikrein. Proteolytic cleavage by kallikrein releases vasoactive bradykinin from LMW kininogen. In addition, LMW kininogen, like HMW kininogen, is a major extracellular cysteine protease inhibitor. Prepared from plasma shown to be non reactive for HbsAG, anti-HCV, anti-HBc, and negative for anti-HIV 1 & 2 by FDA approved tests. 95percent pure by SDS-PAGE. Add deionized water to original volume, aliquot and freeze unused portion.IHK-HMW-1mg Single Chain High Molecular Wt. Kininog High Molecular Weight Kininogen (HK) is a nonenzymatic cofactor of the contact activation system. HK is thought to have two functions in the contact activation system. First, HK links prekallikrein to a negatively charged surface thereby allowing activation to kallikrein by surface bound Factor -Xlla. HK also forms a complex with Factor XI and accelerates its activation to XIa by -Xlla. Also HK serves as a source of Bradykinin, a potent Vasoactive peptide important in hypotension studies. The protein purity is determined by SDS-PAGEIHFXIIIa-0.5mg Human Coagulation Factor XIIIa 0.5mgIHFXIIIa-1mg Human Coagulation Factor XIIIa 1mgIHFXIII-0.25 mg Human coagulation Factor XIII 0.25 mg Human Factor XIII is a tetramer composed of two pairs of chains held together by noncovalent bonds. After activation of the zymogen via Thrombin to its active enzyme form, Factor XIIIa is responsible for catalyzing the formation of covalent bridges between fibrin units to increase the elasticity of the clot network. The resulting cross-linked fibrin is very insoluble and resistant to lysis.IHFXIII-1.0 mg Human coagulation Factor XIII 1.0 mg Human Factor XIII is a tetramer composed of two pairs of chains held together by noncovalent bonds. After activation of the zymogen via Thrombin to its active enzyme form, Factor XIIIa is responsible for catalyzing the formation of covalent bridges between fibrin units to increase the elasticity of the clot network. The resulting cross-linked fibrin is very insoluble and resistant to lysis.IHFXIIab-0.1 mg Human coagulation Factor beta-XIIa 0.1 IHFXIIab-1.0 mg Human coagulation Factor beta-XIIa 1.0 IHFIXA-FL-INFFR-0Human Factor IXa, Active Site Labeled witIHBT-1.0 mg Human beta-thrombin 1.0 mgIHPLSM-1mg Human Plasmin 1mgIHFXII-0.5mg Human Factor XII 0.5mgIHFXII-1mg Human Factor XII 1mgIHFXia-0.1mg Human Factor XI alpha 0.1mgIRHFXabGD-1mg Human Factor Xab gla domainles 1mgIHFXai-100 units Human Factor Xa Inactivate 100 unitsIRHFXGD-1mg Human Factor X-G 1mgIHFIXai-0.5mg Human Factor IXa beta Inactivate 0.5mgIRAPCGD-0.1mg Activated Protein C gla domainles 0.1mgIHAPCi-0.1mg Activated Protein C Inactivate 0.1mg Our Activated Protein C is inactivated using PPACK, Dihydrochloride and is removed via gelfiltration. The above protein was purified from Human plasma that was tested and foundnegative by FDA accepted methods for Anti-HIV1/2, Anti-HTLV I & II, HBsAg, Anti-HCV,Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA. Donors arescreened for CJD (Creutzfeldt-Jakob Disease)IRHPCGD-0.1mg Human Protein C gla domainles 0.1mgIRHPCGD-1mg Human Protein C gla domainles 1mgIRHFVIIaGD-0.1mg Human Factor VIIa gla domainles 0.1mgIHFVII-0.1mg Human Factor VII 0.1mg Prepared from fresh frozen human plasma. Human Factor VII is a single-chain vitamin K dependent glycoprotein found in trace quantities in plasma (0.5 mg/Liter). In the Tissue Factor Pathway of coagulation, Human Factor Vlla, in the presence of calcium ions and tissue factor, activates Factors IX and X to their enzymatically active forms, Factor IXa and Xa.IHFVII-1mg Human Factor VII 1mg Prepared from fresh frozen human plasma. Human Factor VII is a single-chain vitamin K dependent glycoprotein found in trace quantities in plasma (0.5 mg/Liter). In the Tissue Factor Pathway of coagulation, Human Factor Vlla, in the presence of calcium ions and tissue factor, activates Factors IX and X to their enzymatically active forms, Factor IXa and Xa.IRHPGD-10mg Human Prothrombin-gla domainless 10mgHuman prothrombin with the gla domain removed. The above protein was purified fromHuman plasma that was tested and found negative by FDA accepted methods for AntiHIV1/2, Anti-HTLV I & II, HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA,HCV RNA and HBV RNA. Donors are screened for CJD (Creutzfeldt-Jakob Disease)IRBFXa-0.1mg Rabbit Factor Xa 0.1mgIRBFX-0.1mg Rabbit Factor X 0.1mgIPFXa-0.1mg Porcine Factor Xa 0.1mgIMFXIII-0.1mg Mouse Factor XIII 0.1mg The murine XIII is purified from mouse plasma and is judged 94% pure via SDS-PAGEIBFXIa-1mg Bovine Factor XIa 1mg Bovine Factor Xla is purified from freshly collected Bovine Plasma using a combination of salt precipitations and activation on a negative surface. This Factor Xla is a potent activator of both Human and Bovine Factor IX. Bovine Factor XIa purity is determined by SDS-PAGE and shows complete reduction upon incubation with 2-mercaptoethanol.IBFXa-1mg Bovine Factor Xa 1mgIBFIXab-0.5mg Bovine Factor IX ab 0.5mg Prepared from Bovine Factor IX by activation with Bovine Factor Xla, this Bovine Factor Xla is removed after activation. Complete activation is observed by SDS-PAGE. The Factor Xla activates FIX in a two-step reaction. In the first step, an internal Arg-Ala bond is cleaved, and in the second step, an Arg-Val bond is cleaved. The second cleavage leads to the liberation of an activation peptide from the NH2-terminal portion of the heavy chain to produce factor IXaβ.IBFIX-0.5mg Bovine Factor IX 0.5mgIBFV/Va-1mg Bovine Factor V/Va 1mg Purified from freshly collected bovine plasma using a combination of salt precipitations and column chromatography. This protein is a mixture of Factor V/Va and intermediate activation products as judged by 4-20% gradient gels. Bovine Factor Va functions as a cofactor with the serine protease Factor Xa in the activation of prothrombin. This protein may be used as a source of V/Va in the Prothrombinase complexIBFV/Va-5mg Bovine Factor V/Va 5mg Purified from freshly collected bovine plasma using a combination of salt precipitations and column chromatography. This protein is a mixture of Factor V/Va and intermediate activation products as judged by 4-20% gradient gels. Bovine Factor Va functions as a cofactor with the serine protease Factor Xa in the activation of prothrombin. This protein may be used as a source of V/Va in the Prothrombinase complexIMIL2-FC-0.05mg Mouse IL-2, Fc Fusion Protein 0.05mg Interleukin-2 (IL-2) is a O-glycosylated four alpha-helix bundle cytokine that is produced by T-cells in response to antigenic or mitogenic stimulation. IL-2 can stimulate B-cells, monocytes, lymphokine-activated killer cells, natural killer cells, and glioma cells and is required for T-cell proliferation and other activities crucial to regulation of the immune response.This Fc Fusion Protein is glycosylated and expressed as a chimera with the Fc region of mouse immunoglobulin. Fc fusion proteins are typically more stable and resistant to degradation and clearance than native cytokines. Fc fusion proteins appear as a dimer in SDS-PAGE under non-reducing conditions.IMIL2-FC-1mg Mouse IL-2, Fc Fusion Protein 1mg Interleukin-2 (IL-2) is a O-glycosylated four alpha-helix bundle cytokine that is produced by T-cells in response to antigenic or mitogenic stimulation. IL-2 can stimulate B-cells, monocytes, lymphokine-activated killer cells, natural killer cells, and glioma cells and is required for T-cell proliferation and other activities crucial to regulation of the immune response.This Fc Fusion Protein is glycosylated and expressed as a chimera with the Fc region of mouse immunoglobulin. Fc fusion proteins are typically more stable and resistant to degradation and clearance than native cytokines. Fc fusion proteins appear as a dimer in SDS-PAGE under non-reducing conditions.IMZPI-0.1 mg Mouse Protein Z-Dependent Protease InhibMouse Protein Z-Dependent Protease Inhibitor (ZPI), recombinantly produced in insect cells. Active and complexable with Factor XIa. This Serine Protease Inhibitor (SERPIN) requires the cofactors Protein Z, phospholipids and calcium to inhibit endogenous Factor Xa. ZPI contains a tyrosine residue at the P1 position of the reactive center loop, rather than arginine which is present in most SERPINs.ICTI-1mg Corn Trypsin Inhibitor 1mg Corn Trypsin Inhibitor (CTI) is a specific and potent inhibitor of human factor XIIa. It is purified from fresh Indiana sweet corn by solvent extraction and chromatographic methods. A suggested inhibitory concentration is 24 fold molar excess over the enzyme concentration. CTI purity is determined by SDS-PAGE and shows no reduction upon incubation with 2-mercaptoethanol.HY-13225A RJR-2403 .alpha.7-nicotinic receptor agonistHY-13225 RJR-2403 (oxalate) .alpha.7-nicotinic receptor agonistHY-10505 Orteronel 17,20-lyase inhibitorHY-10504 TAK-700 (R-form) 17,20-lyase inhibitorHY-10121 Asenapine 5-HT Receptor AntagonistHY-11100 Asenapine maleate 5-HT Receptor AntagonistHY-B0032 Lurasidone (Hydrochloride) 5-HT(2A) receptor antagonistHY-14782 Adoprazine 5-HT1AHY-15394 rac-Rotigotine (Hydrochloride) 5-HT1AHY-14262 Vilazodone 5-HT1AHY-13105 WAY-100635 (maleate salt) 5-HT1AHY-10349 WAY-100635 5-HT1AHY-A0008 B-HT 920 5-HT1A

The Bovine Factor X is 95% pure on  SDS-PAGE and shows total reduction upon incubationwith 2-mercaptoethanol.  All bovine material is from U.S. cows /+ 36 months of ageThe Activated Bovine Protein C was activated from homogeneous protein C by activation withpurified alpha-thrombin.  The alpha-thrombin is removed after activation. Complete activationis observed on SDS-PAGE gels.  All bovine material is from U.S. cows /+ 36 months of age

Human Factor XIIIa is activated from Factor XIII by cleavage with human alpha thrombin. The thrombin is subsequently removed via chromatography. Factor XIIIa is responsible for catalyzing the formation of covalent bridges between fibrin units to increase the elasticity of the clot network. The resulting cross-linked fibrin is very insoluble and resistant to lysis. Human Factor XIIIa is activated from Factor XIII by cleavage with human alpha thrombin. The thrombin is subsequently removed via chromatography. Factor XIIIa is responsible for catalyzing the formation of covalent bridges between fibrin units to increase the elasticity of the clot network. The resulting cross-linked fibrin is very insoluble and resistant to lysis. 

Human Factor beta-XIIa is generated in vivo by kallikrein cleavage of Factor alpha-XIIa and contains the catalytic light chain and the C-terminal peptide of the heavy chain of Factor alpha-XIIa. Human Factor beta-XIIa is activated from homogeneous Human Factor XII by an autoactivation process with Dextran Sulfate followed by repurification to isolate Factor alpha-XIIa and Factor beta-XIIa. Complete activation is observed on SDS-PAGE. Factor XIIa is 95percent pure by SDS-PAGE and activity is determined via clotting assay. Prepared from plasma found negative by FDA accepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA. Donors are screened for CJD (Creutzfeldt-Jakob Disease). Human Factor beta-XIIa is generated in vivo by kallikrein cleavage of Factor alpha-XIIa and contains the catalytic light chain and the C-terminal peptide of the heavy chain of Factor alpha-XIIa. Human Factor beta-XIIa is activated from homogeneous Human Factor XII by an autoactivation process with Dextran Sulfate followed by repurification to isolate Factor alpha-XIIa and Factor beta-XIIa. Complete activation is observed on SDS-PAGE. Factor XIIa is 95percent pure by SDS-PAGE and activity is determined via clotting assay. Prepared from plasma found negative by FDA accepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA. Donors are screened for CJD (Creutzfeldt-Jakob Disease). Purified Human Factor IXa is active site labeled by incubation with Fluorescein-Phe-Phe-Arg-CMK (FL-INFFR). Excess dye is removed by dialysis. Human beta-thrombin is prepared from purified a-thrombin by limited proteolysis with TPCK-treated trypsin. Beta-thrombin is generated by cleavage of the B-chain at the Arg106-Tyr107 bond. Purity is assessed by SDS-PAGE and activity is assessed using a fibrinogen clotting assay. The Human Plasmin was activated from homogeneous glu-plasminogen using urokinase at a500:1 molar ratio.  This urokinase was not removed after activation.  Complete activation wasobserved using the S-2251 chromogenic substrate.  The above protein was purified fromHuman plasma that was tested and found negative by FDA accepted methods for AntiHIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA,HCV RNA and HBV RNA. Donors are screened for CJD (Creutzfeldt-Jakob Disease)Purified from fresh frozen human plasma. Human Factor XII is part of the contact activation system. Human Factor XII is a single chain glycoprotein with a molecular weight of about 80,000. Once activated, principally from the action of kallikrein, Factor XII is converted into an active serine protease (Factor -Xlla) that functions in the <emin vivo</em initiation of blood coagulation, fibrinolysis, and kinin formation. Human Factor XII has been purified by ion exchange chromatography. Protein purity is determined by SDS-PAGE and activity is determined via clotting assay.Purified from fresh frozen human plasma. Human Factor XII is part of the contact activation system. Human Factor XII is a single chain glycoprotein with a molecular weight of about 80,000. Once activated, principally from the action of kallikrein, Factor XII is converted into an active serine protease (Factor -Xlla) that functions in the <emin vivo</em initiation of blood coagulation, fibrinolysis, and kinin formation. Human Factor XII has been purified by ion exchange chromatography. Protein purity is determined by SDS-PAGE and activity is determined via clotting assay.The Human Factor XIa was activated from homogeneous Human Factor XI using HumanFactor XIIa.  This XIIa was removed using a Corn Trypsin Inhibitor column.  The protein is95% pure via SDS-PAGE.  The above protein was purified from Human plasma that wastested and found negative by FDA accepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II,HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA.Donors are screened for CJD (Creutzfeldt-Jakob Disease)The Human Factor Xa beta gla domainless was prepared from HFX-GD using purified RVV-X.This RVV-X was removed after activation by gel filtration.  Complete activation was observedon SDS PAGE.  The above protein was purified from Human plasma that was tested andfound negative by FDA accepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV,Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA. Donors arescreened for CJD (Creutzfeldt-Jakob Disease)The Human Factor Xa was activated from homogeneous Human Factor X by activation withRussels' Viper Venom.  This RVV-X was removed after activation.  Complete activation isobserved via SDS-PAGE .  The purified Xa was then inactivated using GGACK.  Theinactivator was removed via dialysis. The above protein was purified from Human plasma thatwas tested and found negative by FDA accepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II,HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA.Donors are screened for CJD (Creutzfeldt-Jakob Disease)Factor X- gla domainless was prepared from purified Human Factor X using alphachymotrypsin. The alpha-chymotrypsin and all other products were removed using an anionexchange column after digestion.  The above protein was purified from Human plasma thatwas tested and found negative by FDA accepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II,HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA.Donors are screened for CJD (Creutzfeldt-Jakob Disease)The Human Factor IXab was activated from homogeneous Human Factor IX by activation with Bovine Factor XIa.  This Bovine Factor XIa is removed after activation.  Complete activation isobserved on SDS-PAGE. The IXab was then inactivated using a commercially availablechloromethylketone.  This inactivator is removed via dialysis.The human plasma used was tested and found negative by FDA accepted methods for AntiHIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA,HCV RNA and HBV RNAThe Human Activated Protein C gla domainless was prepared from purified Human APCusing Cathepsin G.  The Cathepsin G is removed using affinity chromatography afterdigestion. The above protein was purified from Human plasma that was tested and foundnegative by FDA accepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV,Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA.  Donors arescreened for CJD (Creutzfeldt-Jakob Disease)

The Human Protein C gla domainless was prepared from purified Human Protein C usingCathepsin G.  The Cathepsin G is removed using affinity chromatography after digestion. Theabove protein was purified from Human plasma that was tested and found negative by FDAaccepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA. Donors are screened for CJD (CreutzfeldtJakob Disease)The Human Protein C gla domainless was prepared from purified Human Protein C usingCathepsin G.  The Cathepsin G is removed using affinity chromatography after digestion. Theabove protein was purified from Human plasma that was tested and found negative by FDAaccepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA. Donors are screened for CJD (CreutzfeldtJakob Disease)The Human Factor VIIa gla domainless was prepared from purified Human Factor VIIa usingCathepsin G.  The Cathepsin G is removed using affinity chromatography after digestion.The above protein was purified from Human plasma that was tested and found negative byFDA accepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV, Syphilis, HBC Ab,HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA. Donors are screened for CJD(Creutzfeldt-Jakob Disease)

Rabbit Factor Xa is prepared from homogeneous Rabbit Factor X by activation with Russells'Viper Venom.  This RVV-X is removed  after activation.  Complete activation is observed viaSDS-PAGERabbit Factor X is purified via salt precipitations along with ion and affinity chromatography.  Itis judged 94% pure on SDS PAGEThe Porcine Factor Xa was activated from homogeneous Porcine Factor X by activation with Russells' Viper Venom.  This RVV-X was removed after activation.  Complete activation isobserved on SDS-PAGE gels

Bovine Factor Xa is prepared from Bovine Factor X by activation with Russell's Viper Venom. This RVV-X is removed after activation. Complete activation is observed by SDS-PAGE. Factor Xa, as part of the prothrombinase complex along with the cofactor Va, phospholipids and calcium ions, catalyzes the rapid conversion of prothrombin to thrombin.

Prepared from freshly collected bovine plasma. Protein purity is determined by SDS-PAGE and shows no reduction upon incubation with 2-mercaptoethanol. Activated Factor IX via factor Xla or the factor VIIa/tissue factor/phospholipid complex, is responsible for the activation of Factor X to Xa

HY-75502 Rotigotine 5-HT1AHY-A0007 Rotigotine (Hydrochloride) 5-HT1AHY-14261 Vilazodone (Hydrochloride) 5-HT1AHY-90003A Tianeptine (sodium salt) 5-HT1B receptor agonistHY-90003 Tianeptine 5-HT1B receptor agonistHY-15419 RS 127445 5-HT2B receptor antagonistHY-17038 Agomelatine 5-HT2C agonistHY-15368 Lorcaserin (Hydrochloride) 5-HT2c receptorHY-B0020 Tropisetron (Hydrochloride) 5-HT3 receptor antagonistHY-A0021 Palonosetron (Hydrochloride) 5-HT3 receptor antagonistHY-A0018 Palonosetron 5-HT3 receptor antagonistHY-14336A SB 271046 (Hydrochloride) 5-HT6 Receptor AntagonistHY-13201 CGS 21680 A2A adenosine receptor agonistHY-13201A CGS 21680 (HCl salt) A2A adenosine receptor agonistHY-12149 A-867744 a7 nAChRsHY-12152 PNU-120596 a7 nAChRsHY-B0034 Donepezil (Hydrochloride) acetylcholinesterase inhibitorHY-A0009 Galanthamine (hydrobromide) AChRHY-17033 Rocuronium AChR antagonistHY-15290 AIM-100 Ack1HY-10995 SYN-115 adenosine A2a receptor antagonistHY-10888 Istradefylline adenosine A2A receptor antagonistHY-15424 5-Iodotubercidin adenosine kinase inhibitorHY-50291 HOKU-81 adrenergic beta receptorsHY-A0007 Rotigotine (Hydrochloride) adrenergic α2B receptorsHY-15394 rac-Rotigotine (Hydrochloride) adrenergic α2B receptorsHY-A0008 B-HT 920 adrenergic α2B receptorsHY-75502 Rotigotine adrenergic α2B receptorsHY-13254 A-674563 AktHY-13260 CCT128930 AKTHY-50909 Perifosine AktHY-10355 AKT inhibitor VIII AktHY-10425 A-443654 AktHY-12063 PHT-427 AktHY-15457 Triciribine AktHY-13065 Isobavachalcone AktHY-10358 MK 2206 AktHY-14581 Palomid 529 AktHY-12059 AT7867 AktHY-10249 GSK-690693 AktHY-15357 ALK inhibitor 1 ALKHY-13011 CH5424802 ALKHY-13020 GSK1838705A ALKHY-15358 ALK inhibitor 2 ALKHY-13326 ASP3026 ALKHY-12043 SB 525334 ALKHY-12071 LDN193189 ALKHY-10192 NVP-TAE 684 ALKHY-12071A LDN193189 (Hydrochloride) ALKHY-76652 VTP-27999 (Hydrochloride) Alkyl Amine Renin Inhibitor HY-50769 VTP-27999 (2,2,2-trifluoroacetate(1:1)) Alkyl Amine Renin InhibitorHY-50768 VTP-27999 Alkyl Amine Renin InhibitorHY-13005 Fagomine alpha.-glucosidase inhibitorsHY-75704 Tezampanel AMPA/Kainate Receptor AntagonistHY-50662 A-769662 AMPKHY-50900 gamma-Secretase Modulators Amyloid-β production inhibitorHY-70006 TOK-001 Androgen Receptor

HY-10561 RU 58841 Androgen ReceptorHY-70002 Enzalutamide Androgen ReceptorHY-13273 Ostarine Androgen ReceptorHY-16060 ARN-509 androgen receptor antagonistHY-17005 Olmesartan medoxomil angiotensin II receptor antagonistHY-17004 Olmesartan angiotensin II receptor antagonistHY-13255 TAME APCHY-14274 Anastrozole aromataseHY-12061 KU-60019 ATMHY-11002 CP-466722 ATMHY-12016 KU-55933 ATMHY-14731 VE-821 ATRHY-12049 CCT129202 AuroraHY-10987 ENMD-2076 (Tartrate) AuroraHY-10804 CCT 137690 AuroraHY-10161 Tozasertib AuroraHY-10180 MLN8054 AuroraHY-10178 PHA-680632 AuroraHY-10128 ZM-447439 AuroraHY-10329 JNJ-7706621 AuroraHY-10558 CYC-116 AuroraHY-70044 GSK-1070916 AuroraHY-12054 Hesperadin AuroraHY-10987A ENMD-2076 AuroraHY-10179 Danusertib AuroraHY-12003 SNS-314 AuroraHY-14574 PF-03814735 AuroraHY-50514 AT9283 AuroraHY-10971 Alisertib AuroraHY-10126 AZD1152-HQPA AuroraHY-13252 MK-5108 Aurora AHY-70061 Aurora A inhibitor I Aurora AHY-12201 TAK-901 Aurora BHY-13344 PF-8380 autotaxin inhibitorHY-15374 Frentizole Aβ-ABAD interaction inhibitorHY-13240 LY2886721 BACEHY-15464 AT-101 Bcl-2HY-10087 Navitoclax Bcl-2HY-50907 ABT-737 Bcl-2HY-12011 HA14-1 Bcl-2HY-10969 Obatoclax Bcl-2HY-12020 TW-37 Bcl-2HY-11007 GNF-2 Bcr-ablHY-10010 Ko 143 BCRPHY-13235 I-BET151 BET bromodomain inhibitorHY-13030 (+)-JQ-1 BET bromodomains inhibitorHY-13032 GSK 525762A BET bromodomains inhibitorHY-13030A (-)-JQ-1 BET bromodomains inhibitorHY-14773 Mirabegron Beta-3 adrenergic receptorHY-14443 XMD8-92 BMK1HY-14660 Dabrafenib B-RafHY-10247 BRAF inhibitor B-RafHY-10201A Sorafenib (Tosylate) B-RafHY-50864 GDC-0879 B-RafHY-10966 SB-590885 B-RafHY-12057 Vemurafenib B-RafHY-51424 PLX-4720 B-Raf

HY-10997 PCI-32765 BTKHY-11999 CGI-1746 BtkHY-17373 Posaconazole C14ɑ demethylaseHY-15416 NS309 Ca2+-activated IK/SK potassium channel activatorHY-12070 DPH c-ABLHY-13258 NVP-BHG712 c-ABLHY-70037 Cinacalcet Calcimimetic agent HY-70037A Cinacalcet (hydrochloride) Calcimimetic agent HY-B0023 Azelnidipine calcium channel blockerHY-50713 Calcium-Sensing Receptor Antagonists I Calcium-Sensing Receptor AntagonistsHY-13290 KN-62 calmodulin protein kinase II (CAMKII) inhibitorHY-13291 WIN 55,212-2 (Mesylate) cannabinoid receptor agonistHY-13015 Lacosamide Carbonic Anhydrase InhibitorsHY-10396 Emricasan Caspase InhibitorHY-13229 Caspase3-Inhibitor BOC-D-FMK Caspase-3 inhibitorHY-10171 NPS-2143 (mono HCl) CaSRHY-10007 NPS-2143 CaSRHY-14137 Rimonabant (Hydrochloride) CB1 AntagonistHY-32733 JWH 073 CB1 AntagonistHY-10013 Taranabant CB1 AntagonistHY-14136 Rimonabant CB1 AntagonistHY-15451 MDA 19 CB2 receptorHY-15421 AM630 CB2 receptor agonistHY-15420 BML-190 CB2 receptor agonistHY-14428 ICG-001 CBP/β-catenin antagonistHY-13245 INCB8761(PF-4136309) CCR2 antagonistHY-15418 RS 504393 CCR2 chemokine receptor antagonistHY-10424 PHA-848125 CDKHY-30237 Roscovitine CDKHY-50943 AT7519 (Hydrochloride) CDKHY-10005 Flavopiridol CDKHY-15241 NVP-LCQ195 CDKHY-10006 Flavopiridol (Hydrochloride) CDKHY-10492 Dinaciclib CDKHY-50940 AT7519 CDKHY-15275 BMS-265246 CDKHY-13266 BS-181 CDKHY-13033 CDK inhibitor II CDKHY-11001 PHA-793887 CDKHY-10008 SNS-032 CDKHY-10014 R547 CDKHY-11009 CGP60474 CDKHY-10012 AZD-5438 CDKHY-15166 SB1317 CDKHY-15339 CVT-313 CDK2HY-13231 CDK9 inhibitor CDK9HY-12090 Anacetrapib CETPHY-14950 Dalcetrapib CETPHY-13327 Evacetrapib CETPHY-13075 c-FMS inhibitor c-FMSHY-10408 Ki20227 c-FMSHY-13262 VX-809 CFTRHY-13017 VX-770 CFTRHY-14832 PTC124 CFTR-G542X nonsense alleleHY-10302 MK-3207 (Hydrochloride) CGRPHY-32709 MK-0974 CGRPHY-10095 Olcegepant CGRP

HY-50669 MK-0812 chemokine receptor CCR-2 antagonistHY-10992 AZD-7762 CHKHY-14720 LY2603618 CHK1HY-13263 CHIR-124 CHK1HY-14715 CCT241533 CHK2HY-17368 Rivastigmine cholinesterase inhibitorHY-11017 Rivastigmine (tartrate) cholinesterase inhibitorHY-10209 Masitinib c-KitHY-10208 Pazopanib c-KitHY-50946 Imatinib (Mesylate) c-KitHY-10228 Motesanib c-KitHY-50905 Dovitinib c-KitHY-15463 Imatinib c-KitHY-12017 PF-04217903 c-MetHY-14721 EMD-1214063 c-MetHY-12014 SU11274 c-MetHY-50686 Tivantinib c-MetHY-50683 JNJ-38877605 c-MetHY-13299 MK-8033 c-MetHY-12017A PF-04217903 methanesulfonate c-MetHY-11107 PHA-665752 c-MetHY-10338 Foretinib c-MetHY-12019 SGX-523 c-MetHY-12044 Cabozantinib (S-malate) c-MetHY-12035 AMG-208 c-MetHY-15456 NVP-BVU972 c-MetHY-10991 MGCD-265 c-MetHY-15182 Collagen proline hydroxylase inhibitor-1 Collagen proline hydroxylase inhibitorHY-15183 Collagen proline hydroxylase inhibitor Collagen proline hydroxylase inhibitorHY-32015 Cot inhibitor-1 COTHY-32018 Cot inhibitor-2 COTHY-10547 OSU-03012 COX-2HY-76251 Etodolac COX-2HY-17009 Iguratimod COX-2HY-17372 Rofecoxib COX-2HY-17357 Nepafenac COX-2HY-70005 CPA inhibitor CPAHY-70003 Carboxypeptidase G2 (CPG2) Inhibitor CPG2 InhibitorHY-50202 Etomoxir CPT1HY-13343 ZM 336372 C-RafHY-13258 NVP-BHG712 c-rafHY-10542 GW 5074 C-RafHY-11004 AZ 628 C-RAFHY-13258 NVP-BHG712 c-srcHY-10042 Odanacatib CTSKHY-10011 SCH 563705 CXCR1HY-10198 SCH 527123 CXCR1/2HY-13021 SRT3190 CXCR2HY-10011 SCH 563705 CXCR2HY-50912 AMD 3100 (octahydrochloride) CXCR4HY-10046 Plerixafor CXCR4HY-50101 AMD-070 CXCR4HY-B0008 Sulindac cyclooxgenase inhibitorHY-75054 Abiraterone acetate CYP17HY-70013 Abiraterone CYP17HY-10493 Cobicistat CYP3A inhibitorHY-13315 Montelukast (sodium) CysLT1 receptor antagonist

HY-75502 Rotigotine D2 and D3 receptorHY-A0008 B-HT 920 D2 and D3 receptorHY-A0007 Rotigotine (Hydrochloride) D2 and D3 receptorHY-14782 Adoprazine D2 and D3 receptorHY-15394 rac-Rotigotine (Hydrochloride) D2 and D3 receptorHY-14546 Aripiprazole D2 receptorHY-B0031 Quetiapine (fumarate) D2 receptorHY-32736 Triptonide dCTP Pyrophosphatase inhibitorHY-13044 ADL-5859 delta.-opioid receptor ligandHY-13264 WP1130 deubiquitinase (DUB)HY-50202 Etomoxir DGATHY-10038 A 922500 DGAT-1HY-50670 DGAT-1 inhibitor 2 DGAT-1HY-32219 DGAT-1 inhibitor DGAT-1HY-13009 PF-04620110 DGAT-1HY-17364 Temozolomide DNAHY-B0003 Gemcitabine (Hydrochloride) DNA synthesis inhibitorHY-B0016 Capecitabine DNA synthesis inhibitorHY-B0028 Fludarabine phosphate DNA synthesis inhibitorHY-11006 KU-57788 DNA-PKHY-13061 Daun02 DNA-PKHY-A0004 Decitabine DNMTHY-13289 Nepicastat dopamine beta-hydroxylase inhibitorHY-B0032 Lurasidone (Hydrochloride) Dopamine D(2) receptor antagonistHY-10847 SB-277011 Dopamine D3 receptor antagonistHY-14539 Clozapine dopamine receptor

HY-17355 Dopamine receptor agonistHY-15238A ST-836 (hydrochloride) dopamine receptor ligandHY-15238 ST-836 dopamine receptor ligandHY-10284 Linagliptin DPP-4 inhibitorHY-A0023 Alogliptin (Benzoate) DPP-4 inhibitorHY-14806 Teneligliptin DPP-4 inhibitorHY-A0013 Bosentan Dual endothelin-receptor antagonistHY-10807 MK-4305 Dual Orexin Receptor AntagonistHY-13256 OSI-420 EGFRHY-10333 BMS-690514 EGFRHY-15164 Icotinib (Hydrochloride) EGFRHY-10222 Ixabepilone EGFRHY-12000 AG-490 EGFRHY-50898A Lapatinib (ditosylate) EGFRHY-15196 TAK-285 EGFRHY-10261 Afatinib EGFRHY-50898 Lapatinib EGFRHY-10223 CUDC-101 EGFRHY-32721 Neratinib EGFRHY-10322 BIBX 1382 EGFRHY-32718 Pelitinib EGFRHY-12010 BMS-599626 (Hydrochloride) EGFR(HER)HY-12026 WZ4002 EGFR(HER)HY-50896 Erlotinib EGFR(HER)HY-12029 WZ8040 EGFR(HER)HY-10251 BMS-599626 EGFR(HER)HY-12013 PD153035 (Hydrochloride) EGFR(HER)HY-14346 PD153035 EGFR(HER)HY-12008 Erlotinib (Hydrochloride) EGFR(HER)HY-50895 Gefitinib EGFR(HER)

Pramipexole (dihydrochloride)

HY-12001 WZ-3146 EGFR(HER)HY-14184 Macitentan Endothelin receptor antagonistsHY-17006 Caspofungin (Acetate) enzyme β(1,3)-D-Glucan synthaseHY-10414 MK-2894 (sodium salt) EP4 antagonistHY-10413 MK-2894 EP4 antagonistHY-50901 ONO-AE3-208 EP4 receptor antagonist (EP4RA)HY-13258 NVP-BHG712 EphB4HY-50898A Lapatinib (ditosylate) ErbB2HY-10531 ARRY-380 ErbB2HY-50898 Lapatinib ErbB2HY-14178 VX-11e ERKHY-14443 XMD8-92 ERK5HY-14507 YK-4-279 ES-FLI1HY-A0031 Bazedoxifene estrogen receptor modulatorHY-76520 sitaxsentan ETA-receptorHY-11103 Sitaxsentan (sodium) ETA-receptorHY-15195 Avosentan ETA-receptorHY-13209 Ambrisentan ETA-receptorHY-10088 Zibotentan ETA-receptor HY-14380 PF-3845 FAAHHY-14376 PF-04457845 FAAHHY-10865 LY2183240 FAAHHY-10864 URB-597 FAAHHY-50667 Apixaban Factor XaHY-50903 Rivaroxaban Factor XaHY-70035 Otamixaban Factor XaHY-76948 5-R-Rivaroxaban Factor XaHY-10459 PF-562271 FAKHY-13203 NVP-TAE 226 FAKHY-11101 Alendronate (sodium hydrate) farnesyl diphosphate synthaseHY-15136 Lonafarnib farnesyl transferase inhibitorHY-10502 Tipifarnib farnesyl transferase inhibitorHY-50904 BIBF 1120 FGFRHY-13330 AZD4547 FGFRHY-10179 Danusertib FGFRHY-13304 LY2874455 FGFRHY-13311 NVP-BGJ398 FGFRHY-12047 Ponatinib FGFRHY-50714 MK591 FLAPHY-10037 MK-0591 FLAPHY-14460 AM679 FLAPHY-10202 Tandutinib FLT3HY-15166 SB1317 FLT3HY-13001 Quizartinib FLT3HY-12044 Cabozantinib (S-malate) FLT3HY-12047 Ponatinib FLT3HY-50751 Linifanib FLT3HY-15002 AST 487 FLT3HY-10339 KW-2449 FLT3HY-10446 Pralatrexate folate analogue metabolic inhibitorHY-50108 GW 4064 FXRHY-76847 Chenodeoxycholic Acid FXRHY-50911 WAY-362450 FXRHY-17030 Acamprosate (calcium) GABA receptor agonistHY-15399 Vigabatrin GABA transaminaseHY-B0009 Flumazenil GABAA receptors antagonistHY-15309 Avermectin B1b GABAA Rα1

HY-15308 Avermectin B1a GABAA Rα1HY-15311 Avermectin B1 GABAA Rα1HY-17354 (R)-Baclofen GABAB receptor agonistHY-50694 Senicapoc Gardos channel inhibitorHY-15295 TAK-438 gastric H,K-ATPaseHY-13282 GANT 58 GLI antagonistHY-50663 MK 0893 glucagon receptor antagonistHY-14234 Glucocorticoid receptor agonist glucocorticoid agonistsHY-13056 SMND-309 Glutathione peroxidaseHY-17369 Tirofiban (hydrochloride monohydrate) glycoprotein IIb/IIIa inhibitorHY-15167 Glyoxalase I inhibitor Glyoxalase IHY-10809 RG1678 GlyT1HY-14134 BMS-378806 gp120/CD4HY-13288 Org 27569 GPCRHY-12066 GSK1292263 GPRHY-15291 MBX-2982 GPR119 agonistHY-50172 GPR120 modulator 2 GPR120 modulatorHY-50162 GPR120 modulator 1 GPR120 modulatorHY-50691 GW-1100 GPR40HY-10480 TAK-875 GPR40 HY-50844 Ibutamoren (Mesylate) growth hormone secretagogueHY-10182 CHIR-99021 GSK-3HY-14872 Tideglusib GSK-3HY-10590 TWS119 GSK-3HY-12012 SB 216763 GSK-3HY-15438 SB 415286 GSK-3HY-17042 Cetirizine H1 receptor inverse agonistHY-14567 Ciproxifan H3 receptor antagonistHY-15289 Ciproxifan (maleate) H3 receptor antagonistHY-13200 BRL-15572 (dihydrochloride) h5-HT1D antagonistHY-15217 CHR-6494 HaspinHY-15450 INCB 3284 (dimesylate) hCCR2 antagonistHY-10444 R-1479 HCVHY-15236 PSI-6206 HCVHY-75800 VX-222 HCVHY-10237 Boceprevir HCVHY-10465 BMS-790052 (dihydrochloride) HCVHY-10870 RO-9187 HCVHY-10544 Tegobuvir HCVHY-10443 Balapiravir HCVHY-13321 Anguizole HCVHY-14434 Asunaprevir HCV NS3 proteaseHY-10242 Ciluprevir HCV NS3 proteaseHY-10466 Daclatasvir HCV NS5A inhibitorHY-14775 Nesbuvir HCV NS5BHY-10300 Narlaprevir HCV proteaseHY-10235 Telaprevir HCV proteaseHY-12164 Mocetinostat HDACHY-10224 Panobinostat HDACHY-15144 Trichostatin A HDACHY-10221 Vorinostat HDACHY-10225 Belinostat HDACHY-13267 Droxinostat HDACHY-12163 Entinostat HDACHY-10990 PCI-24781 HDACHY-13265 AR-42 HDACHY-13322 Pracinostat HDAC

HY-10223 CUDC-101 HDACHY-16026 ACY-1215 HDAC6HY-13271 Tubastatin A (Hydrochloride) HDAC6HY-10440 Vismodegib hedgehogHY-13242 LY2940680 hedgehogHY-10243 Vaniprevir Hepatitis C Virus NS3/4a Protease InhibitorHY-10165 PSI-6130 Hepatitis C Virus Nucleoside InhibitorHY-13068 E-7050 Hepatocyte growth factor receptors (HGFR)HY-32718 Pelitinib HERHY-32721 Neratinib HERHY-10223 CUDC-101 HERHY-10261 Afatinib HER2HY-10367 Canertinib HER2HY-15196 TAK-285 HER2HY-14674 CP-724714 (E-Double bond) HER2HY-10367A Canertinib (dihydrochloride) HER2HY-10036 glucagon receptor antagonists-1 hGluRHY-50158 glucagon receptor antagonists-2 hGluRHY-50159 glucagon receptor antagonists-3 hGluRHY-12033 2-Methoxyestradiol HIFHY-10421 Tyrosine kinase inhibitor histamine c-Met kinaseHY-A0015 Bepotastine Beslilate histamine H1 receptor antagonistHY-12199 Pitolisant Histamine H3 receptorsHY-10587 BIX-01294 Histone Lysine Methyltransferase InhibitorHY-14740 Elvitegravir HIV integraseHY-13238 Dolutegravir HIV integraseHY-17367 Atazanavir HIV proteaseHY-17040 Darunavir HIV Protease HY-17041 Darunavir ethanolate HIV ProteaseHY-17003 Saquinavir (Mesylate) HIV protease inhibitorHY-13025 HIV-1 integrase inhibitor HIV-1 integraseHY-15287 Nelfinavir HIV-1 integraseHY-10522 HIV-1 integrase inhibitor 2 HIV-1 integraseHY-15287A Nelfinavir (Mesylate) HIV-1 integraseHY-13269 BMS-707035 HIV-1 integraseHY-15440 BMS-626529 HIV-1 integraseHY-76649 NBD-557 HIV-1/CD4HY-76648 NBD-556 HIV-1/CD4HY-75957 DMP 777 HLEHY-12040 Elesclomol HSP-70HY-10211A 17-AAG (Hydrochloride) HSP-90HY-11038 PU-H71 HSP-90HY-14463 AT13387 HSP-90HY-10215 NVP-AUY922 HSP-90HY-10213 PF-04929113 HSP-90HY-10214 SNX-2112 HSP-90HY-15230 Geldanamycin HSP-90HY-10389 Alvespimycin HSP-90HY-12024 Alvespimycin (hydrochloride) HSP-90HY-15205 Ganetespib HSP-90HY-10210 Retaspimycin (Hydrochloride) HSP-90HY-10211 17-AAG HSP-90HY-10212 BIIB021 HSP-90HY-15263 Retaspimycin HSP-90HY-10942 NVP-BEP800 HSP-90HY-50735 Fiacitabine HSVHY-15454 AT-406 IAP

HY-14183 Vernakalant (Hydrochloride) ICBHY-14182 Vernakalant ICBHY-10524 GSK1904529A IGF-IIRHY-10524 GSK1904529A IGF-IRHY-13203 NVP-TAE 226 IGF-IRHY-10200 BMS-754807 IGF-IRHY-10191 Linsitinib IGF-IRHY-10252 NVP-ADW742 IGF-IRHY-10262 BMS-536924 IGF-IRHY-50866 NVP-AEW541 IGF-IRHY-10518 BMS-345541 IKKHY-13018 MRT67307 IKKHY-10074 TPCA-1 IKK-2HY-13060 IKK-2 inhibitor VIII IKK-2HY-14682 IKK-3 Inhibitor IKKe HY-50949A Bay 65-1942 (R form) IKK-β inhibitorHY-50949 Bay 65-1942 (free base) IKK-β inhibitorHY-50948 Bay 65-1942 (HCl salt) IKK-β inhibitorHY-10514 BX795 IKKεHY-50001 Nucleozin Influenza A nucleoprotein (NP)HY-A0006 Pentostatin inhibitor of adenosine deaminaseHY-17024 Cyclopamine Inhibitor of hedgehog (Hh) signalingHY-A0022 Azaphen inhibitor of the reuptake of serotoninHY-10241 TMC435350 inhibitors of the hepatitis C virus NS3/4A protease HY-70073 Zaurategrast integrin inhibitorHY-10191 Linsitinib IRHY-13329 IRAK-1-4 Inhibitor I IRAKHY-13278 IRAK inhibitor 4 IRAKHY-13277 IRAK inhibitor 3 IRAKHY-13276 IRAK inhibitor 2 IRAKHY-13275 IRAK inhibitor 1 IRAK-4HY-13279 IRAK inhibitor 5 IRAK-4HY-13280 IRAK inhibitor 6 IRAK-4HY-11092 BMS-509744 ITKHY-11066 ITK inhibitor ITKHY-50858 Ruxolitinib (phosphate) JAKHY-50859 INCB018424 (sulfate) JAKHY-50856 Ruxolitinib JAK HY-12000 AG-490 JAK HY-15315 Baricitinib JAK1HY-13324 Bardoxolone methyl JAK1/STAT3HY-10410 TG101209 JAK2HY-10961 CYT387 JAK2HY-15315 Baricitinib JAK2HY-15166 SB1317 JAK2HY-13034 LY2784544 JAK2HY-10193 AZD-1480 JAK2HY-10962 CYT387 2H2SO4 salt JAK2HY-10409 TG-101348 JAK2HY-11067 WHI-P97 JAK3HY-40354A Tofacitinib (citrate) JAK3HY-13022 CC-401 (HCl) JNKHY-13319 JNK-IN-8 JNKHY-12041 SP600125 JNKHY-14761 AS 602801 JNKHY-14909 Bardoxolone KEAP1-Nrf2HY-10299 GSK-923295 Kinesin-7 (formerly CENP-E)

HY-12069 SB-743921 KspHY-15187 ARRY-520 KspHY-50759 Ispinesib KSPHY-10015 PAP-1 Kv1.3 blockerHY-11011 A-770041 Lck-SrcHY-13285 Ki16425 LPA receptorHY-15460 CHIR-090 LpxCHY-10875 LRRK2-IN-1 LRRK2HY-76511 Verlukast LTD4-receptor antagonistHY-10627 GW3965 LXR agonistHY-10627A GW3965 (hydrochloride) LXR agonistHY-75867 M2 ion channel blocker M2 ion channel blockerHY-70020 Cevimeline M3 muscarinic receptor agonistHY-A0012 Darifenacin (hydrobromide) M3 muscarinic receptor agonistHY-76569 (R)-5-Hydroxymethyl Tolterodine mAChRsHY-17360 Tiotropium (Bromide) mAChRsHY-13248 AR-C155858 MCT2HY-70027 p53 and MDM2 proteins-interaction-inhibitorMDM-2 antagonistHY-10029 Nutlin-3a (chiral) MDM-2 antagonistHY-15335 Nutlin-3b MDM-2 antagonistHY-50696 Nutlin-3 MDM-2 antagonistHY-10959 p53 and MDM2 proteins-interaction-inhibitMDM-2 antagonistHY-12025 Serdemetan MDM-2 antagonistHY-70028 p53 and MDM2 proteins-interaction-inhibitMDM-2 antagonistHY-12055 BIX02188 MEKHY-12042 AS703026 MEKHY-12056 BIX02189 MEKHY-15202 MEK162 MEKHY-50706 Selumetinib MEKHY-10999 Trametinib MEKHY-15437 SL327 MEKHY-13064 GDC-0973 MEKHY-10999A GSK1120212 (DMSO solvate) MEKHY-12202 MEK inhibitor MEKHY-12062 PD318088 MEKHY-12028 PD98059 MEKHY-12031 U0126 MEKHY-12076 BMS 777607 MEKHY-12058 AZD8330 MEKHY-A0014 Ramelteon melatonin receptor agonistHY-15222 MI-2 Menin-MLL inhibitorHY-15223 MI-3 Menin-MLL inhibitorHY-15393 VU 0357121 mGlu5 positive allosteric modulatorHY-14859 Dipraglurant mGlu5 receptorHY-70059 LY341495 mGluR2HY-13239 mGlu2 agonist mGluR2HY-15445 CTEP mGluR5HY-14609 MPEP (Hydrochloride) mGluR5 antagonistHY-14609A MPEP mGluR5 antagonistHY-15162 Monomethyl auristatin E MicrotubuleHY-15459 Cabazitaxel MicrotubuleHY-15417 ML-7 (hydrochloride) MLCKHY-10398 CTS-1027 MMPHY-70057 Safinamide monoamine oxidase type B (MAO-B) inhibitorHY-13283 MF63 mPGES-1HY-10222 Ixabepilone Mps1HY-14710 AZ3146 Mps1

HY-10998 Salmefamol MRP4/ .beta.2-adrenoceptor agonistsHY-10474 PP 242 mTOR HY-15248 GDC-0349 mTORHY-50910 Temsirolimus mTORHY-10044 WYE-125132 mTORHY-50908 Deforolimus mTORHY-13334 NVP-BGT226 mTORHY-15247 AZD2014 mTORHY-15177 PF-04691502 mTORHY-14581 Palomid 529 mTORHY-10423 OSI-027 mTORHY-12034 WYE-354 mTORHY-10422 AZD-8055 mTORHY-13003 Torin 1 mTORHY-13002 Torin 2 mTORHY-13246 GDC-0980 mTORHY-13328 INK-128 mTORHY-15271 WYE-687 mTORHY-10218 Everolimus mTORHY-10219 Rapamycin mTORHY-50710 KU-0063794 mTORHY-14144 Aclidinium Bromide muscarinic M3 antagonistHY-76772 Cevimeline (hydrochloride hemihydrate) muscarinic receptor HY-12100 Umeclidinium bromide muscarinic receptor antagonistHY-A0002 Solifenacin Succinate muscarinic receptor antagonistHY-13204 Biperiden (Hydrochloride) Muscarinic receptor antagonistHY-50937 ST 2825 MyD88 inhibiotrHY-10484 MLN4924 (HCl salt) NAEHY-70062 MLN4924 NAEHY-13318 Oseltamivir acid NeuraminidaseHY-13317 Oseltamivir NeuraminidaseHY-17015A Peramivir NeuraminidaseHY-17016 Oseltamivir phosphate NeuraminidaseHY-13210 Zanamivir NeuraminidaseHY-17015 Peramivir (trihydrate) NeuraminidaseHY-32735 Triptolide NF-κB & IκB HY-14375 CB 300919 Nicotinamide Phosphoribosyltransferase (Nampt)HY-10021 Varenicline (Tartrate) nicotinic receptor partial agonistHY-10019 Varenicline nicotinic receptor partial agonistHY-10020 Varenicline (Hydrochloride) nicotinic receptor partial agonistHY-17001 Flupirtine (Maleate) NMDA receptorsHY-10574 Rilpivirine NNRTIHY-90005 Etravirine non-nucleoside reverse transcriptase inhibitors (NNRTIs)HY-13222 BAN ORL 24 NOP receptor agonistHY-70042A Tapentadol (hydrochloride) norepinephrine reuptake inhibitorHY-10240 R-7128 NS5BHY-15424 5-Iodotubercidin nucleoside transporter inhibitorHY-13057 Glucose-conjugated MGMT inhibitor O6-Methylguanine-DNA Methyltransferase (MGMT)HY-10487 JDTic (2HCl) Opioid .kappa. Receptor AntagonistHY-10486 JDTic Opioid .kappa. Receptor AntagonistHY-76710 Naltrexone (Hydrochloride) Opioid antagonistHY-13243 Alvimopan opioid mu receptor antagonistHY-76711 Naltrexone opioid receptor antagonistHY-13274 JTC-801 ORL1HY-17028 Besifloxacin (Hydrochloride) OthersHY-A0027 Fenspiride (Hydrochloride) OthersHY-17365 Octreotide acetate Others

HY-17036 Naphthoquine (phosphate) OthersHY-17361 Etofenamate OthersHY-13244 NXY-059 OthersHY-13212 (Z)-2-decenoic acid OthersHY-17362 Vancomycin (hydrochloride) OthersHY-13211 (E)-2-Decenoic acid OthersHY-32329A Setiptiline maleate OthersHY-17363 Dimethyl fumarate OthersHY-50938 D149 Dye OthersHY-15194 ASC-J9 OthersHY-15439 (24S)-24,25-Dihydroxyvitamin D3 OthersHY-14617 Paradol OthersHY-32343 Secalciferol OthersHY-17027 Diazepam OthersHY-10394 Linezolid othersHY-17359 Deferasirox OthersHY-17358 Loteprednol Etabonate OthersHY-15278 Epothilone D OthersHY-15279 Mazindol OthersHY-14855 Tedizolid OthersHY-14808 Adarotene OthersHY-10004 Faropenem daloxate OthersHY-14739 Choline Fenofibrate OthersHY-17026 Gemcitabine OthersHY-15435 CHAPS OthersHY-13063 Sodium formononetin-3'-sulfonate OthersHY-13010 Laquinimod OthersHY-77036 Furagin OthersHY-16171 Diphenmanil (methylsulfate) OthersHY-32264 X-NeuNAc OthersHY-15453 CPI-613 OthersHY-14283 Luliconazole OthersHY-10528 Tasquinimod OthersHY-14800 Radezolid OthersHY-15286 sodium 4-pentynoate OthersHY-15423 Dye 993 OthersHY-15422 Dye 937 OthersHY-17035 Doramectin OthersHY-15344 Ketone Ester OthersHY-17031 Captisol OthersHY-76293 I2906 OthersHY-A0019 Paliperidone OthersHY-76210 5-hydroxypyrazine-2-carboxylic acid OthersHY-13071 Nestoron OthersHY-A0032 Valganciclovir OthersHY-17008 Toltrazuril sulfone OthersHY-17025 Rifabutin OthersHY-15204 Tonabersat OthersHY-17010 Retapamulin OthersHY-70068 SB-408124 OX1 receptorHY-10898 SB-674042 OX1 receptorHY-13290 KN-62 P2X receptor antagonistHY-50697 A-740003 P2X7 purinoceptor antagonistHY-10064 Ticagrelor P2Y12 receptor antagonistHY-15284 Prasugrel P2Y12 receptor antagonistHY-15283 Clopidogrel P2Y12 receptor antagonistHY-13104 MRS 2578 P2Y6 nucleotide receptors

HY-10456 TAK-715 p38 MAPKHY-10256 SB 203580 p38 MAPKHY-10401 VX-702 p38 MAPKHY-11087 SD-06 p38 MAPKHY-10295 SB 202190 p38 MAPKHY-10320 Doramapimod p38 MAPKHY-10328 VX-745 p38 MAPKHY-13241 LY2228820 p38 MAPKHY-15300 Skepinone-L p38 MAPKHY-12053 Vinorelbine p38 MAPKHY-11068 SB 239063 p38 MAPKHY-70027 p53 and MDM2 proteins-interaction-inhibitorp53HY-70028 p53 and MDM2 proteins-interaction-inhibitp53HY-12025 Serdemetan p53HY-10959 p53 and MDM2 proteins-interaction-inhibitp53HY-10029 Nutlin-3a (chiral) p53HY-15335 Nutlin-3b p53HY-50696 Nutlin-3 p53HY-13007 PF-3758309 PAK4 inhibitorHY-13253 AMG 900 Pan-Aurora Kinase InhibitorHY-15246 MLN 2480 pan-Raf kinase inhibitorHY-12015 BSI-201 PARPHY-12022 INO-1001 PARPHY-10130 Veliparib (dihydrochloride) PARPHY-10129 Veliparib PARPHY-16106 BMN-673 PARPHY-10619 MK-4827 PARPHY-12032 AG14361 PARPHY-10162 Olaparib PARPHY-70072 D609 PC-PLCHY-13295 Vinpocetine PDEHY-14992 Bay 60-7550 PDE2HY-15178 Oglemilast PDE4HY-10790 Cilomilast PDE4 HY-10285 Saxagliptin PDE4 HY-15455 Roflumilast PDE4HY-12085 Apremilast PDE4HY-10469 GSK256066 PDE4 HY-90009 Nortadalafil PDE5HY-15441 PF-04447943 PDE9HY-50865 PDE-9 inhibitor PDE-9HY-15463 Imatinib PDGFRHY-10208 Pazopanib PDGFRHY-13223 Crenolanib PDGFRHY-10514 BX795 PDK-1HY-14440 PDK1 inhibitor PDK-1HY-11005 BX-912 PDK-1HY-14981 GSK2334470 PDK-1HY-10547 OSU-03012 PDK-1HY-13333 NVP-BAG956 PDK-1HY-17043 Loratadine Peripheral histamine H1 receptor antagonistHY-13316 Mitomycin C P-glycoproteinsHY-15310 Ivermectin P-glycoproteinsHY-15449 Kaempferide P-glycoproteinsHY-50671 LY335979 P-glycoproteinsHY-15255 Zosuquidar P-glycoproteinsHY-10550 Tariquidar P-glycoproteins

HY-70083 SPK-601 Phosphatidylcholine-specific phospholipase C (PC-PLC) inhibitorHY-10297 GSK2126458 PI3KHY-15346 BAY 80-6946 PI3KHY-50847 ZSTK474 PI3KHY-13333 NVP-BAG956 PI3KHY-20180 GDC-0941 (dimethanesulfonate) PI3KHY-50094 GDC-0941 PI3KHY-10683 PKI-402 PI3KHY-50673 BEZ235 PI3KHY-10109 AS-605240 PI3KHY-13261 A66 PI3KHY-13281 PIK-75 PI3KHY-10344 AZD 6482 PI3KHY-15245 GSK2636771 PI3KHY-13334 NVP-BGT226 PI3KHY-13246 GDC-0980 PI3KHY-15244 BYL-719 PI3KHY-15180 NVP-BKM120 (Hydrochloride) PI3KHY-10115A PI-103 (Hydrochloride) PI3KHY-10044 WYE-125132 PI3KHY-15177 PF-04691502 PI3KHY-15174 BEZ235 (Tosylate) PI3KHY-10108 LY294002 PI3KHY-10115 PI-103 PI3KHY-15294 CZC24832 PI3KHY-12068 XL765 PI3KHY-15288 PI3kδ inhibitor 1 PI3KHY-12036 GSK1059615 PI3KHY-12030 PIK-90 PI3KHY-10110 IC-87114 PI3KHY-10114 TGX-221 PI3KHY-10111 TG100-115 PI3KHY-13026 CAL-101 PI3KHY-14581 Palomid 529 PI3KHY-70063 NVP-BKM120 PI3KHY-11105 XL147 PI3KHY-10372 PP121 PI3KHY-17044 IPI-145 PI3KHY-12046 PIK-93 PI4KIIIβHY-13228 YM-201636 PIKfyve-specific inhibitorHY-13287 SGI-1776 PIMHY-10371 LKB1(AAK1 dual inhibitor) Pim-1 kinase inhibitorHY-10249A AKT Kinase Inhibitor PKBHY-12048 Chelerythrine Chloride PKCHY-10342 Enzastaurin PKCHY-10343 Sotrastaurin PKCHY-12134 Poloxin PLKHY-50698 BI 2536 PLKHY-12137 Volasertib PLKHY-12037 ON 01910 PLKHY-12045 HMN-214 PLKHY-11003 GW843682X PLKHY-50877 GSK-461364A PLKHY-75839 Dronedarone (Hydrochloride) potassium channelHY-A0016 Dronedarone potassium channelHY-10838 GW 501516 PPAR.beta./.delta.HY-17356 Fenofibrate PPARα agonist

HY-13202 T0070907 PPARγHY-14792 Inolitazone PPARγHY-20019 L-165041 PPARδ agonistHY-50175 Laropiprant prostaglandin D2 receptor 1 antagonistHY-10238 Danoprevir ProteaseHY-90001 Ritonavir ProteasomeHY-13259 MG-132 proteasome and calpain inhibitorHY-50855 CX-4945 protein kinase CK2 inhibitorHY-13074 VO-Ohpic (trihydrate) PTEN inhibitor HY-32341 Seocalcitol PTHrPHY-10459 PF-562271 Pyk2HY-15317 RI-1 RAD51HY-14754 Salirasib RasHY-12176 Aliskiren reninHY-12177 Aliskiren (hemifumarate) reninHY-15373 Fenretinide retinoid agonistHY-14171 Bexarotene retinoid X receptors (RXR) agonistsHY-15415 KB-R7943 (mesylate) reverse Na+ /Ca2+ exchanger inhibitorHY-70075 CCG-63808 RGSHY-70074 CCG-63802 RGSHY-14507 YK-4-279 RHAHY-A0005 Clofarabine ribonucleotide reductase inhbitorHY-13323 CX-5461 RNA polymerase I (Pol I) inhibitorHY-15005 PSI-7977 RNA polymerase inhibitorHY-13234 Rifaximin RNA synthesis inhibitorHY-10319 ROCK inhibitor ROCKHY-13257 Thiazovivin ROCKHY-11000 GSK429286A ROCKHY-10069 Y-39983 (dihydrochloride) ROCKHY-10067 Y-33075 ROCKHY-10583 Y-27632 (dihydrochloride) ROCKHY-11099 ROCK inhibitor-1 ROCKHY-15392 ROCK-II inhibitor ROCKHY-10071 Y-27632 ROCKHY-10341 Fasudil (Hydrochloride) ROCKHY-15307 ROCK inhibitor 2 ROCKHY-50674 INCB3344 rodent-active CCR2 antagonistHY-52101 CMK RSK2HY-52101A FMK RSK2HY-11097 TMC353121 RSVHY-10330 Toceranib RTKHY-10442 3-Deazaneplanocin A S-adenosylhomocysteine hydrolase inhibitorHY-12186 3-Deazaneplanocin A (hydrochloride) S-adenosylhomocysteine hydrolase inhibitorHY-14233 Omecamtiv mecarbil sarcomere-directed cardiac myosin activatorHY-12023 Andarine SARMHY-50709 SCD inhibitor SCDHY-13077 MK-8245 (Trifluoroacetate) SCDHY-13070 MK-8245 SCDHY-50875 BCX 1470 (methanesulfonate) serine proteaseHY-50874 BCX 1470 serine proteaseHY-70050 Alosetron (Hydrochloride(1:X)) Serotonin 5HT3-receptor antagonistHY-70050B Alosetron ((Z)-2-butenedioate) Serotonin 5HT3-receptor antagonistHY-70050A Alosetron Serotonin 5HT3-receptor antagonistHY-70050C Alosetron (Hydrochloride) Serotonin 5HT3-receptor antagonistHY-14262 Vilazodone serotonin specific reuptake inhibitor (SSRI) HY-14261 Vilazodone (Hydrochloride) serotonin specific reuptake inhibitor (SSRI) HY-10858 WAY 316606 sFRP-1

HY-15193A EMD638683 (R-Form) SGKHY-15193B EMD638683 (S-Form) SGKHY-15409 Empagliflozin SGLT-2HY-10450 Dapagliflozin SGLT2 inhibitorHY-10532 SRT 1720 SIRT1HY-15145 SRT 1720 (Hydrochloride) SIRT1HY-15262 sirtuin modulator sirtuin modulatorHY-10296 LDE225 Smo antagonistHY-11079 A-803467 sodium channel blockerHY-10451 Canagliflozin sodium glucose co-transporter 2 (SGLT2)HY-14779 Riociguat Soluble Guanylate Cyclase Stimulator HY-15425 PF-543 SphK1 inhibitorHY-10184 TG 100572 SrcHY-10185 TG 100572 (Hydrochloride) SrcHY-10340A KX2-391 (dihydrochloride)HY-10340 KX2-391HY-10181 Dasatinib Src-bcr-AblHY-10159 Nilotinib Src-bcr-AblHY-10234 Saracatinib Src-bcr-AblHY-10179 Danusertib Src-bcr-AblHY-12005 Fingolimod Src-bcr-AblHY-12039 Bafetinib Src-bcr-AblHY-12047 Ponatinib Src-bcr-AblHY-B0028 Fludarabine phosphate STAT-1 activation inhibitorHY-15146 NSC 74859 STAT3HY-10989 TAK-700 steroid 17-20-lyase inhibitorHY-13109 TAK-700 (salt) steroid 17-20-lyase inhibitorHY-10052 Aprepitant Substance P antagonists (SPA)HY-13056 SMND-309 Superoxide dismutaseHY-10194 YM-155 survivin suppressantHY-76474 BAY 61-3606 SykHY-13038 R788(prodrug of R406) SykHY-12067 R406 SykHY-11108 R406 (free base) SykHY-14985 BAY 61-3606 (dihydrochloride) SykHY-15434 NG25 TAK1 inhibitorHY-14652 Tamibarotene Tamibarotene, Retinoic acid receptor α (RARα) agonistHY-10514 BX795 TBK1HY-17353 BIBR 1532 telomeraseHY-10326 GW788388 TGF- βtype I and II receptorHY-12075 LY2109761 TGF-βRHY-10431 SB-431542 TGF-βRHY-13226 LY2157299 TGF-βRHY-13227 SD-208 TGF-βRI inhibitorHY-17002 Suplatast (Tosilate) Th2 cytokine inhibitorHY-10535 TH-302 Thioredoxin Reductase and Glutathione Reductase inhibitorHY-10274 Dabigatran etexilate thrombin inhibitorHY-90006 5-Fluorouracil thymidylate synthaseHY-14823 Sobetirome thyroid hormone beta-receptor agonistHY-12044 Cabozantinib (S-malate) Tie2 kinaseHY-10501A SU14813 (maleate) TKIHY-10501 SU14813 TKIHY-10018 Toll-like receptor modulator TLRHY-11109 TAK-242 TLR4HY-10984 Pomalidomide TNF-alphaHY-A0003 Lenalidomide TNF-alphaHY-13067 Celastrol TNF-α-induced NF-κB

Src Src 

HY-10982 Amonafide topoisomeraseHY-16518 Voreloxin (Hydrochloride) Topoisomerase IIHY-10534 Voreloxin topoisomerase II inhibitorHY-76201 Dexrazoxane (Hydrochloride) topoisomerase inhibitorHY-15281 QL-IX-55 TOR2HY-13055 LX1606 TPHHY-13041 LX-1031 TPHHY-32018 Cot inhibitor-2 Tpl2HY-32015 Cot inhibitor-1 Tpl2HY-15359 Episilvestrol translation inhibitorHY-13251 Silvestrol translation inhibitorHY-13250 Silvestrol aglycone translation inhibitorHY-10424 PHA-848125 TRKAHY-10633 SB-705498 TRPV1 antagonistHY-13270 ABT-751 TubulinHY-17029 Epothilone B tubulinHY-10372 PP121 TyrosineHY-15463 Imatinib v-AblHY-17370 Desmopressin Acetate vasopressin receptorHY-17000 Tolvaptan Vasopressin V2 AntagonistsHY-14444 Plinabulin VDAHY-10001 Calcipotriol VDR-like ReceptorsHY-32338 Tacalcitol (monohydrate) VDR-like ReceptorsHY-10003 Alfacalcidol VDR-like ReceptorsHY-15330 VD2-D3 VDR-like ReceptorsHY-10002 Calcitriol VDR-like ReceptorsHY-76814 Calcitriol D6 VDR-like ReceptorsHY-15156 1alpha, 24, 25-Trihydroxy VD2 VDR-like ReceptorsHY-32351 Calcifediol VDR-like ReceptorsHY-50919 Paricalcitol VDR-like ReceptorsHY-76585 Paricalcitol-D6 VDR-like ReceptorsHY-32351A Calcifediol monohydrate VDR-like ReceptorsHY-76801 24, 25-Dihydroxy VD2 VDR-like ReceptorsHY-75958 Vitamin D4 VDR-like ReceptorsHY-32342 Falecalcitriol VDR-like ReceptorsHY-76915 24, 25-Dihydroxy VD3 VDR-like ReceptorsHY-76802 Calcitriol Derivatives VDR-like ReceptorsHY-15157 Calcitetrol VDR-like ReceptorsHY-A0020 Eldecalcitol VDR-like ReceptorsHY-15327 1alpha, 25-Dihydroxy VD2-D6 VDR-like ReceptorsHY-13249 1alpha-Hydroxy VD4 VDR-like ReceptorsHY-15332 Alfacalcidol-D6 VDR-like ReceptorsHY-15328 25-Hydroxy VD2-D6 VDR-like ReceptorsHY-32348 Doxercalciferol VDR-like ReceptorsHY-32350 Ercalcitriol VDR-like ReceptorsHY-32349 Ercalcidiol VDR-like ReceptorsHY-32339 Maxacalcitol VDR-like ReceptorsHY-13332 Calcifediol-D6 VDR-like ReceptorsHY-15329 Maxacalcitol-D6 VDR-like ReceptorsHY-15285 Doxercalciferol-D3 VDR-like ReceptorsHY-15331 VD3-D6 VDR-like ReceptorsHY-32340 Lexacalcitol VDR-like ReceptorsHY-32337 Tacalcitol VDR-like ReceptorsHY-10001A Calcipotriol (monohydrate) VDR-like ReceptorsHY-10208 Pazopanib VEGFRHY-15391 E-3810 VEGFR/FGFRHY-12038 Ki8751 VEGFR2

HY-13258 NVP-BHG712 VEGFR2HY-10333 BMS-690514 VEGFR2HY-13342 Apatinib VEGFR2HY-10185 TG 100572 (Hydrochloride) VEGFR2HY-10186 TG 100801 VEGFR2HY-10187 TG 100801 (Hydrochloride) VEGFR2HY-10184 TG 100572 VEGFR2HY-15458 SAR131675 VEGFR-3HY-10977 Tivozanib VEGFR-PDGFRHY-50904 BIBF 1120 VEGFR-PDGFRHY-12060 KRN-633 VEGFR-PDGFRHY-10981 Lenvatinib VEGFR-PDGFRHY-10204 OSI-930 VEGFR-PDGFRHY-10205 Cediranib VEGFR-PDGFRHY-50946 Imatinib (Mesylate) VEGFR-PDGFRHY-10229 Motesanib (Diphosphate) VEGFR-PDGFRHY-10517 TSU-68 VEGFR-PDGFRHY-10991 MGCD-265 VEGFR-PDGFRHY-10407 SU 5402 VEGFR-PDGFRHY-10260 Vandetanib VEGFR-PDGFRHY-10248 RAF265 VEGFR-PDGFRHY-10321 PD173074 VEGFR-PDGFRHY-13308 Regorafenib (Hydrochloride) VEGFR-PDGFRHY-10206 MP470 VEGFR-PDGFRHY-12044 Cabozantinib (S-malate) VEGFR-PDGFRHY-13016 Cabozantinib VEGFR-PDGFRHY-10331 Regorafenib VEGFR-PDGFRHY-12018 Vatalanib VEGFR-PDGFRHY-12047 Ponatinib VEGFR-PDGFRHY-12050 CP-673451 VEGFR-PDGFRHY-10337 Brivanib VEGFR-PDGFRHY-10336 Brivanib alaninate VEGFR-PDGFRHY-12009 Pazopanib (Hydrochloride) VEGFR-PDGFRHY-10993 MK-1775 Wee1 tyrosine kinaseHY-15147 XAV-939 WntHY-14268 Febuxostat XAOHY-15201 Armodafinil α1-adrenoceptor agonistHY-10122 Silodosin α1-adrenoceptor antagonistHY-17034 Medetomidine α2-adrenoceptor agonistHY-15430 EVP-6124 α7 nicotinic receptor antagonistHY-14299 Indacaterol β2-Adrenoceptor agonistsHY-14879 Avibactam β-LactamaseHY-10043 gamma-secretase modulator 1 γ-secretaseHY-13027 DAPT γ-secretaseHY-11102 RO4929097 γ-secretaseHY-50752 LY-411575 γ-secretaseHY-50884 BMS 433796 γ-secretaseHY-10974 MK-0752 γ-secretaseHY-50754 gamma-secretase modulator 2 γ-secretaseHY-50845 BMS-708163 γ-secretaseHY-10016 E 2012 γ-secretaseHY-10009 Semagacestat γ-secretaseHY-75766 Methylnaltrexone Bromide μ-opioid antagonistHY-70042A Tapentadol (hydrochloride) μ-opioid antagonistcyt-569 Activin A Recombinant Human Activin-Acyt-414 Activin A Active Recombinant Human Activin-A Activecyt-024 Acrp30 Human Adiponectin

cyt-280 Acrp30 Recombinant Human Adiponectin cyt-433 Acrp30 His Recombinant Human Adiponectin, His tagcyt-537 mAcrp30 His Recombinant Mouse Adiponectin, His tagcyt-434 Acrp30 HEK Recombinant Human Adiponectin glycosilated, HEK cyt-435 mAcrp30 HEK Recombinant Mouse Adiponectin glycosilated, HEK cyt-696 pAcrp30 HEK Recombinant Porcine Adiponectin glycosilated, HEK cyt-233 Acrp30 Tri Recombinant Human Adiponectin Trimeric Formcyt-247 mAcrp30 Tri Recombinant Mouse Adiponectin Trimeric Formcyt-615 gAcrp30 Recombinant Human Adiponectin Globularcyt-277 gAcrp30 His Recombinant Human Adiponectin Globular, His tagcyt-432 mgAcrp30 Recombinant Mouse Adiponectin Globularcyt-697 AIF1 Recombinant Human Allograft Inflammatory Factor 1cyt-007 AIF1L Recombinant Human Allograft Inflammatory Factor 1 Likecyt-317 AITRL Recombinant Human AITRLcyt-248 ANGPTL3 Recombinant Human Angiopoietin-like Protein 3 cyt-249 ANGPTL4 Recombinant Human Angiopoietin-like Protein 4cyt-698 ANGPTL4 HEK Recombinant Human Angiopoietin-like Protein 4, HEKcyt-661 APOA1 Recombinant Human Apolipoprotein A-Icyt-037 APOA1 Human Apolipoprotein A-Icyt-038 APOA2 Human Apolipoprotein A-IIcyt-025 APOA5 Recombinant Human Apolipoprotein A-Vcyt-041 AREG Recombinant Human Amphiregulincyt-278 Clusterin Recombinant Human Apoliprotein-Jcyt-548 Clusterin Human Apoliprotein-Jcyt-437 rClusterin Recombinant Rat Apoliprotein-Jcyt-549 k9Clusterin Recombinant Canine Apoliprotein-Jcyt-618 k9Clusterin HEK Recombinant Canine Apoliprotein-J HEKcyt-547 APO D Recombinant Human Apoliprotein-Dcyt-652 APO D GST Recombinant Human APO-D GST Tagcyt-715 APOM Recombinant Human Apolipoprotein-Mcyt-026 APOM HEK Recombinant Human Apolipoprotein-M, HEKcyt-306 Artemin Recombinant Human Artemincyt-564 BD 1 Recombinant Human Beta Defensin -1cyt-044 mBD 1 Recombinant Mouse Beta Defensin -1cyt-571 BD 2 Recombinant Human Beta Defensin -2cyt-035 mBD 2 Recombinant Mouse Beta Defensin -2cyt-461 BD 3 Recombinant Human Beta Defensin -3cyt-036 mBD 3 Recombinant Mouse Beta Defensin -3cyt-599 BD 4 Recombinant Human Beta Defensin -4cyt-207 BDNF Recombinant Human Brain-Derived Neurotrophic Factorcyt-014 proBDNF Recombinant Human Precursor Brain-Derived Neurotrophic Factorcyt-307 BAFF Recombinant Human BAFF (BLyS)cyt-545 BAFF His Recombinant Human BAFF (BLyS), His Tagcyt-429 BAFF R Recombinant Human BAFF (BLyS) Receptorcyt-380 BMPR1A Recombinant Human Bone Morphogenetic protein Receptor-1Acyt-713 BMPR1A HEK Recombinant Human Bone Morphogenetic protein Receptor-1A HEKcyt-261 BMP 2 Recombinant Human Bone Morphogenetic protein-2cyt-627 BMP 2 Mono Recombinant Human Bone Morphogenetic protein-2 Monomercyt-427 Pro BMP 2 Recombinant Human Pro Bone Morphogenetic protein-2cyt-361 BMP 4 Recombinant Human Bone Morphogenetic protein-4cyt-660 BMP 5 Recombinant Human Bone Morphogenetic protein-5cyt-333 BMP 7 Recombinant Human Bone Morphogenetic protein-7cyt-629 BMP 7 His Recombinant Human Bone Morphogenetic protein-7 His Tagcyt-276 BMP 7 CHO Recombinant Human Bone Morphogenetic protein-7, CHOcyt-039 BMP 7 Plant Recombinant Human Bone Morphogenetic protein-7, Plantcyt-579 b NGF Recombinant Human beta Nerve Growth Factorcyt-246 b NGF CHO Recombinant Human beta Nerve Growth Factor, CHO

cyt-581 mb NGF Recombinant Mouse beta Nerve Growth Factorcyt-440 mb NGF Mouse beta Nerve Growth Factorcyt-426 ProNGF Recombinant Human Pro-Nerve Growth Factorcyt-327 BNP Recombinant Human B-type Natriuretic Proteincyt-605 BNP His Recombinant Human B-type Natriuretic Protein His Tagcyt-369 BNP Human B-type Natriuretic Proteincyt-330 BTC Recombinant Human Betacellulincyt-406 bBTC Recombinant Bovine Betacellulincyt-272 CNTF Recombinant Human Ciliary Neurotrophic Factorcyt-573 CNTF His Recombinant Human Ciliary Neurotrophic Factor, His Tagcyt-654 rCNTF Recombinant Rat Ciliary Neurotrophic Factorcyt-436 CT 1 Recombinant Human Cardiotrophin-1cyt-541 CTGF Recombinant Human Connective Tissue Growth Factorcyt-438 CTGF His Recombinant Human Connective Tissue Growth Factor, His Tagcyt-526 CTGF (182-250 a.a.) Recombinant Human Connective Tissue Growth Factor 182-250 a.a.cyt-687 CTGF HEK Recombinant Human Connective Tissue Growth Factor, HEKcyt-366 CTLA 4 Recombinant Human Cytotoxic T-Lymphocyte Associated Antigen-4cyt-367 EBI3 Recombinant Human Epstein Barr Virus Induced 3cyt-668 EBI3 His Recombinant Human Epstein Barr Virus Induced 3, His Tagcyt-621 mEBI3 Recombinant Mouse Epstein Barr Virus Induced 3cyt-338 EG VEGF Recombinant Human Endocrine Gland Vacular Endothelial Growth Factorcyt-217 EGF Recombinant Human Epidermal Growth Factorcyt-332 EGF Pichia Recombinant Human Epidermal Growth Factor, Pichia cyt-466 EGF (Leu 21) Recombinant Human Epidermal Growth Factor 21-Leucyt-326 mEGF Recombinant Mouse Epidermal Growth Factorcyt-554 mEGF Mouse Epidermal Growth Factorcyt-556 rEGF Rat Epidermal Growth Factorcyt-669 rEGF Recombinant Rat Epidermal Growth Factorcyt-607 EMAP II Recombinant Human Endothelial-Monocyte Activating Polypeptide IIcyt-021 AIMP1 Recombinant Human Aminoacyl tRNA Synthetase Complex-Interacting Multifunctional Protein 1cyt-389 Endoglin Sf9 Recombinant Human Endoglin, Sf9cyt-525 Endoglin Recombinant Human Endoglincyt-424 mEndoglin Recombinant Mouse Endoglincyt-601 EPGN Recombinant Human Epigencyt-609 EREG Recombinant Human Epiregulincyt-201 EPO a Recombinant Human Erythropoietin-alphacyt-325 EPO a Fc Recombinant Human Erythropoietin-alpha Fc/Chimeracyt-264 FGF 1 Recombinant Human Fibroblast Growth Factor-acidiccyt-364 FGF 1 Sf9 Recombinant Human Fibroblast Growth Factor-acidic, Sf9cyt-528 mFGF 1 Recombinant Mouse Fibroblast Growth Factor-acidiccyt-613 baFGF Bovine Fibroblast Growth Factor-acidiccyt-218 FGF 2 Recombinant Human Fibroblast Growth Factor-basiccyt-365 FGF 2 Sf9 Recombinant Human Fibroblast Growth Factor-basic, Sf9cyt-557 FGF 2 (147 a.a.) Recombinant Human Fibroblast Growth Factor-basic (147 a.a)cyt-288 bFGF 2 Recombinant Bovine Fibroblast Growth Factor-basiccyt-560 bFGF 2 Bovine Fibroblast Growth Factor-basiccyt-386 mFGF 2 Recombinant Mouse Fibroblast Growth Factor-basiccyt-608 rFGF 2 Recombinant Rat Fibroblast Growth Factor-basiccyt-312 FGF 4 Recombinant Human Fibroblast Growth Factor-4cyt-714 FGF 8 Recombinant Human Fibroblast Growth Factor-8cyt-415 FGF 9 Recombinant Human Fibroblast Growth Factor-9cyt-349 mFGF 9 Recombinant Mouse Fibroblast Growth Factor-9cyt-558 rFGF 9 Recombinant Rat Fibroblast Growth Factor-9cyt-620 FGF12 Recombinant Human Fibroblast Growth Factor 12cyt-027 mFGF-15 Recombinant Mouse Fibroblast Growth Factor-15cyt-700 FGF 19 Recombinant Human Fibroblast Growth Factor-19 cyt-279 FGF 19 His Recombinant Human Fibroblast Growth Factor-19 His Tag

cyt-474 FGF 21 Recombinant Human Fibroblast Growth Factor-21cyt-281 FGF 21 His Recombinant Human Fibroblast Growth Factor-21, His Tagcyt-339 mFGF 21 Recombinant Mouse Fibroblast Growth Factor-21cyt-516 mFGF 21 His Recombinant Mouse Fibroblast Growth Factor-21, His Tagcyt-657 bFGF 21 Recombinant Bovine Fibroblast Growth Factor-21cyt-428 FGF 22 Recombinant Human Fibroblast Growth Factor-22cyt-020 FGF 23 Recombinant Human Fibroblast Growth Factor-23 cyt-374 FGF 23 His Recombinant Human Fibroblast Growth Factor-23 His Tagcyt-028 FGF 23 C-term Recombinant Human Fibroblast Growth Factor-23 C-Terminalcyt-331 Flt3 Ligand Recombinant Human Flt3-Ligandcyt-706 Flt3 Ligand, HEK Recombinant Human Flt3-Ligand, HEKcyt-340 mFlt3 Ligand Recombinant Mouse Flt3-Ligandcyt-409 Flt3 Ligand Sf9 Recombinant Human Flt3-Ligand Sf9 cyt-232 FST Recombinant Human Follistatincyt-029 FST His Recombinant Human Follistatin His Tagcyt-544 LGALS1 Recombinant Human Galectin-1cyt-725 LGALS2 Recombinant Human Galectin-2cyt-606 LGALS3 Recombinant Human Galectin-3cyt-692 LGALS3 GST Recombinant Human Galectin-3 GST-Tagcyt-693 LGALS3 His Recombinant Human Galectin-3 His Tagcyt-686 LGALS4 Recombinant Human Galectin-4cyt-016 LGALS7 Recombinant Human Galectin-7cyt-617 LGALS7 His Recombinant Human Galectin-7 His Tagcyt-017 LGALS8 Recombinant Human Galectin-8cyt-727 LGALS8 His Recombinant Human Galectin-8, His Tagcyt-708 LGALS9 Recombinant Human Galectin-9cyt-004 LGALS13 Recombinant Human Galectin-13cyt-003 LGALS14 Recombinant Human Galectin-14cyt-305 GDNF Recombinant Human Glial-Derived Neurotrophic Factorcyt-694 GDF3 Recombinant Human Growth and Differentiation factor 3cyt-442 GDF5 Recombinant Human Growth and Differentiation factor 5cyt-653 GDF5 His Recombinant Human Growth and Differentiation factor 5 His Tagcyt-659 GDF10 Recombinant Human Growth and Differentiation factor 10cyt-691 GDF15 Recombinant Human Growth and Differentiation factor 15cyt-314 GDF5 D Recombinant Human Growth and Differentiation factor 15 D-Vairantcyt-335 GDF5 H Recombinant Human Growth and Differentiation factor 15 H-Variantcyt-220 G CSF Recombinant Human Granulocyte-Colony Stimulating Factorcyt-476 G CSF His Recombinant Human Granulocyte-Colony Stimulating Factor, His Tagcyt-329 G CSF CHO Recombinant Human Granulocyte-Colony Stimulating Factor, CHO cyt-410 mG CSF Recombinant Mouse Granulocyte-Colony Stimulating Factorcyt-018 G CSF PEG Recombinant Human Pegylated Granulocyte-Colony Stimulating Factorcyt-202 GH Recombinant Human Growth Hormonecyt-235 pGH 22kDa Recombinant Human Placental Corr Growth Hormonecyt-259 GH 20kDa Recombinant Human Pituitary Growth Hormone 20kDacyt-337 pGH 20kDa Recombinant Human Placental Growth Hormone 20kDacyt-238 GHBP Recombinant Human Growth Hormone Binding Proteincyt-470 oGHBP Recombinant Ovine Growth Hormone Binding Proteincyt-471 bGHBP Recombinant Bovine Growth Hormone Binding Proteincyt-593 raGHBP Recombinant Rabbit Growth Hormone Binding Proteincyt-430 chGH Recombinant Chicken Growth Hormonecyt-237 oGH Recombinant Ovine Growth Hormonecyt-594 oGH Placental Recombinant Placental Ovine Growth Hormonecyt-636 bGH Recombinant Bovine Growth Hormonecyt-540 mGH Recombinant Mouse Growth Hormonecyt-296 rGH Recombinant Rat Growth Hormonecyt-297 cGH Recombinant Carp Growth Hormonecyt-498 dGH Recombinant Denis Growth Hormone

cyt-499 maiGH Recombinant Mai Mai Growth Hormonecyt-529 sGH Recombinant Gilthead Seabream Growth Hormonecyt-514 raGH Recombinant Rabbit Growth Hormonecyt-519 pGH Recombinant Porcine Growth Hormonecyt-538 chGH Antagonist Recombinant Chicken Growth Hormone Anatagonistcyt-215 oGH Antagonist Recombinant Ovine Growth Hormone Anatagonistcyt-710 zGH Recombinant Zebrafish Growth Hormone cyt-709 zGH Mutant Recombinant Zebrafish Growth Hormone Mutantcyt-221 GM CSF Recombinant Human Granulocyte Macrophage-Colony Stimulating Factorcyt-324 GM CSF Pichia Recombinant Human Granulocyte Macrophage-Colony Stimulating Factor, Pichia cyt-416 GM CSF Sf9 Recombinant Human Granulocyte Macrophage-Colony Stimulating Factor, Sf9 cyt-360 PIXY321 Recombinant Human gm-csf/IL-3 Fusion Protein (PIXY321)cyt-477 GM CSF His Recombinant Human Granulocyte Macrophage-Colony Stimulating Factor, His Tagcyt-222 mGM CSF Recombinant Mouse Granulocyte Macrophage-Colony Stimulating Factorcyt-395 rGM CSF Recombinant Rat Granulocyte Macrophage-Colony Stimulating Factorcyt-401 pGM CSF Recombinant Porcine Granulocyte Macrophage-Colony Stimulating Factorcyt-720 rmGM CSF Recombinant Rhesus Macaque Granulocyte Macrophage-Colony Stimulating Factorcyt-724 k9GM CSF Recombinant Canine Granulocyte Macrophage-Colony Stimulating Factorcyt-565 GMF b Recombinant Human Glia Maturation Factor Betacyt-726 GMF b His Recombinant Human Glia Maturation Factor Beta His Tagcyt-006 mGMF b Recombinant Mouse Glia Maturation Factor Betacyt-632 GMFG Recombinant Human Glia Maturation Factor Gammacyt-681 HDGF Recombinant Human Hepatoma-Derived Growth Factorcyt-251 HGF CHO Recombinant Human Hepatocyte Growth Factor, CHOcyt-244 HGF Recombinant Human Hepatocyte Growth Factor, Sf9cyt-664 HGF-A Recombinant Human Hepatocyte Growth Factor A Chaincyt-665 HGF-B Recombinant Human Hepatocyte Growth Factor B Chaincyt-522 pHGF Porcine Hepatocyte Promoting Growth Factorcyt-291 IFN a 1 Recombinant Human Interferon-alpha 1cyt-520 IFN a 1a Recombinant Human Interferon-alpha 1acyt-283 IFN a 1b Recombinant Human Interferon-alpha 1bcyt-204 IFN a 2a Recombinant Human Interferon-alpha 2acyt-543 IFN a 2a, Plant Recombinant Human Interferon-alpha 2a, Tobacco cyt-205 IFN a 2b Recombinant Human Interferon-alpha 2bcyt-460 IFN a 2b, Yeast Recombinant Human Interferon-alpha 2b, Saccharomycescyt-019 IFN a 2b 40kd-PEG Recombinant Human Interferon-alpha 2b 40kd-Pegylatedcyt-034 IFN a 2b 20kd-PEG Recombinant Human Interferon-alpha 2b 20kd-Pegylatedcyt-236 IFN b 1a Recombinant Human Interferon-beta 1acyt-234 IFN b 1b Recombinant Human Interferon-beta 1bcyt-550 mIFN b Recombinant Mouse Interferon-beta cyt-651 mIFN b His Recombinant Mouse Interferon-beta His Tagcyt-206 IFN g Recombinant Human Interferon-gammacyt-478 IFN g His Recombinant Human Interferon-gamma His Tagcyt-358 mIFN g Recombinant Mouse Interferon-gammacyt-359 rIFN g Recombinant Rat Interferon-gammacyt-402 pIFN g Recombinant Porcine Interferon-gammacyt-040 IFNW1 Recombinant Human Interferon-Omega 1cyt-377 oIFN tau Recombinant Ovine Interferon-Taucyt-449 IRF 1 Recombinant Human Interferon Regulatory Factor-1cyt-534 IRF 2 Recombinant Human Interferon Regulatory Factor-2cyt-292 IRF 3 Recombinant Human Interferon Regulatory Factor-3 cyt-216 IGF1 Recombinant Human Insulin Like Growth Factor-1cyt-690 IGF1 GST Recombinant Human Insulin Like Growth Factor-1, GST-Tagcyt-518 IGF1 Des1-3 Recombinant Human Insulin Like Growth Factor-1 Des (1-3)cyt-022 Long R3 IGF1 Recombinant Human Long R3 Insulin Like Growth Factor-1cyt-229 mIGF1 Recombinant Mouse Insulin Like Growth Factor-1cyt-289 rIGF1 Recombinant Rat Insulin Like Growth Factor-1

cyt-295 sIGF1 Recombinant Gilthead Seabream Insulin Like Growth Factor-1cyt-265 IGF2 Recombinant Human Insulin Like Growth Factor-2cyt-299 IGFBP 1 Human Insulin Like Growth Factor Binding Protein-1cyt-300 IGFBP 3 Recombinant Human Insulin Like Growth Factor Binding Protein-3cyt-030 IGFBP 4 Recombinant Human Insulin Like Growth Factor Binding Protein-4cyt-464 IGFBP 5 Recombinant Human Insulin Like Growth Factor Binding Protein-5cyt-258 IGFBP 6 Recombinant Human Insulin Like Growth Factor Binding Protein-6cyt-253 IL 1 alpha Recombinant Human Interleukin-1 alphacyt-479 IL 1 alpha His Recombinant Human Interleukin-1 alpha, His Tagcyt-523 mIL 1 alpha Recombinant Mouse Interleukin-1 alphacyt-381 rIL 1 alpha Recombinant Rat Interleukin-1 alphacyt-396 pIL 1 alpha Recombinant Porcine Interleukin-1 alphacyt-208 IL 1 beta Recombinant Human Interleukin-1 betacyt-480 IL 1 beta His Recombinant Human Interleukin-1 beta, His Tagcyt-273 mIL 1 beta Recombinant Mouse Interleukin-1 betacyt-578 mIL 1 beta His Recombinant Mouse Interleukin-1 beta, His Tagcyt-394 rIL 1 beta Recombinant Rat Interleukin-1 betacyt-400 pIL 1 beta Recombinant Porcine Interleukin-1 betacyt-718 rmIL 1 beta Recombinant Rhesus Macaque Interleukin-1 beta cyt-203 IL 1RA Recombinant Human Interleukin-1 Receptor Antagonistcyt-481 IL 1RA His Recombinant Human Interleukin-1 Receptor Antagonist, His Tagcyt-671 IL1RL1 Recombinant Human Interleukin-1 Receptor Like-1cyt-658 mIL 1RA Recombinant Mouse Interleukin-1 Receptor Antagonistcyt-009 IL1F5 Recombinant Human Interleukin 1 Family, Member 5 cyt-010 IL1F6 Recombinant Human Interleukin 1 Family, Member 6cyt-011 IL1F7 Recombinant Human Interleukin 1 Family, Member 7cyt-012 IL1F10 Recombinant Human Interleukin 1 Family, Member 10cyt-209 IL 2 Recombinant Human Interleukin-2cyt-666 IL 2 His Recombinant Human Interleukin-2 His Tagcyt-370 mIL 2 Recombinant Mouse Interleukin-2cyt-624 mIL 2 His Recombinant Mouse Interleukin-2, His Tagcyt-382 rIL 2 Recombinant Rat Interleukin-2cyt-397 pIL 2 Recombinant Porcine Interleukin-2cyt-285 sIL 2R Recombinant Human Soluble Iinterleukin-2 Receptor alphacyt-589 sIL 2R, GST Recombinant Human Soluble Iinterleukin-2 Receptor alpha, GST tagcyt-210 IL 3 Recombinant Human Interleukin-3cyt-482 IL 3 His Recombinant Human Interleukin-3, His Tagcyt-371 mIL 3 Recombinant Mouse Interleukin-3cyt-383 rIL 3 Recombinant Rat Interleukin-3cyt-417 IL 3 Sf9 Recombinant Human Interleukin-3, Sf9 cyt-722 k9 IL 3 Recombinant Canine Interleukin-3cyt-211 IL 4 Recombinant Human Interleukin-4cyt-271 IL 4 CHO Recombinant Human Interleukin-4 CHO cyt-483 IL 4 His Recombinant Human Interleukin-4, His Tagcyt-282 mIL 4 Recombinant Mouse Interleukin-4cyt-385 rIL 4 Recombinant Rat Interleukin-4cyt-398 pIL 4 Recombinant Porcine Interleukin-4cyt-212 IL 5 Recombinant Human Interleukin-5cyt-689 mIL 5 Recombinant Mouse Interleukin-5cyt-387 rIL 5 Recombinant Rat Interleukin-5cyt-213 IL 6 Recombinant Human Interleukin-6cyt-274 IL 6 CHO Recombinant Human Interleukin-6, CHOcyt-484 IL 6 His Recombinant Human Interleukin-6, His Tagcyt-350 mIL 6 Recombinant Mouse Interleukin-6cyt-388 rIL 6 Recombinant Rat Interleukin-6cyt-399 pIL 6 Recombinant Porcine Interleukin-6cyt-286 sIL 6R Recombinant Human Soluble IL-6 Receptor alpha

cyt-254 IL 7 Recombinant Human Interleukin-7cyt-298 IL 7 Yeast Recombinant Human Interleukin-7, Saccharomyces cyt-485 IL 7 His Recombinant Human Interleukin-7, His Tagcyt-372 mIL 7 Recombinant Mouse Interleukin-7cyt-348 IL 9 Recombinant Human Interleukin-9cyt-373 mIL 9 Recombinant Mouse Interleukin-9cyt-500 IL 10 Recombinant Human Interleukin-10cyt-486 IL 10 His Recombinant Human Interleukin-10, His Tagcyt-497 mIL 10 Recombinant Mouse Interleukin-10cyt-465 rIL 10 Recombinant Rat Interleukin-10cyt-404 pIL 10 Recombinant Porcine Interleukin-10cyt-214 IL 11 Recombinant Human Interleukin-11CYT-013 IL 11 Pichia Recombinant Human Interleukin-11, Pichiacyt-646 mIL 11 Recombinant Mouse Interleukin-11cyt-362 IL 12 Recombinant Human Interleukin-12cyt-390 rIL 12 Recombinant Rat Interleukin-12cyt-487 IL 12 p35 His Recombinant Human Interleukin-12 p35, His Tagcyt-488 IL 12 p40 His Recombinant Human Interleukin-12 p40, His Tagcyt-446 IL 13 Recombinant Human Interleukin-13cyt-682 IL 13 Variant Recombinant Human Interleukin-13 Variantcyt-489 IL 13 His Recombinant Human Interleukin-13, His Tagcyt-375 mIL 13 Recombinant Mouse Interleukin-13cyt-391 rIL 13 Recombinant Rat Interleukin-13cyt-230 IL 15 Recombinant Human Interleukin-15cyt-490 IL 15 His Recombinant Human Interleukin-15, His Tagcyt-344 mIL 15 Recombinant Mouse Interleukin-15cyt-647 mIL 15 His Recombinant Mouse Interleukin-15, His Tagcyt-345 rIL 15 Recombinant Rat Interleukin-15cyt-403 pIL 15 Recombinant Porcine Interleukin-15cyt-536 IL 16 Recombinant Human Interleukin-16cyt-562 IL 16, His Recombinant Human Interleukin-16, His Tagcyt-559 mIL 16 Recombinant Mouse Interleukin-16cyt-250 IL 17 Recombinant Human Interleukin-17Acyt-662 IL 17 His Recombinant Human Interleukin-17A His Tagcyt-583 IL 17E Recombinant Human Interleukin-17Ecyt-587 IL 17F Recombinant Human Interleukin-17Fcyt-623 IL 17 A/F Recombinant Human Interleukin-17 A/F Heterodimercyt-378 mIL 17 Recombinant Mouse Interleukin-17Acyt-641 mIL 17E Recombinant Mouse Interleukin-17Ecyt-642 mIL 17F Recombinant Mouse Interleukin-17Fcyt-640 mIL 17 A/F Recombinant Mouse Interleukin-17 A/F Heterodimercyt-677 rIL 17 A/F Recombinant Rat Interleukin-17 A/F Heterodimercyt-542 rIL 17 Recombinant Rat Interleukin-17Acyt-576 rIL 17E Recombinant Rat Interleukin-17Ecyt-643 rIL 17F Recombinant Rat Interleukin-17Fcyt-269 IL 18 Recombinant Human Interleukin-18cyt-663 IL 18 His Recombinant Human Interleukin-18 His Tagcyt-634 mIL 18 Recombinant Mouse Interleukin-18cyt-376 rIL 18 Recombinant Rat Interleukin-18cyt-363 IL 19 Recombinant Human Interleukin-19cyt-411 mIL 19 Recombinant Mouse Interleukin-19cyt-347 IL 20 Recombinant Human Interleukin-20cyt-379 mIL 20 Recombinant Mouse Interleukin-20cyt-408 IL 21 Recombinant Human Interleukin-21cyt-684 mIL 21 Recombinant Mouse Interleukin-21cyt-033 rIL 21 Recombinant Rat Interleukin-21cyt-328 IL 22 Recombinant Human Interleukin-22

cyt-539 mIL 22 Recombinant Mouse Interleukin-22cyt-701 mIL 22 PEG Recombinant Mouse Interleukin-22, Pegylatedcyt-515 IL 24 Recombinant Human Interleukin-24cyt-048 IL 27 Recombinant Human Interleukin-27cyt-570 mIL 27 Recombinant Mouse Interleukin-27cyt-602 IL 28A Recombinant Human Interleukin-28Acyt-603 IL 29 Recombinant Human Interleukin-29cyt-625 IL 31 Recombinant Human Interleukin-31cyt-604 mIL 31 Recombinant Mouse Interleukin-31cyt-584 IL 32A Recombinant Human IL-32 alphacyt-648 IL 32A His Tag Recombinant Human IL-32 alpha His Tagcyt-425 IL 33 Recombinant Human Interleukin-33cyt-667 IL 33 His Recombinant Human Interleukin-33 His Tagcyt-655 mIL 33 Recombinant Mouse Interleukin-33cyt-270 Insulin Recombinant Human Insulincyt-614 Insulin Yeast Recombinant Human Insulin Yeastcyt-468 pInsulin Porcine Insulincyt-219 KGF Recombinant Human Keratinocyte Growth Factorcyt-721 mKGF Recombinant Mouse Keratinocyte Growth Factorcyt-303 KGF 2 Recombinant Human Keratinocyte Growth Factor-2cyt-228 Leptin Recombinant Human Leptincyt-683 Leptin Human Leptincyt-287 Leptin His Recombinant Human Leptin, His Tagcyt-351 mLeptin Recombinant Mouse Leptincyt-591 mLeptin PEG Recombinant Pegylated Mouse Leptincyt-227 rLeptin Recombinant Rat Leptincyt-592 rLeptin PEG Recombinant Pegylated Rat Leptincyt-239 oLeptin Recombinant Ovine Leptincyt-531 oLeptin, MTS Recombinant Ovine Leptin, MTS tagcyt-502 bLeptin Recombinant Bovine Leptincyt-503 pLeptin Recombinant Porcine Leptincyt-530 pfLeptin Recombinant Pufferfish Leptincyt-704 sLeptin Recombinant Salamander Leptincyt-504 hLeptin Recombinant Horse Leptincyt-505 chLeptin Recombinant Chicken Leptincyt-506 dLeptin Recombinant Dog Leptincyt-507 raLeptin Recombinant Rabbit Leptincyt-352 Leptin tA Recombinant Human Leptin Triple Antagonistcyt-702 Leptin tA PEG Recombinant Human Leptin Triple Antagonist, Pegylatedcyt-353 Leptin qA Recombinant Human Leptin Quadruple Antagonistcyt-354 mLeptin tA Recombinant Mouse Leptin Triple Antagonistcyt-566 mLeptin tA PEG Recombinant Pegylated Mouse Leptin Triple Antagonist, Pegylatedcyt-355 rLeptin tA Recombinant Rat Leptin Triple Antagonistcyt-567 rLeptin tA PEG Recombinant Pegylated Rat Leptin Triple Antagonist, Pegylatedcyt-356 oLeptin tA Recombinant Ovine Leptin Triple Antagonistcyt-703 oLeptin tA PEG Recombinant Ovine Leptin Triple Antagonist, Pegylatedcyt-357 oLeptin qA Recombinant Ovine Leptin Quadruple Antagonistcyt-508 Leptin Receptor Recombinant Human Leptin Binding Domaincyt-509 chLeptin Receptor Recombinant Chicken Leptin Binding Domaincyt-243 LeukinFeron Human LeukinFeroncyt-423 LFA 3 Recombinant Human Leukocyte Function Associated Antigen-3 Fusion Protein cyt-644 LIF Recombinant Human Leukemia Inhibitory Factorcyt-645 mLIF Recombinant Mouse Leukemia Inhibitory Factorcyt-001 LIF GST Recombinant Human Leukemia Inhibitory Factor, GST tagcyt-308 M CSF Recombinant Human Macrophage Colony Stimulating Factorcyt-637 M CSF, Baculovirus Recombinant Human Macrophage Colony Stimulating Factor, Baculoviruscyt-695 M CSF His Recombinant Human Macrophage Colony Stimulating Factor, His Tag

cyt-439 mM CSF Recombinant Mouse Macrophage Colony Stimulating Factorcyt-046 rM CSF Recombinant Rat Macrophage Colony Stimulating Factorcyt-575 MIF Recombinant Human Macrophage Migration Inhibitor Factorcyt-596 MIF (Active) Recombinant Human Macrophage Migration Inhibitor Factorcyt-431 MIF His N Recombinant Human Macrophage Migration Inhibitor Factor, His Tag N-Terminuscyt-521 MIF His C Recombinant Human Macrophage Migration Inhibitor Factor, His Tag C-Terminuscyt-310 MIA Recombinant Human Melanoma Inhibitory Activity Proteincyt-638 MIA2 Recombinant Human Melanoma Inhibitory Activity Protein 2cyt-444 Midkine Recombinant Human Midkinecyt-723 MTPN Recombinant Human Myotrophincyt-418 Myostatin Recombinant Human Myostatincyt-445 Myostatin His Recombinant Human Myostatin, His-Tagcyt-448 Myostatin Propetide Recombinant Human Myostatin Propeptidecyt-450 NGB Recombinant Human Neuroglobincyt-407 NRG1 Recombinant Human Neuregulin-1/Heregulin-b2cyt-257 NT 3 Recombinant Human Neurotrophin-3cyt-015 proNT3 Recombinant Human Precursor Neurotrophin-3cyt-688 mNT 3 Recombinant Mouse Neurotrophin-3cyt-626 NT 4 Recombinant Human Neurotrophin-4cyt-475 Noggin Recombinant Human Noggincyt-600 mNoggin Recombinant Mouse Noggincyt-301 Omentin Recombinant Human Omentincyt-551 Omentin His Recombinant Human Omentin His Tagcyt-266 OPG Fc Recombinant Human Osteoprotegerincyt-290 OPG His Recombinant Human Osteoprotegerin, His Tagcyt-633 OPG Hi-5 Recombinant Human Osteoprotegerin Hi-5cyt-231 OSM Recombinant Human Oncostatin-Mcyt-639 OSM (209 a.a.) Recombinant Human Oncostatin-M (209 a.a.)cyt-630 OSTF1 Recombinant Human Osteoclast Stimulating Factor-1cyt-582 OTOR Recombinant Human Otoraplincyt-341 PDGF AA Recombinant Human Platelet Derived Growth Factor-AAcyt-568 PDGF AA Yeast Recombinant Human Platelet Derived Growth Factor-AA Yeastcyt-491 PDGF A Recombinant Human Platelet Derived Growth Factor-Acyt-590 mPDGF AA Recombinant Mouse Platelet Derived Growth Factor-AAcyt-342 PDGF AB Recombinant Human Platelet Derived Growth Factor-ABcyt-242 PDGF BB Yeast Recombinant Human Platelet Derived Growth Factor-BB, Yeastcyt-501 PDGF BB Recombinant Human Platelet Derived Growth Factor-BBcyt-492 PDGF B Recombinant Human Platelet Derived Growth Factor-Bcyt-412 mPDGF BB Recombinant Mouse Platelet Derived Growth Factor-BBcyt-580 PEDF Recombinant Human Pigment Epithelium-Derived Factorcyt-552 PEDF His Recombinant Human Pigment Epithelium-Derived Factor, His Tagcyt-553 PEDF HEK Recombinant Human Pigment Epithelium-Derived Factor, HEKcyt-452 Periostin Recombinant Human Periostincyt-524 PGRN Recombinant Human Progranulincyt-451 Pleiotrophin Recombinant Human Pleiotrophincyt-656 Placental Lactogen Recombinant Human Placental Lactogencyt-511 bPlacental Lactogen Recombinant Bovine Placental Lactogencyt-512 oPlacental Lactogen Recombinant Ovine Placental Lactogencyt-510 cPlacental Lactogen Recombinant Caprine Placental Lactogencyt-419 PLGF 1 Recombinant Human Placenta Growth Factor-1cyt-420 PLGF 2 Recombinant Human Placenta Growth Factor-2cyt-267 Prolactin Recombinant Human Prolactincyt-493 Prolactin His Recombinant Human Prolactin, His Tagcyt-321 mProlactin Recombinant Mouse Prolactincyt-322 rProlactin Recombinant Rat Prolactincyt-240 oProlactin Recombinant Ovine Prolactincyt-513 raProlactin Recombinant Rabbit Prolactin

cyt-469 Prl R, GST Recombinant Human Prolactin Receptor , GST Tagcyt-595 Prl R Recombinant Human Prolactin Receptor cyt-268 raPrl R Recombinant Rabbit Prolactin Soluble Receptorcyt-293 oPrl R Recombinant Ovine Prolactin Soluble Receptorcyt-294 bPrl R Recombinant Bovine Prolactin Soluble Receptorcyt-532 tPrl R Recombinant Raibow Trout Prolactin Soluble Receptorcyt-533 rPrl R Recombinant Rat Prolactin Soluble Receptorcyt-311 oPrl A Recombinant Ovine Prolactin Antagonistcyt-705 oPrl A Mutant Recombinant Ovine Prolactin Antagonist, Mutantcyt-304 sCD4 Recombinant Human Soluble CD4cyt-313 CD4 (26-226) Recombinant Human CD4 (26-226)cyt-315 CD4 (125-202) Recombinant Human CD4 (125-202)cyt-316 CD4 (203-317) Recombinant Human CD4 (203-317)cyt-245 sCD40L Recombinant Human soluble CD40 Ligand/TRAPcyt-670 sCD40L His Recombinant Human soluble CD40 Ligand/TRAP His Tagcyt-472 msCD40L Recombinant Mouse soluble CD40 Ligand/TRAPcyt-676 SHH Recombinant Human Sonic HedgeHog cyt-717 SHH, His Recombinant Human Sonic HedgeHog, His Tagcyt-597 mSHH Recombinant Mouse Sonic HedgeHog cyt-711 mSHH, His Recombinant Mouse Sonic HedgeHog, His Tagcyt-467 DHH Recombinant Human Desert HedgeHogcyt-334 sRANKL Recombinant Human Soluble RANK Ligandcyt-631 sRANKL GST Recombinant Human Soluble RANK Ligand, GST Tagcyt-320 msRANKL Recombinant Mouse Soluble RANK Ligandcyt-309 mRELM a Recombinant Mouse RELM-alphacyt-453 mRELM a His Recombinant Mouse RELM-alpha His Tagcyt-454 RELM b Recombinant Human RELM-betacyt-413 mRELM b Recombinant Mouse RELM-betacyt-455 mRELM g Recombinant Mouse RELM-Gammacyt-456 Resistin Recombinant Human Resistin cyt-256 Resistin His Recombinant Human Resistin, His Tagcyt-585 Resistin Mutant Recombinant Human Resistin Mutant cyt-457 mResistin Recombinant Mouse Resistincyt-458 rResistin Recombinant Rat Resistincyt-535 RBP4 Recombinant Human Retinol Binding Protein-4cyt-555 RBP4 His Recombinant Human Retinol Binding Protein-4 His Tagcyt-650 RBP5 Recombinant Human Retinol Binding Protein-5cyt-023 RBP7 Recombinant Human Retinol Binding Protein-7cyt-675 SAA1 Recombinant Human Serum Amyloid A (APO-SAA1)cyt-719 rmSAA1 Recombinant Rhesus Macaque Serum Amyloid A (APO-SAA1)cyt-002 SAA4 Recombinant Human Serum Amyloid A4cyt-255 SCF Recombinant Human Stem Cell Factorcyt-275 mSCF Recombinant Mouse Stem Cell Factorcyt-323 rSCF Recombinant Rat Stem Cell Factorcyt-421 SCF Sf9 Recombinant Human Stem Cell Factor, Sf9 cyt-622 SF20 Recombinant Human Chromosome 19 Open Reading Frame 10cyt-678 mSF20 Recombinant Mouse Chromosome 19 Open Reading Frame 10cyt-635 SPP1 Recombinant Human Osteopontincyt-047 SPP1 HEK Recombinant Human Osteopontin, HEKcyt-712 TDGF1 Recombinant Human Teratocarcinoma-Derived Growth Factor 1cyt-586 TFF1 Recombinant Human Trefoil Factor-1cyt-610 TFF1 His Recombinant Human Trefoil Factor-1 His Tagcyt-612 TFF2 Recombinant Human Trefoil Factor-2cyt-611 TFF2 His Recombinant Human Trefoil Factor-2 His Tagcyt-005 TFF3 Recombinant Human Trefoil Factor-3 cyt-616 TFF3 His Recombinant Human Trefoil Factor-3 His Tagcyt-716 TGF b 1 Recombinant Human Transforming Growth Factor-Beta 1

cyt-561 TGF b 1 Human Transforming Growth Factor-Beta 1cyt-473 TGF b 1 GST Recombinant Human Transforming Growth Factor-Beta 1, GST tagcyt-672 TGF b 1 His Recombinant Human Transforming Growth Factor-Beta 1 His Tagcyt-679 TGF b 1 (113 a.a.) Recombinant Human Transforming Growth Factor-Beta 1 (113 a.a.)cyt-441 TGF b 2 Recombinant Human Transforming Growth Factor-Beta 2cyt-368 TGF b 3 Recombinant Human Transforming Growth Factor-Beta 3cyt-685 TGF b 3 CHO Recombinant Human Transforming Growth Factor-Beta 3, CHO cyt-588 TGF b 3 Plant Recombinant Human Transforming Growth Factor-Beta 3, Plantcyt-319 TGF b 3 (207 a.a.) Recombinant Human Transforming Growth Factor-Beta 3 (644-850)cyt-463 4 1BBR Recombinant Human 4-1BB Receptorcyt-649 4 1BBL Recombinant Human 4-1BB Ligandcyt-223 TNF a Recombinant Human Tumor Necrosis Factor-alphacyt-494 TNF a His Recombinant Human Tumor Necrosis Factor-alpha, His Tagcyt-252 mTNF a Recombinant Mouse Tumor Necrosis Factor-alphacyt-393 rTNF a Recombinant Rat Tumor Necrosis Factor-alphacyt-405 rpTNF a Recombinant Porcine Tumor Necrosis Factor-alphacyt-008 raTNF a Recombinant Rabbit Tumor Necrosis Factor-alphacyt-384 TNF a Mutant Recombinant Human Tumor Necrosis Factor-alpha, Mutantcyt-224 TNF b Recombinant Human Tumor Necrosis Factor-betacyt-495 TNF b His Recombinant Human Tumor Necrosis Factor-beta, His Tagcyt-422 TNFR Recombinant Human Tumor Necrosis Factor Receptor Fusion Proteincyt-598 TNFRSF17 Recombinant Human B-Cell Maturation Antigencyt-707 TNFR1 Recombinant Human Tumor Necrosis Factor Receptor Type 1cyt-673 TNFR1 His Recombinant Human Tumor Necrosis Factor Receptor Type 1, His Tagcyt-674 TNFR2 Recombinant Human Tumor Necrosis Factor Receptor Type 2cyt-699 TNFSF12 Recombinant Human TNF Ligand Superfamily Member 12cyt-043 TNFRSF12A Recombinant Human TNF Ligand Receptor Superfamily Member 12A cyt-572 TSLP Recombinant Human Thymic Stromal Lymphopoietincyt-302 TPO Recombinant Human Thrombopoietincyt-462 TPO CHO Recombinant Human Thrombopoietin, CHO cyt-346 mTPO Recombinant Mouse Thrombopoietincyt-443 TRAIL Recombinant Human TNF-Related Apoptosis Inducing Ligand/Apo2Lcyt-546 TRAIL (114-281 a.a.) Recombinant Human TNF-Related Apoptosis Inducing Ligand/Apo2L (114-281)cyt-459 Vaspin Recombinant Human Vaspincyt-241 VEGF Recombinant Human Vascular Endothelial Growth Factorcyt-496 VEGF His Recombinant Human Vascular Endothelial Growth Factor His Tagcyt-260 VEGF CHO Recombinant Human Vascular Endothelial Growth Factor, CHO cyt-225 VEGF HEK Recombinant Human Vascular Endothelial Growth Factor, HEKcyt-577 VEGF Yeast Recombinant Human Vascular Endothelial Growth Factor, Yeastcyt-343 VEGF (121a.a.) Recombinant Human Vascular Endothelial Growth Factor (121)cyt-200 VEGF (121a.a.) Sf9 Recombinant Human Vascular Endothelial Growth Factor (121), Sf9cyt-619 VEGF (121a.a.) His Recombinant Human Vascular Endothelial Growth Factor (121) His Tagcyt-336 rmVEGF Recombinant Mouse Vascular Endothelial Growth Factorcyt-226 mVEGF Sf9 Recombinant Mouse Vascular Endothelial Growth Factor-Sf9cyt-574 rmVEGF (121a.a.) Recombinant Mouse Vascular Endothelial Growth Factor (121)cyt-680 rmVEGF His Recombinant Mouse Vascular Endothelial Growth Factor His Tagcyt-392 rVEGF Recombinant Rat Vascular Endothelial Growth Factorcyt-628 VEGFB Recombinant Human Vascular Endothelial Growth Factor Bcyt-527 VEGF C Recombinant Human Vascular Endothelial Growth Factor Related Proteincyt-262 rVEGF C Recombinant Rat Vascular Endothelial Growth Factor Related Proteincyt-284 rVEGF C (152a.a.) Recombinant Rat Vascular Endothelial Growth Factor-C (152)cyt-045 VEGF D Recombinant Human Vascular Endothelial Growth Factor Dcyt-263 VEGF E (Orf Virus) Recombinant Vascular Endothelial Growth Factor-E (Orf Virus)cyt-517 VEGI Recombinant Human Vascular Endothelial Growth Inhibitorcyt-318 Visfatin Recombinant Human Visfatincyt-563 Visfatin, His Recombinant Human Visfatin, His Tagcyt-447 mVisfatin Recombinant Mouse Visfatin

chm-348 BCA 1 Recombinant Human BCA-1/ BLC (CXCL13)chm-239 BRAK His Recombinant Human BRAK (CXCL14), His Tagchm-001 BRAK Recombinant Human BRAK (CXCL14)chm-307 mC 10 Recombinant Mouse C-10 (CCL6)chm-237 CCL16 Recombinant Human LEC/NCC-4 (CCL16)chm-251 CCL3L1 Recombinant Human LD78-beta (CCL3L1)chm-373 CTACK Recombinant Human CTACK (CCL27)chm-363 mCXCL16 Recombinant Mouse CXCL16chm-331 ENA 78 Recombinant Human Epithelial Neutrophil-Activating Protein 78 (CXCL5)chm-365 mENA 78 Recombinant Mouse Epithelial Neutrophil-Activating Protein 78 (CXCL5)chm-256 Eotaxin Recombinant Human Eotaxin (CCL11)chm-344 Eotaxin, His Recombinant Human Eotaxin (CCL11), His Tagchm-308 mEotaxin Recombinant Mouse Eotaxin (CCL11)chm-260 rEotaxin Recombinant Rat Eotaxin (CCL11)chm-238 Eotaxin 2 Recombinant Human Eotaxin-2 (CCL24)chm-368 mEotaxin 2 Recombinant Mouse Eotaxin-2 (CCL24)chm-362 Eotaxin 3 Recombinant Human Eotaxin-3 (CCL26)chm-332 Exodus 2 Recombinant Human Exodus-2 (CCL21)chm-371 mExodus 2 Recombinant Mouse Exodus-2 (CCL21)chm-235 Fractalkine Recombinant Human Fractalkine (CX3CL1)chm-360 Fractalkine His Recombinant Human Fractalkine (CX3CL1) His Tagchm-329 GRO a Recombinant Human GRO-alpha (CXCL1)chm-242 GRO a, His Recombinant Human GRO-alpha (CXCL1), His Tagchm-335 mGRO1/KC Recombinant Mouse GRO/KC (CXCL1)chm-375 rGRO a Recombinant Rat GRO-alpha (CXCL1)chm-309 GRO b Recombinant Human GRO-beta/MIP-2 (CXCL2)chm-356 GRO b His Recombinant Human GRO-beta/MIP-2 (CXCL2) Hischm-338 mGRO b Recombinant Mouse GRO-beta/MIP-2 (CXCL2)chm-372 rGRO b Recombinant Rat GRO-beta/MIP-2 (CXCL2)chm-376 vMIP2 Recombinant Viral Macrophage inflammatory Protein-2chm-310 GRO g Recombinant Human GRO-gamma (CXCL3)chm-244 GRO g His Recombinant Human GRO-gamma (CXCL3), His Tagchm-255 mGRO g Recombinant Mouse GRO-gamma (CXCL3)chm-258 rGRO g Recombinant Rat GRO-gamma (CXCL3)chm-311 HCC 1 Recombinant Human HCC-1 (CCL14)chm-253 HCC 1 His Recombinant Human HCC-1 (CCL14) His Tagchm-312 I 309 Recombinant Human I-309 (CCL1)chm-254 I 309 His Recombinant Human I-309 (CCL1) His Tagchm-231 IL 8 (1-72) Recombinant Human Interleuikin-8 (1-72) (CXCL8)chm-340 pIL 8 Recombinant Porcine Interleuikin-8 (1-72) (CXCL8)chm-327 IL 8 (1-77) Recombinant Human Interleuikin-8 (1-77) (CXCL8)chm-349 IL 8 Pichia Recombinant Human Interleuikin-8 (1-77) (CXCL8) Pichiachm-345 IL 8 (1-77), His Recombinant Human Interleuikin-8 (1-77) (CXCL8), His Tagchm-261 rIL 8 Recombinant Rabbit Interleuikin-8 chm-330 IP 10 Recombinant Human IP-10 (CXCL10)chm-346 IP 10 His Recombinant Human IP-10 (CXCL10), His Tagchm-336 mIP 10 Recombinant Mouse IP-10 (CXCL10)chm-334 I TAC Recombinant Human I-TAC (CXCL11)chm-232 I TAC, His Recombinant Human I-TAC (CXCL11), His Tagchm-314 Lymphotactin Recombinant Human Lymphotactin (XCL1)chm-357 Lymphotactin His Recombinant Human Lymphotactin (XCL1) His Tagchm-271 MCP 1 Recombinant Human Monocyte Chemotactic Protein-1/MCAF (CCL2)chm-246 MCP 1 His Recombinant Human Monocyte Chemotactic Protein-1/MCAF (CCL2), His Tagchm-313 mMCP 1 Recombinant Mouse Monocyte Chemotactic Protein-1 (CCL2)chm-315 rMCP 1 Recombinant Rat Monocyte Chemotactic Protein-1 (CCL2)chm-316 MCP 2 Recombinant Human Monocyte Chemotactic Protein-2 (CCL8)chm-355 mMCP-2 Recombinant Mouse Monocyte Chemotactic Protein-2 (CCL8)

chm-317 MCP 3 Recombinant Human Monocyte Chemotactic Protein-3 (CCL7)chm-318 mMCP 3 Recombinant Mouse Monocyte Chemotactic Protein-3 (CCL7)chm-319 MCP 4 Recombinant Human Monocyte Chemotactic Protein-4 (CCL13)chm-275 MCP 4, His Recombinant Human Monocyte Chemotactic Protein-4 (CCL13), His Tagchm-250 MDC Recombinant Human Macrophage-Derived Chemokine (CCL22) chm-367 MDC His Recombinant Human Macrophage-Derived Chemokine (CCL22) His Tagchm-370 mMDC Recombinant Mouse Macrophage-Derived Chemokine (CCL22) chm-353 MEC Recombinant Human Mucosae-Associated Epithelial Chemokine (CCL28)chm-366 MEC His Recombinant Human Mucosae-Associated Epithelial Chemokine (CCL28) His Tagchm-369 mMEC Recombinant Mouse Mucosae-Associated Epithelial Chemokine (CCL28)chm-333 MIG Recombinant Human MIG (CXCL9)chm-337 rmMIG Recombinant Mouse MIG (CXCL9)chm-233 MIP 1a Recombinant Human Macrophage Inflammatory protein-1 alpha (CCL3)chm-347 MIP 1a, His Recombinant Human Macrophage Inflammatory protein-1 alpha (CCL3), His Tagchm-320 mMIP 1a Recombinant Mouse Macrophage Inflammatory protein-1 alpha (CCL3)chm-343 rMIP 1a Recombinant Rat Macrophage Inflammatory protein-1 alpha (CCL3)chm-276 MIP 1b Recombinant Human Macrophage Inflammatory protein-1 beta (CCL4)chm-321 mMIP 1b Recombinant Mouse Macrophage Inflammatory protein-1 beta (CCL4)chm-257 mMIP-1g Recombinant Mouse Macrophage Inflammatory protein-1 gamma (CCL9)chm-358 MIP 3 Recombinant Human Macrophage Inflammatory protein-3 (CCL23)chm-287 MIP 3b Recombinant Human Macrophage Inflammatory protein-3 beta (CCL19)chm-374 MIP 3, T7 Recombinant Human Macrophage Inflammatory protein-3 (CCL23), T7 Tagchm-341 mMIP 3b Recombinant Mouse Macrophage Inflammatory protein-3 beta (CCL19)chm-351 MIP 3α Recombinant Human Macrophage Inflammatory protein-3 alpha (CCL20)chm-252 MIP 3α His Recombinant Human Macrophage Inflammatory protein-3 alpha (CCL20), His Tagchm-236 mMIP 3α Recombinant Mouse Macrophage Inflammatory protein-3 alpha (CCL20)chm-322 MIP 4 Recombinant Human Macrophage Inflammatory protein-4 (CCL18)chm-339 MIP 4 His Recombinant Human Macrophage Inflammatory protein-4 (CCL18), His-Tagchm-230 MIP 5 Recombinant Human Macrophage Inflammatory protein-5 (CCL15)chm-274 NAP 2 Recombinant Human Neutrophil Activating Protein-2 (CXCL7)chm-234 PF 4 Human Platelet Factor-4 (CXCL4)chm-350 PF 4 Recombinant Human Platelet Factor-4 (CXCL4)chm-243 PF 4 Variant-1 Recombinant Human Platelet Factor-4 (CXCL4) Variant-1chm-245 mPF 4 Recombinant Mouse Platelet Factor-4 (CXCL4)chm-328 Rantes Recombinant Human Rantes (CCL5)chm-361 Rantes His Recombinant Human Rantes (CCL5) His Tagchm-342 rmRantes Recombinant Mouse Rantes (CCL5)chm-352 rRantes Recombinant Rat Rantes (CCL5)chm-262 SDF 1a Recombinant Human Stromal Cell-Derived Factor-1 alpha (CXCL12)chm-241 SDF 1a, His Recombinant Human Stromal Cell-Derived Factor-1 alpha (CXCL12) His-Tagchm-324 mSDF 1a Recombinant Mouse Stromal Cell-Derived Factor-1 alpha (CXCL12)chm-354 rSDF 1a Recombinant Rat Stromal Cell-Derived Factor-1 alpha (CXCL12)chm-325 SDF 1b Recombinant Human Stromal Cell-Derived Factor-1 beta (CXCL12)chm-249 SDF 1b His Recombinant Human Stromal Cell-Derived Factor-1 beta (CXCL12) His Tagchm-326 mSDF 1b Recombinant Mouse Stromal Cell-Derived Factor-1 beta (CXCL12)chm-247 fSDF 1b Recombinant Feline Stromal Cell-Derived Factor-1 beta (CXCL12)chm-248 rSDF 1b Recombinant Rat Stromal Cell-Derived Factor-1 beta (CXCL12)chm-240 TARC Recombinant Human Thymus and Activation Regulated Chemokine (CCL17)chm-359 TARC His Recombinant Human Thymus and Activation Regulated Chemokine (CCL17) His Tagchm-364 TECK Recombinant Human Thymus Expressed Chemokine (CCL25)chm-259 mTECK Recombinant Mouse Thymus Expressed Chemokine (CCL25)hor-279 ACTH Adrenocorticotropic Hormonehor-283 AGRP Recombinant Human Agouti–Related Proteinhor-291 Alarelin Alarelinhor-242 Antide Antidehor-239 Atosiban Human Atosibanhor-255 Buserelin Human Buserelin

hor-277 Cetrorelix Cetrorelixhor-267 CRHBP Recombinant Human Corticotropin Releasing Hormone Binding Proteinhor-270 DDAVP Desmopressinhor-240 Deslorelin Deslorelinhor-307 EDN1 Human Endothelin-1hor-308 EDN2 Human Endothelin-2hor-309 EDN3 Human Endothelin-3hor-302 Elcatonin Elcatoninhor-246 Exenatide Exenatidehor-269 Exendin 4 Recombinant Exendin-4hor-249 FSH Human Follicle Stimulating Hormonehor-253 FSH Recombinant Human Follicle Stimulating Hormonehor-285 pFSH Porcine Follicle Stimulating Hormonehor-276 Ganirelix Ganirelixhor-252 Gastrin Recombinant Human Gastrinhor-235 GHRH Human Growth Hormone Releasing Hormonehor-297 GHRL Human Ghrelinhor-294 GHRL Recombinant Human Ghrelinhor-271 GHRP 2 Human Growth Hormone Releasing Peptide-2hor-298 GHRP 6 Growth Hormone Releasing Peptide-6hor-236 GLP 1 Recombinant Human Glucagon Like Peptide-1 (7-36)hor-284 GLP 1 Human Glucagon Like Peptide-1 (7-36)hor-305 GLP 2 Human Glucagon Like Peptide-2hor-286 Glucagon Glucagonhor-237 Glucagon Recombinant Human Glucagonhor-256 Goserelin Human Goserelinhor-258 GPHA2 Recombinant Human Thyrostimulin Alphahor-257 GPHB5 Recombinant Human Thyrostimulin Betahor-245 GUCA2B Recombinant Human Prouroguanylinhor-250 hCG Human Chorionic Gonadotropinhor-288 Hexarelin Hexarelinhor-244 Histrelin Histrelinhor-303 Inhibin a Recombinant Human Inhibin-Alphahor-293 Inhibin alpha A Chain Recombinant Human Inhibin-Alpha A Chainhor-282 Lanreotide Lanreotidehor-260 Leuprorelin Human Leuprolidehor-268 LHRH Recombinant Human Leutenizing hormone Releasing Hormone (Gonadorelin)hor-261 LHRH Human Leutenizing hormone Releasing Hormone (Gonadorelin)hor-310 pLH Porcine Leutenizing hormone (Gonadorelin)hor-278 Lypressin Lypressinhor-251 MG Human Menopausal Gonadotropinhor-306 MT I Melanotan-Ihor-289 MT II Melanotan-IIhor-248 NAF Human Nafarelinhor-265 OCT Human Octreotidehor-254 OT Human Oxytocinhor-292 OXM Recombinant Human Oxyntomodulinhor-272 PMSG Pregnant Mare Serum Gonadotropinhor-300 Pramlintide Pramlintidehor-304 Procalcitonin Recombinant Human Procalcitoninhor-295 Procalcitonin His Recombinant Human Procalcitonin His Taghor-281 Proguanylin Recombinant Human Proguanylinhor-247 PTH (1-34) Recombinant Human Parathyroid Hormone (1-34)hor-290 PTH (1-34) Human Parathyroid Hormone (1-34)hor-263 PTH (1-84) Recombinant Human Parathyroid Hormone (1-84)hor-266 PTH (7-34) Recombinant Human Parathyroid Hormone (7-34)hor-262 sCalcitonin Salmon Calcitonin Acetate

hor-273 Secretin Human Secretinhor-274 Sincalide Sincalidehor-299 SST Somatostatinhor-259 STC 1 Recombinant Human Stanniocalcin-1 hor-296 STC 2 Recombinant Human Stanniocalcin-2hor-287 Terlipressin Terlipressinhor-243 Thymosin α1 Thymosin-a1 hor-275 Thymosin β4 Thymosin-b4 hor-241 TP 5 Thymopentin hor-264 TRH Human Protirelin (Thyrotropin Releasing Hormone)hor-238 Trp Triptorelinhor-280 Vasopressin Vasopressinenz-008 AASDHPPT Recombinant Human Aminoadipate-Semialdehyde Dehydrogenase-Phosphopantetheinyl Transferaseenz-251 ACAA1 Recombinant Human Acetyl-COA Acyltransferaseenz-294 ACAD8 Recombinant Human Acyl-Coenzyme A Dehydrogenase 8enz-529 ACADM Recombinant Human Acyl-Coenzyme A Dehydrogenase, C-4 to C-12enz-467 ACADS Recombinant Human Acyl-Coenzyme A Dehydrogenase, C-2 to C-3enz-250 ACADVL Recombinant Human Acyl-CoA Dehydrogenase, Very Long Chainenz-295 ACAT2 Recombinant Human Acetyl-Coenzyme A acetyltransferase 2 enz-056 ACO1 Recombinant Human Aconitase-1enz-004 ACOT13 Recombinant Human Acyl-CoA Thioesterase 13enz-408 ACP1 Recombinant Human Acid Phosphatase-1enz-296 ACY1 Recombinant Human AminoAcylase-1 enz-078 ACYP1 Recombinant Human Acylphosphatase 1enz-307 ADAT1 Recombinant Human Adenosine Deaminase tRNA-Specific 1enz-561 ADAT2 Recombinant Human Adenosine Deaminase, tRNA-specific 2enz-532 AHCY Recombinant Human Adenosylhomocysteinaseenz-464 AKR1A1 Recombinant Human Aldo-Keto Reductase Family 1 Member A1enz-390 AKR1B1 Recombinant Human Aldose Reductaseenz-416 AKR1B10 Recombinant Human Aldo-Keto Reductase Family 1 Member B10enz-496 AKR1C1 Recombinant Human Aldo-Keto Reductase Family 1 Member C1enz-406 AKR1C3 Recombinant Human Aldo-Keto Reductase Family 1 Member C3enz-098 AKR1D1 Recombinant Human Aldo-Keto Reductase Family 1 Member D1enz-485 AKR7A2 Recombinant Human Aldo-Keto Reductase Family 7 Member A2enz-484 AKR7A3 Recombinant Human Aldo-Keto Reductase Family 7 Member A3enz-280 ALAT Recombinant Human Alanine Aminotransferaseenz-453 ALDH1A1 Recombinant Human Aldehyde Dehydrogenase 1A1enz-401 ALDH2 Recombinant Human Aldehyde Dehydrogenase 2 enz-479 ALDH3A1 Recombinant Human Aldehyde Dehydrogenase 3 A1enz-567 ALDH5A1 Recombinant Human Aldehyde Dehydrogenase 5 A1enz-486 ALDOA Recombinant Human Aldolase-Aenz-085 ALDOC Recombinant Human Aldolase C Fructose-Bisphosphateenz-112 ALKBH2 Recombinant Human ALKB Alkylation Repair Homolog 2enz-101 ALKBH3 Recombinant Human ALKB Alkylation Repair Homolog 3enz-275 Aminopeptidase Recombinant Aeromonas Aminopeptidaseenz-283 Angiotensin Angiotensinenz-119 ANSA Recombinant E.Coli Cytoplasmic L-asparaginase I enz-349 APC Recombinant Human Activated Protein Cenz-059 APEX1 Recombinant Human APEX nuclease-1enz-487 APRT Recombinant Human Adenine Phosphoribosyltransferaseenz-517 ARG1 Recombinant Human Arginase, Liverenz-526 ARG2 Recombinant Human Arginase Type IIenz-488 ASPH Recombinant Human Aspartate Beta-Hydroxylaseenz-548 ASS1 Recombinant Human Argininosuccinate Synthase 1enz-043 ATP5O Recombinant Human ATP Synthase Subunit O, Mitochondrialenz-353 ATP sulfurylase Yeast Recombinant Yeast Adenosine 5" Triphosphate Sulfurylase enz-046 AUH Recombinant Human AU RNA Binding Protein/Enoyl-CoA Hydratase

enz-358 BACE1 Recombinant Human Beta-Site APP-Cleaving Enzyme 1enz-322 bAlkaline Phosphatase Alkaline Phosphataseenz-563 BAT1 Recombinant Human HLA-B Associated Transcript 1enz-090 BCKDHA Recombinant Human Branched Chain keto Acid Dehydrogenase E1, Alphaenz-084 BCOADC-E2 Recombinant Human 2-Oxo-Acid Dehydrogenase Complex E2enz-060 BDH2 Recombinant Human 3-Hydroxybutyrate Dehydrogenase, Type 2enz-292 BHMT Recombinant Human Betaine-Homocysteine Methyltransferaseenz-018 BLMH Recombinant Human Bleomycin Hydrolaseenz-446 BLVRA Recombinant Human Biliverdin Reductase Aenz-387 BLVRB Recombinant Human Biliverdin Reductase Benz-505 BPGM Recombinant Human 2,3-Bisphosphoglycerate Mutaseenz-061 BPNT1 Recombinant Human 3(2) 5-Bisphosphate Nucleotidase 1enz-055 BPHL Recombinant Human Biphenyl Hydrolase-Like enz-500 CA3 Recombinant Human Carbonic Anhydrase IIIenz-270 CA3 His Recombinant Human Carbonic Anhydrase III, His Tagenz-373 Carbonic Anhydrase 2 Recombinant E.Coli Carbonic Anhydrase 2enz-420 Carbonic Anhydrase 2 Recombinant Human Carbonic Anhydrase 2enz-462 Carbonic Anhydrase-1 Recombinant Human Carbonic Anhydrase-1enz-475 rCarboxypeptidase-B Recombinant Rat Carboxypeptidase-Benz-415 CBR1 Recombinant Human Carbonyl Reductase-1enz-428 CBR3 Recombinant Human Carbonyl Reductase-3enz-022 CBR4 Recombinant Human Carbonyl Reductase-4enz-091 CDC25A Recombinant Human Cell Division Cycle 25Aenz-355 CDC34 Recombinant Cell Division Cycle 34enz-007 CDA Recombinant Human Cytidine Deaminaseenz-449 CDO1 Recombinant Human Cysteine Dioxygenaseenz-031 Chitinase Recombinant Clostridium Paraputrificum Chitinaseenz-032 Chitodextrinase Recombinant Clostridium Botulinum Chitodextrinaseenz-115 CLPP Recombinant Human ClpP Caseinolytic Peptidaseenz-400 COMT Recombinant Human Catechol-O-Methyltransferaseenz-481 CRYZL1 Recombinant Human Quinone Oxidoreductase-like Protein 1enz-110 CTDSP1 Recombinant Human CTD Small Phosphatase 1enz-378 CTSD Recombinant Human Cathepsin-Denz-377 CTSL1 Recombinant Human Cathepsin-Lenz-359 Cyclophilin A Recombinant Human Cyclophilin-Aenz-313 Cyclophilin B Recombinant Human Cyclophilin-Benz-367 Cyclophilin D Recombinant Human Cyclophilin-Denz-383 Cyclophilin E Recombinant Human Cyclophilin-Eenz-463 Cyclophilin G Recombinant Human Cyclophilin-Genz-316 CYP2D6 Recombinant Human Cytochrome P450 2D6enz-425 DAAO Recombinant Human D-Amino Acid Oxidase enz-538 DCTD Recombinant Human dCMP Deaminaseenz-540 DCXR Recombinant Human Dicarbonyl/L-Xylulose Reductaseenz-014 DDAH1 Recombinant Human Dimethylarginine Dimethylaminohydrolase 1enz-527 DDT Recombinant Human D-Dopachrome Tautomeraseenz-102 DECR1 Recombinant Human 2,4-Dienoyl CoA Reductase 1enz-118 DERA Recombinant E.Coli Deoxyribose-Phosphate Aldolase enz-127 DERA 1-259 a.a. Recombinant E.Coli Deoxyribose-Phosphate Aldolase 1-259 a.a.enz-443 DHFR Recombinant Human Dihydrofolate Reductaseenz-069 mDHFR Recombinant Mouse Dihydrofolate Reductaseenz-498 DHPS Recombinant Human Deoxyhypusine Synthaseenz-082 DLAT Recombinant Human Dihydrolipoamide S-Acetyltransferaseenz-502 DLD Recombinant Human Dihydrolipoamide Dehydrogenaseenz-083 DLST Recombinant Human Dihydrolipoamide S-Succinyltransferase enz-318 DMGO Recombinant Dimethylglycine oxidaseenz-319 DNase Recombinant Human Deoxyribonuclease Ienz-417 bDNase Bovine Deoxyribonuclease I

enz-413 Dopa Decarboxylase Recombinant Human Dopa Decarboxylaseenz-375 DPP4 Recombinant Human Dipeptidyl-Peptidase 4enz-382 DPP4 Human Dipeptidyl-Peptidase 4enz-276 DsbA Recombinant Disulfide Oxidoreductaseenz-291 DsbC Recombinant Disulfide Bond Isomeraseenz-568 DUT Recombinant Human Deoxyuridine Triphosphataseenz-281 DUT Recombinant Pyrococcus Fruriosus Deoxyuridine Triphosphataseenz-556 ECHS1 Recombinant Human Enoyl CoA Hydratase, Short chain, 1, Mitochondrialenz-562 ECH1 Recombinant Human Enoyl CoA Hydratase 1, Peroxisomalenz-058 ECOTIN Recombinant E.Coli Ecotinenz-452 ENO1 Recombinant Human Enolase-1enz-324 ENO2 Recombinant Human Neuronal Specific Enolaseenz-371 ENO2 Human Neurone Specific Enolaseenz-298 ENO2, His Recombinant Human Neuronal Specific Enolase, His Tagenz-077 ENOPH1 Recombinant Human Enolase-Phosphatase-1enz-260 Enterokinase Recombinant Human Enteropeptidase/Enterokinase, Light Chainenz-311 bEnterokinase Recombinant Bovine Enteropeptidase/Enterokinaseenz-267 pEnterokinase Porcine Enteropeptidase/Enterokinaseenz-013 MCEE Recombinant Human Methylmalonyl CoA Epimeraseenz-447 Esterase-D Recombinant Human Esterase D,S-Formylglutathione Hydrolaseenz-067 FAHD1 Recombinant Human Fumarylacetoacetate Hydrolase Domain Containing 1enz-111 FARS2 Recombinant Human Phenylalanyl-tRNA Synthetase 2enz-566 FBL Recombinant human Fibrillarinenz-454 FBP1 Recombinant Human Fructose-1,6-Bisphosphatase 1enz-468 FEN1 Recombinant Human Flap Structure-Specific Endonuclease 1enz-374 FKBP1A Recombinant Human FK506 Binding Protein 1Aenz-503 FKBP2 Recombinant Human FK506 Binding Protein 2enz-495 FKBP3 Recombinant Human FK506 Binding Protein 3enz-412 FKBP4 Recombinant Human FK506 Binding Protein 4enz-516 FKBP6 Recombinant Human FK506 Binding Protein 6enz-530 FKBP14 Recombinant Human FK506 Binding Protein 14enz-543 FKBPL Recombinant Human FK506 Binding Protein Likeenz-302 FTCD Recombinant Human Formiminotransferase Cyclodeaminaseenz-395 Fumarase Recombinant Human Fumarate Hydratase enz-048 G3BP1 Recombinant Human GTPase Activating Protein (SH3 domain) Binding Protein 1enz-399 G6PD Recombinant E.coli Glucose-6-Phosphate Dehydrogenaseenz-537 GALE Recombinant Human UDP-Galactose-4-Epimeraseenz-541 GALM Recombinant Human Galactose Mutarotaseenz-460 GAMT Recombinant Human Guanidinoacetate N-Methyltransferaseenz-350 GAPDH Recombinant Human Glyceraldehyde-3-Phosphate Dehydrogenaseenz-542 GCDH Recombinant Human Glutaryl-Coenzyme A Dehydrogenaseenz-062 GGCT Recombinant Human Gamma-Glutamylcyclotransferaseenz-555 GGPS1 Recombinant Human Geranylgeranyl Diphosphate Synthase 1enz-041 GLB1 Recombinant E.coli Galactosidase-Beta 1enz-398 GLO1 Recombinant Human Glyoxalase-Ienz-544 GLUL Recombinant Human Glutamine Synthetaseenz-386 GNMT Recombinant Human Glycine N-Methyltransferase enz-528 GOT1 Recombinant Human Glutamic-Oxaloacetic Transaminase 1enz-282 GPBB Recombinant Human Glycogen Phosphorylaseenz-489 GPD1 Recombinant Human Glycerol-3-Phosphate Dehydrogenase 1 enz-437 GPD2 Recombinant Human Glycerol-3-Phosphate Dehydrogenase 2 enz-430 GPI Recombinant Human Glucose-6-Phosphate Isomeraseenz-391 GLRX1 Recombinant Human Glutaredoxin 1enz-361 GLRX1 Yeast Recombinant Yeast Glutaredoxin 1enz-466 GLRX2 Recombinant Human Glutaredoxin 2enz-360 GLRX2 Recombinant Yeast Glutaredoxin 2enz-482 GLRX3 Recombinant Human Glutaredoxin 3

enz-480 GLRX5 Recombinant Human Glutaredoxin 5enz-557 GMPR2 Recombinant Human Guanosine Monophosphate Reductase 2enz-037 GNPNAT1 Recombinant Human Glucosamine-Phosphate N-Acetyltransferase 1enz-554 GNPDA1 Recombinant Human Glucosamine-6-Phosphate Deaminase 1enz-393 GST Recombinant Glutathione S-Transferase enz-451 GST His Recombinant Glutathione S-Transferase His Tagenz-521 GRHPR Recombinant Human Glyoxylate Reductase/Hydroxypyruvate Reductaseenz-021 GSS Recombinant Human Glutathione Synthetaseenz-469 GSTA1 Recombinant Human Glutathione S-Transferase Alpha 1enz-476 GSTK1 Recombinant Human Glutathione S-Transferase Kappa 1enz-397 mGSTM1 Recombinant Mouse Glutathione S-Transferase M1enz-456 mGSTM1 His Recombinant Mouse Glutathione S-Transferase M1 His-Tagenz-003 GSTM2 Recombinant Human Glutathione S-Transferase MU 2enz-492 GSTM4 Recombinant Human Glutathione S-Transferase MU 4enz-434 GSTO1 Recombinant Human Glutathione S-Transferase Omega 1enz-435 GSTO1 Mutant Recombinant Human Glutathione S-Transferase Omega 1 Mutantenz-427 GSTP1 Recombinant Human Glutathione S-Transferase pi 1enz-429 GSTT1 Recombinant Human Glutathione S-Transferase Theta-1enz-494 GSTZ1 Recombinant Human Glutathione S-Transferase Zeta-1enz-431 GYG1 Recombinant Human Glycogenin-1enz-499 HADH Recombinant Human Hydroxyacyl-Coenzyme A Dehydrogenaseenz-034 HAGH Recombinant Human Hydroxyacylglutathione Hydrolaseenz-001 HARS His Recombinant Human Histidyl-tRNA Synthetase, His Tagenz-268 HARS Recombinant Human Histidyl-tRNA Synthetaseenz-335 HARS Sf9 Recombinant Human Histidyl-tRNA Synthetase Sf9enz-504 HAT1 Recombinant Human Histone Acetyltransferase 1enz-424 HDAC1 Recombinant Human Histone Deacetylase 1 enz-028 HDHD1 Recombinant Human Haloacid Dehalogenase-Like Hydrolase Domain Containing 1enz-038 HDHD2 Recombinant Human Haloacid Dehalogenase-Like Hydrolase Domain Containing 2enz-089 HDHD3 Recombinant Human Haloacid Dehalogenase-Like Hydrolase Domain Containing 3enz-392 HMOX1 Recombinant Human Heme Oxygenase 1enz-478 HMOX2 Recombinant Human Heme Oxygenase 2enz-402 HNMT Recombinant Human Histamine N-Methyltransferaseenz-261 HPA1 Recombinant Human Heparanase-1enz-015 HPD Recombinant Human 4-Hydroxyphenylpyruvate Dioxygenaseenz-564 HPGD Recombinant Human Hydroxyprostaglandin Dehydrogenase 15-(NAD)enz-524 HPRT1 Recombinant Human Hypoxanthine-Guanine Phosphoribosyltransferaseenz-336 HRASLS3 Recombinant Human HRAS-Like Suppressor 3 (PLA2G16)enz-321 HRP Horseradish Peroxidaseenz-108 HSD17B8 Recombinant Human Hydroxysteroid (17-beta) Dehydrogenase 8enz-029 HSD17B14 Recombinant Human Hydroxysteroid (17-beta) Dehydrogenase 14enz-049 HSD17B11 Recombinant Human Hydroxysteroid (17-beta) Dehydrogenase 11enz-546 HTATIP2 Recombinant Human HIV-1 Tat Interactive Protein 2enz-332 HTRA2 Recombinant Human HTRA2enz-289 iCDH Recombinant Isocitrate Dehydrogenaseenz-107 IDI2 Recombinant Human Isopentenyl-Diphosphate Delta Isomerase 2enz-006 IMPA1 Recombinant Human Inositol Monophosphatase 1enz-070 IMPA2 Recombinant Human Inositol Monophosphatase 2enz-525 IMPDH1 Recombinant Human IMP Dehydrogenase 1enz-549 ITPA Recombinant Human Inosine Triphosphataseenz-490 IVD Recombinant Human Isovaleryl Coenzyme A Dehydrogenaseenz-092 KDSR Recombinant Human 3-Ketodihydrosphingosine Reductaseenz-293 KLK1 Recombinant Human Kallikrein-1enz-509 KLK4 Recombinant Human Kallikrein-4enz-510 KLK7 Recombinant Human Kallikrein-7enz-511 KLK11 Recombinant Human Kallikrein-11enz-369 KLOTHO Recombinant Human Klotho

enz-287 L-Asparaginase L-Asparaginaseenz-407 Latexin Recombinant Human Latexinenz-380 LCAT Recombinant Human Lecithin-Cholesterol Acyltransferaseenz-254 LCAT HEK Recombinant Human Lecithin-Cholesterol Acyltransferase, HEKenz-297 LCN2 Recombinant Human Neutrophil Gelatinase Associated Lipocalin/Lipocalin-2enz-064 LCN2 Pichia Recombinant Human Neutrophil Gelatinase Associated Lipocalin/Lipocalin-2, Pichiaenz-491 LDHA Recombinant Human Lactate Dehydrogenase Aenz-279 LDHB Recombinant Lactate Dehydrogenase Benz-539 LDHB Recombinant Human Lactate Dehydrogenase Benz-473 Lipase-A Recombinant Lipase-Aenz-553 Luciferase Recombinant Firefly Luciferin 4-Monooxygenase enz-086 LPL Recombinant Human Lipoprotein Lipaseenz-087 LPL, HEK Recombinant Human Lipoprotein Lipase, HEKenz-565 mLYPLA1 Recombinant Mouse Lysophospholipase Ienz-269 Lysostaphin Recombinant Lysostaphinenz-362 Lysozyme Recombinant Human Lysozymeenz-076 LYPLA2 Recombinant Human Lysophospholipase IIenz-072 M2 Recombinant Human DLAT/DLST/BCOADCenz-440 MAO-B Recombinant Human Monoamine Oxidase Benz-123 MAP Recombinant E.Coli Methionine Aminopeptidaseenz-493 MAT1A Recombinant Human Methionine Adenosyltransferase I, Alphaenz-320 MAT2A Recombinant Human Methionine Adenosyltransferase II, Alphaenz-461 MAT2B Recombinant Human Methionine Adenosyltransferase II, Betaenz-256 MDH1 Recombinant Human Malate Dehydrogenase 1enz-273 MDH1 Recombinant Malate Dehydrogenase 1enz-247 MDH2 Recombinant Human Malate Dehydrogenase 2enz-044 MDP1 Recombinant Human Magnesium-Dependent Phosphatase 1enz-533 MECR Recombinant Human Mitochondrial Trans-2-Enoyl-CoA Reductaseenz-054 METTL1 Recombinant Human Methyltransferase Like 1enz-019 MGLL Recombinant Human Monoglyceride Lipaseenz-389 MGMT Recombinant Human O-6-Methylguanine-DNA Methyltransferaseenz-248 MMAB Recombinant Human Methylmalonic Aciduria Type Benz-310 MMLV RT Recombinant Moloney Mouse Leukemia Virus Reverse Trancscriptaseenz-099 MMP 1 Recombinant Human Matrix Metalloproteinase-1enz-100 MMP 2 Recombinant Human Matrix Metalloproteinase-2enz-284 MMP 3 Recombinant Human Matrix Metalloproteinase-3enz-455 MMP 3 GST Recombinant Human Matrix Metalloproteinase-3 GST-Tagenz-271 MMP 7 Recombinant Human Matrix Metalloproteinase-7enz-301 MMP 8 Recombinant Human Matrix Metalloproteinase-8enz-438 MMP 9 Recombinant Human Matrix Metalloproteinase-9enz-121 rMMP 9 Recombinant Rabbit Matrix Metalloproteinase-9enz-317 MMP 13 Recombinant Human Matrix Metalloproteinase-13enz-334 MPO Recombinant Human Myeloperoxidaseenz-074 MPO Human Myeloperoxidaseenz-124 MSRB Recombinant E.Coli Methionine Sulfoxide Reductase Benz-036 MSRB2 Recombinant Human Methionine Sulfoxide Reductase B2enz-093 MSRB3 Recombinant Human Methionine Sulfoxide Reductase B3enz-096 MTHFS Recombinant Human 5,10-Methenyltetrahydrofolate Synthetase enz-009 NANP Recombinant Human N-Acetylneuraminic Acid Phosphataseenz-024 NANS Recombinant Human N-acetylneuraminic acid synthaseenz-410 NAT6 Recombinant Human N-Acetyltransferase 6enz-421 NDUFS4 Recombinant Human Histidine NADH Dehydrogenase Fe-S Protein 4enz-396 NEDD8 Recombinant Human Neural Precursor Cell Expressed, Developmentally Down-Regulated 8enz-423 NFNB Recombinant E.Coli Dihydropteridine Reductaseenz-039 NIT2 Recombinant Human Nitrilase Family Member 2enz-384 NMNAT1 Recombinant Human Nicotinamide Nucleotide Adenylyltransferase 1enz-068 NMT2 Recombinant Human N-Myristoyltransferase 2

enz-418 NNMT Recombinant Human Nicotinamide N-Methyltransferaseenz-125 NPL Recombinant Human N-acetylneuraminate Pyruvate Lyaseenz-448 NQO1 Recombinant Human NAD(P)H Dehydrogenase Quinone 1enz-515 NQO2 Recombinant Human NAD(P)H Dehydrogenase Quinone 2enz-010 NUDT1 Recombinant Human Nudix Type Motif 1enz-063 NUDT2 Recombinant Human Nudix Type Motif 2enz-071 NUDT3 Recombinant Human Nudix Type Motif 3enz-547 NUDT5 Recombinant Human Nudix Type Motif 5enz-126 NUDT10 Recombinant Human Nudix Type Motif 10enz-053 NUDT16 Recombinant Human Nudix Type Motif 16enz-079 NUDT16L1 Recombinant Human Nudix Type Motif 16 Like-1enz-080 NUDT21 Recombinant Human Nudix Type Motif 21enz-445 OAS1 Recombinant Human 2’-5’ Oligoadenylate Synthetase 1enz-253 OGG1 Recombinant Human 8-Oxoguanine DNA Glycosylaseenz-472 Ornithine Recombinant Human Ornithine Aminotransferaseenz-323 oHYAL 1 Hyaluronidaseenz-252 P4HB Recombinant Human Prolyl 4-Hydroxylase Betaenz-441 PAPP-A Recombinant Human Pregnancy-Associated Plasma Protein-1enz-477 PARP1 Recombinant Human Poly (ADP-Ribose) Polymerase 1enz-552 PCBD1 Recombinant Human Pterin-4-Alpha-Carbinolamine Dehydratase enz-522 PCMT1 Recombinant Human Protein-L-Isoaspartate O-Methyltransferaseenz-483 PDE6D Recombinant Human Phosphodiesterase 6D cGMP-Specific Rod Deltaenz-262 PDI Recombinant Human Protein Disulfide Isomeraseenz-474 PDIA3 Recombinant Human Protein Disulfide Isomerase A3enz-246 PDIA4 Recombinant Human Protein Disulfide Isomerase A4enz-020 PDIA6 Recombinant Human Protein Disulfide Isomerase A6enz-551 PDXP Recombinant Human Pyridoxal Phosphataseenz-531 PECI Recombinant Human Peroxisomal D3,D2-Enoyl-CoA Isomeraseenz-265 Pfu DNA Polymerase Recombinant Pfu DNA Polymeraseenz-337 PGAM1 Recombinant Human Phosphoglycerate Mutase 1enz-501 PGD Recombinant Human Phosphogluconate Dehydrogenaseenz-016 PGLS Recombinant Human 6-Phosphogluconolactonaseenz-363 Phospho1 Recombinant Human Phosphoethanolamine/Phosphocholine Phosphataseenz-012 PHPT1 Recombinant Human Phosphohistidine Phosphatase 1enz-113 PI16 Recombinant Human Peptidase Inhibitor 16enz-331 PIN1 Recombinant Human Peptidyl-Prolyl Cis/Trans Isomerase NIMA-Interacting 1enz-106 PIN4 Recombinant Human Peptidyl-Prolyl Cis/Trans Isomerase NIMA-Interacting 4enz-305 PL 12 Recombinant Human Alanyl t-RNA Synthetaseenz-304 PL 7 Recombinant Human Threonyl t-RNA Synthetaseenz-329 PLA2G10 Recombinant Human Secreted Phospholipase A2-Xenz-330 PLA2G12 Recombinant Human Secreted Phospholipase A2-XIIenz-325 PLA2G1B Recombinant Human Secreted Phospholipase A2-IBenz-290 PLA2G2A Recombinant Human Secreted Phospholipase A2-IIA enz-326 PLA2G2D Recombinant Human Secreted Phospholipase A2-IIDenz-327 PLA2G2E Recombinant Human Secreted Phospholipase A2-IIEenz-328 PLA2G5 Recombinant Human Secreted Phospholipase A2-Venz-436 PLA2G7 Recombinant Human Secreted Phospholipase A2-VIIenz-333 PLAP Recombinant Human Placental Alkaline Phosphatase enz-023 PMM1 Recombinant Human Phosphomannomutase 1enz-002 PMM2 Recombinant Human Phosphomannomutase 2enz-457 PNMT Recombinant Human Phenylethanolamine-N-Methyltransferaseenz-025 PNP Recombinant Human Purine Nucleoside Phosphorylaseenz-030 PNPO Recombinant Human Pyridoxamine 5'-Phosphate Oxidaseenz-299 PON1 Recombinant Human Paraoxonase-1enz-300 PON2 Recombinant Human Paraoxonase-2enz-011 PPCDC Recombinant Human Phosphopantothenoylcysteine Decarboxylaseenz-385 PPIF Recombinant Human Cyclophilin-F

enz-379 PPIH Recombinant Human Cyclophilin-Henz-388 PPIL1 Recombinant Human Peptidylprolyl Isomerase (Cyclophilin)-Like 1enz-497 PPIL2 Recombinant Human Peptidylprolyl Isomerase (Cyclophilin)-Like 2enz-026 PPIL4 Recombinant Human Peptidylprolyl Isomerase (Cyclophilin)-Like 4enz-266 PPK Recombinant Polyphosphate Kinaseenz-368 PPM1G Recombinant Human Protein Phosphatase 1Genz-370 PPP1R14A Recombinant Human Protein Phosphatase-1, Regulatory Subunit-14Aenz-366 PPP1R1A Recombinant Human Protein Phosphatase Inhibitor-1enz-051 PPP3CA Recombinant Human Protein Phosphatase 3, Catalytic subunit, Alpha Isozymeenz-066 PPP3R1 Recombinant Human Protein Phosphatase 3, Regulatory subunit, Alpha Isozymeenz-103 PPP3R2 Recombinant Human Protein Phosphatase 3, Regulatory subunit, Beta Isozymeenz-372 PRDX1 Recombinant Human Peroxiredoxin-1enz-414 PRDX2 Recombinant Human Peroxiredoxin-2enz-419 PRDX3 Recombinant Human Peroxiredoxin-3enz-513 PRDX4 Recombinant Human Peroxiredoxin-4enz-426 PRDX5 Recombinant Human Peroxiredoxin-5enz-432 PRDX6 Recombinant Human Peroxiredoxin-6enz-364 PRMT1 Recombinant Human Protein Arginine Methyltransferase 1enz-365 mPRMT1 Recombinant Mouse Protein Arginine Methyltransferase 1enz-272 ProMatrilysin Recombinant ProMatrix Metalloproteinase-7enz-439 ProMMP 9 Recombinant Human ProMatrix Metalloproteinase-9enz-354 Protease Recombinant Proteaseenz-075 PRTN3 Human Proteinase-3enz-403 PSMA7 Recombinant Human Proteasome Subunit Alpha Type 7enz-405 PSMB1 Recombinant Human Proteasome Subunit Beta Type 1enz-050 PSMB5 Recombinant Human Proteasome Subunit Beta Type 5enz-105 PSMB9 Recombinant Human Proteasome Subunit Beta Type 9enz-404 PSMD10 Recombinant Human Gankyrinenz-109 PTGDS Recombinant Human Prostaglandin D2 Synthase enz-458 PTGES3 Recombinant Human Prostaglandin E Synthase 3enz-052 PTP4A1 Recombinant Human Protein Tyrosine Phosphatase Type IVA Member 1enz-558 PTP4A2 Recombinant Human Protein Tyrosine Phosphatase Type IVA Member 3enz-450 PTP4A3 Recombinant Human Protein Tyrosine Phosphatase Type IVA Member 3enz-471 PTPS Recombinant Human 6-Pyruvoyltetrahydropterin Synthaseenz-045 PTRH2 Recombinant Human Peptidyl-tRNA Hydrolase 2enz-035 PYCR1 Recombinant Human Pyrroline-5-Carboxylate Reductase 1enz-559 QPRT Recombinant Human Quinolinate Phosphoribosyltransferaseenz-459 Rhodanese Recombinant Human Thiosulfate Sulfurtransferaseenz-114 RNMT Recombinant Human RNA (guanine-7-) Methyltransferaseenz-040 RPP30 Recombinant Human Ribonuclease P/MRP 30kDa Subunitenz-523 RRM2 Recombinant Human Ribonucleotide Reductase M2enz-534 SAE1 Recombinant Human SUMO1 Activating Enzyme Subunit 1enz-433 SAT1 Recombinant Human Spermidine/Spermine N1-Acetyltransferase 1enz-465 Seprase Recombinant Human Fibroblast Activation Protein Alpha enz-033 SEPSECS Recombinant Human Selenocysteinyl-tRNA(Sec) synthaseenz-356 SERPINE1 Human Plasminogen Activator Inhibitor-1enz-357 SERPINE1 Recobinant Human Plasminogen Activator Inhibitor-1enz-314 SETD7 Recombinant Human Set7/9 Histone Methyltransferaseenz-376 SKP2 Recombinant Human S-Phase Kinase-Associated Protein 2enz-338 SlyD E.Coli Recombinant E.Coli KBP-Type Peptidyl-Prolyl Cis-Trans Isomeraseenz-520 SORD Recombinant Human Sorbitol Dehydrogenaseenz-411 SPR Recombinant Human Sepiapterin Reductaseenz-027 SRM Recombinant Human Spermidine Synthaseenz-351 LACTB Recombinant Beta Lactamaseenz-088 LACTB, His Recombinant E.Coli Beta Lactamase, His Tagenz-288 Staphylokinase Recombinant Staphylokinaseenz-315 Streptokinase Recombinant Streptokinase

enz-512 SULT2B1 Recombinant Human Sulfotransferase Family, Cytosolic, 2B, Member 1enz-409 SULT1E1 Recombinant Human Estrogen Sulfotransferaseenz-047 SULT1C2 Recombinant Human Sulfotransferase Family, Cytosolic 1C, Member 2enz-257 SURA Recombinant E.Coli Chaperone SURAenz-286 T4 DNA Recombinant T4 DNA Ligaseenz-065 TAF9 Recombinant Human TAF9 RNA Polymerase IIenz-255 TALDO1 Recombinant Human Transaldolaseenz-309 Taq Plus DNA Recombinant Taq Plus DNA Polymeraseenz-308 TaqDNA Recombinant Taq DNA Polymeraseenz-081 TDO2 Recombinant Human Tryptophan 2,3-Dioxygenaseenz-394 TGM2 Recombinant Human Tissue Transglutaminaseenz-303 TGM2 Sf9 Recombinant Human Tissue Transglutaminase, Sf9enz-249 THTPA Recombinant Human Thiamine Triphosphataseenz-442 TIMP1 Recombinant Human Tissue Inhibitor of Metalloprotease 1enz-508 TIMP1 HEK Recombinant Human Tissue Inhibitor of Metalloprotease 1, HEKenz-120 TIMP2 Recombinant Human Tissue Inhibitor of Metalloprotease 2enz-306 TOP1 Recombinant Human DNA Topoisomerase-Ienz-073 TOP1 70kDa Recombinant Human DNA Topoisomerase-I 70kDaenz-519 TP53I3 Recombinant Human Tumor Protein p53 Inducible Protein 3enz-263 tPA Recombinant Human Tissue Plasminogen Activatorenz-017 TPI1 Recombinant Human Triosephosphate Isomerase 1enz-285 TPO Recombinant Human Thyroid Peroxidaseenz-095 TREX2 Recombinant Human Three Prime Repair Exonuclease 2enz-507 TRXR Recombinant E.Coli Thioredoxin Reductaseenz-278 TRXR Recombinant Yeast Thioredoxin Reductase enz-259 TSTA3 Recombinant Human Tissue Specific Transplantation Antigen P35Benz-094 TSTD1 Recombinant Human Thiosulfate Sulfurtransferase Like Domain Containing 1enz-518 TXNRD1 Recombinant Human Thioredoxin Reductase 1enz-042 TXNRD1 161-649 Recombinant Human Thioredoxin Reductase 1 161-649 a.a.enz-470 TYMS Recombinant Human Thymidylate Synthetaseenz-005 TYMP Recombinant Human Thymidine Phosphorylaseenz-514 UBE2A Recombinant Human Ubiquitin Conjugating Enzyme E2Aenz-340 UBE2B Recombinant Human Ubiquitin Conjugating Enzyme E2Benz-346 UBE2C Recombinant Human Ubiquitin Conjugating Enzyme E2Cenz-116 UBE2D1 Recombinant Human Ubiquitin Conjugating Enzyme E2Denz-343 UBE2D3 Recombinant Human Ubiquitin Conjugating Enzyme E2D3enz-341 UBE2I Recombinant Human Ubiquitin-Conjugating Enzyme E2Ienz-274 UBE2I His Recombinant Human Ubiquitin-Conjugating Enzyme E2I , His tagenz-339 UBE2K Recombinant Human Ubiquitin-Conjugating Enzyme E2Kenz-342 UBE2L3 Recombinant Human Ubiquitin-Conjugating Enzyme E2L 3enz-344 UBE2L3 His Recombinant Human Ubiquitin-Conjugating Enzyme E2L 3, His Tagenz-347 UBE2L6 Recombinant Human Ubiquitin Conjugating Enzyme E2L 6enz-345 UBE2M Recombinant Human Ubiquitin Conjugating Enzyme E2Menz-104 UBE2N Recombinant Human Ubiquitin Conjugating Enzyme E2Nenz-444 UBE2S Recombinant Human Ubiquitin Conjugating Enzyme E2Senz-506 UBE2T Recombinant Human Ubiquitin Conjugating Enzyme E2Tenz-550 UBE2V2 Recombinant Human Ubiquitin-Conjugating Enzyme E2 Variant 2enz-117 UBE2W Recombinant Human Ubiquitin Conjugating Enzyme E2Wenz-057 UCHL3 Recombinant Human Ubiquitin Carboxyl-Terminal Esterase L3 enz-097 UCHL5 Recombinant Human Ubiquitin Carboxyl-Terminal Esterase L5enz-535 UGDH Recombinant Human UDP-Glucose Dehydrogenaseenz-381 UMOD Human Uromodulinenz-352 UNG Uracil DNA Glycosylaseenz-560 UPP1 Recombinant Human Typhimurium Uridine phosphorylase enz-348 UPP1 Recombinant Salmonella Typhimurium Uridine phosphorylase enz-258 UPP1 Recombinant E.Coli Uridine phosphorylase enz-277 Urease Recombinant Urease

enz-312 Uricase Recombinant Urate Oxidaseenz-536 UROD Recombinant Human Uroporphyrinogen Decarboxylaseenz-264 Urokinase Human Urokinaseenz-545 WARS Recombinant Human Tryptophanyl-tRNA Synthetaseenz-422 WWOX Recombinant Human WW Domain Containing Oxidoreductasepka-366 ACVR1B Recombinant Human Activin A Receptor, Type IB pka-367 ADK Recombinant Human Adenosine Kinasepka-316 AK1 Recombinant Human Adenylate Kinase 1pka-260 AK2 Recombinant Human Adenylate Kinase 2pka-346 AK3L1 Recombinant Human Adenylate Kinase 3 Like 1pka-267 AK4 Recombinant Human Adenylate Kinase 4pka-305 AKT-1 Recombinant Human AKT1pka-306 ATF-2 Recombinant Human Activating Transcription Factor-2pka-350 AURKA Recombinant Human Aurora Kinase Apka-355 AURKB Recombinant Human Aurora Kinase Bpka-311 CCNC Recombinant Human cyclin-Cpka-364 CCNH Recombinant Human Cyclin-Hpka-362 CDK2AP1 Recombinant Human Cyclin-Dependent Kinase 2 Associated Protein 1pka-325 CDK4 Recombinant Human cyclin-dependent kinase 4pka-310 CDK8 Recombinant Human cyclin-dependent kinase 8pka-336 CDKN3 Recombinant Human Cyclin-Dependent Kinase Inhibitor 3pka-340 c-erbB-2 Recombinant Human c-erbB2 pka-202 cfPKAR-1a Recombinant Protein Kinase A regulatory subunit-1 alphapka-345 CIB1 Recombinant Human Calcium and Integrin Binding 1pka-268 CIB2 Recombinant Human Calcium and Integrin Binding 2pka-323 C-JUN Recombinant Human Jun Proto-Oncogenepka-001 C-JUN (241 a.a.) Recombinant Human Jun Proto-Oncogene (1-241 a.a.)pka-223 CK2b Recombinant Human Casein Kinase 2 beta pka-209 CK2b Active Recombinant Human Casein Kinase 2 beta Activepka-211 CK2h Recombinant Human Casein Kinase 2 Holoenzymepka-258 CKS2 Recombinant Human CDC28 protein kinase 2pka-002 CMPK1 Recombinant Human Cytidine Monophosphate Kinase 1pka-208 CSNK2A1 Recombinant Human Casein Kinase 2 alphapka-225 CSNK2A1 His Recombinant Human Protein kinase Casein Kinase 2 alpha, His Tagpka-317 C-SRC Recombinant Human C-SRCpka-313 DCK Recombinant Human Deoxycytidine Kinasepka-344 EGFR Sf9 Recombinant Human Epidermal Growth Factor Receptor-Sf9 (ErbB1)pka-335 EGFR Sf9 Recombinant Human Epidermal Growth Factor Receptor-Sf9 (ErbB1), Activepka-309 ELK-1 Recombinant Human ELK-1pka-343 ErbB2 Recombinant Human Tyrosine Kinase ErbB-2pka-342 ErbB3 Recombinant Human Tyrosine Kinase ErbB-3pka-004 MAP2K3 Recombinant Human Mitogen-Activated Protein Kinase Kinase 3pka-212 MAPK3 Active Recombinant Human Mitogen-Activated Protein Kinase 3, Active pka-213 MAPK3 Recombinant Human Mitogen-Activated Protein Kinase 3pka-265 MAPK3 His Recombinant Human Mitogen-Activated Protein Kinase 3 His Tagpka-214 MAPK1 Active Recombinant Human Mitogen-Activated Protein Kinase 1, Active pka-215 MAPK1 Recombinant Human Mitogen-Activated Protein Kinase 1pka-360 MAPK1 His Recombinant Human Mitogen-Activated Protein Kinase 1 His Tagpka-312 FAK1 Recombinant Human Active Focal Adhesion Kinasepka-230 FGFR1 Recombinant Human Fibroblast Growth Factor Receptor-1pka-231 FGFR2 Recombinant Human Fibroblast Growth Factor Receptor-2pka-232 FGFR3 Recombinant Human Fibroblast Growth Factor Receptor-3pka-233 FGFR4 Recombinant Human Fibroblast Growth Factor Receptor-4pka-352 Flavokinase Recombinant Human Riboflavin Kinasepka-240 FLT1 Recombinant Human Vascular Endothelial Growth Factor receptor-1pka-234 FLT1 D3 Recombinant Human Vascular Endothelial Growth Factor receptor-1 D1-3pka-338 FLT1 D3 His Recombinant Human Vascular Endothelial Growth Factor receptor-1 D1-3, His Tag

pka-235 FLT1 D4 Recombinant Human Vascular Endothelial Growth Factor receptor-1 D1-4pka-239 FLT1 D5 Recombinant Human Vascular Endothelial Growth Factor receptor-1 D1-5pka-241 FLT1 D7 Recombinant Human Vascular Endothelial Growth Factor receptor-1 D1-7pka-354 FLT1 His Recombinant Human Vascular Endothelial Growth Factor receptor-1 His Tagpka-244 FLT4 Recombinant Human Vascular Endothelial Growth Factor receptor-3pka-245 FLT4 Fc Recombinant Human Vascular Endothelial Growth Factor receptor-3 Fc Chimerapka-264 GALK1 Recombinant Human Galactokinase 1pka-236 GCK Recombinant Human Hexokinase-4pka-266 GUK1 Recombinant Human Guanylate Kinase 1pka-226 HK-1 Recombinant Human Hexokinase-1pka-227 HK-2 Recombinant Human Hexokinase-2pka-229 HK-3 Recombinant Human Hexokinase-3pka-237 IGF-IR Recombinant Human Insulin Like Growth Factor-I Receptorpka-353 ILK1 Recombinant Human Integrin Linked Kinasepka-216 JNK2/SAPK1 Recombinant Human JNK2/SAPK1pka-220 JNK2a-1 Recombinant Human Jun N-terminal kinase 2, alpha 1pka-314 JNK2a-2 Recombinant Human Jun N-terminal kinase 2, alpha 2pka-359 Ketohexokinase Recombinant Human Ketohexokinasepka-252 LYVE-1 Recombinant Human Lymphatic Endothelial Hyluronan Receptor-1pka-349 LYVE-1 (25-235) Recombinant Human Lymphatic Vessel Endothelial Hyaluronic Acid Receptor 1 (25-235)pka-250 LYVE-1 Sf9 Recombinant Human Lymphatic Vessel Endothelial Hyaluronic Acid Receptor 1, Sf9pka-251 mLYVE-1 Sf9 Recombinant Mouse Lymphatic Vessel Endothelial Hyaluronic Acid Receptor 1, Sf9pka-256 MEK1 Recombinant Human Mitogen Activated Kinase Kinase 1pka-337 NCK2 Recombinant Human NCK2pka-363 NME2 Recombinant Human Non-Metastatic Cells 2pka-341 p16-INK4a Recombinant Human Cyclin-Dependent Kinase Inhibitor 2Apka-217 p38a/SAPK2a Recombinant Human p38 alpha/SAPK2 alphapka-259 PAK4 Recombinant Human p21 Activated Kinase 4pka-328 bP85a Recombinant bovine Phosphoinositide 3-kinase a, regulatory subunitpka-327 bPI3Ka Recombinant bovine Phosphoinositide 3-kinase alpha p110a/p85apka-263 PDK1 Recombinant Human Pyruvate Dehydrogenase Kinase Isozyme 1pka-326 PDXK Recombinant Human Pyridoxal Kinasepka-365 PFKM Recombinant Human Phosphofructokinase, Musclepka-351 PGK1 Recombinant Human Phosphoglycerate Kinase 1pka-333 PI3Kb Recombinant Human Phosphoinositide 3-kinase beta P110β/p85apka-330 PI3KdGST Recombinant Human Phosphoinositide 3-kinase p110d/p85apka-329 PI3KgHis Recombinant Human Phosphoinositide 3-kinase p110gpka-331 PI3KγD946GST Recombinant Human Phosphoinositide 3-kinase p110g inactive mutantpka-203 PKACa2/RIa2 Recombinant Protein Kinase A Inactive holoenzyme type 1 alphapka-205 PKACa2/RIIa2 Recombinant Protein Kinase A Inactive holoenzyme type 2 alphapka-206 PKAkt1/PKBa Recombinant Human Protein Kinase Akt1/PKB alpha Active Enzymepka-207 PKAkt1/PKBa Recombinant Human Protein Kinase Akt1/PKB alpha Inactive Enzymepka-204 PKAr-1a Recombinant c-AMP dependant Protein Kinase A regulatory subunit 2 alphapka-218 PKC-a Recombinant Human Protein Kinase C alphapka-318 PKC-b1 Recombinant Human Protein Kinase C beta 1pka-319 PKC-b2 Recombinant Human Protein Kinase C beta 2pka-321 PKC-d Recombinant Human Protein Kinase C deltapka-322 PKC-e Recombinant Human Protein Kinase C epka-320 PKC-g Recombinant Human Protein Kinase C gammapka-324 PKC-q Recombinant Human Protein Kinase C qpka-003 PKIB Recombinant Human Protein Kinase Inhibitor Betapka-307 PKLR Recombinant Human Pyruvate Kinase, Liver and RBCpka-339 PKM2 Recombinant Human Tumour Type M2 Pyruvate Kinase pka-308 PMVK Recombinant Human Phosphomevalonate Kinasepka-228 PPARG Recombinant Human Peroxisome Proliferator Activated Receptor Gammapka-334 PPARG (1-477) Recombinant Human Peroxisome Proliferator Activated Receptor Gamma (1-477)pka-222 PPM1A Recombinant Human Protein Phosphatase 1A Alpha Isoform

pka-201 PRKA1RA Recombinant c-AMP dependant Protein Kinase A regulatory subunit-1 alphapka-200 PRKACA Recombinant c-AMP dependant Protein Kinase A catalytic subunit alphapka-361 PRPS1 Recombinant Human Phosphoribosyl Pyrophosphate Synthetase 1pka-224 PSPH Recombinant Human Phosphoserine Phosphatasepka-219 PTPN1 Recombinant Human Protein Tyrosine Phosphatase Non Receptor Type-1pka-221 PTPN6 Recombinant Human Protein Tyrosine Phosphatase Non Receptor Type-6pka-358 RBKS Recombinant Human Ribokinasepka-356 SKP1 Recombinant Human S-phase Kinase-Associated Protein 1 Isoform Apka-315 STAT1 Recombinant Human Signal Transducer and Activator of Transcription 1pka-261 TGFBR2 Recombinant Human Transforming Growth Factor Beta Receptor IIpka-246 TIE-1 Fc Recombinant Human TIE-1 Fc Chimerapka-247 mTIE-1 Fc Recombinant Mouse TIE-1 Fc Chimerapka-248 TIE-2 Fc Recombinant Human TIE-2 Fc Chimerapka-249 mTIE-2 Fc Recombinant Mouse TIE-2 Fc Chimerapka-255 TPMT Recombinant Human Thiopurine S-methyltransferasepka-332 UCK2 Recombinant Human Uridine-Cytidine Kinase 2pka-242 VEGFR2 Recombinant Human Vascular Endothelial Growth Factor receptor-2pka-243 VEGFR2 Fc Recombinant Human Vascular Endothelial Growth Factor receptor-2 Fc Chimerapka-348 YWHAB Recombinant Human Tyr-3/Trp-5 Monooxygenase Activation Protein, Betapka-253 YWHAE Recombinant Human Tyr-3/Trp-5 Monooxygenase Activation Protein, Epsilonpka-238 YWHAG Recombinant Human Tyr-3/Trp-5 Monooxygenase Activation Protein, Gammapka-262 YWHAG His Recombinant Human Tyr-3/Trp-5 Monooxygenase Activation Protein, Gamma His Tagpka-347 YWHAH Recombinant Human Tyr-3/Trp-5 Monooxygenase Activation Protein, ETApka-254 YWHAQ Recombinant Human Tyr-3/trp-5 Monooxygenase Activation Protein, Taupka-357 Stratifin Recombinant Human Tyr-3/trp-5 Monooxygenase Activation Protein, Sigmapka-257 YWHAZ Recombinant Human Tyr- 3/Trp-5 Mmonooxygenase Activation protein, Zetapka-210 ZMCK2a Recombinant Zea Mays Casein Kinase 2 alphacki-268 CKB Recombinant Human Creatine Kinase Brain cki-274 CKB His Recombinant Human Creatine Kinase Brain, His Tagcki-269 CKMB Type-1 Recombinant Human Creatine Kinase MB Isoenzyme Type-1cki-270 CKMB Type-2 Recombinant Human Creatine Kinase MB Isoenzyme Type-2cki-273 CKM Human Creatine Kinase Muscle cki-271 CKM Type-1 Recombinant Human Creatine Kinase Muscle Type-1cki-272 CKM Type-3 Recombinant Human Creatine Kinase Muscle Type-3pro-407 A1M Human Alpha-1 Microglobulin Proteinpro-551 A2M Human Alpha-2 Macroglobulin Proteinpro-377 ACTG1 Recombinant Human Actin Gamma 1 pro-517 Actin Actinpro-379 ACTL6A Recombinant Human Actin-Like 6Apro-476 ADAM10 Recombinant Human A Disintegrin and Metalloproteinase Domain 10pro-474 ADAM12 Recombinant Human A Disintegrin and Metalloproteinase Domain 12 S Isoformpro-405 ADFP Recombinant Human Adipose Differentiation-Related Proteinpro-169 AES Recombinant Human Amino-Terminal Enhancer of Splitpro-406 AFP Human Alpha Fetoproteinpro-589 Ag85B Recombinant Mycobacterium Tuberculosis major secretory protein Antigen 85Bpro-580 AGR2 Recombinant Human Anterior Gradient Protein 2 Homolog pro-720 AHSP Recombinant Human Alpha Hemoglobin Stabilizing Proteinpro-172 A2LD1 Recombinant Human AIG2-Like Domain 1pro-455 ALK/P80 Recombinant Human ALK-P80pro-518 Alpha Actinin Alpha Actininpro-284 Angiostatin K1-3 Recombinant Human Angiostatin Kringles 1-3pro-604 Angiostatin K1-4 Human Angiostatin Kringles 1-4pro-252 ANP32A Recombinant Human Acidic Nuclear Phosphoprotein 32 Family, Member Apro-679 ANXA1 Recombinant Human Annexin A1pro-777 ANXA2 Recombinant Human Annexin A2pro-765 ANXA3 Recombinant Human Annexin A3pro-766 ANXA4 Recombinant Human Annexin A4

pro-732 ANXA5 Recombinant Human Annexin A5pro-137 ANXA5 Sf9 Recombinant Human Annexin A5, Sf9pro-767 ANXA6 Recombinant Human Annexin A6pro-449 ANXA7 Recombinant Human Annexin A7pro-548 ANXA8 Recombinant Human Annexin A8pro-450 ANXA9 Recombinant Human Annexin A9pro-278 ANXA11 Recombinant Human Annexin A11pro-197 ANXA13 Recombinant Human Annexin A13pro-451 AP2M1 Recombinant Human Assembly Protein Complex 2pro-452 AP3S2 Recombinant Human Assembly Protein Complex 3pro-453 APCS Recombinant Human Amyloid P Componentpro-867 ARF1 Recombinant Human ADP-Ribosylation Factor 1pro-066 ARF4 Recombinant Human ADP-Ribosylation Factor 4pro-032 ARF6 Recombinant Human ADP-Ribosylation Factor 6pro-002 ARHGDIA Recombinant Human Rho GDP Dissociation Inhibitor (GDI) Alphapro-508 ARL1 Recombinant Human ADP-Ribosylation Factor-Like 1pro-074 ARL2 Recombinant Human ADP-Ribosylation Factor-Like 2pro-040 ARL5A Recombinant Human ADP-Ribosylation Factor-Like 5Apro-145 ARPC5 Recombinant Human Actin Related Protein 2/3 Complex, Subunit 5pro-454 ATG5 Recombinant Human Autophagy Related 5pro-325 Apo Transferrin Human Apo Transferrinpro-511 bApo Transferrin Bovine Apo Transferrinpro-285 bAprotinin Bovine Aprotininpro-414 bAprotinin Recombinant Bovine Aprotininpro-790 APTX Recombinant Human Aprataxinpro-274 ARL2BP Recombinant Human ADP-Ribosylation Factor-Like 2 Binding Proteinpro-682 ASF1A Recombinant Human ASF1 Anti-Silencing Function 1 Homolog Apro-393 SNCA Recombinant Human Alpha-Synucleinpro-158 SNCA A30P Recombinant Human Alpha-Synuclein A30Ppro-159 SNCA A53T Recombinant Human Alpha-Synuclein A53Tpro-160 SNCA A30P/A53T Recombinant Human Alpha-Synuclein A30P/A53T pro-161 SNCA Delta-NAC Recombinant Human Alpha-Synuclein Delta-NACpro-162 SNCA NACP112 Recombinant Human Alpha-Synuclein NACP112pro-163 SNCA 61-140 Recombinant Human Alpha-Synuclein 61-140pro-164 SNCA 96-140 Recombinant Human Alpha-Synuclein 96-140pro-165 SNCA 1-60 Recombinant Human Alpha-Synuclein 1-60pro-858 mSNCA Recombinant Mouse Alpha-Synucleinpro-754 ATOX1 Recombinant Human Copper Transport Protein ATOX1 pro-708 ATXN3 Recombinant Human Ataxin-3pro-500 Avidin Avidinpro-446 Avidin-Biotin Modified Affinity Purified Avidin pro-758 BAALC Recombinant Human Brain and Acute Leukemia, Cytoplasmaticpro-817 BAG1 Recombinant Human BCL2-Associated Athanogene 1pro-168 BAG2 Recombinant Human BCL2-Associated Athanogene 2pro-760 BAG3 Recombinant Human BCL2-Associated Athanogene 3pro-119 BATF Recombinant Human Basic Leucine Zipper Transcription Factorpro-388 B2GP1 Recombinant Human Beta 2 Glycoprotein-Ipro-552 B2GP1 Human Beta 2 Glycoprotein-Ipro-337 B2M Recombinant Human Beta 2 Microglobulinpro-859 B2M His Recombinant Human Beta 2 Microglobulin, His Tagpro-553 B2M Human Beta 2 Microglobulinpro-458 BAD Recombinant Human BADpro-607 Batroxobin Recombinant Batroxobinpro-412 mBAX Recombinant Mouse Baxpro-647 mBAX GST Recombinant Mouse Bax GST Tagpro-116 BCAS2 Recombinant Human Breast Carcinoma Amplified Sequence 2pro-630 Bcl-2 Recombinant Human B-Cell Leukemia/Lymphoma 2

pro-631 Bcl-2 -BH1 Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH1pro-632 Bcl-2 -BH2 Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH2pro-633 Bcl-2 -BH3 Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH3pro-411 Bcl-2 -BH4 Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH4pro-683 BCL2 His Recombinant Human B-Cell Lymphoma Protein 2 Alpha, His Tagpro-768 BCL2L2 Recombinant Human BCL2 Like 2pro-634 Bcl-2 -NWGR Recombinant Human B-Cell Leukemia/Lymphoma 2 -NWGRpro-460 Bcl-6 Recombinant Human Bcl-6pro-639 Bcl-XL Recombinant Human B-Cell Leukemia/Lymphoma 2 XL pro-640 Bcl-XL GST Recombinant Human B-Cell Leukemia/Lymphoma 2 XL GST Tagpro-641 Bcl-XL His Recombinant Human B-Cell Leukemia/Lymphoma 2 His Tagpro-627 BID Recombinant Human BH3 Interacting Domain Death Agonistpro-642 mBID Recombinant Mouse BH3 Interacting Domain Death Agonistpro-643 mBID GST Recombinant Mouse BH3 Interacting Domain Death Agonist GSTpro-546 BIN1 Recombinant Human Bridging Integrator 1pro-613 BIRC5 Recombinant Human Survivinpro-612 BIRC7 Recombinant Human Baculoviral IAP Repeat-Containing 7pro-357 Bivalirudin Human Bivalirudin pro-102 BLNK Recombinant Human B-Cell Linkerpro-700 BMF Recombinant Human Bcl2 Modifying Factor, Isoform 3pro-463 BP-1 Recombinant Human BP-1pro-129 BPI Human Bactericidal/Permeability-Increasing Proteinpro-422 BSA Bovine Serum Albuminpro-394 SNCB Recombinant Human Beta-Synucleinpro-279 CALN1 Recombinant Human Calnueron-1pro-257 CARHSP1 Recombinant Human Calcium Regulated Heat Stable Protein 1pro-831 CACYBP Recombinant Human Calcyclin Binding Proteinpro-636 C1QBP Recombinant Human Complement Component 1pro-654 C1QTNF1 Recombinant Human Complement C1q Tumor Necrosis Factor-Related Protein 1pro-133 C1QTNF2 Recombinant Human Complement C1q Tumor Necrosis Factor-Related Protein 2pro-653 C1QTNF3 Recombinant Human Complement C1q Tumor Necrosis Factor-Related Protein 3 pro-655 C1QTNF6 Recombinant Human Complement C1q Tumor Necrosis Factor-Related Protein 6pro-514 C1QTNF7 Recombinant Human Complement C1q Tumor Necrosis Factor-Related Protein 7pro-134 C1QTNF8 Recombinant Human Complement C1q Tumor Necrosis Factor-Related Protein 8pro-135 C1QTNF9 Recombinant Human Complement C1q Tumor Necrosis Factor-Related Protein 9pro-249 C6ORF108 Recombinant Human Chromosome 6 Open Reading Frame 108pro-051 C12ORF5 Recombinant Human Chromosome 12 Open Reading Frame 5pro-193 C14ORF129 Recombinant Human Chromosome 14 Open Reading Frame 129pro-857 CAB39 Recombinant Human Calcium Binding Protein 39pro-211 CABP7 Recombinant Human Calcium Binding Protein 7pro-400 rCALB1 Recombinant Rat Calbindin-1pro-399 S100G Recombinant Rat S100 Calcium Binding Protein Gpro-461 Cadherin-E Recombinant Human Cadherin-Epro-721 CALB1 Recombinant Human Calbindin-1pro-618 CALM2 Recombinant Human Calmodulin-2pro-370 Calmodulin Recombinant Human Calmodulinpro-401 CALB2 Recombinant Human Calbindin-2pro-290 mCALB2 Recombinant Mouse Calbindin-2pro-813 CALR Recombinant Human Calreticulinpro-185 CAPSL Recombinant Human Calcyphosine-Likepro-799 CASQ2 Recombinant Human Calsequestrinpro-410 dCASQ2 Dog Calsequestrin-2pro-696 Calumenin Recombinant Human Calumeninpro-725 CANX Recombinant Human Calnexinpro-759 CAPG Recombinant Human Capping Protein Gelsolin-Likepro-363 CAPN1 Human Calpain-1 Catalytic Subunitpro-330 bCAPN2 Bovine Calpain-2 Catalytic Subunit

pro-117 CAPS Recombinant Human Calcyphosinepro-519 Cardiac Actin Cardiac Actinpro-534 CBFB Recombinant Human Core Binding Factor Betapro-251 CCS Recombinant Human Copper Chaperone for Superoxide Dismutasepro-472 CD11b Recombinant Human CD11bpro-473 CD146 Recombinant Human CD146pro-536 CD14-CHO Recombinant Human CD14 CHO derivedpro-537 mCD14 Recombinant Mouse CD14pro-468 CD2 Recombinant Human CD2pro-470 CD23 Recombinant Human CD23pro-471 CD31 Recombinant Human CD31pro-292 CD34 Recombinant Human CD34pro-482 CD45 Recombinant Human CD45pro-483 CD56 Recombinant Human CD56pro-293 CD68 Recombinant Human CD68pro-486 CD72 Recombinant Human CD72pro-485 CD9 Recombinant Human CD9pro-594 CD95 His Recombinant Human CD95, His Tagpro-294 CD99 Recombinant Human CD99pro-856 CD163 Recombinant Human CD163pro-464 CDC37 Recombinant Human Cell Division Cycle 37pro-140 CDC37, His Recombinant Human Cell Division Cycle 37, His Tagpro-727 CDC42 Recombinant Human Cell Division Cycle 42pro-287 CEA Recombinant Human Carcinoembryonic Antigen pro-433 CEBP-a Recombinant Human CCAAT/enhancer binding protein(C/EBP) Alphapro-434 CEBP-g Recombinant Human CCAAT/enhancer binding protein(C/EBP) Gammapro-389 CENPA Recombinant Human Centromere Protein-Apro-390 CENPB Recombinant Human Centromere Protein-Bpro-060 CETN2 Recombinant Human Centrin-2pro-533 CETN3 Recombinant Human Centrin-3pro-591 CFL1 Recombinant Human Cofilin-1pro-112 CHD4 Recombinant Human Chromodomain Helicase DNA Binding Protein 4pro-692 CHGA Recombinant Human Chromogranin A pro-491 CHGA GST Recombinant Human Chromogranin A GST Tagpro-699 CHGA His Recombinant Human Chromogranin A His Tagpro-824 CHGB Recombinant Human Chromogranin Bpro-503 CHMP2A Recombinant Human Chromatin Modifying Protein 2Apro-847 CHP Recombinant Human Calcium Binding Protein P22pro-701 CITED2 Recombinant Human Cbp/p300-Interacting Transactivator 2pro-203 CLDN4 Recombinant Human Claudin-4pro-833 CLIC1 Recombinant Human Chloride Intracellular Channel 1pro-198 CLIC2 Recombinant Human Chloride Intracellular Channel 2pro-173 CLIC4 Recombinant Human Chloride Intracellular Channel 4pro-387 COL4A3 Recombinant Human Collagen Type IV Alpha 3 pro-837 COL4A3BP Recombinant Human Collagen Type IV Alpha 3 Binding Proteinpro-359 Collagen Recombinant Human Like Collagenpro-479 Collagen-1 Recombinant Human Collagen-1pro-480 Collagen-3 Recombinant Human Collagen-3pro-492 Collagen-VI Recombinant Human Collagen-VIpro-862 COMMD1 Recombinant Human Copper Metabolism Domain Containing 1pro-554 C1q Human Complement Component C1qpro-555 C3c Human Complement Component C3cpro-556 C4c Human Complement Component C4cpro-085 mC5a Recombinant Mouse Complement Component C5apro-132 COMP HEK Recombinant Human Cartilage Oligomeric Matrix Protein, HEKpro-064 COTL1 Recombinant Human Coactosin-Like 1 pro-645 CPLX1 Recombinant Human Complexin-1

pro-710 CRABP1 Recombinant Human Cellular Retinoic Acid Binding Protein 1 pro-637 CRABP2 Recombinant Human Cellular Retinoic Acid binding Protein 2pro-465 CRADD Recombinant Human Caspase and RIP Adapter with Death Domainpro-275 CRK Recombinant Human V-crk Sarcoma Virus CT10 Oncogenepro-063 CRKL Recombinant Human V-crk Sarcoma Virus CT10 Oncogene Homolog (Avian)-Likepro-493 CRMP-1 Recombinant Human Collapsin Response Mediator Protein-1pro-797 CRNN Recombinant Human Cornulinpro-335 CRP Recombinant Human C-Reactive Proteinpro-557 CRP Human C-Reactive Proteinpro-609 CSTB Recombinant Human Cystatin-Bpro-796 CTBP1 Recombinant Human C-Terminal Binding Protein 1pro-850 CTNNBIP1 Recombinant Human Catenin, Beta Interacting Protein 1pro-408 Cyclosporin-A Cyclosporin-Apro-543 CSTA GST Recombinant Human Cystatin-A, GST tagpro-086 CSTA Recombinant Human Cystatin-Apro-504 CSTA His Recombinant Human Cystatin-A His Tagpro-656 Cystatin-C Recombinant Human Cystatin Cpro-413 Cystatin-C Human Cystatin Cpro-597 mCystatin-C Recombinant Mouse Cystatin-Cpro-438 rCystatin-C Recombinant Rat Cystatin Cpro-138 k9Cystatin-C Recombinant Canine Cystatin-Cpro-268 CUL1 Recombinant Human Cullin-1pro-812 CUTA Recombinant Human CutA Divalent Cation Tolerance Homologpro-842 CYGB Recombinant Human Cytoglobinpro-296 D4GDI Recombinant Human D4-GDIpro-832 DBI Recombinant Human Diazepam Binding Inhibitorpro-078 DCUN1D1 Recombinant Human DCN1 Defective in Cullin Neddylation 1 Domain Containing 1 pro-638 DDIT3 Recombinant Human DNA Damage Inducible Transcript 3pro-094 DDIT4 Recombinant Human DNA Damage Inducible Transcript 4pro-520 Desmin Recombinant Human Desminpro-718 DFFA Recombinant Human DNA Fragmentation Factor Subunit Alphapro-673 DKK1 Recombinant Human Dickkopf-Related Protein 1 pro-815 DKK1 HEK Recombinant Human Dickkopf-Related Protein 1 HEKpro-256 DIRAS1 Recombinant Human DIRAS family, GTP-binding RAS-like 1pro-542 DR1 Recombinant Human Down-Regulator of Transcription 1pro-675 DTNBP1 Recombinant Human Dystrobrevin-Binding Protein 1 Isoform C pro-262 DYNLL1 Recombinant Human Dynein Light Chain LC8 Type-1pro-489 DYNLRB1 Recombinant Human Dynein Light Chain Roadblock-Type 1pro-174 DYNLRB2 Recombinant Human Dynein Light Chain Roadblock-Type 2pro-199 EEF1E1 Recombinant Human Eukaryotic Translation Elongation Factor 1 Epsilon 1pro-291 ESAT6 Recombinant Early Secretory Target Mycobacterium Tuberculosispro-343 EBAG9 Recombinant Human Estrogen Receptor Binding Site Associated Antigen 9pro-603 bECGS Bovine Endothelial Mitogenpro-494 EDF1 Recombinant Human Endothelial Differentiation-Related Factor 1 pro-167 EEF1B2 Recombinant Human Eukaryotic Translation Elongation Factor 1 Beta 2pro-170 EEF1D Recombinant Human Eukaryotic Translation Elongation Factor 1 Deltapro-773 EIF1 Recombinant Human Eukaryotic Translation Initiation Factor 1pro-175 EIF1B Recombinant Human Eukaryotic Translation Initiation Factor 1Bpro-253 EIF1AX Recombinant Human Eukaryotic Translation Initiation Factor 1A X-linkedpro-098 EIF1AY Recombinant Human Eukaryotic Translation Initiation Factor 1A Y-linkedpro-209 EIF2B1 Recombinant Human Eukaryotic Translation Initiation Factor 2B Subunit 1 Alphapro-845 EIF2S1 Recombinant Human Eukaryotic Translation Initiation Factor 2 Subunit 1 Alphapro-179 EIF3K Recombinant Human Eukaryotic Translation Initiation Factor 3Kpro-530 EIF4E Recombinant Human Eukaryotic Translation Initiation Factor 4Epro-532 EIF4EBP1 Recombinant Human Eukaryotic Translation Initiation Factor 4E-Binding Protein 1pro-176 EIF4EBP2 Recombinant Human Eukaryotic Translation Initiation Factor 4E-Binding Protein 2pro-674 EIF5A Recombinant Human Eukaryotic Translation Initiation Factor 5A

pro-846 EIF5A2 Recombinant Human Eukaryotic Translation Initiation Factor 5A2pro-281 Eledoisin Eledoisinpro-248 Endostatin Recombinant Human Endostatinpro-376 Enfuvirtide Enfuvirtide T-20pro-772 ENSA Recombinant Human Endosulfine Alphapro-498 EphrinA4 Recombinant Human Ephrin A4pro-496 EphrinB1 Recombinant Human Ephrin B1pro-497 EphrinB3 Recombinant Human Ephrin B3pro-358 Eptifibatide Human Eptifibatidepro-499 ER-a Recombinant Human Estrogen Receptor Alphapro-121 ERH Recombinant Human Enhancer of Rudimentary pro-046 ERP27 Recombinant Human Endoplasmic Reticulum Protein 27pro-547 ERP44 Recombinant Human Endoplasmic Reticulum Protein 44pro-380 E-Selectin Recombinant Human E-Selectinpro-501 ETS1 Recombinant Human C-ets-1 Proteinpro-588 FABP1 Recombinant Human Fatty Acid Binding Protein-1pro-669 FABP2 Recombinant Human Fatty Acid Binding Protein-2pro-340 FABP3 Recombinant Human Fatty Acid Binding Protein-3pro-668 FABP3 His Recombinant Human Fatty Acid Binding Protein-3, His Tagpro-416 FABP4 Recombinant Human Fatty Acid Binding Protein-4pro-566 FABP4 His Recombinant Human Fatty Acid Binding Protein-4, His Tagpro-417 FABP5 Recombinant Human Fatty Acid Binding Protein-5pro-666 FABP5 His Recombinant Human Fatty Acid Binding Protein-5, His Tagpro-649 FABP6 Recombinant Human Fatty Acid Binding Protein-6pro-667 FABP6 His Recombinant Human Fatty Acid Binding Protein-6, His Tagpro-628 FABP7 Recombinant Human Fatty Acid Binding Protein-7pro-661 FABP7 His Recombinant Human Fatty Acid Binding Protein-7, His Tagpro-353 Factor-IX Human Factor IXpro-331 Factor-VIIa Recombinant Human Factor VIIapro-317 Factor-VIII Human Factor VIIIpro-318 Factor-VIII Recombinant Human Factor VIIIpro-733 FADD Recombinant Human Fas-Associated Death Domainpro-139 FAM3B Recombinant Human Family with Sequence Similarity 3, Member Bpro-713 FDX1 Recombinant Human Ferredoxin-1pro-564 Ferritin Human Liver Ferritinpro-658 Ferritin Heavy Recombinant Human Ferritin Heavy Chainpro-650 Ferritin Light Recombinant Human Ferritin Light Chainpro-418 Fetuin-A Human Alpha-2-HS-Glycoproteinpro-828 FHIT Recombinant Human Fragile Histidine Triadpro-297 FHIT, GST Recombinant Human Fragile Histidine Triad, GST Tagpro-448 Fibronectin Human Fibronectinpro-059 bFibronectin Bovine Fibronectinpro-131 rFibronectin Rat Fibronectinpro-521 Filamin Filaminpro-120 FIMC Recombinant E.Coli Chaperone Protein fimCpro-829 FIS1 Recombinant Human Fission-1pro-505 FOS-B Recombinant Human FOS-Bpro-761 Frataxin Recombinant Human Frataxinpro-527 FSCN1 Recombinant Human Fascinpro-622 FUR Recombinant E.Coli Ferric Uptake Regulatorpro-506 Fyn-p59 Recombinant Human Fyn-p59pro-816 FZD1 Recombinant Human Frizzled-1pro-775 GABARAP Recombinant Human Gamma-Aminobutyric Acid Receptor-Associated Proteinpro-048 GABARAPL1 Recombinant Human GABA(A) Receptor-Associated Protein Like 1pro-079 GABARAPL2 Recombinant Human GABA(A) Receptor-Associated Protein Like 2pro-783 GADD45A Recombinant Human Growth Arrest and DNA-Damage-Inducible Alphapro-563 GADD45B Recombinant Human Growth Arrest and DNA-Damage-Inducible Beta

pro-570 GADD45G Recombinant Human Growth Arrest and DNA-Damage-Inducible Gammapro-435 GAGA-POZ Recombinant Drosophila melanogaster GAGA-POZpro-680 GAS7 Recombinant Human Growth Arrest-Specific 7, Isoform bpro-757 GANP Recombinant Human Germinal Center-Associated Nuclear Protein syn-001 GCV Ganciclovirpro-481 Gelatin Recombinant Human Gelatinpro-522 GFP Glial Filament Proteinpro-855 GIPC1 Recombinant Human GIPC PDZ Domain Member 1pro-540 GLC8 Recombinant Yeast GLC8pro-114 Gliadin Recombinant Wheat Gliadinpro-550 GLIPR2 Recombinant Human GLI Pathogenesis-Related 2pro-579 GMNN Recombinant Human Gemininpro-852 GNLY Recombinant Human Granulysinpro-793 GOPC Recombinant Human Golgi-Associated PDZ and Coiled-Coil Motif Containingpro-115 GP2 Recombinant Human Glycoprotein-2pro-080 GCA Recombinant Human Grancalcinpro-081 GRAP2 Recombinant Human GRB2-Related Adaptor Protein 2pro-678 GRB2 Recombinant Human Growth Factor Receptor-Bound Protein 2pro-263 GRPEL1 Recombinant Human GrpE-Like 1pro-395 SNCG Recombinant Human Gamma-Synucleinpro-762 GTF2B Recombinant Human General Transcription Factor IIBpro-567 Haptoglobin Recombinant Human Haptoglobinpro-558 Haptoglobin Human Haptoglobinpro-299 HbA1c Human Hemoglobin A1cpro-803 HBZ Recombinant Human Hemoglobin-Zetapro-559 HDL Human High Density Lipoproteinpro-560 Hemopexin Human Hemopexinpro-789 HEXIM1 Recombinant Human Hexamethylene Bis-Acetamide Inducible 1pro-477 HIF1A Recombinant Human Hypoxia-Inducible Factor-1 Alpha pro-415 HIF1A His Recombinant Human Hypoxia-Inducible Factor-1 Alpha His Tagpro-258 HIF1A (85 a.a.) Recombinant Human Hypoxia-Inducible Factor-1 Alpha (85 a.a.)pro-662 HIF1AN Recombinant Human Hypoxia-Inducible Factor-1 Alpha Inhibitorpro-702 HINT1 Recombinant Human Histidine Triad Nucleotide Binding Protein 1pro-362 Hirudin Recombinant Hirudinpro-581 HMGB1 Recombinant Human High-Mobility Group Box 1pro-610 HMGB1 Hi-5 Recombinant Human High-Mobility Group Box 1 Hi-5 Insect Cellspro-821 HMGN1 Recombinant Human High-Mobility Group Nucleosome Binding Domain 1pro-315 Holo Transferrin Human Holo Transferrinpro-510 bHolo Transferrin Bovine Holo Transferrinpro-695 HOMER1 Recombinant Human Homer Homolog-1pro-177 HNRNPC Recombinant Human Heterogeneous Nuclear Ribonucleoprotein Cpro-254 HPCAL1 Recombinant Human Hippocalcin-Like 1pro-423 HPG1 Recombinant Human Prostate Specific Gene-1 pro-822 HRAS Recombinant Human V-Ha-ras Harvey Rat Sarcoma Viral Oncogene Homologpro-052 HRSP12 Recombinant Human Heat-Responsive Protein 12pro-354 HSA Human Serum Albuminpro-823 HSD17B10 Recombinant Human Hydroxysteroid (17-beta) Dehydrogenase 10pro-039 HUS1 Recombinant Human HUS1 Checkpoint Homolog pro-383 ICAM-1 Recombinant Human Intercellular Adhesion Molecule-1pro-031pro-375 Intrinsic Factor Recombinant Human Intrinsic Factorpro-512 Involucrin Recombinant Human Involucrinpro-436 IPP-POZ Recombinant Human IPP-POZpro-513 IRF4 Recombinant Human IRF4 / MUM-1pro-072 ISCU Recombinant Human Iron-sulfur Cluster Scaffold Homolog pro-611 ISG15 Recombinant Human Interferon Stimulated Gene 15pro-192 KAAG1 Recombinant Human Kidney Associated Antigen 1

Internalin  Recombinant Listeria Monocytogenes Internalin 

pro-009 KCNIP3 Recombinant Human Kv Channel Interacting Protein 3pro-428 KIR2DL1 Recombinant Human Killer Cell Immunoglobulin-Like Receptor, 2 Domains Long Cytoplasmic Tail 1pro-429 KIR2DL3 Recombinant Human Killer Cell Immunoglobulin-Like Receptor, 2 Domains Long Cytoplasmic Tail 3pro-430 KIR2DS4 Recombinant Human Killer Cell Immunoglobulin-Like Receptor, 2 Domains Short Cytoplasmic Tail 4pro-427 KIR3DL1 Recombinant Human Killer Cell Immunoglobulin-Like Receptor, 3 Domains Long Cytoplasmic Tail 1pro-419 KISS1 Recombinant Human KISS-1 Metastasis-Suppressorpro-854 KRAS Recombinant Human Kirsten Rat Sarcoma Viral Oncogene pro-348 KRT14 Recombinant Human Cytokeratin 14pro-349 KRT18 Recombinant Human Cytokeratin 18pro-484 KRT18 His Recombinant Human Cytokeratin 18 His Tagpro-350 KRT19 Recombinant Human Cytokeratin 19pro-351 KRT20 Recombinant Human Cytokeratin 20pro-347 KRT8 Recombinant Human Cytokeratin 8pro-298 KRT8 GST Recombinant Human Cytokeratin 8 GST-Tagpro-397 Ku P70/P80 Recombinant Human Ku P70/P80pro-327 LA/SS-B Recombinant Human LA / SS-Bpro-431 LAIR1 Recombinant Human Leukocyte-Associated Ig-Like Receptor 1pro-690 Lamin-A Recombinant Lamin-Apro-130 LAMP2 Recombinant Human Lysosomal-Associated Membrane Protein 2pro-538 LBP Recombinant Human Lipopolysaccarid Binding Proteinpro-539 mLBP Recombinant Mouse Lipopolysaccarid Binding Proteinpro-562 LDL Low Density Lipoproteinpro-743 LIN28 Recombinant Human LIN28pro-561 LLC Human Lambda Light Chainpro-320 LLO Recombinant Listeriolysin-Opro-373 LLO-pest Recombinant Listeriolysin-O PEST-freepro-381 L-Selectin Recombinant Human L-Selectinpro-259 LSM1 Recombinant Human LSM1 Homolog, U6 Small Nuclear RNA Associated pro-065 LSM4 Recombinant Human LSM4 Homolog, U6 Small Nuclear RNA Associated pro-593 LTF Apo Recombinant Human Lactoferrin Apopro-592 LTF Holo Recombinant Human Lactoferrin Holopro-141 LRG1 Human Leucine-Rich Alpha-2-Glycoprotein 1pro-746 LYN Recombinant Human Tyrosine-Protein Kinase LYNpro-311 MAGEA1 Recombinant Human Melanoma Antigen Family A, 1pro-502 MAGEA3 Recombinant Human Melanoma Antigen Family A, 3pro-843 MAGEA4 Recombinant Human Melanoma Antigen Family A, 4pro-810 MAGOH Recombinant Human Mago-Nashi Homologpro-515 SCGB2A2 Recombinant Human Mammaglobin-Apro-034 MAPKSP1 Recombinant Human MAPK Scaffold Protein 1pro-495 MAP1LC3A Recombinant Human Microtubule-Associated Protein 1 Light Chain 3 Alpha pro-076 MAP1LC3B Recombinant Human Microtubule-Associated Protein 1 Light Chain 3 Betapro-295 MAPT Recombinant Human Microtubule-Associated Protein Tau pro-210 MAPT 412a.a. Recombinant Human Microtubule-Associated Protein Tau 412 a.a.pro-012 MAPT 383a.a. Recombinant Human Microtubule-Associated Protein Tau 383 a.a.pro-042 MAPT 381a.a. Recombinant Human Microtubule-Associated Protein Tau 381 a.a.pro-058 MAPRE1 Recombinant Human Microtubule-Associated Protein, RP/EB Family, Member 1pro-264 MAPRE3 Recombinant Human Microtubule-Associated Protein, RP/EB Family, Member 3pro-811 MAX Recombinant Human MYC Associated Factor Xpro-616 MBP Recombinant E.Coli Maltose Binding Proteinpro-769 MCFD2 Recombinant Human Multiple Coagulation Factor Deficiency 2pro-212 MECP2 Recombinant Human Methyl CpG Binding Protein 2pro-785 MED4 Recombinant Human Mediator Complex Subunit 4pro-509 Melanoma Recombinant Human Melanoma (gp100)pro-122 MESDC2 Recombinant Human Mesoderm Development Candidate 2pro-207 MET Recombinant Human Met Proto-Oncogenepro-367 MICA Recombinant Human MHC class I chain-related gene Apro-368 MICB Recombinant Human MHC class I chain-related gene B

pro-516 MITF Recombinant Human Microphtalmiapro-100 MLF1 Recombinant Human Myeloid Leukemia Factor 1pro-526 MLH1 Recombinant Human MutL Homolog-1pro-763 MNDA Recombinant Human Myeloid Cell Nuclear Differentiation Antigen pro-049 MOBLK3 Recombinant Human MOB1, Mps One Binder Kinase Activator-Like 3 pro-068 MOBKL1B Recombinant Human MOB1, Mps One Binder Kinase Activator-Like 1Bpro-371 MOG Myelin Oligodendrocyte Glycoproteinpro-466 MOG Recombinant Human Myelin Oligodendrocyte Glycoproteinpro-475 MORF4L2 Recombinant Human Mortality Factor 4 Like 2pro-795 M.Pneumoniae Recombinant Mycoplasma Pneumoniae P1-N2pro-801 M.Pneumoniae Recombinant Mycoplasma Pneumoniae P1-Cpro-087 MYC Recombinant Human V-Myc Myelocytomatosis Viral Oncogenepro-365 MYL1 Recombinant Human Myosin Light Chain 1pro-524 MYL2 Recombinant Human Myosin Light Chain 2 pro-171 MYL6 Recombinant Human Myosin Light Chain 6pro-107 MYL9 Recombinant Human Myosin Light Chain 9 pro-336 Myoglobin Recombinant Human Myoglobinpro-071 Myoglobin His Recombinant Human Myoglobin, His Tagpro-565 Myoglobin Human Myoglobinpro-374 Myoglobin heme free Recombinant Human Myoglobin Heme freepro-090 NANOG Recombinant Human Nanogpro-250 NAPA Recombinant Human N-Ethylmaleimide-Sensitive Factor Attachment Protein, Alphapro-093 NCALD Recombinant Human Neurocalcin Deltapro-265 NCBP2 Recombinant Human Nuclear Cap Binding Protein Subunit 2pro-488 NCF1 Recombinant Human Neutrophil Cytosolic Factor 1pro-839 NCK1 Recombinant Human NCK Adaptor Protein 1pro-802 NCS1 Recombinant Human Neuronal Calcium Sensor 1pro-204 NDE1 Recombinant Human nudE Nuclear Distribution Gene E Homolog 1pro-724 NDRG1 Recombinant Human N-Myc Downstream Regulated 1pro-180 NECAP2 Recombinant Human NECAP Endocytosis Associated 2pro-523 bNEFM Bovine Neurofilament Medium Polypeptide pro-067 NHP2 Recombinant Human NHP2 Ribonucleoprotein Homologpro-038 NHP2L1 Recombinant Human NHP2 Non-Histone Chromosome Protein 2-Likepro-780 NIP7 Recombinant Human Nuclear Import 7 Homologpro-432 NKp46 Recombinant Human Natural Cytotoxicity Receptor NKp46pro-715 NME1 Recombinant Human Non-Metastatic Cells 1pro-082 NME3 Recombinant Human Non-Metastatic Cells 3pro-070 NMI Recombinant Human N-Myc Interactorpro-366 NMM Recombinant Human Non-Muscle Myosin-II Regulatory Light Chainpro-869 NR1H2 Recombinant Human Nuclear Receptor Subfamily 1 Group H, Member 2pro-794 NRAS Recombinant Human Neuroblastoma RAS Viral Oncogene Homologpro-827 NTAL Recombinant Human Non-T-cell Activation Linkerpro-142 NUCB2 Recombinant Human Nucleobindin-2pro-605 mNUCB2 Recombinant Mouse Nucleobindin-2pro-623 NusA Recombinant E.Coli Transcription Termination/Antitermination L Factorpro-109 NUP210 Recombinant Human Nucleopurin 210kDapro-844 NUTF2 Recombinant Human Nuclear Transport Factor 2pro-531 NY-ESO-1 Recombinant Human New York Esophageal Squamous Cell Carcinoma pro-571 OmpA Recombinant Bacterial Outer Membrane Protein-A pro-369 Omp Pylori Recombinant Helicobacter Pylori Outer Membrane Proteinpro-143 OCM Recombinant Human Oncomodulin-1pro-420 Osteocrin Recombinant Human Osteocrinpro-711 OTUB1 Recombinant Human Ubiquitin Aldehyde Binding 1pro-310 P504s Recombinant Human P504/alpha Methylacyl CoA Racemasepro-302 p53 Recombinant Human p53pro-742 p53 GST Recombinant Human p53 GST-Tagpro-301 p53 Mutant Recombinant Human p53 Mutant

pro-782 PA2G4 Recombinant Human Proliferation-associated protein 2G4pro-748 PAIP2 Recombinant Human Polyadenylate-Binding Protein-Interacting Protein 2pro-575 PARK7 Recombinant Human Parkinson Disease Protein 7pro-004 PVALB Recombinant Human Parvalbuminpro-398 rPVALB Recombinant Rat Parvalbuminpro-744 Paxillin Recombinant Human Paxillinpro-010 PBLD Recombinant Human Phenazine Biosynthesis-Like Protein Domain Containingpro-615 PCNA Recombinant Human Proliferating Cell Antigenpro-741 PCNA GST Recombinant Human Proliferating Cell Antigen, GST Tagpro-303 PCNA Sf9 Recombinant Human Proliferating Cell Antigen, S9pro-490 PDAP1 Recombinant Human PDGFA Associated Protein 1pro-736 PDCD1LG2 Recombinant Human Programmed Cell Death 1 Ligand 2pro-606 PDCD4 Recombinant Human ProgrammedCell Death 4pro-624 PDCD5 Recombinant Human Programmed Cell Death 5pro-184 PDCD6 Recombinant Human Programmed Cell Death 6pro-792 PDCD6IP Recombinant Human ProgrammedCell Death 6 Interacting Proteinpro-626 PDPN Recombinant Human Podoplaninpro-007 PDRG1 Recombinant Human p53 and DNA-Damage Regulated 1pro-729 PEA15 Recombinant Human Phosphoprotein Enriched in Astrocytes 15pro-722 PEBP1 Recombinant Human Phosphatidylethanolamine Binding Protein 1 pro-099 PEF1 Recombinant Human Penta-EF-Hand Domain Containing 1pro-360 PEX Recombinant Human C-terminal hemopexin-like domain of MMP-2 (445-635 a.a.)pro-277 PFDN1 Recombinant Human Prefoldin Subunit 1pro-001 PFDN2 Recombinant Human Prefoldin Subunit 2pro-092 PFDN4 Recombinant Human Prefoldin Subunit 4pro-178 PFDN6 Recombinant Human Prefoldin Subunit 6pro-528 PFN1 Recombinant Human Profilin-1pro-809 PFN2 Recombinant Human Profilin-2pro-818 PFN4 Recombinant Human Profilin-4pro-576 PGP9.5 Recombinant Human Ubiquitin Carboxyl-Terminal Hydrolase L1 pro-304 PGP9.5 GST Recombinant Human Ubiquitin Carboxyl-Terminal Hydrolase L1 GST tagpro-535 PGR Recombinant Human Progesterone Receptor pro-781 PHLDA2 Recombinant Human Pleckstrin Homology-Like Domain Family A Member 2pro-693 PINX1 Recombinant Human PIN2-Interacting Protein 1pro-003 PITPNB Recombinant Human Phosphatidylinositol Transfer Protein, Betapro-044 PITPNA Recombinant Human Phosphatidylinositol Transfer Protein, Alphapro-126 EXOSC9 Recombinant Human Exosome Component 9pro-444 EXOSC10 Recombinant Human Exosome Component 10pro-651 PMP2 Recombinant Human Peripheral Myelin Protein-2pro-671 PMP2 His Recombinant Human Peripheral Myelin Protein-2, His Tagpro-088 POU5F1 Recombinant Human POU Class 5 Homeobox 1pro-091 POU5F1 PolyR Recombinant Human POU Class 5 Homeobox 1 Polyarginine-Tagpro-771 Prealbumin Recombinant Human Transthyretinpro-689 Prelamin-A Recombinant Prelamin-Apro-646 Protein-A/G Recombinant Protein A/Gpro-402 Protein-G Recombinant Protein Gpro-439 Prothrombin Human Prothrombin Complexpro-382 P-Selectin Recombinant Human P-Selectinpro-740 PSMA Recombinant Human Prostate Specific Membrane Antigen pro-266 PSME1 Recombinant Human Proteasome Activator Subunit 1pro-261 PSMG3 Recombinant Human Proteasome Assembly Chaperone 3pro-598 PSP94 Recombinant Human Beta-Microseminoproteinpro-305 PTEN Recombinant Human Phosphatase and Tensin Homolog pro-712 PTEN His Recombinant Human Phosphatase and Tensin homolog His Tagpro-316 PTGDS Recombinant Human Beta-Tracepro-717 PTTG1 Recombinant Human Pituitary Tumor-Transforming Protein 1 pro-694 PTX3 Recombinant Human Pentraxin-3

pro-097 RAB1A Recombinant Human RAB1A, Member RAS Oncogene Familypro-045 RAB1B Recombinant Human RAB1B, Member RAS Oncogene Familypro-590 RAB5A Recombinant Human RAB5A, Member RAS Oncogene Familypro-056 RAB5B Recombinant Human RAB5B, Member RAS Oncogene Familypro-047 RAB6A Recombinant Human RAB6A, Member RAS Oncogene Familypro-103 RAB6B Recombinant Human RAB6B, Member RAS Oncogene Familypro-077 RAB7A Recombinant Human RAB7A, Member RAS Oncogene Familypro-826 RAB11A Recombinant Human RAB11A, Member RAS Oncogene Familypro-101 RAB21 Recombinant Human RAB21, Member RAS Oncogene Familypro-825 RAB27A Recombinant Human RAB27A, Member RAS Oncogene Familypro-075 RAB27B Recombinant Human RAB27B, Member RAS Oncogene Familypro-300 RABIF Recombinant Human RAB Interacting Factorpro-572 RAC1 Recombinant Human Ras-Related C3 Botulinum Toxin substrate 1pro-731 RAC1 His Recombinant Human Ras-Related C3 Botulinum Toxin substrate 1 His Tagpro-619 RAC2 Recombinant Human Ras-Related C3 Botulinum Toxin Substrate 2pro-719 RAC2 (189) Recombinant Human Ras-Related C3 Botulinum Toxin Substrate 2 (1-189)pro-073 RAC3 Recombinant Human Ras-Related C3 Botulinum Toxin Substrate 3pro-868 RAD1 Recombinant Human RAD1 pro-043 RALA Recombinant Human V-ral Simian Leukemia Viral Oncogene Homolog Apro-053 RALB Recombinant Human V-ral Simian Leukemia Viral Oncogene Homolog Bpro-841 RAN Recombinant Human RAN, Member RAS Oncogene Familypro-848 RAP1A Recombinant Human RAP1A, Member RAS Oncogene Familypro-083 RAP1B Recombinant Human RAP1B, Member RAS Oncogene Familypro-061 RAP2A Recombinant Human RAP2A, Member RAS Oncogene Familypro-352 rRAP Recombinant Rat Receptor Associated Proteinpro-596 RARA Recombinant Retnoid Acid Receptor Alphapro-788 RARRES2 Recombinant Human Retinoic Acid Receptor Responder 2pro-584 RB1 Recombinant Human Retinoblastoma Associated Proteinpro-186 RBM8A Recombinant Human RNA Binding Motif Protein 8Apro-319 RCAN1 Recombinant Human Regulator of Calcineurin 1pro-544 RCN1 Recombinant Human Reticulocalbin 1pro-189 RCN2 Recombinant Human Reticulocalbin 2pro-441 RCVRN Recombinant Human Recoverinpro-181 RDBP Recombinant Human RD RNA Binding Proteinpro-289 REG1A Recombinant Human Regenerating Islet-Derived 1 Alphapro-391 REG1B Recombinant Human Regenerating Islet-Derived 1 Betapro-424 REG4 Recombinant Human Regenerating Islet-Derived 4pro-421 REG3A Recombinant Human Regenerating Islet-Derived 3 Alphapro-106 RERG Recombinant Human RAS-like, Estrogen-Regulated, Growth Inhibitorpro-687 rGFP Recombinant Green Fluorescent Proteinpro-182 RGS2 Recombinant Human Regulator of G-Protein Signaling 2pro-798 RGS16 Recombinant Human Regulator of G-Protein Signaling 16pro-037 RGS19 Recombinant Human Regulator of G-Protein Signaling 19pro-308 RHEB Recombinant Human Ras Homolog Enriched in Brainpro-057 RHOA Recombinant Human Ras Homolog Gene Family Member Apro-865 RHOC Recombinant Human Ras Homolog Gene Family Member Cpro-190 RHOD Recombinant Human Ras Homolog Gene Family Member Dpro-332 rHSA Recombinant Human Serum Albuminpro-595 rHSA Recombinant Human Serum Albumin, Plant pro-487 RND3 Recombinant Human Rho Family GTPase 3pro-206 RORC Recombinant Human RAR-Related Orphan Receptor Cpro-328 ROSS52 Recombinant Human RO-52/SS-Apro-329 TROVE2 Recombinant Human TROVE Domain Family Member 2pro-110 TROVE2 His Recombinant Human TROVE Domain Family Member 2 His Tagpro-111 bTROVE2 Bovine TROVE Domain Family, Member 2pro-011 RPA2 Recombinant Human Replication Protein A2pro-050 ROBLD3 Recombinant Human Roadblock Domain Containing 3

pro-392 RPLP0 Recombinant Human Ribosomal Phosphoprotein P0pro-127 RPLP1 Recombinant Human Ribosomal Phosphoprotein P1pro-128 RPLP2 Recombinant Human Ribosomal Phosphoprotein P2pro-118 RPS14 Recombinant Human Ribosomal Protein S14pro-008 RQCD1 Recombinant Human RCD1 Required for Cell Differentiation1 pro-808 RRAS Recombinant Human Related RAS Viral (r-ras) Oncogene Homolog pro-728 RRAS2 Recombinant Human Related RAS Viral (r-ras) Oncogene Homolog 2pro-323 rTroponin-C Rabbit Skeletal Muscle Troponin-Cpro-836 RUNX3 Recombinant Human Runt-Related Transcription Factor 3pro-861 RUVBL1 Recombinant Human RuvB-Like 1pro-437 RXRA Recombinant Human Retinoid X Receptor Alphapro-364 S100A1 Recombinant Human S100 Calcium Binding Protein A1pro-146 S100A2 Recombinant Human S100 Calcium Binding Protein A2pro-755 S100A3 Recombinant Human S100 Calcium Binding Protein A3pro-307 S100A4 Recombinant Human S100 Calcium Binding Protein A4pro-698 S100A4 His Recombinant Human S100 Calcium Binding Protein A4 His Tagpro-147 S100A5 Recombinant Human S100 Calcium Binding Protein A5pro-148 S100A6 Recombinant Human S100 Calcium Binding Protein A6pro-409 mS100A6 Mouse S100 Calcium Binding Protein A6pro-149 S100A7 Recombinant Human S100 Calcium Binding Protein A7pro-756 S100A7A Recombinant Human S100 Calcium Binding Protein A7Apro-800 S100A8 Recombinant Human S100 Calcium Binding Protein A8pro-150 S100A8, His Recombinant Human S100 Calcium Binding Protein A8, His Tagpro-814 S100A9 Recombinant Human S100 Calcium Binding Protein A9pro-151 S100A9, His Recombinant Human S100 Calcium Binding Protein A9, His Tagpro-384 S100A10 Recombinant Human S100 Calcium Binding Protein A10pro-385 S100A11 Recombinant Human S100 Calcium Binding Protein A11pro-152 S100A12 Recombinant Human S100 Calcium Binding Protein A12pro-153 S100A13 Recombinant Human S100 Calcium Binding Protein A13pro-154 S100A14 Recombinant Human S100 Calcium Binding Protein A14pro-155 S100A16 Recombinant Human S100 Calcium Binding Protein A16pro-306 S100b Recombinant Human S100 Calcium Binding Protein Bpro-737 S100b GST Recombinant Human S100 Calcium Binding Protein B, GST Tagpro-853 mS100b Recombinant Mouse S100 Calcium Binding Protein Bpro-156 S100G Recombinant Human S100 Calcium Binding Protein Gpro-425 S100P Recombinant Human S100 Calcium Binding Protein Ppro-830 S100P His Recombinant Human S100 Calcium Binding Protein P, His Tagpro-426 S100Z Recombinant Human S100 Calcium Binding Protein Zpro-840 S100Z, His Recombinant HumanS100 Calcium Binding Protein Z, His Tagpro-707 SAP18 Recombinant Human Sin3A-Associated Protein, 18kDapro-709 SAR1A Recombinant Human GTP-Binding Protein SAR1Apro-272 SBDS Recombinant Human Shwachman-Bodian-Diamond Syndromepro-269 SCAND1 Recombinant Human SCAN domain containing 1pro-467 SCG5 Recombinant Human Secretogranin Vpro-599 SCGN Recombinant Human Secretagoginpro-657 rSCGN Recombinant Rat Secretagoginpro-054 SCO2 Recombinant Human SCO Cytochrome Oxidase Deficient Homolog 2pro-697 SecB Recombinant Protein Export Protein SecBpro-194 SEC13 Recombinant Human SEC13pro-255 Sep-02 Recombinant Human Septin-2pro-260 SEPX1 Recombinant Human Selenoprotein X 1pro-456 SERPINA1 Human Alpha-1 Antitrypsinpro-529 SERPINA1 Recombinant Human Alpha-1 Antitrypsinpro-750 SERPINA3 Recombinant Human Alpha-1 AntiChymotrypsinpro-378 SERPINA3 Human Alpha-1 AntiChymotrypsinpro-749 SERPINA5 Recombinant Human Serpin Peptidase Inhibitor, Clade A Member 5pro-202 SERPINB5 Recombinant Human Serpin Peptidase Inhibitor, Clade B Member 5

pro-704 SERPINB5 His Recombinant Human Serpin Peptidase Inhibitor, Clade B Member 5, His Tagpro-105 SF3B14 Recombinant Human Splicing Factor 3B, 14 kDa Subunit pro-807 SGTA Recombinant Human Small Glutamine-Rich Tetratricopeptide Repeat-Containing Protein Alphapro-006 SH2D1A Recombinant Human SH2 domain containing 1Apro-033 SIRT2 Recombinant Human SIrtuin-2pro-462 SIRT3 Recombinant Human SIrtuin-3pro-282 SIRT6 Recombinant Human SIrtuin-6pro-688 SLC4A4 Recombinant Human Solute Carrier Family 4, Sodium Bicarbonate Cotransporter, Member 4pro-849 SLPI Recombinant Human Secretory Leukocyte Peptidase Inhibitorpro-614 SMAC/DIABLO Recombinant Human SMAC/DIABLOpro-691 SMAD2 Recombinant Human SMAD Family Member 2pro-751 SMAD3 Recombinant Human Mothers Against Decapentaplegic Homolog 3pro-459 SMAD4 Recombinant Human Mothers Against Decapentaplegic Homolog 4pro-035 SMNDC1 Recombinant Human Survival Motor Neuron Domain Containing 1pro-659 SNAP23 Recombinant Human Synaptosomal-associated protein 23kDapro-573 SNAP25 Recombinant Human Synaptosomal-associated protein 25kDapro-396 SNAP-25 Recombinant Synaptosomal-associated protein 25kDa, C.eleganspro-635 SNAP25B Recombinant Human Synaptosomal-associated protein 25Bpro-663 SNAPIN Recombinant Human SNAP Associated Protein pro-201 SNIP1 Recombinant Human Smad Nuclear Interacting Protein 1pro-545 SNPH Recombinant Human Syntaphilinpro-123 SNRPD2 Recombinant Human Small Nuclear Ribonucleoprotein Polypeptide D2pro-041 SNRPF Recombinant Human Small Nuclear Ribonucleoprotein Polypeptide Fpro-104 SNRPE Recombinant Human Small Nuclear Ribonucleoprotein Polypeptide Epro-196 SNRPG Recombinant Human Small Nuclear Ribonucleoprotein Polypeptide Gpro-665 SNX1 Recombinant Human Sorting Nexin 1pro-866 SNUPN Recombinant Human Snurportin 1pro-286 SOD Recombinant Human Superoxide Dismutasepro-648 SOD1 Recombinant Human Superoxide Dismutase-1pro-819 SOD2 Recombinant Human Superoxide Dismutase-2pro-738 SOX9 Recombinant Human SOX9pro-739 SOX9 150a.a. Recombinant Human SOX9 150 a.a.pro-820 SOX2 Recombinant Human SRY (sex determining region Y)-box 2pro-089 SOX2 PolyR Recombinant Human SRY (sex determining region Y)-box 2 Polyarginine-Tagpro-108 SP100 Recombinant Human SP100pro-356 SPA Recombinant Staphylococcal Protein-Apro-774 SPA 41kDa Recombinant Staphylococcal Protein-A 41kDapro-686 SPA 434a.a. Recombinant Staphylococcal Protein A 434 a.apro-582 SPARC Recombinant Human Secreted Protein Acidic & Rich in Cysteinepro-404 Spectrin alpha Recombinant Spectrin-alphapro-677 SPG21 Recombinant Human Spastic Paraplegia 21pro-195 SPOP Recombinant Human Speckle-Type POZ Proteinpro-600 sRAGE Recombinant Human Advanced Glycosylation End Product-Specific Receptorpro-601 sRAGE HEK Recombinant Human Advanced Glycosylation End Product-Specific Receptor, HEKpro-166 SRI Recombinant Human Sorcinpro-013 SRP14 Recombinant Human Signal Recognition Particle 14kDa pro-113 SRP54 Recombinant Human Signal Recognition Particle 54kDapro-620 STIM1 Recombinant Human Stromal Interaction Molecule 1pro-753 STIP1 Recombinant Human Stress-Induced-Phosphoprotein 1pro-676 STMN1 Recombinant Human Stathmin-1pro-752 STMN2 Recombinant Human Stathmin Like-2pro-838 STMN3 Recombinant Human Stathmin Like-3pro-283 Streptavidin Streptavidinpro-791 Streptavidin Recombinant Streptavidinpro-621 Streptavidin, His Recombinant Streptavidin, His Tagpro-338 Streptavidin-NC Recombinant Streptavidin-NCpro-574 STX1A Recombinant Human Syntaxin-1A

pro-096 SUGT1 Recombinant Human SGT1pro-326 SUMO1 Recombinant Human Small Ubiquitin-Related Modifier 1pro-586 SUMO2 Recombinant Human Small Ubiquitin-Related Modifier 2pro-541 SUMO2 GST Recombinant Human Small Ubiquitin-Related Modifier 2, GSTpro-267 SUMO3 Recombinant Human Small Ubiquitin-Related Modifier 3pro-764 SURF1 Recombinant Human Surfeit-1pro-778 SDC4 Recombinant Human Syndecan-4pro-583 SDC4, His Recombinant Human Syndecan-4, His Tagpro-036 SDCBP Recombinant Human Syndecan Binding Protein pro-806 SQSTM1 Recombinant Human Sequestosome 1pro-835 SUB1 Recombinant Human SUB1 Homolog pro-716 TAC3 Recombinant Human Tachykinin-3pro-705 TBCA Recombinant Human Tubulin Folding Cofactor Apro-644 mtBID Recombinant Mouse BH3 Interacting Domain Death Agonist p15pro-851 TAGLN Recombinant Human Transgelinpro-124 TAGLN2 Recombinant Human Transgelin-2pro-507 TCEAL1 Recombinant Human Transcription Elongation Factor A (SII)-Like 1pro-664 TCEB2 Recombinant Human Transcription Elongation Factor B Polypeptide 2 pro-726 TCL1A Recombinant Human T-cell Leukemia/Lymphoma 1Apro-276 TCP1 Recombinant Human T-Complex 1pro-549 TES Recombinant Human Testis Derived Transcript pro-585 TEV Recombinant Tobacco Etch Virus Proteasepro-095 TFAM Recombinant Human Transcription Factor-Apro-860 TFPI2 Recombinant Human Tissue Factor Pathway Inhibitor 2pro-568 TGFBI Recombinant Human Transforming Growth Factor Beta Induced pro-672 TGFBI 182 Recombinant Human Transforming Growth Factor Beta Induced 182 a.a.pro-288 THBS1 Recombinant Human Thrombospondin pro-339 Thrombin Human Thrombinpro-447 bThrombin Bovine Thrombinpro-617 pThrombin Porcine Thrombinpro-270 THYN1 Recombinant Human Thymocyte Nuclear Protein 1pro-443 Thyroglobulin Human Thyroglobulinpro-312 Tissue Factor Recombinant Human Coagulation Factor IIIpro-005 TNIP1 Recombinant Human TNFAIP3 Interacting Protein 1pro-703 TNNT2 Recombinant Human Troponin T Type 2, Cardiac Isoform 3pro-442 TPD52L1 Recombinant Human Tumor Protein D52 L1pro-469 TPM1 Recombinant Human Tropomyosin-1pro-069 TPM2 Recombinant Human Tropomyosin-2pro-187 TPM4 Recombinant Human Tropomyosin-4pro-776 TPT1 Recombinant Human Tumor Protein Translationally-Controlled 1pro-834 TRAF1 Recombinant Human TNF receptor-Associated Factor 1pro-685 TRAF2 Recombinant Human TNF receptor-Associated Factor 2pro-747 Transferrin Recombinant Human Transferrinpro-457 TREM1 Recombinant Human Triggering Receptor Expressed on Myeloid Cells 1pro-587 rTpc1808 Recombinant Rat Tropic 1808pro-341 Troponin 1 Recombinant Human fast skeletal Troponin 1pro-344 Troponin I-C Recombinant Human Cardiac Troponin I-C Complex pro-345 Troponin I-C Recombinant Single Chain Cardiac Troponin I-C pro-346 Troponin I-C Recombinant Single Chain Cardiac Troponin I-C 2nd generation pro-322 Troponin-C Recombinant Human Cardiac Troponin-Cpro-324 Troponin-I Recombinant Human Cardiac Troponin-Ipro-342 Troponin-T Human Cardiac Troponin-Tpro-770 Trypsin Recombinant Human Trypsinpro-786 Trypsin Yeast Recombinant Human Trypsin, Yeastpro-313 bTrypsin Recombinant Bovine Trypsinpro-787 pTrypsin Recombinant Porcine Trypsinpro-144 TSEN15 Recombinant Human tRNA Splicing Endonuclease 15

pro-805 TSG101 Recombinant Human Tumor Susceptibility Gene 101pro-271 TSN Recombinant Human Translinpro-334 TXN1 Recombinant E.Coli Thioredoxinpro-784 TXN1, His Recombinant E.Coli Thioredoxin, Hispro-569 TXN1 Recombinant Human Thioredoxinpro-804 TXN1, His Recombinant Human Thioredoxin His Tagpro-084 TXNL1 Recombinant Human Thioredoxin-Like 1pro-625 TXN2 Recombinant Human Thioredoxin-2pro-445 SNRNP70 Recombinant Human Small Nuclear Ribonucleoprotein 70kDa pro-125 UFM1 Recombinant Human Ubiquitin-Fold Modifier 1pro-188 URM1 Recombinant Human Ubiquitin Related Modifier 1pro-314 Ubiquitin Recombinant Human Ubiquitinpro-629 Ubiquitin Biotin Recombinant Human Ubiquitin Biotinpro-280 Ubiquitin G76A Recombinant Human Ubiquitin Gly76 to Ala76 mutation pro-735 Ubiquitin GST Recombinant Human Ubiquitin, GST Tagpro-372 Ubiquitin K48R Recombinant Human Ubiquitin Lys 48 to Arg 48 mutationpro-608 Ulinastatin Recombinant Human Urinary Trypsin Inhibitor (UTI)pro-321 Ulinastatin Human Urinary Trypsin Inhibitor (UTI)pro-670 U. Urealyticum Recombinant Ureaplasma Urealyticum Parvumpro-706 USH1C Recombinant Human Usher Syndrome 1C pro-577 VAMP1 Recombinant Human Synaptobrevin-1pro-578 VAMP2 Recombinant Human Synaptobrevin-2pro-652 VAMP3 Recombinant Human Synaptobrevin-3pro-714 VAMP4 Recombinant Human Vesicle-Associated Membrane Protein 4pro-681 VAMP5 Recombinant Human Synaptobrevin-5pro-660 VAMP8 Recombinant Human Synaptobrevin-8pro-779 VAPA Recombinant Human VAMP Associated Protein A, 33kDapro-014 VAPB Recombinant Human VAMP Associated Protein B and Cpro-191 VASP Recombinant Human Vasodilator-Stimulated Phosphoproteinpro-386 VCAM1 Recombinant Human Vascular cell adhesion molecule 1pro-361 rVCAM1 Recombinant Rabbit Vascular cell adhesion molecule 1pro-440 VHL Recombinant Human Von Hippel-Lindau Proteinpro-309 Vimentin Recombinant Human Vimentinpro-734 Vimentin GST Recombinant Human Vimentin, GST Tagpro-525 bVimentin Bovine Vimentinpro-200 VOPP1 Recombinant Human Vesicular Overexpressed in Cancer, Prosurvival Protein 1pro-730 VPS28 Recombinant Human Vacuolar Protein Sorting 28pro-723 VSNL1 Recombinant Human Visinin-Like Protein-1pro-602 VSNL1 His Recombinant Human Visinin-Like Protein-1 His Tagpro-863 WDR5 Recombinant Human WD Repeat Domain 5pro-062 WHSC2 Recombinant Human Wolf-Hirschhorn Syndrome Candidate 2pro-864 WIBG Recombinant Human within BCGN Homologpro-684 WIF1 Recombinant Human WNT Inhibitory Factor 1pro-205 VDR Recombinant Human Vitamin D Receptorpro-333 yTXN1 Recombinant Yeast Thioredoxin pro-403 ZA2G Recombinant Human Zinc-Alpha 2 Glycoproteinpro-183 ZCCHC17 Recombinant Human Zinc Finger, CCHC Domain Containing 17pro-478 ZG16 Recombinant Human Zymogen Granule Protein 16 Homolog hsp-013 AHA1hsp-002 CRYAAhsp-003 CRYABhsp-018 mCRYABhsp-033 CRYBB1hsp-007 DnaJhsp-012 DnaJhsp-035 DNAJB2hsp-038 DNAJB6

hsp-042 DNAJB11hsp-039 DNAJC19hsp-006 Dnakhsp-008 Dnak SBDhsp-009 Dnak SBD C-terminalhsp-010 Dnak ATPase BDhsp-011 Dnak LCShsp-070 Dnakhsp-170 Dnak Hishsp-025 DsbEhsp-024 DsbGhsp-004 GroELhsp-016 GroELhsp-005 GroEShsp-015 GroEShsp-040 GroES Hishsp-014 GrpEhsp-043 hchAhsp-001 HSBP-1hsp-017 HSF1hsp-021 HSPA5hsp-037 HSPA5 Hi-5hsp-028 HSPA6hsp-026 HSPA8hsp-023 HSPA9hsp-041 HSPA13hsp-030 HSPBP1hsp-020 HSP20hsp-032 HSPB7hsp-022 HSPB8hsp-031 HSPB8 Hishsp-027 HSP27hsp-029 HSP27 Hishsp-047 HSP47hsp-065 HSP65hsp-090 HSP90 hsp-091 HSP90B1hsp-104 HSP104hsp-105 HSP105hsp-034 SKPhsp-130 ST13hsp-019 STUB1

Cantidad Peso Molecular50mg C30H23N5O100mg C30H23N5O5mg C24H25ClFN5O310mg C24H25ClFN5O350mg C24H25ClFN5O3200mg C24H25ClFN5O310mg C24H25ClFN5O325mg C24H25ClFN5O350mg C24H25ClFN5O3200mg C24H25ClFN5O35mg C53H84NO14P10mg C53H84NO14P50mg C53H84NO14P200mg C53H84NO14P100mg C22H23N3O4.HCl500mg C22H23N3O4.HCl100mg C22H24ClFN4O3250mg C22H24ClFN4O325mg C29H26ClFN4O4S.2C7H8O3S100mg C29H26ClFN4O4S.2C7H8O3S5mg C25H52NO4P10mg C25H52NO4P50mg C25H52NO4P200mg C25H52NO4P5mg C19H16N4O310mg C19H16N4O325mg C19H16N4O350mg C19H16N4O3100mg C19H16N4O35mg C51H79NO1325mg C51H79NO13100mg C51H79NO1310mg C56H87NO1625mg C56H87NO1650mg C56H87NO16200mg C56H87NO165mg C27H27FN8O3.HCl25mg C27H27FN8O3.HCl100mg C27H27FN8O3.HCl5mg C30H33N3O5S10mg C30H33N3O5S50mg C30H33N3O5S200mg C30H33N3O5S10mg C19H21F2N7O250mg C19H21F2N7O25mg C19H12N2O2Cl210mg C19H12N2O2Cl250mg C19H12N2O2Cl2100mg C19H12N2O2Cl25mg C25H21N5O.2HCl10mg C25H21N5O.2HCl25mg C25H21N5O.2HCl50mg C25H21N5O.2HCl10mg C16H14BrN3O2.HCl50mg C16H14BrN3O2.HCl200mg C16H14BrN3O2.HCl

5mg C21H17NO3S210mg C21H17NO3S250mg C21H17NO3S210mg C19H17NO325mg C19H17NO3200mg C19H17NO35mg C26H19F3N4O25mg C26H19F3N4O100mg C26H19F3N4O10mg C21H27N7O350mg C21H27N7O3200mg C21H27N7O35mg C13H16N6O410mg C13H16N6O450mg C13H16N6O4200mg C13H16N6O410mg C21H16N6O2S250mg C21H16N6O2S2100mg C21H16N6O2S2200mg C21H16N6O2S210mg C53H83NO1425mg C53H83NO14100mg C53H83NO142mg C19H23N7O25mg C19H23N7O210mg C19H23N7O250mg C19H23N7O2100mg C19H23N7O210mg C17H14N2O325mg C17H14N2O35mg C16H15NO7S10mg C16H15NO7S50mg C16H15NO7S5mg C27H27N5O310mg C27H27N5O325mg C27H27N5O350mg C27H27N5O35mg C21H24N4O225mg C21H24N4O2100mg C21H24N4O25mg C24H25ClN6O210mg C24H25ClN6O250mg C24H25ClN6O2200mg C24H25ClN6O210mg C25H27ClN6O350mg C25H27ClN6O3100mg C25H27ClN6O3200mg C25H27ClN6O35mg C24H25ClN6OS10mg C24H25ClN6OS50mg C24H25ClN6OS200mg C24H25ClN6OS5mg C18H17N5O310mg C18H17N5O350mg C18H17N5O310mg C24H26N4O450mg C24H26N4O4

200mg C24H26N4O410mg C16H14BrN5O4S.HCl25mg C16H14BrN5O4S.HCl100mg C16H14BrN5O4S.HCl5mg C25H21N7O310mg C25H21N7O325mg C25H21N7O350mg C25H21N7O35mg C25H31N5O410mg C25H31N5O450mg C25H31N5O4100mg C25H31N5O45mg C24H29N7O510mg C24H29N7O550mg C24H29N7O55mg C22H19N7O10mg C22H19N7O50mg C22H19N7O10mg C23H26IN7O2S25mg C23H26IN7O2S50mg C23H26IN7O2S100mg C23H26IN7O2S2mg C20H23BrN8O5mg C20H23BrN8O50mg C20H23BrN8O100mg C20H23BrN8O5mg C18H14N6O210mg C18H14N6O250mg C18H14N6O2100mg C18H14N6O25mg C17H18N610mg C17H18N625mg C17H18N6100mg C17H18N65mg C24H23ClFN5O225mg C24H23ClFN5O2100mg C24H23ClFN5O25mg C12H7N3O2S10mg C12H7N3O2S50mg C12H7N3O2S100mg C12H7N3O2S5mg C22H24N4O410mg C22H24N4O450mg C22H24N4O45mg C27H32N610mg C27H32N625mg C27H32N650mg C27H32N65mg C14H16ClN3O4S225mg C14H16ClN3O4S2100mg C14H16ClN3O4S210mg C10H12FN5O450mg C10H12FN5O4100mg C10H12FN5O45mg C31H29N5O6S10mg C31H29N5O6S50mg C31H29N5O6S

200mg C31H29N5O6S10mg C25H31N5O450mg C25H31N5O410mg C20H31N3O2S250mg C20H31N3O2S2200mg C20H31N3O2S210mg C20H20ClN350mg C20H20ClN3200mg C20H20ClN310mg C30H33N3O5S50mg C30H33N3O5S200mg C30H33N3O5S10mg C18H14N4O225mg C18H14N4O250mg C18H14N4O250mg C9H14N4O5200mg C9H14N4O525mg C29H26ClFN4O4S100mg C29H26ClFN4O4S5mg C30H29ClN6O325mg C30H29ClN6O3100mg C30H29ClN6O35mg C14H14ClFN810mg C14H14ClFN850mg C14H14ClFN8200mg C14H14ClFN85mg C23H25ClFN7O10mg C23H25ClFN7O50mg C23H25ClFN7O200mg C23H25ClFN7O5mg C24H18ClFN4O2,C7H8O3S10mg C24H18ClFN4O2,C7H8O3S50mg C24H18ClFN4O2,C7H8O3S200mg C24H18ClFN4O2,C7H8O3S5mg C23H25ClFN5O310mg C23H25ClFN5O350mg C23H25ClFN5O3200mg C23H25ClFN5O35mg C20H22F3N5O10mg C20H22F3N5O50mg C20H22F3N5O5mg C21H21N3O4.HCl10mg C21H21N3O4.HCl50mg C21H21N3O4.HCl200mg C21H21N3O4.HCl5mg C22H19N7O10mg C22H19N7O50mg C22H19N7O200mg C22H19N7O2mg C18H16F2N65mg C18H16F2N610mg C18H16F2N650mg C18H16F2N65mg C16H16N6O10mg C16H16N6O50mg C16H16N6O10mg C23H22N6O2

50mg C23H22N6O2200mg C23H22N6O210mg C22H18FN7O50mg C22H18FN7O200mg C22H18FN7O5mg C28H23N7O210mg C28H23N7O250mg C28H23N7O2200mg C28H23N7O210mg C24H22O650mg C24H22O6200mg C24H22O62mg C17H15N7O25mg C17H15N7O225mg C17H15N7O210mg C18H18O225mg C18H18O250mg C18H18O2100mg C18H18O2500mg C10H15N5.HCl10mg C17H17N750mg C17H17N7200mg C17H17N75mg C21H22N6O310mg C21H22N6O350mg C21H22N6O35mg C32H41N9O410mg C32H41N9O450mg C32H41N9O4200mg C32H41N9O45mg C18H20ClN510mg C18H20ClN550mg C18H20ClN5200mg C18H20ClN55mg C17H23N5O2S210mg C17H23N5O2S250mg C17H23N5O2S2200mg C17H23N5O2S25mg C25H19NO3S10mg C25H19NO3S50mg C25H19NO3S200mg C25H19NO3S5mg C27H33N7O410mg C27H33N7O450mg C27H33N7O4200mg C27H33N7O45mg C28H32N8O310mg C28H32N8O350mg C28H32N8O3200mg C28H32N8O32mg C22H22N4O5mg C22H22N4O10mg C22H22N4O50mg C22H22N4O100mg C22H22N4O2mg C14H8FNO4S5mg C14H8FNO4S

25mg C14H8FNO4S100mg C14H8FNO4S2mg C11H5F2NO4S5mg C11H5F2NO4S25mg C11H5F2NO4S100mg C11H5F2NO4S10mg C14H8FNO3S25mg C14H8FNO3S50mg C14H8FNO3S200mg C14H8FNO3S5mg C27H28F2N6O.2HCl10mg C27H28F2N6O.2HCl50mg C27H28F2N6O.2HCl200mg C27H28F2N6O.2HCl5mg C28H30N8O10mg C28H30N8O50mg C28H30N8O200mg C28H30N8O5mg C26H35N7O2S10mg C26H35N7O2S50mg C26H35N7O2S200mg C26H35N7O2S5mg C23H30N8O3S10mg C23H30N8O3S50mg C23H30N8O3S200mg C23H30N8O3S5mg C20H12N2O3S10mg C20H12N2O3S50mg C20H12N2O3S200mg C20H12N2O3Sout of stock C15H19N7O3S5mg C24H25ClFN5O210mg C24H25ClFN5O250mg C24H25ClFN5O2200mg C24H25ClFN5O25mg C16H14ClN3O210mg C16H14ClN3O225mg C16H14ClN3O250mg C16H14ClN3O210mg C16H10ClN3O550mg C16H10ClN3O55mg C27H36N6O3S10mg C27H36N6O3S25mg C27H36N6O3S50mg C27H36N6O3S5mg C29H34N10O310mg C29H34N10O350mg C29H34N10O3200mg C29H34N10O35mg C22H27N5O410mg C22H27N5O450mg C22H27N5O4200mg C22H27N5O45mg C20H17Cl2N9O225mg C20H17Cl2N9O25mg C28H25F3N6O2.C4H4O410mg C28H25F3N6O2.C4H4O4

50mg C28H25F3N6O2.C4H4O4200mg C28H25F3N6O2.C4H4O45mg C29H27N7O4S10mg C29H27N7O4S50mg C29H27N7O4S200mg C29H27N7O4S5mg C22H19ClN6O2S10mg C22H19ClN6O2S50mg C22H19ClN6O2S200mg C22H19ClN6O2S5mg C23H24O810mg C23H24O820mg C23H24O85mg C23H24N8O4S10mg C23H24N8O4S50mg C23H24N8O4S200mg C23H24N8O4S50mg C6H7N5500mg C6H7N55mg C25H30N6O310mg C25H30N6O3100mg C25H30N6O3200mg C25H30N6O35mg C26H25ClF3N5O310mg C26H25ClF3N5O350mg C26H25ClF3N5O3100mg C26H25ClF3N5O35mg C16H20N6O10mg C16H20N6O50mg C16H20N6O100mg C16H20N6O10mg C17H14BrN3O25mg C17H14BrN3O5mg C24H26N6O2S10mg C24H26N6O2S50mg C24H26N6O2S100mg C24H26N6O2S5mg C24H32ClN5O210mg C24H32ClN5O250mg C24H32ClN5O2100mg C24H32ClN5O25mg C15H15N7O10mg C15H15N7O50mg C15H15N7O100mg C15H15N7O5mg C19H22F3N5O2S10mg C19H22F3N5O2S20mg C19H22F3N5O2S50mg C19H22F3N5O2S100mg C19H22F3N5O2S200mg C19H22F3N5O2S50mg C19H14N2O2S200mg C19H14N2O2S25mg C21H21N3O4250mg C21H21N3O410mg C35H28F3N5O225mg C35H28F3N5O2

50mg C35H28F3N5O2200mg C13H8Cl2N2O410mg C16H20N6O.C6H8O750mg C16H20N6O.C6H8O710mg C27H27N5O250mg C27H27N5O2200mg C27H27N5O2out of stock C30H31F3N8O5mg C21H23N3O510mg C21H23N3O520mg C21H23N3O5200mg C21H23N3O510mg C22H25N3O350mg C22H25N3O3200mg C22H25N3O35mg C21H26N6O210mg C21H26N6O250mg C21H26N6O2200mg C21H26N6O2200mg C8H15NaO25mg C11H14ClNO310mg C11H14ClNO325mg C11H14ClNO35mg C20H30N4O210mg C20H30N4O250mg C20H30N4O25mg C24H27N3O4.HCl.H2O10mg C24H27N3O4.HCl.H2O50mg C24H27N3O4.HCl.H2O200mg C24H27N3O4.HCl.H2O2mg C18H20N2O35mg C18H20N2O310mg C18H20N2O350mg C18H20N2O310mg C20H21N3O2.HCl50mg C20H21N3O2.HCl100mg C20H21N3O2.HCl200mg C20H21N3O2.HCl10mg C15H15N3O250mg C15H15N3O210mg C17H16N2O3100mg C17H16N2O35mg C16H25N3O350mg C16H25N3O31mg C24H36N4O6S25mg C24H36N4O6S210mg C17H15FN2O325mg C17H15FN2O35mg C23H20N6O10mg C23H20N6O25mg C23H20N6O50mg C23H20N6O10mg C15H14N2O4S50mg C15H14N2O4S100mg C15H14N2O4S200mg C15H14N2O4S5mg C17H22N2O3

10mg C17H22N2O350mg C17H22N2O310mg C21H23N3O250mg C21H23N3O2200mg C21H23N3O210mg C21H20N4O325mg C21H20N4O350mg C21H20N4O3200mg C21H20N4O3200mg C14H20N2O3500mg C14H20N2O310mg C12H10FN3O2S5mg C15H13N5OS10mg C15H13N5OS50mg C15H13N5OS200mg C14H17N3O2S.HCl500mg C14H17N3O2S.HCl2mg C14H21N3O.2HCl5mg C14H21N3O.2HCl10mg C14H21N3O.2HCl50mg C14H21N3O.2HCl25mg C5H10N2O7P2100mg C5H10N2O7P25mg C25H22N6O225mg C25H22N6O25mg C21H18NO4.HCl10mg C21H18NO4.HCl50mg C21H18NO4.HCl2mg C19H12ClN3O25mg C19H12ClN3O250mg C19H12ClN3O2100mg C19H12ClN3O22mg C28H26N4O35mg C28H26N4O310mg C28H26N4O3100mg C28H26N4O310mg C32H29N5O250mg C32H29N5O2200mg C32H29N5O210mg C20H20N4O50mg C20H20N4O200mg C20H20N4O5mg C19H18BrN3O10mg C19H18BrN3O50mg C19H18BrN3O200mg C19H18BrN3O10mg C30H28FN7O350mg C30H28FN7O3100mg C30H28FN7O3200mg C30H28FN7O35mg C26H30N6O310mg C26H30N6O350mg C26H30N6O310mg C29H27F3N6O50mg C29H27F3N6O200mg C29H27F3N6O25mg C28H22F3N7O

100mg C28H22F3N7O300mg C28H22F3N7O10mg C27H32ClN5O525mg C27H32ClN5O5200mg C27H32ClN5O5100mg C19H33NO2.HCl200mg C19H33NO2.HCl100mg C29H31N7O.CH4SO3250mg C29H31N7O.CH4SO325mg C22H26ClN7O2S100mg C22H26ClN7O2S10mg C17H12N425mg C17H12N450mg C17H12N45mg C25H23N5O210mg C25H23N5O225mg C25H23N5O250mg C25H23N5O210mg C20H21N3O250mg C20H21N3O25mg C26H27N5O210mg C26H27N5O250mg C26H27N5O2200mg C26H27N5O25mg C21H21N510mg C21H21N550mg C21H21N5100mg C21H21N52mg C25H22N65mg C25H22N625mg C25H22N65mg C22H19N5O10mg C22H19N5O50mg C22H19N5O200mg C22H19N5O10mg C22H16N4O350mg C22H16N4O3200mg C22H16N4O310mg C14H8N2O50mg C14H8N2O200mg C14H8N2O5mg C22H19BrF2N2O310mg C22H19BrF2N2O350mg C22H19BrF2N2O3200mg C22H19BrF2N2O310mg C19H9Cl2F2N3OS50mg C19H9Cl2F2N3OS10mg C19H12F4N4O2250mg C19H12F4N4O2100mg C19H12F4N4O2200mg C19H12F4N4O25mg C24H29FN6.2CH4O3S10mg C24H29FN6.2CH4O3S50mg C24H29FN6.2CH4O3S200mg C24H29FN6.2CH4O3S25mg C20H14N3OF100mg C20H14N3OF

5mg C31H37N5O310mg C31H37N5O350mg C31H37N5O3200mg C31H37N5O325mg C21H16FN3OS50mg C21H16FN3OS100mg C21H16FN3OS200mg C21H16FN3OS10mg C23H14F6N6O25mg C23H14F6N6O50mg C23H14F6N6O100mg C23H14F6N6O5mg C23H23N3O310mg C23H23N3O350mg C23H23N3O3200mg C23H23N3O35mg C27H25N5O225mg C27H25N5O25mg C23H20F3N5O2S210mg C23H20F3N5O2S220mg C23H20F3N5O2S250mg C23H20F3N5O2S2100mg C23H20F3N5O2S25mg C26H20F3N7O10mg C26H20F3N7O50mg C26H20F3N7O200mg C26H20F3N7O5mg C24H16F6N6O10mg C24H16F6N6O50mg C24H16F6N6O100mg C24H16F6N6O5mg C21H15ClF4N4O310mg C21H15ClF4N4O325mg C21H15ClF4N4O3100mg C21H15ClF4N4O32mg C19H18N4O25mg C19H18N4O210mg C19H18N4O225mg C19H18N4O210mg C17H14ClF2N3O3S25mg C17H14ClF2N3O3S100mg C17H14ClF2N3O3S5mg C21H16ClF3N4O3.C7H8O3S10mg C21H16ClF3N4O3.C7H8O3S50mg C21H16ClF3N4O3.C7H8O3S100mg C21H16ClF3N4O3.C7H8O3S10mg C23H18ClF2N3O3S50mg C23H18ClF2N3O3S200mg C23H18ClF2N3O3S5mg C15H15FIN3O310mg C15H15FIN3O325mg C15H15FIN3O350mg C15H15FIN3O35mg C26H26N4O210mg C26H26N4O250mg C26H26N4O2200mg C26H26N4O2

5mg C16H13BrF3IN2O410mg C16H13BrF3IN2O450mg C16H13BrF3IN2O4200mg C16H13BrF3IN2O45mg C16H17FIN3O410mg C16H17FIN3O450mg C16H17FIN3O4200mg C16H17FIN3O45mg C17H15F2IN4O410mg C17H15F2IN4O450mg C17H15F2IN4O4200mg C17H15F2IN4O45mg C27H28N4O210mg C27H28N4O250mg C27H28N4O2200mg C27H28N4O25mg C26H23FIN5O410mg C26H23FIN5O450mg C26H23FIN5O4100mg C26H23FIN5O410mg C16H13NO350mg C16H13NO3200mg C16H13NO325mg C18H16N6S2.C2H6O100mg C18H16N6S2.C2H6O300mg C18H16N6S2.C2H6O5mg C17H14ClF2IN2O210mg C17H14ClF2IN2O225mg C17H14ClF2IN2O2100mg C17H14ClF2IN2O2200mg C17H14ClF2IN2O25mg C16H14F3IN2O410mg C16H14F3IN2O425mg C16H14F3IN2O4100mg C16H14F3IN2O450mg C17H15BrClFN4O3100mg C17H15BrClFN4O3200mg C17H15BrClFN4O3500mg C17H15BrClFN4O35mg C47H55ClF3N5O6S310mg C47H55ClF3N5O6S325mg C47H55ClF3N5O6S3100mg C47H55ClF3N5O6S35mg C42H45ClN6O5S210mg C42H45ClN6O5S250mg C42H45ClN6O5S2100mg C42H45ClN6O5S250mg C13H13N3O3500mg C13H13N3O35mg C19H20N4O2S210mg C19H20N4O2S250mg C19H20N4O2S2200mg C19H20N4O2S25mg C20H19N3O.CH4O3S10mg C20H19N3O.CH4O3S50mg C20H19N3O.CH4O3S5mg C30H30Cl2N4O4

10mg C30H30Cl2N4O425mg C30H30Cl2N4O4100mg C30H30Cl2N4O410mg C28H30N6OS25mg C28H30N6OS200mg C28H30N6OS5mg C26H31N3O510mg C26H31N3O525mg C26H31N3O5200mg C26H31N3O510mg C33H35NO6S50mg C33H35NO6S5mg C20H19BrN4O310mg C20H19BrN4O325mg C20H19BrN4O3100mg C20H19BrN4O325mg C31H43N3O8100mg C31H43N3O8200mg C31H43N3O825mg C32H48N4O8-HCl100mg C32H48N4O8-HCl200mg C32H48N4O8-HCl10mg C43H53NO1450mg C43H53NO1410mg C47H51NO1450mg C47H51NO1410mg C20H20N4O3200mg C20H20N4O35mg C24H31N3O310mg C24H31N3O350mg C24H31N3O3200mg C24H31N3O35mg C21H20N425mg C21H20N4100mg C21H20N45mg C14H15ClN6O10mg C14H15ClN6O25mg C14H15ClN6O50mg C14H15ClN6O10mg C14H11F3N2OS25mg C14H11F3N2OS50mg C14H11F3N2OS200mg C14H11F3N2OS2mg C35H48FN5O8S5mg C35H48FN5O8S50mg C35H48FN5O8S10mg C37H48N6O5S250mg C37H48N6O5S2100mg C37H48N6O5S22mg C23H21N5O3S5mg C23H21N5O3S10mg C23H21N5O3S50mg C23H21N5O3S2mg C26H39NO6S5mg C26H39NO6S2mg C27H41NO6S5mg C27H41NO6S

10mg C27H41NO6S25mg C27H41NO6S5mg C17H19FN4O5S10mg C17H19FN4O5S50mg C17H19FN4O5S200mg C17H19FN4O5S10mg C37H48N4O5100mg C37H48N4O5200mg C37H48N4O525mg C10H12N2O450mg C10H12N2O4100mg C10H12N2O410mg C19H30N5O10P.C4H4O450mg C19H30N5O10P.C4H4O4100mg C19H30N5O10P.C4H4O45mg C9H14N5O4P20mg C9H14N5O4P50mg C9H14N5O4P10mg C30H33ClN4O250mg C30H33ClN4O2200mg C30H33ClN4O25mg C38H52N6O7.H2SO410mg C38H52N6O7.H2SO450mg C38H52N6O7.H2SO45mg C25H35NO4S10mg C25H35NO4S50mg C25H35NO4S200mg C25H35NO4S5mg C40H50N8O610mg C40H50N8O650mg C40H50N8O6200mg C40H50N8O65mg C21H23Cl2N5O2S10mg C21H23Cl2N5O2S50mg C21H23Cl2N5O2S200mg C21H23Cl2N5O2S5mg C36H53N7O610mg C36H53N7O650mg C36H53N7O65mg C13H11N3O410mg C13H11N3O450mg C13H11N3O4200mg C13H11N3O410mg C8H10FN3O3S50mg C8H10FN3O3S10mg C23H23ClFNO550mg C23H23ClFNO5200mg C23H23ClFNO55mg C29H41F2N5O25mg C29H41F2N5O100mg C29H41F2N5O5mg C28H38F3N5O2.C4H6O510mg C28H38F3N5O2.C4H6O550mg C28H38F3N5O2.C4H6O55mg C20H21FN6O510mg C20H21FN6O550mg C20H21FN6O5

5mg C31H33N2O3.HCl10mg C31H33N2O3.HCl50mg C31H33N2O3.HCl200mg C31H33N2O3.HCl5mg C24H30N6O210mg C24H30N6O250mg C24H30N6O2200mg C24H30N6O25mg C45H54F2N4O8.xC4H6O610mg C45H54F2N4O8.xC4H6O650mg C45H54F2N4O8.xC4H6O6200mg C45H54F2N4O8.xC4H6O6out of stock C24H33ClN4O65mg C23H27F3N4O310mg C23H27F3N4O350mg C23H27F3N4O3200mg C23H27F3N4O35mg C25H30F3N5O410mg C25H30F3N5O450mg C25H30F3N5O4200mg C25H30F3N5O45mg C33H32N4O425mg C33H32N4O4100mg C33H32N4O45mg C20H19F2N3O510mg C20H19F2N3O550mg C20H19F2N3O5200mg C20H19F2N3O55mg C21H20F3N7O3S.C6H6O3S10mg C21H20F3N7O3S.C6H6O3S50mg C21H20F3N7O3S.C6H6O3S200mg C21H20F3N7O3S.C6H6O3S5mg C11H13N5O410mg C11H13N5O450mg C11H13N5O4200mg C11H13N5O45mg C30H42N2O910mg C30H42N2O950mg C30H42N2O9200mg C30H42N2O95mg C29H40N2O910mg C29H40N2O950mg C29H40N2O95mg C23H25F3N6O210mg C23H25F3N6O250mg C23H25F3N6O2200mg C23H25F3N6O210mg C24H32N6O350mg C24H32N6O310mg C23H28N4O225mg C23H28N4O250mg C23H28N4O2250mg C23H28N4O25mg C32H43N5O410mg C32H43N5O450mg C32H43N5O4200mg C32H43N5O4

5mg C21H21ClFN5O410mg C21H21ClFN5O450mg C21H21ClFN5O4200mg C21H21ClFN5O410mg C14H11N3O3S50mg C14H11N3O3S5mg C14H12O3S210mg C14H12O3S250mg C14H12O3S25mg C23H25ClN6O310mg C23H25ClN6O3100mg C23H25ClN6O3200mg C23H25ClN6O310mg C14H18N6O.1/2 H2O4S50mg C14H18N6O.1/2 H2O4S5mg C25H27F4N3O3S10mg C25H27F4N3O3S50mg C25H27F4N3O3S5mg C31H29F2N5O3.HCl10mg C31H29F2N5O3.HCl50mg C31H29F2N5O3.HCl200mg C31H29F2N5O3.HCl5mg C25H24F2N2O310mg C25H24F2N2O350mg C25H24F2N2O3200mg C25H24F2N2O35mg C22H22N4O410mg C22H22N4O450mg C22H22N4O4250mg C22H29FO5500mg C22H29FO55mg C33H31ClF3NO3.HCl10mg C33H31ClF3NO3.HCl50mg C33H31ClF3NO3.HCl200mg C33H31ClF3NO3.HCl25mg C20H24O1050mg C20H24O10500mg C20H24O105mg C21H22ClN3O310mg C21H22ClN3O3100mg C21H22ClN3O32mg C23H21F7N4O35mg C23H21F7N4O310mg C23H21F7N4O325mg C23H21F7N4O35mg C25H25N7O310mg C25H25N7O350mg C25H25N7O3200mg C25H25N7O35mg C17H16BrF3N4O10mg C17H16BrF3N4O50mg C17H16BrF3N4O200mg C17H16BrF3N4O5mg C19H25BN4O425mg C19H25BN4O4100mg C19H25BN4O45mg C26H41N3O5

25mg C26H41N3O5100mg C26H41N3O55mg C14H19BCl2N2O410mg C14H19BCl2N2O4200mg C14H19BCl2N2O45mg C20H23BCl2N2O910mg C20H23BCl2N2O950mg C20H23BCl2N2O9200mg C20H23BCl2N2O910mg C19H17N5O2.2CH4O3S50mg C19H17N5O2.2CH4O3S100mg C19H17N5O2.2CH4O3S5mg C38H52N6O710mg C38H52N6O725mg C38H52N6O750mg C38H52N6O7out of stock C21H28BN3O55mg C16H23N3O4.CH4O3S50mg C16H23N3O4.CH4O3S5mg C40H57N5O710mg C40H57N5O750mg C40H57N5O7100mg C40H57N5O7200mg C40H57N5O7out of stock C36H47N5O4.H2SO45mg C22H20F5N3O310mg C22H20F5N3O350mg C22H20F5N3O3200mg C22H20F5N3O35mg C23H26F2N2O410mg C23H26F2N2O425mg C23H26F2N2O450mg C23H26F2N2O45mg C20H17ClF4N4O4S10mg C20H17ClF4N4O4S50mg C20H17ClF4N4O4S200mg C20H17ClF4N4O4S5mg C19H27N3O410mg C19H27N3O450mg C19H27N3O4200mg C19H27N3O45mg C21H21ClF2O4S10mg C21H21ClF2O4S50mg C21H21ClF2O4S200mg C21H21ClF2O4S2mg C26H23F2N3O35mg C26H23F2N3O325mg C26H23F2N3O3100mg C26H23F2N3O3out of stock C26H23F2N3O45mg C38H37D15N6O720mg C38H37D15N6O750mg C38H37D15N6O7200mg C38H37D15N6O75mg C38H43D9N6O720mg C38H43D9N6O750mg C38H43D9N6O7

200mg C38H43D9N6O75mg C38H34D18N6O720mg C38H34D18N6O750mg C38H34D18N6O7200mg C38H34D18N6O7200mg C16H15F6N5O.H3PO4.H2O20mg C24H34N4O5S50mg C24H34N4O5S200mg C24H34N4O5S10mg C18H25N3O225mg C18H25N3O2100mg C18H25N3O25mg C25H28N8O210mg C25H28N8O2100mg C25H28N8O2200mg C25H28N8O210mg C17H25N3O225mg C17H25N3O220mg C27H28N2O750mg C27H28N2O7500mg C27H28N2O710mg C35H38N4O6100mg C35H38N4O650mg C20H25ClN2O5.C6H6O3S250mg C20H25ClN2O5.C6H6O3S10mg C18H19Cl2NO425mg C18H19Cl2NO450mg C18H19Cl2NO4100mg C18H19Cl2NO450mg C24H33N3O4.2HCl100mg C24H33N3O4.2HCl500mg C24H33N3O4.2HCl100mg C20H25ClN2O510mg C33H34N4O650mg C33H34N4O610mg C21H23Cl2NO6100mg C21H23Cl2NO610mg C12H6N2O8S.2Sr2mg C26H26F2N2.2HCl10mg C19H19N3O650mg C19H19N3O6100mg C28H31N3O6.HCl10mg C26H33NO650mg C26H33NO625mg C35H38N4O6.2HCl50mg C35H38N4O6.2HCl200mg C35H38N4O6.2HCl50mg C18H20N2O6100mg C18H20N2O6200mg C21H26N2O710mg C13H18N2O325mg C13H18N2O3100mg C13H18N2O350mg C8H5F3N2OS200mg C8H5F3N2OS500mg C8H5F3N2OS10mg C10H8F2N4O

25mg C10H8F2N4O100mg C10H8F2N4O200mg C15H11N2NaO2100mg C15H12N2O1gr C15H12N2O210mg C21H27NO325mg C21H27NO350mg C21H27NO310mg C9H7Cl2N550mg C9H7Cl2N510mg C19H16ClNO450mg C19H16ClNO420mg C22H26N2O2100mg C22H26N2O210mg (C20H36N2O3S)2.C4H4O4100mg (C20H36N2O3S)2.C4H4O41gr C16H26N2O3.HCl200mg C6H8ClN7O.HCl.2H2O5mg C45H74O1110mg C45H74O1125mg C45H74O115mg C20H24FN5O310mg C20H24FN5O350mg C20H24FN5O3200mg C20H24FN5O3100mg C12H9N3O100mg Na3O4V100mg C17H19N3O3S500mg C17H19N3O3Sout of stock C22H26N4O35mg C17H18N3O3S.Na10mg C17H18N3O3S.Na50mg C17H18N3O3S.Na200mg C17H18N3O3S.Na200mg C12H17NO2.C2H7NO50mg C27H36N2O4100mg C27H36N2O4200mg C27H36N2O4300mg C27H36N2O4100mg C8H9N3O4200mg C8H9N3O410mg C19H27NO325mg C19H27NO350mg C19H27NO3100mg C19H27NO31gr C17H19ClN2S.HCl5mg C22H17ClN225mg C22H17ClN2100mg (C19H24NO3)2.Ca250mg (C19H24NO3)2.Ca200mg C12H18N2O3S10mg C16H18FN3O250mg C16H18FN3O21gr C25H30ClI2NO31gr C27H33N3O6S5mg C19H19NO.HCl10mg C19H19NO.HCl

25mg C19H19NO.HCl50mg C19H19NO.HCl10mg C9H17NO2.HCl50mg C9H17NO2.HCl25mg C15H14FN3O350mg C15H14FN3O3100mg C15H14FN3O3500mg C15H14FN3O310mg C14H16N2O225mg C14H16N2O250mg C14H16N2O225mg C9H17NO2100mg C9H17NO2out of stock C22H25NO2.HCl50mg C14H18N2O2250mg C14H18N2O210mg C20H24O925mg C20H24O9100mg C13H9F3N2O25mg C19H14Cl2N2O3S10mg C19H14Cl2N2O3S50mg C19H14Cl2N2O3S200mg C19H14Cl2N2O3S5mg C32H31F2N3O2.3HCl10mg C32H31F2N3O2.3HCl50mg C32H31F2N3O2.3HCl200mg C32H31F2N3O2.3HCl500mg C16H14F3N3O2Sout of stock C35H58O9100mg C16H15F2N3O4S500mg C16H15F2N3O4S5mg C24H18F2N2O510mg C24H18F2N2O550mg C24H18F2N2O5200mg C24H18F2N2O55mg C24H28N2O310mg C24H28N2O350mg C24H28N2O3200mg C24H28N2O35mg C21H18FN5O10mg C21H18FN5O50mg C21H18FN5O200mg C21H18FN5O50mg C22H18N4OS100mg C22H18N4OS10mg C19H16N2O550mg C19H16N2O55mg C31H33N5O410mg C31H33N5O450mg C31H33N5O4200mg C31H33N5O410mg C26H29Cl2N5O350mg C26H29Cl2N5O35mg C25H27FN4O310mg C25H27FN4O325mg C25H27FN4O350mg C25H27FN4O3

10mg C21H21FN6O25mg C21H21FN6O50mg C21H21FN6O5mg C22H23N5O.2H3PO410mg C22H23N5O.2H3PO450mg C22H23N5O.2H3PO4200mg C22H23N5O.2H3PO410mg C21H23N7O2S.HCl25mg C21H23N7O2S.HCl100mg C21H23N7O2S.HCl50mg C22H27FN4O2.C4H6O5100mg C22H27FN4O2.C4H6O5500mg C22H27FN4O2.C4H6O525mg C31H42N6O4100mg C31H42N6O4200mg C31H42N6O425mg C22H24BrFN4O2100mg C22H24BrFN4O2500mg C22H24BrFN4O25mg C21H22Cl2FN5O10mg C21H22Cl2FN5O50mg C21H22Cl2FN5Oout of stock C24H25Cl2FN4O25mg C19H19FN4O310mg C19H19FN4O350mg C19H19FN4O3200mg C19H19FN4O310mg C20H15ClN4-2HCl50mg C20H15ClN4-2HCl100mg C20H15ClN4-2HCl5mg C30H40ClN7O3S10mg C30H40ClN7O3S50mg C30H40ClN7O3S200mg C30H40ClN7O3S5mg C34H34F2N4O650mg C34H34F2N4O6200mg C34H34F2N4O65mg C28H24FN3O510mg C28H24FN3O550mg C28H24FN3O5200mg C28H24FN3O510mg C22H24FN5O450mg C22H24FN5O42mg C21H19ClN4O45mg C21H19ClN4O410mg C21H19ClN4O450mg C21H19ClN4O4100mg C21H19ClN4O410mg C18H20N6OS50mg C18H20N6OS200mg C18H20N6OS5mg C19H20N4O210mg C19H20N4O250mg C19H20N4O2200mg C19H20N4O25mg C25H31N7O610mg C25H31N7O6

50mg C25H31N7O6200mg C25H31N7O65mg C22H19ClN4O510mg C22H19ClN4O550mg C22H19ClN4O55mg C22H16F3N3O2S25mg C22H16F3N3O2S50mg C22H16F3N3O2S10mg C19H26O350mg C19H26O3100mg C19H26O3300mg C19H26O35mg C28H41N7O310mg C28H41N7O350mg C28H41N7O35mg C26H20FN5O2S210mg C26H20FN5O2S250mg C26H20FN5O2S2200mg C26H20FN5O2S25mg C24H18F3N3O410mg C24H18F3N3O425mg C24H18F3N3O450mg C24H18F3N3O4out of stock C27H29N5O5mg C18H18N2O310mg C18H18N2O350mg C18H18N2O3200mg C18H18N2O35mg C29H32N6O4S10mg C29H32N6O4S50mg C29H32N6O4S200mg C29H32N6O4S10mg C22H23FN6O550mg C22H23FN6O5200mg C22H23FN6O55mg C17H14O425mg C17H14O4100mg C17H14O45mg C20H21ClN4O410mg C20H21ClN4O450mg C20H21ClN4O4200mg C20H21ClN4O45mg C26H31Cl2N7O310mg C26H31Cl2N7O325mg C26H31Cl2N7O3100mg C26H31Cl2N7O3200mg C26H31Cl2N7O32mg C22H23FN6O5.C6H6O3S5mg C22H23FN6O5.C6H6O3S10mg C22H23FN6O5.C6H6O3S50mg C22H23FN6O5.C6H6O3S200mg C22H23FN6O5.C6H6O3S5mg C23H15ClF2N4O310mg C23H15ClF2N4O350mg C23H15ClF2N4O3200mg C23H15ClF2N4O35mg C23H24FN6O9P.2Na

10mg C23H24FN6O9P.2Na50mg C23H24FN6O9P.2Na200mg C23H24FN6O9P.2Na10mg C25H23F3N4O225mg C25H23F3N4O2200mg C25H23F3N4O210mg C25H27N5O4S50mg C25H27N5O4S200mg C25H27N5O4S5mg C20H16ClN5O310mg C20H16ClN5O350mg C20H16ClN5O3200mg C20H16ClN5O3250mg C29H31N7O500mg C29H31N7O2mg C23H26FN6O9P5mg C23H26FN6O9P10mg C23H26FN6O9P50mg C23H26FN6O9P100mg C23H26FN6O9P5mg C25H24N6O210mg C25H24N6O250mg C25H24N6O2200mg C25H24N6O25mg C26H29N3O310mg C26H29N3O350mg C26H29N3O3100mg C26H29N3O3200mg C26H29N3O35mg C27H29FN8O310mg C27H29FN8O350mg C27H29FN8O3200mg C27H29FN8O35mg C26H29N5O210mg C26H29N5O250mg C26H29N5O2200mg C26H29N5O25mg C30H34N4O210mg C30H34N4O250mg C30H34N4O2100mg C30H34N4O25mg C24H25N5O5S10mg C24H25N5O5S50mg C24H25N5O5S100mg C24H25N5O5S5mg C26H33N5O310mg C26H33N5O350mg C26H33N5O3100mg C26H33N5O3200mg C26H33N5O35mg C18H24N2OS10mg C18H24N2OS25mg C18H24N2OS10mg C18H22N4O450mg C18H22N4O45mg C15H14N2O10mg C15H14N2O

50mg C15H14N2O100mg C15H14N2O5mg C16H17N7O2S10mg C16H17N7O2S50mg C16H17N7O2S200mg C16H17N7O2S5mg C33H37F2N7O410mg C33H37F2N7O450mg C33H37F2N7O4200mg C33H37F2N7O410mg C16H14BrN3O350mg C16H14BrN3O325mg C21H23N7O2S100mg C21H23N7O2S10mg C14H12O425mg C14H12O450mg C14H12O4out of stock C25H26ClN5O3out of stock C27H29N5O25mg C23H28N8OS100mg C23H28N8OS250mg C23H28N8OS5mg C32H34Cl2N4O4S10mg C32H34Cl2N4O4S50mg C32H34Cl2N4O4S200mg C32H34Cl2N4O4S2mg C28H30CIN5O4S5mg C28H30CIN5O4S25mg C28H30CIN5O4S200mg C28H30CIN5O4S5mg C28H31N5O10mg C28H31N5O50mg C28H31N5O200mg C28H31N5O5mg C26H23N5O10mg C26H23N5O50mg C26H23N5O200mg C26H23N5O10mg C44H47F2N9O5S50mg C44H47F2N9O5S5mg C19H16N8O10mg C19H16N8O50mg C19H16N8O100mg C19H16N8O5mg C25H15ClF2N4O210mg C25H15ClF2N4O250mg C25H15ClF2N4O2200mg C25H15ClF2N4O25mg C29H31N5O410mg C29H31N5O425mg C29H31N5O450mg C29H31N5O45mg C28H39N7O310mg C28H39N7O350mg C28H39N7O3100mg C28H39N7O35mg C18H13N7S

10mg C18H13N7S25mg C18H13N7S50mg C18H13N7S2mg C19H13F2N75mg C19H13F2N710mg C19H13F2N750mg C19H13F2N7100mg C19H13F2N75mg C24H29N7O2.HCl10mg C24H29N7O2.HCl50mg C24H29N7O2.HClout of stock C23H24FN9O5mg C27H20ClFN4O410mg C27H20ClFN4O450mg C27H20ClFN4O4200mg C27H20ClFN4O45mg C17H24N4O2S210mg C17H24N4O2S250mg C17H24N4O2S2200mg C17H24N4O2S25mg C26H30FN7O310mg C26H30FN7O350mg C26H30FN7O310mg C19H26N6O50mg C19H26N6O200mg C19H26N6O5mg C18H15ClN6OS2.CH4O3S10mg C18H15ClN6OS2.CH4O3S50mg C18H15ClN6OS2.CH4O3S200mg C18H15ClN6OS2.CH4O3S5mg C21H20ClNO525mg C21H20ClNO5100mg C21H20ClNO55mg C14H13BrN2O10mg C14H13BrN2Oout of stock C27H34F3N7O32mg C15H12F2N6O3S5mg C15H12F2N6O3S10mg C15H12F2N6O3S50mg C15H12F2N6O3S100mg C15H12F2N6O3S10mg C22H17N5O250mg C22H17N5O2200mg C22H17N5O25mg C21H24NNaO8S10mg C21H24NNaO8S50mg C21H24NNaO8S200mg C21H24NNaO8S5mg C31H31ClFN7O210mg C31H31ClFN7O250mg C31H31ClFN7O25mg C28H35N7O210mg C28H35N7O250mg C28H35N7O2200mg C28H35N7O22mg C21H16F4N4O250mg C21H16F4N4O2

5mg C22H20N2O5S10mg C22H20N2O5S50mg C22H20N2O5S200mg C22H20N2O5S5mg C19H31N5O210mg C19H31N5O250mg C19H31N5O2200mg C19H31N5O25mg C23H25ClN8OS10mg C23H25ClN8OS50mg C23H25ClN8OS200mg C23H25ClN8OS5mg C16H17Cl2N5O210mg C16H17Cl2N5O225mg C16H17Cl2N5O2100mg C16H17Cl2N5O25mg C27H32N8O210mg C27H32N8O225mg C27H32N8O250mg C27H32N8O25mg C29H32N4O3S10mg C29H32N4O3S50mg C29H32N4O3S200mg C29H32N4O3S2mg C17H19FN4O2S5mg C17H19FN4O2S25mg C17H19FN4O2S100mg C17H19FN4O2S5mg C25H19ClF2N4O410mg C25H19ClF2N4O450mg C25H19ClF2N4O410mg C22H32N6.HCl50mg C22H32N6.HCl5mg C18H17F2N3O210mg C18H17F2N3O250mg C18H17F2N3O2200mg C18H17F2N3O210mg C27H28F3N5O2S50mg C27H28F3N5O2S5mg C14H22N4O4S10mg C14H22N4O4S50mg C14H22N4O4S200mg C14H22N4O4S5mg C34H50N8O310mg C34H50N8O350mg C34H50N8O31g C16H18O910mg C18H21N5O2S50mg C18H21N5O2S200mg C18H21N5O2S5mg C18H22BrN5O310mg C18H22BrN5O350mg C18H22BrN5O3200mg C18H22BrN5O310mg C21H20ClNO5.HCl25mg C21H20ClNO5.HCl50mg C21H20ClNO5.HCl

100mg C21H20ClNO5.HCl200mg C21H20ClNO5.HCl2mg C23H22ClN5O5mg C23H22ClN5O25mg C23H22ClN5O100mg C23H22ClN5Oout of stock C18H21F2N5O4S5mg C28H32N4O3S10mg C28H32N4O3S50mg C28H32N4O3S200mg C28H32N4O3S5mg C28H21N7OS10mg C28H21N7OS50mg C28H21N7OS200mg C28H21N7OS5mg C15H18BrN710mg C15H18BrN750mg C15H18BrN7200mg C15H18BrN75mg C30H33N7O10mg C30H33N7O50mg C30H33N7O200mg C30H33N7O10mg C12H11N3O50mg C12H11N3O10mg C26H31BrN8O50mg C26H31BrN8O5mg C30H29N5O510mg C30H29N5O550mg C30H29N5O5200mg C30H29N5O55mg C25H32N8O10mg C25H32N8O50mg C25H32N8O200mg C25H32N8O50mg C23H19N3O2200mg C23H19N3O25mg C20H16N610mg C20H16N650mg C20H16N6200mg C20H16N65mg C21H28N6O225mg C21H28N6O250mg C21H28N6O2200mg C21H28N6O25mg C22H21ClFN3O3S10mg C22H21ClFN3O3S50mg C22H21ClFN3O3S200mg C22H21ClFN3O3S10mg C23H17FN6O50mg C23H17FN6O25mg C9H11F2N3O4.HCI100mg C9H11F2N3O4.HCI200mg Cl2H6N2Pt10mg C20H19N5Na2O650mg C20H19N5Na2O6200mg C20H19N5Na2O6

10mg C8H12N4O425mg C8H12N4O450mg C8H12N4O4100mg C8H12N4O410mg C55H85N17O25S450mg C55H85N17O25S450mg C6H12N2O4Pt100mg C6H12N2O4Pt200mg C6H12N2O4Pt1g C15H22FN3O62g C9H12N2O6200mg C5H5N5200mg C5H5N5.HCl500mg 2(C5H5N5).H2SO45mg C27H27N7O2S10mg C27H27N7O2S50mg C27H27N7O2S200mg C27H27N7O2S10mg C9H6O425mg C9H6O450mg C9H6O41g C9H13N3O5200mg C8H12N4O5100mg C6H10N6O100mg C9H11F2N3O4300mg C9H11F2N3O410mg C9H13N3O625mg C9H13N3O6100mg C9H13N3O6200mg C9H13N3O610mg C15H17FN4O2.C4H4O425mg C15H17FN4O2.C4H4O4100mg C15H17FN4O2.C4H4O450mg C9H11FN2O5200mg C9H11FN2O510mg C8H9FN2O350mg C8H9FN2O31g C7H15Cl2N2O2P50mg C11H16FN3O350mg C8H14N2O4Pt100mg C8H14N2O4Pt200mg C8H14N2O4Pt5mg C11H15N5O510mg C11H15N5O550mg C11H15N5O5200mg C11H15N5O5100mg C7H15Cl2N2O2P200mg C7H15Cl2N2O2P10mg C10H11ClFN5O350mg C10H11ClFN5O325mg C10H12ClN5O350mg C10H12ClN5O310mg C21H22N4O6S50mg C21H22N4O6S100mg C21H22N4O6S10mg C27H29NO11.HCl25mg C27H29NO11.HCl

100mg C27H29NO11.HCl100mg C29H32O13500mg C29H32O1350mg C23H23N3O5.HCl100mg C23H23N3O5.HCl100mg C33H38N4O6200mg C33H38N4O6100mg C20H16N2O4250mg C20H16N2O4500mg C20H16N2O45mg C27H29NO11.HCl10mg C27H29NO11.HCl25mg C27H29NO11.HCl100mg C27H29NO11.HCl50mg C21H24FN3O4.HCl200mg C21H24FN3O4.HCl200mg C18H20FN3O410mg C32H37NO1250mg C32H37NO12200mg C32H37NO1210mg C16H17N3O250mg C16H17N3O2100mg C16H17N3O2500mg C14H6O825mg C15H10O550mg C15H10O5100mg C15H10O55mg C26H27NO9.HCl10mg C26H27NO9.HCl50mg C26H27NO9.HCl10mg C24H23FN4O325mg C24H23FN4O3100mg C24H23FN4O3500mg C24H23FN4O310mg C13H16N4O50mg C13H16N4O200mg C13H16N4O10mg C7H5IN2O350mg C7H5IN2O3200mg C7H5IN2O35mg C19H18FN3O.H3PO410mg C19H18FN3O.H3PO450mg C19H18FN3O.H3PO4200mg C19H18FN3O.H3PO45mg C19H20N4O10mg C19H20N4O50mg C19H20N4O100mg C19H20N4O5mg C7H8N2O10mg C7H8N2O50mg C7H8N2O200mg C7H8N2O5mg C18H17FN4O10mg C18H17FN4O50mg C18H17FN4O200mg C18H17FN4Oout of stock C17H17N3O2.HCl

out of stock C19H20N4O25mg C18H19N3O3S.C4H4O4200mg C18H19N3O3S.C4H4O425mg C18H19N3O3S50mg C18H19N3O3S200mg C18H19N3O3S25mg C13H14Cl2O3100mg C13H14Cl2O3200mg C13H14Cl2O35mg C18H19N3O3S.HClout of stock C35H36F3N3O45mg C12H8ClN3O310mg C12H8ClN3O325mg C12H8ClN3O350mg C12H8ClN3O35mg C13H13ClN2O10mg C13H13ClN2O25mg C13H13ClN2O100mg C14H12O3200mg C14H12O3500mg C14H12O35mg C26H22N2O225mg C26H22N2O25mg C25H23N7OS.HCl10mg C25H23N7OS.HCl50mg C25H23N7OS.HCl200mg C25H23N7OS.HCl10mg C21H17NO350mg C21H17NO3200mg C21H17NO35mg C15H20O210mg C15H20O210mg C27H29NO10.HCl50mg C27H29NO10.HCl250mg C13H21NO3.H2SO4500mg C13H21NO3.H2SO45mg C25H32F3N3O410mg C25H32F3N3O450mg C25H32F3N3O4200mg C25H32F3N3O41g C12H16N2S.HCl10mg C17H16ClNO.C4H4O450mg C17H16ClNO.C4H4O4100mg C17H16ClNO.C4H4O450mg C23H25N5O5.CH4O3S250mg C23H25N5O5.CH4O3S100mg C16H24N2O.HCl200mg C16H24N2O.HCl50mg C9H13NO35mg C9H13NO2.HCl10mg C9H13NO2.HCl100mg C9H13NO2.HCl200mg C9H13NO2.HCl25mg C53H72N2O12.2C6H5O3S100mg C53H72N2O12.2C6H5O3S10mg C16H22N2O3.HCl50mg C16H22N2O3.HCl

10mg C27H36N2O5.HCl100mg C27H36N2O5.HCl10mg C13H16N2.HCl50mg C13H16N2.HCl10mg C18H29NO350mg C18H29NO310mg C12H14N2.HCl100mg C12H14N2.HCl50mg C19H25N5O4.HCl250mg C19H25N5O4.HCl50mg 2C15H25NO3.C4H6O6100mg C8H13NO2100mg C17H19N3O.CH4O3S500mg C17H19N3O.CH4O3S10mg C18H29NO3.HCl50mg C18H29NO3.HCl10mg C19H24N2O4.1/2C4H4O450mg C19H24N2O4.1/2C4H4O45mg C24H28N2O3.C4H4O410mg C24H28N2O3.C4H4O450mg C24H28N2O3.C4H4O4200mg C24H28N2O3.C4H4O4200mg C9H13NO3.HCl10mg C13H16N2.HCl50mg C13H16N2.HCl100mg C13H16N25mg C21H15F4N5O2S10mg C21H15F4N5O2S50mg C21H15F4N5O2S100mg C21H15F4N5O2S100mg C9H11NO3.HCl10mg C13H21NO3.HCl50mg C13H21NO3.HCl100mg C9H13NO2.HCl500mg C11H17NO3.HCl500mg C17H21NO3.HCl50mg C14H14N2.HCl100mg C9H13NO3.C4H6O6200mg C9H13NO3.C4H6O650mg C12H20N2O3S.HCl100mg C12H20N2O3S.HCl200mg C12H20N2O3S.HCl100mg C18H22ClNO.HCl10mg C19H28O225mg C24H28N2O350mg C24H28N2O3100mg C24H28N2O310mg C12H14N2.HCl50mg C12H14N2.HCl200mg C12H14N2.HCl10mg C22H25F2NO4.HCl25mg C22H25F2NO4.HCl10mg C19H27N5O4.HCl50mg C19H27N5O4.HCl200mg C19H27N5O4.HCl25mg C24H28N2O3.2HCl50mg C24H28N2O3.2HCl

500mg C24H28N2O3.2HCl10mg C14H19N3O2.HCl50mg C14H19N3O2.HCl25mg C22H35NO8100mg C22H35NO810mg C15H17NO250mg C15H17NO2100mg C15H17NO225mg C14H21N3O2S.C4H6O450mg C14H21N3O2S.C4H6O4200mg C14H21N3O2S.C4H6O4500mg C14H21N3O2S.C4H6O4100mg C17H20N4S300mg C17H20N4S100mg C18H19ClN4500mg C18H19ClN410mg C21H24ClN2NaO4S50mg C21H24ClN2NaO4S100mg C21H24ClN2NaO4S10mg C25H34N4O250mg C25H34N4O2200mg C25H34N4O210mg C18H26ClN3O350mg C18H26ClN3O310mg C13H15ClN450mg C13H15ClN410mg C19H20FNO3.HCl.50mg C19H20FNO3.HCl.10mg C17H20ClN3O3.HCl50mg C17H20ClN3O3.HCl10mg C17H25N3O2S.C4H6O5100mg C17H25N3O2S.C4H6O520mg C23H30FN3100mg C23H30FN310mg C18H19NOS.HCl100mg C18H19NOS.HCl100mg C23H27Cl2N3O2500mg C23H27Cl2N3O2100mg C20H29N5O3.HCl500mg C20H29N5O3.HCl5mg C17H20ClN3O3.HCl50mg C17H20ClN3O3.HCl100mg C19H22ClN5O.HCl5mg C17H16FN310mg C17H16FN350mg C17H16FN310mg C18H19N3O50mg C18H19N3O10mg C19H24N2O.HCl10mg C18H28N2O3S.HCl50mg C18H28N2O3S.HCl10mg C14H18N2O50mg C14H18N2O5mg C25H27ClN2O.2HCl10mg C25H27ClN2O.2HCl50mg C25H27ClN2O.2HCl200mg C25H27ClN2O.2HCl

10mg C24H27FN2O2.HCl50mg C24H27FN2O2.HCl200mg C24H27FN2O2.HCl10mg C16H30N2.2HBr50mg C16H30N2.2HBr10mg C17H21NO.HCl50mg C17H21NO.HCl10mg C22H26N2O2S.HBr50mg C22H26N2O2S.HBr50mg C20H23N.HCl10mg C22H31N3O3.2HCl50mg C22H31N3O3.2HCl200mg C22H31N3O3.2HCl1g C19H23ClN2.HCl25mg C21H23NO.HCl50mg C21H23NO.HCl100mg C21H23NO.HCl10mg C16H21N3O225mg C16H21N3O250mg C16H21N3O2100mg C16H21N3O210mg C22H25N5O250mg C22H25N5O2100mg C22H25N5O210mg C23H27FN4O250mg C23H27FN4O2200mg C23H27FN4O210mg C17H25N3O2S50mg C17H25N3O2S25mg C17H27NO2.HCl50mg C17H27NO2.HCl200mg C17H27NO2.HCl10mg C21H25ClFN3O3.C6H8O725mg C21H25ClFN3O3.C6H8O750mg C21H25ClFN3O3.C6H8O7100mg C21H25ClFN3O3.C6H8O710mg C18H19N3O.HCl25mg C18H19N3O.HCl50mg C18H19N3O.HCl10mg C17H19ClF3NO25mg C17H19ClF3NO50mg C17H19ClF3NO25mg C18H24N4O.HCl50mg C18H24N4O.HCl100mg C18H24N4O.HCl10mg C24H29NO3.HCl25mg C24H29NO3.HCl50mg C24H29NO3.HCl100mg C24H29NO3.HCl10mg C5H9NO3S50mg C5H9NO3S5mg C13H13N3.C4H6O610mg C13H13N3.C4H6O650mg C13H13N3.C4H6O6100mg C13H13N3.C4H6O610mg C32H53N2O4.Br25mg C32H53N2O4.Br

500mg C22H31NO32mg C26H37NO3.C4H4O45mg C26H37NO3.C4H4O410mg C26H37NO3.C4H4O450mg C26H37NO3.C4H4O450mg C14H22N2O2.C4H6O6100mg C18H23NO.C6H8O7100mg C17H20N2O25mg C22H31NO210mg C22H31NO250mg C22H31NO2200mg C22H31NO210mg C23H26N2O.C4H6O4200mg C23H26N2O.C4H6O4out of stock C29H43BrN2O410mg C28H30N2O2.HBr100mg C28H30N2O2.HBrout of stock C22H31NO3.HCl250mg C8H13NO2.HBr10mg C13H14ClN3O450mg C13H14ClN3O4200mg C13H14ClN3O45mg C19H22NO4S2.Br.xH2O25mg C19H22NO4S2.Br.xH2O50mg C19H22NO4S2.Br.xH2O100mg C19H22NO4S2.Br.xH2O25mg C25H30NO3.Cl50mg C25H30NO3.Cl200mg C25H30NO3.Cl10mg C22H31NO.C4H6O625mg C22H31NO.C4H6O650mg C22H31NO.C4H6O6100mg C22H31NO.C4H6O6250mg C7H17N2O2.Cl100mg C12H19N2O2.Br10mg 2(C17H23NO3).H2O.H2SO450mg 2(C17H23NO3).H2O.H2SO450mg C18H24BrNO4200mg C18H24BrNO4100mg C9H7Cl2N5250mg C9H7Cl2N550mg C7H16NO2.Cl100mg C7H16NO2.Cl200mg C7H16NO2.Cl500mg C7H16NO2.Cl10mg C9H13BrN2O250mg C9H13BrN2O2100mg C9H13BrN2O250mg C17H21NO3.HBr100mg C17H21NO3.HBr500mg C17H21NO3.HBr10mg C12H11NO50mg C12H11NO5mg C27H41NO210mg C27H41NO225mg C27H41NO250mg C27H41NO2

5mg C26H24F4N6O10mg C26H24F4N6O50mg C26H24F4N6O200mg C26H24F4N6O5mg C26H26F3N3O310mg C26H26F3N3O325mg C26H26F3N3O350mg C26H26F3N3O35mg C20H25ClN4O3S10mg C20H25ClN4O3S50mg C20H25ClN4O3S100mg C20H25ClN4O3S10mg C22H23ClN2O250mg C22H23ClN2O2100mg C22H23ClN2O2100mg C21H26ClNO.C4H4O4100mg C18H20N2.HC200mg C18H20N2.HC100mg C21H25ClN2O3.2HCl200mg C21H25ClN2O3.2HCl500mg C21H25ClN2O3.2HCl5g C14H22N2O250mg C10H16N6S100mg C16H19ClN2.C4H4O410mg C26H26ClN3.C4H4O41g C21H25NO.CH4SO3100mg C8H12N2.2HCl5mg C16H18N2O2.C4H4O425mg C16H18N2O2.C4H4O4100mg C19H28N2O4.HCl100mg C24H25FN6O10mg C22H29N3O4S50mg C22H29N3O4S50mg C21H21N.HCl1g C19H19NOS.C4H4O410mg C21H25ClN2O3.C6H6O3S50mg C21H25ClN2O3.C6H6O3S10mg C32H39NO4.HCl50mg C32H39NO4.HCl5mg C20H22N2.2C4H4O4200mg C20H22N2.2C4H4O41g C16H21N3.HCl1g C19H22ClNO100mg C16H19BrN2.C4H4100mg C22H24ClN3O.HCl200mg C22H24ClN3O.HCl200mg C12H21N5O2S225mg C46H54N6O8S250mg C46H54N6O8S2100mg C46H54N6O8S250mg C17H27N3O4S100mg C17H27N3O4S500mg C17H27N3O4S100mg C18H18ClNS25mg C23H27FN4O350mg C23H27FN4O3100mg C23H27FN4O3

5g C15H23N3O4S10mg C16H16ClNO350mg C16H16ClNO35mg C28H36N4O2S.HCl200mg C16H24N2O100mg C8H11NO2.HCl200mg C8H11NO2.HClout of stock C11H13N3O.C4H4O4out of stock C11H13N3O.C4H4O4out of stock C11H13N3O.C4H4O4out of stock C11H13N3O.C4H4O450mg C13H18ClNO.HCl100mg C13H18ClNO.HCl200mg C13H18ClNO.HCl500mg C13H18ClNO.HCl10mg C10H15N3O5.HCl50mg C10H15N3O5.HCl100mg C10H15N3O5.HCl25mg C10H17N.HCl100mg C10H17N.HCl100mg C20H28N2O5.C4H4O45mg C24H28N2O3.HCl10mg C24H28N2O3.HCl50mg C24H28N2O3.HCl200mg C24H28N2O3.HCl1g C29H33ClN2O2.HCl5mg C26H25N3O2.HCl10mg C26H25N3O2.HCl50mg C26H25N3O2.HCl100mg C22H29NO5100mg C20H23NO4.HCl250mg C20H23NO4.HCl50mg C19H21NO4.HCl100mg C19H21NO4.HCl2mg C22H22IN3O35mg C22H22IN3O310mg C22H22IN3O325mg C22H22IN3O3out of stock C24H28ClN3O5mg C18H17Cl2F3N4O210mg C18H17Cl2F3N4O225mg C18H17Cl2F3N4O210mg C22H21Cl3N4O25mg C22H21Cl3N4O50mg C22H21Cl3N4O100mg C22H21Cl3N4O10mg C23H23ClN2O450mg C23H23ClN2O45mg C22H21Cl2IN4O10mg C22H21Cl2IN4O50mg C22H21Cl2IN4O100mg C18H28N2O.HCl10mg C22H34O725mg C22H34O750mg C22H34O7200mg C22H34O75mg C19H16N6O4S

10mg C19H16N6O4S50mg C19H16N6O4S5mg C18H14ClN2O6S2.Na10mg C18H14ClN2O6S2.Na50mg C18H14ClN2O6S2.Na100mg C18H14ClN2O6S2.Na10mg C27H29N5O6S.H2O200mg C27H29N5O6S.H2O10mg C22H22F3N.HCl100mg C22H22F3N.HCl10mg C24H25ClN2O250mg C24H25ClN2O2200mg C24H25ClN2O25mg C28H54N8.8HCl10mg C28H54N8.8HCl50mg C28H54N8.8HClout of stock C24H38N6.6HBr5mg C19H18F2N4O10mg C19H18F2N4O25mg C19H18F2N4O100mg C19H18F2N4Oout of stock C23H27N3O45mg C21H25ClO610mg C21H25ClO650mg C21H25ClO6200mg C21H25ClO65mg C24H25FO5S10mg C24H25FO5S50mg C24H25FO5S200mg C24H25FO5S2mg C23H23ClN2O5S5mg C23H23ClN2O5S10mg C23H23ClN2O5S10mg C24H20N6O3100mg C24H20N6O32mg C30H53N3O6.1/2C4H4O410mg C30H53N3O6.1/2C4H4O450mg C30H53N3O6.1/2C4H4O410mg C25H28N6O50mg C25H28N6O50mg C22H23ClKN6O100mg C22H23ClKN6O200mg C22H23ClKN6O100mg C19H32N2O5.C4H11N200mg C19H32N2O5.C4H11N500mg C19H32N2O5.C4H11N50mg C18H24N2O5.2H2O10mg C24H29N5O350mg C24H29N5O3100mg C24H29N5O3200mg C24H29N5O350mg C33H30N4O2100mg C33H30N4O250mg C24H28N2O5.HCl250mg C24H28N2O5.HCl500mg C24H28N2O5.HCl500mg C23H32N2O5

10mg C29H30N6O6100mg C29H30N6O610mg C28H36O650mg C28H36O6200mg C28H36O6250mg C25H30N2O5.HCl100mg C9H15NO3S100mg C21H31N3O510mg C22H31N3O5.H2O100mg C22H31N3O5.H2O10mg C27H34N2O750mg C27H34N2O725mg C30H45NO7P.Na100mg C30H45NO7P.Na10mg C23H28N2O5S225mg C23H28N2O5S210mg C20H27N3O650mg C20H27N3O610mg C25H20N4O550mg C25H20N4O55mg C30H24N4O810mg C30H24N4O8100mg C30H24N4O8200mg C30H24N4O810mg C23H28N2O5S2.HCl25mg C23H28N2O5S2.HCl25mg C32H47F5O3S100mg C32H47F5O3S250mg C26H29NO.C6H8O750mg C28H27NO4S.HCl100mg C28H27NO4S.HCl5mg C18H18O310mg C18H18O350mg C18H18O3200mg C18H18O310mg C20H25NO225mg C20H25NO2100mg C20H25NO210mg C21H26O225mg C21H26O2100mg C21H26O210mg C24H30O325mg C24H30O3100mg C24H30O3500mg C24H30O31g C19H30O210mg C26H25ClN2O350mg C26H25ClN2O35g C21H28O25mg C15H14O325mg C15H14O3500mg C24H32O41g C23H32O3100mg C21H26O21g C24H34O41g C26H28ClNO.C6H8O71g C18H24O3

25mg C32H36ClNO850mg C32H36ClNO8100mg C32H36ClNO8200mg C32H36ClNO8100mg C18H22O2200mg C18H22O250mg C29H35NO210mg C27H30F6N2O2100mg C27H30F6N2O2100mg C23H36N2O2200mg C23H36N2O250mg C8H11N5O3100mg C8H11N5O3200mg C8H11N5O3500mg C8H11N5O3out of stock C33H48O6out of stock C29H42N4O5S3out of stock C22H16O610mg C14H12O3S50mg C14H12O3S5mg C14H19NO3.HCl10mg C14H19NO3.HCl50mg C14H19NO3.HCl100mg C14H19NO3.HClout of stock C28H32F2N2O.2HCl10mg C20H20BrN3O2S.2HCl50mg C20H20BrN3O2S.2HCl200mg C20H20BrN3O2S.2HCl5mg C15H14F2N4S10mg C15H14F2N4S50mg C15H14F2N4S200mg C15H14F2N4S5mg C20H34O510mg C20H34O550mg C20H34O5100mg C20H34O5out of stock C18H19N5O3S5mg C21H16F4N4O2S10mg C21H16F4N4O2S50mg C21H16F4N4O2S50mg C18H14F4N2O4S100mg C18H14F4N2O4S200mg C18H14F4N2O4S5mg C19H14F3N3O310mg C19H14F3N3O350mg C19H14F3N3O3200mg C19H14F3N3O35mg C19H18F3N3O610mg C19H18F3N3O650mg C19H18F3N3O61g C24H32O45g C24H32O4out of stock C24H34O5100mg C24H29ClO4250mg C24H29ClO45mg C26H32N2O25mg C26H32N2O

50mg C26H32N2O200mg C26H32N2O10mg C17H19N550mg C17H19N5100mg C17H19N510mg C20H24O225mg C20H24O250mg C20H24O2100mg C20H24O21g C19H26O3100mg C13H16N2O2200mg C13H16N2O2500mg C13H16N2O25mg C29H32O7S.1/2H2O10mg C29H32O7S.1/2H2O50mg C29H32O7S.1/2H2O200mg C29H32O7S.1/2H2O10mg C23H28N4O4S50mg C23H28N4O4S5mg C24H31NO25mg C24H31NO100mg C24H31NO10mg C16H14F3N5O25mg C16H14F3N5O100mg C16H14F3N5O200mg C16H14F3N5O5mg C26H33NO225mg C26H33NO2100mg C26H33NO210mg C29H43NO4S50mg C29H43NO4S200mg C29H43NO4S100mg C26H28Cl2N4O4500mg C26H28Cl2N4O4out of stock C9H16Br2N5O4Pout of stock C19H20N2O3S.HCl100mg C38H69NO13250mg C38H69NO13500mg C38H69NO1325mg C14H8O4100mg C14H8O4100mg C11H11F3N2O35mg C18H17N3O210mg C18H17N3O250mg C18H17N3O25mg C20H25NO410mg C20H25NO450mg C20H25NO4200mg C20H25NO45mg C17H14Cl2F2N2O310mg C17H14Cl2F2N2O325mg C17H14Cl2F2N2O350mg C17H14Cl2F2N2O35mg C19H18N4O210mg C19H18N4O250mg C19H18N4O2200mg C19H18N4O2

25mg C22H30N6O4S.C6H8O750mg C22H30N6O4S.C6H8O7500mg C22H30N6O4S.C6H8O750mg C22H19N3O4100mg C22H19N3O4500mg C22H19N3O410mg C16H21NO325mg C16H21NO350mg C16H21NO310mg C14H18N2O50mg C14H18N2O10mg C10H7Cl2N3O.HCl50mg C10H7Cl2N3O.HCl5mg C25H20N4O10mg C25H20N4O50mg C25H20N4O200mg C25H20N4O10mg C27H26N4O5S50mg C27H26N4O5S200mg C27H26N4O5S5mg C16H21NO310mg C16H21NO325mg C16H21NO350mg C16H21NO325mg C16H24N10O4200mg C16H24N10O4100mg C10H14N4O425mg C20H27N5O2100mg C20H27N5O2500mg C20H27N5O210mg C10H16N2O4S3.HCl25mg C10H16N2O4S3.HCl100mg C10H16N2O4S3.HCl500mg C7H4O3S10mg C12H21N3O5S350mg C12H21N3O5S35mg C13H12FN3O3S10mg C13H12FN3O3S25mg C13H12FN3O3S50mg C13H12FN3O3S50mg C23H31NO7100mg C23H31NO7200mg C23H31NO75mg C17H16BrFN6O410mg C17H16BrFN6O450mg C17H16BrFN6O4200mg C17H16BrFN6O45mg C22H28O2S250mg C22H28O2S225mg C5H4ClNO25mg C19H18ClN3O5S10mg C19H18ClN3O5S50mg C19H18ClN3O5S10mg C25H25N5O450mg C25H25N5O4200mg C25H25N5O410mg C13H12N2O2

25mg C13H12N2O250mg C13H12N2O2200mg C13H12N2O2out of stock C31H27F3N6O350mg C24H25FNNaO4100mg C24H25FNNaO4200mg C24H25FNNaO450mg C24H36O550mg 2(C33H34FN2O5).Ca500mg 2(C33H34FN2O5).Ca50mg C23H35O7.Na200mg C23H35O7.Na10mg C27H22Cl2N4O50mg C27H22Cl2N4O200mg C27H22Cl2N4O5mg C26H24N2O410mg C26H24N2O450mg C26H24N2O4200mg C26H24N2O45mg C27H31Br2ClN4O210mg C27H31Br2ClN4O2100mg C27H31Br2ClN4O2200mg C27H31Br2ClN4O210mg C19H14N2O450mg C19H14N2O45mg C30H25F10NO310mg C30H25F10NO350mg C30H25F10NO3200mg C30H25F10NO35mg C23H35NO2S10mg C23H35NO2S50mg C23H35NO2S100mg C23H35NO2S10mg C26H25F9N2O450mg C26H25F9N2O4100mg C20H22N8O5200mg C20H22N8O5500mg C20H22N8O510mg C23H23N7O550mg C23H23N7O55mg C20H22N2O325mg C20H22N2O3100mg C20H22N2O3500mg C20H22N2O310mg C24H23F3N4O250mg C24H23F3N4O2200mg C24H23F3N4O210mg C19H19N5OS25mg C19H19N5OS50mg C19H19N5OS5mg C17H19FN2O2.CH4O3S10mg C17H19FN2O2.CH4O3S50mg C17H19FN2O2.CH4O3S200mg C17H19FN2O2.CH4O3S50mg C12H13N.CH4O3S100mg C12H13N.CH4O3S10mg C13H17ClN2O2

50mg C13H17ClN2O25mg C14H15F2N3S.HCl10mg C14H15F2N3S.HCl50mg C14H15F2N3S.HCl200mg C14H15F2N3S.HCl200mg C20H28O2500mg C20H28O25mg C21H30N2O610mg C21H30N2O650mg C21H30N2O65mg C21H20N2O510mg C21H20N2O550mg C21H20N2O5200mg C21H20N2O5out of stock C22H18F3N3O4S2mg C22H19Cl3N85mg C22H19Cl3N825mg C22H19Cl3N8100mg C22H19Cl3N810mg C5H4N4O50mg C5H4N4O2mg C25H17F2N5O3S5mg C25H17F2N5O3S10mg C25H17F2N5O3S50mg C25H17F2N5O3S200mg C18H22O225mg C17H11N550mg C17H11N5200mg C17H11N5

In the renin-angiotensin system (RAS), renin activates angiotensinogen to yield angiotensin I, which is further converted into angiotensin II by angiotensin-converting enzyme. Removal of the kidney generates renin/prorenin deficient plasma with high levels of angiotensinogen. This nephrectomized rat plasma can be used as a source of angiotensinogen or as a substrate for renin generation of Ang I. Plasma is collected from male rats at least 48 hours post nephrectomy. The substrate activity is determined by incubation with renin followed by Ang I radio-immune assay (RIA).In the renin-angiotensin system (RAS), renin activates angiotensinogen to yield angiotensin I, which is further converted into angiotensin II by angiotensin-converting enzyme. Removal of the kidney generates renin/prorenin deficient plasma with high levels of angiotensinogen. This nephrectomized rat plasma can be used as a source of angiotensinogen or as a substrate for renin generation of Ang I. Plasma is collected from male rats at least 48 hours post nephrectomy. The substrate activity is determined by incubation with renin followed by Ang I radio-immune assay (RIA).In the renin-angiotensin system (RAS), renin activates angiotensinogen to yield angiotensin I, which is further converted into angiotensin II by angiotensin-converting enzyme. Removal of the kidney generates renin/prorenin deficient plasma with high levels of angiotensinogen. This nephrectomized rat plasma can be used as a source of angiotensinogen or as a substrate for renin generation of Ang I. Plasma is collected from male rats at least 48 hours post nephrectomy. The substrate activity is determined by incubation with renin followed by Ang I radio-immune assay (RIA).In the renin-angiotensin system (RAS), renin activates angiotensinogen to yield angiotensin I, which is further converted into angiotensin II by angiotensin-converting enzyme. Removal of the kidney generates renin/prorenin deficient plasma with high levels of angiotensinogen. This nephrectomized rat plasma can be used as a source of angiotensinogen or as a substrate for renin generation of Ang I. Plasma is collected from male rats at least 48 hours post nephrectomy. The substrate activity is determined by incubation with renin followed by Ang I radio-immune assay (RIA).Recombinantly produced in HEK cell culture and purified by chelated metal affinity chromatography. Contains a 8X-Histidine tag at C terminus for purification. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminusRecombinantly produced in HEK cell culture and purified by chelated metal affinity chromatography. Contains a 8X-Histidine tag at C terminus for purification. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminusRecombinantly produced in HEK cell culture as untagged native form prorenin and purified by affinity chromatography. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus. This so called prosegment appears to block the full enzymatic potential of the active site (1). Renin activates the renin-angiotensin system by cleaving angiotensinogen, produced by the liver, to yield angiotensin I, which is further converted into angiotensin II by ACE, the angiotensin-converting enzyme primarily within the capillaries of the lungs. It has been reported that the levels of circulating prorenin (but not renin) are increased in diabetic subjects(2).Recombinantly produced in HEK cell culture as untagged native form prorenin and purified by affinity chromatography. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus. This so called prosegment appears to block the full enzymatic potential of the active site (1). Renin activates the renin-angiotensin system by cleaving angiotensinogen, produced by the liver, to yield angiotensin I, which is further converted into angiotensin II by ACE, the angiotensin-converting enzyme primarily within the capillaries of the lungs. It has been reported that the levels of circulating prorenin (but not renin) are increased in diabetic subjects(2).Recombinantly produced in HEK cell culture as untagged native form prorenin and purified by affinity chromatography. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus.Recombinantly produced in HEK cell culture as untagged native form prorenin and purified by affinity chromatography. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus.Recombinantly produced in HEK cell culture and purified by chelated metal affinity chromatography. Contains a 8X-Histidine tag at C terminus for purification. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus. This so called prosegment appears to block the full enzymatic potential of the active site (1). Renin activates the renin-angiotensin system by cleaving angiotensinogen, produced by the liver, to yield angiotensin I, which is further converted into angiotensin II by ACE, the angiotensin-converting enzyme primarily within the capillaries of the lungs.Recombinantly produced in HEK cell culture and purified by chelated metal affinity chromatography. Contains a 8X-Histidine tag at C terminus for purification. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus. This so called prosegment appears to block the full enzymatic potential of the active site (1). Renin activates the renin-angiotensin system by cleaving angiotensinogen, produced by the liver, to yield angiotensin I, which is further converted into angiotensin II by ACE, the angiotensin-converting enzyme primarily within the capillaries of the lungs.Recombinantly produced in HEK cell culture and purified by chelated metal affinity chromatography. Contains a 8X-Histidine tag at C terminus for purification. Resistant to activation to renin by trypsin digestion. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus.Recombinantly produced in HEK cell culture and purified by chelated metal affinity chromatography. Contains a 8X-Histidine tag at C terminus for purification. Resistant to activation to renin by trypsin digestion. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus.

Sprague Dawley Rat Albumin is a water-soluble protein with considerable structural stability which makes up 60percent of the total protein of plasma. It functions as a carrier of hormones, enzymes, fatty acids, metal ions, and medicinal products. Prepared from US origin rat plasma by proprietary fractionation methods and lyophilized. 95percent pure by SDS-PAGE.Sprague Dawley Rat Albumin is a water-soluble protein with considerable structural stability which makes up 60percent of the total protein of plasma. It functions as a carrier of hormones, enzymes, fatty acids, metal ions, and medicinal products. Prepared from US origin rat plasma by proprietary fractionation methods and lyophilized. 95percent pure by SDS-PAGE.Rabbit albumin is a water-soluble protein with considerable structural stability which makes up 60percent of the total protein of plasma. It functions as a carrier of hormones, enzymes, fatty acids, metal ions, and medicinal products. Prepared from US origin rabbit plasma by proprietary fractionation methods and lyophilized. 95percent pure by SDS-PAGE.Rabbit albumin is a water-soluble protein with considerable structural stability which makes up 60percent of the total protein of plasma. It functions as a carrier of hormones, enzymes, fatty acids, metal ions, and medicinal products. Prepared from US origin rabbit plasma by proprietary fractionation methods and lyophilized. 95percent pure by SDS-PAGE.Albumin is a water-soluble protein with considerable structural stability which makes up 60percent of the total protein of plasma. It functions as a carrier of hormones, enzymes, fatty acids, metal ions, and medicinal products. Prepared from US origin horse plasma by proprietary fractionation methods and lyophilized. 95percent pure by SDS-PAGE.Albumin is a water-soluble protein with considerable structural stability which makes up 60percent of the total protein of plasma. It functions as a carrier of hormones, enzymes, fatty acids, metal ions, and medicinal products. Prepared from cyno plasma by proprietary fractionation methods and lyophilized. 95percent pure by SDS-PAGE.Albumin is a water-soluble protein with considerable structural stability which makes up 60percent of the total protein of plasma. It functions as a carrier of hormones, enzymes, fatty acids, metal ions, and medicinal products. Prepared from US origin canine plasma by proprietary fractionation methods and lyophilized. 95percent pure by SDS-PAGE.Albumin is a water-soluble protein with considerable structural stability which makes up 60percent of the total protein of plasma. It functions as a carrier of hormones, enzymes, fatty acids, metal ions, and medicinal products. Prepared from US origin canine plasma by proprietary fractionation methods and lyophilized. 95percent pure by SDS-PAGE.Human Albumin (HSA) solubility: Albumin(s) are readily soluble in dionized water and can only preciptated by high concentrations of nuetral salts. Human Serum Albumin helps stabilize other solubilized proteins. Human Serum Albumin (HSA)is readily coagulated with heat. Human Serum Albumin(s) with other albumin(s) are acidic proteins which occur in abundance in body fluids and tissues. As a poducer, Manufacturer and supplier of finished human proteins for research and IVD manufacturing we can custom fill to your requirement.Human Albumin (HSA) solubility: Albumin(s) are readily soluble in dionized water and can only preciptated by high concentrations of nuetral salts. Human Serum Albumin helps stabilize other solubilized proteins. Human Serum Albumin (HSA)is readily coagulated with heat. Human Serum Albumin(s) with other albumin(s) are acidic proteins which occur in abundance in body fluids and tissues. As a poducer, Manufacturer and supplier of finished human proteins for research and IVD manufacturing we can custom fill to your requirement.

Using information obtained from the studies which produced stabilized human PAI-1 (ICPAI) we have available a form of mouse PAI-1 that has a single conservative mutation (Isoleucine 91 to Leucine).Latent mouse PAI-1 is a useful control for experiments when used in conjunction with the active form.Latent mouse PAI-1 is a useful control for experiments when used in conjunction with the active form.Recombinant mouse PAI-1 is the ideal choice for studies involving this animal model of fibrinolysis and cancer studies. The active fraction typically contains 70percent active PAI-1.Recombinant mouse PAI-1 is the ideal choice for studies involving this animal model of fibrinolysis and cancer studies. The active fraction typically contains 70percent active PAI-1.Prepared from frozen mouse plasma using immobilized anti-mouse PAI-1 IgG.Prepared from frozen mouse plasma using immobilized anti-mouse PAI-1 IgG.Porcine (pig) PAI-1 displays a close homology to bovine and human PAI-1 with 90 and 86percent amino acid homology, respectively.Porcine (pig) PAI-1 displays a close homology to bovine and human PAI-1 with 90 and 86percent amino acid homology, respectively.This latent fraction of recombinant rabbit PAI-1 is biotin labeled on lysine residues.Latent Rabbit PAI-1 is a useful control for experiments when used in conjunction with the active formLatent Rabbit PAI-1 is a useful control for experiments when used in conjunction with the active formRabbit PAI-1 is now available and is preferred for animal studies that utilize rabbit models. Wild type rabbit PAI-1 is less than 20percent active and may not be suitable for most experiments. As a replacement please consider rabbit PAI-1 stable mutant which is 70-80percent activeRabbit PAI-1 is now available and is preferred for animal studies that utilize rabbit models. Wild type rabbit PAI-1 is less than 20percent active and may not be suitable for most experiments. As a replacement please consider rabbit PAI-1 stable mutant which is 70-80percent activePrepared from frozen rabbit plasma using immobilized anti-rat PAI-1 IgG.Prepared from frozen rabbit plasma using immobilized anti-rat PAI-1 IgG.

Latent rat PAI-1 is a useful control for experiments when used in conjunction with the active form or stable mutant.Latent rat PAI-1 is a useful control for experiments when used in conjunction with the active form or stable mutant.Recombinant rat PAI-1 is the ideal choice for studies involving this animal model of fibrinolysis and cancer studies. The active fraction typically contains 95percent active PAI-1.Recombinant rat PAI-1 is the ideal choice for studies involving this animal model of fibrinolysis and cancer studies. The active fraction typically contains 95percent active PAI-1.A single mutation at the P1 position of PAI-1 alters the target specificity of PAI-1 from the plasminogen activators tPA and uPA to Cathepsin G.A single mutation at the P1 position of PAI-1 alters the target specificity of PAI-1 from the plasminogen activators tPA and uPA to Cathepsin G.A single mutation at the P1 position of PAI-1 alters the target specificity of PAI-1 from the plasminogen activators tPA and uPA to elastase. PAI-1 is normally a substrate for pancreatic and neutrophil elastase becoming cleaved at the P3 position.A single mutation at the P1 position of PAI-1 alters the target specificity of PAI-1 from the plasminogen activators tPA and uPA to elastase. PAI-1 is normally a substrate for pancreatic and neutrophil elastase becoming cleaved at the P3 position.This human PAI-1 variant contains a mutation at the active site to make it specific for inhibition of neutrophil elastase. Additional mutations provide resistance to cleavage and stability.Human PAI-1 stable mutant is reacted with an excess of human urokinase at physiological pH. Excess uPA is removed from the resulting 1:1 molar complex by immobilized benzamidine resin.Human PAI-1 stable mutant is reacted with an excess of human sc-tPA at physiological pH. The resulting 1:1 molar complex is purified from the remaining tPA by cobalt metal affinity chromatography resin.This mutant contains a Ser to Cys replacement around the vitronectin binding site. Incorporation of an NBD labels allows for the reporting of binding to vitronectin.This mutant contains a Ser to Cys replacement around the vitronectin binding site. Incorporation of an NBD labels allows for the reporting of binding to vitronectin.A single mutation results in nearly complete loss of binding of the PAI-1 mutant to the important ligand vitronectin. All other aspects of PAI-1 biological activity such as anti-protease activity remain unaffected.A single mutation results in nearly complete loss of binding of the PAI-1 mutant to the important ligand vitronectin. All other aspects of PAI-1 biological activity such as anti-protease activity remain unaffected.Stable mutant human PAI-1 fluorescein labeled by iodoacetamide substitution at the N-terminal cysteine (patent pending).Stable mutant human PAI-1 fluorescein labeled by iodoacetamide substitution at the N-terminal cysteine (patent pending).Latent human PAI-1 fluorescein labeled by iodoacetamide substitution at the N-terminal cysteine (patent pending).Latent human PAI-1 fluorescein labeled by iodoacetamide substitution at the N-terminal cysteine (patent pending).Latent human PAI-1 fluorescein labeled by iodoacetamide substitution at the N-terminal cysteine (patent pending).Latent human PAI-1 fluorescein labeled by iodoacetamide substitution at the N-terminal cysteine (patent pending).

Albumin is a water-soluble protein with considerable structural stability which makes up 60percent of the total protein of plasma. It functions as a carrier of hormones, enzymes, fatty acids, metal ions, and medicinal products. Prepared from US origin mouse (murine) plasma by proprietary fractionation methods and lyophilized. 95percent pure by SDS-PAGE. Add deionized water or buffer to original or desired volume, aliquot and freeze unused portion. Albumin is a water-soluble protein with considerable structural stability which makes up 60percent of the total protein of plasma. It functions as a carrier of hormones, enzymes, fatty acids, metal ions, and medicinal products. Prepared from US origin mouse (murine) plasma by proprietary fractionation methods and lyophilized. 95percent pure by SDS-PAGE. Add deionized water or buffer to original or desired volume, aliquot and freeze unused portion. 

This recombinant rat PAI-1 has a single conservative mutation (Isoleucine 91 to Leucine) that yields a rat PAI-1 with an enhanced half-life as compared to the wild type. This recombinant rat PAI-1 has a single conservative mutation (Isoleucine 91 to Leucine) that yields a rat PAI-1 with an enhanced half-life as compared to the wild type. 

Stable mutant human PAI-1 biotin labeled by iodoacetamide substitution at the N-terminal cysteine (patent pending).Stable mutant human PAI-1 biotin labeled by iodoacetamide substitution at the N-terminal cysteine (patent pending).Glycosylated wild type human PAI-1 produced in insect cells with molecular weight of 46,000 Da. Latent form.Glycosylated wild type human PAI-1 produced in insect cells with molecular weight of 46,000 Da. Latent form.Glycosylated wild type human PAI-1 produced in insect cells with molecular weight of 46,000 Da. Active form.Glycosylated wild type human PAI-1 produced in insect cells with molecular weight of 46,000 Da. Active form.A patent pending mutant of human PAI-1 containing four mutations that stabilize the activity of PAI-1 has been made available. The N-terminus has been additionally modified with the introduction of a 6-X histidine tag. The tag allows for the immobilization of functionally active PAI-1 onto surfaces such as metal chelate microtiter plates or Ni+2 resins. Many new applications for PAI-1 can be envisioned with this unique reagent.A patent pending mutant of human PAI-1 containing four mutations that stabilize the activity of PAI-1 has been made available. The N-terminus has been additionally modified with the introduction of a 6-X histidine tag. The tag allows for the immobilization of functionally active PAI-1 onto surfaces such as metal chelate microtiter plates or Ni+2 resins. Many new applications for PAI-1 can be envisioned with this unique reagent.The human form of PAI-1 contains the following four mutations: K154T, Q319L, M354I and N150H. These mutations combine to confer great stability to the otherwise labile molecule essentially locking in into the active conformation. It is an ideal choice for in vivo studies.The human form of PAI-1 contains the following four mutations: K154T, Q319L, M354I and N150H. These mutations combine to confer great stability to the otherwise labile molecule essentially locking in into the active conformation. It is an ideal choice for in vivo studies.The Q123K point mutation on the human PAI-1 stable mutant background (K154T, Q319L, M354I and N150H) results in PAI-1 with a greatly extended half life and reduced binding to the important ligand vitronectin.

Prepared from fresh bovine plasma by immobilized lysine chromatographyPrepared from fresh bovine plasma by immobilized lysine chromatographyPrepared from fresh bovine plasma by immobilized lysine chromatography.Prepared from fresh bovine plasma by immobilized lysine chromatography.Prepared from fresh US origin dog (canine) plasma by immobilized lysine chromatography.Prepared from plasminogen by activation with immobilized human uPA. 100% functionally active plasmin is purified from the activation reaction by immobilized SBTI. Plasmin will undergo rapid auto proteolysis in the absence of benzamidine and should be used quickly once thawed. Aliquot to avoid freeze-thaw cyclesPrepared from plasminogen by activation with immobilized human uPA. 100% functionally active plasmin is purified from the activation reaction by immobilized SBTI. Plasmin will undergo rapid auto proteolysis in the absence of benzamidine and should be used quickly once thawed. Aliquot to avoid freeze-thaw cyclesPrepared from fresh chicken plasma by immobilized lysine chromatography.Prepared from fresh chicken plasma by immobilized lysine chromatography.

Prepared from plasminogen by activation with immobilized human uPA.Prepared from plasminogen by activation with immobilized human uPA.Prepared from fresh mouse plasma by immobilized lysine chromatography.Prepared from plasminogen by activation with immobilized human uPA.Prepared from plasminogen by activation with immobilized human uPA.Prepared from fresh rabbit plasma by immobilized lysine chromatography.Prepared from fresh rabbit plasma by immobilized lysine chromatography.Prepared from plasminogen by activation with immobilized human uPA.Prepared from plasminogen by activation with immobilized human uPA.Prepared from fresh rat plasma by immobilized lysine chromatography.Prepared from fresh rat plasma by immobilized lysine chromatography.The plasmin substrate is chemically and functionally identical to Chromogenix S-2251. Each 25 mg of substrate is lyophilized with 60 mg mannitol as a bulking agentEfficiently inhibits the plasminogen-activator-induced lysis of fibrin clots. Found in plasma at about 70 ug per ml. Alpha-antiplasmin-deficiency is a rare coagulation disorder which allows unrestrained fibrinolytic activity.Prepared from Lys plasmin by active site-specific inactivation with Phe-Pro-Arg chloromethyl ketone.Prepared from Lys plasmin by active site-specific inactivation with Phe-Pro-Arg chloromethyl ketone.Prepared from Glu plasminogen by activation with immobilized human uPA.Prepared from Glu plasminogen by activation with immobilized human uPA.Prepared from fresh human plasma by immobilized lysine chromatography.Prepared from fresh human plasma by immobilized lysine chromatography.Recombinantly produced in insect cells and fluorescein labeled.Recombinantly produced in insect cells and fluorescein labeled.Recombinantly produced in insect cells and biotin labeled.Recombinantly produced in insect cells and biotin labeled.Mouse tPA with a double mutation that is permanently single chain and lacks catalytic activity. The non-catalytic mutation site is S481A on the mature protein and S510A on the complete mRNA sequence (UniProtKB: locus TPA_MOUSE, accession P11214).Mouse tPA with a double mutation that is permanently single chain and lacks catalytic activity. The non-catalytic mutation site is S481A on the mature protein and S510A on the complete mRNA sequence (UniProtKB: locus TPA_MOUSE, accession P11214).The addition of an arginine to glutamic acid mutation generates mouse tPA that is 100percent single chain and resistant to cleavage by plasmin. The mutation site is R279E on the mature protein and R308E on the complete mRNA sequence (UniProtKB: locus TPA_MOUSE, accession P11214). Recombinantly produced in insect cells.The addition of an arginine to glutamic acid mutation generates mouse tPA that is 100percent single chain and resistant to cleavage by plasmin. The mutation site is R279E on the mature protein and R308E on the complete mRNA sequence (UniProtKB: locus TPA_MOUSE, accession P11214). Recombinantly produced in insect cells.This single chain mouse tPA has the active site serine mutated to alanine rendering the enzyme catalytically inactive. The mutation site is S481A on the mature protein and S510A on the complete mRNA sequence (UniProtKB: locus TPA_MOUSE, accession P11214). The tPA still retains exosite binding as well as other biological properties of tPA including but not limited to surface binding to fibrin.This single chain mouse tPA has the active site serine mutated to alanine rendering the enzyme catalytically inactive. The mutation site is S481A on the mature protein and S510A on the complete mRNA sequence (UniProtKB: locus TPA_MOUSE, accession P11214). The tPA still retains exosite binding as well as other biological properties of tPA including but not limited to surface binding to fibrin.Recombinantly produced in insect cells. 95percent active.Recombinantly produced in insect cells. 95percent active.Recombinantly produced in insect cells. 95percent active. For ELISA and Western Blotting of pig tPA, please use our Rabbit Polyclonal Antibodies to Human tPA or our Mouse Monoclonal to Human tPA which cross reactRecombinantly produced in insect cells. 95percent active. For ELISA and Western Blotting of pig tPA, please use our Rabbit Polyclonal Antibodies to Human tPA or our Mouse Monoclonal to Human tPA which cross react

Glycosylated mouse PAI-1 produced in insect cells with a single conservative mutation (Isoleucine 91 to Leucine) to increase stability. Glycolyslated human PAI-1 produced in insect cells with a molecular weight of 46,000 Da. The stable mutant contains mutations to confer additional stability to the otherwise labile molecule. 

Rabbit tPA recombinantly produced in insect cells which is 95percent active.Rabbit tPA recombinantly produced in insect cells which is 95percent active.Prepared from human tPA by incubation with an excess of ATA-Phe-Pro-Arg-CMK. After labeling at the active site, remaining free peptide is removed by dialysis.This human tPA has an active site serine to alanine mutation which renders it catalytically inactive. The mutation site is S478A on the mature protein and S513A on the complete mRNA sequence (UniProtKB: locus TPA_HUMAN, accession P00750)This human tPA has an active site serine to alanine mutation which renders it catalytically inactive. The mutation site is S478A on the mature protein and S513A on the complete mRNA sequence (UniProtKB: locus TPA_HUMAN, accession P00750)The addition of an arginine to glutamic acid mutation generates human tPA that is 100percent single chain and resistant to cleavage by plasmin. The mutation site is R275E on the mature protein and R310E on the complete mRNA sequence (UniProtKB: locus TPA_HUMAN, accession P00750). Recombinantly produced in insect cells.The addition of an arginine to glutamic acid mutation generates human tPA that is 100percent single chain and resistant to cleavage by plasmin. The mutation site is R275E on the mature protein and R310E on the complete mRNA sequence (UniProtKB: locus TPA_HUMAN, accession P00750). Recombinantly produced in insect cells.This human tPA has an active site serine to alanine mutation which renders it catalytically inactive. The mutation site is S478A on the mature protein and S513A on the complete mRNA sequence (UniProtKB: locus TPA_HUMAN, accession P00750). It is 90percent single chain and retains exosite binding as well as other properties of wild type tPA. Recombinantly produced in insect cells.This human tPA has an active site serine to alanine mutation which renders it catalytically inactive. The mutation site is S478A on the mature protein and S513A on the complete mRNA sequence (UniProtKB: locus TPA_HUMAN, accession P00750). It is 90percent single chain and retains exosite binding as well as other properties of wild type tPA. Recombinantly produced in insect cells.

Active two-chain canine urokinase (uPA), recombinantly produced in insect cells.Active two-chain canine urokinase (uPA), recombinantly produced in insect cells.Mouse Urokinase Receptor, Soluble form. Recombinantly produced in insect cells. Contains a 6X-Histidine tag at N terminus for purification. Demonstrates preferential binding to mouse uPA over human uPA coated on an ELISA plate.Mouse Urokinase Receptor, Soluble form. Recombinantly produced in insect cells. Contains a 6X-Histidine tag at N terminus for purification. Demonstrates preferential binding to mouse uPA over human uPA coated on an ELISA plate.Amino terminal fragment of mouse urokinase.

Low molecular weight active mouse urokinase, recombinantly produced in insect cells.Active two-chain HMW mouse urokinase, recombinantly produced in insect cells.Active two-chain HMW mouse urokinase, recombinantly produced in insect cells.Active two-chain rabbit urokinase (uPA), recombinantly produced in insect cells.Active two-chain rabbit urokinase (uPA), recombinantly produced in insect cells.FITC labeled LMW urokinase purified from auto-catalytic digestion of HMW human urokinase. LMW uPA contains the proteinase domain and is separated from the amino terminal fragment by cleavage at the Lys135-Lys136 bond.FITC labeled LMW urokinase purified from auto-catalytic digestion of HMW human urokinase. LMW uPA contains the proteinase domain and is separated from the amino terminal fragment by cleavage at the Lys135-Lys136 bond.Horseradish peroxidase conjugated LMW urokinase purified from auto-catalytic digestion of HMW human urokinase. LMW uPA contains the proteinase domain and is separated from the amino terminal fragment by cleavage at the Lys135-Lys136 bond.Horseradish peroxidase conjugated LMW urokinase purified from auto-catalytic digestion of HMW human urokinase. LMW uPA contains the proteinase domain and is separated from the amino terminal fragment by cleavage at the Lys135-Lys136 bond.The low molecular weight form of uPA is purified from auto-catalytic digestion of recombinant human urokinase produced in insect cells. LMW uPA contains the proteinase domain and is separated from the amino terminal fragment by cleavage at the Lys135-Lys136 bond. For plasminogen activation and receptor binding studies.The low molecular weight form of uPA is purified from auto-catalytic digestion of recombinant human urokinase produced in insect cells. LMW uPA contains the proteinase domain and is separated from the amino terminal fragment by cleavage at the Lys135-Lys136 bond. For plasminogen activation and receptor binding studies.

Horseradish peroxidase conjugated two-chain urokinaseHorseradish peroxidase conjugated two-chain urokinasePrepared from human urine as the two-chain form. For plasminogen activation and receptor binding studies.Prepared from human urine as the two-chain form. For plasminogen activation and receptor binding studies.Prepared from fresh hamster plasma. Ideal reagent for tissue culture studies and protein-protein interactions. Thaw the fibronectin by placing the vial in a 37 C water bath and leaving it undisturbed until completely thawed. Do not disturb the vial at any time during the thawing process. If the vial is disturbed or removed prior to complete thawing, the fibronectin will form a gel and be unusable. Mix very gently with pipette after thawing. Vortexing, excessive agitation, repeated freezing and thawing of fibronectin are not recommended.Prepared from fresh mouse plasma using several chromatographic steps. Plasminogen depleted by lysine affinity chromatography. Thaw protein in a 37C water bath

Prepared from fresh mouse plasma using urea as a denaturant.Prepared from fresh mouse plasma using urea as a denaturant.Prepared from fresh porcine plasma using several chromatographic steps. Plasminogen depleted by lysine affinity chromatography. Thaw protein in a 37C water bath.Prepared from fresh rabbit plasma using several chromatographic steps. Plasminogen depleted by lysine affinity chromatography.Prepared from fresh porcine (pig) plasma using urea as a denaturant.Prepared from fresh porcine (pig) plasma using urea as a denaturant.Prepared from fresh rabbit plasma using urea as a denaturant.Prepared from fresh rabbit plasma using urea as a denaturant.Prepared from fresh rat plasma using several chromatographic steps. Plasminogen depleted by lysine affinity chromatography.Prepared from fresh human plasma using several chromatographic steps. Plasminogen depleted by lysine affinity chromatography. Thaw at 37C without agitation until completely liquid, then gently mix before usePrepared from fresh human plasma using several chromatographic steps. Plasminogen depleted by lysine affinity chromatography. Thaw at 37C without agitation until completely liquid, then gently mix before usePrepared from fresh human plasma. Ideal reagent for tissue culture studies and protein-protein interactions. Thaw the fibronectin by placing the vial in a 37Prepared from fresh bovine plasma using several chromatographic steps. Plasminogen depleted by lysine affinity chromatography. Thaw at 37C without agitation until completely liquid, then gently mix before use.Prepared from fresh US origin dog (canine) plasma using several chromatographic steps. Plasminogen depleted by lysine affinity chromatography.Prepared from fresh bovine plasma using urea as a denaturant.

Human tissue-type plasminogen activator (tPA) is a 527 amino acid glycoprotein. Synthesized from cDNA from a human melanoma cell line. It is recombinantly produced in Chinese Hamster Ovary (CHO) cells. Fully active, 85percent single chain. Human tissue-type plasminogen activator (tPA) is a 527 amino acid glycoprotein. Synthesized from cDNA from a human melanoma cell line. It is recombinantly produced in Chinese Hamster Ovary (CHO) cells. Fully active, 85percent single chain. Mouse sc-tPA is reacted with an excess of mouse PAI-1 stable mutant at physiological pH. The resulting 1:1 molar complex is purified from the remaining PAI-1 by affinity chromatography with immobilized antibodies to mouse tPA. A triple mutation on the wild-type background makes this Human PAI-1 selectively inhibit tPA. Urokinase inhibition is limited to 1/25,000 of tPA inhibition by the P3Tyr-P2Ser-P1Tyr mutation. 

Fluorescein labeled two-chain urokinase.0.05M Sodium Acetate; 0.1M NaCl; 1mM EDTA; pH 5.0 Fluorescein labeled two-chain urokinase.0.05M Sodium Acetate; 0.1M NaCl; 1mM EDTA; pH 5.0 

Prepared from fresh mouse plasma. Ideal reagent for tissue culture studies and protein-protein interactions. Thaw the fibronectin by placing the vial in a 37 C water bath and leaving it undisturbed until completely thawed. Do not disturb the vial at any time during the thawing process. If the vial is disturbed or removed prior to complete thawing, the fibronectin will form a gel and be unusable. Mix very gently with pipette after thawing. Vortexing, excessive agitation, repeated freezing and thawing of fibronectin are not recommended. 

Prepared from fresh bovine plasma using urea as a denaturant.

Prothrombin is activated on the surface of a phospholipid membrane that binds the amino end of prothrombin and factors Va and Xa in Ca-dependent interactions; factor Xa removes the activation peptide and cleaves the remaining part into light and heavy chains. The activation process starts slowly because factor V itself has to be activated by the initial, small amounts of thrombin.Factor Xa is prepared by activating purified factor X with the factor X activator isolated from Russell's viper venom. Factor Xa is purified from the activation mixture by chromatography over benzamidine-Sepharose. Purity is determined by SDS-PAGE analysis and activity is measured in a factor Xa clotting assay and/or chromogenic substrate assay.Factor Xa is a vitamin K-dependent glycoprotein that converts prothrombin to thrombin in the presence of factor Va, calcium and phospholipid during blood clotting.Mouse thrombin is prepared from purified mouse prothrombin by activation with Saw Scaled Viper Venom. The venom was removed after activation. Complete activation is observed on SDS-PAGE.Protein C is a vitamin K-dependent serine protease that regulates blood coagulation by inactivating factors Va and VIIIa in the presence of calcium ions and phospholipids.Protein C is a vitamin K-dependent serine protease that regulates blood coagulation by inactivating factors Va and VIIIa in the presence of calcium ions and phospholipids.Recombinantly produced in insect cells and purified by chelated metal affinity chromatography.Recombinantly produced in insect cells and purified by FLAG affinity.Prepared from fresh mouse plasma using several chromatographic steps.Prepared from fresh mouse plasma using several chromatographic steps.Prepared from fresh rabbit plasma using several chromatographic steps.Prepared from fresh rabbit plasma using several chromatographic steps.Factor IXa is prepared from highly purified factor IX by activation with factor XIa. The factor IXa is further purified by gel filtration, followed by immunoaffinity purification. Purity is assessed by SDS-PAGE analysis. Activity is determined in a one-stage clotting assay.Rat thrombin is prepared from purified rat prothrombin by activation with Russells Viper Venom. This venom is removed after activation. Purity is 90percent as determined by SDS-PAGE analysis. Activity is measured in a thrombin specific clotting assay, and compared to standardized NIH thrombin.Rat factor IX is prepared from fresh frozen plasma by a combination of conventional procedures and immunoaffinity chromatography. Purity is determined by SDS-PAGE analysis and activity is measured using a factor IX clotting assay.

Heparin cofactor II (HCII) (heparin cofactor A, antithrombin BM, dermatan sulfate cofactor, human leuserpin-2) is a single chain glycoprotein (Mr=65,600, 10% carbohydrate) member of the serine protease inhibitor (serpin) family (1-3). Amino acid sequence analysis of heparin cofactor II reveals 3 potential N-glycosylation sites and 2 sulfated tyrosines located in two internal repeats of 7 residues located near the NH2-terminal (4-6). The plasma concentration is estimated to be 90Activation of Prekallikrein with Factor a-XIIa produces the enzymatically active Kallikrein. Kallikrein is a serine protease which consists of a heavy chain (Mr 52kD) and light chains (Mr either 36 or 33 kD) linked by disulfide bridges. Kallikrein possesses enzymatic activity toward Factor XII, HK, Plasminogen, Factors XI, IX, and VII, prorenin and the complement system. After activation, the activating enzyme Factor XIIa is removed by affinity chromatography. Human Kallikrein purity is determined by SDS-PAGE and shows complete reduction upon incubation with 2-mercaptoethanol.Purified from fresh frozen human plasma. Human Prekallikrein is a single chain gamma globulin glycoprotein that participates in the early phase of contact activation, kinin formation and fibrinolysis. Prekallikrein purity is determined by SDS-PAGE and shows no reduction upon incubation with 2-mercaptoethanol. Activity is determined via clotting assay.Human Factor XIIa is a serine protease responsible for the activation of Factor XI to XIa in the contact activation system. Human Factor XII and prekallikrein are thought to be involved in a reciprocal activation mechanism in which Factor XIIa activates prekallikrein to kallikrein, which in turn converts Factor XII to XIIa. Factor XIIa activates Factor XI to XIa thereby triggering the Contact Factor cascade. ERL offers Factor ?-XIIa which is activated by the autoactivation process with Dextran Sulfate and re-purified to remove the activator. The protein purity is determined by SDS-PAGE and activity is determined via clotting assay.Human Factor XIIa is a serine protease responsible for the activation of Factor XI to XIa in the contact activation system. Human Factor XII and prekallikrein are thought to be involved in a reciprocal activation mechanism in which Factor XIIa activates prekallikrein to kallikrein, which in turn converts Factor XII to XIIa. Factor XIIa activates Factor XI to XIa thereby triggering the Contact Factor cascade. ERL offers Factor ?-XIIa which is activated by the autoactivation process with Dextran Sulfate and re-purified to remove the activator. The protein purity is determined by SDS-PAGE and activity is determined via clotting assay.Human Factor Xa is prepared from Human Factor X by activation with Russell's Viper Venom. This RVV-X is removed after activation. Complete activation is observed by SDS-PAGE. Factor Xa along with cofactor Va, phospholipids and calcium ions, (the prothrombinase complex) catalyzes the rapid conversion of prothrombin to thrombin.

Prepared from fresh frozen human plasma. This protein purity is determined by SDS-PAGE and shows no reduction upon incubation with 2-mercaptoethanol.

Purified from fresh frozen human plasma using a combination of salt precipitations and column chromatography. The protein purity is determined by SDS-PAGE and shows total reduction upon incubation with 2-mercaptoethanol. Protein C is activated to the serine protease, Activated Protein C (APC), by a-thrombin or the complex of a-thrombin/thrombomodulin and is a potent anticoagulant through the selective inactivation of Factors Va and VIIIa.Purified from fresh frozen human plasma using a combination of salt precipitations and column chromatography. The protein purity is determined by SDS-PAGE and shows total reduction upon incubation with 2-mercaptoethanol. Protein C is activated to the serine protease, Activated Protein C (APC), by a-thrombin or the complex of a-thrombin/thrombomodulin and is a potent anticoagulant through the selective inactivation of Factors Va and VIIIa.

Prepared from homogeneous human prothrombin by activation with Factor Xa, Factor Va, and phospholipid. Human Thrombin purity is determined by SDS-PAGE. This activated enzyme has a minimum activity of 2,700 NIH units/mg when compared to NIH standard thrombin.Prepared from fresh frozen human plasma. Human Prothrombin is a glycoprotein of molecular weight 72,000, and consists of a single polypeptide chain. Activation of Prothrombin by Factor Va, Xa and phospholipids yields the serine protease Thrombin. Prothrombin purity is determined by SDS-PAGE and shows no reduction upon incubation with 2-mercaptoethanol.Prepared from fresh frozen human plasma. Human Prothrombin is a glycoprotein of molecular weight 72,000, and consists of a single polypeptide chain. Activation of Prothrombin by Factor Va, Xa and phospholipids yields the serine protease Thrombin. Prothrombin purity is determined by SDS-PAGE and shows no reduction upon incubation with 2-mercaptoethanol.Serine protease inhibitor purified from E. coli. At least 98percent pure as determined by SDS-PAGE.Serine protease inhibitor purified from E. coli. At least 98percent pure as determined by SDS-PAGE.The Bovine Antithrombin is 95% pure on SDS-PAGE gels and shows no reduction uponincubation with 2-mercaptoethanol. All bovine material is from U.S. cows /+ 36 months ofage

Canine fibrinogen amino terminal labeled with fluorescein isothiocyanate (FITC). Prepared from fresh dog plasma using several chromatographic steps. Plasminogen depleted by lysine affinity chromatography. Thaw at 37C without agitation until completely liquid, then gently mix before use. Keep fibrinogen at 25-37C, aliquot and flash freeze unused portion. 

Prepared from fresh frozen human plasma. Human Factor XI is a two-chain glycoprotein with molecular weight of 160,000 daltons.  The two chains are identical disulfide bonded polypeptides with molecular weights of 80,000 daltons.  Factor XI is activated to Factor XIa by Factor Xlla. Purity of Factor XI is assessed by SDS-PAGE.  Activity is determined by clotting assay.Prepared from fresh frozen human plasma. Human Factor XI is a two-chain glycoprotein with molecular weight of 160,000 daltons.  The two chains are identical disulfide bonded polypeptides with molecular weights of 80,000 daltons.  Factor XI is activated to Factor XIa by Factor Xlla. Purity of Factor XI is assessed by SDS-PAGE.  Activity is determined by clotting assay.Prepared from fresh frozen human plasma. The purity of this Vitamin K dependent protein is determined by SDS-PAGE  and shows total reduction upon incubation with 2-mercaptoethanol. Activity is determined via clotting assay. Human Factor X, once activated via the Contact Factor Pathway or the Tissue Factor Pathway, is responsible for the conversion of Prothrombin to Thrombin.

Prepared from fresh frozen human plasma. This protein purity is determined by SDS-PAGE and shows no reduction upon incubation with 2-mercaptoethanol.  Activity is determined via clotting assay.  Human Factor IX, activated by either the Contact or Tissue Factor Pathway, is responsible for the activation of Factor X to Xa.Activated Protein C (APC) is a serine protease derived from the two chain vitamin K dependent zymogen, Protein C. APC inhibits blood coagulation through the selective inactivation of the cofactors Va and VIIIa. APC is prepared from protein C by activation with purified thrombin. This thrombin is removed after activation by ion exchange chromatography. Activated Protein C purity is determined by SDS-PAGE and shows complete reduction upon incubation with 2-mercaptoethanol.Activated Protein C (APC) is a serine protease derived from the two chain vitamin K dependent zymogen, Protein C. APC inhibits blood coagulation through the selective inactivation of the cofactors Va and VIIIa. APC is prepared from protein C by activation with purified thrombin. This thrombin is removed after activation by ion exchange chromatography. Activated Protein C purity is determined by SDS-PAGE and shows complete reduction upon incubation with 2-mercaptoethanol.

Prepared from purified Human Factor VII using Human Factor XIIa. The Factor Xlla is removed using affinity chromatography. Purity is determined by SDS-PAGE. Human Factor VIIa reduces to 29,500 and 23,500 with the addition of 2-mercaptoethanol. Activity is determined via clotting assay.  Factor Vlla, in the presence of calcium ions and Tissue factor, activates Factors IX and X to their enzymatically active forms, Factor IXa and Xa.Prepared from purified Human Factor VII using Human Factor XIIa. The Factor Xlla is removed using affinity chromatography. Purity is determined by SDS-PAGE. Human Factor VIIa reduces to 29,500 and 23,500 with the addition of 2-mercaptoethanol. Activity is determined via clotting assay.  Factor Vlla, in the presence of calcium ions and Tissue factor, activates Factors IX and X to their enzymatically active forms, Factor IXa and Xa.Human factor V is prepared from fresh frozen human plasma using immunoaffinity chromatography. Purity is determined by SDS-PAGE analysis and activity is measured in a factor V clotting assay.  Human factor V is prepared from fresh frozen human plasma using immunoaffinity chromatography. Purity is determined by SDS-PAGE analysis and activity is measured in a factor V clotting assay.  

The Bovine Protein C is 95% on SDS-PAGE gels and shows total reduction upon incubationwith 2-mercaptoethanol. All bovine material is from U.S. cows /+ 36 months of agInnovative offers the two chain Kinin-free form of Kininogen. This is prepared by Kallikrein digestion of Kininogen which is then repurified to remove traces of Kallikrein.LMW Kininogn is involved in blood pressure regulation since it is an endogenous protein substrate for tissue kallikrein. Proteolytic cleavage by kallikrein releases vasoactive bradykinin from LMW kininogen. In addition, LMW kininogen, like HMW kininogen, is a major extracellular cysteine protease inhibitor. Prepared from plasma shown to be non reactive for HbsAG, anti-HCV, anti-HBc, and negative for anti-HIV 1 &amp; 2 by FDA approved tests. 95percent pure by SDS-PAGE. Add deionized water to original volume, aliquot and freeze unused portion.High Molecular Weight Kininogen (HK) is a nonenzymatic cofactor of the contact activation system. HK is thought to have two functions in the contact activation system. First, HK links prekallikrein to a negatively charged surface thereby allowing activation to kallikrein by surface bound Factor -Xlla. HK also forms a complex with Factor XI and accelerates its activation to XIa by -Xlla. Also HK serves as a source of Bradykinin, a potent Vasoactive peptide important in hypotension studies. The protein purity is determined by SDS-PAGE

Human Factor XIII is a tetramer composed of two pairs of chains held together by noncovalent bonds. After activation of the zymogen via Thrombin to its active enzyme form, Factor XIIIa is responsible for catalyzing the formation of covalent bridges between fibrin units to increase the elasticity of the clot network. The resulting cross-linked fibrin is very insoluble and resistant to lysis.Human Factor XIII is a tetramer composed of two pairs of chains held together by noncovalent bonds. After activation of the zymogen via Thrombin to its active enzyme form, Factor XIIIa is responsible for catalyzing the formation of covalent bridges between fibrin units to increase the elasticity of the clot network. The resulting cross-linked fibrin is very insoluble and resistant to lysis.

Our Activated Protein C is inactivated using PPACK, Dihydrochloride and is removed via gelfiltration. The above protein was purified from Human plasma that was tested and foundnegative by FDA accepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV,Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA. Donors arescreened for CJD (Creutzfeldt-Jakob Disease)

Prepared from fresh frozen human plasma. Human Factor VII is a single-chain vitamin K dependent glycoprotein found in trace quantities in plasma (0.5 mg/Liter). In the Tissue Factor Pathway of coagulation, Human Factor Vlla, in the presence of calcium ions and tissue factor, activates Factors IX and X to their enzymatically active forms, Factor IXa and Xa.Prepared from fresh frozen human plasma. Human Factor VII is a single-chain vitamin K dependent glycoprotein found in trace quantities in plasma (0.5 mg/Liter). In the Tissue Factor Pathway of coagulation, Human Factor Vlla, in the presence of calcium ions and tissue factor, activates Factors IX and X to their enzymatically active forms, Factor IXa and Xa.Human prothrombin with the gla domain removed. The above protein was purified fromHuman plasma that was tested and found negative by FDA accepted methods for AntiHIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA,HCV RNA and HBV RNA. Donors are screened for CJD (Creutzfeldt-Jakob Disease)

The murine XIII is purified from mouse plasma and is judged 94% pure via SDS-PAGEBovine Factor Xla is purified from freshly collected Bovine Plasma using a combination of salt precipitations and activation on a negative surface. This Factor Xla is a potent activator of both Human and Bovine Factor IX. Bovine Factor XIa purity is determined by SDS-PAGE and shows complete reduction upon incubation with 2-mercaptoethanol.

Prepared from Bovine Factor IX by activation with Bovine Factor Xla, this Bovine Factor Xla is removed after activation. Complete activation is observed by SDS-PAGE. The Factor Xla activates FIX in a two-step reaction. In the first step, an internal Arg-Ala bond is cleaved, and in the second step, an Arg-Val bond is cleaved. The second cleavage leads to the liberation of an activation peptide from the NH2-terminal portion of the heavy chain to produce factor IXaβ.

Purified from freshly collected bovine plasma using a combination of salt precipitations and column chromatography. This protein is a mixture of Factor V/Va and intermediate activation products as judged by 4-20% gradient gels. Bovine Factor Va functions as a cofactor with the serine protease Factor Xa in the activation of prothrombin. This protein may be used as a source of V/Va in the Prothrombinase complexPurified from freshly collected bovine plasma using a combination of salt precipitations and column chromatography. This protein is a mixture of Factor V/Va and intermediate activation products as judged by 4-20% gradient gels. Bovine Factor Va functions as a cofactor with the serine protease Factor Xa in the activation of prothrombin. This protein may be used as a source of V/Va in the Prothrombinase complexInterleukin-2 (IL-2) is a O-glycosylated four alpha-helix bundle cytokine that is produced by T-cells in response to antigenic or mitogenic stimulation. IL-2 can stimulate B-cells, monocytes, lymphokine-activated killer cells, natural killer cells, and glioma cells and is required for T-cell proliferation and other activities crucial to regulation of the immune response.This Fc Fusion Protein is glycosylated and expressed as a chimera with the Fc region of mouse immunoglobulin. Fc fusion proteins are typically more stable and resistant to degradation and clearance than native cytokines. Fc fusion proteins appear as a dimer in SDS-PAGE under non-reducing conditions.Interleukin-2 (IL-2) is a O-glycosylated four alpha-helix bundle cytokine that is produced by T-cells in response to antigenic or mitogenic stimulation. IL-2 can stimulate B-cells, monocytes, lymphokine-activated killer cells, natural killer cells, and glioma cells and is required for T-cell proliferation and other activities crucial to regulation of the immune response.This Fc Fusion Protein is glycosylated and expressed as a chimera with the Fc region of mouse immunoglobulin. Fc fusion proteins are typically more stable and resistant to degradation and clearance than native cytokines. Fc fusion proteins appear as a dimer in SDS-PAGE under non-reducing conditions.Mouse Protein Z-Dependent Protease Inhibitor (ZPI), recombinantly produced in insect cells. Active and complexable with Factor XIa. This Serine Protease Inhibitor (SERPIN) requires the cofactors Protein Z, phospholipids and calcium to inhibit endogenous Factor Xa. ZPI contains a tyrosine residue at the P1 position of the reactive center loop, rather than arginine which is present in most SERPINs.Corn Trypsin Inhibitor (CTI) is a specific and potent inhibitor of human factor XIIa. It is purified from fresh Indiana sweet corn by solvent extraction and chromatographic methods. A suggested inhibitory concentration is 24 fold molar excess over the enzyme concentration. CTI purity is determined by SDS-PAGE and shows no reduction upon incubation with 2-mercaptoethanol.

The Bovine Factor X is 95% pure on  SDS-PAGE and shows total reduction upon incubationwith 2-mercaptoethanol.  All bovine material is from U.S. cows /+ 36 months of ageThe Activated Bovine Protein C was activated from homogeneous protein C by activation withpurified alpha-thrombin.  The alpha-thrombin is removed after activation. Complete activationis observed on SDS-PAGE gels.  All bovine material is from U.S. cows /+ 36 months of age

Human Factor XIIIa is activated from Factor XIII by cleavage with human alpha thrombin. The thrombin is subsequently removed via chromatography. Factor XIIIa is responsible for catalyzing the formation of covalent bridges between fibrin units to increase the elasticity of the clot network. The resulting cross-linked fibrin is very insoluble and resistant to lysis. Human Factor XIIIa is activated from Factor XIII by cleavage with human alpha thrombin. The thrombin is subsequently removed via chromatography. Factor XIIIa is responsible for catalyzing the formation of covalent bridges between fibrin units to increase the elasticity of the clot network. The resulting cross-linked fibrin is very insoluble and resistant to lysis. 

Human Factor beta-XIIa is generated in vivo by kallikrein cleavage of Factor alpha-XIIa and contains the catalytic light chain and the C-terminal peptide of the heavy chain of Factor alpha-XIIa. Human Factor beta-XIIa is activated from homogeneous Human Factor XII by an autoactivation process with Dextran Sulfate followed by repurification to isolate Factor alpha-XIIa and Factor beta-XIIa. Complete activation is observed on SDS-PAGE. Factor XIIa is 95percent pure by SDS-PAGE and activity is determined via clotting assay. Prepared from plasma found negative by FDA accepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA. Donors are screened for CJD (Creutzfeldt-Jakob Disease). Human Factor beta-XIIa is generated in vivo by kallikrein cleavage of Factor alpha-XIIa and contains the catalytic light chain and the C-terminal peptide of the heavy chain of Factor alpha-XIIa. Human Factor beta-XIIa is activated from homogeneous Human Factor XII by an autoactivation process with Dextran Sulfate followed by repurification to isolate Factor alpha-XIIa and Factor beta-XIIa. Complete activation is observed on SDS-PAGE. Factor XIIa is 95percent pure by SDS-PAGE and activity is determined via clotting assay. Prepared from plasma found negative by FDA accepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA. Donors are screened for CJD (Creutzfeldt-Jakob Disease). Purified Human Factor IXa is active site labeled by incubation with Fluorescein-Phe-Phe-Arg-CMK (FL-INFFR). Excess dye is removed by dialysis. Human beta-thrombin is prepared from purified a-thrombin by limited proteolysis with TPCK-treated trypsin. Beta-thrombin is generated by cleavage of the B-chain at the Arg106-Tyr107 bond. Purity is assessed by SDS-PAGE and activity is assessed using a fibrinogen clotting assay. The Human Plasmin was activated from homogeneous glu-plasminogen using urokinase at a500:1 molar ratio.  This urokinase was not removed after activation.  Complete activation wasobserved using the S-2251 chromogenic substrate.  The above protein was purified fromHuman plasma that was tested and found negative by FDA accepted methods for AntiHIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA,HCV RNA and HBV RNA. Donors are screened for CJD (Creutzfeldt-Jakob Disease)Purified from fresh frozen human plasma. Human Factor XII is part of the contact activation system. Human Factor XII is a single chain glycoprotein with a molecular weight of about 80,000. Once activated, principally from the action of kallikrein, Factor XII is converted into an active serine protease (Factor -Xlla) that functions in the <emin vivo</em initiation of blood coagulation, fibrinolysis, and kinin formation. Human Factor XII has been purified by ion exchange chromatography. Protein purity is determined by SDS-PAGE and activity is determined via clotting assay.Purified from fresh frozen human plasma. Human Factor XII is part of the contact activation system. Human Factor XII is a single chain glycoprotein with a molecular weight of about 80,000. Once activated, principally from the action of kallikrein, Factor XII is converted into an active serine protease (Factor -Xlla) that functions in the <emin vivo</em initiation of blood coagulation, fibrinolysis, and kinin formation. Human Factor XII has been purified by ion exchange chromatography. Protein purity is determined by SDS-PAGE and activity is determined via clotting assay.The Human Factor XIa was activated from homogeneous Human Factor XI using HumanFactor XIIa.  This XIIa was removed using a Corn Trypsin Inhibitor column.  The protein is95% pure via SDS-PAGE.  The above protein was purified from Human plasma that wastested and found negative by FDA accepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II,HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA.Donors are screened for CJD (Creutzfeldt-Jakob Disease)The Human Factor Xa beta gla domainless was prepared from HFX-GD using purified RVV-X.This RVV-X was removed after activation by gel filtration.  Complete activation was observedon SDS PAGE.  The above protein was purified from Human plasma that was tested andfound negative by FDA accepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV,Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA. Donors arescreened for CJD (Creutzfeldt-Jakob Disease)The Human Factor Xa was activated from homogeneous Human Factor X by activation withRussels' Viper Venom.  This RVV-X was removed after activation.  Complete activation isobserved via SDS-PAGE .  The purified Xa was then inactivated using GGACK.  Theinactivator was removed via dialysis. The above protein was purified from Human plasma thatwas tested and found negative by FDA accepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II,HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA.Donors are screened for CJD (Creutzfeldt-Jakob Disease)Factor X- gla domainless was prepared from purified Human Factor X using alphachymotrypsin. The alpha-chymotrypsin and all other products were removed using an anionexchange column after digestion.  The above protein was purified from Human plasma thatwas tested and found negative by FDA accepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II,HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA.Donors are screened for CJD (Creutzfeldt-Jakob Disease)The Human Factor IXab was activated from homogeneous Human Factor IX by activation with Bovine Factor XIa.  This Bovine Factor XIa is removed after activation.  Complete activation isobserved on SDS-PAGE. The IXab was then inactivated using a commercially availablechloromethylketone.  This inactivator is removed via dialysis.The human plasma used was tested and found negative by FDA accepted methods for AntiHIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA,HCV RNA and HBV RNAThe Human Activated Protein C gla domainless was prepared from purified Human APCusing Cathepsin G.  The Cathepsin G is removed using affinity chromatography afterdigestion. The above protein was purified from Human plasma that was tested and foundnegative by FDA accepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV,Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA.  Donors arescreened for CJD (Creutzfeldt-Jakob Disease)

The Human Protein C gla domainless was prepared from purified Human Protein C usingCathepsin G.  The Cathepsin G is removed using affinity chromatography after digestion. Theabove protein was purified from Human plasma that was tested and found negative by FDAaccepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA. Donors are screened for CJD (CreutzfeldtJakob Disease)The Human Protein C gla domainless was prepared from purified Human Protein C usingCathepsin G.  The Cathepsin G is removed using affinity chromatography after digestion. Theabove protein was purified from Human plasma that was tested and found negative by FDAaccepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA. Donors are screened for CJD (CreutzfeldtJakob Disease)The Human Factor VIIa gla domainless was prepared from purified Human Factor VIIa usingCathepsin G.  The Cathepsin G is removed using affinity chromatography after digestion.The above protein was purified from Human plasma that was tested and found negative byFDA accepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV, Syphilis, HBC Ab,HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA. Donors are screened for CJD(Creutzfeldt-Jakob Disease)

Rabbit Factor Xa is prepared from homogeneous Rabbit Factor X by activation with Russells'Viper Venom.  This RVV-X is removed  after activation.  Complete activation is observed viaSDS-PAGERabbit Factor X is purified via salt precipitations along with ion and affinity chromatography.  Itis judged 94% pure on SDS PAGEThe Porcine Factor Xa was activated from homogeneous Porcine Factor X by activation with Russells' Viper Venom.  This RVV-X was removed after activation.  Complete activation isobserved on SDS-PAGE gels

Bovine Factor Xa is prepared from Bovine Factor X by activation with Russell's Viper Venom. This RVV-X is removed after activation. Complete activation is observed by SDS-PAGE. Factor Xa, as part of the prothrombinase complex along with the cofactor Va, phospholipids and calcium ions, catalyzes the rapid conversion of prothrombin to thrombin.

Prepared from freshly collected bovine plasma. Protein purity is determined by SDS-PAGE and shows no reduction upon incubation with 2-mercaptoethanol. Activated Factor IX via factor Xla or the factor VIIa/tissue factor/phospholipid complex, is responsible for the activation of Factor X to Xa

Ca2+-activated IK/SK potassium channel activator

calmodulin protein kinase II (CAMKII) inhibitor

Hepatitis C Virus NS3/4a Protease Inhibitor

Hepatocyte growth factor receptors (HGFR)

Histone Lysine Methyltransferase Inhibitor

inhibitors of the hepatitis C virus NS3/4A protease

monoamine oxidase type B (MAO-B) inhibitor

Nicotinamide Phosphoribosyltransferase (Nampt)

non-nucleoside reverse transcriptase inhibitors (NNRTIs)

O6-Methylguanine-DNA Methyltransferase (MGMT)

Peripheral histamine H1 receptor antagonist

Phosphatidylcholine-specific phospholipase C (PC-PLC) inhibitor

S-adenosylhomocysteine hydrolase inhibitorS-adenosylhomocysteine hydrolase inhibitorsarcomere-directed cardiac myosin activator

serotonin specific reuptake inhibitor (SSRI) serotonin specific reuptake inhibitor (SSRI)

Tamibarotene, Retinoic acid receptor α (RARα) agonist

Thioredoxin Reductase and Glutathione Reductase inhibitor

Recombinant Human Adiponectin, His tag

Recombinant Human Adiponectin glycosilated, HEK Recombinant Mouse Adiponectin glycosilated, HEK Recombinant Porcine Adiponectin glycosilated, HEK Recombinant Human Adiponectin Trimeric FormRecombinant Mouse Adiponectin Trimeric FormRecombinant Human Adiponectin GlobularRecombinant Human Adiponectin Globular, His tagRecombinant Mouse Adiponectin GlobularRecombinant Human Allograft Inflammatory Factor 1Recombinant Human Allograft Inflammatory Factor 1 Like

Recombinant Human Angiopoietin-like Protein 3 Recombinant Human Angiopoietin-like Protein 4Recombinant Human Angiopoietin-like Protein 4, HEK

Recombinant Human Apolipoprotein-M, HEK

Recombinant Human Brain-Derived Neurotrophic FactorRecombinant Human Precursor Brain-Derived Neurotrophic Factor

Recombinant Human BAFF (BLyS), His TagRecombinant Human BAFF (BLyS) ReceptorRecombinant Human Bone Morphogenetic protein Receptor-1ARecombinant Human Bone Morphogenetic protein Receptor-1A HEKRecombinant Human Bone Morphogenetic protein-2Recombinant Human Bone Morphogenetic protein-2 MonomerRecombinant Human Pro Bone Morphogenetic protein-2Recombinant Human Bone Morphogenetic protein-4Recombinant Human Bone Morphogenetic protein-5Recombinant Human Bone Morphogenetic protein-7Recombinant Human Bone Morphogenetic protein-7 His TagRecombinant Human Bone Morphogenetic protein-7, CHORecombinant Human Bone Morphogenetic protein-7, PlantRecombinant Human beta Nerve Growth FactorRecombinant Human beta Nerve Growth Factor, CHO

Recombinant Mouse beta Nerve Growth Factor

Recombinant Human Pro-Nerve Growth FactorRecombinant Human B-type Natriuretic ProteinRecombinant Human B-type Natriuretic Protein His Tag

Recombinant Human Ciliary Neurotrophic FactorRecombinant Human Ciliary Neurotrophic Factor, His TagRecombinant Rat Ciliary Neurotrophic Factor

Recombinant Human Connective Tissue Growth FactorRecombinant Human Connective Tissue Growth Factor, His TagRecombinant Human Connective Tissue Growth Factor 182-250 a.a.Recombinant Human Connective Tissue Growth Factor, HEKRecombinant Human Cytotoxic T-Lymphocyte Associated Antigen-4Recombinant Human Epstein Barr Virus Induced 3Recombinant Human Epstein Barr Virus Induced 3, His TagRecombinant Mouse Epstein Barr Virus Induced 3Recombinant Human Endocrine Gland Vacular Endothelial Growth FactorRecombinant Human Epidermal Growth FactorRecombinant Human Epidermal Growth Factor, Pichia Recombinant Human Epidermal Growth Factor 21-LeuRecombinant Mouse Epidermal Growth Factor

Recombinant Rat Epidermal Growth FactorRecombinant Human Endothelial-Monocyte Activating Polypeptide IIRecombinant Human Aminoacyl tRNA Synthetase Complex-Interacting Multifunctional Protein 1

Recombinant Human Erythropoietin-alphaRecombinant Human Erythropoietin-alpha Fc/ChimeraRecombinant Human Fibroblast Growth Factor-acidicRecombinant Human Fibroblast Growth Factor-acidic, Sf9Recombinant Mouse Fibroblast Growth Factor-acidic

Recombinant Human Fibroblast Growth Factor-basicRecombinant Human Fibroblast Growth Factor-basic, Sf9Recombinant Human Fibroblast Growth Factor-basic (147 a.a)Recombinant Bovine Fibroblast Growth Factor-basic

Recombinant Mouse Fibroblast Growth Factor-basicRecombinant Rat Fibroblast Growth Factor-basicRecombinant Human Fibroblast Growth Factor-4Recombinant Human Fibroblast Growth Factor-8Recombinant Human Fibroblast Growth Factor-9Recombinant Mouse Fibroblast Growth Factor-9Recombinant Rat Fibroblast Growth Factor-9Recombinant Human Fibroblast Growth Factor 12Recombinant Mouse Fibroblast Growth Factor-15Recombinant Human Fibroblast Growth Factor-19 Recombinant Human Fibroblast Growth Factor-19 His Tag

Recombinant Human Fibroblast Growth Factor-21Recombinant Human Fibroblast Growth Factor-21, His TagRecombinant Mouse Fibroblast Growth Factor-21Recombinant Mouse Fibroblast Growth Factor-21, His TagRecombinant Bovine Fibroblast Growth Factor-21Recombinant Human Fibroblast Growth Factor-22Recombinant Human Fibroblast Growth Factor-23 Recombinant Human Fibroblast Growth Factor-23 His TagRecombinant Human Fibroblast Growth Factor-23 C-Terminal

Recombinant Human Galectin-3 GST-Tag

Recombinant Human Glial-Derived Neurotrophic FactorRecombinant Human Growth and Differentiation factor 3Recombinant Human Growth and Differentiation factor 5Recombinant Human Growth and Differentiation factor 5 His TagRecombinant Human Growth and Differentiation factor 10Recombinant Human Growth and Differentiation factor 15Recombinant Human Growth and Differentiation factor 15 D-VairantRecombinant Human Growth and Differentiation factor 15 H-VariantRecombinant Human Granulocyte-Colony Stimulating FactorRecombinant Human Granulocyte-Colony Stimulating Factor, His TagRecombinant Human Granulocyte-Colony Stimulating Factor, CHO Recombinant Mouse Granulocyte-Colony Stimulating FactorRecombinant Human Pegylated Granulocyte-Colony Stimulating Factor

Recombinant Human Placental Corr Growth HormoneRecombinant Human Pituitary Growth Hormone 20kDaRecombinant Human Placental Growth Hormone 20kDaRecombinant Human Growth Hormone Binding ProteinRecombinant Ovine Growth Hormone Binding ProteinRecombinant Bovine Growth Hormone Binding ProteinRecombinant Rabbit Growth Hormone Binding Protein

Recombinant Placental Ovine Growth Hormone

Recombinant Gilthead Seabream Growth Hormone

Recombinant Chicken Growth Hormone AnatagonistRecombinant Ovine Growth Hormone AnatagonistRecombinant Zebrafish Growth Hormone Recombinant Zebrafish Growth Hormone MutantRecombinant Human Granulocyte Macrophage-Colony Stimulating FactorRecombinant Human Granulocyte Macrophage-Colony Stimulating Factor, Pichia Recombinant Human Granulocyte Macrophage-Colony Stimulating Factor, Sf9 Recombinant Human gm-csf/IL-3 Fusion Protein (PIXY321)Recombinant Human Granulocyte Macrophage-Colony Stimulating Factor, His TagRecombinant Mouse Granulocyte Macrophage-Colony Stimulating FactorRecombinant Rat Granulocyte Macrophage-Colony Stimulating FactorRecombinant Porcine Granulocyte Macrophage-Colony Stimulating FactorRecombinant Rhesus Macaque Granulocyte Macrophage-Colony Stimulating FactorRecombinant Canine Granulocyte Macrophage-Colony Stimulating FactorRecombinant Human Glia Maturation Factor BetaRecombinant Human Glia Maturation Factor Beta His TagRecombinant Mouse Glia Maturation Factor BetaRecombinant Human Glia Maturation Factor GammaRecombinant Human Hepatoma-Derived Growth FactorRecombinant Human Hepatocyte Growth Factor, CHORecombinant Human Hepatocyte Growth Factor, Sf9Recombinant Human Hepatocyte Growth Factor A ChainRecombinant Human Hepatocyte Growth Factor B ChainPorcine Hepatocyte Promoting Growth Factor

Recombinant Human Interferon-alpha 2a, Tobacco

Recombinant Human Interferon-alpha 2b, SaccharomycesRecombinant Human Interferon-alpha 2b 40kd-PegylatedRecombinant Human Interferon-alpha 2b 20kd-Pegylated

Recombinant Mouse Interferon-beta His Tag

Recombinant Human Interferon-gamma His Tag

Recombinant Human Interferon Regulatory Factor-1Recombinant Human Interferon Regulatory Factor-2Recombinant Human Interferon Regulatory Factor-3 Recombinant Human Insulin Like Growth Factor-1Recombinant Human Insulin Like Growth Factor-1, GST-TagRecombinant Human Insulin Like Growth Factor-1 Des (1-3)Recombinant Human Long R3 Insulin Like Growth Factor-1Recombinant Mouse Insulin Like Growth Factor-1Recombinant Rat Insulin Like Growth Factor-1

Recombinant Gilthead Seabream Insulin Like Growth Factor-1Recombinant Human Insulin Like Growth Factor-2Human Insulin Like Growth Factor Binding Protein-1Recombinant Human Insulin Like Growth Factor Binding Protein-3Recombinant Human Insulin Like Growth Factor Binding Protein-4Recombinant Human Insulin Like Growth Factor Binding Protein-5Recombinant Human Insulin Like Growth Factor Binding Protein-6

Recombinant Human Interleukin-1 alpha, His Tag

Recombinant Human Interleukin-1 beta, His Tag

Recombinant Mouse Interleukin-1 beta, His Tag

Recombinant Rhesus Macaque Interleukin-1 beta Recombinant Human Interleukin-1 Receptor AntagonistRecombinant Human Interleukin-1 Receptor Antagonist, His TagRecombinant Human Interleukin-1 Receptor Like-1Recombinant Mouse Interleukin-1 Receptor AntagonistRecombinant Human Interleukin 1 Family, Member 5 Recombinant Human Interleukin 1 Family, Member 6Recombinant Human Interleukin 1 Family, Member 7Recombinant Human Interleukin 1 Family, Member 10

Recombinant Human Interleukin-2 His Tag

Recombinant Mouse Interleukin-2, His Tag

Recombinant Human Soluble Iinterleukin-2 Receptor alphaRecombinant Human Soluble Iinterleukin-2 Receptor alpha, GST tag

Recombinant Human Interleukin-3, His Tag

Recombinant Human Interleukin-4, His Tag

Recombinant Human Interleukin-6, His Tag

Recombinant Human Soluble IL-6 Receptor alpha

Recombinant Human Interleukin-7, Saccharomyces Recombinant Human Interleukin-7, His Tag

Recombinant Human Interleukin-10, His Tag

Recombinant Human Interleukin-11, Pichia

Recombinant Human Interleukin-12 p35, His TagRecombinant Human Interleukin-12 p40, His Tag

Recombinant Human Interleukin-13 VariantRecombinant Human Interleukin-13, His Tag

Recombinant Human Interleukin-15, His Tag

Recombinant Mouse Interleukin-15, His Tag

Recombinant Human Interleukin-16, His Tag

Recombinant Human Interleukin-17A His Tag

Recombinant Human Interleukin-17 A/F Heterodimer

Recombinant Mouse Interleukin-17 A/F HeterodimerRecombinant Rat Interleukin-17 A/F Heterodimer

Recombinant Human Interleukin-18 His Tag

Recombinant Mouse Interleukin-22, Pegylated

Recombinant Human Interleukin-33 His Tag

Recombinant Human Keratinocyte Growth FactorRecombinant Mouse Keratinocyte Growth FactorRecombinant Human Keratinocyte Growth Factor-2

Recombinant Human Leptin Triple AntagonistRecombinant Human Leptin Triple Antagonist, PegylatedRecombinant Human Leptin Quadruple AntagonistRecombinant Mouse Leptin Triple AntagonistRecombinant Pegylated Mouse Leptin Triple Antagonist, PegylatedRecombinant Rat Leptin Triple AntagonistRecombinant Pegylated Rat Leptin Triple Antagonist, PegylatedRecombinant Ovine Leptin Triple AntagonistRecombinant Ovine Leptin Triple Antagonist, PegylatedRecombinant Ovine Leptin Quadruple AntagonistRecombinant Human Leptin Binding DomainRecombinant Chicken Leptin Binding Domain

Recombinant Human Leukocyte Function Associated Antigen-3 Fusion Protein Recombinant Human Leukemia Inhibitory FactorRecombinant Mouse Leukemia Inhibitory FactorRecombinant Human Leukemia Inhibitory Factor, GST tagRecombinant Human Macrophage Colony Stimulating FactorRecombinant Human Macrophage Colony Stimulating Factor, BaculovirusRecombinant Human Macrophage Colony Stimulating Factor, His Tag

Recombinant Mouse Macrophage Colony Stimulating FactorRecombinant Rat Macrophage Colony Stimulating FactorRecombinant Human Macrophage Migration Inhibitor FactorRecombinant Human Macrophage Migration Inhibitor FactorRecombinant Human Macrophage Migration Inhibitor Factor, His Tag N-TerminusRecombinant Human Macrophage Migration Inhibitor Factor, His Tag C-TerminusRecombinant Human Melanoma Inhibitory Activity ProteinRecombinant Human Melanoma Inhibitory Activity Protein 2

Recombinant Human Myostatin Propeptide

Recombinant Human Neuregulin-1/Heregulin-b2

Recombinant Human Precursor Neurotrophin-3

Recombinant Human Osteoprotegerin, His TagRecombinant Human Osteoprotegerin Hi-5

Recombinant Human Oncostatin-M (209 a.a.)Recombinant Human Osteoclast Stimulating Factor-1

Recombinant Human Platelet Derived Growth Factor-AARecombinant Human Platelet Derived Growth Factor-AA YeastRecombinant Human Platelet Derived Growth Factor-ARecombinant Mouse Platelet Derived Growth Factor-AARecombinant Human Platelet Derived Growth Factor-ABRecombinant Human Platelet Derived Growth Factor-BB, YeastRecombinant Human Platelet Derived Growth Factor-BBRecombinant Human Platelet Derived Growth Factor-BRecombinant Mouse Platelet Derived Growth Factor-BBRecombinant Human Pigment Epithelium-Derived FactorRecombinant Human Pigment Epithelium-Derived Factor, His TagRecombinant Human Pigment Epithelium-Derived Factor, HEK

Recombinant Caprine Placental LactogenRecombinant Human Placenta Growth Factor-1Recombinant Human Placenta Growth Factor-2

Recombinant Human Prolactin Receptor , GST Tag

Recombinant Rabbit Prolactin Soluble ReceptorRecombinant Ovine Prolactin Soluble ReceptorRecombinant Bovine Prolactin Soluble ReceptorRecombinant Raibow Trout Prolactin Soluble ReceptorRecombinant Rat Prolactin Soluble Receptor

Recombinant Ovine Prolactin Antagonist, Mutant

Recombinant Human soluble CD40 Ligand/TRAPRecombinant Human soluble CD40 Ligand/TRAP His TagRecombinant Mouse soluble CD40 Ligand/TRAP

Recombinant Human Sonic HedgeHog, His Tag

Recombinant Mouse Sonic HedgeHog, His Tag

Recombinant Human Soluble RANK LigandRecombinant Human Soluble RANK Ligand, GST TagRecombinant Mouse Soluble RANK Ligand

Recombinant Mouse RELM-alpha His Tag

Recombinant Human Retinol Binding Protein-4Recombinant Human Retinol Binding Protein-4 His TagRecombinant Human Retinol Binding Protein-5Recombinant Human Retinol Binding Protein-7Recombinant Human Serum Amyloid A (APO-SAA1)Recombinant Rhesus Macaque Serum Amyloid A (APO-SAA1)

Recombinant Human Stem Cell Factor, Sf9 Recombinant Human Chromosome 19 Open Reading Frame 10Recombinant Mouse Chromosome 19 Open Reading Frame 10

Recombinant Human Teratocarcinoma-Derived Growth Factor 1

Recombinant Human Trefoil Factor-1 His Tag

Recombinant Human Trefoil Factor-2 His Tag

Recombinant Human Trefoil Factor-3 His TagRecombinant Human Transforming Growth Factor-Beta 1

Human Transforming Growth Factor-Beta 1Recombinant Human Transforming Growth Factor-Beta 1, GST tagRecombinant Human Transforming Growth Factor-Beta 1 His TagRecombinant Human Transforming Growth Factor-Beta 1 (113 a.a.)Recombinant Human Transforming Growth Factor-Beta 2Recombinant Human Transforming Growth Factor-Beta 3Recombinant Human Transforming Growth Factor-Beta 3, CHO Recombinant Human Transforming Growth Factor-Beta 3, PlantRecombinant Human Transforming Growth Factor-Beta 3 (644-850)

Recombinant Human Tumor Necrosis Factor-alphaRecombinant Human Tumor Necrosis Factor-alpha, His TagRecombinant Mouse Tumor Necrosis Factor-alphaRecombinant Rat Tumor Necrosis Factor-alphaRecombinant Porcine Tumor Necrosis Factor-alphaRecombinant Rabbit Tumor Necrosis Factor-alphaRecombinant Human Tumor Necrosis Factor-alpha, MutantRecombinant Human Tumor Necrosis Factor-betaRecombinant Human Tumor Necrosis Factor-beta, His TagRecombinant Human Tumor Necrosis Factor Receptor Fusion ProteinRecombinant Human B-Cell Maturation AntigenRecombinant Human Tumor Necrosis Factor Receptor Type 1Recombinant Human Tumor Necrosis Factor Receptor Type 1, His TagRecombinant Human Tumor Necrosis Factor Receptor Type 2Recombinant Human TNF Ligand Superfamily Member 12Recombinant Human TNF Ligand Receptor Superfamily Member 12A Recombinant Human Thymic Stromal Lymphopoietin

Recombinant Human Thrombopoietin, CHO

Recombinant Human TNF-Related Apoptosis Inducing Ligand/Apo2LRecombinant Human TNF-Related Apoptosis Inducing Ligand/Apo2L (114-281)

Recombinant Human Vascular Endothelial Growth FactorRecombinant Human Vascular Endothelial Growth Factor His TagRecombinant Human Vascular Endothelial Growth Factor, CHO Recombinant Human Vascular Endothelial Growth Factor, HEKRecombinant Human Vascular Endothelial Growth Factor, YeastRecombinant Human Vascular Endothelial Growth Factor (121)Recombinant Human Vascular Endothelial Growth Factor (121), Sf9Recombinant Human Vascular Endothelial Growth Factor (121) His TagRecombinant Mouse Vascular Endothelial Growth FactorRecombinant Mouse Vascular Endothelial Growth Factor-Sf9Recombinant Mouse Vascular Endothelial Growth Factor (121)Recombinant Mouse Vascular Endothelial Growth Factor His TagRecombinant Rat Vascular Endothelial Growth FactorRecombinant Human Vascular Endothelial Growth Factor BRecombinant Human Vascular Endothelial Growth Factor Related ProteinRecombinant Rat Vascular Endothelial Growth Factor Related ProteinRecombinant Rat Vascular Endothelial Growth Factor-C (152)Recombinant Human Vascular Endothelial Growth Factor DRecombinant Vascular Endothelial Growth Factor-E (Orf Virus)Recombinant Human Vascular Endothelial Growth Inhibitor

Recombinant Human BCA-1/ BLC (CXCL13)Recombinant Human BRAK (CXCL14), His Tag

Recombinant Human LEC/NCC-4 (CCL16)Recombinant Human LD78-beta (CCL3L1)

Recombinant Human Epithelial Neutrophil-Activating Protein 78 (CXCL5)Recombinant Mouse Epithelial Neutrophil-Activating Protein 78 (CXCL5)

Recombinant Human Eotaxin (CCL11), His Tag

Recombinant Human Fractalkine (CX3CL1)Recombinant Human Fractalkine (CX3CL1) His TagRecombinant Human GRO-alpha (CXCL1)Recombinant Human GRO-alpha (CXCL1), His Tag

Recombinant Human GRO-beta/MIP-2 (CXCL2)Recombinant Human GRO-beta/MIP-2 (CXCL2) HisRecombinant Mouse GRO-beta/MIP-2 (CXCL2)Recombinant Rat GRO-beta/MIP-2 (CXCL2)Recombinant Viral Macrophage inflammatory Protein-2Recombinant Human GRO-gamma (CXCL3)Recombinant Human GRO-gamma (CXCL3), His TagRecombinant Mouse GRO-gamma (CXCL3)

Recombinant Human HCC-1 (CCL14) His Tag

Recombinant Human I-309 (CCL1) His TagRecombinant Human Interleuikin-8 (1-72) (CXCL8)Recombinant Porcine Interleuikin-8 (1-72) (CXCL8)Recombinant Human Interleuikin-8 (1-77) (CXCL8)Recombinant Human Interleuikin-8 (1-77) (CXCL8) PichiaRecombinant Human Interleuikin-8 (1-77) (CXCL8), His Tag

Recombinant Human IP-10 (CXCL10), His Tag

Recombinant Human I-TAC (CXCL11), His TagRecombinant Human Lymphotactin (XCL1)Recombinant Human Lymphotactin (XCL1) His TagRecombinant Human Monocyte Chemotactic Protein-1/MCAF (CCL2)Recombinant Human Monocyte Chemotactic Protein-1/MCAF (CCL2), His TagRecombinant Mouse Monocyte Chemotactic Protein-1 (CCL2)Recombinant Rat Monocyte Chemotactic Protein-1 (CCL2)Recombinant Human Monocyte Chemotactic Protein-2 (CCL8)Recombinant Mouse Monocyte Chemotactic Protein-2 (CCL8)

Recombinant Human Monocyte Chemotactic Protein-3 (CCL7)Recombinant Mouse Monocyte Chemotactic Protein-3 (CCL7)Recombinant Human Monocyte Chemotactic Protein-4 (CCL13)Recombinant Human Monocyte Chemotactic Protein-4 (CCL13), His TagRecombinant Human Macrophage-Derived Chemokine (CCL22) Recombinant Human Macrophage-Derived Chemokine (CCL22) His TagRecombinant Mouse Macrophage-Derived Chemokine (CCL22) Recombinant Human Mucosae-Associated Epithelial Chemokine (CCL28)Recombinant Human Mucosae-Associated Epithelial Chemokine (CCL28) His TagRecombinant Mouse Mucosae-Associated Epithelial Chemokine (CCL28)

Recombinant Human Macrophage Inflammatory protein-1 alpha (CCL3)Recombinant Human Macrophage Inflammatory protein-1 alpha (CCL3), His TagRecombinant Mouse Macrophage Inflammatory protein-1 alpha (CCL3)Recombinant Rat Macrophage Inflammatory protein-1 alpha (CCL3)Recombinant Human Macrophage Inflammatory protein-1 beta (CCL4)Recombinant Mouse Macrophage Inflammatory protein-1 beta (CCL4)Recombinant Mouse Macrophage Inflammatory protein-1 gamma (CCL9)Recombinant Human Macrophage Inflammatory protein-3 (CCL23)Recombinant Human Macrophage Inflammatory protein-3 beta (CCL19)Recombinant Human Macrophage Inflammatory protein-3 (CCL23), T7 TagRecombinant Mouse Macrophage Inflammatory protein-3 beta (CCL19)Recombinant Human Macrophage Inflammatory protein-3 alpha (CCL20)Recombinant Human Macrophage Inflammatory protein-3 alpha (CCL20), His TagRecombinant Mouse Macrophage Inflammatory protein-3 alpha (CCL20)Recombinant Human Macrophage Inflammatory protein-4 (CCL18)Recombinant Human Macrophage Inflammatory protein-4 (CCL18), His-TagRecombinant Human Macrophage Inflammatory protein-5 (CCL15)Recombinant Human Neutrophil Activating Protein-2 (CXCL7)

Recombinant Human Platelet Factor-4 (CXCL4)Recombinant Human Platelet Factor-4 (CXCL4) Variant-1Recombinant Mouse Platelet Factor-4 (CXCL4)

Recombinant Human Rantes (CCL5) His Tag

Recombinant Human Stromal Cell-Derived Factor-1 alpha (CXCL12)Recombinant Human Stromal Cell-Derived Factor-1 alpha (CXCL12) His-TagRecombinant Mouse Stromal Cell-Derived Factor-1 alpha (CXCL12)Recombinant Rat Stromal Cell-Derived Factor-1 alpha (CXCL12)Recombinant Human Stromal Cell-Derived Factor-1 beta (CXCL12)Recombinant Human Stromal Cell-Derived Factor-1 beta (CXCL12) His TagRecombinant Mouse Stromal Cell-Derived Factor-1 beta (CXCL12)Recombinant Feline Stromal Cell-Derived Factor-1 beta (CXCL12)Recombinant Rat Stromal Cell-Derived Factor-1 beta (CXCL12)Recombinant Human Thymus and Activation Regulated Chemokine (CCL17)Recombinant Human Thymus and Activation Regulated Chemokine (CCL17) His TagRecombinant Human Thymus Expressed Chemokine (CCL25)Recombinant Mouse Thymus Expressed Chemokine (CCL25)

Recombinant Human Agouti–Related Protein

Recombinant Human Corticotropin Releasing Hormone Binding Protein

Recombinant Human Follicle Stimulating Hormone

Human Growth Hormone Releasing Hormone

Human Growth Hormone Releasing Peptide-2

Recombinant Human Glucagon Like Peptide-1 (7-36)

Recombinant Human Inhibin-Alpha A Chain

Recombinant Human Leutenizing hormone Releasing Hormone (Gonadorelin)Human Leutenizing hormone Releasing Hormone (Gonadorelin)Porcine Leutenizing hormone (Gonadorelin)

Recombinant Human Procalcitonin His Tag

Recombinant Human Parathyroid Hormone (1-34)

Recombinant Human Parathyroid Hormone (1-84)Recombinant Human Parathyroid Hormone (7-34)

Human Protirelin (Thyrotropin Releasing Hormone)

Recombinant Human Aminoadipate-Semialdehyde Dehydrogenase-Phosphopantetheinyl TransferaseRecombinant Human Acetyl-COA AcyltransferaseRecombinant Human Acyl-Coenzyme A Dehydrogenase 8Recombinant Human Acyl-Coenzyme A Dehydrogenase, C-4 to C-12Recombinant Human Acyl-Coenzyme A Dehydrogenase, C-2 to C-3Recombinant Human Acyl-CoA Dehydrogenase, Very Long ChainRecombinant Human Acetyl-Coenzyme A acetyltransferase 2

Recombinant Human Acyl-CoA Thioesterase 13Recombinant Human Acid Phosphatase-1

Recombinant Human Adenosine Deaminase tRNA-Specific 1Recombinant Human Adenosine Deaminase, tRNA-specific 2Recombinant Human AdenosylhomocysteinaseRecombinant Human Aldo-Keto Reductase Family 1 Member A1

Recombinant Human Aldo-Keto Reductase Family 1 Member B10Recombinant Human Aldo-Keto Reductase Family 1 Member C1Recombinant Human Aldo-Keto Reductase Family 1 Member C3Recombinant Human Aldo-Keto Reductase Family 1 Member D1Recombinant Human Aldo-Keto Reductase Family 7 Member A2Recombinant Human Aldo-Keto Reductase Family 7 Member A3Recombinant Human Alanine AminotransferaseRecombinant Human Aldehyde Dehydrogenase 1A1Recombinant Human Aldehyde Dehydrogenase 2 Recombinant Human Aldehyde Dehydrogenase 3 A1Recombinant Human Aldehyde Dehydrogenase 5 A1

Recombinant Human Aldolase C Fructose-BisphosphateRecombinant Human ALKB Alkylation Repair Homolog 2Recombinant Human ALKB Alkylation Repair Homolog 3Recombinant Aeromonas Aminopeptidase

Recombinant E.Coli Cytoplasmic L-asparaginase I

Recombinant Human Adenine Phosphoribosyltransferase

Recombinant Human Aspartate Beta-HydroxylaseRecombinant Human Argininosuccinate Synthase 1Recombinant Human ATP Synthase Subunit O, MitochondrialRecombinant Yeast Adenosine 5" Triphosphate Sulfurylase Recombinant Human AU RNA Binding Protein/Enoyl-CoA Hydratase

Recombinant Human Beta-Site APP-Cleaving Enzyme 1

Recombinant Human HLA-B Associated Transcript 1Recombinant Human Branched Chain keto Acid Dehydrogenase E1, AlphaRecombinant Human 2-Oxo-Acid Dehydrogenase Complex E2Recombinant Human 3-Hydroxybutyrate Dehydrogenase, Type 2Recombinant Human Betaine-Homocysteine MethyltransferaseRecombinant Human Bleomycin HydrolaseRecombinant Human Biliverdin Reductase ARecombinant Human Biliverdin Reductase BRecombinant Human 2,3-Bisphosphoglycerate MutaseRecombinant Human 3(2) 5-Bisphosphate Nucleotidase 1Recombinant Human Biphenyl Hydrolase-Like Recombinant Human Carbonic Anhydrase IIIRecombinant Human Carbonic Anhydrase III, His TagRecombinant E.Coli Carbonic Anhydrase 2Recombinant Human Carbonic Anhydrase 2Recombinant Human Carbonic Anhydrase-1

Recombinant Human Carbonyl Reductase-1Recombinant Human Carbonyl Reductase-3Recombinant Human Carbonyl Reductase-4Recombinant Human Cell Division Cycle 25A

Recombinant Human Cytidine DeaminaseRecombinant Human Cysteine DioxygenaseRecombinant Clostridium Paraputrificum ChitinaseRecombinant Clostridium Botulinum ChitodextrinaseRecombinant Human ClpP Caseinolytic PeptidaseRecombinant Human Catechol-O-MethyltransferaseRecombinant Human Quinone Oxidoreductase-like Protein 1Recombinant Human CTD Small Phosphatase 1

Recombinant Human Cytochrome P450 2D6Recombinant Human D-Amino Acid Oxidase

Recombinant Human Dicarbonyl/L-Xylulose ReductaseRecombinant Human Dimethylarginine Dimethylaminohydrolase 1Recombinant Human D-Dopachrome TautomeraseRecombinant Human 2,4-Dienoyl CoA Reductase 1Recombinant E.Coli Deoxyribose-Phosphate Aldolase Recombinant E.Coli Deoxyribose-Phosphate Aldolase 1-259 a.a.Recombinant Human Dihydrofolate ReductaseRecombinant Mouse Dihydrofolate ReductaseRecombinant Human Deoxyhypusine SynthaseRecombinant Human Dihydrolipoamide S-AcetyltransferaseRecombinant Human Dihydrolipoamide DehydrogenaseRecombinant Human Dihydrolipoamide S-Succinyltransferase

Recombinant Human Deoxyribonuclease I

Recombinant Human Dopa DecarboxylaseRecombinant Human Dipeptidyl-Peptidase 4

Recombinant Human Deoxyuridine TriphosphataseRecombinant Pyrococcus Fruriosus Deoxyuridine TriphosphataseRecombinant Human Enoyl CoA Hydratase, Short chain, 1, MitochondrialRecombinant Human Enoyl CoA Hydratase 1, Peroxisomal

Recombinant Human Neuronal Specific Enolase

Recombinant Human Neuronal Specific Enolase, His TagRecombinant Human Enolase-Phosphatase-1Recombinant Human Enteropeptidase/Enterokinase, Light ChainRecombinant Bovine Enteropeptidase/Enterokinase

Recombinant Human Methylmalonyl CoA EpimeraseRecombinant Human Esterase D,S-Formylglutathione HydrolaseRecombinant Human Fumarylacetoacetate Hydrolase Domain Containing 1Recombinant Human Phenylalanyl-tRNA Synthetase 2

Recombinant Human Fructose-1,6-Bisphosphatase 1Recombinant Human Flap Structure-Specific Endonuclease 1Recombinant Human FK506 Binding Protein 1ARecombinant Human FK506 Binding Protein 2Recombinant Human FK506 Binding Protein 3Recombinant Human FK506 Binding Protein 4Recombinant Human FK506 Binding Protein 6Recombinant Human FK506 Binding Protein 14Recombinant Human FK506 Binding Protein LikeRecombinant Human Formiminotransferase CyclodeaminaseRecombinant Human Fumarate Hydratase Recombinant Human GTPase Activating Protein (SH3 domain) Binding Protein 1Recombinant E.coli Glucose-6-Phosphate DehydrogenaseRecombinant Human UDP-Galactose-4-EpimeraseRecombinant Human Galactose MutarotaseRecombinant Human Guanidinoacetate N-MethyltransferaseRecombinant Human Glyceraldehyde-3-Phosphate DehydrogenaseRecombinant Human Glutaryl-Coenzyme A DehydrogenaseRecombinant Human Gamma-GlutamylcyclotransferaseRecombinant Human Geranylgeranyl Diphosphate Synthase 1Recombinant E.coli Galactosidase-Beta 1

Recombinant Human Glutamine SynthetaseRecombinant Human Glycine N-Methyltransferase Recombinant Human Glutamic-Oxaloacetic Transaminase 1Recombinant Human Glycogen PhosphorylaseRecombinant Human Glycerol-3-Phosphate Dehydrogenase 1 Recombinant Human Glycerol-3-Phosphate Dehydrogenase 2 Recombinant Human Glucose-6-Phosphate Isomerase

Recombinant Human Guanosine Monophosphate Reductase 2Recombinant Human Glucosamine-Phosphate N-Acetyltransferase 1Recombinant Human Glucosamine-6-Phosphate Deaminase 1

Recombinant Glutathione S-Transferase His TagRecombinant Human Glyoxylate Reductase/Hydroxypyruvate ReductaseRecombinant Human Glutathione SynthetaseRecombinant Human Glutathione S-Transferase Alpha 1Recombinant Human Glutathione S-Transferase Kappa 1Recombinant Mouse Glutathione S-Transferase M1Recombinant Mouse Glutathione S-Transferase M1 His-TagRecombinant Human Glutathione S-Transferase MU 2Recombinant Human Glutathione S-Transferase MU 4Recombinant Human Glutathione S-Transferase Omega 1Recombinant Human Glutathione S-Transferase Omega 1 MutantRecombinant Human Glutathione S-Transferase pi 1Recombinant Human Glutathione S-Transferase Theta-1Recombinant Human Glutathione S-Transferase Zeta-1

Recombinant Human Hydroxyacyl-Coenzyme A DehydrogenaseRecombinant Human Hydroxyacylglutathione HydrolaseRecombinant Human Histidyl-tRNA Synthetase, His TagRecombinant Human Histidyl-tRNA SynthetaseRecombinant Human Histidyl-tRNA Synthetase Sf9Recombinant Human Histone Acetyltransferase 1Recombinant Human Histone Deacetylase 1 Recombinant Human Haloacid Dehalogenase-Like Hydrolase Domain Containing 1Recombinant Human Haloacid Dehalogenase-Like Hydrolase Domain Containing 2Recombinant Human Haloacid Dehalogenase-Like Hydrolase Domain Containing 3Recombinant Human Heme Oxygenase 1Recombinant Human Heme Oxygenase 2Recombinant Human Histamine N-Methyltransferase

Recombinant Human 4-Hydroxyphenylpyruvate DioxygenaseRecombinant Human Hydroxyprostaglandin Dehydrogenase 15-(NAD)Recombinant Human Hypoxanthine-Guanine PhosphoribosyltransferaseRecombinant Human HRAS-Like Suppressor 3 (PLA2G16)

Recombinant Human Hydroxysteroid (17-beta) Dehydrogenase 8Recombinant Human Hydroxysteroid (17-beta) Dehydrogenase 14Recombinant Human Hydroxysteroid (17-beta) Dehydrogenase 11Recombinant Human HIV-1 Tat Interactive Protein 2

Recombinant Human Isopentenyl-Diphosphate Delta Isomerase 2Recombinant Human Inositol Monophosphatase 1Recombinant Human Inositol Monophosphatase 2Recombinant Human IMP Dehydrogenase 1Recombinant Human Inosine TriphosphataseRecombinant Human Isovaleryl Coenzyme A DehydrogenaseRecombinant Human 3-Ketodihydrosphingosine Reductase

Recombinant Human Lecithin-Cholesterol AcyltransferaseRecombinant Human Lecithin-Cholesterol Acyltransferase, HEKRecombinant Human Neutrophil Gelatinase Associated Lipocalin/Lipocalin-2Recombinant Human Neutrophil Gelatinase Associated Lipocalin/Lipocalin-2, PichiaRecombinant Human Lactate Dehydrogenase A

Recombinant Human Lactate Dehydrogenase B

Recombinant Firefly Luciferin 4-Monooxygenase

Recombinant Human Lipoprotein Lipase, HEKRecombinant Mouse Lysophospholipase I

Recombinant Human Lysophospholipase IIRecombinant Human DLAT/DLST/BCOADCRecombinant Human Monoamine Oxidase BRecombinant E.Coli Methionine AminopeptidaseRecombinant Human Methionine Adenosyltransferase I, AlphaRecombinant Human Methionine Adenosyltransferase II, AlphaRecombinant Human Methionine Adenosyltransferase II, BetaRecombinant Human Malate Dehydrogenase 1

Recombinant Human Malate Dehydrogenase 2Recombinant Human Magnesium-Dependent Phosphatase 1Recombinant Human Mitochondrial Trans-2-Enoyl-CoA ReductaseRecombinant Human Methyltransferase Like 1Recombinant Human Monoglyceride LipaseRecombinant Human O-6-Methylguanine-DNA MethyltransferaseRecombinant Human Methylmalonic Aciduria Type BRecombinant Moloney Mouse Leukemia Virus Reverse TrancscriptaseRecombinant Human Matrix Metalloproteinase-1Recombinant Human Matrix Metalloproteinase-2Recombinant Human Matrix Metalloproteinase-3Recombinant Human Matrix Metalloproteinase-3 GST-TagRecombinant Human Matrix Metalloproteinase-7Recombinant Human Matrix Metalloproteinase-8Recombinant Human Matrix Metalloproteinase-9Recombinant Rabbit Matrix Metalloproteinase-9Recombinant Human Matrix Metalloproteinase-13

Recombinant E.Coli Methionine Sulfoxide Reductase BRecombinant Human Methionine Sulfoxide Reductase B2Recombinant Human Methionine Sulfoxide Reductase B3Recombinant Human 5,10-Methenyltetrahydrofolate Synthetase Recombinant Human N-Acetylneuraminic Acid PhosphataseRecombinant Human N-acetylneuraminic acid synthaseRecombinant Human N-Acetyltransferase 6Recombinant Human Histidine NADH Dehydrogenase Fe-S Protein 4Recombinant Human Neural Precursor Cell Expressed, Developmentally Down-Regulated 8Recombinant E.Coli Dihydropteridine ReductaseRecombinant Human Nitrilase Family Member 2Recombinant Human Nicotinamide Nucleotide Adenylyltransferase 1Recombinant Human N-Myristoyltransferase 2

Recombinant Human Nicotinamide N-MethyltransferaseRecombinant Human N-acetylneuraminate Pyruvate LyaseRecombinant Human NAD(P)H Dehydrogenase Quinone 1Recombinant Human NAD(P)H Dehydrogenase Quinone 2

Recombinant Human Nudix Type Motif 10Recombinant Human Nudix Type Motif 16Recombinant Human Nudix Type Motif 16 Like-1Recombinant Human Nudix Type Motif 21Recombinant Human 2’-5’ Oligoadenylate Synthetase 1Recombinant Human 8-Oxoguanine DNA GlycosylaseRecombinant Human Ornithine Aminotransferase

Recombinant Human Prolyl 4-Hydroxylase BetaRecombinant Human Pregnancy-Associated Plasma Protein-1Recombinant Human Poly (ADP-Ribose) Polymerase 1Recombinant Human Pterin-4-Alpha-Carbinolamine Dehydratase Recombinant Human Protein-L-Isoaspartate O-MethyltransferaseRecombinant Human Phosphodiesterase 6D cGMP-Specific Rod DeltaRecombinant Human Protein Disulfide IsomeraseRecombinant Human Protein Disulfide Isomerase A3Recombinant Human Protein Disulfide Isomerase A4Recombinant Human Protein Disulfide Isomerase A6Recombinant Human Pyridoxal PhosphataseRecombinant Human Peroxisomal D3,D2-Enoyl-CoA Isomerase

Recombinant Human Phosphoglycerate Mutase 1Recombinant Human Phosphogluconate DehydrogenaseRecombinant Human 6-PhosphogluconolactonaseRecombinant Human Phosphoethanolamine/Phosphocholine PhosphataseRecombinant Human Phosphohistidine Phosphatase 1Recombinant Human Peptidase Inhibitor 16Recombinant Human Peptidyl-Prolyl Cis/Trans Isomerase NIMA-Interacting 1Recombinant Human Peptidyl-Prolyl Cis/Trans Isomerase NIMA-Interacting 4Recombinant Human Alanyl t-RNA SynthetaseRecombinant Human Threonyl t-RNA SynthetaseRecombinant Human Secreted Phospholipase A2-XRecombinant Human Secreted Phospholipase A2-XIIRecombinant Human Secreted Phospholipase A2-IBRecombinant Human Secreted Phospholipase A2-IIA Recombinant Human Secreted Phospholipase A2-IIDRecombinant Human Secreted Phospholipase A2-IIERecombinant Human Secreted Phospholipase A2-VRecombinant Human Secreted Phospholipase A2-VIIRecombinant Human Placental Alkaline Phosphatase Recombinant Human Phosphomannomutase 1Recombinant Human Phosphomannomutase 2Recombinant Human Phenylethanolamine-N-MethyltransferaseRecombinant Human Purine Nucleoside PhosphorylaseRecombinant Human Pyridoxamine 5'-Phosphate Oxidase

Recombinant Human Phosphopantothenoylcysteine Decarboxylase

Recombinant Human Peptidylprolyl Isomerase (Cyclophilin)-Like 1Recombinant Human Peptidylprolyl Isomerase (Cyclophilin)-Like 2Recombinant Human Peptidylprolyl Isomerase (Cyclophilin)-Like 4

Recombinant Human Protein Phosphatase 1GRecombinant Human Protein Phosphatase-1, Regulatory Subunit-14ARecombinant Human Protein Phosphatase Inhibitor-1Recombinant Human Protein Phosphatase 3, Catalytic subunit, Alpha IsozymeRecombinant Human Protein Phosphatase 3, Regulatory subunit, Alpha IsozymeRecombinant Human Protein Phosphatase 3, Regulatory subunit, Beta Isozyme

Recombinant Human Protein Arginine Methyltransferase 1Recombinant Mouse Protein Arginine Methyltransferase 1Recombinant ProMatrix Metalloproteinase-7Recombinant Human ProMatrix Metalloproteinase-9

Recombinant Human Proteasome Subunit Alpha Type 7Recombinant Human Proteasome Subunit Beta Type 1Recombinant Human Proteasome Subunit Beta Type 5Recombinant Human Proteasome Subunit Beta Type 9

Recombinant Human Prostaglandin D2 Synthase Recombinant Human Prostaglandin E Synthase 3Recombinant Human Protein Tyrosine Phosphatase Type IVA Member 1Recombinant Human Protein Tyrosine Phosphatase Type IVA Member 3Recombinant Human Protein Tyrosine Phosphatase Type IVA Member 3Recombinant Human 6-Pyruvoyltetrahydropterin SynthaseRecombinant Human Peptidyl-tRNA Hydrolase 2Recombinant Human Pyrroline-5-Carboxylate Reductase 1Recombinant Human Quinolinate PhosphoribosyltransferaseRecombinant Human Thiosulfate SulfurtransferaseRecombinant Human RNA (guanine-7-) MethyltransferaseRecombinant Human Ribonuclease P/MRP 30kDa SubunitRecombinant Human Ribonucleotide Reductase M2Recombinant Human SUMO1 Activating Enzyme Subunit 1Recombinant Human Spermidine/Spermine N1-Acetyltransferase 1Recombinant Human Fibroblast Activation Protein Alpha Recombinant Human Selenocysteinyl-tRNA(Sec) synthase

Recobinant Human Plasminogen Activator Inhibitor-1Recombinant Human Set7/9 Histone MethyltransferaseRecombinant Human S-Phase Kinase-Associated Protein 2Recombinant E.Coli KBP-Type Peptidyl-Prolyl Cis-Trans IsomeraseRecombinant Human Sorbitol DehydrogenaseRecombinant Human Sepiapterin ReductaseRecombinant Human Spermidine Synthase

Recombinant E.Coli Beta Lactamase, His Tag

Recombinant Human Sulfotransferase Family, Cytosolic, 2B, Member 1Recombinant Human Estrogen SulfotransferaseRecombinant Human Sulfotransferase Family, Cytosolic 1C, Member 2

Recombinant Human TAF9 RNA Polymerase II

Recombinant Human Tryptophan 2,3-DioxygenaseRecombinant Human Tissue TransglutaminaseRecombinant Human Tissue Transglutaminase, Sf9Recombinant Human Thiamine TriphosphataseRecombinant Human Tissue Inhibitor of Metalloprotease 1Recombinant Human Tissue Inhibitor of Metalloprotease 1, HEKRecombinant Human Tissue Inhibitor of Metalloprotease 2Recombinant Human DNA Topoisomerase-IRecombinant Human DNA Topoisomerase-I 70kDaRecombinant Human Tumor Protein p53 Inducible Protein 3Recombinant Human Tissue Plasminogen ActivatorRecombinant Human Triosephosphate Isomerase 1

Recombinant Human Three Prime Repair Exonuclease 2Recombinant E.Coli Thioredoxin ReductaseRecombinant Yeast Thioredoxin Reductase Recombinant Human Tissue Specific Transplantation Antigen P35BRecombinant Human Thiosulfate Sulfurtransferase Like Domain Containing 1Recombinant Human Thioredoxin Reductase 1Recombinant Human Thioredoxin Reductase 1 161-649 a.a.Recombinant Human Thymidylate SynthetaseRecombinant Human Thymidine PhosphorylaseRecombinant Human Ubiquitin Conjugating Enzyme E2ARecombinant Human Ubiquitin Conjugating Enzyme E2BRecombinant Human Ubiquitin Conjugating Enzyme E2CRecombinant Human Ubiquitin Conjugating Enzyme E2DRecombinant Human Ubiquitin Conjugating Enzyme E2D3Recombinant Human Ubiquitin-Conjugating Enzyme E2IRecombinant Human Ubiquitin-Conjugating Enzyme E2I , His tagRecombinant Human Ubiquitin-Conjugating Enzyme E2KRecombinant Human Ubiquitin-Conjugating Enzyme E2L 3Recombinant Human Ubiquitin-Conjugating Enzyme E2L 3, His TagRecombinant Human Ubiquitin Conjugating Enzyme E2L 6Recombinant Human Ubiquitin Conjugating Enzyme E2MRecombinant Human Ubiquitin Conjugating Enzyme E2NRecombinant Human Ubiquitin Conjugating Enzyme E2SRecombinant Human Ubiquitin Conjugating Enzyme E2TRecombinant Human Ubiquitin-Conjugating Enzyme E2 Variant 2Recombinant Human Ubiquitin Conjugating Enzyme E2WRecombinant Human Ubiquitin Carboxyl-Terminal Esterase L3 Recombinant Human Ubiquitin Carboxyl-Terminal Esterase L5Recombinant Human UDP-Glucose Dehydrogenase

Recombinant Human Typhimurium Uridine phosphorylase Recombinant Salmonella Typhimurium Uridine phosphorylase Recombinant E.Coli Uridine phosphorylase

Recombinant Human Uroporphyrinogen Decarboxylase

Recombinant Human Tryptophanyl-tRNA SynthetaseRecombinant Human WW Domain Containing OxidoreductaseRecombinant Human Activin A Receptor, Type IB

Recombinant Human Adenylate Kinase 3 Like 1

Recombinant Human Activating Transcription Factor-2

Recombinant Human Cyclin-Dependent Kinase 2 Associated Protein 1Recombinant Human cyclin-dependent kinase 4Recombinant Human cyclin-dependent kinase 8Recombinant Human Cyclin-Dependent Kinase Inhibitor 3

Recombinant Protein Kinase A regulatory subunit-1 alphaRecombinant Human Calcium and Integrin Binding 1Recombinant Human Calcium and Integrin Binding 2Recombinant Human Jun Proto-OncogeneRecombinant Human Jun Proto-Oncogene (1-241 a.a.)Recombinant Human Casein Kinase 2 beta Recombinant Human Casein Kinase 2 beta ActiveRecombinant Human Casein Kinase 2 HoloenzymeRecombinant Human CDC28 protein kinase 2Recombinant Human Cytidine Monophosphate Kinase 1Recombinant Human Casein Kinase 2 alphaRecombinant Human Protein kinase Casein Kinase 2 alpha, His Tag

Recombinant Human Deoxycytidine KinaseRecombinant Human Epidermal Growth Factor Receptor-Sf9 (ErbB1)Recombinant Human Epidermal Growth Factor Receptor-Sf9 (ErbB1), Active

Recombinant Human Tyrosine Kinase ErbB-2Recombinant Human Tyrosine Kinase ErbB-3Recombinant Human Mitogen-Activated Protein Kinase Kinase 3Recombinant Human Mitogen-Activated Protein Kinase 3, Active Recombinant Human Mitogen-Activated Protein Kinase 3Recombinant Human Mitogen-Activated Protein Kinase 3 His TagRecombinant Human Mitogen-Activated Protein Kinase 1, Active Recombinant Human Mitogen-Activated Protein Kinase 1Recombinant Human Mitogen-Activated Protein Kinase 1 His TagRecombinant Human Active Focal Adhesion KinaseRecombinant Human Fibroblast Growth Factor Receptor-1Recombinant Human Fibroblast Growth Factor Receptor-2Recombinant Human Fibroblast Growth Factor Receptor-3Recombinant Human Fibroblast Growth Factor Receptor-4

Recombinant Human Vascular Endothelial Growth Factor receptor-1Recombinant Human Vascular Endothelial Growth Factor receptor-1 D1-3Recombinant Human Vascular Endothelial Growth Factor receptor-1 D1-3, His Tag

Recombinant Human Vascular Endothelial Growth Factor receptor-1 D1-4Recombinant Human Vascular Endothelial Growth Factor receptor-1 D1-5Recombinant Human Vascular Endothelial Growth Factor receptor-1 D1-7Recombinant Human Vascular Endothelial Growth Factor receptor-1 His TagRecombinant Human Vascular Endothelial Growth Factor receptor-3Recombinant Human Vascular Endothelial Growth Factor receptor-3 Fc Chimera

Recombinant Human Insulin Like Growth Factor-I ReceptorRecombinant Human Integrin Linked Kinase

Recombinant Human Jun N-terminal kinase 2, alpha 1Recombinant Human Jun N-terminal kinase 2, alpha 2

Recombinant Human Lymphatic Endothelial Hyluronan Receptor-1Recombinant Human Lymphatic Vessel Endothelial Hyaluronic Acid Receptor 1 (25-235)Recombinant Human Lymphatic Vessel Endothelial Hyaluronic Acid Receptor 1, Sf9Recombinant Mouse Lymphatic Vessel Endothelial Hyaluronic Acid Receptor 1, Sf9Recombinant Human Mitogen Activated Kinase Kinase 1

Recombinant Human Non-Metastatic Cells 2Recombinant Human Cyclin-Dependent Kinase Inhibitor 2ARecombinant Human p38 alpha/SAPK2 alphaRecombinant Human p21 Activated Kinase 4Recombinant bovine Phosphoinositide 3-kinase a, regulatory subunitRecombinant bovine Phosphoinositide 3-kinase alpha p110a/p85aRecombinant Human Pyruvate Dehydrogenase Kinase Isozyme 1

Recombinant Human Phosphofructokinase, MuscleRecombinant Human Phosphoglycerate Kinase 1Recombinant Human Phosphoinositide 3-kinase beta P110β/p85aRecombinant Human Phosphoinositide 3-kinase p110d/p85aRecombinant Human Phosphoinositide 3-kinase p110gRecombinant Human Phosphoinositide 3-kinase p110g inactive mutantRecombinant Protein Kinase A Inactive holoenzyme type 1 alphaRecombinant Protein Kinase A Inactive holoenzyme type 2 alphaRecombinant Human Protein Kinase Akt1/PKB alpha Active EnzymeRecombinant Human Protein Kinase Akt1/PKB alpha Inactive EnzymeRecombinant c-AMP dependant Protein Kinase A regulatory subunit 2 alphaRecombinant Human Protein Kinase C alphaRecombinant Human Protein Kinase C beta 1Recombinant Human Protein Kinase C beta 2Recombinant Human Protein Kinase C delta

Recombinant Human Protein Kinase C gamma

Recombinant Human Protein Kinase Inhibitor BetaRecombinant Human Pyruvate Kinase, Liver and RBCRecombinant Human Tumour Type M2 Pyruvate Kinase Recombinant Human Phosphomevalonate KinaseRecombinant Human Peroxisome Proliferator Activated Receptor GammaRecombinant Human Peroxisome Proliferator Activated Receptor Gamma (1-477)Recombinant Human Protein Phosphatase 1A Alpha Isoform

Recombinant c-AMP dependant Protein Kinase A regulatory subunit-1 alphaRecombinant c-AMP dependant Protein Kinase A catalytic subunit alphaRecombinant Human Phosphoribosyl Pyrophosphate Synthetase 1Recombinant Human Phosphoserine PhosphataseRecombinant Human Protein Tyrosine Phosphatase Non Receptor Type-1Recombinant Human Protein Tyrosine Phosphatase Non Receptor Type-6

Recombinant Human S-phase Kinase-Associated Protein 1 Isoform ARecombinant Human Signal Transducer and Activator of Transcription 1Recombinant Human Transforming Growth Factor Beta Receptor II

Recombinant Human Thiopurine S-methyltransferaseRecombinant Human Uridine-Cytidine Kinase 2Recombinant Human Vascular Endothelial Growth Factor receptor-2Recombinant Human Vascular Endothelial Growth Factor receptor-2 Fc ChimeraRecombinant Human Tyr-3/Trp-5 Monooxygenase Activation Protein, BetaRecombinant Human Tyr-3/Trp-5 Monooxygenase Activation Protein, EpsilonRecombinant Human Tyr-3/Trp-5 Monooxygenase Activation Protein, GammaRecombinant Human Tyr-3/Trp-5 Monooxygenase Activation Protein, Gamma His TagRecombinant Human Tyr-3/Trp-5 Monooxygenase Activation Protein, ETARecombinant Human Tyr-3/trp-5 Monooxygenase Activation Protein, TauRecombinant Human Tyr-3/trp-5 Monooxygenase Activation Protein, SigmaRecombinant Human Tyr- 3/Trp-5 Mmonooxygenase Activation protein, ZetaRecombinant Zea Mays Casein Kinase 2 alphaRecombinant Human Creatine Kinase Brain Recombinant Human Creatine Kinase Brain, His TagRecombinant Human Creatine Kinase MB Isoenzyme Type-1Recombinant Human Creatine Kinase MB Isoenzyme Type-2

Recombinant Human Creatine Kinase Muscle Type-1Recombinant Human Creatine Kinase Muscle Type-3

Recombinant Human A Disintegrin and Metalloproteinase Domain 10Recombinant Human A Disintegrin and Metalloproteinase Domain 12 S IsoformRecombinant Human Adipose Differentiation-Related ProteinRecombinant Human Amino-Terminal Enhancer of Split

Recombinant Mycobacterium Tuberculosis major secretory protein Antigen 85BRecombinant Human Anterior Gradient Protein 2 Homolog Recombinant Human Alpha Hemoglobin Stabilizing ProteinRecombinant Human AIG2-Like Domain 1

Recombinant Human Angiostatin Kringles 1-3

Recombinant Human Acidic Nuclear Phosphoprotein 32 Family, Member A

Recombinant Human Assembly Protein Complex 2Recombinant Human Assembly Protein Complex 3Recombinant Human Amyloid P ComponentRecombinant Human ADP-Ribosylation Factor 1Recombinant Human ADP-Ribosylation Factor 4Recombinant Human ADP-Ribosylation Factor 6Recombinant Human Rho GDP Dissociation Inhibitor (GDI) AlphaRecombinant Human ADP-Ribosylation Factor-Like 1Recombinant Human ADP-Ribosylation Factor-Like 2Recombinant Human ADP-Ribosylation Factor-Like 5ARecombinant Human Actin Related Protein 2/3 Complex, Subunit 5Recombinant Human Autophagy Related 5

Recombinant Human ADP-Ribosylation Factor-Like 2 Binding ProteinRecombinant Human ASF1 Anti-Silencing Function 1 Homolog A

Recombinant Human Alpha-Synuclein A30PRecombinant Human Alpha-Synuclein A53TRecombinant Human Alpha-Synuclein A30P/A53T Recombinant Human Alpha-Synuclein Delta-NACRecombinant Human Alpha-Synuclein NACP112Recombinant Human Alpha-Synuclein 61-140Recombinant Human Alpha-Synuclein 96-140Recombinant Human Alpha-Synuclein 1-60

Recombinant Human Copper Transport Protein ATOX1

Recombinant Human Brain and Acute Leukemia, CytoplasmaticRecombinant Human BCL2-Associated Athanogene 1Recombinant Human BCL2-Associated Athanogene 2Recombinant Human BCL2-Associated Athanogene 3Recombinant Human Basic Leucine Zipper Transcription FactorRecombinant Human Beta 2 Glycoprotein-I

Recombinant Human Beta 2 MicroglobulinRecombinant Human Beta 2 Microglobulin, His Tag

Recombinant Human Breast Carcinoma Amplified Sequence 2Recombinant Human B-Cell Leukemia/Lymphoma 2

Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH1Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH2Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH3Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH4Recombinant Human B-Cell Lymphoma Protein 2 Alpha, His Tag

Recombinant Human B-Cell Leukemia/Lymphoma 2 -NWGR

Recombinant Human B-Cell Leukemia/Lymphoma 2 XL Recombinant Human B-Cell Leukemia/Lymphoma 2 XL GST TagRecombinant Human B-Cell Leukemia/Lymphoma 2 His TagRecombinant Human BH3 Interacting Domain Death AgonistRecombinant Mouse BH3 Interacting Domain Death AgonistRecombinant Mouse BH3 Interacting Domain Death Agonist GSTRecombinant Human Bridging Integrator 1

Recombinant Human Baculoviral IAP Repeat-Containing 7

Recombinant Human Bcl2 Modifying Factor, Isoform 3

Human Bactericidal/Permeability-Increasing Protein

Recombinant Human Calcium Regulated Heat Stable Protein 1Recombinant Human Calcyclin Binding ProteinRecombinant Human Complement Component 1Recombinant Human Complement C1q Tumor Necrosis Factor-Related Protein 1Recombinant Human Complement C1q Tumor Necrosis Factor-Related Protein 2Recombinant Human Complement C1q Tumor Necrosis Factor-Related Protein 3 Recombinant Human Complement C1q Tumor Necrosis Factor-Related Protein 6Recombinant Human Complement C1q Tumor Necrosis Factor-Related Protein 7Recombinant Human Complement C1q Tumor Necrosis Factor-Related Protein 8Recombinant Human Complement C1q Tumor Necrosis Factor-Related Protein 9Recombinant Human Chromosome 6 Open Reading Frame 108Recombinant Human Chromosome 12 Open Reading Frame 5Recombinant Human Chromosome 14 Open Reading Frame 129Recombinant Human Calcium Binding Protein 39Recombinant Human Calcium Binding Protein 7

Recombinant Rat S100 Calcium Binding Protein G

Recombinant Human Capping Protein Gelsolin-Like

Recombinant Human Core Binding Factor BetaRecombinant Human Copper Chaperone for Superoxide Dismutase

Recombinant Human Cell Division Cycle 37Recombinant Human Cell Division Cycle 37, His TagRecombinant Human Cell Division Cycle 42Recombinant Human Carcinoembryonic Antigen Recombinant Human CCAAT/enhancer binding protein(C/EBP) Alpha Recombinant Human CCAAT/enhancer binding protein(C/EBP) GammaRecombinant Human Centromere Protein-ARecombinant Human Centromere Protein-B

Recombinant Human Chromodomain Helicase DNA Binding Protein 4

Recombinant Human Chromogranin A GST TagRecombinant Human Chromogranin A His Tag

Recombinant Human Chromatin Modifying Protein 2ARecombinant Human Calcium Binding Protein P22Recombinant Human Cbp/p300-Interacting Transactivator 2

Recombinant Human Chloride Intracellular Channel 1Recombinant Human Chloride Intracellular Channel 2Recombinant Human Chloride Intracellular Channel 4Recombinant Human Collagen Type IV Alpha 3 Recombinant Human Collagen Type IV Alpha 3 Binding Protein

Recombinant Human Copper Metabolism Domain Containing 1

Recombinant Mouse Complement Component C5aRecombinant Human Cartilage Oligomeric Matrix Protein, HEK

Recombinant Human Cellular Retinoic Acid Binding Protein 1 Recombinant Human Cellular Retinoic Acid binding Protein 2Recombinant Human Caspase and RIP Adapter with Death DomainRecombinant Human V-crk Sarcoma Virus CT10 OncogeneRecombinant Human V-crk Sarcoma Virus CT10 Oncogene Homolog (Avian)-LikeRecombinant Human Collapsin Response Mediator Protein-1

Recombinant Human C-Terminal Binding Protein 1Recombinant Human Catenin, Beta Interacting Protein 1

Recombinant Human Cystatin-A, GST tag

Recombinant Human CutA Divalent Cation Tolerance Homolog

Recombinant Human Diazepam Binding InhibitorRecombinant Human DCN1 Defective in Cullin Neddylation 1 Domain Containing 1 Recombinant Human DNA Damage Inducible Transcript 3Recombinant Human DNA Damage Inducible Transcript 4

Recombinant Human DNA Fragmentation Factor Subunit AlphaRecombinant Human Dickkopf-Related Protein 1 Recombinant Human Dickkopf-Related Protein 1 HEKRecombinant Human DIRAS family, GTP-binding RAS-like 1Recombinant Human Down-Regulator of Transcription 1Recombinant Human Dystrobrevin-Binding Protein 1 Isoform C Recombinant Human Dynein Light Chain LC8 Type-1Recombinant Human Dynein Light Chain Roadblock-Type 1Recombinant Human Dynein Light Chain Roadblock-Type 2Recombinant Human Eukaryotic Translation Elongation Factor 1 Epsilon 1Recombinant Early Secretory Target Mycobacterium TuberculosisRecombinant Human Estrogen Receptor Binding Site Associated Antigen 9

Recombinant Human Endothelial Differentiation-Related Factor 1 Recombinant Human Eukaryotic Translation Elongation Factor 1 Beta 2Recombinant Human Eukaryotic Translation Elongation Factor 1 DeltaRecombinant Human Eukaryotic Translation Initiation Factor 1Recombinant Human Eukaryotic Translation Initiation Factor 1BRecombinant Human Eukaryotic Translation Initiation Factor 1A X-linkedRecombinant Human Eukaryotic Translation Initiation Factor 1A Y-linkedRecombinant Human Eukaryotic Translation Initiation Factor 2B Subunit 1 AlphaRecombinant Human Eukaryotic Translation Initiation Factor 2 Subunit 1 AlphaRecombinant Human Eukaryotic Translation Initiation Factor 3KRecombinant Human Eukaryotic Translation Initiation Factor 4ERecombinant Human Eukaryotic Translation Initiation Factor 4E-Binding Protein 1Recombinant Human Eukaryotic Translation Initiation Factor 4E-Binding Protein 2Recombinant Human Eukaryotic Translation Initiation Factor 5A

Recombinant Human Eukaryotic Translation Initiation Factor 5A2

Recombinant Human Estrogen Receptor AlphaRecombinant Human Enhancer of Rudimentary Recombinant Human Endoplasmic Reticulum Protein 27Recombinant Human Endoplasmic Reticulum Protein 44

Recombinant Human Fatty Acid Binding Protein-1Recombinant Human Fatty Acid Binding Protein-2Recombinant Human Fatty Acid Binding Protein-3Recombinant Human Fatty Acid Binding Protein-3, His TagRecombinant Human Fatty Acid Binding Protein-4Recombinant Human Fatty Acid Binding Protein-4, His TagRecombinant Human Fatty Acid Binding Protein-5Recombinant Human Fatty Acid Binding Protein-5, His TagRecombinant Human Fatty Acid Binding Protein-6Recombinant Human Fatty Acid Binding Protein-6, His TagRecombinant Human Fatty Acid Binding Protein-7Recombinant Human Fatty Acid Binding Protein-7, His Tag

Recombinant Human Fas-Associated Death DomainRecombinant Human Family with Sequence Similarity 3, Member B

Recombinant Human Ferritin Heavy Chain

Recombinant Human Fragile Histidine TriadRecombinant Human Fragile Histidine Triad, GST Tag

Recombinant E.Coli Chaperone Protein fimC

Recombinant E.Coli Ferric Uptake Regulator

Recombinant Human Gamma-Aminobutyric Acid Receptor-Associated ProteinRecombinant Human GABA(A) Receptor-Associated Protein Like 1Recombinant Human GABA(A) Receptor-Associated Protein Like 2Recombinant Human Growth Arrest and DNA-Damage-Inducible AlphaRecombinant Human Growth Arrest and DNA-Damage-Inducible Beta

Recombinant Human Growth Arrest and DNA-Damage-Inducible GammaRecombinant Drosophila melanogaster GAGA-POZRecombinant Human Growth Arrest-Specific 7, Isoform bRecombinant Human Germinal Center-Associated Nuclear Protein

Recombinant Human GIPC PDZ Domain Member 1

Recombinant Human GLI Pathogenesis-Related 2

Recombinant Human Golgi-Associated PDZ and Coiled-Coil Motif Containing

Recombinant Human GRB2-Related Adaptor Protein 2Recombinant Human Growth Factor Receptor-Bound Protein 2

Recombinant Human General Transcription Factor IIB

Recombinant Human Hexamethylene Bis-Acetamide Inducible 1Recombinant Human Hypoxia-Inducible Factor-1 Alpha Recombinant Human Hypoxia-Inducible Factor-1 Alpha His TagRecombinant Human Hypoxia-Inducible Factor-1 Alpha (85 a.a.)Recombinant Human Hypoxia-Inducible Factor-1 Alpha InhibitorRecombinant Human Histidine Triad Nucleotide Binding Protein 1

Recombinant Human High-Mobility Group Box 1Recombinant Human High-Mobility Group Box 1 Hi-5 Insect CellsRecombinant Human High-Mobility Group Nucleosome Binding Domain 1

Recombinant Human Heterogeneous Nuclear Ribonucleoprotein C

Recombinant Human Prostate Specific Gene-1 Recombinant Human V-Ha-ras Harvey Rat Sarcoma Viral Oncogene HomologRecombinant Human Heat-Responsive Protein 12

Recombinant Human Hydroxysteroid (17-beta) Dehydrogenase 10Recombinant Human HUS1 Checkpoint Homolog Recombinant Human Intercellular Adhesion Molecule-1

Recombinant Human Iron-sulfur Cluster Scaffold Homolog Recombinant Human Interferon Stimulated Gene 15Recombinant Human Kidney Associated Antigen 1

Recombinant Listeria Monocytogenes Internalin 

Recombinant Human Kv Channel Interacting Protein 3Recombinant Human Killer Cell Immunoglobulin-Like Receptor, 2 Domains Long Cytoplasmic Tail 1Recombinant Human Killer Cell Immunoglobulin-Like Receptor, 2 Domains Long Cytoplasmic Tail 3Recombinant Human Killer Cell Immunoglobulin-Like Receptor, 2 Domains Short Cytoplasmic Tail 4Recombinant Human Killer Cell Immunoglobulin-Like Receptor, 3 Domains Long Cytoplasmic Tail 1Recombinant Human KISS-1 Metastasis-SuppressorRecombinant Human Kirsten Rat Sarcoma Viral Oncogene

Recombinant Human Cytokeratin 18 His Tag

Recombinant Human Cytokeratin 8 GST-Tag

Recombinant Human Leukocyte-Associated Ig-Like Receptor 1

Recombinant Human Lysosomal-Associated Membrane Protein 2Recombinant Human Lipopolysaccarid Binding ProteinRecombinant Mouse Lipopolysaccarid Binding Protein

Recombinant Human LSM1 Homolog, U6 Small Nuclear RNA Associated Recombinant Human LSM4 Homolog, U6 Small Nuclear RNA Associated

Human Leucine-Rich Alpha-2-Glycoprotein 1Recombinant Human Tyrosine-Protein Kinase LYNRecombinant Human Melanoma Antigen Family A, 1Recombinant Human Melanoma Antigen Family A, 3Recombinant Human Melanoma Antigen Family A, 4Recombinant Human Mago-Nashi Homolog

Recombinant Human MAPK Scaffold Protein 1Recombinant Human Microtubule-Associated Protein 1 Light Chain 3 Alpha Recombinant Human Microtubule-Associated Protein 1 Light Chain 3 BetaRecombinant Human Microtubule-Associated Protein Tau Recombinant Human Microtubule-Associated Protein Tau 412 a.a.Recombinant Human Microtubule-Associated Protein Tau 383 a.a.Recombinant Human Microtubule-Associated Protein Tau 381 a.a.Recombinant Human Microtubule-Associated Protein, RP/EB Family, Member 1Recombinant Human Microtubule-Associated Protein, RP/EB Family, Member 3Recombinant Human MYC Associated Factor XRecombinant E.Coli Maltose Binding ProteinRecombinant Human Multiple Coagulation Factor Deficiency 2Recombinant Human Methyl CpG Binding Protein 2Recombinant Human Mediator Complex Subunit 4

Recombinant Human Mesoderm Development Candidate 2Recombinant Human Met Proto-OncogeneRecombinant Human MHC class I chain-related gene ARecombinant Human MHC class I chain-related gene B

Recombinant Human Myeloid Leukemia Factor 1

Recombinant Human Myeloid Cell Nuclear Differentiation Antigen Recombinant Human MOB1, Mps One Binder Kinase Activator-Like 3 Recombinant Human MOB1, Mps One Binder Kinase Activator-Like 1B

Recombinant Human Myelin Oligodendrocyte GlycoproteinRecombinant Human Mortality Factor 4 Like 2Recombinant Mycoplasma Pneumoniae P1-N2Recombinant Mycoplasma Pneumoniae P1-CRecombinant Human V-Myc Myelocytomatosis Viral OncogeneRecombinant Human Myosin Light Chain 1Recombinant Human Myosin Light Chain 2 Recombinant Human Myosin Light Chain 6Recombinant Human Myosin Light Chain 9

Recombinant Human Myoglobin Heme free

Recombinant Human N-Ethylmaleimide-Sensitive Factor Attachment Protein, Alpha

Recombinant Human Nuclear Cap Binding Protein Subunit 2Recombinant Human Neutrophil Cytosolic Factor 1Recombinant Human NCK Adaptor Protein 1Recombinant Human Neuronal Calcium Sensor 1Recombinant Human nudE Nuclear Distribution Gene E Homolog 1Recombinant Human N-Myc Downstream Regulated 1Recombinant Human NECAP Endocytosis Associated 2Bovine Neurofilament Medium Polypeptide Recombinant Human NHP2 Ribonucleoprotein HomologRecombinant Human NHP2 Non-Histone Chromosome Protein 2-LikeRecombinant Human Nuclear Import 7 HomologRecombinant Human Natural Cytotoxicity Receptor NKp46Recombinant Human Non-Metastatic Cells 1Recombinant Human Non-Metastatic Cells 3

Recombinant Human Non-Muscle Myosin-II Regulatory Light ChainRecombinant Human Nuclear Receptor Subfamily 1 Group H, Member 2Recombinant Human Neuroblastoma RAS Viral Oncogene HomologRecombinant Human Non-T-cell Activation Linker

Recombinant E.Coli Transcription Termination/Antitermination L FactorRecombinant Human Nucleopurin 210kDaRecombinant Human Nuclear Transport Factor 2Recombinant Human New York Esophageal Squamous Cell Carcinoma Recombinant Bacterial Outer Membrane Protein-A Recombinant Helicobacter Pylori Outer Membrane Protein

Recombinant Human Ubiquitin Aldehyde Binding 1Recombinant Human P504/alpha Methylacyl CoA Racemase

Recombinant Human Proliferation-associated protein 2G4Recombinant Human Polyadenylate-Binding Protein-Interacting Protein 2Recombinant Human Parkinson Disease Protein 7

Recombinant Human Phenazine Biosynthesis-Like Protein Domain ContainingRecombinant Human Proliferating Cell AntigenRecombinant Human Proliferating Cell Antigen, GST TagRecombinant Human Proliferating Cell Antigen, S9Recombinant Human PDGFA Associated Protein 1Recombinant Human Programmed Cell Death 1 Ligand 2Recombinant Human ProgrammedCell Death 4Recombinant Human Programmed Cell Death 5Recombinant Human Programmed Cell Death 6Recombinant Human ProgrammedCell Death 6 Interacting Protein

Recombinant Human p53 and DNA-Damage Regulated 1Recombinant Human Phosphoprotein Enriched in Astrocytes 15Recombinant Human Phosphatidylethanolamine Binding Protein 1 Recombinant Human Penta-EF-Hand Domain Containing 1Recombinant Human C-terminal hemopexin-like domain of MMP-2 (445-635 a.a.)

Recombinant Human Ubiquitin Carboxyl-Terminal Hydrolase L1 Recombinant Human Ubiquitin Carboxyl-Terminal Hydrolase L1 GST tagRecombinant Human Progesterone Receptor Recombinant Human Pleckstrin Homology-Like Domain Family A Member 2Recombinant Human PIN2-Interacting Protein 1Recombinant Human Phosphatidylinositol Transfer Protein, BetaRecombinant Human Phosphatidylinositol Transfer Protein, AlphaRecombinant Human Exosome Component 9Recombinant Human Exosome Component 10Recombinant Human Peripheral Myelin Protein-2Recombinant Human Peripheral Myelin Protein-2, His TagRecombinant Human POU Class 5 Homeobox 1Recombinant Human POU Class 5 Homeobox 1 Polyarginine-Tag

Recombinant Human Prostate Specific Membrane Antigen Recombinant Human Proteasome Activator Subunit 1Recombinant Human Proteasome Assembly Chaperone 3Recombinant Human Beta-MicroseminoproteinRecombinant Human Phosphatase and Tensin Homolog Recombinant Human Phosphatase and Tensin homolog His Tag

Recombinant Human Pituitary Tumor-Transforming Protein 1

Recombinant Human RAB1A, Member RAS Oncogene FamilyRecombinant Human RAB1B, Member RAS Oncogene FamilyRecombinant Human RAB5A, Member RAS Oncogene FamilyRecombinant Human RAB5B, Member RAS Oncogene FamilyRecombinant Human RAB6A, Member RAS Oncogene FamilyRecombinant Human RAB6B, Member RAS Oncogene FamilyRecombinant Human RAB7A, Member RAS Oncogene FamilyRecombinant Human RAB11A, Member RAS Oncogene FamilyRecombinant Human RAB21, Member RAS Oncogene FamilyRecombinant Human RAB27A, Member RAS Oncogene FamilyRecombinant Human RAB27B, Member RAS Oncogene FamilyRecombinant Human RAB Interacting FactorRecombinant Human Ras-Related C3 Botulinum Toxin substrate 1Recombinant Human Ras-Related C3 Botulinum Toxin substrate 1 His TagRecombinant Human Ras-Related C3 Botulinum Toxin Substrate 2Recombinant Human Ras-Related C3 Botulinum Toxin Substrate 2 (1-189)Recombinant Human Ras-Related C3 Botulinum Toxin Substrate 3

Recombinant Human V-ral Simian Leukemia Viral Oncogene Homolog ARecombinant Human V-ral Simian Leukemia Viral Oncogene Homolog BRecombinant Human RAN, Member RAS Oncogene FamilyRecombinant Human RAP1A, Member RAS Oncogene FamilyRecombinant Human RAP1B, Member RAS Oncogene FamilyRecombinant Human RAP2A, Member RAS Oncogene FamilyRecombinant Rat Receptor Associated ProteinRecombinant Retnoid Acid Receptor AlphaRecombinant Human Retinoic Acid Receptor Responder 2Recombinant Human Retinoblastoma Associated ProteinRecombinant Human RNA Binding Motif Protein 8ARecombinant Human Regulator of Calcineurin 1

Recombinant Human RD RNA Binding ProteinRecombinant Human Regenerating Islet-Derived 1 AlphaRecombinant Human Regenerating Islet-Derived 1 BetaRecombinant Human Regenerating Islet-Derived 4Recombinant Human Regenerating Islet-Derived 3 AlphaRecombinant Human RAS-like, Estrogen-Regulated, Growth Inhibitor

Recombinant Human Regulator of G-Protein Signaling 2Recombinant Human Regulator of G-Protein Signaling 16Recombinant Human Regulator of G-Protein Signaling 19Recombinant Human Ras Homolog Enriched in BrainRecombinant Human Ras Homolog Gene Family Member ARecombinant Human Ras Homolog Gene Family Member CRecombinant Human Ras Homolog Gene Family Member D

Recombinant Human Serum Albumin, Plant Recombinant Human Rho Family GTPase 3Recombinant Human RAR-Related Orphan Receptor C

Recombinant Human TROVE Domain Family Member 2Recombinant Human TROVE Domain Family Member 2 His TagBovine TROVE Domain Family, Member 2Recombinant Human Replication Protein A2Recombinant Human Roadblock Domain Containing 3

Recombinant Human Ribosomal Phosphoprotein P0Recombinant Human Ribosomal Phosphoprotein P1Recombinant Human Ribosomal Phosphoprotein P2Recombinant Human Ribosomal Protein S14Recombinant Human RCD1 Required for Cell Differentiation1 Recombinant Human Related RAS Viral (r-ras) Oncogene Homolog Recombinant Human Related RAS Viral (r-ras) Oncogene Homolog 2

Recombinant Human Runt-Related Transcription Factor 3

Recombinant Human Retinoid X Receptor AlphaRecombinant Human S100 Calcium Binding Protein A1Recombinant Human S100 Calcium Binding Protein A2Recombinant Human S100 Calcium Binding Protein A3Recombinant Human S100 Calcium Binding Protein A4Recombinant Human S100 Calcium Binding Protein A4 His TagRecombinant Human S100 Calcium Binding Protein A5Recombinant Human S100 Calcium Binding Protein A6

Recombinant Human S100 Calcium Binding Protein A7Recombinant Human S100 Calcium Binding Protein A7ARecombinant Human S100 Calcium Binding Protein A8Recombinant Human S100 Calcium Binding Protein A8, His TagRecombinant Human S100 Calcium Binding Protein A9Recombinant Human S100 Calcium Binding Protein A9, His TagRecombinant Human S100 Calcium Binding Protein A10Recombinant Human S100 Calcium Binding Protein A11Recombinant Human S100 Calcium Binding Protein A12Recombinant Human S100 Calcium Binding Protein A13Recombinant Human S100 Calcium Binding Protein A14Recombinant Human S100 Calcium Binding Protein A16Recombinant Human S100 Calcium Binding Protein BRecombinant Human S100 Calcium Binding Protein B, GST TagRecombinant Mouse S100 Calcium Binding Protein BRecombinant Human S100 Calcium Binding Protein GRecombinant Human S100 Calcium Binding Protein PRecombinant Human S100 Calcium Binding Protein P, His TagRecombinant Human S100 Calcium Binding Protein ZRecombinant HumanS100 Calcium Binding Protein Z, His TagRecombinant Human Sin3A-Associated Protein, 18kDaRecombinant Human GTP-Binding Protein SAR1ARecombinant Human Shwachman-Bodian-Diamond SyndromeRecombinant Human SCAN domain containing 1

Recombinant Human SCO Cytochrome Oxidase Deficient Homolog 2Recombinant Protein Export Protein SecB

Recombinant Human Alpha-1 AntiChymotrypsin

Recombinant Human Serpin Peptidase Inhibitor, Clade A Member 5Recombinant Human Serpin Peptidase Inhibitor, Clade B Member 5

Recombinant Human Serpin Peptidase Inhibitor, Clade B Member 5, His TagRecombinant Human Splicing Factor 3B, 14 kDa Subunit Recombinant Human Small Glutamine-Rich Tetratricopeptide Repeat-Containing Protein AlphaRecombinant Human SH2 domain containing 1A

Recombinant Human Solute Carrier Family 4, Sodium Bicarbonate Cotransporter, Member 4Recombinant Human Secretory Leukocyte Peptidase Inhibitor

Recombinant Human SMAD Family Member 2Recombinant Human Mothers Against Decapentaplegic Homolog 3Recombinant Human Mothers Against Decapentaplegic Homolog 4Recombinant Human Survival Motor Neuron Domain Containing 1Recombinant Human Synaptosomal-associated protein 23kDaRecombinant Human Synaptosomal-associated protein 25kDaRecombinant Synaptosomal-associated protein 25kDa, C.elegansRecombinant Human Synaptosomal-associated protein 25BRecombinant Human SNAP Associated Protein Recombinant Human Smad Nuclear Interacting Protein 1

Recombinant Human Small Nuclear Ribonucleoprotein Polypeptide D2Recombinant Human Small Nuclear Ribonucleoprotein Polypeptide FRecombinant Human Small Nuclear Ribonucleoprotein Polypeptide ERecombinant Human Small Nuclear Ribonucleoprotein Polypeptide G

Recombinant Human Superoxide DismutaseRecombinant Human Superoxide Dismutase-1Recombinant Human Superoxide Dismutase-2

Recombinant Human SRY (sex determining region Y)-box 2Recombinant Human SRY (sex determining region Y)-box 2 Polyarginine-Tag

Recombinant Staphylococcal Protein-A 41kDaRecombinant Staphylococcal Protein A 434 a.aRecombinant Human Secreted Protein Acidic & Rich in Cysteine

Recombinant Human Spastic Paraplegia 21Recombinant Human Speckle-Type POZ ProteinRecombinant Human Advanced Glycosylation End Product-Specific ReceptorRecombinant Human Advanced Glycosylation End Product-Specific Receptor, HEK

Recombinant Human Signal Recognition Particle 14kDa Recombinant Human Signal Recognition Particle 54kDaRecombinant Human Stromal Interaction Molecule 1Recombinant Human Stress-Induced-Phosphoprotein 1

Recombinant Human Small Ubiquitin-Related Modifier 1Recombinant Human Small Ubiquitin-Related Modifier 2Recombinant Human Small Ubiquitin-Related Modifier 2, GSTRecombinant Human Small Ubiquitin-Related Modifier 3

Recombinant Human Syndecan-4, His TagRecombinant Human Syndecan Binding Protein

Recombinant Human Tubulin Folding Cofactor ARecombinant Mouse BH3 Interacting Domain Death Agonist p15

Recombinant Human Transcription Elongation Factor A (SII)-Like 1Recombinant Human Transcription Elongation Factor B Polypeptide 2 Recombinant Human T-cell Leukemia/Lymphoma 1A

Recombinant Human Testis Derived Transcript Recombinant Tobacco Etch Virus ProteaseRecombinant Human Transcription Factor-ARecombinant Human Tissue Factor Pathway Inhibitor 2Recombinant Human Transforming Growth Factor Beta Induced Recombinant Human Transforming Growth Factor Beta Induced 182 a.a.

Recombinant Human Thymocyte Nuclear Protein 1

Recombinant Human Coagulation Factor IIIRecombinant Human TNFAIP3 Interacting Protein 1Recombinant Human Troponin T Type 2, Cardiac Isoform 3Recombinant Human Tumor Protein D52 L1

Recombinant Human Tumor Protein Translationally-Controlled 1Recombinant Human TNF receptor-Associated Factor 1Recombinant Human TNF receptor-Associated Factor 2

Recombinant Human Triggering Receptor Expressed on Myeloid Cells 1

Recombinant Human fast skeletal Troponin 1Recombinant Human Cardiac Troponin I-C Complex Recombinant Single Chain Cardiac Troponin I-C Recombinant Single Chain Cardiac Troponin I-C 2nd generation

Recombinant Human tRNA Splicing Endonuclease 15

Recombinant Human Tumor Susceptibility Gene 101

Recombinant Human Thioredoxin His Tag

Recombinant Human Small Nuclear Ribonucleoprotein 70kDa Recombinant Human Ubiquitin-Fold Modifier 1Recombinant Human Ubiquitin Related Modifier 1

Recombinant Human Ubiquitin Gly76 to Ala76 mutation

Recombinant Human Ubiquitin Lys 48 to Arg 48 mutationRecombinant Human Urinary Trypsin Inhibitor (UTI)

Recombinant Ureaplasma Urealyticum ParvumRecombinant Human Usher Syndrome 1C

Recombinant Human Vesicle-Associated Membrane Protein 4

Recombinant Human VAMP Associated Protein A, 33kDaRecombinant Human VAMP Associated Protein B and CRecombinant Human Vasodilator-Stimulated PhosphoproteinRecombinant Human Vascular cell adhesion molecule 1Recombinant Rabbit Vascular cell adhesion molecule 1Recombinant Human Von Hippel-Lindau Protein

Recombinant Human Vesicular Overexpressed in Cancer, Prosurvival Protein 1Recombinant Human Vacuolar Protein Sorting 28Recombinant Human Visinin-Like Protein-1Recombinant Human Visinin-Like Protein-1 His TagRecombinant Human WD Repeat Domain 5Recombinant Human Wolf-Hirschhorn Syndrome Candidate 2Recombinant Human within BCGN HomologRecombinant Human WNT Inhibitory Factor 1

Recombinant Human Zinc-Alpha 2 GlycoproteinRecombinant Human Zinc Finger, CCHC Domain Containing 17Recombinant Human Zymogen Granule Protein 16 Homolog

In the renin-angiotensin system (RAS), renin activates angiotensinogen to yield angiotensin I, which is further converted into angiotensin II by angiotensin-converting enzyme. Removal of the kidney generates renin/prorenin deficient plasma with high levels of angiotensinogen. This nephrectomized rat plasma can be used as a source of angiotensinogen or as a substrate for renin generation of Ang I. Plasma is collected from male rats at least 48 hours post nephrectomy. The substrate activity is determined by incubation with renin followed by Ang I radio-immune assay (RIA).In the renin-angiotensin system (RAS), renin activates angiotensinogen to yield angiotensin I, which is further converted into angiotensin II by angiotensin-converting enzyme. Removal of the kidney generates renin/prorenin deficient plasma with high levels of angiotensinogen. This nephrectomized rat plasma can be used as a source of angiotensinogen or as a substrate for renin generation of Ang I. Plasma is collected from male rats at least 48 hours post nephrectomy. The substrate activity is determined by incubation with renin followed by Ang I radio-immune assay (RIA).In the renin-angiotensin system (RAS), renin activates angiotensinogen to yield angiotensin I, which is further converted into angiotensin II by angiotensin-converting enzyme. Removal of the kidney generates renin/prorenin deficient plasma with high levels of angiotensinogen. This nephrectomized rat plasma can be used as a source of angiotensinogen or as a substrate for renin generation of Ang I. Plasma is collected from male rats at least 48 hours post nephrectomy. The substrate activity is determined by incubation with renin followed by Ang I radio-immune assay (RIA).In the renin-angiotensin system (RAS), renin activates angiotensinogen to yield angiotensin I, which is further converted into angiotensin II by angiotensin-converting enzyme. Removal of the kidney generates renin/prorenin deficient plasma with high levels of angiotensinogen. This nephrectomized rat plasma can be used as a source of angiotensinogen or as a substrate for renin generation of Ang I. Plasma is collected from male rats at least 48 hours post nephrectomy. The substrate activity is determined by incubation with renin followed by Ang I radio-immune assay (RIA).Recombinantly produced in HEK cell culture and purified by chelated metal affinity chromatography. Contains a 8X-Histidine tag at C terminus for purification. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminusRecombinantly produced in HEK cell culture and purified by chelated metal affinity chromatography. Contains a 8X-Histidine tag at C terminus for purification. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminusRecombinantly produced in HEK cell culture as untagged native form prorenin and purified by affinity chromatography. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus. This so called prosegment appears to block the full enzymatic potential of the active site (1). Renin activates the renin-angiotensin system by cleaving angiotensinogen, produced by the liver, to yield angiotensin I, which is further converted into angiotensin II by ACE, the angiotensin-converting enzyme primarily within the capillaries of the lungs. It has been reported that the levels of circulating prorenin (but not renin) are increased in diabetic subjects(2).Recombinantly produced in HEK cell culture as untagged native form prorenin and purified by affinity chromatography. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus. This so called prosegment appears to block the full enzymatic potential of the active site (1). Renin activates the renin-angiotensin system by cleaving angiotensinogen, produced by the liver, to yield angiotensin I, which is further converted into angiotensin II by ACE, the angiotensin-converting enzyme primarily within the capillaries of the lungs. It has been reported that the levels of circulating prorenin (but not renin) are increased in diabetic subjects(2).Recombinantly produced in HEK cell culture as untagged native form prorenin and purified by affinity chromatography. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus.Recombinantly produced in HEK cell culture as untagged native form prorenin and purified by affinity chromatography. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus.Recombinantly produced in HEK cell culture and purified by chelated metal affinity chromatography. Contains a 8X-Histidine tag at C terminus for purification. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus. This so called prosegment appears to block the full enzymatic potential of the active site (1). Renin activates the renin-angiotensin system by cleaving angiotensinogen, produced by the liver, to yield angiotensin I, which is further converted into angiotensin II by ACE, the angiotensin-converting enzyme primarily within the capillaries of the lungs.Recombinantly produced in HEK cell culture and purified by chelated metal affinity chromatography. Contains a 8X-Histidine tag at C terminus for purification. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus. This so called prosegment appears to block the full enzymatic potential of the active site (1). Renin activates the renin-angiotensin system by cleaving angiotensinogen, produced by the liver, to yield angiotensin I, which is further converted into angiotensin II by ACE, the angiotensin-converting enzyme primarily within the capillaries of the lungs.Recombinantly produced in HEK cell culture and purified by chelated metal affinity chromatography. Contains a 8X-Histidine tag at C terminus for purification. Resistant to activation to renin by trypsin digestion. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus.Recombinantly produced in HEK cell culture and purified by chelated metal affinity chromatography. Contains a 8X-Histidine tag at C terminus for purification. Resistant to activation to renin by trypsin digestion. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus.

Sprague Dawley Rat Albumin is a water-soluble protein with considerable structural stability which makes up 60percent of the total protein of plasma. It functions as a carrier of hormones, enzymes, fatty acids, metal ions, and medicinal products. Prepared from US origin rat plasma by proprietary fractionation methods and lyophilized. 95percent pure by SDS-PAGE.Sprague Dawley Rat Albumin is a water-soluble protein with considerable structural stability which makes up 60percent of the total protein of plasma. It functions as a carrier of hormones, enzymes, fatty acids, metal ions, and medicinal products. Prepared from US origin rat plasma by proprietary fractionation methods and lyophilized. 95percent pure by SDS-PAGE.Rabbit albumin is a water-soluble protein with considerable structural stability which makes up 60percent of the total protein of plasma. It functions as a carrier of hormones, enzymes, fatty acids, metal ions, and medicinal products. Prepared from US origin rabbit plasma by proprietary fractionation methods and lyophilized. 95percent pure by SDS-PAGE.Rabbit albumin is a water-soluble protein with considerable structural stability which makes up 60percent of the total protein of plasma. It functions as a carrier of hormones, enzymes, fatty acids, metal ions, and medicinal products. Prepared from US origin rabbit plasma by proprietary fractionation methods and lyophilized. 95percent pure by SDS-PAGE.Albumin is a water-soluble protein with considerable structural stability which makes up 60percent of the total protein of plasma. It functions as a carrier of hormones, enzymes, fatty acids, metal ions, and medicinal products. Prepared from US origin horse plasma by proprietary fractionation methods and lyophilized. 95percent pure by SDS-PAGE.Albumin is a water-soluble protein with considerable structural stability which makes up 60percent of the total protein of plasma. It functions as a carrier of hormones, enzymes, fatty acids, metal ions, and medicinal products. Prepared from cyno plasma by proprietary fractionation methods and lyophilized. 95percent pure by SDS-PAGE.Albumin is a water-soluble protein with considerable structural stability which makes up 60percent of the total protein of plasma. It functions as a carrier of hormones, enzymes, fatty acids, metal ions, and medicinal products. Prepared from US origin canine plasma by proprietary fractionation methods and lyophilized. 95percent pure by SDS-PAGE.Albumin is a water-soluble protein with considerable structural stability which makes up 60percent of the total protein of plasma. It functions as a carrier of hormones, enzymes, fatty acids, metal ions, and medicinal products. Prepared from US origin canine plasma by proprietary fractionation methods and lyophilized. 95percent pure by SDS-PAGE.Human Albumin (HSA) solubility: Albumin(s) are readily soluble in dionized water and can only preciptated by high concentrations of nuetral salts. Human Serum Albumin helps stabilize other solubilized proteins. Human Serum Albumin (HSA)is readily coagulated with heat. Human Serum Albumin(s) with other albumin(s) are acidic proteins which occur in abundance in body fluids and tissues. As a poducer, Manufacturer and supplier of finished human proteins for research and IVD manufacturing we can custom fill to your requirement.Human Albumin (HSA) solubility: Albumin(s) are readily soluble in dionized water and can only preciptated by high concentrations of nuetral salts. Human Serum Albumin helps stabilize other solubilized proteins. Human Serum Albumin (HSA)is readily coagulated with heat. Human Serum Albumin(s) with other albumin(s) are acidic proteins which occur in abundance in body fluids and tissues. As a poducer, Manufacturer and supplier of finished human proteins for research and IVD manufacturing we can custom fill to your requirement.

Using information obtained from the studies which produced stabilized human PAI-1 (ICPAI) we have available a form of mouse PAI-1 that has a single conservative mutation (Isoleucine 91 to Leucine).

Recombinant mouse PAI-1 is the ideal choice for studies involving this animal model of fibrinolysis and cancer studies. The active fraction typically contains 70percent active PAI-1.Recombinant mouse PAI-1 is the ideal choice for studies involving this animal model of fibrinolysis and cancer studies. The active fraction typically contains 70percent active PAI-1.

Rabbit PAI-1 is now available and is preferred for animal studies that utilize rabbit models. Wild type rabbit PAI-1 is less than 20percent active and may not be suitable for most experiments. As a replacement please consider rabbit PAI-1 stable mutant which is 70-80percent activeRabbit PAI-1 is now available and is preferred for animal studies that utilize rabbit models. Wild type rabbit PAI-1 is less than 20percent active and may not be suitable for most experiments. As a replacement please consider rabbit PAI-1 stable mutant which is 70-80percent active

Recombinant rat PAI-1 is the ideal choice for studies involving this animal model of fibrinolysis and cancer studies. The active fraction typically contains 95percent active PAI-1.Recombinant rat PAI-1 is the ideal choice for studies involving this animal model of fibrinolysis and cancer studies. The active fraction typically contains 95percent active PAI-1.

A single mutation at the P1 position of PAI-1 alters the target specificity of PAI-1 from the plasminogen activators tPA and uPA to elastase. PAI-1 is normally a substrate for pancreatic and neutrophil elastase becoming cleaved at the P3 position.A single mutation at the P1 position of PAI-1 alters the target specificity of PAI-1 from the plasminogen activators tPA and uPA to elastase. PAI-1 is normally a substrate for pancreatic and neutrophil elastase becoming cleaved at the P3 position.This human PAI-1 variant contains a mutation at the active site to make it specific for inhibition of neutrophil elastase. Additional mutations provide resistance to cleavage and stability.Human PAI-1 stable mutant is reacted with an excess of human urokinase at physiological pH. Excess uPA is removed from the resulting 1:1 molar complex by immobilized benzamidine resin.Human PAI-1 stable mutant is reacted with an excess of human sc-tPA at physiological pH. The resulting 1:1 molar complex is purified from the remaining tPA by cobalt metal affinity chromatography resin.This mutant contains a Ser to Cys replacement around the vitronectin binding site. Incorporation of an NBD labels allows for the reporting of binding to vitronectin.This mutant contains a Ser to Cys replacement around the vitronectin binding site. Incorporation of an NBD labels allows for the reporting of binding to vitronectin.A single mutation results in nearly complete loss of binding of the PAI-1 mutant to the important ligand vitronectin. All other aspects of PAI-1 biological activity such as anti-protease activity remain unaffected.A single mutation results in nearly complete loss of binding of the PAI-1 mutant to the important ligand vitronectin. All other aspects of PAI-1 biological activity such as anti-protease activity remain unaffected.

Albumin is a water-soluble protein with considerable structural stability which makes up 60percent of the total protein of plasma. It functions as a carrier of hormones, enzymes, fatty acids, metal ions, and medicinal products. Prepared from US origin mouse (murine) plasma by proprietary fractionation methods and lyophilized. 95percent pure by SDS-PAGE. Add deionized water or buffer to original or desired volume, aliquot and freeze unused portion. Albumin is a water-soluble protein with considerable structural stability which makes up 60percent of the total protein of plasma. It functions as a carrier of hormones, enzymes, fatty acids, metal ions, and medicinal products. Prepared from US origin mouse (murine) plasma by proprietary fractionation methods and lyophilized. 95percent pure by SDS-PAGE. Add deionized water or buffer to original or desired volume, aliquot and freeze unused portion. 

This recombinant rat PAI-1 has a single conservative mutation (Isoleucine 91 to Leucine) that yields a rat PAI-1 with an enhanced half-life as compared to the wild type. This recombinant rat PAI-1 has a single conservative mutation (Isoleucine 91 to Leucine) that yields a rat PAI-1 with an enhanced half-life as compared to the wild type. 

A patent pending mutant of human PAI-1 containing four mutations that stabilize the activity of PAI-1 has been made available. The N-terminus has been additionally modified with the introduction of a 6-X histidine tag. The tag allows for the immobilization of functionally active PAI-1 onto surfaces such as metal chelate microtiter plates or Ni+2 resins. Many new applications for PAI-1 can be envisioned with this unique reagent.A patent pending mutant of human PAI-1 containing four mutations that stabilize the activity of PAI-1 has been made available. The N-terminus has been additionally modified with the introduction of a 6-X histidine tag. The tag allows for the immobilization of functionally active PAI-1 onto surfaces such as metal chelate microtiter plates or Ni+2 resins. Many new applications for PAI-1 can be envisioned with this unique reagent.The human form of PAI-1 contains the following four mutations: K154T, Q319L, M354I and N150H. These mutations combine to confer great stability to the otherwise labile molecule essentially locking in into the active conformation. It is an ideal choice for in vivo studies.The human form of PAI-1 contains the following four mutations: K154T, Q319L, M354I and N150H. These mutations combine to confer great stability to the otherwise labile molecule essentially locking in into the active conformation. It is an ideal choice for in vivo studies.The Q123K point mutation on the human PAI-1 stable mutant background (K154T, Q319L, M354I and N150H) results in PAI-1 with a greatly extended half life and reduced binding to the important ligand vitronectin.

Prepared from plasminogen by activation with immobilized human uPA. 100% functionally active plasmin is purified from the activation reaction by immobilized SBTI. Plasmin will undergo rapid auto proteolysis in the absence of benzamidine and should be used quickly once thawed. Aliquot to avoid freeze-thaw cyclesPrepared from plasminogen by activation with immobilized human uPA. 100% functionally active plasmin is purified from the activation reaction by immobilized SBTI. Plasmin will undergo rapid auto proteolysis in the absence of benzamidine and should be used quickly once thawed. Aliquot to avoid freeze-thaw cycles

The plasmin substrate is chemically and functionally identical to Chromogenix S-2251. Each 25 mg of substrate is lyophilized with 60 mg mannitol as a bulking agentEfficiently inhibits the plasminogen-activator-induced lysis of fibrin clots. Found in plasma at about 70 ug per ml. Alpha-antiplasmin-deficiency is a rare coagulation disorder which allows unrestrained fibrinolytic activity.

Mouse tPA with a double mutation that is permanently single chain and lacks catalytic activity. The non-catalytic mutation site is S481A on the mature protein and S510A on the complete mRNA sequence (UniProtKB: locus TPA_MOUSE, accession P11214).Mouse tPA with a double mutation that is permanently single chain and lacks catalytic activity. The non-catalytic mutation site is S481A on the mature protein and S510A on the complete mRNA sequence (UniProtKB: locus TPA_MOUSE, accession P11214).The addition of an arginine to glutamic acid mutation generates mouse tPA that is 100percent single chain and resistant to cleavage by plasmin. The mutation site is R279E on the mature protein and R308E on the complete mRNA sequence (UniProtKB: locus TPA_MOUSE, accession P11214). Recombinantly produced in insect cells.The addition of an arginine to glutamic acid mutation generates mouse tPA that is 100percent single chain and resistant to cleavage by plasmin. The mutation site is R279E on the mature protein and R308E on the complete mRNA sequence (UniProtKB: locus TPA_MOUSE, accession P11214). Recombinantly produced in insect cells.This single chain mouse tPA has the active site serine mutated to alanine rendering the enzyme catalytically inactive. The mutation site is S481A on the mature protein and S510A on the complete mRNA sequence (UniProtKB: locus TPA_MOUSE, accession P11214). The tPA still retains exosite binding as well as other biological properties of tPA including but not limited to surface binding to fibrin.This single chain mouse tPA has the active site serine mutated to alanine rendering the enzyme catalytically inactive. The mutation site is S481A on the mature protein and S510A on the complete mRNA sequence (UniProtKB: locus TPA_MOUSE, accession P11214). The tPA still retains exosite binding as well as other biological properties of tPA including but not limited to surface binding to fibrin.

Recombinantly produced in insect cells. 95percent active. For ELISA and Western Blotting of pig tPA, please use our Rabbit Polyclonal Antibodies to Human tPA or our Mouse Monoclonal to Human tPA which cross reactRecombinantly produced in insect cells. 95percent active. For ELISA and Western Blotting of pig tPA, please use our Rabbit Polyclonal Antibodies to Human tPA or our Mouse Monoclonal to Human tPA which cross react

Glycolyslated human PAI-1 produced in insect cells with a molecular weight of 46,000 Da. The stable mutant contains mutations to confer additional stability to the otherwise labile molecule. 

Prepared from human tPA by incubation with an excess of ATA-Phe-Pro-Arg-CMK. After labeling at the active site, remaining free peptide is removed by dialysis.This human tPA has an active site serine to alanine mutation which renders it catalytically inactive. The mutation site is S478A on the mature protein and S513A on the complete mRNA sequence (UniProtKB: locus TPA_HUMAN, accession P00750)This human tPA has an active site serine to alanine mutation which renders it catalytically inactive. The mutation site is S478A on the mature protein and S513A on the complete mRNA sequence (UniProtKB: locus TPA_HUMAN, accession P00750)The addition of an arginine to glutamic acid mutation generates human tPA that is 100percent single chain and resistant to cleavage by plasmin. The mutation site is R275E on the mature protein and R310E on the complete mRNA sequence (UniProtKB: locus TPA_HUMAN, accession P00750). Recombinantly produced in insect cells.The addition of an arginine to glutamic acid mutation generates human tPA that is 100percent single chain and resistant to cleavage by plasmin. The mutation site is R275E on the mature protein and R310E on the complete mRNA sequence (UniProtKB: locus TPA_HUMAN, accession P00750). Recombinantly produced in insect cells.This human tPA has an active site serine to alanine mutation which renders it catalytically inactive. The mutation site is S478A on the mature protein and S513A on the complete mRNA sequence (UniProtKB: locus TPA_HUMAN, accession P00750). It is 90percent single chain and retains exosite binding as well as other properties of wild type tPA. Recombinantly produced in insect cells.This human tPA has an active site serine to alanine mutation which renders it catalytically inactive. The mutation site is S478A on the mature protein and S513A on the complete mRNA sequence (UniProtKB: locus TPA_HUMAN, accession P00750). It is 90percent single chain and retains exosite binding as well as other properties of wild type tPA. Recombinantly produced in insect cells.

Mouse Urokinase Receptor, Soluble form. Recombinantly produced in insect cells. Contains a 6X-Histidine tag at N terminus for purification. Demonstrates preferential binding to mouse uPA over human uPA coated on an ELISA plate.Mouse Urokinase Receptor, Soluble form. Recombinantly produced in insect cells. Contains a 6X-Histidine tag at N terminus for purification. Demonstrates preferential binding to mouse uPA over human uPA coated on an ELISA plate.

FITC labeled LMW urokinase purified from auto-catalytic digestion of HMW human urokinase. LMW uPA contains the proteinase domain and is separated from the amino terminal fragment by cleavage at the Lys135-Lys136 bond.FITC labeled LMW urokinase purified from auto-catalytic digestion of HMW human urokinase. LMW uPA contains the proteinase domain and is separated from the amino terminal fragment by cleavage at the Lys135-Lys136 bond.Horseradish peroxidase conjugated LMW urokinase purified from auto-catalytic digestion of HMW human urokinase. LMW uPA contains the proteinase domain and is separated from the amino terminal fragment by cleavage at the Lys135-Lys136 bond.Horseradish peroxidase conjugated LMW urokinase purified from auto-catalytic digestion of HMW human urokinase. LMW uPA contains the proteinase domain and is separated from the amino terminal fragment by cleavage at the Lys135-Lys136 bond.The low molecular weight form of uPA is purified from auto-catalytic digestion of recombinant human urokinase produced in insect cells. LMW uPA contains the proteinase domain and is separated from the amino terminal fragment by cleavage at the Lys135-Lys136 bond. For plasminogen activation and receptor binding studies.The low molecular weight form of uPA is purified from auto-catalytic digestion of recombinant human urokinase produced in insect cells. LMW uPA contains the proteinase domain and is separated from the amino terminal fragment by cleavage at the Lys135-Lys136 bond. For plasminogen activation and receptor binding studies.

Prepared from fresh hamster plasma. Ideal reagent for tissue culture studies and protein-protein interactions. Thaw the fibronectin by placing the vial in a 37 C water bath and leaving it undisturbed until completely thawed. Do not disturb the vial at any time during the thawing process. If the vial is disturbed or removed prior to complete thawing, the fibronectin will form a gel and be unusable. Mix very gently with pipette after thawing. Vortexing, excessive agitation, repeated freezing and thawing of fibronectin are not recommended.Prepared from fresh mouse plasma using several chromatographic steps. Plasminogen depleted by lysine affinity chromatography. Thaw protein in a 37C water bath

Prepared from fresh porcine plasma using several chromatographic steps. Plasminogen depleted by lysine affinity chromatography. Thaw protein in a 37C water bath.

Prepared from fresh human plasma using several chromatographic steps. Plasminogen depleted by lysine affinity chromatography. Thaw at 37C without agitation until completely liquid, then gently mix before usePrepared from fresh human plasma using several chromatographic steps. Plasminogen depleted by lysine affinity chromatography. Thaw at 37C without agitation until completely liquid, then gently mix before usePrepared from fresh human plasma. Ideal reagent for tissue culture studies and protein-protein interactions. Thaw the fibronectin by placing the vial in a 37Prepared from fresh bovine plasma using several chromatographic steps. Plasminogen depleted by lysine affinity chromatography. Thaw at 37C without agitation until completely liquid, then gently mix before use.

Human tissue-type plasminogen activator (tPA) is a 527 amino acid glycoprotein. Synthesized from cDNA from a human melanoma cell line. It is recombinantly produced in Chinese Hamster Ovary (CHO) cells. Fully active, 85percent single chain. Human tissue-type plasminogen activator (tPA) is a 527 amino acid glycoprotein. Synthesized from cDNA from a human melanoma cell line. It is recombinantly produced in Chinese Hamster Ovary (CHO) cells. Fully active, 85percent single chain. Mouse sc-tPA is reacted with an excess of mouse PAI-1 stable mutant at physiological pH. The resulting 1:1 molar complex is purified from the remaining PAI-1 by affinity chromatography with immobilized antibodies to mouse tPA. A triple mutation on the wild-type background makes this Human PAI-1 selectively inhibit tPA. Urokinase inhibition is limited to 1/25,000 of tPA inhibition by the P3Tyr-P2Ser-P1Tyr mutation. 

Prepared from fresh mouse plasma. Ideal reagent for tissue culture studies and protein-protein interactions. Thaw the fibronectin by placing the vial in a 37 C water bath and leaving it undisturbed until completely thawed. Do not disturb the vial at any time during the thawing process. If the vial is disturbed or removed prior to complete thawing, the fibronectin will form a gel and be unusable. Mix very gently with pipette after thawing. Vortexing, excessive agitation, repeated freezing and thawing of fibronectin are not recommended. 

Prothrombin is activated on the surface of a phospholipid membrane that binds the amino end of prothrombin and factors Va and Xa in Ca-dependent interactions; factor Xa removes the activation peptide and cleaves the remaining part into light and heavy chains. The activation process starts slowly because factor V itself has to be activated by the initial, small amounts of thrombin.Factor Xa is prepared by activating purified factor X with the factor X activator isolated from Russell's viper venom. Factor Xa is purified from the activation mixture by chromatography over benzamidine-Sepharose. Purity is determined by SDS-PAGE analysis and activity is measured in a factor Xa clotting assay and/or chromogenic substrate assay.Factor Xa is a vitamin K-dependent glycoprotein that converts prothrombin to thrombin in the presence of factor Va, calcium and phospholipid during blood clotting.Mouse thrombin is prepared from purified mouse prothrombin by activation with Saw Scaled Viper Venom. The venom was removed after activation. Complete activation is observed on SDS-PAGE.Protein C is a vitamin K-dependent serine protease that regulates blood coagulation by inactivating factors Va and VIIIa in the presence of calcium ions and phospholipids.Protein C is a vitamin K-dependent serine protease that regulates blood coagulation by inactivating factors Va and VIIIa in the presence of calcium ions and phospholipids.

Factor IXa is prepared from highly purified factor IX by activation with factor XIa. The factor IXa is further purified by gel filtration, followed by immunoaffinity purification. Purity is assessed by SDS-PAGE analysis. Activity is determined in a one-stage clotting assay.Rat thrombin is prepared from purified rat prothrombin by activation with Russells Viper Venom. This venom is removed after activation. Purity is 90percent as determined by SDS-PAGE analysis. Activity is measured in a thrombin specific clotting assay, and compared to standardized NIH thrombin.Rat factor IX is prepared from fresh frozen plasma by a combination of conventional procedures and immunoaffinity chromatography. Purity is determined by SDS-PAGE analysis and activity is measured using a factor IX clotting assay.

Heparin cofactor II (HCII) (heparin cofactor A, antithrombin BM, dermatan sulfate cofactor, human leuserpin-2) is a single chain glycoprotein (Mr=65,600, 10% carbohydrate) member of the serine protease inhibitor (serpin) family (1-3). Amino acid sequence analysis of heparin cofactor II reveals 3 potential N-glycosylation sites and 2 sulfated tyrosines located in two internal repeats of 7 residues located near the NH2-terminal (4-6). The plasma concentration is estimated to be 90Activation of Prekallikrein with Factor a-XIIa produces the enzymatically active Kallikrein. Kallikrein is a serine protease which consists of a heavy chain (Mr 52kD) and light chains (Mr either 36 or 33 kD) linked by disulfide bridges. Kallikrein possesses enzymatic activity toward Factor XII, HK, Plasminogen, Factors XI, IX, and VII, prorenin and the complement system. After activation, the activating enzyme Factor XIIa is removed by affinity chromatography. Human Kallikrein purity is determined by SDS-PAGE and shows complete reduction upon incubation with 2-mercaptoethanol.Purified from fresh frozen human plasma. Human Prekallikrein is a single chain gamma globulin glycoprotein that participates in the early phase of contact activation, kinin formation and fibrinolysis. Prekallikrein purity is determined by SDS-PAGE and shows no reduction upon incubation with 2-mercaptoethanol. Activity is determined via clotting assay.Human Factor XIIa is a serine protease responsible for the activation of Factor XI to XIa in the contact activation system. Human Factor XII and prekallikrein are thought to be involved in a reciprocal activation mechanism in which Factor XIIa activates prekallikrein to kallikrein, which in turn converts Factor XII to XIIa. Factor XIIa activates Factor XI to XIa thereby triggering the Contact Factor cascade. ERL offers Factor ?-XIIa which is activated by the autoactivation process with Dextran Sulfate and re-purified to remove the activator. The protein purity is determined by SDS-PAGE and activity is determined via clotting assay.Human Factor XIIa is a serine protease responsible for the activation of Factor XI to XIa in the contact activation system. Human Factor XII and prekallikrein are thought to be involved in a reciprocal activation mechanism in which Factor XIIa activates prekallikrein to kallikrein, which in turn converts Factor XII to XIIa. Factor XIIa activates Factor XI to XIa thereby triggering the Contact Factor cascade. ERL offers Factor ?-XIIa which is activated by the autoactivation process with Dextran Sulfate and re-purified to remove the activator. The protein purity is determined by SDS-PAGE and activity is determined via clotting assay.Human Factor Xa is prepared from Human Factor X by activation with Russell's Viper Venom. This RVV-X is removed after activation. Complete activation is observed by SDS-PAGE. Factor Xa along with cofactor Va, phospholipids and calcium ions, (the prothrombinase complex) catalyzes the rapid conversion of prothrombin to thrombin.

Prepared from fresh frozen human plasma. This protein purity is determined by SDS-PAGE and shows no reduction upon incubation with 2-mercaptoethanol.

Purified from fresh frozen human plasma using a combination of salt precipitations and column chromatography. The protein purity is determined by SDS-PAGE and shows total reduction upon incubation with 2-mercaptoethanol. Protein C is activated to the serine protease, Activated Protein C (APC), by a-thrombin or the complex of a-thrombin/thrombomodulin and is a potent anticoagulant through the selective inactivation of Factors Va and VIIIa.Purified from fresh frozen human plasma using a combination of salt precipitations and column chromatography. The protein purity is determined by SDS-PAGE and shows total reduction upon incubation with 2-mercaptoethanol. Protein C is activated to the serine protease, Activated Protein C (APC), by a-thrombin or the complex of a-thrombin/thrombomodulin and is a potent anticoagulant through the selective inactivation of Factors Va and VIIIa.

Prepared from homogeneous human prothrombin by activation with Factor Xa, Factor Va, and phospholipid. Human Thrombin purity is determined by SDS-PAGE. This activated enzyme has a minimum activity of 2,700 NIH units/mg when compared to NIH standard thrombin.Prepared from fresh frozen human plasma. Human Prothrombin is a glycoprotein of molecular weight 72,000, and consists of a single polypeptide chain. Activation of Prothrombin by Factor Va, Xa and phospholipids yields the serine protease Thrombin. Prothrombin purity is determined by SDS-PAGE and shows no reduction upon incubation with 2-mercaptoethanol.Prepared from fresh frozen human plasma. Human Prothrombin is a glycoprotein of molecular weight 72,000, and consists of a single polypeptide chain. Activation of Prothrombin by Factor Va, Xa and phospholipids yields the serine protease Thrombin. Prothrombin purity is determined by SDS-PAGE and shows no reduction upon incubation with 2-mercaptoethanol.

The Bovine Antithrombin is 95% pure on SDS-PAGE gels and shows no reduction uponincubation with 2-mercaptoethanol. All bovine material is from U.S. cows /+ 36 months ofage

Canine fibrinogen amino terminal labeled with fluorescein isothiocyanate (FITC). Prepared from fresh dog plasma using several chromatographic steps. Plasminogen depleted by lysine affinity chromatography. Thaw at 37C without agitation until completely liquid, then gently mix before use. Keep fibrinogen at 25-37C, aliquot and flash freeze unused portion. 

Prepared from fresh frozen human plasma. Human Factor XI is a two-chain glycoprotein with molecular weight of 160,000 daltons.  The two chains are identical disulfide bonded polypeptides with molecular weights of 80,000 daltons.  Factor XI is activated to Factor XIa by Factor Xlla. Purity of Factor XI is assessed by SDS-PAGE.  Activity is determined by clotting assay.Prepared from fresh frozen human plasma. Human Factor XI is a two-chain glycoprotein with molecular weight of 160,000 daltons.  The two chains are identical disulfide bonded polypeptides with molecular weights of 80,000 daltons.  Factor XI is activated to Factor XIa by Factor Xlla. Purity of Factor XI is assessed by SDS-PAGE.  Activity is determined by clotting assay.Prepared from fresh frozen human plasma. The purity of this Vitamin K dependent protein is determined by SDS-PAGE  and shows total reduction upon incubation with 2-mercaptoethanol. Activity is determined via clotting assay. Human Factor X, once activated via the Contact Factor Pathway or the Tissue Factor Pathway, is responsible for the conversion of Prothrombin to Thrombin.

Prepared from fresh frozen human plasma. This protein purity is determined by SDS-PAGE and shows no reduction upon incubation with 2-mercaptoethanol.  Activity is determined via clotting assay.  Human Factor IX, activated by either the Contact or Tissue Factor Pathway, is responsible for the activation of Factor X to Xa.Activated Protein C (APC) is a serine protease derived from the two chain vitamin K dependent zymogen, Protein C. APC inhibits blood coagulation through the selective inactivation of the cofactors Va and VIIIa. APC is prepared from protein C by activation with purified thrombin. This thrombin is removed after activation by ion exchange chromatography. Activated Protein C purity is determined by SDS-PAGE and shows complete reduction upon incubation with 2-mercaptoethanol.Activated Protein C (APC) is a serine protease derived from the two chain vitamin K dependent zymogen, Protein C. APC inhibits blood coagulation through the selective inactivation of the cofactors Va and VIIIa. APC is prepared from protein C by activation with purified thrombin. This thrombin is removed after activation by ion exchange chromatography. Activated Protein C purity is determined by SDS-PAGE and shows complete reduction upon incubation with 2-mercaptoethanol.

Prepared from purified Human Factor VII using Human Factor XIIa. The Factor Xlla is removed using affinity chromatography. Purity is determined by SDS-PAGE. Human Factor VIIa reduces to 29,500 and 23,500 with the addition of 2-mercaptoethanol. Activity is determined via clotting assay.  Factor Vlla, in the presence of calcium ions and Tissue factor, activates Factors IX and X to their enzymatically active forms, Factor IXa and Xa.Prepared from purified Human Factor VII using Human Factor XIIa. The Factor Xlla is removed using affinity chromatography. Purity is determined by SDS-PAGE. Human Factor VIIa reduces to 29,500 and 23,500 with the addition of 2-mercaptoethanol. Activity is determined via clotting assay.  Factor Vlla, in the presence of calcium ions and Tissue factor, activates Factors IX and X to their enzymatically active forms, Factor IXa and Xa.Human factor V is prepared from fresh frozen human plasma using immunoaffinity chromatography. Purity is determined by SDS-PAGE analysis and activity is measured in a factor V clotting assay.  Human factor V is prepared from fresh frozen human plasma using immunoaffinity chromatography. Purity is determined by SDS-PAGE analysis and activity is measured in a factor V clotting assay.  

The Bovine Protein C is 95% on SDS-PAGE gels and shows total reduction upon incubationwith 2-mercaptoethanol. All bovine material is from U.S. cows /+ 36 months of agInnovative offers the two chain Kinin-free form of Kininogen. This is prepared by Kallikrein digestion of Kininogen which is then repurified to remove traces of Kallikrein.LMW Kininogn is involved in blood pressure regulation since it is an endogenous protein substrate for tissue kallikrein. Proteolytic cleavage by kallikrein releases vasoactive bradykinin from LMW kininogen. In addition, LMW kininogen, like HMW kininogen, is a major extracellular cysteine protease inhibitor. Prepared from plasma shown to be non reactive for HbsAG, anti-HCV, anti-HBc, and negative for anti-HIV 1 &amp; 2 by FDA approved tests. 95percent pure by SDS-PAGE. Add deionized water to original volume, aliquot and freeze unused portion.High Molecular Weight Kininogen (HK) is a nonenzymatic cofactor of the contact activation system. HK is thought to have two functions in the contact activation system. First, HK links prekallikrein to a negatively charged surface thereby allowing activation to kallikrein by surface bound Factor -Xlla. HK also forms a complex with Factor XI and accelerates its activation to XIa by -Xlla. Also HK serves as a source of Bradykinin, a potent Vasoactive peptide important in hypotension studies. The protein purity is determined by SDS-PAGE

Human Factor XIII is a tetramer composed of two pairs of chains held together by noncovalent bonds. After activation of the zymogen via Thrombin to its active enzyme form, Factor XIIIa is responsible for catalyzing the formation of covalent bridges between fibrin units to increase the elasticity of the clot network. The resulting cross-linked fibrin is very insoluble and resistant to lysis.Human Factor XIII is a tetramer composed of two pairs of chains held together by noncovalent bonds. After activation of the zymogen via Thrombin to its active enzyme form, Factor XIIIa is responsible for catalyzing the formation of covalent bridges between fibrin units to increase the elasticity of the clot network. The resulting cross-linked fibrin is very insoluble and resistant to lysis.

Our Activated Protein C is inactivated using PPACK, Dihydrochloride and is removed via gelfiltration. The above protein was purified from Human plasma that was tested and foundnegative by FDA accepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV,Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA. Donors arescreened for CJD (Creutzfeldt-Jakob Disease)

Prepared from fresh frozen human plasma. Human Factor VII is a single-chain vitamin K dependent glycoprotein found in trace quantities in plasma (0.5 mg/Liter). In the Tissue Factor Pathway of coagulation, Human Factor Vlla, in the presence of calcium ions and tissue factor, activates Factors IX and X to their enzymatically active forms, Factor IXa and Xa.Prepared from fresh frozen human plasma. Human Factor VII is a single-chain vitamin K dependent glycoprotein found in trace quantities in plasma (0.5 mg/Liter). In the Tissue Factor Pathway of coagulation, Human Factor Vlla, in the presence of calcium ions and tissue factor, activates Factors IX and X to their enzymatically active forms, Factor IXa and Xa.Human prothrombin with the gla domain removed. The above protein was purified fromHuman plasma that was tested and found negative by FDA accepted methods for AntiHIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA,HCV RNA and HBV RNA. Donors are screened for CJD (Creutzfeldt-Jakob Disease)

Bovine Factor Xla is purified from freshly collected Bovine Plasma using a combination of salt precipitations and activation on a negative surface. This Factor Xla is a potent activator of both Human and Bovine Factor IX. Bovine Factor XIa purity is determined by SDS-PAGE and shows complete reduction upon incubation with 2-mercaptoethanol.

Prepared from Bovine Factor IX by activation with Bovine Factor Xla, this Bovine Factor Xla is removed after activation. Complete activation is observed by SDS-PAGE. The Factor Xla activates FIX in a two-step reaction. In the first step, an internal Arg-Ala bond is cleaved, and in the second step, an Arg-Val bond is cleaved. The second cleavage leads to the liberation of an activation peptide from the NH2-terminal portion of the heavy chain to produce factor IXaβ.

Purified from freshly collected bovine plasma using a combination of salt precipitations and column chromatography. This protein is a mixture of Factor V/Va and intermediate activation products as judged by 4-20% gradient gels. Bovine Factor Va functions as a cofactor with the serine protease Factor Xa in the activation of prothrombin. This protein may be used as a source of V/Va in the Prothrombinase complexPurified from freshly collected bovine plasma using a combination of salt precipitations and column chromatography. This protein is a mixture of Factor V/Va and intermediate activation products as judged by 4-20% gradient gels. Bovine Factor Va functions as a cofactor with the serine protease Factor Xa in the activation of prothrombin. This protein may be used as a source of V/Va in the Prothrombinase complexInterleukin-2 (IL-2) is a O-glycosylated four alpha-helix bundle cytokine that is produced by T-cells in response to antigenic or mitogenic stimulation. IL-2 can stimulate B-cells, monocytes, lymphokine-activated killer cells, natural killer cells, and glioma cells and is required for T-cell proliferation and other activities crucial to regulation of the immune response.This Fc Fusion Protein is glycosylated and expressed as a chimera with the Fc region of mouse immunoglobulin. Fc fusion proteins are typically more stable and resistant to degradation and clearance than native cytokines. Fc fusion proteins appear as a dimer in SDS-PAGE under non-reducing conditions.Interleukin-2 (IL-2) is a O-glycosylated four alpha-helix bundle cytokine that is produced by T-cells in response to antigenic or mitogenic stimulation. IL-2 can stimulate B-cells, monocytes, lymphokine-activated killer cells, natural killer cells, and glioma cells and is required for T-cell proliferation and other activities crucial to regulation of the immune response.This Fc Fusion Protein is glycosylated and expressed as a chimera with the Fc region of mouse immunoglobulin. Fc fusion proteins are typically more stable and resistant to degradation and clearance than native cytokines. Fc fusion proteins appear as a dimer in SDS-PAGE under non-reducing conditions.Mouse Protein Z-Dependent Protease Inhibitor (ZPI), recombinantly produced in insect cells. Active and complexable with Factor XIa. This Serine Protease Inhibitor (SERPIN) requires the cofactors Protein Z, phospholipids and calcium to inhibit endogenous Factor Xa. ZPI contains a tyrosine residue at the P1 position of the reactive center loop, rather than arginine which is present in most SERPINs.Corn Trypsin Inhibitor (CTI) is a specific and potent inhibitor of human factor XIIa. It is purified from fresh Indiana sweet corn by solvent extraction and chromatographic methods. A suggested inhibitory concentration is 24 fold molar excess over the enzyme concentration. CTI purity is determined by SDS-PAGE and shows no reduction upon incubation with 2-mercaptoethanol.

The Bovine Factor X is 95% pure on  SDS-PAGE and shows total reduction upon incubationwith 2-mercaptoethanol.  All bovine material is from U.S. cows /+ 36 months of ageThe Activated Bovine Protein C was activated from homogeneous protein C by activation withpurified alpha-thrombin.  The alpha-thrombin is removed after activation. Complete activationis observed on SDS-PAGE gels.  All bovine material is from U.S. cows /+ 36 months of age

Human Factor XIIIa is activated from Factor XIII by cleavage with human alpha thrombin. The thrombin is subsequently removed via chromatography. Factor XIIIa is responsible for catalyzing the formation of covalent bridges between fibrin units to increase the elasticity of the clot network. The resulting cross-linked fibrin is very insoluble and resistant to lysis. Human Factor XIIIa is activated from Factor XIII by cleavage with human alpha thrombin. The thrombin is subsequently removed via chromatography. Factor XIIIa is responsible for catalyzing the formation of covalent bridges between fibrin units to increase the elasticity of the clot network. The resulting cross-linked fibrin is very insoluble and resistant to lysis. 

Human Factor beta-XIIa is generated in vivo by kallikrein cleavage of Factor alpha-XIIa and contains the catalytic light chain and the C-terminal peptide of the heavy chain of Factor alpha-XIIa. Human Factor beta-XIIa is activated from homogeneous Human Factor XII by an autoactivation process with Dextran Sulfate followed by repurification to isolate Factor alpha-XIIa and Factor beta-XIIa. Complete activation is observed on SDS-PAGE. Factor XIIa is 95percent pure by SDS-PAGE and activity is determined via clotting assay. Prepared from plasma found negative by FDA accepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA. Donors are screened for CJD (Creutzfeldt-Jakob Disease). Human Factor beta-XIIa is generated in vivo by kallikrein cleavage of Factor alpha-XIIa and contains the catalytic light chain and the C-terminal peptide of the heavy chain of Factor alpha-XIIa. Human Factor beta-XIIa is activated from homogeneous Human Factor XII by an autoactivation process with Dextran Sulfate followed by repurification to isolate Factor alpha-XIIa and Factor beta-XIIa. Complete activation is observed on SDS-PAGE. Factor XIIa is 95percent pure by SDS-PAGE and activity is determined via clotting assay. Prepared from plasma found negative by FDA accepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA. Donors are screened for CJD (Creutzfeldt-Jakob Disease). 

Human beta-thrombin is prepared from purified a-thrombin by limited proteolysis with TPCK-treated trypsin. Beta-thrombin is generated by cleavage of the B-chain at the Arg106-Tyr107 bond. Purity is assessed by SDS-PAGE and activity is assessed using a fibrinogen clotting assay. The Human Plasmin was activated from homogeneous glu-plasminogen using urokinase at a500:1 molar ratio.  This urokinase was not removed after activation.  Complete activation wasobserved using the S-2251 chromogenic substrate.  The above protein was purified fromHuman plasma that was tested and found negative by FDA accepted methods for AntiHIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA,HCV RNA and HBV RNA. Donors are screened for CJD (Creutzfeldt-Jakob Disease)Purified from fresh frozen human plasma. Human Factor XII is part of the contact activation system. Human Factor XII is a single chain glycoprotein with a molecular weight of about 80,000. Once activated, principally from the action of kallikrein, Factor XII is converted into an active serine protease (Factor -Xlla) that functions in the <emin vivo</em initiation of blood coagulation, fibrinolysis, and kinin formation. Human Factor XII has been purified by ion exchange chromatography. Protein purity is determined by SDS-PAGE and activity is determined via clotting assay.Purified from fresh frozen human plasma. Human Factor XII is part of the contact activation system. Human Factor XII is a single chain glycoprotein with a molecular weight of about 80,000. Once activated, principally from the action of kallikrein, Factor XII is converted into an active serine protease (Factor -Xlla) that functions in the <emin vivo</em initiation of blood coagulation, fibrinolysis, and kinin formation. Human Factor XII has been purified by ion exchange chromatography. Protein purity is determined by SDS-PAGE and activity is determined via clotting assay.The Human Factor XIa was activated from homogeneous Human Factor XI using HumanFactor XIIa.  This XIIa was removed using a Corn Trypsin Inhibitor column.  The protein is95% pure via SDS-PAGE.  The above protein was purified from Human plasma that wastested and found negative by FDA accepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II,HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA.Donors are screened for CJD (Creutzfeldt-Jakob Disease)The Human Factor Xa beta gla domainless was prepared from HFX-GD using purified RVV-X.This RVV-X was removed after activation by gel filtration.  Complete activation was observedon SDS PAGE.  The above protein was purified from Human plasma that was tested andfound negative by FDA accepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV,Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA. Donors arescreened for CJD (Creutzfeldt-Jakob Disease)The Human Factor Xa was activated from homogeneous Human Factor X by activation withRussels' Viper Venom.  This RVV-X was removed after activation.  Complete activation isobserved via SDS-PAGE .  The purified Xa was then inactivated using GGACK.  Theinactivator was removed via dialysis. The above protein was purified from Human plasma thatwas tested and found negative by FDA accepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II,HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA.Donors are screened for CJD (Creutzfeldt-Jakob Disease)Factor X- gla domainless was prepared from purified Human Factor X using alphachymotrypsin. The alpha-chymotrypsin and all other products were removed using an anionexchange column after digestion.  The above protein was purified from Human plasma thatwas tested and found negative by FDA accepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II,HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA.Donors are screened for CJD (Creutzfeldt-Jakob Disease)The Human Factor IXab was activated from homogeneous Human Factor IX by activation with Bovine Factor XIa.  This Bovine Factor XIa is removed after activation.  Complete activation isobserved on SDS-PAGE. The IXab was then inactivated using a commercially availablechloromethylketone.  This inactivator is removed via dialysis.The human plasma used was tested and found negative by FDA accepted methods for AntiHIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA,HCV RNA and HBV RNAThe Human Activated Protein C gla domainless was prepared from purified Human APCusing Cathepsin G.  The Cathepsin G is removed using affinity chromatography afterdigestion. The above protein was purified from Human plasma that was tested and foundnegative by FDA accepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV,Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA.  Donors arescreened for CJD (Creutzfeldt-Jakob Disease)

The Human Protein C gla domainless was prepared from purified Human Protein C usingCathepsin G.  The Cathepsin G is removed using affinity chromatography after digestion. Theabove protein was purified from Human plasma that was tested and found negative by FDAaccepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA. Donors are screened for CJD (CreutzfeldtJakob Disease)The Human Protein C gla domainless was prepared from purified Human Protein C usingCathepsin G.  The Cathepsin G is removed using affinity chromatography after digestion. Theabove protein was purified from Human plasma that was tested and found negative by FDAaccepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA. Donors are screened for CJD (CreutzfeldtJakob Disease)The Human Factor VIIa gla domainless was prepared from purified Human Factor VIIa usingCathepsin G.  The Cathepsin G is removed using affinity chromatography after digestion.The above protein was purified from Human plasma that was tested and found negative byFDA accepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV, Syphilis, HBC Ab,HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA. Donors are screened for CJD(Creutzfeldt-Jakob Disease)

Rabbit Factor Xa is prepared from homogeneous Rabbit Factor X by activation with Russells'Viper Venom.  This RVV-X is removed  after activation.  Complete activation is observed viaSDS-PAGE

The Porcine Factor Xa was activated from homogeneous Porcine Factor X by activation with Russells' Viper Venom.  This RVV-X was removed after activation.  Complete activation isobserved on SDS-PAGE gels

Bovine Factor Xa is prepared from Bovine Factor X by activation with Russell's Viper Venom. This RVV-X is removed after activation. Complete activation is observed by SDS-PAGE. Factor Xa, as part of the prothrombinase complex along with the cofactor Va, phospholipids and calcium ions, catalyzes the rapid conversion of prothrombin to thrombin.

Prepared from freshly collected bovine plasma. Protein purity is determined by SDS-PAGE and shows no reduction upon incubation with 2-mercaptoethanol. Activated Factor IX via factor Xla or the factor VIIa/tissue factor/phospholipid complex, is responsible for the activation of Factor X to Xa

In the renin-angiotensin system (RAS), renin activates angiotensinogen to yield angiotensin I, which is further converted into angiotensin II by angiotensin-converting enzyme. Removal of the kidney generates renin/prorenin deficient plasma with high levels of angiotensinogen. This nephrectomized rat plasma can be used as a source of angiotensinogen or as a substrate for renin generation of Ang I. Plasma is collected from male rats at least 48 hours post nephrectomy. The substrate activity is determined by incubation with renin followed by Ang I radio-immune assay (RIA).In the renin-angiotensin system (RAS), renin activates angiotensinogen to yield angiotensin I, which is further converted into angiotensin II by angiotensin-converting enzyme. Removal of the kidney generates renin/prorenin deficient plasma with high levels of angiotensinogen. This nephrectomized rat plasma can be used as a source of angiotensinogen or as a substrate for renin generation of Ang I. Plasma is collected from male rats at least 48 hours post nephrectomy. The substrate activity is determined by incubation with renin followed by Ang I radio-immune assay (RIA).In the renin-angiotensin system (RAS), renin activates angiotensinogen to yield angiotensin I, which is further converted into angiotensin II by angiotensin-converting enzyme. Removal of the kidney generates renin/prorenin deficient plasma with high levels of angiotensinogen. This nephrectomized rat plasma can be used as a source of angiotensinogen or as a substrate for renin generation of Ang I. Plasma is collected from male rats at least 48 hours post nephrectomy. The substrate activity is determined by incubation with renin followed by Ang I radio-immune assay (RIA).In the renin-angiotensin system (RAS), renin activates angiotensinogen to yield angiotensin I, which is further converted into angiotensin II by angiotensin-converting enzyme. Removal of the kidney generates renin/prorenin deficient plasma with high levels of angiotensinogen. This nephrectomized rat plasma can be used as a source of angiotensinogen or as a substrate for renin generation of Ang I. Plasma is collected from male rats at least 48 hours post nephrectomy. The substrate activity is determined by incubation with renin followed by Ang I radio-immune assay (RIA).Recombinantly produced in HEK cell culture and purified by chelated metal affinity chromatography. Contains a 8X-Histidine tag at C terminus for purification. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminusRecombinantly produced in HEK cell culture and purified by chelated metal affinity chromatography. Contains a 8X-Histidine tag at C terminus for purification. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminusRecombinantly produced in HEK cell culture as untagged native form prorenin and purified by affinity chromatography. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus. This so called prosegment appears to block the full enzymatic potential of the active site (1). Renin activates the renin-angiotensin system by cleaving angiotensinogen, produced by the liver, to yield angiotensin I, which is further converted into angiotensin II by ACE, the angiotensin-converting enzyme primarily within the capillaries of the lungs. It has been reported that the levels of circulating prorenin (but not renin) are increased in diabetic subjects(2).Recombinantly produced in HEK cell culture as untagged native form prorenin and purified by affinity chromatography. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus. This so called prosegment appears to block the full enzymatic potential of the active site (1). Renin activates the renin-angiotensin system by cleaving angiotensinogen, produced by the liver, to yield angiotensin I, which is further converted into angiotensin II by ACE, the angiotensin-converting enzyme primarily within the capillaries of the lungs. It has been reported that the levels of circulating prorenin (but not renin) are increased in diabetic subjects(2).Recombinantly produced in HEK cell culture as untagged native form prorenin and purified by affinity chromatography. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus.Recombinantly produced in HEK cell culture as untagged native form prorenin and purified by affinity chromatography. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus.Recombinantly produced in HEK cell culture and purified by chelated metal affinity chromatography. Contains a 8X-Histidine tag at C terminus for purification. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus. This so called prosegment appears to block the full enzymatic potential of the active site (1). Renin activates the renin-angiotensin system by cleaving angiotensinogen, produced by the liver, to yield angiotensin I, which is further converted into angiotensin II by ACE, the angiotensin-converting enzyme primarily within the capillaries of the lungs.Recombinantly produced in HEK cell culture and purified by chelated metal affinity chromatography. Contains a 8X-Histidine tag at C terminus for purification. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus. This so called prosegment appears to block the full enzymatic potential of the active site (1). Renin activates the renin-angiotensin system by cleaving angiotensinogen, produced by the liver, to yield angiotensin I, which is further converted into angiotensin II by ACE, the angiotensin-converting enzyme primarily within the capillaries of the lungs.Recombinantly produced in HEK cell culture and purified by chelated metal affinity chromatography. Contains a 8X-Histidine tag at C terminus for purification. Resistant to activation to renin by trypsin digestion. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus.Recombinantly produced in HEK cell culture and purified by chelated metal affinity chromatography. Contains a 8X-Histidine tag at C terminus for purification. Resistant to activation to renin by trypsin digestion. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus.

Sprague Dawley Rat Albumin is a water-soluble protein with considerable structural stability which makes up 60percent of the total protein of plasma. It functions as a carrier of hormones, enzymes, fatty acids, metal ions, and medicinal products. Prepared from US origin rat plasma by proprietary fractionation methods and lyophilized. 95percent pure by SDS-PAGE.Sprague Dawley Rat Albumin is a water-soluble protein with considerable structural stability which makes up 60percent of the total protein of plasma. It functions as a carrier of hormones, enzymes, fatty acids, metal ions, and medicinal products. Prepared from US origin rat plasma by proprietary fractionation methods and lyophilized. 95percent pure by SDS-PAGE.Rabbit albumin is a water-soluble protein with considerable structural stability which makes up 60percent of the total protein of plasma. It functions as a carrier of hormones, enzymes, fatty acids, metal ions, and medicinal products. Prepared from US origin rabbit plasma by proprietary fractionation methods and lyophilized. 95percent pure by SDS-PAGE.Rabbit albumin is a water-soluble protein with considerable structural stability which makes up 60percent of the total protein of plasma. It functions as a carrier of hormones, enzymes, fatty acids, metal ions, and medicinal products. Prepared from US origin rabbit plasma by proprietary fractionation methods and lyophilized. 95percent pure by SDS-PAGE.Albumin is a water-soluble protein with considerable structural stability which makes up 60percent of the total protein of plasma. It functions as a carrier of hormones, enzymes, fatty acids, metal ions, and medicinal products. Prepared from US origin horse plasma by proprietary fractionation methods and lyophilized. 95percent pure by SDS-PAGE.Albumin is a water-soluble protein with considerable structural stability which makes up 60percent of the total protein of plasma. It functions as a carrier of hormones, enzymes, fatty acids, metal ions, and medicinal products. Prepared from cyno plasma by proprietary fractionation methods and lyophilized. 95percent pure by SDS-PAGE.Albumin is a water-soluble protein with considerable structural stability which makes up 60percent of the total protein of plasma. It functions as a carrier of hormones, enzymes, fatty acids, metal ions, and medicinal products. Prepared from US origin canine plasma by proprietary fractionation methods and lyophilized. 95percent pure by SDS-PAGE.Albumin is a water-soluble protein with considerable structural stability which makes up 60percent of the total protein of plasma. It functions as a carrier of hormones, enzymes, fatty acids, metal ions, and medicinal products. Prepared from US origin canine plasma by proprietary fractionation methods and lyophilized. 95percent pure by SDS-PAGE.Human Albumin (HSA) solubility: Albumin(s) are readily soluble in dionized water and can only preciptated by high concentrations of nuetral salts. Human Serum Albumin helps stabilize other solubilized proteins. Human Serum Albumin (HSA)is readily coagulated with heat. Human Serum Albumin(s) with other albumin(s) are acidic proteins which occur in abundance in body fluids and tissues. As a poducer, Manufacturer and supplier of finished human proteins for research and IVD manufacturing we can custom fill to your requirement.Human Albumin (HSA) solubility: Albumin(s) are readily soluble in dionized water and can only preciptated by high concentrations of nuetral salts. Human Serum Albumin helps stabilize other solubilized proteins. Human Serum Albumin (HSA)is readily coagulated with heat. Human Serum Albumin(s) with other albumin(s) are acidic proteins which occur in abundance in body fluids and tissues. As a poducer, Manufacturer and supplier of finished human proteins for research and IVD manufacturing we can custom fill to your requirement.

Rabbit PAI-1 is now available and is preferred for animal studies that utilize rabbit models. Wild type rabbit PAI-1 is less than 20percent active and may not be suitable for most experiments. As a replacement please consider rabbit PAI-1 stable mutant which is 70-80percent activeRabbit PAI-1 is now available and is preferred for animal studies that utilize rabbit models. Wild type rabbit PAI-1 is less than 20percent active and may not be suitable for most experiments. As a replacement please consider rabbit PAI-1 stable mutant which is 70-80percent active

Albumin is a water-soluble protein with considerable structural stability which makes up 60percent of the total protein of plasma. It functions as a carrier of hormones, enzymes, fatty acids, metal ions, and medicinal products. Prepared from US origin mouse (murine) plasma by proprietary fractionation methods and lyophilized. 95percent pure by SDS-PAGE. Add deionized water or buffer to original or desired volume, aliquot and freeze unused portion. Albumin is a water-soluble protein with considerable structural stability which makes up 60percent of the total protein of plasma. It functions as a carrier of hormones, enzymes, fatty acids, metal ions, and medicinal products. Prepared from US origin mouse (murine) plasma by proprietary fractionation methods and lyophilized. 95percent pure by SDS-PAGE. Add deionized water or buffer to original or desired volume, aliquot and freeze unused portion. 

A patent pending mutant of human PAI-1 containing four mutations that stabilize the activity of PAI-1 has been made available. The N-terminus has been additionally modified with the introduction of a 6-X histidine tag. The tag allows for the immobilization of functionally active PAI-1 onto surfaces such as metal chelate microtiter plates or Ni+2 resins. Many new applications for PAI-1 can be envisioned with this unique reagent.A patent pending mutant of human PAI-1 containing four mutations that stabilize the activity of PAI-1 has been made available. The N-terminus has been additionally modified with the introduction of a 6-X histidine tag. The tag allows for the immobilization of functionally active PAI-1 onto surfaces such as metal chelate microtiter plates or Ni+2 resins. Many new applications for PAI-1 can be envisioned with this unique reagent.The human form of PAI-1 contains the following four mutations: K154T, Q319L, M354I and N150H. These mutations combine to confer great stability to the otherwise labile molecule essentially locking in into the active conformation. It is an ideal choice for in vivo studies.The human form of PAI-1 contains the following four mutations: K154T, Q319L, M354I and N150H. These mutations combine to confer great stability to the otherwise labile molecule essentially locking in into the active conformation. It is an ideal choice for in vivo studies.

Prepared from plasminogen by activation with immobilized human uPA. 100% functionally active plasmin is purified from the activation reaction by immobilized SBTI. Plasmin will undergo rapid auto proteolysis in the absence of benzamidine and should be used quickly once thawed. Aliquot to avoid freeze-thaw cyclesPrepared from plasminogen by activation with immobilized human uPA. 100% functionally active plasmin is purified from the activation reaction by immobilized SBTI. Plasmin will undergo rapid auto proteolysis in the absence of benzamidine and should be used quickly once thawed. Aliquot to avoid freeze-thaw cycles

Mouse tPA with a double mutation that is permanently single chain and lacks catalytic activity. The non-catalytic mutation site is S481A on the mature protein and S510A on the complete mRNA sequence (UniProtKB: locus TPA_MOUSE, accession P11214).Mouse tPA with a double mutation that is permanently single chain and lacks catalytic activity. The non-catalytic mutation site is S481A on the mature protein and S510A on the complete mRNA sequence (UniProtKB: locus TPA_MOUSE, accession P11214).The addition of an arginine to glutamic acid mutation generates mouse tPA that is 100percent single chain and resistant to cleavage by plasmin. The mutation site is R279E on the mature protein and R308E on the complete mRNA sequence (UniProtKB: locus TPA_MOUSE, accession P11214). Recombinantly produced in insect cells.The addition of an arginine to glutamic acid mutation generates mouse tPA that is 100percent single chain and resistant to cleavage by plasmin. The mutation site is R279E on the mature protein and R308E on the complete mRNA sequence (UniProtKB: locus TPA_MOUSE, accession P11214). Recombinantly produced in insect cells.This single chain mouse tPA has the active site serine mutated to alanine rendering the enzyme catalytically inactive. The mutation site is S481A on the mature protein and S510A on the complete mRNA sequence (UniProtKB: locus TPA_MOUSE, accession P11214). The tPA still retains exosite binding as well as other biological properties of tPA including but not limited to surface binding to fibrin.This single chain mouse tPA has the active site serine mutated to alanine rendering the enzyme catalytically inactive. The mutation site is S481A on the mature protein and S510A on the complete mRNA sequence (UniProtKB: locus TPA_MOUSE, accession P11214). The tPA still retains exosite binding as well as other biological properties of tPA including but not limited to surface binding to fibrin.

The addition of an arginine to glutamic acid mutation generates human tPA that is 100percent single chain and resistant to cleavage by plasmin. The mutation site is R275E on the mature protein and R310E on the complete mRNA sequence (UniProtKB: locus TPA_HUMAN, accession P00750). Recombinantly produced in insect cells.The addition of an arginine to glutamic acid mutation generates human tPA that is 100percent single chain and resistant to cleavage by plasmin. The mutation site is R275E on the mature protein and R310E on the complete mRNA sequence (UniProtKB: locus TPA_HUMAN, accession P00750). Recombinantly produced in insect cells.This human tPA has an active site serine to alanine mutation which renders it catalytically inactive. The mutation site is S478A on the mature protein and S513A on the complete mRNA sequence (UniProtKB: locus TPA_HUMAN, accession P00750). It is 90percent single chain and retains exosite binding as well as other properties of wild type tPA. Recombinantly produced in insect cells.This human tPA has an active site serine to alanine mutation which renders it catalytically inactive. The mutation site is S478A on the mature protein and S513A on the complete mRNA sequence (UniProtKB: locus TPA_HUMAN, accession P00750). It is 90percent single chain and retains exosite binding as well as other properties of wild type tPA. Recombinantly produced in insect cells.

The low molecular weight form of uPA is purified from auto-catalytic digestion of recombinant human urokinase produced in insect cells. LMW uPA contains the proteinase domain and is separated from the amino terminal fragment by cleavage at the Lys135-Lys136 bond. For plasminogen activation and receptor binding studies.The low molecular weight form of uPA is purified from auto-catalytic digestion of recombinant human urokinase produced in insect cells. LMW uPA contains the proteinase domain and is separated from the amino terminal fragment by cleavage at the Lys135-Lys136 bond. For plasminogen activation and receptor binding studies.

Prepared from fresh hamster plasma. Ideal reagent for tissue culture studies and protein-protein interactions. Thaw the fibronectin by placing the vial in a 37 C water bath and leaving it undisturbed until completely thawed. Do not disturb the vial at any time during the thawing process. If the vial is disturbed or removed prior to complete thawing, the fibronectin will form a gel and be unusable. Mix very gently with pipette after thawing. Vortexing, excessive agitation, repeated freezing and thawing of fibronectin are not recommended.

Prepared from fresh mouse plasma. Ideal reagent for tissue culture studies and protein-protein interactions. Thaw the fibronectin by placing the vial in a 37 C water bath and leaving it undisturbed until completely thawed. Do not disturb the vial at any time during the thawing process. If the vial is disturbed or removed prior to complete thawing, the fibronectin will form a gel and be unusable. Mix very gently with pipette after thawing. Vortexing, excessive agitation, repeated freezing and thawing of fibronectin are not recommended. 

Prothrombin is activated on the surface of a phospholipid membrane that binds the amino end of prothrombin and factors Va and Xa in Ca-dependent interactions; factor Xa removes the activation peptide and cleaves the remaining part into light and heavy chains. The activation process starts slowly because factor V itself has to be activated by the initial, small amounts of thrombin.Factor Xa is prepared by activating purified factor X with the factor X activator isolated from Russell's viper venom. Factor Xa is purified from the activation mixture by chromatography over benzamidine-Sepharose. Purity is determined by SDS-PAGE analysis and activity is measured in a factor Xa clotting assay and/or chromogenic substrate assay.

Factor IXa is prepared from highly purified factor IX by activation with factor XIa. The factor IXa is further purified by gel filtration, followed by immunoaffinity purification. Purity is assessed by SDS-PAGE analysis. Activity is determined in a one-stage clotting assay.Rat thrombin is prepared from purified rat prothrombin by activation with Russells Viper Venom. This venom is removed after activation. Purity is 90percent as determined by SDS-PAGE analysis. Activity is measured in a thrombin specific clotting assay, and compared to standardized NIH thrombin.

Heparin cofactor II (HCII) (heparin cofactor A, antithrombin BM, dermatan sulfate cofactor, human leuserpin-2) is a single chain glycoprotein (Mr=65,600, 10% carbohydrate) member of the serine protease inhibitor (serpin) family (1-3). Amino acid sequence analysis of heparin cofactor II reveals 3 potential N-glycosylation sites and 2 sulfated tyrosines located in two internal repeats of 7 residues located near the NH2-terminal (4-6). The plasma concentration is estimated to be 90Activation of Prekallikrein with Factor a-XIIa produces the enzymatically active Kallikrein. Kallikrein is a serine protease which consists of a heavy chain (Mr 52kD) and light chains (Mr either 36 or 33 kD) linked by disulfide bridges. Kallikrein possesses enzymatic activity toward Factor XII, HK, Plasminogen, Factors XI, IX, and VII, prorenin and the complement system. After activation, the activating enzyme Factor XIIa is removed by affinity chromatography. Human Kallikrein purity is determined by SDS-PAGE and shows complete reduction upon incubation with 2-mercaptoethanol.Purified from fresh frozen human plasma. Human Prekallikrein is a single chain gamma globulin glycoprotein that participates in the early phase of contact activation, kinin formation and fibrinolysis. Prekallikrein purity is determined by SDS-PAGE and shows no reduction upon incubation with 2-mercaptoethanol. Activity is determined via clotting assay.Human Factor XIIa is a serine protease responsible for the activation of Factor XI to XIa in the contact activation system. Human Factor XII and prekallikrein are thought to be involved in a reciprocal activation mechanism in which Factor XIIa activates prekallikrein to kallikrein, which in turn converts Factor XII to XIIa. Factor XIIa activates Factor XI to XIa thereby triggering the Contact Factor cascade. ERL offers Factor ?-XIIa which is activated by the autoactivation process with Dextran Sulfate and re-purified to remove the activator. The protein purity is determined by SDS-PAGE and activity is determined via clotting assay.Human Factor XIIa is a serine protease responsible for the activation of Factor XI to XIa in the contact activation system. Human Factor XII and prekallikrein are thought to be involved in a reciprocal activation mechanism in which Factor XIIa activates prekallikrein to kallikrein, which in turn converts Factor XII to XIIa. Factor XIIa activates Factor XI to XIa thereby triggering the Contact Factor cascade. ERL offers Factor ?-XIIa which is activated by the autoactivation process with Dextran Sulfate and re-purified to remove the activator. The protein purity is determined by SDS-PAGE and activity is determined via clotting assay.Human Factor Xa is prepared from Human Factor X by activation with Russell's Viper Venom. This RVV-X is removed after activation. Complete activation is observed by SDS-PAGE. Factor Xa along with cofactor Va, phospholipids and calcium ions, (the prothrombinase complex) catalyzes the rapid conversion of prothrombin to thrombin.

Purified from fresh frozen human plasma using a combination of salt precipitations and column chromatography. The protein purity is determined by SDS-PAGE and shows total reduction upon incubation with 2-mercaptoethanol. Protein C is activated to the serine protease, Activated Protein C (APC), by a-thrombin or the complex of a-thrombin/thrombomodulin and is a potent anticoagulant through the selective inactivation of Factors Va and VIIIa.Purified from fresh frozen human plasma using a combination of salt precipitations and column chromatography. The protein purity is determined by SDS-PAGE and shows total reduction upon incubation with 2-mercaptoethanol. Protein C is activated to the serine protease, Activated Protein C (APC), by a-thrombin or the complex of a-thrombin/thrombomodulin and is a potent anticoagulant through the selective inactivation of Factors Va and VIIIa.

Prepared from homogeneous human prothrombin by activation with Factor Xa, Factor Va, and phospholipid. Human Thrombin purity is determined by SDS-PAGE. This activated enzyme has a minimum activity of 2,700 NIH units/mg when compared to NIH standard thrombin.Prepared from fresh frozen human plasma. Human Prothrombin is a glycoprotein of molecular weight 72,000, and consists of a single polypeptide chain. Activation of Prothrombin by Factor Va, Xa and phospholipids yields the serine protease Thrombin. Prothrombin purity is determined by SDS-PAGE and shows no reduction upon incubation with 2-mercaptoethanol.Prepared from fresh frozen human plasma. Human Prothrombin is a glycoprotein of molecular weight 72,000, and consists of a single polypeptide chain. Activation of Prothrombin by Factor Va, Xa and phospholipids yields the serine protease Thrombin. Prothrombin purity is determined by SDS-PAGE and shows no reduction upon incubation with 2-mercaptoethanol.

Canine fibrinogen amino terminal labeled with fluorescein isothiocyanate (FITC). Prepared from fresh dog plasma using several chromatographic steps. Plasminogen depleted by lysine affinity chromatography. Thaw at 37C without agitation until completely liquid, then gently mix before use. Keep fibrinogen at 25-37C, aliquot and flash freeze unused portion. 

Prepared from fresh frozen human plasma. Human Factor XI is a two-chain glycoprotein with molecular weight of 160,000 daltons.  The two chains are identical disulfide bonded polypeptides with molecular weights of 80,000 daltons.  Factor XI is activated to Factor XIa by Factor Xlla. Purity of Factor XI is assessed by SDS-PAGE.  Activity is determined by clotting assay.Prepared from fresh frozen human plasma. Human Factor XI is a two-chain glycoprotein with molecular weight of 160,000 daltons.  The two chains are identical disulfide bonded polypeptides with molecular weights of 80,000 daltons.  Factor XI is activated to Factor XIa by Factor Xlla. Purity of Factor XI is assessed by SDS-PAGE.  Activity is determined by clotting assay.Prepared from fresh frozen human plasma. The purity of this Vitamin K dependent protein is determined by SDS-PAGE  and shows total reduction upon incubation with 2-mercaptoethanol. Activity is determined via clotting assay. Human Factor X, once activated via the Contact Factor Pathway or the Tissue Factor Pathway, is responsible for the conversion of Prothrombin to Thrombin.

Prepared from fresh frozen human plasma. This protein purity is determined by SDS-PAGE and shows no reduction upon incubation with 2-mercaptoethanol.  Activity is determined via clotting assay.  Human Factor IX, activated by either the Contact or Tissue Factor Pathway, is responsible for the activation of Factor X to Xa.Activated Protein C (APC) is a serine protease derived from the two chain vitamin K dependent zymogen, Protein C. APC inhibits blood coagulation through the selective inactivation of the cofactors Va and VIIIa. APC is prepared from protein C by activation with purified thrombin. This thrombin is removed after activation by ion exchange chromatography. Activated Protein C purity is determined by SDS-PAGE and shows complete reduction upon incubation with 2-mercaptoethanol.Activated Protein C (APC) is a serine protease derived from the two chain vitamin K dependent zymogen, Protein C. APC inhibits blood coagulation through the selective inactivation of the cofactors Va and VIIIa. APC is prepared from protein C by activation with purified thrombin. This thrombin is removed after activation by ion exchange chromatography. Activated Protein C purity is determined by SDS-PAGE and shows complete reduction upon incubation with 2-mercaptoethanol.

Prepared from purified Human Factor VII using Human Factor XIIa. The Factor Xlla is removed using affinity chromatography. Purity is determined by SDS-PAGE. Human Factor VIIa reduces to 29,500 and 23,500 with the addition of 2-mercaptoethanol. Activity is determined via clotting assay.  Factor Vlla, in the presence of calcium ions and Tissue factor, activates Factors IX and X to their enzymatically active forms, Factor IXa and Xa.Prepared from purified Human Factor VII using Human Factor XIIa. The Factor Xlla is removed using affinity chromatography. Purity is determined by SDS-PAGE. Human Factor VIIa reduces to 29,500 and 23,500 with the addition of 2-mercaptoethanol. Activity is determined via clotting assay.  Factor Vlla, in the presence of calcium ions and Tissue factor, activates Factors IX and X to their enzymatically active forms, Factor IXa and Xa.

LMW Kininogn is involved in blood pressure regulation since it is an endogenous protein substrate for tissue kallikrein. Proteolytic cleavage by kallikrein releases vasoactive bradykinin from LMW kininogen. In addition, LMW kininogen, like HMW kininogen, is a major extracellular cysteine protease inhibitor. Prepared from plasma shown to be non reactive for HbsAG, anti-HCV, anti-HBc, and negative for anti-HIV 1 &amp; 2 by FDA approved tests. 95percent pure by SDS-PAGE. Add deionized water to original volume, aliquot and freeze unused portion.High Molecular Weight Kininogen (HK) is a nonenzymatic cofactor of the contact activation system. HK is thought to have two functions in the contact activation system. First, HK links prekallikrein to a negatively charged surface thereby allowing activation to kallikrein by surface bound Factor -Xlla. HK also forms a complex with Factor XI and accelerates its activation to XIa by -Xlla. Also HK serves as a source of Bradykinin, a potent Vasoactive peptide important in hypotension studies. The protein purity is determined by SDS-PAGE

Human Factor XIII is a tetramer composed of two pairs of chains held together by noncovalent bonds. After activation of the zymogen via Thrombin to its active enzyme form, Factor XIIIa is responsible for catalyzing the formation of covalent bridges between fibrin units to increase the elasticity of the clot network. The resulting cross-linked fibrin is very insoluble and resistant to lysis.Human Factor XIII is a tetramer composed of two pairs of chains held together by noncovalent bonds. After activation of the zymogen via Thrombin to its active enzyme form, Factor XIIIa is responsible for catalyzing the formation of covalent bridges between fibrin units to increase the elasticity of the clot network. The resulting cross-linked fibrin is very insoluble and resistant to lysis.

Our Activated Protein C is inactivated using PPACK, Dihydrochloride and is removed via gelfiltration. The above protein was purified from Human plasma that was tested and foundnegative by FDA accepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV,Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA. Donors arescreened for CJD (Creutzfeldt-Jakob Disease)

Prepared from fresh frozen human plasma. Human Factor VII is a single-chain vitamin K dependent glycoprotein found in trace quantities in plasma (0.5 mg/Liter). In the Tissue Factor Pathway of coagulation, Human Factor Vlla, in the presence of calcium ions and tissue factor, activates Factors IX and X to their enzymatically active forms, Factor IXa and Xa.Prepared from fresh frozen human plasma. Human Factor VII is a single-chain vitamin K dependent glycoprotein found in trace quantities in plasma (0.5 mg/Liter). In the Tissue Factor Pathway of coagulation, Human Factor Vlla, in the presence of calcium ions and tissue factor, activates Factors IX and X to their enzymatically active forms, Factor IXa and Xa.Human prothrombin with the gla domain removed. The above protein was purified fromHuman plasma that was tested and found negative by FDA accepted methods for AntiHIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA,HCV RNA and HBV RNA. Donors are screened for CJD (Creutzfeldt-Jakob Disease)

Bovine Factor Xla is purified from freshly collected Bovine Plasma using a combination of salt precipitations and activation on a negative surface. This Factor Xla is a potent activator of both Human and Bovine Factor IX. Bovine Factor XIa purity is determined by SDS-PAGE and shows complete reduction upon incubation with 2-mercaptoethanol.

Prepared from Bovine Factor IX by activation with Bovine Factor Xla, this Bovine Factor Xla is removed after activation. Complete activation is observed by SDS-PAGE. The Factor Xla activates FIX in a two-step reaction. In the first step, an internal Arg-Ala bond is cleaved, and in the second step, an Arg-Val bond is cleaved. The second cleavage leads to the liberation of an activation peptide from the NH2-terminal portion of the heavy chain to produce factor IXaβ.

Purified from freshly collected bovine plasma using a combination of salt precipitations and column chromatography. This protein is a mixture of Factor V/Va and intermediate activation products as judged by 4-20% gradient gels. Bovine Factor Va functions as a cofactor with the serine protease Factor Xa in the activation of prothrombin. This protein may be used as a source of V/Va in the Prothrombinase complexPurified from freshly collected bovine plasma using a combination of salt precipitations and column chromatography. This protein is a mixture of Factor V/Va and intermediate activation products as judged by 4-20% gradient gels. Bovine Factor Va functions as a cofactor with the serine protease Factor Xa in the activation of prothrombin. This protein may be used as a source of V/Va in the Prothrombinase complexInterleukin-2 (IL-2) is a O-glycosylated four alpha-helix bundle cytokine that is produced by T-cells in response to antigenic or mitogenic stimulation. IL-2 can stimulate B-cells, monocytes, lymphokine-activated killer cells, natural killer cells, and glioma cells and is required for T-cell proliferation and other activities crucial to regulation of the immune response.This Fc Fusion Protein is glycosylated and expressed as a chimera with the Fc region of mouse immunoglobulin. Fc fusion proteins are typically more stable and resistant to degradation and clearance than native cytokines. Fc fusion proteins appear as a dimer in SDS-PAGE under non-reducing conditions.Interleukin-2 (IL-2) is a O-glycosylated four alpha-helix bundle cytokine that is produced by T-cells in response to antigenic or mitogenic stimulation. IL-2 can stimulate B-cells, monocytes, lymphokine-activated killer cells, natural killer cells, and glioma cells and is required for T-cell proliferation and other activities crucial to regulation of the immune response.This Fc Fusion Protein is glycosylated and expressed as a chimera with the Fc region of mouse immunoglobulin. Fc fusion proteins are typically more stable and resistant to degradation and clearance than native cytokines. Fc fusion proteins appear as a dimer in SDS-PAGE under non-reducing conditions.Mouse Protein Z-Dependent Protease Inhibitor (ZPI), recombinantly produced in insect cells. Active and complexable with Factor XIa. This Serine Protease Inhibitor (SERPIN) requires the cofactors Protein Z, phospholipids and calcium to inhibit endogenous Factor Xa. ZPI contains a tyrosine residue at the P1 position of the reactive center loop, rather than arginine which is present in most SERPINs.Corn Trypsin Inhibitor (CTI) is a specific and potent inhibitor of human factor XIIa. It is purified from fresh Indiana sweet corn by solvent extraction and chromatographic methods. A suggested inhibitory concentration is 24 fold molar excess over the enzyme concentration. CTI purity is determined by SDS-PAGE and shows no reduction upon incubation with 2-mercaptoethanol.

The Activated Bovine Protein C was activated from homogeneous protein C by activation withpurified alpha-thrombin.  The alpha-thrombin is removed after activation. Complete activationis observed on SDS-PAGE gels.  All bovine material is from U.S. cows /+ 36 months of age

Human Factor XIIIa is activated from Factor XIII by cleavage with human alpha thrombin. The thrombin is subsequently removed via chromatography. Factor XIIIa is responsible for catalyzing the formation of covalent bridges between fibrin units to increase the elasticity of the clot network. The resulting cross-linked fibrin is very insoluble and resistant to lysis. Human Factor XIIIa is activated from Factor XIII by cleavage with human alpha thrombin. The thrombin is subsequently removed via chromatography. Factor XIIIa is responsible for catalyzing the formation of covalent bridges between fibrin units to increase the elasticity of the clot network. The resulting cross-linked fibrin is very insoluble and resistant to lysis. 

Human Factor beta-XIIa is generated in vivo by kallikrein cleavage of Factor alpha-XIIa and contains the catalytic light chain and the C-terminal peptide of the heavy chain of Factor alpha-XIIa. Human Factor beta-XIIa is activated from homogeneous Human Factor XII by an autoactivation process with Dextran Sulfate followed by repurification to isolate Factor alpha-XIIa and Factor beta-XIIa. Complete activation is observed on SDS-PAGE. Factor XIIa is 95percent pure by SDS-PAGE and activity is determined via clotting assay. Prepared from plasma found negative by FDA accepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA. Donors are screened for CJD (Creutzfeldt-Jakob Disease). Human Factor beta-XIIa is generated in vivo by kallikrein cleavage of Factor alpha-XIIa and contains the catalytic light chain and the C-terminal peptide of the heavy chain of Factor alpha-XIIa. Human Factor beta-XIIa is activated from homogeneous Human Factor XII by an autoactivation process with Dextran Sulfate followed by repurification to isolate Factor alpha-XIIa and Factor beta-XIIa. Complete activation is observed on SDS-PAGE. Factor XIIa is 95percent pure by SDS-PAGE and activity is determined via clotting assay. Prepared from plasma found negative by FDA accepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA. Donors are screened for CJD (Creutzfeldt-Jakob Disease). 

Human beta-thrombin is prepared from purified a-thrombin by limited proteolysis with TPCK-treated trypsin. Beta-thrombin is generated by cleavage of the B-chain at the Arg106-Tyr107 bond. Purity is assessed by SDS-PAGE and activity is assessed using a fibrinogen clotting assay. The Human Plasmin was activated from homogeneous glu-plasminogen using urokinase at a500:1 molar ratio.  This urokinase was not removed after activation.  Complete activation wasobserved using the S-2251 chromogenic substrate.  The above protein was purified fromHuman plasma that was tested and found negative by FDA accepted methods for AntiHIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA,HCV RNA and HBV RNA. Donors are screened for CJD (Creutzfeldt-Jakob Disease)Purified from fresh frozen human plasma. Human Factor XII is part of the contact activation system. Human Factor XII is a single chain glycoprotein with a molecular weight of about 80,000. Once activated, principally from the action of kallikrein, Factor XII is converted into an active serine protease (Factor -Xlla) that functions in the <emin vivo</em initiation of blood coagulation, fibrinolysis, and kinin formation. Human Factor XII has been purified by ion exchange chromatography. Protein purity is determined by SDS-PAGE and activity is determined via clotting assay.Purified from fresh frozen human plasma. Human Factor XII is part of the contact activation system. Human Factor XII is a single chain glycoprotein with a molecular weight of about 80,000. Once activated, principally from the action of kallikrein, Factor XII is converted into an active serine protease (Factor -Xlla) that functions in the <emin vivo</em initiation of blood coagulation, fibrinolysis, and kinin formation. Human Factor XII has been purified by ion exchange chromatography. Protein purity is determined by SDS-PAGE and activity is determined via clotting assay.The Human Factor XIa was activated from homogeneous Human Factor XI using HumanFactor XIIa.  This XIIa was removed using a Corn Trypsin Inhibitor column.  The protein is95% pure via SDS-PAGE.  The above protein was purified from Human plasma that wastested and found negative by FDA accepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II,HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA.Donors are screened for CJD (Creutzfeldt-Jakob Disease)The Human Factor Xa beta gla domainless was prepared from HFX-GD using purified RVV-X.This RVV-X was removed after activation by gel filtration.  Complete activation was observedon SDS PAGE.  The above protein was purified from Human plasma that was tested andfound negative by FDA accepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV,Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA. Donors arescreened for CJD (Creutzfeldt-Jakob Disease)The Human Factor Xa was activated from homogeneous Human Factor X by activation withRussels' Viper Venom.  This RVV-X was removed after activation.  Complete activation isobserved via SDS-PAGE .  The purified Xa was then inactivated using GGACK.  Theinactivator was removed via dialysis. The above protein was purified from Human plasma thatwas tested and found negative by FDA accepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II,HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA.Donors are screened for CJD (Creutzfeldt-Jakob Disease)Factor X- gla domainless was prepared from purified Human Factor X using alphachymotrypsin. The alpha-chymotrypsin and all other products were removed using an anionexchange column after digestion.  The above protein was purified from Human plasma thatwas tested and found negative by FDA accepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II,HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA.Donors are screened for CJD (Creutzfeldt-Jakob Disease)The Human Factor IXab was activated from homogeneous Human Factor IX by activation with Bovine Factor XIa.  This Bovine Factor XIa is removed after activation.  Complete activation isobserved on SDS-PAGE. The IXab was then inactivated using a commercially availablechloromethylketone.  This inactivator is removed via dialysis.The human plasma used was tested and found negative by FDA accepted methods for AntiHIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA,HCV RNA and HBV RNAThe Human Activated Protein C gla domainless was prepared from purified Human APCusing Cathepsin G.  The Cathepsin G is removed using affinity chromatography afterdigestion. The above protein was purified from Human plasma that was tested and foundnegative by FDA accepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV,Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA.  Donors arescreened for CJD (Creutzfeldt-Jakob Disease)

The Human Protein C gla domainless was prepared from purified Human Protein C usingCathepsin G.  The Cathepsin G is removed using affinity chromatography after digestion. Theabove protein was purified from Human plasma that was tested and found negative by FDAaccepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA. Donors are screened for CJD (CreutzfeldtJakob Disease)The Human Protein C gla domainless was prepared from purified Human Protein C usingCathepsin G.  The Cathepsin G is removed using affinity chromatography after digestion. Theabove protein was purified from Human plasma that was tested and found negative by FDAaccepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA. Donors are screened for CJD (CreutzfeldtJakob Disease)The Human Factor VIIa gla domainless was prepared from purified Human Factor VIIa usingCathepsin G.  The Cathepsin G is removed using affinity chromatography after digestion.The above protein was purified from Human plasma that was tested and found negative byFDA accepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV, Syphilis, HBC Ab,HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA. Donors are screened for CJD(Creutzfeldt-Jakob Disease)

Bovine Factor Xa is prepared from Bovine Factor X by activation with Russell's Viper Venom. This RVV-X is removed after activation. Complete activation is observed by SDS-PAGE. Factor Xa, as part of the prothrombinase complex along with the cofactor Va, phospholipids and calcium ions, catalyzes the rapid conversion of prothrombin to thrombin.

Prepared from freshly collected bovine plasma. Protein purity is determined by SDS-PAGE and shows no reduction upon incubation with 2-mercaptoethanol. Activated Factor IX via factor Xla or the factor VIIa/tissue factor/phospholipid complex, is responsible for the activation of Factor X to Xa

In the renin-angiotensin system (RAS), renin activates angiotensinogen to yield angiotensin I, which is further converted into angiotensin II by angiotensin-converting enzyme. Removal of the kidney generates renin/prorenin deficient plasma with high levels of angiotensinogen. This nephrectomized rat plasma can be used as a source of angiotensinogen or as a substrate for renin generation of Ang I. Plasma is collected from male rats at least 48 hours post nephrectomy. The substrate activity is determined by incubation with renin followed by Ang I radio-immune assay (RIA).In the renin-angiotensin system (RAS), renin activates angiotensinogen to yield angiotensin I, which is further converted into angiotensin II by angiotensin-converting enzyme. Removal of the kidney generates renin/prorenin deficient plasma with high levels of angiotensinogen. This nephrectomized rat plasma can be used as a source of angiotensinogen or as a substrate for renin generation of Ang I. Plasma is collected from male rats at least 48 hours post nephrectomy. The substrate activity is determined by incubation with renin followed by Ang I radio-immune assay (RIA).In the renin-angiotensin system (RAS), renin activates angiotensinogen to yield angiotensin I, which is further converted into angiotensin II by angiotensin-converting enzyme. Removal of the kidney generates renin/prorenin deficient plasma with high levels of angiotensinogen. This nephrectomized rat plasma can be used as a source of angiotensinogen or as a substrate for renin generation of Ang I. Plasma is collected from male rats at least 48 hours post nephrectomy. The substrate activity is determined by incubation with renin followed by Ang I radio-immune assay (RIA).In the renin-angiotensin system (RAS), renin activates angiotensinogen to yield angiotensin I, which is further converted into angiotensin II by angiotensin-converting enzyme. Removal of the kidney generates renin/prorenin deficient plasma with high levels of angiotensinogen. This nephrectomized rat plasma can be used as a source of angiotensinogen or as a substrate for renin generation of Ang I. Plasma is collected from male rats at least 48 hours post nephrectomy. The substrate activity is determined by incubation with renin followed by Ang I radio-immune assay (RIA).Recombinantly produced in HEK cell culture and purified by chelated metal affinity chromatography. Contains a 8X-Histidine tag at C terminus for purification. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminusRecombinantly produced in HEK cell culture and purified by chelated metal affinity chromatography. Contains a 8X-Histidine tag at C terminus for purification. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminusRecombinantly produced in HEK cell culture as untagged native form prorenin and purified by affinity chromatography. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus. This so called prosegment appears to block the full enzymatic potential of the active site (1). Renin activates the renin-angiotensin system by cleaving angiotensinogen, produced by the liver, to yield angiotensin I, which is further converted into angiotensin II by ACE, the angiotensin-converting enzyme primarily within the capillaries of the lungs. It has been reported that the levels of circulating prorenin (but not renin) are increased in diabetic subjects(2).Recombinantly produced in HEK cell culture as untagged native form prorenin and purified by affinity chromatography. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus. This so called prosegment appears to block the full enzymatic potential of the active site (1). Renin activates the renin-angiotensin system by cleaving angiotensinogen, produced by the liver, to yield angiotensin I, which is further converted into angiotensin II by ACE, the angiotensin-converting enzyme primarily within the capillaries of the lungs. It has been reported that the levels of circulating prorenin (but not renin) are increased in diabetic subjects(2).Recombinantly produced in HEK cell culture as untagged native form prorenin and purified by affinity chromatography. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus.Recombinantly produced in HEK cell culture as untagged native form prorenin and purified by affinity chromatography. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus.Recombinantly produced in HEK cell culture and purified by chelated metal affinity chromatography. Contains a 8X-Histidine tag at C terminus for purification. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus. This so called prosegment appears to block the full enzymatic potential of the active site (1). Renin activates the renin-angiotensin system by cleaving angiotensinogen, produced by the liver, to yield angiotensin I, which is further converted into angiotensin II by ACE, the angiotensin-converting enzyme primarily within the capillaries of the lungs.Recombinantly produced in HEK cell culture and purified by chelated metal affinity chromatography. Contains a 8X-Histidine tag at C terminus for purification. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus. This so called prosegment appears to block the full enzymatic potential of the active site (1). Renin activates the renin-angiotensin system by cleaving angiotensinogen, produced by the liver, to yield angiotensin I, which is further converted into angiotensin II by ACE, the angiotensin-converting enzyme primarily within the capillaries of the lungs.Recombinantly produced in HEK cell culture and purified by chelated metal affinity chromatography. Contains a 8X-Histidine tag at C terminus for purification. Resistant to activation to renin by trypsin digestion. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus.Recombinantly produced in HEK cell culture and purified by chelated metal affinity chromatography. Contains a 8X-Histidine tag at C terminus for purification. Resistant to activation to renin by trypsin digestion. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus.

Sprague Dawley Rat Albumin is a water-soluble protein with considerable structural stability which makes up 60percent of the total protein of plasma. It functions as a carrier of hormones, enzymes, fatty acids, metal ions, and medicinal products. Prepared from US origin rat plasma by proprietary fractionation methods and lyophilized. 95percent pure by SDS-PAGE.Sprague Dawley Rat Albumin is a water-soluble protein with considerable structural stability which makes up 60percent of the total protein of plasma. It functions as a carrier of hormones, enzymes, fatty acids, metal ions, and medicinal products. Prepared from US origin rat plasma by proprietary fractionation methods and lyophilized. 95percent pure by SDS-PAGE.

Human Albumin (HSA) solubility: Albumin(s) are readily soluble in dionized water and can only preciptated by high concentrations of nuetral salts. Human Serum Albumin helps stabilize other solubilized proteins. Human Serum Albumin (HSA)is readily coagulated with heat. Human Serum Albumin(s) with other albumin(s) are acidic proteins which occur in abundance in body fluids and tissues. As a poducer, Manufacturer and supplier of finished human proteins for research and IVD manufacturing we can custom fill to your requirement.Human Albumin (HSA) solubility: Albumin(s) are readily soluble in dionized water and can only preciptated by high concentrations of nuetral salts. Human Serum Albumin helps stabilize other solubilized proteins. Human Serum Albumin (HSA)is readily coagulated with heat. Human Serum Albumin(s) with other albumin(s) are acidic proteins which occur in abundance in body fluids and tissues. As a poducer, Manufacturer and supplier of finished human proteins for research and IVD manufacturing we can custom fill to your requirement.Albumin is a water-soluble protein with considerable structural stability which makes up 60percent of the total protein of plasma. It functions as a carrier of hormones, enzymes, fatty acids, metal ions, and medicinal products. Prepared from US origin mouse (murine) plasma by proprietary fractionation methods and lyophilized. 95percent pure by SDS-PAGE. Add deionized water or buffer to original or desired volume, aliquot and freeze unused portion. Albumin is a water-soluble protein with considerable structural stability which makes up 60percent of the total protein of plasma. It functions as a carrier of hormones, enzymes, fatty acids, metal ions, and medicinal products. Prepared from US origin mouse (murine) plasma by proprietary fractionation methods and lyophilized. 95percent pure by SDS-PAGE. Add deionized water or buffer to original or desired volume, aliquot and freeze unused portion. 

A patent pending mutant of human PAI-1 containing four mutations that stabilize the activity of PAI-1 has been made available. The N-terminus has been additionally modified with the introduction of a 6-X histidine tag. The tag allows for the immobilization of functionally active PAI-1 onto surfaces such as metal chelate microtiter plates or Ni+2 resins. Many new applications for PAI-1 can be envisioned with this unique reagent.A patent pending mutant of human PAI-1 containing four mutations that stabilize the activity of PAI-1 has been made available. The N-terminus has been additionally modified with the introduction of a 6-X histidine tag. The tag allows for the immobilization of functionally active PAI-1 onto surfaces such as metal chelate microtiter plates or Ni+2 resins. Many new applications for PAI-1 can be envisioned with this unique reagent.

This single chain mouse tPA has the active site serine mutated to alanine rendering the enzyme catalytically inactive. The mutation site is S481A on the mature protein and S510A on the complete mRNA sequence (UniProtKB: locus TPA_MOUSE, accession P11214). The tPA still retains exosite binding as well as other biological properties of tPA including but not limited to surface binding to fibrin.This single chain mouse tPA has the active site serine mutated to alanine rendering the enzyme catalytically inactive. The mutation site is S481A on the mature protein and S510A on the complete mRNA sequence (UniProtKB: locus TPA_MOUSE, accession P11214). The tPA still retains exosite binding as well as other biological properties of tPA including but not limited to surface binding to fibrin.

This human tPA has an active site serine to alanine mutation which renders it catalytically inactive. The mutation site is S478A on the mature protein and S513A on the complete mRNA sequence (UniProtKB: locus TPA_HUMAN, accession P00750). It is 90percent single chain and retains exosite binding as well as other properties of wild type tPA. Recombinantly produced in insect cells.This human tPA has an active site serine to alanine mutation which renders it catalytically inactive. The mutation site is S478A on the mature protein and S513A on the complete mRNA sequence (UniProtKB: locus TPA_HUMAN, accession P00750). It is 90percent single chain and retains exosite binding as well as other properties of wild type tPA. Recombinantly produced in insect cells.

Prepared from fresh hamster plasma. Ideal reagent for tissue culture studies and protein-protein interactions. Thaw the fibronectin by placing the vial in a 37 C water bath and leaving it undisturbed until completely thawed. Do not disturb the vial at any time during the thawing process. If the vial is disturbed or removed prior to complete thawing, the fibronectin will form a gel and be unusable. Mix very gently with pipette after thawing. Vortexing, excessive agitation, repeated freezing and thawing of fibronectin are not recommended.

Prepared from fresh mouse plasma. Ideal reagent for tissue culture studies and protein-protein interactions. Thaw the fibronectin by placing the vial in a 37 C water bath and leaving it undisturbed until completely thawed. Do not disturb the vial at any time during the thawing process. If the vial is disturbed or removed prior to complete thawing, the fibronectin will form a gel and be unusable. Mix very gently with pipette after thawing. Vortexing, excessive agitation, repeated freezing and thawing of fibronectin are not recommended. 

Prothrombin is activated on the surface of a phospholipid membrane that binds the amino end of prothrombin and factors Va and Xa in Ca-dependent interactions; factor Xa removes the activation peptide and cleaves the remaining part into light and heavy chains. The activation process starts slowly because factor V itself has to be activated by the initial, small amounts of thrombin.

Heparin cofactor II (HCII) (heparin cofactor A, antithrombin BM, dermatan sulfate cofactor, human leuserpin-2) is a single chain glycoprotein (Mr=65,600, 10% carbohydrate) member of the serine protease inhibitor (serpin) family (1-3). Amino acid sequence analysis of heparin cofactor II reveals 3 potential N-glycosylation sites and 2 sulfated tyrosines located in two internal repeats of 7 residues located near the NH2-terminal (4-6). The plasma concentration is estimated to be 90Activation of Prekallikrein with Factor a-XIIa produces the enzymatically active Kallikrein. Kallikrein is a serine protease which consists of a heavy chain (Mr 52kD) and light chains (Mr either 36 or 33 kD) linked by disulfide bridges. Kallikrein possesses enzymatic activity toward Factor XII, HK, Plasminogen, Factors XI, IX, and VII, prorenin and the complement system. After activation, the activating enzyme Factor XIIa is removed by affinity chromatography. Human Kallikrein purity is determined by SDS-PAGE and shows complete reduction upon incubation with 2-mercaptoethanol.

Human Factor XIIa is a serine protease responsible for the activation of Factor XI to XIa in the contact activation system. Human Factor XII and prekallikrein are thought to be involved in a reciprocal activation mechanism in which Factor XIIa activates prekallikrein to kallikrein, which in turn converts Factor XII to XIIa. Factor XIIa activates Factor XI to XIa thereby triggering the Contact Factor cascade. ERL offers Factor ?-XIIa which is activated by the autoactivation process with Dextran Sulfate and re-purified to remove the activator. The protein purity is determined by SDS-PAGE and activity is determined via clotting assay.Human Factor XIIa is a serine protease responsible for the activation of Factor XI to XIa in the contact activation system. Human Factor XII and prekallikrein are thought to be involved in a reciprocal activation mechanism in which Factor XIIa activates prekallikrein to kallikrein, which in turn converts Factor XII to XIIa. Factor XIIa activates Factor XI to XIa thereby triggering the Contact Factor cascade. ERL offers Factor ?-XIIa which is activated by the autoactivation process with Dextran Sulfate and re-purified to remove the activator. The protein purity is determined by SDS-PAGE and activity is determined via clotting assay.

Purified from fresh frozen human plasma using a combination of salt precipitations and column chromatography. The protein purity is determined by SDS-PAGE and shows total reduction upon incubation with 2-mercaptoethanol. Protein C is activated to the serine protease, Activated Protein C (APC), by a-thrombin or the complex of a-thrombin/thrombomodulin and is a potent anticoagulant through the selective inactivation of Factors Va and VIIIa.Purified from fresh frozen human plasma using a combination of salt precipitations and column chromatography. The protein purity is determined by SDS-PAGE and shows total reduction upon incubation with 2-mercaptoethanol. Protein C is activated to the serine protease, Activated Protein C (APC), by a-thrombin or the complex of a-thrombin/thrombomodulin and is a potent anticoagulant through the selective inactivation of Factors Va and VIIIa.

Prepared from fresh frozen human plasma. Human Prothrombin is a glycoprotein of molecular weight 72,000, and consists of a single polypeptide chain. Activation of Prothrombin by Factor Va, Xa and phospholipids yields the serine protease Thrombin. Prothrombin purity is determined by SDS-PAGE and shows no reduction upon incubation with 2-mercaptoethanol.Prepared from fresh frozen human plasma. Human Prothrombin is a glycoprotein of molecular weight 72,000, and consists of a single polypeptide chain. Activation of Prothrombin by Factor Va, Xa and phospholipids yields the serine protease Thrombin. Prothrombin purity is determined by SDS-PAGE and shows no reduction upon incubation with 2-mercaptoethanol.

Prepared from fresh frozen human plasma. Human Factor XI is a two-chain glycoprotein with molecular weight of 160,000 daltons.  The two chains are identical disulfide bonded polypeptides with molecular weights of 80,000 daltons.  Factor XI is activated to Factor XIa by Factor Xlla. Purity of Factor XI is assessed by SDS-PAGE.  Activity is determined by clotting assay.Prepared from fresh frozen human plasma. Human Factor XI is a two-chain glycoprotein with molecular weight of 160,000 daltons.  The two chains are identical disulfide bonded polypeptides with molecular weights of 80,000 daltons.  Factor XI is activated to Factor XIa by Factor Xlla. Purity of Factor XI is assessed by SDS-PAGE.  Activity is determined by clotting assay.Prepared from fresh frozen human plasma. The purity of this Vitamin K dependent protein is determined by SDS-PAGE  and shows total reduction upon incubation with 2-mercaptoethanol. Activity is determined via clotting assay. Human Factor X, once activated via the Contact Factor Pathway or the Tissue Factor Pathway, is responsible for the conversion of Prothrombin to Thrombin.

Activated Protein C (APC) is a serine protease derived from the two chain vitamin K dependent zymogen, Protein C. APC inhibits blood coagulation through the selective inactivation of the cofactors Va and VIIIa. APC is prepared from protein C by activation with purified thrombin. This thrombin is removed after activation by ion exchange chromatography. Activated Protein C purity is determined by SDS-PAGE and shows complete reduction upon incubation with 2-mercaptoethanol.Activated Protein C (APC) is a serine protease derived from the two chain vitamin K dependent zymogen, Protein C. APC inhibits blood coagulation through the selective inactivation of the cofactors Va and VIIIa. APC is prepared from protein C by activation with purified thrombin. This thrombin is removed after activation by ion exchange chromatography. Activated Protein C purity is determined by SDS-PAGE and shows complete reduction upon incubation with 2-mercaptoethanol.

Prepared from purified Human Factor VII using Human Factor XIIa. The Factor Xlla is removed using affinity chromatography. Purity is determined by SDS-PAGE. Human Factor VIIa reduces to 29,500 and 23,500 with the addition of 2-mercaptoethanol. Activity is determined via clotting assay.  Factor Vlla, in the presence of calcium ions and Tissue factor, activates Factors IX and X to their enzymatically active forms, Factor IXa and Xa.Prepared from purified Human Factor VII using Human Factor XIIa. The Factor Xlla is removed using affinity chromatography. Purity is determined by SDS-PAGE. Human Factor VIIa reduces to 29,500 and 23,500 with the addition of 2-mercaptoethanol. Activity is determined via clotting assay.  Factor Vlla, in the presence of calcium ions and Tissue factor, activates Factors IX and X to their enzymatically active forms, Factor IXa and Xa.

LMW Kininogn is involved in blood pressure regulation since it is an endogenous protein substrate for tissue kallikrein. Proteolytic cleavage by kallikrein releases vasoactive bradykinin from LMW kininogen. In addition, LMW kininogen, like HMW kininogen, is a major extracellular cysteine protease inhibitor. Prepared from plasma shown to be non reactive for HbsAG, anti-HCV, anti-HBc, and negative for anti-HIV 1 &amp; 2 by FDA approved tests. 95percent pure by SDS-PAGE. Add deionized water to original volume, aliquot and freeze unused portion.High Molecular Weight Kininogen (HK) is a nonenzymatic cofactor of the contact activation system. HK is thought to have two functions in the contact activation system. First, HK links prekallikrein to a negatively charged surface thereby allowing activation to kallikrein by surface bound Factor -Xlla. HK also forms a complex with Factor XI and accelerates its activation to XIa by -Xlla. Also HK serves as a source of Bradykinin, a potent Vasoactive peptide important in hypotension studies. The protein purity is determined by SDS-PAGE

Human Factor XIII is a tetramer composed of two pairs of chains held together by noncovalent bonds. After activation of the zymogen via Thrombin to its active enzyme form, Factor XIIIa is responsible for catalyzing the formation of covalent bridges between fibrin units to increase the elasticity of the clot network. The resulting cross-linked fibrin is very insoluble and resistant to lysis.Human Factor XIII is a tetramer composed of two pairs of chains held together by noncovalent bonds. After activation of the zymogen via Thrombin to its active enzyme form, Factor XIIIa is responsible for catalyzing the formation of covalent bridges between fibrin units to increase the elasticity of the clot network. The resulting cross-linked fibrin is very insoluble and resistant to lysis.

Our Activated Protein C is inactivated using PPACK, Dihydrochloride and is removed via gelfiltration. The above protein was purified from Human plasma that was tested and foundnegative by FDA accepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV,Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA. Donors arescreened for CJD (Creutzfeldt-Jakob Disease)

Prepared from Bovine Factor IX by activation with Bovine Factor Xla, this Bovine Factor Xla is removed after activation. Complete activation is observed by SDS-PAGE. The Factor Xla activates FIX in a two-step reaction. In the first step, an internal Arg-Ala bond is cleaved, and in the second step, an Arg-Val bond is cleaved. The second cleavage leads to the liberation of an activation peptide from the NH2-terminal portion of the heavy chain to produce factor IXaβ.

Purified from freshly collected bovine plasma using a combination of salt precipitations and column chromatography. This protein is a mixture of Factor V/Va and intermediate activation products as judged by 4-20% gradient gels. Bovine Factor Va functions as a cofactor with the serine protease Factor Xa in the activation of prothrombin. This protein may be used as a source of V/Va in the Prothrombinase complexPurified from freshly collected bovine plasma using a combination of salt precipitations and column chromatography. This protein is a mixture of Factor V/Va and intermediate activation products as judged by 4-20% gradient gels. Bovine Factor Va functions as a cofactor with the serine protease Factor Xa in the activation of prothrombin. This protein may be used as a source of V/Va in the Prothrombinase complexInterleukin-2 (IL-2) is a O-glycosylated four alpha-helix bundle cytokine that is produced by T-cells in response to antigenic or mitogenic stimulation. IL-2 can stimulate B-cells, monocytes, lymphokine-activated killer cells, natural killer cells, and glioma cells and is required for T-cell proliferation and other activities crucial to regulation of the immune response.This Fc Fusion Protein is glycosylated and expressed as a chimera with the Fc region of mouse immunoglobulin. Fc fusion proteins are typically more stable and resistant to degradation and clearance than native cytokines. Fc fusion proteins appear as a dimer in SDS-PAGE under non-reducing conditions.Interleukin-2 (IL-2) is a O-glycosylated four alpha-helix bundle cytokine that is produced by T-cells in response to antigenic or mitogenic stimulation. IL-2 can stimulate B-cells, monocytes, lymphokine-activated killer cells, natural killer cells, and glioma cells and is required for T-cell proliferation and other activities crucial to regulation of the immune response.This Fc Fusion Protein is glycosylated and expressed as a chimera with the Fc region of mouse immunoglobulin. Fc fusion proteins are typically more stable and resistant to degradation and clearance than native cytokines. Fc fusion proteins appear as a dimer in SDS-PAGE under non-reducing conditions.Mouse Protein Z-Dependent Protease Inhibitor (ZPI), recombinantly produced in insect cells. Active and complexable with Factor XIa. This Serine Protease Inhibitor (SERPIN) requires the cofactors Protein Z, phospholipids and calcium to inhibit endogenous Factor Xa. ZPI contains a tyrosine residue at the P1 position of the reactive center loop, rather than arginine which is present in most SERPINs.Corn Trypsin Inhibitor (CTI) is a specific and potent inhibitor of human factor XIIa. It is purified from fresh Indiana sweet corn by solvent extraction and chromatographic methods. A suggested inhibitory concentration is 24 fold molar excess over the enzyme concentration. CTI purity is determined by SDS-PAGE and shows no reduction upon incubation with 2-mercaptoethanol.

Human Factor beta-XIIa is generated in vivo by kallikrein cleavage of Factor alpha-XIIa and contains the catalytic light chain and the C-terminal peptide of the heavy chain of Factor alpha-XIIa. Human Factor beta-XIIa is activated from homogeneous Human Factor XII by an autoactivation process with Dextran Sulfate followed by repurification to isolate Factor alpha-XIIa and Factor beta-XIIa. Complete activation is observed on SDS-PAGE. Factor XIIa is 95percent pure by SDS-PAGE and activity is determined via clotting assay. Prepared from plasma found negative by FDA accepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA. Donors are screened for CJD (Creutzfeldt-Jakob Disease). Human Factor beta-XIIa is generated in vivo by kallikrein cleavage of Factor alpha-XIIa and contains the catalytic light chain and the C-terminal peptide of the heavy chain of Factor alpha-XIIa. Human Factor beta-XIIa is activated from homogeneous Human Factor XII by an autoactivation process with Dextran Sulfate followed by repurification to isolate Factor alpha-XIIa and Factor beta-XIIa. Complete activation is observed on SDS-PAGE. Factor XIIa is 95percent pure by SDS-PAGE and activity is determined via clotting assay. Prepared from plasma found negative by FDA accepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA. Donors are screened for CJD (Creutzfeldt-Jakob Disease). 

The Human Plasmin was activated from homogeneous glu-plasminogen using urokinase at a500:1 molar ratio.  This urokinase was not removed after activation.  Complete activation wasobserved using the S-2251 chromogenic substrate.  The above protein was purified fromHuman plasma that was tested and found negative by FDA accepted methods for AntiHIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA,HCV RNA and HBV RNA. Donors are screened for CJD (Creutzfeldt-Jakob Disease)Purified from fresh frozen human plasma. Human Factor XII is part of the contact activation system. Human Factor XII is a single chain glycoprotein with a molecular weight of about 80,000. Once activated, principally from the action of kallikrein, Factor XII is converted into an active serine protease (Factor -Xlla) that functions in the <emin vivo</em initiation of blood coagulation, fibrinolysis, and kinin formation. Human Factor XII has been purified by ion exchange chromatography. Protein purity is determined by SDS-PAGE and activity is determined via clotting assay.Purified from fresh frozen human plasma. Human Factor XII is part of the contact activation system. Human Factor XII is a single chain glycoprotein with a molecular weight of about 80,000. Once activated, principally from the action of kallikrein, Factor XII is converted into an active serine protease (Factor -Xlla) that functions in the <emin vivo</em initiation of blood coagulation, fibrinolysis, and kinin formation. Human Factor XII has been purified by ion exchange chromatography. Protein purity is determined by SDS-PAGE and activity is determined via clotting assay.The Human Factor XIa was activated from homogeneous Human Factor XI using HumanFactor XIIa.  This XIIa was removed using a Corn Trypsin Inhibitor column.  The protein is95% pure via SDS-PAGE.  The above protein was purified from Human plasma that wastested and found negative by FDA accepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II,HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA.Donors are screened for CJD (Creutzfeldt-Jakob Disease)The Human Factor Xa beta gla domainless was prepared from HFX-GD using purified RVV-X.This RVV-X was removed after activation by gel filtration.  Complete activation was observedon SDS PAGE.  The above protein was purified from Human plasma that was tested andfound negative by FDA accepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV,Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA. Donors arescreened for CJD (Creutzfeldt-Jakob Disease)The Human Factor Xa was activated from homogeneous Human Factor X by activation withRussels' Viper Venom.  This RVV-X was removed after activation.  Complete activation isobserved via SDS-PAGE .  The purified Xa was then inactivated using GGACK.  Theinactivator was removed via dialysis. The above protein was purified from Human plasma thatwas tested and found negative by FDA accepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II,HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA.Donors are screened for CJD (Creutzfeldt-Jakob Disease)Factor X- gla domainless was prepared from purified Human Factor X using alphachymotrypsin. The alpha-chymotrypsin and all other products were removed using an anionexchange column after digestion.  The above protein was purified from Human plasma thatwas tested and found negative by FDA accepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II,HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA.Donors are screened for CJD (Creutzfeldt-Jakob Disease)The Human Factor IXab was activated from homogeneous Human Factor IX by activation with Bovine Factor XIa.  This Bovine Factor XIa is removed after activation.  Complete activation isobserved on SDS-PAGE. The IXab was then inactivated using a commercially availablechloromethylketone.  This inactivator is removed via dialysis.The human plasma used was tested and found negative by FDA accepted methods for AntiHIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA,HCV RNA and HBV RNAThe Human Activated Protein C gla domainless was prepared from purified Human APCusing Cathepsin G.  The Cathepsin G is removed using affinity chromatography afterdigestion. The above protein was purified from Human plasma that was tested and foundnegative by FDA accepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV,Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA.  Donors arescreened for CJD (Creutzfeldt-Jakob Disease)

The Human Protein C gla domainless was prepared from purified Human Protein C usingCathepsin G.  The Cathepsin G is removed using affinity chromatography after digestion. Theabove protein was purified from Human plasma that was tested and found negative by FDAaccepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA. Donors are screened for CJD (CreutzfeldtJakob Disease)The Human Protein C gla domainless was prepared from purified Human Protein C usingCathepsin G.  The Cathepsin G is removed using affinity chromatography after digestion. Theabove protein was purified from Human plasma that was tested and found negative by FDAaccepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA. Donors are screened for CJD (CreutzfeldtJakob Disease)The Human Factor VIIa gla domainless was prepared from purified Human Factor VIIa usingCathepsin G.  The Cathepsin G is removed using affinity chromatography after digestion.The above protein was purified from Human plasma that was tested and found negative byFDA accepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV, Syphilis, HBC Ab,HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA. Donors are screened for CJD(Creutzfeldt-Jakob Disease)

In the renin-angiotensin system (RAS), renin activates angiotensinogen to yield angiotensin I, which is further converted into angiotensin II by angiotensin-converting enzyme. Removal of the kidney generates renin/prorenin deficient plasma with high levels of angiotensinogen. This nephrectomized rat plasma can be used as a source of angiotensinogen or as a substrate for renin generation of Ang I. Plasma is collected from male rats at least 48 hours post nephrectomy. The substrate activity is determined by incubation with renin followed by Ang I radio-immune assay (RIA).In the renin-angiotensin system (RAS), renin activates angiotensinogen to yield angiotensin I, which is further converted into angiotensin II by angiotensin-converting enzyme. Removal of the kidney generates renin/prorenin deficient plasma with high levels of angiotensinogen. This nephrectomized rat plasma can be used as a source of angiotensinogen or as a substrate for renin generation of Ang I. Plasma is collected from male rats at least 48 hours post nephrectomy. The substrate activity is determined by incubation with renin followed by Ang I radio-immune assay (RIA).In the renin-angiotensin system (RAS), renin activates angiotensinogen to yield angiotensin I, which is further converted into angiotensin II by angiotensin-converting enzyme. Removal of the kidney generates renin/prorenin deficient plasma with high levels of angiotensinogen. This nephrectomized rat plasma can be used as a source of angiotensinogen or as a substrate for renin generation of Ang I. Plasma is collected from male rats at least 48 hours post nephrectomy. The substrate activity is determined by incubation with renin followed by Ang I radio-immune assay (RIA).In the renin-angiotensin system (RAS), renin activates angiotensinogen to yield angiotensin I, which is further converted into angiotensin II by angiotensin-converting enzyme. Removal of the kidney generates renin/prorenin deficient plasma with high levels of angiotensinogen. This nephrectomized rat plasma can be used as a source of angiotensinogen or as a substrate for renin generation of Ang I. Plasma is collected from male rats at least 48 hours post nephrectomy. The substrate activity is determined by incubation with renin followed by Ang I radio-immune assay (RIA).Recombinantly produced in HEK cell culture and purified by chelated metal affinity chromatography. Contains a 8X-Histidine tag at C terminus for purification. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminusRecombinantly produced in HEK cell culture and purified by chelated metal affinity chromatography. Contains a 8X-Histidine tag at C terminus for purification. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminusRecombinantly produced in HEK cell culture as untagged native form prorenin and purified by affinity chromatography. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus. This so called prosegment appears to block the full enzymatic potential of the active site (1). Renin activates the renin-angiotensin system by cleaving angiotensinogen, produced by the liver, to yield angiotensin I, which is further converted into angiotensin II by ACE, the angiotensin-converting enzyme primarily within the capillaries of the lungs. It has been reported that the levels of circulating prorenin (but not renin) are increased in diabetic subjects(2).Recombinantly produced in HEK cell culture as untagged native form prorenin and purified by affinity chromatography. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus. This so called prosegment appears to block the full enzymatic potential of the active site (1). Renin activates the renin-angiotensin system by cleaving angiotensinogen, produced by the liver, to yield angiotensin I, which is further converted into angiotensin II by ACE, the angiotensin-converting enzyme primarily within the capillaries of the lungs. It has been reported that the levels of circulating prorenin (but not renin) are increased in diabetic subjects(2).

Recombinantly produced in HEK cell culture and purified by chelated metal affinity chromatography. Contains a 8X-Histidine tag at C terminus for purification. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus. This so called prosegment appears to block the full enzymatic potential of the active site (1). Renin activates the renin-angiotensin system by cleaving angiotensinogen, produced by the liver, to yield angiotensin I, which is further converted into angiotensin II by ACE, the angiotensin-converting enzyme primarily within the capillaries of the lungs.Recombinantly produced in HEK cell culture and purified by chelated metal affinity chromatography. Contains a 8X-Histidine tag at C terminus for purification. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus. This so called prosegment appears to block the full enzymatic potential of the active site (1). Renin activates the renin-angiotensin system by cleaving angiotensinogen, produced by the liver, to yield angiotensin I, which is further converted into angiotensin II by ACE, the angiotensin-converting enzyme primarily within the capillaries of the lungs.Recombinantly produced in HEK cell culture and purified by chelated metal affinity chromatography. Contains a 8X-Histidine tag at C terminus for purification. Resistant to activation to renin by trypsin digestion. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus.Recombinantly produced in HEK cell culture and purified by chelated metal affinity chromatography. Contains a 8X-Histidine tag at C terminus for purification. Resistant to activation to renin by trypsin digestion. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus.

Human Albumin (HSA) solubility: Albumin(s) are readily soluble in dionized water and can only preciptated by high concentrations of nuetral salts. Human Serum Albumin helps stabilize other solubilized proteins. Human Serum Albumin (HSA)is readily coagulated with heat. Human Serum Albumin(s) with other albumin(s) are acidic proteins which occur in abundance in body fluids and tissues. As a poducer, Manufacturer and supplier of finished human proteins for research and IVD manufacturing we can custom fill to your requirement.Human Albumin (HSA) solubility: Albumin(s) are readily soluble in dionized water and can only preciptated by high concentrations of nuetral salts. Human Serum Albumin helps stabilize other solubilized proteins. Human Serum Albumin (HSA)is readily coagulated with heat. Human Serum Albumin(s) with other albumin(s) are acidic proteins which occur in abundance in body fluids and tissues. As a poducer, Manufacturer and supplier of finished human proteins for research and IVD manufacturing we can custom fill to your requirement.

Prepared from fresh hamster plasma. Ideal reagent for tissue culture studies and protein-protein interactions. Thaw the fibronectin by placing the vial in a 37 C water bath and leaving it undisturbed until completely thawed. Do not disturb the vial at any time during the thawing process. If the vial is disturbed or removed prior to complete thawing, the fibronectin will form a gel and be unusable. Mix very gently with pipette after thawing. Vortexing, excessive agitation, repeated freezing and thawing of fibronectin are not recommended.

Prepared from fresh mouse plasma. Ideal reagent for tissue culture studies and protein-protein interactions. Thaw the fibronectin by placing the vial in a 37 C water bath and leaving it undisturbed until completely thawed. Do not disturb the vial at any time during the thawing process. If the vial is disturbed or removed prior to complete thawing, the fibronectin will form a gel and be unusable. Mix very gently with pipette after thawing. Vortexing, excessive agitation, repeated freezing and thawing of fibronectin are not recommended. 

Heparin cofactor II (HCII) (heparin cofactor A, antithrombin BM, dermatan sulfate cofactor, human leuserpin-2) is a single chain glycoprotein (Mr=65,600, 10% carbohydrate) member of the serine protease inhibitor (serpin) family (1-3). Amino acid sequence analysis of heparin cofactor II reveals 3 potential N-glycosylation sites and 2 sulfated tyrosines located in two internal repeats of 7 residues located near the NH2-terminal (4-6). The plasma concentration is estimated to be 90Activation of Prekallikrein with Factor a-XIIa produces the enzymatically active Kallikrein. Kallikrein is a serine protease which consists of a heavy chain (Mr 52kD) and light chains (Mr either 36 or 33 kD) linked by disulfide bridges. Kallikrein possesses enzymatic activity toward Factor XII, HK, Plasminogen, Factors XI, IX, and VII, prorenin and the complement system. After activation, the activating enzyme Factor XIIa is removed by affinity chromatography. Human Kallikrein purity is determined by SDS-PAGE and shows complete reduction upon incubation with 2-mercaptoethanol.

Human Factor XIIa is a serine protease responsible for the activation of Factor XI to XIa in the contact activation system. Human Factor XII and prekallikrein are thought to be involved in a reciprocal activation mechanism in which Factor XIIa activates prekallikrein to kallikrein, which in turn converts Factor XII to XIIa. Factor XIIa activates Factor XI to XIa thereby triggering the Contact Factor cascade. ERL offers Factor ?-XIIa which is activated by the autoactivation process with Dextran Sulfate and re-purified to remove the activator. The protein purity is determined by SDS-PAGE and activity is determined via clotting assay.Human Factor XIIa is a serine protease responsible for the activation of Factor XI to XIa in the contact activation system. Human Factor XII and prekallikrein are thought to be involved in a reciprocal activation mechanism in which Factor XIIa activates prekallikrein to kallikrein, which in turn converts Factor XII to XIIa. Factor XIIa activates Factor XI to XIa thereby triggering the Contact Factor cascade. ERL offers Factor ?-XIIa which is activated by the autoactivation process with Dextran Sulfate and re-purified to remove the activator. The protein purity is determined by SDS-PAGE and activity is determined via clotting assay.

Activated Protein C (APC) is a serine protease derived from the two chain vitamin K dependent zymogen, Protein C. APC inhibits blood coagulation through the selective inactivation of the cofactors Va and VIIIa. APC is prepared from protein C by activation with purified thrombin. This thrombin is removed after activation by ion exchange chromatography. Activated Protein C purity is determined by SDS-PAGE and shows complete reduction upon incubation with 2-mercaptoethanol.Activated Protein C (APC) is a serine protease derived from the two chain vitamin K dependent zymogen, Protein C. APC inhibits blood coagulation through the selective inactivation of the cofactors Va and VIIIa. APC is prepared from protein C by activation with purified thrombin. This thrombin is removed after activation by ion exchange chromatography. Activated Protein C purity is determined by SDS-PAGE and shows complete reduction upon incubation with 2-mercaptoethanol.

LMW Kininogn is involved in blood pressure regulation since it is an endogenous protein substrate for tissue kallikrein. Proteolytic cleavage by kallikrein releases vasoactive bradykinin from LMW kininogen. In addition, LMW kininogen, like HMW kininogen, is a major extracellular cysteine protease inhibitor. Prepared from plasma shown to be non reactive for HbsAG, anti-HCV, anti-HBc, and negative for anti-HIV 1 &amp; 2 by FDA approved tests. 95percent pure by SDS-PAGE. Add deionized water to original volume, aliquot and freeze unused portion.High Molecular Weight Kininogen (HK) is a nonenzymatic cofactor of the contact activation system. HK is thought to have two functions in the contact activation system. First, HK links prekallikrein to a negatively charged surface thereby allowing activation to kallikrein by surface bound Factor -Xlla. HK also forms a complex with Factor XI and accelerates its activation to XIa by -Xlla. Also HK serves as a source of Bradykinin, a potent Vasoactive peptide important in hypotension studies. The protein purity is determined by SDS-PAGE

Interleukin-2 (IL-2) is a O-glycosylated four alpha-helix bundle cytokine that is produced by T-cells in response to antigenic or mitogenic stimulation. IL-2 can stimulate B-cells, monocytes, lymphokine-activated killer cells, natural killer cells, and glioma cells and is required for T-cell proliferation and other activities crucial to regulation of the immune response.This Fc Fusion Protein is glycosylated and expressed as a chimera with the Fc region of mouse immunoglobulin. Fc fusion proteins are typically more stable and resistant to degradation and clearance than native cytokines. Fc fusion proteins appear as a dimer in SDS-PAGE under non-reducing conditions.Interleukin-2 (IL-2) is a O-glycosylated four alpha-helix bundle cytokine that is produced by T-cells in response to antigenic or mitogenic stimulation. IL-2 can stimulate B-cells, monocytes, lymphokine-activated killer cells, natural killer cells, and glioma cells and is required for T-cell proliferation and other activities crucial to regulation of the immune response.This Fc Fusion Protein is glycosylated and expressed as a chimera with the Fc region of mouse immunoglobulin. Fc fusion proteins are typically more stable and resistant to degradation and clearance than native cytokines. Fc fusion proteins appear as a dimer in SDS-PAGE under non-reducing conditions.

Human Factor beta-XIIa is generated in vivo by kallikrein cleavage of Factor alpha-XIIa and contains the catalytic light chain and the C-terminal peptide of the heavy chain of Factor alpha-XIIa. Human Factor beta-XIIa is activated from homogeneous Human Factor XII by an autoactivation process with Dextran Sulfate followed by repurification to isolate Factor alpha-XIIa and Factor beta-XIIa. Complete activation is observed on SDS-PAGE. Factor XIIa is 95percent pure by SDS-PAGE and activity is determined via clotting assay. Prepared from plasma found negative by FDA accepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA. Donors are screened for CJD (Creutzfeldt-Jakob Disease). Human Factor beta-XIIa is generated in vivo by kallikrein cleavage of Factor alpha-XIIa and contains the catalytic light chain and the C-terminal peptide of the heavy chain of Factor alpha-XIIa. Human Factor beta-XIIa is activated from homogeneous Human Factor XII by an autoactivation process with Dextran Sulfate followed by repurification to isolate Factor alpha-XIIa and Factor beta-XIIa. Complete activation is observed on SDS-PAGE. Factor XIIa is 95percent pure by SDS-PAGE and activity is determined via clotting assay. Prepared from plasma found negative by FDA accepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA. Donors are screened for CJD (Creutzfeldt-Jakob Disease). 

The Human Plasmin was activated from homogeneous glu-plasminogen using urokinase at a500:1 molar ratio.  This urokinase was not removed after activation.  Complete activation wasobserved using the S-2251 chromogenic substrate.  The above protein was purified fromHuman plasma that was tested and found negative by FDA accepted methods for AntiHIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA,HCV RNA and HBV RNA. Donors are screened for CJD (Creutzfeldt-Jakob Disease)Purified from fresh frozen human plasma. Human Factor XII is part of the contact activation system. Human Factor XII is a single chain glycoprotein with a molecular weight of about 80,000. Once activated, principally from the action of kallikrein, Factor XII is converted into an active serine protease (Factor -Xlla) that functions in the <emin vivo</em initiation of blood coagulation, fibrinolysis, and kinin formation. Human Factor XII has been purified by ion exchange chromatography. Protein purity is determined by SDS-PAGE and activity is determined via clotting assay.Purified from fresh frozen human plasma. Human Factor XII is part of the contact activation system. Human Factor XII is a single chain glycoprotein with a molecular weight of about 80,000. Once activated, principally from the action of kallikrein, Factor XII is converted into an active serine protease (Factor -Xlla) that functions in the <emin vivo</em initiation of blood coagulation, fibrinolysis, and kinin formation. Human Factor XII has been purified by ion exchange chromatography. Protein purity is determined by SDS-PAGE and activity is determined via clotting assay.The Human Factor XIa was activated from homogeneous Human Factor XI using HumanFactor XIIa.  This XIIa was removed using a Corn Trypsin Inhibitor column.  The protein is95% pure via SDS-PAGE.  The above protein was purified from Human plasma that wastested and found negative by FDA accepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II,HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA.Donors are screened for CJD (Creutzfeldt-Jakob Disease)The Human Factor Xa beta gla domainless was prepared from HFX-GD using purified RVV-X.This RVV-X was removed after activation by gel filtration.  Complete activation was observedon SDS PAGE.  The above protein was purified from Human plasma that was tested andfound negative by FDA accepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV,Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA. Donors arescreened for CJD (Creutzfeldt-Jakob Disease)The Human Factor Xa was activated from homogeneous Human Factor X by activation withRussels' Viper Venom.  This RVV-X was removed after activation.  Complete activation isobserved via SDS-PAGE .  The purified Xa was then inactivated using GGACK.  Theinactivator was removed via dialysis. The above protein was purified from Human plasma thatwas tested and found negative by FDA accepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II,HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA.Donors are screened for CJD (Creutzfeldt-Jakob Disease)Factor X- gla domainless was prepared from purified Human Factor X using alphachymotrypsin. The alpha-chymotrypsin and all other products were removed using an anionexchange column after digestion.  The above protein was purified from Human plasma thatwas tested and found negative by FDA accepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II,HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA.Donors are screened for CJD (Creutzfeldt-Jakob Disease)The Human Factor IXab was activated from homogeneous Human Factor IX by activation with Bovine Factor XIa.  This Bovine Factor XIa is removed after activation.  Complete activation isobserved on SDS-PAGE. The IXab was then inactivated using a commercially availablechloromethylketone.  This inactivator is removed via dialysis.The human plasma used was tested and found negative by FDA accepted methods for AntiHIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA,HCV RNA and HBV RNAThe Human Activated Protein C gla domainless was prepared from purified Human APCusing Cathepsin G.  The Cathepsin G is removed using affinity chromatography afterdigestion. The above protein was purified from Human plasma that was tested and foundnegative by FDA accepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV,Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA.  Donors arescreened for CJD (Creutzfeldt-Jakob Disease)

The Human Protein C gla domainless was prepared from purified Human Protein C usingCathepsin G.  The Cathepsin G is removed using affinity chromatography after digestion. Theabove protein was purified from Human plasma that was tested and found negative by FDAaccepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA. Donors are screened for CJD (CreutzfeldtJakob Disease)The Human Protein C gla domainless was prepared from purified Human Protein C usingCathepsin G.  The Cathepsin G is removed using affinity chromatography after digestion. Theabove protein was purified from Human plasma that was tested and found negative by FDAaccepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA. Donors are screened for CJD (CreutzfeldtJakob Disease)The Human Factor VIIa gla domainless was prepared from purified Human Factor VIIa usingCathepsin G.  The Cathepsin G is removed using affinity chromatography after digestion.The above protein was purified from Human plasma that was tested and found negative byFDA accepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV, Syphilis, HBC Ab,HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA. Donors are screened for CJD(Creutzfeldt-Jakob Disease)

In the renin-angiotensin system (RAS), renin activates angiotensinogen to yield angiotensin I, which is further converted into angiotensin II by angiotensin-converting enzyme. Removal of the kidney generates renin/prorenin deficient plasma with high levels of angiotensinogen. This nephrectomized rat plasma can be used as a source of angiotensinogen or as a substrate for renin generation of Ang I. Plasma is collected from male rats at least 48 hours post nephrectomy. The substrate activity is determined by incubation with renin followed by Ang I radio-immune assay (RIA).In the renin-angiotensin system (RAS), renin activates angiotensinogen to yield angiotensin I, which is further converted into angiotensin II by angiotensin-converting enzyme. Removal of the kidney generates renin/prorenin deficient plasma with high levels of angiotensinogen. This nephrectomized rat plasma can be used as a source of angiotensinogen or as a substrate for renin generation of Ang I. Plasma is collected from male rats at least 48 hours post nephrectomy. The substrate activity is determined by incubation with renin followed by Ang I radio-immune assay (RIA).In the renin-angiotensin system (RAS), renin activates angiotensinogen to yield angiotensin I, which is further converted into angiotensin II by angiotensin-converting enzyme. Removal of the kidney generates renin/prorenin deficient plasma with high levels of angiotensinogen. This nephrectomized rat plasma can be used as a source of angiotensinogen or as a substrate for renin generation of Ang I. Plasma is collected from male rats at least 48 hours post nephrectomy. The substrate activity is determined by incubation with renin followed by Ang I radio-immune assay (RIA).In the renin-angiotensin system (RAS), renin activates angiotensinogen to yield angiotensin I, which is further converted into angiotensin II by angiotensin-converting enzyme. Removal of the kidney generates renin/prorenin deficient plasma with high levels of angiotensinogen. This nephrectomized rat plasma can be used as a source of angiotensinogen or as a substrate for renin generation of Ang I. Plasma is collected from male rats at least 48 hours post nephrectomy. The substrate activity is determined by incubation with renin followed by Ang I radio-immune assay (RIA).

Recombinantly produced in HEK cell culture as untagged native form prorenin and purified by affinity chromatography. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus. This so called prosegment appears to block the full enzymatic potential of the active site (1). Renin activates the renin-angiotensin system by cleaving angiotensinogen, produced by the liver, to yield angiotensin I, which is further converted into angiotensin II by ACE, the angiotensin-converting enzyme primarily within the capillaries of the lungs. It has been reported that the levels of circulating prorenin (but not renin) are increased in diabetic subjects(2).Recombinantly produced in HEK cell culture as untagged native form prorenin and purified by affinity chromatography. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus. This so called prosegment appears to block the full enzymatic potential of the active site (1). Renin activates the renin-angiotensin system by cleaving angiotensinogen, produced by the liver, to yield angiotensin I, which is further converted into angiotensin II by ACE, the angiotensin-converting enzyme primarily within the capillaries of the lungs. It has been reported that the levels of circulating prorenin (but not renin) are increased in diabetic subjects(2).

Recombinantly produced in HEK cell culture and purified by chelated metal affinity chromatography. Contains a 8X-Histidine tag at C terminus for purification. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus. This so called prosegment appears to block the full enzymatic potential of the active site (1). Renin activates the renin-angiotensin system by cleaving angiotensinogen, produced by the liver, to yield angiotensin I, which is further converted into angiotensin II by ACE, the angiotensin-converting enzyme primarily within the capillaries of the lungs.Recombinantly produced in HEK cell culture and purified by chelated metal affinity chromatography. Contains a 8X-Histidine tag at C terminus for purification. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus. This so called prosegment appears to block the full enzymatic potential of the active site (1). Renin activates the renin-angiotensin system by cleaving angiotensinogen, produced by the liver, to yield angiotensin I, which is further converted into angiotensin II by ACE, the angiotensin-converting enzyme primarily within the capillaries of the lungs.

Activation of Prekallikrein with Factor a-XIIa produces the enzymatically active Kallikrein. Kallikrein is a serine protease which consists of a heavy chain (Mr 52kD) and light chains (Mr either 36 or 33 kD) linked by disulfide bridges. Kallikrein possesses enzymatic activity toward Factor XII, HK, Plasminogen, Factors XI, IX, and VII, prorenin and the complement system. After activation, the activating enzyme Factor XIIa is removed by affinity chromatography. Human Kallikrein purity is determined by SDS-PAGE and shows complete reduction upon incubation with 2-mercaptoethanol.

Human Factor XIIa is a serine protease responsible for the activation of Factor XI to XIa in the contact activation system. Human Factor XII and prekallikrein are thought to be involved in a reciprocal activation mechanism in which Factor XIIa activates prekallikrein to kallikrein, which in turn converts Factor XII to XIIa. Factor XIIa activates Factor XI to XIa thereby triggering the Contact Factor cascade. ERL offers Factor ?-XIIa which is activated by the autoactivation process with Dextran Sulfate and re-purified to remove the activator. The protein purity is determined by SDS-PAGE and activity is determined via clotting assay.Human Factor XIIa is a serine protease responsible for the activation of Factor XI to XIa in the contact activation system. Human Factor XII and prekallikrein are thought to be involved in a reciprocal activation mechanism in which Factor XIIa activates prekallikrein to kallikrein, which in turn converts Factor XII to XIIa. Factor XIIa activates Factor XI to XIa thereby triggering the Contact Factor cascade. ERL offers Factor ?-XIIa which is activated by the autoactivation process with Dextran Sulfate and re-purified to remove the activator. The protein purity is determined by SDS-PAGE and activity is determined via clotting assay.

Interleukin-2 (IL-2) is a O-glycosylated four alpha-helix bundle cytokine that is produced by T-cells in response to antigenic or mitogenic stimulation. IL-2 can stimulate B-cells, monocytes, lymphokine-activated killer cells, natural killer cells, and glioma cells and is required for T-cell proliferation and other activities crucial to regulation of the immune response.This Fc Fusion Protein is glycosylated and expressed as a chimera with the Fc region of mouse immunoglobulin. Fc fusion proteins are typically more stable and resistant to degradation and clearance than native cytokines. Fc fusion proteins appear as a dimer in SDS-PAGE under non-reducing conditions.Interleukin-2 (IL-2) is a O-glycosylated four alpha-helix bundle cytokine that is produced by T-cells in response to antigenic or mitogenic stimulation. IL-2 can stimulate B-cells, monocytes, lymphokine-activated killer cells, natural killer cells, and glioma cells and is required for T-cell proliferation and other activities crucial to regulation of the immune response.This Fc Fusion Protein is glycosylated and expressed as a chimera with the Fc region of mouse immunoglobulin. Fc fusion proteins are typically more stable and resistant to degradation and clearance than native cytokines. Fc fusion proteins appear as a dimer in SDS-PAGE under non-reducing conditions.

Human Factor beta-XIIa is generated in vivo by kallikrein cleavage of Factor alpha-XIIa and contains the catalytic light chain and the C-terminal peptide of the heavy chain of Factor alpha-XIIa. Human Factor beta-XIIa is activated from homogeneous Human Factor XII by an autoactivation process with Dextran Sulfate followed by repurification to isolate Factor alpha-XIIa and Factor beta-XIIa. Complete activation is observed on SDS-PAGE. Factor XIIa is 95percent pure by SDS-PAGE and activity is determined via clotting assay. Prepared from plasma found negative by FDA accepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA. Donors are screened for CJD (Creutzfeldt-Jakob Disease). Human Factor beta-XIIa is generated in vivo by kallikrein cleavage of Factor alpha-XIIa and contains the catalytic light chain and the C-terminal peptide of the heavy chain of Factor alpha-XIIa. Human Factor beta-XIIa is activated from homogeneous Human Factor XII by an autoactivation process with Dextran Sulfate followed by repurification to isolate Factor alpha-XIIa and Factor beta-XIIa. Complete activation is observed on SDS-PAGE. Factor XIIa is 95percent pure by SDS-PAGE and activity is determined via clotting assay. Prepared from plasma found negative by FDA accepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA. Donors are screened for CJD (Creutzfeldt-Jakob Disease). 

The Human Factor Xa was activated from homogeneous Human Factor X by activation withRussels' Viper Venom.  This RVV-X was removed after activation.  Complete activation isobserved via SDS-PAGE .  The purified Xa was then inactivated using GGACK.  Theinactivator was removed via dialysis. The above protein was purified from Human plasma thatwas tested and found negative by FDA accepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II,HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA.Donors are screened for CJD (Creutzfeldt-Jakob Disease)

Recombinantly produced in HEK cell culture as untagged native form prorenin and purified by affinity chromatography. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus. This so called prosegment appears to block the full enzymatic potential of the active site (1). Renin activates the renin-angiotensin system by cleaving angiotensinogen, produced by the liver, to yield angiotensin I, which is further converted into angiotensin II by ACE, the angiotensin-converting enzyme primarily within the capillaries of the lungs. It has been reported that the levels of circulating prorenin (but not renin) are increased in diabetic subjects(2).Recombinantly produced in HEK cell culture as untagged native form prorenin and purified by affinity chromatography. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus. This so called prosegment appears to block the full enzymatic potential of the active site (1). Renin activates the renin-angiotensin system by cleaving angiotensinogen, produced by the liver, to yield angiotensin I, which is further converted into angiotensin II by ACE, the angiotensin-converting enzyme primarily within the capillaries of the lungs. It has been reported that the levels of circulating prorenin (but not renin) are increased in diabetic subjects(2).

Recombinantly produced in HEK cell culture and purified by chelated metal affinity chromatography. Contains a 8X-Histidine tag at C terminus for purification. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus. This so called prosegment appears to block the full enzymatic potential of the active site (1). Renin activates the renin-angiotensin system by cleaving angiotensinogen, produced by the liver, to yield angiotensin I, which is further converted into angiotensin II by ACE, the angiotensin-converting enzyme primarily within the capillaries of the lungs.Recombinantly produced in HEK cell culture and purified by chelated metal affinity chromatography. Contains a 8X-Histidine tag at C terminus for purification. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus. This so called prosegment appears to block the full enzymatic potential of the active site (1). Renin activates the renin-angiotensin system by cleaving angiotensinogen, produced by the liver, to yield angiotensin I, which is further converted into angiotensin II by ACE, the angiotensin-converting enzyme primarily within the capillaries of the lungs.

Human Factor beta-XIIa is generated in vivo by kallikrein cleavage of Factor alpha-XIIa and contains the catalytic light chain and the C-terminal peptide of the heavy chain of Factor alpha-XIIa. Human Factor beta-XIIa is activated from homogeneous Human Factor XII by an autoactivation process with Dextran Sulfate followed by repurification to isolate Factor alpha-XIIa and Factor beta-XIIa. Complete activation is observed on SDS-PAGE. Factor XIIa is 95percent pure by SDS-PAGE and activity is determined via clotting assay. Prepared from plasma found negative by FDA accepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA. Donors are screened for CJD (Creutzfeldt-Jakob Disease). Human Factor beta-XIIa is generated in vivo by kallikrein cleavage of Factor alpha-XIIa and contains the catalytic light chain and the C-terminal peptide of the heavy chain of Factor alpha-XIIa. Human Factor beta-XIIa is activated from homogeneous Human Factor XII by an autoactivation process with Dextran Sulfate followed by repurification to isolate Factor alpha-XIIa and Factor beta-XIIa. Complete activation is observed on SDS-PAGE. Factor XIIa is 95percent pure by SDS-PAGE and activity is determined via clotting assay. Prepared from plasma found negative by FDA accepted methods for Anti-HIV1/2, Anti-HTLV I &amp; II, HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA. Donors are screened for CJD (Creutzfeldt-Jakob Disease). 

Recombinantly produced in HEK cell culture as untagged native form prorenin and purified by affinity chromatography. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus. This so called prosegment appears to block the full enzymatic potential of the active site (1). Renin activates the renin-angiotensin system by cleaving angiotensinogen, produced by the liver, to yield angiotensin I, which is further converted into angiotensin II by ACE, the angiotensin-converting enzyme primarily within the capillaries of the lungs. It has been reported that the levels of circulating prorenin (but not renin) are increased in diabetic subjects(2).Recombinantly produced in HEK cell culture as untagged native form prorenin and purified by affinity chromatography. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus. This so called prosegment appears to block the full enzymatic potential of the active site (1). Renin activates the renin-angiotensin system by cleaving angiotensinogen, produced by the liver, to yield angiotensin I, which is further converted into angiotensin II by ACE, the angiotensin-converting enzyme primarily within the capillaries of the lungs. It has been reported that the levels of circulating prorenin (but not renin) are increased in diabetic subjects(2).

Recombinantly produced in HEK cell culture and purified by chelated metal affinity chromatography. Contains a 8X-Histidine tag at C terminus for purification. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus. This so called prosegment appears to block the full enzymatic potential of the active site (1). Renin activates the renin-angiotensin system by cleaving angiotensinogen, produced by the liver, to yield angiotensin I, which is further converted into angiotensin II by ACE, the angiotensin-converting enzyme primarily within the capillaries of the lungs.Recombinantly produced in HEK cell culture and purified by chelated metal affinity chromatography. Contains a 8X-Histidine tag at C terminus for purification. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus. This so called prosegment appears to block the full enzymatic potential of the active site (1). Renin activates the renin-angiotensin system by cleaving angiotensinogen, produced by the liver, to yield angiotensin I, which is further converted into angiotensin II by ACE, the angiotensin-converting enzyme primarily within the capillaries of the lungs.

Recombinantly produced in HEK cell culture as untagged native form prorenin and purified by affinity chromatography. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus. This so called prosegment appears to block the full enzymatic potential of the active site (1). Renin activates the renin-angiotensin system by cleaving angiotensinogen, produced by the liver, to yield angiotensin I, which is further converted into angiotensin II by ACE, the angiotensin-converting enzyme primarily within the capillaries of the lungs. It has been reported that the levels of circulating prorenin (but not renin) are increased in diabetic subjects(2).Recombinantly produced in HEK cell culture as untagged native form prorenin and purified by affinity chromatography. Fully activatable to renin by catalytic amounts of trypsin. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin which is generated from prorenin by proteolytic cleavage of the first ~43 amino acids at the N-terminus. This so called prosegment appears to block the full enzymatic potential of the active site (1). Renin activates the renin-angiotensin system by cleaving angiotensinogen, produced by the liver, to yield angiotensin I, which is further converted into angiotensin II by ACE, the angiotensin-converting enzyme primarily within the capillaries of the lungs. It has been reported that the levels of circulating prorenin (but not renin) are increased in diabetic subjects(2).